Citrus Sinensis ID: 006317
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 650 | 2.2.26 [Sep-21-2011] | |||||||
| Q8H199 | 658 | Cysteine-rich receptor-li | yes | no | 0.970 | 0.958 | 0.495 | 0.0 | |
| Q9ZP16 | 667 | Cysteine-rich receptor-li | no | no | 0.950 | 0.926 | 0.510 | 1e-178 | |
| Q9LDQ3 | 669 | Putative cysteine-rich re | no | no | 0.966 | 0.938 | 0.477 | 1e-177 | |
| Q9LDT0 | 700 | Putative cysteine-rich re | no | no | 0.987 | 0.917 | 0.481 | 1e-175 | |
| Q9T0J1 | 665 | Cysteine-rich receptor-li | no | no | 0.921 | 0.900 | 0.504 | 1e-172 | |
| O65468 | 676 | Cysteine-rich receptor-li | no | no | 0.956 | 0.920 | 0.489 | 1e-169 | |
| O65472 | 690 | Putative cysteine-rich re | no | no | 0.970 | 0.914 | 0.475 | 1e-169 | |
| O65476 | 662 | Putative cysteine-rich re | no | no | 0.976 | 0.959 | 0.472 | 1e-167 | |
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.94 | 0.913 | 0.484 | 1e-167 | |
| Q8L710 | 686 | Cysteine-rich receptor-li | no | no | 0.983 | 0.931 | 0.488 | 1e-166 |
| >sp|Q8H199|CRK14_ARATH Cysteine-rich receptor-like protein kinase 14 OS=Arabidopsis thaliana GN=CRK14 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 634 bits (1634), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 323/652 (49%), Positives = 429/652 (65%), Gaps = 21/652 (3%)
Query: 8 LTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALCRG 67
+ S Q C TG F S Y NR L LSSL S V+A GFY ++IGQ PD VY L +C
Sbjct: 19 VVSAQECGKTGFFVPQSRYETNRGLLLSSLPSNVSARGGFYNSSIGQGPDRVYALGMCIE 78
Query: 68 DSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEIAH 127
+ P+ C+ C+ + ++ C NQ E ++W C+VRYS+ SFFG L+ +P H
Sbjct: 79 GAEPDVCSDCIEYASNLLLDTCLNQTEGLAWPEKRILCMVRYSNSSFFGSLKAEPHFYIH 138
Query: 128 NVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKF-ATDEANLTSSETIYALMQCTPDI 186
NV++ITS+LT+FD++W L R++A + +SK K+ A D A LT+ + IYALMQCTPD+
Sbjct: 139 NVDDITSNLTEFDQVWEELARRMIASTTSPSSKRKYYAADVAALTAFQIIYALMQCTPDL 198
Query: 187 SQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATAD-SLSPSPLSP-- 243
S DC CLRQS+ D ++CC GK+G + SC+FRWE++PF A + SL+P P SP
Sbjct: 199 SLEDCHICLRQSVGDYETCCNGKQGGIVYRASCVFRWELFPFSEAFSRISLAPPPQSPAF 258
Query: 244 PSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRKA 303
P+ T A KG +IS G V I++ T + ++ + V RRRK Q +
Sbjct: 259 PTLPAVTNTATKKGSITISIGIVWAIIIPTVIVVFLVLLALGFVVYRRRKSYQG----SS 314
Query: 304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG 363
+I SLQFDF I DATN FS N +G+GGFG V+ G L +G E+A+KRLSK S QG
Sbjct: 315 TDITITHSLQFDFKAIEDATNKFSESNIIGRGGFGEVFMGVL-NGTEVAIKRLSKASRQG 373
Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423
EFKNEV++VA+L HRNLV+LLGF E E++L+YEFVPN S+D F+FD K+ QLDW
Sbjct: 374 AREFKNEVVVVAKLHHRNLVKLLGFCLEGEEKILVYEFVPNKSLDYFLFDPTKQGQLDWT 433
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
RY II GI RGILYLH+DSRL IIHRDLKASNILLDADM PKI+DFGMAR+F +DQS
Sbjct: 434 KRYNIIRGITRGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGIDQSGA 493
Query: 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF--RIGEEAEDLLT 541
+T +I GT GYM PEYV +G FS +SDV+SFGVLVLEII G +NN F + E+L+T
Sbjct: 494 NTKKIAGTRGYMPPEYVRQGQFSTRSDVYSFGVLVLEIICG-RNNRFIHQSDTTVENLVT 552
Query: 542 YAWKNWNEGTALNLIDPTL-RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSS 600
YAW+ W + L L+DPT+ N + E+ RC+HI LLCVQ N +RP+++++ +ML ++S
Sbjct: 553 YAWRLWRNDSPLELVDPTISENCETEEVTRCIHIALLCVQHNPTDRPSLSTINMMLINNS 612
Query: 601 LSLPLPSQPAFFMH--STMEQDNLEFTSSDQSKSGSIHFTVNEVTISELDPR 650
LP P QP FF S E+D L+ + + T+N+VTI++ +PR
Sbjct: 613 YVLPDPQQPGFFFPIISNQERDGLDSMNRSNPQ------TINDVTITDFEPR 658
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9ZP16|CRK11_ARATH Cysteine-rich receptor-like protein kinase 11 OS=Arabidopsis thaliana GN=CRK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 625 bits (1611), Expect = e-178, Method: Compositional matrix adjust.
Identities = 325/637 (51%), Positives = 420/637 (65%), Gaps = 19/637 (2%)
Query: 10 SGQTCY-DTGNFTTNSTYGKNRDLFLSSLASTVTANKG-FYTATIGQIPDEVYGLALCRG 67
S QTC D G F N TY NR L LSSL S VT G +Y +IGQ P+ VY + +C
Sbjct: 23 SAQTCTTDKGTFRPNGTYDVNRRLILSSLPSNVTDQDGLYYNGSIGQQPNRVYAIGMCIP 82
Query: 68 DSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEIAH 127
S+ E C+ C+ +KNCPNQ EA SW G C VRYS+ SF G +L P
Sbjct: 83 GSTSEDCSDCIKKESEFFLKNCPNQTEAYSWPGEPTLCYVRYSNTSFSGSADLNPRNWLT 142
Query: 128 NVNNITSSLTQFDRIWRSLMDRVL-----AKASLGTSKLKFATDEANLTSSETIYALMQC 182
N ++ S+LT+F +IW LM R++ AK++ +S ++ D A LT IYALMQC
Sbjct: 143 NTGDLDSNLTEFTKIWEGLMGRMISAASTAKSTPSSSDNHYSADSAVLTPLLNIYALMQC 202
Query: 183 TPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLS 242
TPD+S DCE CLRQS D QSCC K+G +M PSC RW++Y + A D+L+ +
Sbjct: 203 TPDLSSGDCENCLRQSAIDYQSCCSQKRGGVVMRPSCFLRWDLYTYSNA-FDNLTVASPP 261
Query: 243 PPSTTTDTTIAKDKGG------NSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQ 296
P T A D+ IS+G VV I V T I+ L+ L V RRRK Q
Sbjct: 262 PEPPVTVPQPAGDQDNPTNNDSKGISAGVVVAITVPTVIAILILLVL-GFVLFRRRKSYQ 320
Query: 297 KQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRL 356
+ +I+T +SL +DF TI ATN FST NKLG+GGFGAVYKG+LS+G ++AVKRL
Sbjct: 321 RTKTESESDISTTDSLVYDFKTIEAATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRL 380
Query: 357 SKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIK 416
SK S QG EF+NE +LV +LQHRNLVRLLGF E E++LIYEFV N S+D F+FD K
Sbjct: 381 SKKSGQGTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEK 440
Query: 417 RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476
+ QLDW RYKIIGGIARGILYLH+DSRL+IIHRDLKASNILLDADM PKI+DFG+A +F
Sbjct: 441 QSQLDWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGLATIF 500
Query: 477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE- 535
++Q+QG+T+RI GT+ YM+PEY G +S+KSD++SFGVLVLEIISG+KN+ +E
Sbjct: 501 GVEQTQGNTNRIAGTYAYMSPEYAMHGQYSMKSDIYSFGVLVLEIISGKKNSGVYQMDET 560
Query: 536 --AEDLLTYAWKNWNEGTALNLIDPTL-RNGSSSEIMRCVHIGLLCVQENVANRPTMASV 592
A +L+TYA + W + L L+DPT RN S+E+ RC+HI LLCVQEN +RP ++++
Sbjct: 561 STAGNLVTYASRLWRNKSPLELVDPTFGRNYQSNEVTRCIHIALLCVQENPEDRPMLSTI 620
Query: 593 VVMLNSSSLSLPLPSQPAFFMHSTMEQDNLEFTSSDQ 629
++ML S++++LP+P P FF S + E + SDQ
Sbjct: 621 ILMLTSNTITLPVPRLPGFFPRSRQLKLVSEGSESDQ 657
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 621 bits (1602), Expect = e-177, Method: Compositional matrix adjust.
Identities = 324/678 (47%), Positives = 448/678 (66%), Gaps = 50/678 (7%)
Query: 1 MLLSIIRLTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVY 60
L+S+ +T+ + C+ +G F NSTY NR LS+L+S VT++ GF+ + GQ P+ V+
Sbjct: 14 FLISLDSVTAQEICF-SGFFKPNSTYDLNRRQILSTLSSNVTSHNGFFNSKFGQAPNRVF 72
Query: 61 GLALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLEL 120
+C + PE+C+ C+ + ++CPN+ +A +W C+VRYS+ SF G L +
Sbjct: 73 INGMCIPGTKPETCSDCIKGASDKISESCPNKTDAYTWPDC---CMVRYSNVSFSGSLVM 129
Query: 121 KPTEIAHNVNNIT---SSLTQFDRIWRSLMDRVLAKASLGT------SKLKFATDEANLT 171
+P+E ++ +I ++LT FDRIW LM R + ASL + + FA + A+LT
Sbjct: 130 EPSETLYHTGDIEDTGTNLTVFDRIWEELMLRTITAASLSSSNGSSFGQKYFAAEVASLT 189
Query: 172 SSETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGA 231
+ +T+YA+MQCTPD+S DCEFCL+ S+ D +SCC GK+G ++ PSC RW++YP+ GA
Sbjct: 190 TFQTMYAMMQCTPDVSSKDCEFCLKTSVGDYESCCRGKQGGAVIRPSCFVRWDLYPYAGA 249
Query: 232 TAD----------------SLSPSPLSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTST 275
+ SL P P+S D+ +I V I+V
Sbjct: 250 FENVTFPPPPPQSLPQPPVSLIPPPVS------------DRANTTIKGIIVAIVVPIIVI 297
Query: 276 FIIALVALITCVFLRRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQG 335
+ +V L+ C RR+K + ++ DEI T SLQF F TI AT+ FS N +G+G
Sbjct: 298 LVSLVVLLVVC---RRKKSYKTTEVQATDEITTTHSLQFSFKTIEAATDKFSDSNMIGRG 354
Query: 336 GFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETER 395
GFG VY+G+LS G E+AVKRLSK S QG EFKNE +LV++LQH+NLVRLLGF E E+
Sbjct: 355 GFGEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEK 414
Query: 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKAS 455
+L+YEFVPN S+D F+FD K+ +LDW RY IIGGIARGILYLH+DSRL IIHRDLKAS
Sbjct: 415 ILVYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKAS 474
Query: 456 NILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFG 515
NILLDADM PKI+DFGMAR+F +DQSQ +T RI GTFGYM+PEY RGHFS+KSDV+SFG
Sbjct: 475 NILLDADMNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFG 534
Query: 516 VLVLEIISGQKNNSF-RIGEEAEDLLTYAWKNWNEGTALNLIDPTL-RNGSSSEIMRCVH 573
VLVLEIISG+KN+SF I + +L+T+AW+ W G+ L L+DPT+ + SSE RC+H
Sbjct: 535 VLVLEIISGKKNSSFYNIDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIH 594
Query: 574 IGLLCVQENVANRPTMASVVVMLNSSSLSLPLPSQPAFFMHS-TMEQDNLEFTSSDQSKS 632
I LLCVQE+ A+RP + ++++ML SS+ +L +P P F + +EQD +E+T +S S
Sbjct: 595 IALLCVQEDPADRPLLPAIIMMLTSSTTTLHVPRAPGFCLSGRDLEQDGVEYT---ESTS 651
Query: 633 GSIHFTVNEVTISELDPR 650
SI ++N+ +I+E PR
Sbjct: 652 RSIPGSINDASITEFYPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LDT0|CRK30_ARATH Putative cysteine-rich receptor-like protein kinase 30 OS=Arabidopsis thaliana GN=CRK30 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 617 bits (1590), Expect = e-175, Method: Compositional matrix adjust.
Identities = 318/661 (48%), Positives = 430/661 (65%), Gaps = 19/661 (2%)
Query: 3 LSIIRLTSGQTCYDT-GNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYG 61
+S+I + S Q C + G FT T+ KNR + LSSL S VTA GFY A+IG PD++Y
Sbjct: 16 VSLIIVVSAQLCSEKFGTFTPGGTFDKNRRIILSSLPSEVTAQDGFYNASIGTDPDQLYA 75
Query: 62 LALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGM-DFPCVVRYSSRSFFGKLEL 120
+ +C + + C C+ +++ CPNQ AI W G C+ RY ++ L+L
Sbjct: 76 MGMCIPGAKQKLCRDCIMDVTRQLIQTCPNQTAAIHWSGGGKTVCMARYYNQPSSRPLDL 135
Query: 121 KPTEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLK-------FATDEANLTSS 173
+ I +NV N++++LT FDR+W L+ ++ KAS + K +A DE NLT+S
Sbjct: 136 ESVSIGYNVGNLSTNLTDFDRLWERLIAHMVTKASSASIKYLSFDNSRFYAADETNLTNS 195
Query: 174 ETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGA-T 232
+ +YALMQCTPD+S S+C CL+QS+ D CC+GK+G Y+ PSCIFRW++YPF GA
Sbjct: 196 QMVYALMQCTPDVSPSNCNTCLKQSVDDYVGCCHGKQGGYVYRPSCIFRWDLYPFNGAFD 255
Query: 233 ADSLSPSPLSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRR 292
+L+P P S + T +K ++ + +VI+V + + + C R R
Sbjct: 256 LLTLAPPPSSQLQSPPPVTNKDEKTIHTGTIIGIVIVVAMVIIMALLALGVSVC---RSR 312
Query: 293 KKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIA 352
KK Q AD+I TV LQFD I AT+NF NK+GQGGFG VYKG LS+G E+A
Sbjct: 313 KKYQAFASETADDITTVGYLQFDIKDIEAATSNFLASNKIGQGGFGEVYKGTLSNGTEVA 372
Query: 353 VKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIF 412
VKRLS+ S QGELEFKNEVLLVA+LQHRNLVRLLGF+ + E++L++EFVPN S+D F+F
Sbjct: 373 VKRLSRTSDQGELEFKNEVLLVAKLQHRNLVRLLGFALQGEEKILVFEFVPNKSLDYFLF 432
Query: 413 ---DAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD 469
+ K+ QLDW RY IIGGI RG+LYLH+DSRL IIHRD+KASNILLDADM PKI+D
Sbjct: 433 GSTNPTKKGQLDWTRRYNIIGGITRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIAD 492
Query: 470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529
FGMAR F Q++ T R+VGTFGYM PEYV G FS KSDV+SFGVL+LEI+SG+KN+S
Sbjct: 493 FGMARNFRDHQTEDSTGRVVGTFGYMPPEYVAHGQFSTKSDVYSFGVLILEIVSGRKNSS 552
Query: 530 F-RIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNG-SSSEIMRCVHIGLLCVQENVANRP 587
F ++ +L+TY W+ WN ++L L+DP + E+ RC+HIGLLCVQEN NRP
Sbjct: 553 FYQMDGSVCNLVTYVWRLWNTDSSLELVDPAISGSYEKDEVTRCIHIGLLCVQENPVNRP 612
Query: 588 TMASVVVMLNSSSLSLPLPSQPAFFMHSTMEQDNLEF-TSSDQSKSGSIHFTVNEVTISE 646
++++ ML +SS++L +P P FF + E D L DQ + S+ +++ TI+
Sbjct: 613 ALSTIFQMLTNSSITLNVPQPPGFFFRNRPESDTLRRGLEPDQYNNESVTCSIDNATITT 672
Query: 647 L 647
L
Sbjct: 673 L 673
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9T0J1|CRK26_ARATH Cysteine-rich receptor-like protein kinase 26 OS=Arabidopsis thaliana GN=CRK26 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 606 bits (1562), Expect = e-172, Method: Compositional matrix adjust.
Identities = 310/614 (50%), Positives = 419/614 (68%), Gaps = 15/614 (2%)
Query: 12 QTCYD-TGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALCRGDSS 70
Q C + TGNFT N+ Y N D +SSL+S GFY ++G ++V ++ CRGD
Sbjct: 29 QICSNVTGNFTVNTPYAVNLDRLISSLSSLRRNVNGFYNISVGDSDEKVNSISQCRGDVK 88
Query: 71 PESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEIAHNVN 130
E C +C+ ++ CP QKEAI W C RYS+R+ F +LE+ P
Sbjct: 89 LEVCINCIAMAGKRLVTLCPVQKEAIIWYD---KCTFRYSNRTIFNRLEISPHTSITGTR 145
Query: 131 NITSSLTQFDRIWRSLMDRVLAKAS-LGTSKLKFATDEANLTSSETIYALMQCTPDISQS 189
N T +++ R L++ + +AS +G SK F E + S +T++ L+QCTPDIS+
Sbjct: 146 NFTGDRDSWEKSLRGLLEGLKNRASVIGRSKKNFVVGETSGPSFQTLFGLVQCTPDISEE 205
Query: 190 DCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGAT----ADSLSPSPLSPPS 245
DC +CL Q +A + SCC K GSY+M PSC+ + + FY S+ +P PP
Sbjct: 206 DCSYCLSQGIAKIPSCCDMKMGSYVMSPSCMLAYAPWRFYDPVDTDDPSSVPATPSRPPK 265
Query: 246 TTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRKADE 305
T + DK N ++ S + ++ +V L+ + LRR++ + + +E
Sbjct: 266 NETRSVTQGDK--NRGVPKALIFASASVAIVVLFIVLLVVFLKLRRKENIRNSENKHENE 323
Query: 306 INTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGEL 365
+ +S++FDFS ++DAT++FS +NKLG+GGFGAVYKG LS GQ+IAVKRLSKN+ QGE
Sbjct: 324 NISTDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAVKRLSKNAQQGET 383
Query: 366 EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETR 425
EFKNE LLVA+LQHRNLV+LLG+S E TERLL+YEF+P++S+DKFIFD I+ +L+WE R
Sbjct: 384 EFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNELEWEIR 443
Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ-SQGD 484
YKIIGG+ARG+LYLH+DSRLRIIHRDLKASNILLD +M PKI+DFGMARLF++D +Q
Sbjct: 444 YKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDIDHTTQRY 503
Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAW 544
T+RIVGTFGYMAPEYV G FS K+DV+SFGVLVLEIISG+KN+ F + DL+++AW
Sbjct: 504 TNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISGKKNSGFSSEDSMGDLISFAW 563
Query: 545 KNWNEGTALNLIDP---TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSL 601
+NW EG ALNL+D T+ + SS+ IMRC++IGLLCVQE VA RP+MASVV+ML+ ++
Sbjct: 564 RNWKEGVALNLVDKILMTMSSYSSNMIMRCINIGLLCVQEKVAERPSMASVVLMLDGHTI 623
Query: 602 SLPLPSQPAFFMHS 615
+L PS+PAFF HS
Sbjct: 624 ALSEPSKPAFFSHS 637
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 595 bits (1533), Expect = e-169, Method: Compositional matrix adjust.
Identities = 317/648 (48%), Positives = 437/648 (67%), Gaps = 26/648 (4%)
Query: 14 CYDTGNFTTNSTYGKNRDLFLSSLAS-TVTANKGFYTATIGQIPDEVYGLALCRGDSSPE 72
C + +++NSTY N LSS AS + + GF GQ PD V GL LCRGD SPE
Sbjct: 44 CPNRTTYSSNSTYSTNLKTLLSSFASRNASYSTGFQNIRAGQTPDRVTGLFLCRGDLSPE 103
Query: 73 SCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEIAHNVNNI 132
C++C+ F+V + + CPNQ+EA+ + C++RYS ++F + + I N NNI
Sbjct: 104 VCSNCVAFSVNESLTRCPNQREAVFYYE---ECILRYSHKNFLSTVTYEGELIMRNPNNI 160
Query: 133 TSSLTQFDR---IWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPDISQS 189
+S Q D+ + +S M++ +A+ S KF+T + LTS +T+Y L+QCTPD+++
Sbjct: 161 SSIQNQRDQFIDLVQSNMNQAANEAA--NSSRKFSTIKTELTSLQTLYGLVQCTPDLARQ 218
Query: 190 DCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATA-DSLSPSPLSPPSTTT 248
DC CL S+ + + G+ PSC R+E+Y FY TA + SP PL P ST
Sbjct: 219 DCFSCLTSSINRMMPLF--RIGARQFWPSCNSRYELYAFYNETAIGTPSPPPLFPGSTPP 276
Query: 249 DTTIA-KDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRKA---D 304
T+ + K GNS ++++ +AL+ FL +R KK + D
Sbjct: 277 LTSPSIPGKSGNSTVLVVAIVVLAVL-----LFIALVGYCFLAQRTKKTFDTASASEVGD 331
Query: 305 EINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGE 364
++ T +SLQ D+ TI+ ATN+F+ NK+G+GGFG VYKG S+G+E+AVKRLSKNS QGE
Sbjct: 332 DMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGE 391
Query: 365 LEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWET 424
EFK EV++VA+LQHRNLVRLLGFS + ER+L+YE++PN S+D +FD K+ QLDW
Sbjct: 392 AEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQ 451
Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
RY IIGGIARGILYLH+DSRL IIHRDLKASNILLDAD+ PKI+DFGMAR+F +DQ+Q +
Sbjct: 452 RYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDN 511
Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAW 544
TSRIVGT+GYMAPEY G FS+KSDV+SFGVLVLEIISG+KN+SF + A+DLLT+ W
Sbjct: 512 TSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLTHTW 571
Query: 545 KNWNEGTALNLIDPTLRNG-SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSL 603
+ W TAL+L+DP + N +SE++RC+HIGLLCVQE+ A RPT+++V +ML S++++L
Sbjct: 572 RLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLTSNTVTL 631
Query: 604 PLPSQPAFFMHSTMEQDNLEFTSSDQS-KSGSIHFTVNEVTISELDPR 650
P+P QP FF+ S+ +D T SDQS + S ++++ I++L PR
Sbjct: 632 PVPRQPGFFIQSSPVKDP---TDSDQSTTTKSTPASIDDELITDLYPR 676
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65472|CRK12_ARATH Putative cysteine-rich receptor-like protein kinase 12 OS=Arabidopsis thaliana GN=CRK12 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 595 bits (1533), Expect = e-169, Method: Compositional matrix adjust.
Identities = 320/673 (47%), Positives = 428/673 (63%), Gaps = 42/673 (6%)
Query: 14 CYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALCRGDSSPES 73
C +T F NSTY NR + LS L S VT++ GF+ +IGQ P+ VY + +C + ES
Sbjct: 24 CINTTYFIPNSTYDTNRRVILSLLPSNVTSHFGFFNGSIGQAPNRVYAVGMCLPGTEEES 83
Query: 74 CASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEIAHNVNNIT 133
C CL +++ C ++ A+ W C++RYS SF G EL+P +++
Sbjct: 84 CIGCLLSASNTLLETCLTEENALIWIANRTICMIRYSDTSFVGSFELEPHREFLSIHGYK 143
Query: 134 SSLTQFDRIWRSLMDRVLAKASLGT----SKLKFAT-DEANLTSSETIYALMQCTPDISQ 188
++ T+F+ +W L R++ +AS T S K+ T D A L S+T+YA+MQCTPD+S
Sbjct: 144 TNETEFNTVWSRLTQRMVQEASSSTDATWSGAKYYTADVAALPDSQTLYAMMQCTPDLSP 203
Query: 189 SDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGA-TADSLSPSPLSPPSTT 247
++C CL +S+ + QSCC G++G I+ SC FR E+YPF GA T + P PPS
Sbjct: 204 AECNLCLTESVVNYQSCCLGRQGGSIVRLSCAFRAELYPFGGAFTVMTARPLSQPPPSLI 263
Query: 248 TDTTIAKDKGGNS------ISSGTVVIIV--------VSTST--------------FIIA 279
NS I + VV+++ ST T F++
Sbjct: 264 KKGEFFAKFMSNSQEPVKMIQNLYVVVLIFYFLDSGKFSTETIAAIVVPIIVVAIIFLVL 323
Query: 280 LVALITCVFLRRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGA 339
LV ++ +F RRRK Q+ +L ++ I T+ Q DF TI AT NF+ NKLGQGGFG
Sbjct: 324 LV--LSRLFARRRKSYQEIDLDQSG-ITTLHFQQLDFKTIEVATENFAKTNKLGQGGFGE 380
Query: 340 VYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399
VYKG L +G E+AVKRLSK S QG EFKNEV+LVA+LQHRNLV+LLG+ E E++L+Y
Sbjct: 381 VYKGTLVNGTEVAVKRLSKTSEQGAQEFKNEVVLVAKLQHRNLVKLLGYCLEPEEKILVY 440
Query: 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 459
EFVPN S+D F+FD K+ QLDW RY IIGGI RGILYLH+DSRL IIHRDLKASNILL
Sbjct: 441 EFVPNKSLDYFLFDPTKQGQLDWTKRYNIIGGITRGILYLHQDSRLTIIHRDLKASNILL 500
Query: 460 DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVL 519
DADMIPKI+DFGMAR+ +DQS +T RI GTFGYM PEYV G FS+KSDV+SFGVL+L
Sbjct: 501 DADMIPKIADFGMARISGIDQSVANTKRIAGTFGYMPPEYVIHGQFSMKSDVYSFGVLIL 560
Query: 520 EIISGQKNNSFRIGE-EAEDLLTYAWKNWNEGTALNLIDPTL-RNGSSSEIMRCVHIGLL 577
EII G+KN SF + +AE+L+TY W+ W G+ L L+D T+ N + E++RC+HI LL
Sbjct: 561 EIICGKKNRSFYQADTKAENLVTYVWRLWTNGSPLELVDLTISENCQTEEVIRCIHIALL 620
Query: 578 CVQENVANRPTMASVVVMLNSSSLSLPLPSQPAFFMHSTMEQDNLEFTSSDQSKSGSIHF 637
CVQE+ +RP ++++++ML +SSL L +P P FF+ E+D+ F SS Q G
Sbjct: 621 CVQEDPKDRPNLSTIMMMLTNSSLILSVPQPPGFFVPQNKERDS--FLSS-QFTMGCTSQ 677
Query: 638 TVNEVTISELDPR 650
T N+VTI+ LDPR
Sbjct: 678 TKNDVTITNLDPR 690
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65476|CRK16_ARATH Putative cysteine-rich receptor-like protein kinase 16 OS=Arabidopsis thaliana GN=CRK16 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 590 bits (1520), Expect = e-167, Method: Compositional matrix adjust.
Identities = 306/648 (47%), Positives = 411/648 (63%), Gaps = 13/648 (2%)
Query: 8 LTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALCRG 67
++S Q C TG F N Y NR L LSSLAS V+A GFY A+IGQ PD +Y C
Sbjct: 23 ISSAQKCGKTGLFKPNDKYDINRHLLLSSLASNVSARGGFYNASIGQGPDRLYASGTCIQ 82
Query: 68 DSSPESCASCLNFTVLDMMKNCPNQKEAISWEGM--DFPCVVRYSSRSFFGKLELKPTEI 125
S PE C++C++ + ++K C NQ EA+ W ++PC++RYS+RSFFG LE+ P
Sbjct: 83 GSEPELCSACIDSAFIRVIKKCHNQTEALDWSSFNEEYPCMIRYSNRSFFGLLEMTPFFK 142
Query: 126 AHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPD 185
+N + +LT+F + W +LM V+A A + + KF +T+YA + C+ D
Sbjct: 143 NYNATDFQVNLTEFYQKWEALMLGVIADA-ISSPNPKFYGAGTGKIGIQTVYAFVLCSKD 201
Query: 186 ISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLSPPS 245
IS +C CLR ++ + + C GK + PSC RW++Y FYG SP+ P
Sbjct: 202 ISPWNCSRCLRGNVDNYKLSCSGKPRGHSFSPSCYMRWDLYQFYGFIEYRASPTL---PR 258
Query: 246 TTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRKADE 305
+ D GG IS+ ++ I V+ + FI L+ L + R++K Q ++
Sbjct: 259 EKGRISELSDDGGK-ISTRNILGITVALAFFITVLLVL---GYALSRRRKAYQEFATEND 314
Query: 306 INTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGEL 365
I T SLQFDF I ATNNF NKLG GGFG V+KG +G E+AVKRLSK S QGE
Sbjct: 315 ITTSGSLQFDFKAIEAATNNFQKSNKLGHGGFGEVFKGTFPNGTEVAVKRLSKISGQGEE 374
Query: 366 EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETR 425
EFKNEVLLVA+LQHRNLVRLLGFS E E++L+YE++PN S+D F+FD +R QLDW TR
Sbjct: 375 EFKNEVLLVAKLQHRNLVRLLGFSVEGEEKILVYEYMPNKSLDYFLFDHRRRGQLDWRTR 434
Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485
Y II G+ RGILYLH+DSRL IIHRDLKA NILLD DM PKI+DFG+AR F +DQ++ T
Sbjct: 435 YNIIRGVTRGILYLHQDSRLTIIHRDLKAGNILLDVDMNPKIADFGVARNFRVDQTEATT 494
Query: 486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR-IGEEAEDLLTYAW 544
R+VGTFGYM PEYV G FS+KSDV+SFGVL+LEII G+K++SF I +L+TY W
Sbjct: 495 GRVVGTFGYMPPEYVANGQFSMKSDVYSFGVLILEIIVGKKSSSFHEIDGSVGNLVTYVW 554
Query: 545 KNWNEGTALNLIDPTL-RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSL 603
+ WN + L L+DP + + E++RC+HI LLCVQEN A+RPTM++V ML ++ L+L
Sbjct: 555 RLWNNESFLELVDPAMGESYDKDEVIRCIHISLLCVQENPADRPTMSTVFQMLTNTFLTL 614
Query: 604 PLPSQPAFFMHSTMEQDNL-EFTSSDQSKSGSIHFTVNEVTISELDPR 650
P+P P F E + L E S + S ++++ +I+ +D R
Sbjct: 615 PVPQLPGFVFRVRSEPNPLAERLEPGPSTTMSFACSIDDASITSVDLR 662
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 588 bits (1515), Expect = e-167, Method: Compositional matrix adjust.
Identities = 318/656 (48%), Positives = 429/656 (65%), Gaps = 45/656 (6%)
Query: 12 QTCYDTGNFTTNSTYGKNRDLFLSSLAS-TVTANKGFYTATIGQIPDEVYGLALCRGDSS 70
TC +T N+T+NSTY N L+SL+S + + GF AT+GQ PD V GL CRGD S
Sbjct: 42 HTCQNTANYTSNSTYNNNLKTLLASLSSRNASYSTGFQNATVGQAPDRVTGLFNCRGDVS 101
Query: 71 PESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEIAHNVN 130
E C C++F V D + CPNQKEA + CV+RYS+++ L I N
Sbjct: 102 TEVCRRCVSFAVNDTLTRCPNQKEATLYYD---ECVLRYSNQNILSTLITTGGVILVNTR 158
Query: 131 NITSSLTQFDRIWRSLMDRVL------AKASLGTSKLKFATDEANLTSSETIYALMQCTP 184
N+TS+ Q D L D VL A +L +SK KF T + N T+ ++ Y L+QCTP
Sbjct: 159 NVTSN--QLDL----LSDLVLPTLNQAATVALNSSK-KFGTRKNNFTALQSFYGLVQCTP 211
Query: 185 DISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATA--------DSL 236
D+++ DC CL+ + + + + G+ I+ PSC R+E+Y FY +A
Sbjct: 212 DLTRQDCSRCLQLVINQIPT---DRIGARIINPSCTSRYEIYAFYTESAVPPPPPPPSIS 268
Query: 237 SPSPLSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRR-RKKK 295
+P +PP + KD + VV I+V+ FI C RR RK
Sbjct: 269 TPPVSAPPRS------GKDGNSKVLVIAIVVPIIVAVLLFIAGY-----CFLTRRARKSY 317
Query: 296 QKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKR 355
+ D+I T +SLQ D+ TI+ AT++F NK+GQGGFG VYKG LS G E+AVKR
Sbjct: 318 YTPSAFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKR 377
Query: 356 LSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI 415
LSK+S QGE+EFKNEV+LVA+LQHRNLVRLLGF + ER+L+YE+VPN S+D F+FD
Sbjct: 378 LSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPA 437
Query: 416 KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475
K+ QLDW RYKIIGG+ARGILYLH+DSRL IIHRDLKASNILLDADM PKI+DFGMAR+
Sbjct: 438 KKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARI 497
Query: 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
F +DQ++ +TSRIVGT+GYM+PEY G +S+KSDV+SFGVLVLEIISG+KN+SF +
Sbjct: 498 FGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDG 557
Query: 536 AEDLLTYAWKNWNEGTALNLIDPTL-RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594
A DL++YAW W+ G L L+DP + N +E++RCVHIGLLCVQE+ A RPT++++V+
Sbjct: 558 AHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVL 617
Query: 595 MLNSSSLSLPLPSQPAFFMHSTMEQDNLEFTSSDQSKSGSIHFTVNEVTISELDPR 650
ML S++++LP+P QP F S + +D L+ ++ +S GS V++ +I+++ PR
Sbjct: 618 MLTSNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLGS----VDDASITDIHPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8L710|CRK17_ARATH Cysteine-rich receptor-like protein kinase 17 OS=Arabidopsis thaliana GN=CRK17 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 586 bits (1510), Expect = e-166, Method: Compositional matrix adjust.
Identities = 329/673 (48%), Positives = 436/673 (64%), Gaps = 34/673 (5%)
Query: 5 IIRLTSGQTCYDT-GNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLA 63
+I +++ QTC +T G+F NSTY NR L LS+ AS VTA G++ + G D VY +
Sbjct: 21 VISVSAQQTCDNTAGSFKPNSTYDNNRRLLLSTFASNVTAQNGYFNGSFGLGTDRVYAMG 80
Query: 64 LCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPT 123
+C + P+ C++C+ T +++ C NQ + SW G + C+VRYS++SF G L L+P+
Sbjct: 81 MCAPGAEPDVCSNCIKNTAEGLLQICLNQTDGFSWSGEETLCLVRYSNKSFSGLLGLEPS 140
Query: 124 EIAHNVNNI-TSSLTQFDRIWRSLMDRVLAKASLGT---------SKLKFATDEANLTSS 173
NVN I +FD ++ LM R + AS S +A D A
Sbjct: 141 NDFFNVNEIRKEDQKEFDSVFDELMFRTIQGASSSVRNNSNSLSLSGKYYAKDVAPEPVY 200
Query: 174 ETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATA 233
I +MQCTPD+S DC CL +S+ + GK+G+ I+ PSC FRWE+Y F+GA
Sbjct: 201 GNISVVMQCTPDVSSKDCNLCLERSLDFYKKWYNGKRGTIILRPSCFFRWELYTFFGA-F 259
Query: 234 DSLSP------------SPLSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALV 281
DS++ PL PS T T I K K + IS GT+ IVV II +V
Sbjct: 260 DSINARHPPPPPRPLSPPPLKTPSVTNQTNITK-KNDSRISGGTIAAIVVVVVVTIILIV 318
Query: 282 -ALITCVFLRRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAV 340
L+ C +++KQKQ + +N ES+QFD TI AT NFS NKLG GGFG V
Sbjct: 319 VGLVIC-----KRRKQKQEIELPIVLNEAESVQFDLKTIEAATGNFSEHNKLGAGGFGEV 373
Query: 341 YKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400
YKG L +G EIAVKRLSK S QGE+EFKNEV++VA+LQH NLVRLLGFS + E+LL+YE
Sbjct: 374 YKGMLLNGTEIAVKRLSKTSGQGEIEFKNEVVVVAKLQHINLVRLLGFSLQGEEKLLVYE 433
Query: 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 460
FVPN S+D F+FD KR QLDW R IIGGI RGILYLH+DSRL+IIHRDLKASNILLD
Sbjct: 434 FVPNKSLDYFLFDPNKRNQLDWTVRRNIIGGITRGILYLHQDSRLKIIHRDLKASNILLD 493
Query: 461 ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLE 520
ADM PKI+DFGMAR+F +DQ+ +T+R+VGTFGYM+PEYVT G FS+KSDV+SFGVL+LE
Sbjct: 494 ADMNPKIADFGMARIFGVDQTVANTARVVGTFGYMSPEYVTHGQFSMKSDVYSFGVLILE 553
Query: 521 IISGQKNNSF-RIGEEAEDLLTYAWKNWNEGTALNLIDPTLR-NGSSSEIMRCVHIGLLC 578
IISG+KN+SF ++ +L+TY WK W T LIDP ++ + S E++R VHIGLLC
Sbjct: 554 IISGKKNSSFYQMDGLVNNLVTYVWKLWENKTMHELIDPFIKEDCKSDEVIRYVHIGLLC 613
Query: 579 VQENVANRPTMASVVVMLNSSSLSLPLPSQPAFFMHSTMEQD-NLEFTSSDQSKSGSIHF 637
VQEN A+RPTM+++ +L +SS++LP+P P FF + + + + QS S S
Sbjct: 614 VQENPADRPTMSTIHQVLTTSSITLPVPQPPGFFFRNGPGSNPSSQGMVPGQSSSKSFTS 673
Query: 638 TVNEVTISELDPR 650
+V+E TI++++PR
Sbjct: 674 SVDEATITQVNPR 686
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 650 | ||||||
| 224113943 | 641 | predicted protein [Populus trichocarpa] | 0.946 | 0.959 | 0.582 | 0.0 | |
| 359496752 | 751 | PREDICTED: cysteine-rich receptor-like p | 0.98 | 0.848 | 0.544 | 0.0 | |
| 224116134 | 668 | predicted protein [Populus trichocarpa] | 0.98 | 0.953 | 0.564 | 0.0 | |
| 359497268 | 675 | PREDICTED: cysteine-rich receptor-like p | 0.990 | 0.954 | 0.547 | 0.0 | |
| 224113947 | 645 | predicted protein [Populus trichocarpa] | 0.961 | 0.968 | 0.564 | 0.0 | |
| 224113951 | 645 | predicted protein [Populus trichocarpa] | 0.961 | 0.968 | 0.563 | 0.0 | |
| 147811956 | 839 | hypothetical protein VITISV_019620 [Viti | 0.990 | 0.767 | 0.544 | 0.0 | |
| 356575765 | 666 | PREDICTED: cysteine-rich receptor-like p | 0.970 | 0.947 | 0.547 | 0.0 | |
| 356575763 | 665 | PREDICTED: cysteine-rich receptor-like p | 0.969 | 0.947 | 0.549 | 0.0 | |
| 356574361 | 846 | PREDICTED: cysteine-rich receptor-like p | 0.990 | 0.761 | 0.552 | 0.0 |
| >gi|224113943|ref|XP_002316622.1| predicted protein [Populus trichocarpa] gi|222859687|gb|EEE97234.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 749 bits (1934), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/654 (58%), Positives = 472/654 (72%), Gaps = 39/654 (5%)
Query: 6 IRLTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALC 65
I LT + CY+TGNFT NSTY KNRDL L SLAS VT N GFY TIG D VYGL LC
Sbjct: 18 ITLTGAEVCYNTGNFTANSTYAKNRDLVLRSLASNVTNNGGFYNTTIGLGNDTVYGLVLC 77
Query: 66 RGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEI 125
S E+C+ C++ + + CPNQKEAISW G PC+V Y++R F G LE P I
Sbjct: 78 MASPSAENCSRCVSSAIQTLTAGCPNQKEAISWGGNPLPCIVHYANRYFLGSLEQSPNSI 137
Query: 126 AHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPD 185
+NV + ++ QF++ W L + V AS G+S+L A + A+L S++ Y MQCTPD
Sbjct: 138 LYNVGILDATFRQFEQFWSGLGETV-KNASTGSSRLMPAVETADLPSNQKAYVFMQCTPD 196
Query: 186 ISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLSPPS 245
+S S+C CL+QS+ D SCCYG +G + P+C+FRW++
Sbjct: 197 VSPSNCSVCLQQSVNDYXSCCYGHQGGIVQKPNCVFRWDL-------------------- 236
Query: 246 TTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALIT-CVFLRRRKKKQKQNLRKAD 304
T + K N TV IIV++ + A++ +I C+F+R RK+++K+ + D
Sbjct: 237 ---ATLVYAGKKSN-----TVRIIVITVVPAVGAVILVICMCLFIRTRKQREKERIETGD 288
Query: 305 EINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGE 364
EI + ESLQF FSTIRDAT +FS NKLGQGGFGAVYKG L GQEIAVKRLSK+S QG+
Sbjct: 289 EIESAESLQFAFSTIRDATEDFSEKNKLGQGGFGAVYKGALPSGQEIAVKRLSKDSGQGD 348
Query: 365 LEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWET 424
LEFKNEVLLVARLQHRNLVRLLGF + ERLLIYEFVPN+S+D FIFD IKRV L+WE
Sbjct: 349 LEFKNEVLLVARLQHRNLVRLLGFCLQGIERLLIYEFVPNASLDHFIFDPIKRVHLNWER 408
Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
RYKIIGGIARG+LYLHEDSRLRIIHRDLKASNILLD +M PKISDFGMARLF +DQ+QG+
Sbjct: 409 RYKIIGGIARGLLYLHEDSRLRIIHRDLKASNILLDEEMNPKISDFGMARLFVVDQTQGN 468
Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAW 544
TSRIVGT+GYMAPEY +GHFS+KSDVFSFGVLVLEI++G+K NSFR G + E LL++AW
Sbjct: 469 TSRIVGTYGYMAPEYAMQGHFSVKSDVFSFGVLVLEIVTGKK-NSFRNGNDIEHLLSHAW 527
Query: 545 KNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSLP 604
+NW EGTA ++IDP L +GS++E++RC+HIGLLCVQENVA RPTMASVV+ML+SSSL+L
Sbjct: 528 RNWREGTAQDIIDPVLSSGSATEMLRCIHIGLLCVQENVAERPTMASVVLMLSSSSLTLQ 587
Query: 605 LPSQPAFFMHSTMEQDNL--------EFTSSDQSKSGSIHFTVNEVTISELDPR 650
+PSQPAFFM+S+ Q +L T S S+S +I + NEV+I+EL PR
Sbjct: 588 IPSQPAFFMNSSTYQSDLSSSMEHNSRVTESSLSESVAIPLSKNEVSITELYPR 641
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496752|ref|XP_003635322.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 724 bits (1869), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/681 (54%), Positives = 478/681 (70%), Gaps = 44/681 (6%)
Query: 1 MLLSIIRLTSGQTCY-------DTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIG 53
++L ++ +T+ Q + GN+T NSTY N + L+SL+S + GFY + G
Sbjct: 84 LILHLLAVTNAQPKFLYYRCSNGVGNYTNNSTYKANLNTLLTSLSSNNEIDYGFYNFSAG 143
Query: 54 QIPDEVYGLALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISW-EGMDFPCVVRYSSR 112
Q D+V +ALCRGD P +C SC+N + + + + CPNQKEAI W +G C++RYS+
Sbjct: 144 QNSDKVNAIALCRGDVMPTACRSCINDSRIQLTRLCPNQKEAIGWYDG----CMLRYSND 199
Query: 113 SFFGKLELKPTEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTS 172
S FGK + P+ N+ N+ S++ F+++ +LM + +KA+ G + KFAT+EAN+TS
Sbjct: 200 SIFGKAQTSPSFTMWNLQNV-SNVEDFNQVLGNLMASLRSKAASGDWRRKFATEEANVTS 258
Query: 173 SETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGAT 232
++IY LMQCTPD+S+ C CL ++ ++ +CC +K ++ PSC R+ Y FY T
Sbjct: 259 FQSIYGLMQCTPDLSELSCSNCLEGAINEIPTCCNRRKAGRVVKPSCNLRYGTYRFYYFT 318
Query: 233 ADS----------------LSPSPLSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTF 276
A + LSP PL+ ++T +T S SS T+++I+V +
Sbjct: 319 AANAPPPTATPQPSPPSADLSPQPLANTTSTQET--------RSNSSRTIILIIVPSVII 370
Query: 277 IIALVALITCVFLRRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGG 336
+I ++ C F R+R +K D+I VESL FDF TIR ATNNFS NKLGQGG
Sbjct: 371 LIIILVGFICFFSRKRSSMEKLETNDEDDIINVESLHFDFDTIRVATNNFSDSNKLGQGG 430
Query: 337 FGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL 396
FG VYKG+LS+GQ+IAVKRLS S QGELEFKNEV+LVA+LQHRNLVRLLGF + ERL
Sbjct: 431 FGPVYKGKLSNGQDIAVKRLSSGSGQGELEFKNEVVLVAKLQHRNLVRLLGFCLDGAERL 490
Query: 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 456
LIYEFVPN+S+D FIFD I+R QLDWE RYKIIGGIARG+LYLHEDSRLRIIHRDLKASN
Sbjct: 491 LIYEFVPNTSLDHFIFDPIRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKASN 550
Query: 457 ILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGV 516
ILLDA+M PKISDFGMARLF +DQ+QG+TSRIVGT+GYMAPEY GHFS+K+DV+SFGV
Sbjct: 551 ILLDAEMNPKISDFGMARLFLVDQTQGNTSRIVGTYGYMAPEYAMHGHFSVKTDVYSFGV 610
Query: 517 LVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGL 576
LVLE++SGQ+NN FR+ E E LL+YAWKNW EGTA NLIDPT+R S SEIMRC+HIGL
Sbjct: 611 LVLELVSGQRNNCFRVSENIEHLLSYAWKNWREGTATNLIDPTMRISSISEIMRCIHIGL 670
Query: 577 LCVQENVANRPTMASVVVMLNSSSLSLPLPSQPAFFMHSTME-------QDNLEFTSSDQ 629
LCVQEN A+RPTMAS+ +MLNS SLSLPLPS PAFFM+++M +DN S+
Sbjct: 671 LCVQENEADRPTMASIALMLNSYSLSLPLPSHPAFFMNTSMNRDMSLELEDNSRVAQSNY 730
Query: 630 SKSGSIHFTVNEVTISELDPR 650
S S HF+VNE +I++ PR
Sbjct: 731 LPSRSSHFSVNEASITDPYPR 751
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116134|ref|XP_002317220.1| predicted protein [Populus trichocarpa] gi|222860285|gb|EEE97832.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 724 bits (1868), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/659 (56%), Positives = 462/659 (70%), Gaps = 22/659 (3%)
Query: 6 IRLTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALC 65
I LT + CY+TGNFT NSTY KNRDL L SLAS VTAN GFY TIG D VYGL LC
Sbjct: 18 ITLTGAEVCYNTGNFTANSTYAKNRDLVLRSLASNVTANGGFYNTTIGLGNDTVYGLVLC 77
Query: 66 RGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEI 125
S E C+SC+N + +M CPNQKEAISW G PC+V Y++R FFG LE P+
Sbjct: 78 MASPSAEICSSCVNSAIQTLMAACPNQKEAISWGGNPLPCIVHYANRYFFGSLEPSPSSA 137
Query: 126 AHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPD 185
+N + ++ QFD+ W L + V KAS +S+L + A+L+S++ IY MQCTPD
Sbjct: 138 FYNTGILDATFRQFDQFWSGLGETV-TKASTASSRLMPVAETADLSSTQKIYVFMQCTPD 196
Query: 186 ISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYG----------ATADS 235
+S S+C CL+QS+ +SCCYG KG P+C FRW++YPFY + + S
Sbjct: 197 VSPSNCSVCLQQSVDYYKSCCYGHKGGGAQKPNCFFRWDLYPFYDLFPQVTSPPPSPSPS 256
Query: 236 LSPSPLSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKK 295
SP + T+TTI K G + +S TV++ +V T+ F+ ALV LI VF R +K
Sbjct: 257 PSPPFVISSPPPTNTTIRK--GKENTASRTVIVTIVPTAIFL-ALVILILTVF---RFRK 310
Query: 296 QKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKR 355
KQ + DEI+ + L+F F+TI+ ATN+FS DNKLGQGGFGAVYKG L+ GQ IAVKR
Sbjct: 311 PKQEVENFDEISIAKCLEFKFATIKLATNDFSDDNKLGQGGFGAVYKGILADGQAIAVKR 370
Query: 356 LSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI 415
LS NS QGE+EFKNEV L+A+L HRNLVRLLGF E TE+LLIYEFVPNSS+D+FI D
Sbjct: 371 LSSNSGQGEVEFKNEVRLLAKLDHRNLVRLLGFCLEGTEKLLIYEFVPNSSLDQFIHDPN 430
Query: 416 KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475
KR LDWE RYKII GIARGILYLH+DS+LRIIHRDLK SNILLD M KISDFGMA+L
Sbjct: 431 KRFILDWEKRYKIIEGIARGILYLHQDSQLRIIHRDLKPSNILLDGKMNAKISDFGMAKL 490
Query: 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
+ DQ+ SRI GTFGY+APEY + FS+KSDVFSFGVLVLEI+SGQK SFR G++
Sbjct: 491 MKTDQTHDAASRIAGTFGYIAPEYARQRQFSVKSDVFSFGVLVLEIVSGQK-PSFRDGDD 549
Query: 536 AEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595
E L ++AW+ W EGTAL+LIDP LRN S++ +M C+HIGLLCVQENVA+RPTMASVV+M
Sbjct: 550 MEHLTSHAWRRWREGTALDLIDPILRNDSTAAMMTCIHIGLLCVQENVADRPTMASVVLM 609
Query: 596 LNSSSLSLPLPSQPAFFMHSTMEQDNLEFTSS----DQSKSGSIHFTVNEVTISELDPR 650
L++SS +L +PS+PAFF+ Q TS QS ++ + NE++I+ELDPR
Sbjct: 610 LSNSSFTLQIPSKPAFFISRRTYQPASSLTSYTSRMTQSHLKTVPPSKNEISITELDPR 668
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359497268|ref|XP_003635466.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1855), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/668 (54%), Positives = 470/668 (70%), Gaps = 24/668 (3%)
Query: 1 MLLSIIRLTSGQTCY-------DTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIG 53
++L ++ +T+ Q + GN+T NSTY N + L+SL+S + GFY + G
Sbjct: 14 LILHLLAVTNAQPKFLYYRCSNGVGNYTNNSTYKANLNTLLTSLSSNNEIDYGFYNFSAG 73
Query: 54 QIPDEVYGLALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRS 113
Q D+V +ALCRGD P +C SC+N + + + + CPNQKEAI W C++RYS+ S
Sbjct: 74 QNSDKVNAIALCRGDVMPTACRSCINDSRIQLTRLCPNQKEAIGWYD---GCMLRYSNDS 130
Query: 114 FFGKLELKPTEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSS 173
FGK + PT N+ N+ S++ F+++ +LM + +KA+ G + KFAT+EAN+TS
Sbjct: 131 IFGKAQTSPTFTMWNLQNV-SNVEDFNQVLGNLMASLRSKAASGDWRRKFATEEANVTSF 189
Query: 174 ETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATA 233
++IY LMQCTPD+S+ C CL ++ ++ +CC +K ++ PSC R+ Y FY TA
Sbjct: 190 QSIYGLMQCTPDLSELSCSNCLEGAINEIPTCCNRRKAGRVVKPSCNLRYATYHFYDITA 249
Query: 234 DSLSPSPLSPPSTT----TDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFL 289
+ P + +TT ++ NS S T+++I+V + +I ++ C F
Sbjct: 250 ANAPPPSPPSADLSPPPLANTTSTQETRSNS--SRTIILIIVPSVIILIIILVGFICFFS 307
Query: 290 RRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQ 349
R+R +K DEI VESL FDF TIR ATNNFS NKLGQGGFG VYKG+LS+GQ
Sbjct: 308 RKRSSMEKLETHDEDEITNVESLHFDFDTIRVATNNFSDSNKLGQGGFGPVYKGKLSNGQ 367
Query: 350 EIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDK 409
+AVKRLS S QGELEFKNEV+LVA+LQHRNLVRLLGF + ERLLIYEFVPN+S+D
Sbjct: 368 NVAVKRLSSGSAQGELEFKNEVVLVAKLQHRNLVRLLGFCLDGAERLLIYEFVPNTSLDH 427
Query: 410 FIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD 469
FIFD I+R QLDWE RYKIIGGIARG+LYLHEDSRLRIIHRDLKASNILLDA+M PKISD
Sbjct: 428 FIFDLIRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 487
Query: 470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529
FGMARLF +DQ+QG TSRIVGT+GYMAPEY GHFS+K+DV+SFGVLVLE++SGQ+NN
Sbjct: 488 FGMARLFLVDQTQGSTSRIVGTYGYMAPEYAMHGHFSVKTDVYSFGVLVLELVSGQRNNC 547
Query: 530 FRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTM 589
FR+ E E LL+YAWKNW EGTA NLIDPT+R S SEIMRC+HIGLLCVQEN A+RPTM
Sbjct: 548 FRVSENIEHLLSYAWKNWREGTATNLIDPTMRISSISEIMRCIHIGLLCVQENEADRPTM 607
Query: 590 ASVVVMLNSSSLSLPLPSQPAFFMHSTME-------QDNLEFTSSDQSKSGSIHFTVNEV 642
AS+ +MLNS SLSLP+PS PAFFM+++M +DN S+ S S HF+VNE
Sbjct: 608 ASIALMLNSYSLSLPVPSHPAFFMNTSMNRDMSLELEDNSRVAQSNYLPSRSSHFSVNEA 667
Query: 643 TISELDPR 650
+I++ PR
Sbjct: 668 SITDPYPR 675
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113947|ref|XP_002316623.1| predicted protein [Populus trichocarpa] gi|222859688|gb|EEE97235.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 717 bits (1850), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/648 (56%), Positives = 458/648 (70%), Gaps = 23/648 (3%)
Query: 6 IRLTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALC 65
I LT + CY+TGNFT NSTY KNRDL L SLAS VTAN GFY TIG D VYGL C
Sbjct: 18 ITLTGAEVCYNTGNFTANSTYAKNRDLVLRSLASNVTANGGFYNTTIGLGNDTVYGLVFC 77
Query: 66 RGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEI 125
S E C+SC+N + +M CPNQKEAISW G PC+V Y++R F G LEL PT+
Sbjct: 78 MASPSAEICSSCVNSAIQTLMAACPNQKEAISWGGNPVPCIVHYANRYFLGSLELSPTDA 137
Query: 126 AHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPD 185
+N + S QF +IW LM + AS G+S+ K A + A+L+S++ IY MQCTPD
Sbjct: 138 GYNTGILDPSFRQFLQIWSGLMTDTVTIASTGSSRFKLAAETADLSSTQKIYVFMQCTPD 197
Query: 186 ISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLSPPS 245
+S S+C CL+ S+ +SCC G +G Y P+C+FRW++YPFY +L P SP
Sbjct: 198 VSPSNCRDCLQHSVDYYKSCCNGYQGGYAQKPNCVFRWDLYPFY-----NLFPQVTSPSP 252
Query: 246 TTTDTTIAK-DKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRKAD 304
++ T KG + +S TV++ +V TS F+ ALV LI +F R +K KQ ++ D
Sbjct: 253 SSPPPTNTTIRKGKENNASRTVIVTIVPTSIFL-ALVILILTIF---RFRKPKQEVKNFD 308
Query: 305 EINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGE 364
E ++ + +F F+TI+ ATN+FS DNKLGQGGFGAVYKG L+ GQ IAVKRLS NS QG
Sbjct: 309 ENSSTKCWEFKFATIKLATNDFSDDNKLGQGGFGAVYKGILADGQAIAVKRLSSNSGQGA 368
Query: 365 LEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWET 424
+EF+NEV L+A+L HRNLVRLLGF E TE+LLIYEFVPNSS+D+FI D KR+ LDWE
Sbjct: 369 VEFRNEVGLLAKLAHRNLVRLLGFCLEGTEKLLIYEFVPNSSLDQFIHDPNKRLVLDWEK 428
Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
RYKII GIARGI+YLH+DS+L IIHRDLK NILLD +M KISDFGMA+L + DQ+
Sbjct: 429 RYKIIEGIARGIVYLHQDSQLWIIHRDLKPGNILLDGNMNAKISDFGMAKLMKTDQTHDA 488
Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAW 544
TSRI GTFGY+APEY +G FS+KSDVFSFGVLVLEI+SGQK SFR G++ E L ++AW
Sbjct: 489 TSRIAGTFGYIAPEYAWKGQFSVKSDVFSFGVLVLEIVSGQK-PSFRNGDDMEHLTSHAW 547
Query: 545 KNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSLP 604
+ W EGTAL+LIDP LRN S++ +MRC+HIGLLCVQENVA+RPTMASVV ML++SSL+L
Sbjct: 548 RRWREGTALDLIDPILRNDSTAAMMRCIHIGLLCVQENVADRPTMASVVQMLSNSSLTLQ 607
Query: 605 LPSQPAFFMH--STMEQDNLEFTSSDQSKSGSIHFTVNEVTISELDPR 650
P +PA + STMEQ L+ I + NE++I+ELDPR
Sbjct: 608 TPFEPASSLSYTSTMEQSQLKI----------IPLSKNEISITELDPR 645
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113951|ref|XP_002316624.1| predicted protein [Populus trichocarpa] gi|222859689|gb|EEE97236.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 715 bits (1846), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/648 (56%), Positives = 458/648 (70%), Gaps = 23/648 (3%)
Query: 6 IRLTSGQTCYDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGLALC 65
I LT + CY+TGNFT NSTY KNRDL L SLAS VTAN GFY TIG D VYGL C
Sbjct: 18 ITLTGAEVCYNTGNFTANSTYAKNRDLVLRSLASNVTANGGFYNTTIGLGNDTVYGLVFC 77
Query: 66 RGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKPTEI 125
+S E C+SC+N + +M CPNQKEAISW G PC+V Y++R F G LEL PT+
Sbjct: 78 MASASAEICSSCVNSAIQTLMAACPNQKEAISWGGNPVPCIVHYANRYFLGSLELSPTDA 137
Query: 126 AHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPD 185
+N + S QF +IW LM + AS G+S+ K A + A+L+S++ IY MQCTPD
Sbjct: 138 GYNTGILDPSFRQFLQIWSGLMTDTVTIASTGSSRFKLAAETADLSSTQKIYVFMQCTPD 197
Query: 186 ISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLSPPS 245
+S S+C CL+ S+ +SCC G +G Y P+C+FRW++YPFY +L P SP
Sbjct: 198 VSPSNCRDCLQHSVDYYKSCCNGYQGGYAQKPNCVFRWDLYPFY-----NLFPQVTSPSP 252
Query: 246 TTTDTTIAK-DKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRKAD 304
++ T KG + +S TV++ +V TS F+ ALV LI +F R +K KQ ++ D
Sbjct: 253 SSPPPTNTTIRKGKENNASRTVIVTIVPTSIFL-ALVILILTIF---RFRKPKQEVKNFD 308
Query: 305 EINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGE 364
E ++ + +F F+TI+ ATN+FS DNKLGQGGFGAVYKG ++ GQ IAVKRLS NS QG
Sbjct: 309 ENSSTKCWEFKFATIKLATNDFSDDNKLGQGGFGAVYKGIIADGQAIAVKRLSSNSGQGA 368
Query: 365 LEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWET 424
+EF+NEV L+A+L HRNLVRLLGF E TE+LLIYEFVPNSS+D+FI D KR+ LDWE
Sbjct: 369 VEFRNEVGLLAKLAHRNLVRLLGFCLEGTEKLLIYEFVPNSSLDQFIHDPNKRLVLDWEK 428
Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
RYKII GIARGILYLH+DS+L IIHRDLK NILLD +M KISD GMA+L + DQ+
Sbjct: 429 RYKIIEGIARGILYLHQDSQLWIIHRDLKPGNILLDGNMNAKISDSGMAKLMKTDQTHDA 488
Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAW 544
TSRI GTFGY+APEY +G FS+KSDVFSFGVLVLEI+SGQK SFR G++ E L ++AW
Sbjct: 489 TSRIAGTFGYIAPEYAWKGQFSVKSDVFSFGVLVLEIVSGQK-PSFRNGDDMEHLTSHAW 547
Query: 545 KNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSLP 604
+ W EGTAL+LIDP LRN S++ +MRC+HIGLLCVQENVA+RPTMASVV ML++SSL+L
Sbjct: 548 RRWREGTALDLIDPILRNDSTAAMMRCIHIGLLCVQENVADRPTMASVVQMLSNSSLTLQ 607
Query: 605 LPSQPAFFMH--STMEQDNLEFTSSDQSKSGSIHFTVNEVTISELDPR 650
P +PA + STMEQ L+ I + NE++I+ELDPR
Sbjct: 608 TPFEPASSLSYTSTMEQSQLKI----------IPLSKNEISITELDPR 645
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147811956|emb|CAN74851.1| hypothetical protein VITISV_019620 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 711 bits (1836), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/668 (54%), Positives = 465/668 (69%), Gaps = 24/668 (3%)
Query: 1 MLLSIIRLTSGQTCY-------DTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIG 53
++L ++ +T+ Q + GN+T NSTY N + L+SL+S + GFY + G
Sbjct: 178 LILHLLAVTNAQPRFLSYWCSNGVGNYTNNSTYKANLNTLLTSLSSNNEIDYGFYNFSAG 237
Query: 54 QIPDEVYGLALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRS 113
Q D+V +ALCRGD P +C SC+N + + + + CPNQKEAI W C++RYS+ S
Sbjct: 238 QNSDKVNAIALCRGDVMPTACRSCINDSRIQLTQLCPNQKEAIGWYDN---CMLRYSNDS 294
Query: 114 FFGKLELKPTEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSS 173
FG + P N N S + +F+++ ++M + +KA+ G + KFAT EAN+TS
Sbjct: 295 IFGTQQSSPYFYMRNSKN-ASDVEEFNQVLGNMMASLRSKAASGDWRRKFATGEANVTSF 353
Query: 174 ETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATA 233
++IY LMQCTPD+S+ C CL + ++ +CC +KG ++ PSC R+E Y FY TA
Sbjct: 354 QSIYGLMQCTPDLSELSCSNCLEGATNEIPTCCDSRKGGRVVKPSCNLRYETYRFYDFTA 413
Query: 234 DSLSPSPLSPPSTT----TDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFL 289
+ P + +TT ++ NS S T+++I+V + +I ++ C F
Sbjct: 414 ANAPPPSPPSADLSPPPLANTTSTQETRSNS--SRTIILIIVPSVIILIIILVGFICFFS 471
Query: 290 RRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQ 349
R+R +K DEI VESL FDF TIR ATNNFS NKLGQGGFG VYKG+LS+GQ
Sbjct: 472 RKRSSMEKLETHDEDEITNVESLHFDFDTIRVATNNFSDSNKLGQGGFGPVYKGKLSNGQ 531
Query: 350 EIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDK 409
+AVKRLS S QGELEFKNE +LVA+LQHRNLVRLLGF + ERLLIYEFVPN+S+D
Sbjct: 532 YVAVKRLSSGSAQGELEFKNEAVLVAKLQHRNLVRLLGFCLDGAERLLIYEFVPNTSLDH 591
Query: 410 FIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD 469
FIFD I+R QLDWE RYKIIGGIARG+LYLHEDSRLRIIHRDLKASNILLDA+M PKISD
Sbjct: 592 FIFDLIRRAQLDWERRYKIIGGIARGLLYLHEDSRLRIIHRDLKASNILLDAEMNPKISD 651
Query: 470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529
FGMARLF +DQ+QG TSRIVGT+GYMAPEY GHFS+K+DV+SFGVLVLE++SGQ+NN
Sbjct: 652 FGMARLFLVDQTQGSTSRIVGTYGYMAPEYAMHGHFSVKTDVYSFGVLVLELVSGQRNNC 711
Query: 530 FRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTM 589
FR+ E E LL+YAWKNW EGTA NLIDPT+R S SEIMRC+HIGLLCVQEN A+RPTM
Sbjct: 712 FRVSENIEHLLSYAWKNWREGTATNLIDPTMRISSISEIMRCIHIGLLCVQENEADRPTM 771
Query: 590 ASVVVMLNSSSLSLPLPSQPAFFMHSTME-------QDNLEFTSSDQSKSGSIHFTVNEV 642
AS+ +MLNS SLSLP+PS PAFFM+++M +DN S+ S S HF+VNE
Sbjct: 772 ASIALMLNSYSLSLPVPSHPAFFMNTSMNRDMSLELEDNSRVAQSNYLPSRSSHFSVNEA 831
Query: 643 TISELDPR 650
+I++ PR
Sbjct: 832 SITDPYPR 839
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575765|ref|XP_003556007.1| PREDICTED: cysteine-rich receptor-like protein kinase 29-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 709 bits (1830), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/663 (54%), Positives = 465/663 (70%), Gaps = 32/663 (4%)
Query: 5 IIRLTSGQT-C-YDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGL 62
II S QT C D GN+T NSTY N + LS+ +S GFY + GQ PD+VY +
Sbjct: 19 IISQASAQTNCDNDKGNYTINSTYHSNLNTLLSNFSSHTDIYYGFYNFSYGQDPDKVYAI 78
Query: 63 ALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKP 122
LCRGD +P+ C CLN + + + CPNQKEAI+W G C++RYS+RS FG++E +P
Sbjct: 79 GLCRGDQNPDQCLKCLNESRVSLADECPNQKEAINWRG---ECMLRYSNRSIFGRMENQP 135
Query: 123 TEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQC 182
T + N+T S+ +F+ + SLM + + A+ G S+ K+AT +T Y QC
Sbjct: 136 TSRIVYLKNVTGSVDEFNDVLESLMRNLSSTAASGDSRRKYATGSKPAPDFQTTYGYTQC 195
Query: 183 TPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLS 242
TPD+S DC CL ++++D+ + GK G ++ PSC R++ Y +YG T L P +
Sbjct: 196 TPDLSSEDCTTCLGEAISDIPNYFNGKAGGNVLKPSCRIRFDPYSYYGPT---LKLDPDA 252
Query: 243 PPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRK 302
P+ T +T+ ++++ GN+ + +II + + LV ++ C++LR RK + KQN K
Sbjct: 253 SPTMTNNTSSSQERKGNT----SRIIIAIVVPVASVVLVLILFCIYLRARKSR-KQNESK 307
Query: 303 AD----EINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSK 358
D EI+ ESLQFDF TIR ATN F+ NK+GQGGFGAVY+G+LS+GQEIAVKRLS+
Sbjct: 308 EDNNEDEISFAESLQFDFDTIRVATNEFADCNKIGQGGFGAVYRGQLSNGQEIAVKRLSR 367
Query: 359 NSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV 418
+S QG++EFKNEVLLVA+LQHRNLVRLLGF E TERLL+YEFVPN S+D FIFD IK+
Sbjct: 368 DSGQGDMEFKNEVLLVAKLQHRNLVRLLGFCLEGTERLLVYEFVPNKSLDYFIFDPIKKA 427
Query: 419 QLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478
QLDW+ RYKIIGGIARG+LYLHEDSRLRIIHRDLKASNILLD +M PKISDFGMARL M
Sbjct: 428 QLDWQRRYKIIGGIARGLLYLHEDSRLRIIHRDLKASNILLDEEMHPKISDFGMARLVHM 487
Query: 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAED 538
DQ+Q +TSRIVGT+GYMAPEY G FS KSDVFSFGVLVLEIISG KN+ R GE ED
Sbjct: 488 DQTQENTSRIVGTYGYMAPEYAIYGQFSAKSDVFSFGVLVLEIISGHKNSGVRRGENVED 547
Query: 539 LLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598
LL +AW+NW +GT N++DPTL +G +EIMRC+HIGLLCVQENVA RPTMASV +MLNS
Sbjct: 548 LLCFAWRNWRDGTTTNIVDPTLTDGLRNEIMRCIHIGLLCVQENVAARPTMASVALMLNS 607
Query: 599 SSLSLPLPSQPAFF----------MHSTMEQDNLE-FTSSDQSKSGSIHFTVNEVTISEL 647
SL+LP+PS+PAF M S+ E ++ + S++QS S VNE +I+EL
Sbjct: 608 YSLTLPVPSEPAFVGDGRTRSLPDMQSSSEHNSRQTIESANQSAQNS----VNEASITEL 663
Query: 648 DPR 650
PR
Sbjct: 664 YPR 666
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575763|ref|XP_003556006.1| PREDICTED: cysteine-rich receptor-like protein kinase 29-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 707 bits (1824), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/663 (54%), Positives = 462/663 (69%), Gaps = 33/663 (4%)
Query: 5 IIRLTSGQT-C-YDTGNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYGL 62
II S QT C D GN+T NSTY N + LS+ +S GFY + GQ PD+VY +
Sbjct: 19 IISQASAQTNCDNDKGNYTINSTYHSNLNTLLSNFSSHTDIYYGFYNFSYGQDPDKVYAI 78
Query: 63 ALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKLELKP 122
LCRGD +P+ C CLN + + + CPNQKEAI+W G C++RYS+RS FG++E +P
Sbjct: 79 GLCRGDQNPDQCLKCLNESRVSLADECPNQKEAINWRG---ECMLRYSNRSIFGRMENQP 135
Query: 123 TEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQC 182
T + N+T S+ +F+ + SLM + + A+ G S+ K+AT +T Y QC
Sbjct: 136 TSRIVYLKNVTGSVDEFNDVLESLMRNLSSTAASGDSRRKYATGSKPAPDFQTTYGYTQC 195
Query: 183 TPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLS 242
TPD+S DC CL ++++D+ + GK G ++ PSC R++ Y +YG T L P +
Sbjct: 196 TPDLSSEDCTTCLGEAISDIPNYFNGKAGGNVLKPSCRIRFDPYSYYGPT---LKLDPDA 252
Query: 243 PPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRK 302
P+ T +T+ ++ KG S +II + + LV ++ C++LR RK + KQN K
Sbjct: 253 SPTMTNNTSSSQGKGNTS-----RIIIAIVVPVASVVLVLILFCIYLRARKSR-KQNESK 306
Query: 303 AD----EINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSK 358
D EI+ ESLQFDF TIR ATN F+ NK+GQGGFGAVY+G+LS+GQEIAVKRLS+
Sbjct: 307 EDNNEDEISFAESLQFDFDTIRVATNEFADCNKIGQGGFGAVYRGQLSNGQEIAVKRLSR 366
Query: 359 NSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV 418
+S QG++EFKNEVLLVA+LQHRNLVRLLGF E TERLL+YEFVPN S+D FIFD IK+
Sbjct: 367 DSGQGDMEFKNEVLLVAKLQHRNLVRLLGFCLEGTERLLVYEFVPNKSLDYFIFDPIKKA 426
Query: 419 QLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478
QLDW+ RYKIIGGIARG+LYLHEDSRLRIIHRDLKASNILLD +M PKISDFGMARL M
Sbjct: 427 QLDWQRRYKIIGGIARGLLYLHEDSRLRIIHRDLKASNILLDEEMHPKISDFGMARLVHM 486
Query: 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAED 538
DQ+Q +TSRIVGT+GYMAPEY G FS KSDVFSFGVLVLEIISG KN+ R GE ED
Sbjct: 487 DQTQENTSRIVGTYGYMAPEYAIYGQFSAKSDVFSFGVLVLEIISGHKNSGVRRGENVED 546
Query: 539 LLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598
LL +AW+NW +GT N++DPTL +G +EIMRC+HIGLLCVQENVA RPTMASV +MLNS
Sbjct: 547 LLCFAWRNWRDGTTTNIVDPTLTDGLRNEIMRCIHIGLLCVQENVAARPTMASVALMLNS 606
Query: 599 SSLSLPLPSQPAFF----------MHSTMEQDNLE-FTSSDQSKSGSIHFTVNEVTISEL 647
SL+LP+PS+PAF M S+ E ++ + S++QS S VNE +I+EL
Sbjct: 607 YSLTLPVPSEPAFVGDGRTRSLPDMQSSSEHNSRQTIESANQSAQNS----VNEASITEL 662
Query: 648 DPR 650
PR
Sbjct: 663 YPR 665
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574361|ref|XP_003555317.1| PREDICTED: cysteine-rich receptor-like protein kinase 28-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 706 bits (1821), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/657 (55%), Positives = 453/657 (68%), Gaps = 13/657 (1%)
Query: 1 MLLSIIRLTSGQTCYDT--GNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDE 58
+ + II S QT D GN+T +STY N + LSS +S GFY + GQ D+
Sbjct: 196 LFVIIISQASSQTPCDNSKGNYTIHSTYHNNLNTLLSSFSSHTEIKYGFYNFSYGQGTDK 255
Query: 59 VYGLALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSFFGKL 118
VY + LCRGD P+ C LN T + + K+CPNQKEAI W C++RY++RS G +
Sbjct: 256 VYAIGLCRGDLKPDECLRILNDTRVSLTKDCPNQKEAIMWT---VECMLRYTNRSILGVM 312
Query: 119 ELKPTEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYA 178
E +PT + N+T S+ QF+ SLM + A+ G S+ K+AT A + +TIYA
Sbjct: 313 ENQPTNHNYYDKNVTGSVNQFNDALESLMRNLTRTAASGDSRSKYATASAKAPNFQTIYA 372
Query: 179 LMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSP 238
QCTPDIS DC CL ++++ + CC GK G ++ PSC R++ Y FYG T L
Sbjct: 373 QAQCTPDISSEDCTKCLEEAISIIPECCSGKAGGNVVKPSCRIRFDPYIFYGPT---LKL 429
Query: 239 SPLSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQK- 297
P +PP+T + + S+ + II + + LV + C++LR K ++K
Sbjct: 430 DPDAPPTTPLQSPSTNNTSSQGKSNTSRTIIAIVVPVGSVVLVLSLFCIYLRLWKPRKKI 489
Query: 298 QNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLS 357
+ + DEI ESLQF+F TIR ATN F NKLGQGGFGAVYKG+LS+GQ IAVKRLS
Sbjct: 490 EKDKDEDEITFAESLQFNFDTIRVATNEFDDCNKLGQGGFGAVYKGQLSNGQVIAVKRLS 549
Query: 358 KNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKR 417
++S QG++EF+NEVLLVA+LQHRNLVRLLGFS E ERLL+YEFVPN S+D FIFD IK+
Sbjct: 550 RDSGQGDMEFENEVLLVAKLQHRNLVRLLGFSLEGRERLLVYEFVPNKSLDYFIFDPIKK 609
Query: 418 VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477
+QL+W+ RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD M PKISDFGMARL
Sbjct: 610 IQLNWQKRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDEQMHPKISDFGMARLIR 669
Query: 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAE 537
+DQ+QG+TSRIVGT+GYMAPEY G FS KSDVFSFGVLVLEI+SGQKN+ R GE E
Sbjct: 670 VDQTQGNTSRIVGTYGYMAPEYAIYGQFSAKSDVFSFGVLVLEIVSGQKNSGIRRGENVE 729
Query: 538 DLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597
DLLT+ W+NW EGTA N++DPTL +GS +EIMRC+HIGLLCVQEN A RPTM SVV+MLN
Sbjct: 730 DLLTFVWRNWREGTATNIVDPTLNDGSRNEIMRCIHIGLLCVQENDAGRPTMTSVVLMLN 789
Query: 598 SSSLSLPLPSQPAFFMHS---TMEQDNL-EFTSSDQSKSGSIHFTVNEVTISELDPR 650
S SLSLP+PS+PAF + S ++ L E SS S S +VNE +I+EL PR
Sbjct: 790 SYSLSLPVPSEPAFVVDSRTRSLPSSELTEHNSSQTRSSESTQNSVNEASITELYPR 846
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 650 | ||||||
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.529 | 0.514 | 0.582 | 3e-155 | |
| TAIR|locus:2123116 | 700 | CRK30 "cysteine-rich RLK (RECE | 0.987 | 0.917 | 0.462 | 7.6e-151 | |
| TAIR|locus:2121691 | 667 | CRK11 "cysteine-rich RLK (RECE | 0.513 | 0.500 | 0.571 | 4.1e-149 | |
| TAIR|locus:2141762 | 665 | CRK26 "cysteine-rich RLK (RECE | 0.487 | 0.476 | 0.636 | 3.6e-148 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.527 | 0.512 | 0.580 | 1.6e-143 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.529 | 0.508 | 0.584 | 6.2e-142 | |
| TAIR|locus:2123126 | 666 | CRK31 "cysteine-rich RLK (RECE | 0.533 | 0.521 | 0.548 | 1e-141 | |
| TAIR|locus:2121636 | 659 | CRK7 "cysteine-rich RLK (RECEP | 0.529 | 0.522 | 0.584 | 1.9e-140 | |
| TAIR|locus:2123056 | 656 | CRK32 "cysteine-rich RLK (RECE | 0.533 | 0.528 | 0.533 | 2.4e-140 | |
| TAIR|locus:2141201 | 679 | CRK29 "cysteine-rich RLK (RECE | 0.524 | 0.502 | 0.566 | 1.2e-138 |
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1030 (367.6 bits), Expect = 3.0e-155, Sum P(2) = 3.0e-155
Identities = 204/350 (58%), Positives = 253/350 (72%)
Query: 304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG 363
DEI T SLQF F TI AT+ FS N +G+GGFG VY+G+LS G E+AVKRLSK S QG
Sbjct: 323 DEITTTHSLQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQG 382
Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423
EFKNE +LV++LQH+NLVRLLGF E E++L+YEFVPN S+D F+FD K+ +LDW
Sbjct: 383 AEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWT 442
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
RY IIGGIARGILYLH+DSRL IIHRDLKASNILLDADM PKI+DFGMAR+F +DQSQ
Sbjct: 443 RRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQA 502
Query: 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF-RIGEEAEDLLTY 542
+T RI GTFGYM+PEY RGHFS+KSDV+SFGVLVLEIISG+KN+SF I + +L+T+
Sbjct: 503 NTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGSNLVTH 562
Query: 543 AWKNWNEGTALNLIDPTLRNG-SSSEIMRCVHIGLLCVQENVANRPTMAXXXXXXXXXXX 601
AW+ W G+ L L+DPT+ SSE RC+HI LLCVQE+ A+RP +
Sbjct: 563 AWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLPAIIMMLTSSTT 622
Query: 602 XXXXXXXXAFFMHST-MEQDNLEFTSSDQSKSGSIHFTVNEVTISELDPR 650
F + +EQD +E+T +S S SI ++N+ +I+E PR
Sbjct: 623 TLHVPRAPGFCLSGRDLEQDGVEYT---ESTSRSIPGSINDASITEFYPR 669
|
|
| TAIR|locus:2123116 CRK30 "cysteine-rich RLK (RECEPTOR-like protein kinase) 30" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1472 (523.2 bits), Expect = 7.6e-151, P = 7.6e-151
Identities = 306/661 (46%), Positives = 402/661 (60%)
Query: 3 LSIIRLTSGQTCYDT-GNFTTNSTYGKNRDLFLSSLASTVTANKGFYTATIGQIPDEVYG 61
+S+I + S Q C + G FT T+ KNR + LSSL S VTA GFY A+IG PD++Y
Sbjct: 16 VSLIIVVSAQLCSEKFGTFTPGGTFDKNRRIILSSLPSEVTAQDGFYNASIGTDPDQLYA 75
Query: 62 LALCRGDSSPESCASCLNFTVLDMMKNCPNQKEAISWEGMDFP-CVVRYSSRSFFGKLEL 120
+ +C + + C C+ +++ CPNQ AI W G C+ RY ++ L+L
Sbjct: 76 MGMCIPGAKQKLCRDCIMDVTRQLIQTCPNQTAAIHWSGGGKTVCMARYYNQPSSRPLDL 135
Query: 121 KPTEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSK-LKF------ATDEANLTSS 173
+ I +NV N++++LT FDR+W L+ ++ KAS + K L F A DE NLT+S
Sbjct: 136 ESVSIGYNVGNLSTNLTDFDRLWERLIAHMVTKASSASIKYLSFDNSRFYAADETNLTNS 195
Query: 174 ETIYALMQCTPDISQSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPFYGXXX 233
+ +YALMQCTPD+S S+C CL+QS+ D CC+GK+G Y+ PSCIFRW++YPF G
Sbjct: 196 QMVYALMQCTPDVSPSNCNTCLKQSVDDYVGCCHGKQGGYVYRPSCIFRWDLYPFNGAFD 255
Query: 234 XXXXXXXXXXXXXXXXXXIAKDKGGNXXXXXXXXXXXXXXXXXXXALVALITCVFXXXXX 293
KD+ AL+AL V
Sbjct: 256 LLTLAPPPSSQLQSPPPVTNKDEK-TIHTGTIIGIVIVVAMVIIMALLALGVSVCRSRKK 314
Query: 294 XXXXXXXXXADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAV 353
AD+I TV LQFD I AT+NF NK+GQGGFG VYKG LS+G E+AV
Sbjct: 315 YQAFASET-ADDITTVGYLQFDIKDIEAATSNFLASNKIGQGGFGEVYKGTLSNGTEVAV 373
Query: 354 KRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFD 413
KRLS+ S QGELEFKNEVLLVA+LQHRNLVRLLGF+ + E++L++EFVPN S+D F+F
Sbjct: 374 KRLSRTSDQGELEFKNEVLLVAKLQHRNLVRLLGFALQGEEKILVFEFVPNKSLDYFLFG 433
Query: 414 AI---KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF 470
+ K+ QLDW RY IIGGI RG+LYLH+DSRL IIHRD+KASNILLDADM PKI+DF
Sbjct: 434 STNPTKKGQLDWTRRYNIIGGITRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADF 493
Query: 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF 530
GMAR F Q++ T R+VGTFGYM PEYV G FS KSDV+SFGVL+LEI+SG+KN+SF
Sbjct: 494 GMARNFRDHQTEDSTGRVVGTFGYMPPEYVAHGQFSTKSDVYSFGVLILEIVSGRKNSSF 553
Query: 531 -RIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGS--SSEIMRCVHIGLLCVQENVANRP 587
++ +L+TY W+ WN ++L L+DP + +GS E+ RC+HIGLLCVQEN NRP
Sbjct: 554 YQMDGSVCNLVTYVWRLWNTDSSLELVDPAI-SGSYEKDEVTRCIHIGLLCVQENPVNRP 612
Query: 588 TMAXXXXXXXXXXXXXXXXXXXAFFMHSTMEQDNLEF-TSSDQSKSGSIHFTVNEVTISE 646
++ FF + E D L DQ + S+ +++ TI+
Sbjct: 613 ALSTIFQMLTNSSITLNVPQPPGFFFRNRPESDTLRRGLEPDQYNNESVTCSIDNATITT 672
Query: 647 L 647
L
Sbjct: 673 L 673
|
|
| TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 961 (343.3 bits), Expect = 4.1e-149, Sum P(2) = 4.1e-149
Identities = 193/338 (57%), Positives = 245/338 (72%)
Query: 305 EINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGE 364
+I+T +SL +DF TI ATN FST NKLG+GGFGAVYKG+LS+G ++AVKRLSK S QG
Sbjct: 329 DISTTDSLVYDFKTIEAATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVKRLSKKSGQGT 388
Query: 365 LEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWET 424
EF+NE +LV +LQHRNLVRLLGF E E++LIYEFV N S+D F+FD K+ QLDW
Sbjct: 389 REFRNEAVLVTKLQHRNLVRLLGFCLEREEQILIYEFVHNKSLDYFLFDPEKQSQLDWTR 448
Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
RYKIIGGIARGILYLH+DSRL+IIHRDLKASNILLDADM PKI+DFG+A +F ++Q+QG+
Sbjct: 449 RYKIIGGIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGLATIFGVEQTQGN 508
Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS-FRIGEE--AEDLLT 541
T+RI GT+ YM+PEY G +S+KSD++SFGVLVLEIISG+KN+ +++ E A +L+T
Sbjct: 509 TNRIAGTYAYMSPEYAMHGQYSMKSDIYSFGVLVLEIISGKKNSGVYQMDETSTAGNLVT 568
Query: 542 YAWKNWNEGTALNLIDPTL-RNGSSSEIMRCVHIGLLCVQENVANRPTMAXXXXXXXXXX 600
YA + W + L L+DPT RN S+E+ RC+HI LLCVQEN +RP ++
Sbjct: 569 YASRLWRNKSPLELVDPTFGRNYQSNEVTRCIHIALLCVQENPEDRPMLSTIILMLTSNT 628
Query: 601 XXXXXXXXXAFFMHSTMEQDNLEFTSSDQSKSGSIHFT 638
FF S + E + SDQ S S F+
Sbjct: 629 ITLPVPRLPGFFPRSRQLKLVSEGSESDQYTSKSSSFS 666
|
|
| TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1049 (374.3 bits), Expect = 3.6e-148, Sum P(2) = 3.6e-148
Identities = 205/322 (63%), Positives = 255/322 (79%)
Query: 304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG 363
+ I+T +S++FDFS ++DAT++FS +NKLG+GGFGAVYKG LS GQ+IAVKRLSKN+ QG
Sbjct: 323 ENIST-DSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAVKRLSKNAQQG 381
Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423
E EFKNE LLVA+LQHRNLV+LLG+S E TERLL+YEF+P++S+DKFIFD I+ +L+WE
Sbjct: 382 ETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNELEWE 441
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS-Q 482
RYKIIGG+ARG+LYLH+DSRLRIIHRDLKASNILLD +M PKI+DFGMARLF++D + Q
Sbjct: 442 IRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDIDHTTQ 501
Query: 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTY 542
T+RIVGTFGYMAPEYV G FS K+DV+SFGVLVLEIISG+KN+ F + DL+++
Sbjct: 502 RYTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISGKKNSGFSSEDSMGDLISF 561
Query: 543 AWKNWNEGTALNLIDP---TLRNGSSSEIMRCVHIGLLCVQENVANRPTMAXXXXXXXXX 599
AW+NW EG ALNL+D T+ + SS+ IMRC++IGLLCVQE VA RP+MA
Sbjct: 562 AWRNWKEGVALNLVDKILMTMSSYSSNMIMRCINIGLLCVQEKVAERPSMASVVLMLDGH 621
Query: 600 XXXXXXXXXXAFFMHSTMEQDN 621
AFF HS D+
Sbjct: 622 TIALSEPSKPAFFSHSNAVSDS 643
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1036 (369.7 bits), Expect = 1.6e-143, Sum P(2) = 1.6e-143
Identities = 202/348 (58%), Positives = 260/348 (74%)
Query: 304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG 363
D+I T +SLQ D+ TI+ AT++F NK+GQGGFG VYKG LS G E+AVKRLSK+S QG
Sbjct: 326 DDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQG 385
Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423
E+EFKNEV+LVA+LQHRNLVRLLGF + ER+L+YE+VPN S+D F+FD K+ QLDW
Sbjct: 386 EVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWT 445
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
RYKIIGG+ARGILYLH+DSRL IIHRDLKASNILLDADM PKI+DFGMAR+F +DQ++
Sbjct: 446 RRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEE 505
Query: 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYA 543
+TSRIVGT+GYM+PEY G +S+KSDV+SFGVLVLEIISG+KN+SF + A DL++YA
Sbjct: 506 NTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYA 565
Query: 544 WKNWNEGTALNLIDPTL-RNGSSSEIMRCVHIGLLCVQENVANRPTMAXXXXXXXXXXXX 602
W W+ G L L+DP + N +E++RCVHIGLLCVQE+ A RPT++
Sbjct: 566 WGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVT 625
Query: 603 XXXXXXXAFFMHSTMEQDNLEFTSSDQSKSGSIHFTVNEVTISELDPR 650
F S + +D L+ ++ +S GS V++ +I+++ PR
Sbjct: 626 LPVPRQPGLFFQSRIGKDPLDTDTTSKSLLGS----VDDASITDIHPR 669
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1041 (371.5 bits), Expect = 6.2e-142, Sum P(2) = 6.2e-142
Identities = 204/349 (58%), Positives = 263/349 (75%)
Query: 304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG 363
D++ T +SLQ D+ TI+ ATN+F+ NK+G+GGFG VYKG S+G+E+AVKRLSKNS QG
Sbjct: 331 DDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQG 390
Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423
E EFK EV++VA+LQHRNLVRLLGFS + ER+L+YE++PN S+D +FD K+ QLDW
Sbjct: 391 EAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWM 450
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
RY IIGGIARGILYLH+DSRL IIHRDLKASNILLDAD+ PKI+DFGMAR+F +DQ+Q
Sbjct: 451 QRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQD 510
Query: 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYA 543
+TSRIVGT+GYMAPEY G FS+KSDV+SFGVLVLEIISG+KN+SF + A+DLLT+
Sbjct: 511 NTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLTHT 570
Query: 544 WKNWNEGTALNLIDPTLRNG-SSSEIMRCVHIGLLCVQENVANRPTMAXXXXXXXXXXXX 602
W+ W TAL+L+DP + N +SE++RC+HIGLLCVQE+ A RPT++
Sbjct: 571 WRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLTSNTVT 630
Query: 603 XXXXXXXAFFMHSTMEQDNLEFTSSDQSKSG-SIHFTVNEVTISELDPR 650
FF+ S+ +D T SDQS + S ++++ I++L PR
Sbjct: 631 LPVPRQPGFFIQSSPVKDP---TDSDQSTTTKSTPASIDDELITDLYPR 676
|
|
| TAIR|locus:2123126 CRK31 "cysteine-rich RLK (RECEPTOR-like protein kinase) 31" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 995 (355.3 bits), Expect = 1.0e-141, Sum P(2) = 1.0e-141
Identities = 192/350 (54%), Positives = 251/350 (71%)
Query: 304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG 363
D++ + +SLQFDF+TI AT+NFS +NKLGQGGFG VYKG L + EIAVKRLS NS QG
Sbjct: 317 DDMTSPQSLQFDFTTIEVATDNFSRNNKLGQGGFGEVYKGMLPNETEIAVKRLSSNSGQG 376
Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423
EFKNEV++VA+LQH+NLVRLLGF E E++L+YEFV N S+D F+FD + QLDW+
Sbjct: 377 TQEFKNEVVIVAKLQHKNLVRLLGFCIERDEQILVYEFVSNKSLDYFLFDPKMKSQLDWK 436
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
RY IIGG+ RG+LYLH+DSRL IIHRD+KASNILLDADM PKI+DFGMAR F +DQ++
Sbjct: 437 RRYNIIGGVTRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRVDQTED 496
Query: 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF-RIGEEAEDLLTY 542
T R+VGTFGYM PEYVT G FS KSDV+SFGVL+LEI+ G+KN+SF ++ + +L+T+
Sbjct: 497 QTGRVVGTFGYMPPEYVTHGQFSTKSDVYSFGVLILEIVCGKKNSSFFQMDDSGGNLVTH 556
Query: 543 AWKNWNEGTALNLIDPTLRNG-SSSEIMRCVHIGLLCVQENVANRPTMAXXXXXXXXXXX 601
W+ WN + L+LIDP ++ + E++RC+HIG+LCVQE A+RP M+
Sbjct: 557 VWRLWNNDSPLDLIDPAIKESYDNDEVIRCIHIGILCVQETPADRPEMSTIFQMLTNSSI 616
Query: 602 XXXXXXXXAFFMHSTMEQDNLEFTSSD-QSKSGSIHFTVNEVTISELDPR 650
FF + D L + S QS S S+ F+++ +I+ PR
Sbjct: 617 TLPVPRPPGFFFRNRPNLDPLTYGSEQGQSSSMSVPFSIDSASITRATPR 666
|
|
| TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1046 (373.3 bits), Expect = 1.9e-140, Sum P(2) = 1.9e-140
Identities = 204/349 (58%), Positives = 262/349 (75%)
Query: 304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG 363
D+ T+ESLQ D+ I+ ATN+FS +NK+G+GGFG VYKG S+G E+AVKRLSK S QG
Sbjct: 314 DDKTTIESLQLDYRAIQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSEQG 373
Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423
+ EFKNEV++VA L+H+NLVR+LGFS E ER+L+YE+V N S+D F+FD K+ QL W
Sbjct: 374 DTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLYWT 433
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
RY IIGGIARGILYLH+DSRL IIHRDLKASNILLDADM PKI+DFGMAR+F MDQ+Q
Sbjct: 434 QRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQ 493
Query: 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYA 543
+TSRIVGT+GYM+PEY RG FS+KSDV+SFGVLVLEIISG+KNNSF ++A+DL+T+A
Sbjct: 494 NTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQDLVTHA 553
Query: 544 WKNWNEGTALNLIDPTLRNGS-SSEIMRCVHIGLLCVQENVANRPTMAXXXXXXXXXXXX 602
W+ W GTAL+L+DP + + SE++RC HIGLLCVQE+ RP M+
Sbjct: 554 WRLWRNGTALDLVDPFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVMLTSNTMA 613
Query: 603 XXXXXXXAFFMHSTMEQDNLEFTSSDQSKSG-SIHFTVNEVTISELDPR 650
FF+ S + L+ SDQS + S+ ++++ ++S+LDPR
Sbjct: 614 LPAPQQPGFFVRSRPGTNRLD---SDQSTTNKSVTVSIDDKSMSDLDPR 659
|
|
| TAIR|locus:2123056 CRK32 "cysteine-rich RLK (RECEPTOR-like protein kinase) 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 971 (346.9 bits), Expect = 2.4e-140, Sum P(2) = 2.4e-140
Identities = 191/358 (53%), Positives = 251/358 (70%)
Query: 304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG 363
D++ + +SLQFDF T+ AT+ FS +NKLG+GGFG VYKG L + E+AVKRLS NS QG
Sbjct: 299 DDMTSPQSLQFDFMTLEAATDKFSRNNKLGKGGFGEVYKGMLPNETEVAVKRLSSNSGQG 358
Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIF--------DAI 415
EFKNEV++VA+LQH+NLVRLLGF E E++L+YEFVPN S++ F+F D
Sbjct: 359 TQEFKNEVVIVAKLQHKNLVRLLGFCLERDEQILVYEFVPNKSLNYFLFGNKQKHLLDPT 418
Query: 416 KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475
K+ QLDW+ RY IIGGI RG+LYLH+DSRL IIHRD+KASNILLDADM PKI+DFGMAR
Sbjct: 419 KKSQLDWKRRYNIIGGITRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARN 478
Query: 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF-RIGE 534
F +DQ++ +T R+VGTFGYM PEYVT G FS KSDV+SFGVL+LEI+ G+KN+SF +I +
Sbjct: 479 FRVDQTEDNTRRVVGTFGYMPPEYVTHGQFSTKSDVYSFGVLILEIVCGKKNSSFYKIDD 538
Query: 535 EAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSE-IMRCVHIGLLCVQENVANRPTMAXXX 593
+L+T+ W+ WN + L+LIDP + ++ ++RC+HIGLLCVQE +RP M+
Sbjct: 539 SGGNLVTHVWRLWNNDSPLDLIDPAIEESCDNDKVIRCIHIGLLCVQETPVDRPEMSTIF 598
Query: 594 XXXXXXXXXXXXXXXXAFFMHSTMEQDNLEFTSS-DQSKSGSIHFTVNEVTISELDPR 650
FF + D L + S QS S SI +T++ +I+ + PR
Sbjct: 599 QMLTNSSITLPVPRPPGFFFRNRSNLDPLTYGSELGQSSSKSIPYTIDSASITRVTPR 656
|
|
| TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1010 (360.6 bits), Expect = 1.2e-138, Sum P(2) = 1.2e-138
Identities = 199/351 (56%), Positives = 255/351 (72%)
Query: 304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG 363
DE + ESL F T++ AT+NFS++N+LG+GGFG+VYKG GQEIAVKRLS NS QG
Sbjct: 335 DEFSNTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQG 394
Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423
+ EFKNE+LL+A+LQHRNLVRL+GF + ERLL+YEF+ N+S+D+FIFD KR LDW
Sbjct: 395 DNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQLLDWV 454
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
RYK+IGGIARG+LYLHEDSR RIIHRDLKASNILLD +M PKI+DFG+A+LF+ Q+
Sbjct: 455 VRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMT 514
Query: 484 D--TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIG--EEAEDL 539
TSRI GT+GYMAPEY G FS+K+DVFSFGVLV+EII+G++NN+ E+AEDL
Sbjct: 515 HRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDL 574
Query: 540 LTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMAXXXXXXXXX 599
L++ W++W E T L++IDP+L GS +EI+RC+HIGLLCVQE+ A RPTMA
Sbjct: 575 LSWVWRSWREDTILSVIDPSLTAGSRNEILRCIHIGLLCVQESAATRPTMATVSLMLNSY 634
Query: 600 XXXXXXXXXXAFFMHSTMEQDNLEFTSSDQSKSGSIHFTVNEVTISELDPR 650
AF + S + N+ S + + + N+VT+SE PR
Sbjct: 635 SFTLPTPLRPAFVLESVVIPSNVS------SSTEGLQMSSNDVTVSEFSPR 679
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8H199 | CRK14_ARATH | 2, ., 7, ., 1, 1, ., - | 0.4953 | 0.9707 | 0.9589 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 650 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-49 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-47 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-34 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-32 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-29 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-29 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 7e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-29 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-28 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-27 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-26 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 2e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-25 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-24 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-23 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-22 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-21 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-18 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-17 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-16 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-04 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.001 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.002 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-50
Identities = 90/282 (31%), Positives = 134/282 (47%), Gaps = 42/282 (14%)
Query: 329 DNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNL 382
KLG+G FG VYKG+L E+AVK L +++ + ++ EF E ++ +L H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
V+LLG EE ++ E++ + ++ R +L IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT---FGYMAPEY 499
IHRDL A N L+ +++ KISDFG++R D D R G +MAPE
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPES 174
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559
+ G F+ KSDV+SFGVL+ EI + GE+ Y + E L
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTL--------GEQP-----YPGMSNEE--VLEY---- 215
Query: 560 LRNGSSSEIM-RC----VHIGLLCVQENVANRPTMASVVVML 596
L+NG C + L C E+ +RPT + +V +L
Sbjct: 216 LKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 3e-50
Identities = 74/218 (33%), Positives = 116/218 (53%), Gaps = 23/218 (10%)
Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLGFS 389
LG+GGFG VY R G+++A+K + K LE E+ ++ +L H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
+E L+ E+ S+ + + +L + +I+ I G+ YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 450 RDLKASNILLDAD-MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE-YVTRGHFSI 507
RDLK NILLD+D K++DFG+++L D+S IVGT YMAPE + +G++S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 508 KSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWK 545
KSD++S GV++ E+ E +DL+ +
Sbjct: 174 KSDIWSLGVILYEL------------PELKDLIRKMLQ 199
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 1e-49
Identities = 89/283 (31%), Positives = 133/283 (46%), Gaps = 43/283 (15%)
Query: 329 DNKLGQGGFGAVYKGRLS-----HGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNL 382
KLG+G FG VYKG L E+AVK L ++ S Q EF E ++ +L H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
V+LLG EE +++ E++P + ++ + +L IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT---FGYMAPEY 499
IHRDL A N L+ +++ KISDFG++R D D ++ G +MAPE
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPES 175
Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558
+ G F+ KSDV+SFGVL+ EI + G+ G ++L Y
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGE---EPYPGMSNAEVLEY---------------- 216
Query: 559 TLRNGSSSEIM-RC----VHIGLLCVQENVANRPTMASVVVML 596
L+ G C + L C E+ +RPT + +V +L
Sbjct: 217 -LKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 2e-47
Identities = 86/280 (30%), Positives = 135/280 (48%), Gaps = 41/280 (14%)
Query: 331 KLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVR 384
KLG+G FG VYKG L ++AVK L + + + E EF E ++ +L H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
LLG + ++ E++P + F+ +L + ++ IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRK--HGEKLTLKDLLQMALQIAKGMEYLES--- 120
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
+HRDL A N L+ +++ KISDFG++R ++E D + + +MAPE + G
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK-WMAPESLKDG 179
Query: 504 HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID-----P 558
F+ KSDV+SFGVL+ EI + GE+ Y + E L L++ P
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTL--------GEQ-----PYPGMSNEE--VLELLEDGYRLP 224
Query: 559 TLRNGSSS--EIMRCVHIGLLCVQENVANRPTMASVVVML 596
N E+M L C + +RPT + +V L
Sbjct: 225 RPENCPDELYELM------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 4e-47
Identities = 74/262 (28%), Positives = 123/262 (46%), Gaps = 29/262 (11%)
Query: 326 FSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLV 383
+ KLG+G FG VY R G+ +A+K + K ++ + E E+ ++ +L+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLD-WETRYKIIGGIARGILYLHED 442
RL +E + L+ E+ + + KR +L E R+ + I + YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARF-YLRQILSALEYLHS- 115
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
I+HRDLK NILLD D K++DFG+AR + VGT YMAPE +
Sbjct: 116 --KGIVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLG 170
Query: 503 GHFSIKSDVFSFGVLVLEIISG--------QKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554
+ D++S GV++ E+++G Q F+ + + + + A +
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISP-EAKD 229
Query: 555 LI------DPTLRNGSSSEIMR 570
LI DP R ++ E ++
Sbjct: 230 LIRKLLVKDPEKR-LTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 7e-47
Identities = 81/252 (32%), Positives = 121/252 (48%), Gaps = 30/252 (11%)
Query: 331 KLGQGGFGAVYKGRLSH-GQEIAVKRLSK--NSVQGELEFKNEVLLVARLQHRNLVRLLG 387
KLG G FG VYK + G+ +AVK L K + + + E+ ++ RL H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
++ L+ E+ + ++ + L + KI I RG+ YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH--F 505
IHRDLK NILLD + + KI+DFG+A+ S + VGT YMAPE V G +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPE-VLLGGNGY 176
Query: 506 SIKSDVFSFGVLVLEIISGQ--------KNNSFRIGEEAEDLLTYAWKNWNEG--TALNL 555
K DV+S GV++ E+++G+ + I L + W+ G A +L
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL 236
Query: 556 I------DPTLR 561
I DP+ R
Sbjct: 237 IKKCLNKDPSKR 248
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-46
Identities = 87/297 (29%), Positives = 134/297 (45%), Gaps = 66/297 (22%)
Query: 330 NKLGQGGFGAVYKGRLSHGQ----EIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVR 384
KLG+G FG VYKG+L E+AVK L +++ + E +F E ++ +L H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKIIGGIARGILY 438
LLG EE L+ E++ + ++ F + ++ L + IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMA 496
L + +HRDL A N L+ D++ KISDFG++R ++ + G +MA
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR--DVYDDDYYRKKTGGKLPIRWMA 175
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE------AEDLLTYAWKNWNEG 550
PE + G F+ KSDV+SFGVL+ EI + G E++L Y
Sbjct: 176 PESLKDGIFTSKSDVWSFGVLLWEIFTL--------GATPYPGLSNEEVLEY-------- 219
Query: 551 TALNLIDPTLRNGS--------SSEI---MRCVHIGLLCVQENVANRPTMASVVVML 596
LR G E+ M C Q + +RPT + +V L
Sbjct: 220 ---------LRKGYRLPKPEYCPDELYELMLS------CWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 17/204 (8%)
Query: 330 NKLGQGGFGAVYKGRLSH-GQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRNLVRLL 386
LG+G FG+VY G+ +AVK LS +S + + E+ +++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 387 GFSFEETER-LLIY-EFVPNSSVDKFIFDAIKRVQLDWET---RYKIIGGIARGILYLHE 441
G +E + L I+ E+V S + +K+ E +Y I G+ YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGS----LSSLLKKFGKLPEPVIRKY--TRQILEGLAYLH- 118
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
I+HRD+K +NIL+D+D + K++DFG A+ ++ T + GT +MAPE +
Sbjct: 119 --SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 502 RGHFSIKSDVFSFGVLVLEIISGQ 525
+ +D++S G V+E+ +G+
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 78/278 (28%), Positives = 128/278 (46%), Gaps = 50/278 (17%)
Query: 326 FSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
F K+G+GGFG VYK R G+E+A+K + S + + + NE+ ++ + +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGGIARGIL----YL 439
G ++ E ++ EF S+ D +K Q E+ I + + +L YL
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLK----DLLKSTNQTLTES---QIAYVCKELLKGLEYL 114
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
H IIHRD+KA+NILL +D K+ DFG++ + +VGT +MAPE
Sbjct: 115 HS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS---DTKARNTMVGTPYWMAPEV 168
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ----KNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555
+ + K+D++S G+ +E+ G+ + + AL
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK--------------------ALFK 208
Query: 556 ID----PTLRNGS-SSEIMRCVHIGLLCVQENVANRPT 588
I P LRN S+ + C+Q+N RPT
Sbjct: 209 IATNGPPGLRNPEKWSDEFK--DFLKKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 6e-33
Identities = 70/217 (32%), Positives = 113/217 (52%), Gaps = 7/217 (3%)
Query: 326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
F+ + KLG G FG V++G + +A+K L + + + +F+ EV + RL+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445
+I E + S+ F+ +V L + + +A G+ YL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
IHRDL A NIL+ D++ K++DFG+ARL + D +I + + APE + G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 506 SIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLT 541
S KSDV+SFG+L+ E+ + GQ E D +T
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 65/206 (31%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 325 NFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGE--LEFKNEVLLVARLQHRN 381
N+ + +G+G FG VYKG L G +A+K++S ++ E E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFI--FDAIKRVQLDWETRYKIIGGIARGILYL 439
+V+ +G +I E+ N S+ + I F + Y + + +G+ YL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV---AVY--VYQVLQGLAYL 115
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
HE +IHRD+KA+NIL D + K++DFG+A +++ D + +VGT +MAPE
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVAT--KLNDVSKDDASVVGTPYWMAPEV 170
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
+ S SD++S G V+E+++G
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 81/279 (29%), Positives = 123/279 (44%), Gaps = 39/279 (13%)
Query: 330 NKLGQGGFGAVYKG--RLSHGQEI--AVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVR 384
+LG G FG+V KG + G+E+ AVK L + G+ EF E ++A+L H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFD--AIKRVQL-DWETRYKIIGGIARGILYLHE 441
L+G E +L+ E P + K++ I L + + +A G+ YL
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEY 499
+HRDL A N+LL KISDFGM+R S + G + + APE
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG-SDYYRATTAGRWPLKWYAPEC 169
Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558
+ G FS KSDV+S+GV + E S G K Y E + +++
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAK--------------PYGEMKGAE--VIAMLES 213
Query: 559 TLRNGSSSEIMRCVH-IGLLCVQENVANRPTMASVVVML 596
R E + ++ I L C + +RPT + +
Sbjct: 214 GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 66/211 (31%), Positives = 109/211 (51%), Gaps = 17/211 (8%)
Query: 330 NKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLV 383
+LG+G FG V R + G+++AVK L+ + + +F+ E+ ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 384 RLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
+ G + R LI E++P+ S+ ++ R Q++ + I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS--QGDTSRIVGTFGYMAPEY 499
R IHRDL A NIL++++ + KISDFG+A++ D+ F Y APE
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS 529
+ FS SDV+SFGV + E+ + G + S
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (303), Expect = 8e-30
Identities = 83/337 (24%), Positives = 137/337 (40%), Gaps = 20/337 (5%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE---FKNEVLLVARLQH-R 380
++ KLG+G FG VY R + +A+K L+K E F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
N+V+L F +E L+ E+V S++ + ++ L I+ I + YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 441 EDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARLFEMDQS----QGDTSRIVGTFGYM 495
IIHRD+K NILLD D + K+ DFG+A+L S S VGT GYM
Sbjct: 119 S---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 496 APEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA 552
APE + + S SD++S G+ + E+++G A +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 553 LNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSLPLPSQPAFF 612
+ + P+ S + + ++ NR + +S + + L L
Sbjct: 236 ASPLSPSNPELISKAAS---DLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292
Query: 613 MHSTMEQDNLEFTSSDQSKSGSIHFTVNEVTISELDP 649
L S ++ S++ + +LD
Sbjct: 293 KPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDD 329
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 29/214 (13%)
Query: 332 LGQGGFGAVYKGRLSHGQE------IAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVR 384
LG+G FG V+ G H + +AVK L + + +F+ E L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIF----DAI-------KRVQLDWETRYKIIGGIA 433
G E ++++E++ + ++KF+ DA +L +I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT-- 491
G++YL + +HRDL N L+ D++ KI DFGM+R D D R+ G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185
Query: 492 --FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+M PE + F+ +SDV+SFGV++ EI +
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 64/200 (32%), Positives = 103/200 (51%), Gaps = 16/200 (8%)
Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLG 387
LG+G FG V R G+ A+K L K + + E +++R+ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRL 445
++F+ E+L L+ E+ P + + K + E R + I + YLH L
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLS---KEGRFS-EERARFYAAEIVLALEYLH---SL 112
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
II+RDLK NILLDAD K++DFG+A+ + S+ +T GT Y+APE + +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGY 170
Query: 506 SIKSDVFSFGVLVLEIISGQ 525
D +S GVL+ E+++G+
Sbjct: 171 GKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 65/194 (33%), Positives = 101/194 (52%), Gaps = 15/194 (7%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE 391
+G+G FG V G GQ++AVK L K+ F E ++ L+H NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 392 ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRD 451
++ E++ S+ ++ + R + + + G+ YL E +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 452 LKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTRGHFSIKS 509
L A N+L+ D++ K+SDFG+A+ + SQG S G + APE + FS KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK----EASQGQDS---GKLPVKWTAPEALREKKFSTKS 180
Query: 510 DVFSFGVLVLEIIS 523
DV+SFG+L+ EI S
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 69/203 (33%), Positives = 106/203 (52%), Gaps = 12/203 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
+ + KLG G FG V+ G + ++AVK L ++ E F E ++ +L+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLV 64
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
+L EE ++ E++ S+ F+ + +L + IA G+ YL
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYLE--- 120
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ---SQGDTSRIVGTFGYMAPEYV 500
IHRDL A NIL+ +++ KI+DFG+ARL E D+ +G I T APE
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAA 176
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
G F+IKSDV+SFG+L+ EI++
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEI-AVKRLS-KNSVQGELEF-KNEVLLVARLQHRNLVRLL 386
++G+G FG VY R ++ +K + N + E E NEV ++ +L H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 387 GFSFEETERLLI-YEFVPNSSVDKFIFDAIKRVQ-------LDWETRYKIIGGIARGILY 438
SFEE +L I E+ + + I K + LDW + + + Y
Sbjct: 66 E-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALKY 118
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
LH +I+HRD+K NI L ++ + K+ DFG++++ T +VGT Y++PE
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPE 173
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQK 526
++ KSD++S G ++ E+ + +
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-29
Identities = 45/102 (44%), Positives = 57/102 (55%), Gaps = 6/102 (5%)
Query: 16 DTGNFTT-NSTYGKNRDLFLSSLAS--TVTANKGFYTATIGQIPDEVYGLALCRGDSSPE 72
+GN+TT NST+ N + LSSL+S ++ KGF T G PD VYGLA CRGD S
Sbjct: 8 TSGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSAS 67
Query: 73 SCASCLNFTVLDMMKNCPNQKEAISWEGMDFPCVVRYSSRSF 114
C SCL V ++ + CPN+K W C +RY S F
Sbjct: 68 DCRSCLATAVSELRRCCPNKKGGRIWYD---SCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 60/203 (29%), Positives = 107/203 (52%), Gaps = 21/203 (10%)
Query: 331 KLGQGGFGAVYKGRLSH---GQEIAVKRL-SKNSVQGELEFKNEVLLVARLQHRNLVRLL 386
LGQG G VYK R H G+ A+K++ + + E+ + + +V+
Sbjct: 8 VLGQGSSGVVYKVR--HKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL----YLHED 442
G ++E E ++ E++ S+ D +K+V E ++ IAR IL YLH
Sbjct: 66 GAFYKEGEISIVLEYMDGGSLA----DLLKKVGKIPE---PVLAYIARQILKGLDYLH-- 116
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
++ IIHRD+K SN+L+++ KI+DFG++++ ++ + + VGT YM+PE +
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVGTVTYMSPERIQG 174
Query: 503 GHFSIKSDVFSFGVLVLEIISGQ 525
+S +D++S G+ +LE G+
Sbjct: 175 ESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 87/283 (30%), Positives = 127/283 (44%), Gaps = 41/283 (14%)
Query: 330 NKLGQGGFGAVYKGRLSHG------QEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNL 382
LG G FG VY+G ++AVK L ++ S Q E +F E L++++ H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV----QLDWETRYKIIGGIARGILY 438
VRL+G SFE R ++ E + + F+ + R L + +A+G Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 439 LHEDSRLRIIHRDLKASNILLD---ADMIPKISDFGMARLFEMDQSQGDTSRIVGT---- 491
L E+ IHRD+ A N LL + KI+DFGMAR D + R G
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAMLP 184
Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEG 550
+M PE G F+ K+DV+SFGVL+ EI S G R +E + +T G
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-------GG 237
Query: 551 TALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVV 593
L+ P G IM C Q +RP A+++
Sbjct: 238 GRLD--PPKGCPGPVYRIMT------DCWQHTPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 64/211 (30%), Positives = 116/211 (54%), Gaps = 15/211 (7%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGE-LEFKNEVLLVARLQ 378
+ + + +G G FG V +GRL + +A+K L S + L+F E ++ +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
H N++RL G + ++I E++ N S+DKF+ + + ++ GIA G+ Y
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKY 121
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS--RIVGTFGYMA 496
L S + +HRDL A NIL++++++ K+SDFG++R E ++ T +I + A
Sbjct: 122 L---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTA 176
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
PE + F+ SDV+SFG+++ E++S G++
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 83/280 (29%), Positives = 135/280 (48%), Gaps = 58/280 (20%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVK--------RLSKNSVQGELEFKNEVLLVARLQHRNL 382
LG G FG+VY+G L G AVK + + +V+ +LE E+ L+++LQH N+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK-QLE--QEIALLSKLQHPNI 64
Query: 383 VRLLGFSFEETERLLIY-EFVPNSSVDKFI--FDAIKRVQLDWETRYKIIGGIARGILYL 439
V+ LG EE + L I+ E VP S+ K + + + + TR +I+ G+ YL
Sbjct: 65 VQYLGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLE----YL 118
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
H+ +HRD+K +NIL+D + + K++DFGMA+ G+ +MAPE
Sbjct: 119 HDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV---EFSFAKSFKGSPYWMAPEV 172
Query: 500 VTR-GHFSIKSDVFSFGVLVLEIISGQKNNS--------FRIGEEAEDLLTYAWKNWNEG 550
+ + G + + +D++S G VLE+ +G+ S F+IG E
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE------------- 219
Query: 551 TALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMA 590
L I L + + I+ C+Q + + RPT A
Sbjct: 220 --LPPIPDHLSDEAKDFIL-------KCLQRDPSLRPTAA 250
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 21/206 (10%)
Query: 332 LGQGGFGAVYKGR-LSHGQ----EIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRL 385
LG G FG VYKG + G+ +A+K L + + + E +E ++A + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIARGILYLHE 441
LG LI + +P + ++ + + L+W + IA+G+ YL E
Sbjct: 75 LGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
R++HRDL A N+L+ KI+DFG+A+L ++D+ + +MA E +
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 502 RGHFSIKSDVFSFGVLVLEIIS-GQK 526
++ KSDV+S+GV V E+++ G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 9e-28
Identities = 76/267 (28%), Positives = 126/267 (47%), Gaps = 35/267 (13%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
++G G FG V+ G +++A+K + + ++ E +F E ++ +L H LV+L G
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE-DFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
E + L++EF+ + + ++ +R + ET + + G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT---FGYMAPEYVTRGHFSI 507
DL A N L+ + + K+SDFGM R DQ T GT + +PE + +S
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180
Query: 508 KSDVFSFGVLVLEIISGQK----NNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNG 563
KSDV+SFGVL+ E+ S K N S E E + L P L +
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSN--SEVVETI----------NAGFRLYKPRLASQ 228
Query: 564 SSSEIMRCVHIGLLCVQENVANRPTMA 590
S E+M+ C +E +RP+ +
Sbjct: 229 SVYELMQ------HCWKERPEDRPSFS 249
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 9e-28
Identities = 71/195 (36%), Positives = 110/195 (56%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
KLG G FG V+ G + ++A+K L + S+ E F E L+ +LQH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
+E +I E++ N S+ F+ + ++L + IA G+ ++ R IHR
Sbjct: 72 QEP-IYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHR 126
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTRGHFSIK 508
DL+A+NIL+ + KI+DFG+ARL E ++ T+R F + APE + G F+IK
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 509 SDVFSFGVLVLEIIS 523
SDV+SFG+L+ EI++
Sbjct: 184 SDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 72/216 (33%), Positives = 105/216 (48%), Gaps = 31/216 (14%)
Query: 332 LGQGGFGAVYKGRL------SHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVR 384
LG+G FG VYKG L +A+K L +N + + EF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 385 LLGFSFEETERLLIYEFV-------------PNSSVDKFIFDAIKRVQLDWETRYKIIGG 431
LLG +E +++E++ P+S V D + LD I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
IA G+ YL S +HRDL A N L+ + KISDFG++R D D R+
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR----DIYSADYYRVQSK 185
Query: 492 ----FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+M PE + G F+ +SD++SFGV++ EI S
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 65/227 (28%), Positives = 108/227 (47%), Gaps = 33/227 (14%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSK---NSVQGELEFKNEVLLVARL-Q 378
++F +G+G F V + +E A+K L K + K E ++ RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWE-TRYKIIGGIARGI 436
H +++L ++F++ E L + E+ PN + ++I K LD + TR+ I +
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRF-YAAEILLAL 115
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF-------------EMDQSQG 483
YLH IIHRDLK NILLD DM KI+DFG A++ SQ
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 484 DTSRI-----VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
+ +R VGT Y++PE + SD+++ G ++ ++++G+
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 74/198 (37%), Positives = 110/198 (55%), Gaps = 16/198 (8%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGF 388
KLG G FG V+ G ++ ++AVK L SVQ LE N L+ LQH LVRL
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEAN---LMKTLQHDKLVRLYAV 69
Query: 389 SFEETERLLIYEFVPNSSVDKFI-FDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
+E +I E++ S+ F+ D +V L + IA G+ Y+ R
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFS--AQIAEGMAYIE---RKNY 124
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTRGHF 505
IHRDL+A+N+L+ ++ KI+DFG+AR+ E ++ T+R F + APE + G F
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSF 181
Query: 506 SIKSDVFSFGVLVLEIIS 523
+IKSDV+SFG+L+ EI++
Sbjct: 182 TIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 71/278 (25%), Positives = 125/278 (44%), Gaps = 53/278 (19%)
Query: 330 NKLGQGGFGAVYKGRLSH---GQEIAVKRL---SKNSVQGELEFKNEVLLVARLQHRNLV 383
+LG G G V K H G+ +AVK + ++Q ++ + ++L + +V
Sbjct: 7 GELGAGNSGVVSKVL--HRPTGKIMAVKTIRLEINEAIQKQILRELDILH--KCNSPYIV 62
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL----YL 439
G + + + E++ S+DK + + R+ I+G IA +L YL
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPER------ILGKIAVAVLKGLTYL 116
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
HE +IIHRD+K SNIL+++ K+ DFG++ ++ S T VGT YMAPE
Sbjct: 117 HEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSG--QLVNSLAKTF--VGTSSYMAPER 170
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG--TALNLID 557
+ +S+KSD++S G+ ++E+ +G+ + + N+ L+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGR----------------FPYPPENDPPDGIFELLQ 214
Query: 558 -------PTLRNGSSSEIMRCVHIGLLCVQENVANRPT 588
P L +G S LC+ ++ RP+
Sbjct: 215 YIVNEPPPRLPSGKFSPDF--QDFVNLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 6e-27
Identities = 66/208 (31%), Positives = 106/208 (50%), Gaps = 20/208 (9%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRL---SKNSVQGELEFKN---EVLLVARLQHRNLV 383
LG+G +G VY G + GQ IAVK++ + N + E E++ EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFI--FDAIKRVQLDWETRYKIIGGIARGILYLHE 441
+ LG ++ + EFVP S+ + F + T+ I G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ-----ILDGVAYLHN 120
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV----GTFGYMAP 497
+ ++HRD+K +N++L + I K+ DFG AR G S ++ GT +MAP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
E + + KSD++S G V E+ +G+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 59/203 (29%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 326 FSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLV 383
F KLG+G +G+VYK GQ +A+K + V+ +L E E+ ++ + +V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP---VEEDLQEIIKEISILKQCDSPYIV 61
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ--LDWETRYKIIGGIARGILYLHE 441
+ G F+ T+ ++ E+ SV D +K L E I+ +G+ YLH
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVS----DIMKITNKTLTEEEIAAILYQTLKGLEYLH- 116
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
+ IHRD+KA NILL+ + K++DFG++ ++ + + ++GT +MAPE +
Sbjct: 117 --SNKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQ 172
Query: 502 RGHFSIKSDVFSFGVLVLEIISG 524
++ K+D++S G+ +E+ G
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEG 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 2/101 (1%)
Query: 128 NVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPDIS 187
N T++ + F+ +L+ + + A+ + K FA + + +T+Y L QC D+S
Sbjct: 8 TSGNYTTANSTFESNLNALLSSLSSNAASSSGKG-FAAG-TSGAAPDTVYGLAQCRGDLS 65
Query: 188 QSDCEFCLRQSMADVQSCCYGKKGSYIMGPSCIFRWEMYPF 228
SDC CL ++++++ CC KKG I SC R+E YPF
Sbjct: 66 ASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 67/195 (34%), Positives = 108/195 (55%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
KLG G FG V+ G + ++AVK L ++ E F E ++ +L+H LV+L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
EE ++ E++ S+ F+ D R L + +A G+ Y+ R+ IHR
Sbjct: 72 EEP-IYIVTEYMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTRGHFSIK 508
DL+++NIL+ ++ KI+DFG+ARL E ++ T+R F + APE G F+IK
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 509 SDVFSFGVLVLEIIS 523
SDV+SFG+L+ E+++
Sbjct: 184 SDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 65/197 (32%), Positives = 108/197 (54%), Gaps = 15/197 (7%)
Query: 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
+KLG G +G VY+G + +AVK L +++++ E EF E ++ ++H NLV+LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRII 448
E +I EF+ ++ ++ + R +++ + I+ + YL + + I
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FI 126
Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD--TSRIVGTF--GYMAPEYVTRGH 504
HRDL A N L+ + + K++DFG++RL GD T+ F + APE +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPESLAYNK 181
Query: 505 FSIKSDVFSFGVLVLEI 521
FSIKSDV++FGVL+ EI
Sbjct: 182 FSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 61/195 (31%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
KLG G FG V++G ++ +AVK L ++ + +F E ++ +L+H L++L
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
E ++ E + S+ +++ R L + +A G+ YL + IHR
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTRGHFSIK 508
DL A N+L+ + I K++DFG+AR+ + D +R F + APE FSIK
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIY---EAREGAKFPIKWTAPEAALYNRFSIK 184
Query: 509 SDVFSFGVLVLEIIS 523
SDV+SFG+L+ EI++
Sbjct: 185 SDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 63/197 (31%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLGFS 389
K+G+G FG VYKG L E+AVK F E ++ + H N+V+L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
++ ++ E VP S+ F+ K+ +L + ++ A G+ YL +S+ IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRK--KKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116
Query: 450 RDLKASNILLDADMIPKISDFGMARLFE--MDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
RDL A N L+ + + KISDFGM+R E + +I + APE + G ++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGRYTS 174
Query: 508 KSDVFSFGVLVLEIISG 524
+SDV+S+G+L+ E S
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 73/264 (27%), Positives = 113/264 (42%), Gaps = 31/264 (11%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE 391
LG G FG V+ G+ ++A+K + + E +F E ++ +L H NLV+L G +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 392 ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRD 451
+ ++ E++ N + ++ + ++ +W + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 452 LKASNILLDADMIPKISDFGMARLFEMDQ---SQGDTSRIVGTFGYMAPEYVTRGHFSIK 508
L A N L+ D + K+SDFG+AR DQ SQG + + PE FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV----KWAPPEVFDYSRFSSK 181
Query: 509 SDVFSFGVLVLEIISGQKN--NSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSS 566
SDV+SFGVL+ E+ S K F E E + L P L
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS----------AGYRLYRPKLAPTEVY 231
Query: 567 EIMRCVHIGLLCVQENVANRPTMA 590
IM C E +RP
Sbjct: 232 TIMY------SCWHEKPEDRPAFK 249
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 19/211 (9%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQH 379
D + K+G+G G VYK G+E+A+K++ Q + NE+L++ +H
Sbjct: 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKH 74
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSS----VDKFIFDAIKRVQLDWETRYKIIGGIAR 434
N+V S+ + L ++ E++ S + + + Q+ + + + +
Sbjct: 75 PNIVDYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVR-MNEPQIAY-----VCREVLQ 127
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
G+ YLH +IHRD+K+ NILL D K++DFG A ++S+ ++ +VGT +
Sbjct: 128 GLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYW 182
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
MAPE + R + K D++S G++ +E+ G+
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 74/216 (34%), Positives = 113/216 (52%), Gaps = 27/216 (12%)
Query: 332 LGQGGFGAVYKGRL-------SHGQEIAVKRLSKNSVQGE-LEFKNEVLLVARLQHRNLV 383
LG G FG VY+G S +AVK L K + E EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ------LDWETRYKIIGGIARGIL 437
+LLG + +I E + + ++ DA RV+ L + I +A+G +
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDA--RVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 438 YLHEDSRLRIIHRDLKASNILL-----DADMIPKISDFGMAR-LFEMDQSQGDTSRIVGT 491
YL ++ IHRDL A N L+ DAD + KI DFG+AR +++ D + + ++
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL-P 176
Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
+MAPE + G F+ +SDV+SFGVL+ EI++ GQ+
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 83/289 (28%), Positives = 120/289 (41%), Gaps = 58/289 (20%)
Query: 331 KLGQGGFGAVYKGR----LSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRL 385
KLG G FG V +G +AVK L + + + +F E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQL---------DWETRYKIIGGIARGI 436
G +++ E P S + D +++ L D+ + IA G+
Sbjct: 62 YGVVLTHP-LMMVTELAPLGS----LLDRLRKDALGHFLISTLCDYAVQ------IANGM 110
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGTFGYM 495
YL R IHRDL A NILL +D KI DFG+ R L + + + F +
Sbjct: 111 RYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC 167
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555
APE + FS SDV+ FGV + E+ F GEE W + L
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEM--------FTYGEE-------PWAGLSGSQILKK 212
Query: 556 IDPTLRNG--------SSSEIMRCVHIGLLCVQENVANRPTMASVVVML 596
ID + G +I ++ L C N A+RPT A++ L
Sbjct: 213 ID---KEGERLERPEACPQDIY---NVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 70/201 (34%), Positives = 112/201 (55%), Gaps = 19/201 (9%)
Query: 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
+ KLG G FG V+ + ++AVK + S+ E F E ++ LQH LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAV 69
Query: 389 SFEETERLLIYEFVPNSSVDKFI-FDAIKRVQLDWETRYKII---GGIARGILYLHEDSR 444
+E +I EF+ S+ F+ D + L K+I IA G+ ++ + +
Sbjct: 70 VTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLP-----KLIDFSAQIAEGMAFIEQRN- 122
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTR 502
IHRDL+A+NIL+ A ++ KI+DFG+AR+ E ++ T+R F + APE +
Sbjct: 123 --YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINF 177
Query: 503 GHFSIKSDVFSFGVLVLEIIS 523
G F+IKSDV+SFG+L++EI++
Sbjct: 178 GSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 69/197 (35%), Positives = 110/197 (55%), Gaps = 11/197 (5%)
Query: 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
D KLGQG FG V+ G + ++A+K L ++ E F E ++ +L+H LV L
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYAV 69
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRII 448
EE ++ EF+ S+ F+ + + L + IA G+ Y+ R+ I
Sbjct: 70 VSEEP-IYIVTEFMGKGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAYIE---RMNYI 124
Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTRGHFS 506
HRDL+A+NIL+ +++ KI+DFG+ARL E ++ T+R F + APE G F+
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFT 181
Query: 507 IKSDVFSFGVLVLEIIS 523
IKSDV+SFG+L+ E+++
Sbjct: 182 IKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 31/221 (14%)
Query: 324 NNFSTDNKLGQGGFGAVYKG---RLSHGQ---EIAVKRLSKNSVQGE-LEFKNEVLLVAR 376
+ +LGQG FG VY+G + G+ +A+K +++N+ E +EF NE ++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFV-------------PNSSVDKFIFDAIKRVQLDWE 423
++VRLLG L++ E + P + + +
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPG-LGPPTLQKF--- 121
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQ 482
++ IA G+ YL + +HRDL A N ++ D+ KI DFGM R ++E D +
Sbjct: 122 --IQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176
Query: 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
++ +MAPE + G F+ KSDV+SFGV++ E+ +
Sbjct: 177 KGGKGLL-PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 63/210 (30%), Positives = 107/210 (50%), Gaps = 33/210 (15%)
Query: 332 LGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLL 386
LG+G FG+V R + G+ +AVK+L ++ + +F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 387 GFSFEETER--LLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKIIGGIARGILY 438
G + R L+ E++P S+ ++ D K + + I +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ-----SQGDTSRIVGTFG 493
L R +HRDL NIL++++ KI DFG+ ++ D+ + S I F
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI---FW 177
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
Y APE +T FS+ SDV+SFGV++ E+ +
Sbjct: 178 Y-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 67/197 (34%), Positives = 108/197 (54%), Gaps = 21/197 (10%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
+G+G FGAV +G + GQ++AVK + K V + F E ++ +L H+NLVRLLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNI-KCDVTAQ-AFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 391 EETERLLIYEFVPNSSVDKFIFD----AIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
++ E + ++ F+ + +QL ++ + +A G+ YL +
Sbjct: 70 HNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQL---LQFSL--DVAEGMEYLESK---K 120
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
++HRDL A NIL+ D + K+SDFG+AR+ M D S++ + APE + FS
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSM---GVDNSKL--PVKWTAPEALKHKKFS 175
Query: 507 IKSDVFSFGVLVLEIIS 523
KSDV+S+GVL+ E+ S
Sbjct: 176 SKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 76/230 (33%), Positives = 120/230 (52%), Gaps = 34/230 (14%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELE---------FKNEVLLVARLQHRN 381
+G G FG+VY G S G+ +AVK++ SV + E+ L+ LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFI--FDAIKRVQLDWETRYK-IIGGIARGILY 438
+V+ LG S + + E+VP SV + + A + ET + + I +G+ Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE------ETLVRNFVRQILKGLNY 121
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR----IVGTFGY 494
LH +R IIHRD+K +NIL+D KISDFG+++ E + T+ + G+ +
Sbjct: 122 LH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISG--------QKNNSFRIGEEA 536
MAPE V + ++ K+D++S G LV+E+++G Q F+IGE A
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-24
Identities = 65/195 (33%), Positives = 108/195 (55%), Gaps = 11/195 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
KLGQG FG V+ G + +A+K L ++ E F E ++ +L+H LV+L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
EE ++ E++ S+ F+ + + L + IA G+ Y+ R+ +HR
Sbjct: 72 EEP-IYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTRGHFSIK 508
DL+A+NIL+ +++ K++DFG+ARL E ++ T+R F + APE G F+IK
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 509 SDVFSFGVLVLEIIS 523
SDV+SFG+L+ E+ +
Sbjct: 184 SDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 80/284 (28%), Positives = 132/284 (46%), Gaps = 35/284 (12%)
Query: 325 NFSTDNKLGQGGFGAVYK-GRLSHGQEIAVKR--LSKNSVQGELEFKNEVLLVARLQHRN 381
+F KLG+G +G+VYK RLS Q A+K L S + + NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 382 LVRLLGFSFEETERLLI-YEFVPNSSVDKFIFD-AIKRVQLDWETRYKIIGGIARGILYL 439
++ +F + +L I E+ P + K I KR + + ++I + RG+ L
Sbjct: 61 IISY-KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
HE +I+HRDLK++NILL A+ + KI D G++++ + +GT YMAPE
Sbjct: 120 HE---QKILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEV 172
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDL--LTYAWKNWNEGTALNLID 557
+S KSD++S G L+ E+ +F EA + L Y + G
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMA------TFAPPFEARSMQDLRYKVQR---GKY----- 218
Query: 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSL 601
P + S ++ + +Q RP + L S ++
Sbjct: 219 PPIPPIYSQDLQNFIR---SMLQVKPKLRPNCDKI---LASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 33/215 (15%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKR--LSKNSVQGELE--------FKNEVLLVARLQHR 380
+G+G +G VY ++ G+ +AVK+ L ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVD-------KFIFDAIKRVQLDWETRYKIIGGIA 433
N+V+ LGF E + E+VP S+ +F ++ T +++ G+A
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFF-----TE-QVLEGLA 122
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
YLH I+HRDLKA N+L+DAD I KISDFG+++ + + G+
Sbjct: 123 ----YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF 175
Query: 494 YMAPEYVTRGH--FSIKSDVFSFGVLVLEIISGQK 526
+MAPE + +S K D++S G +VLE+ +G++
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 41/281 (14%)
Query: 332 LGQGGFGAVYKGRLSHG----QEIAVKRL-SKNSVQGELEFKNEVLLVARLQHRNLVRLL 386
+G G FG V +GRL +A+K L S + + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 387 GFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKIIGGIARGILYLH 440
G + ++I EF+ N ++D F+ F I+ V ++ GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLV--------GMLRGIAAGMKYLS 123
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG---TFGYMAP 497
E + +HRDL A NIL++++++ K+SDFG++R E D S + +G + AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557
E + F+ SDV+S+G+++ E++S GE W N+ +N I+
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS--------YGERP------YWDMSNQ-DVINAIE 225
Query: 558 PTLRNGSSSEIMRCVHIGLL-CVQENVANRPTMASVVVMLN 597
R + +H +L C Q++ RP +V L+
Sbjct: 226 QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 68/218 (31%), Positives = 112/218 (51%), Gaps = 33/218 (15%)
Query: 331 KLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRNL 382
+LG+ FG VYKG L Q +A+K L K+ +G L EFK+E ++ +RLQH N+
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIF-------------DAIKRVQLDWETRYKII 429
V LLG +E +I+ + +S + +F+ D + L+ I+
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
IA G+ +L S ++H+DL N+L+ + KISD G+ R + D +++
Sbjct: 131 TQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR----EVYAADYYKLM 183
Query: 490 GT----FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
G +M+PE + G FSI SD++S+GV++ E+ S
Sbjct: 184 GNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 67/202 (33%), Positives = 116/202 (57%), Gaps = 20/202 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEI----AVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRL 385
LG G FG VYKG + G+ + A+K L++ + + +EF +E L++A + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIF---DAI-KRVQLDWETRYKIIGGIARGILYLHE 441
LG T +L + + +P+ + ++ D I ++ L+W + IA+G++YL E
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
R++HRDL A N+L+ + KI+DFG+ARL E D+ + + +MA E +
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
F+ +SDV+S+GV + E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 39/214 (18%)
Query: 330 NKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEF----KNEVLLVARLQHRNLVR 384
++G+G +G VYK R G+ +A+K++ + F E+ L+ +L+H N+VR
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 385 LLG--FSFEETERLLIYEFVPN-------SSVDKFIFDAIKRV--QLDWETRYKIIGGIA 433
L S + +++E++ + S KF IK QL
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQL------------L 110
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
G+ YLH + I+HRD+K SNIL++ D + K++DFG+AR + S T+R++ T
Sbjct: 111 EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLW 166
Query: 494 YMAPEYV---TRGHFSIKSDVFSFGVLVLEIISG 524
Y PE + TR + + D++S G ++ E+ G
Sbjct: 167 YRPPELLLGATR--YGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 66/212 (31%), Positives = 110/212 (51%), Gaps = 28/212 (13%)
Query: 326 FSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---------EVLLVA 375
+ KLG+G +G VYK R G+ +A+K++ L+ + E+ L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-------RLDNEEEGIPSTALREISLLK 53
Query: 376 RLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARG 435
L+H N+V+LL E + L++E+ + + K++ + L I+ + RG
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYL--DKRPGPLSPNLIKSIMYQLLRG 110
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
+ Y H S RI+HRDLK NIL++ D + K++DFG+AR F + T +V T Y
Sbjct: 111 LAYCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVV-TLWYR 165
Query: 496 APEYVTRG--HFSIKSDVFSFGVLVLEIISGQ 525
APE + G H+S D++S G + E+I+G+
Sbjct: 166 APE-ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 3e-23
Identities = 65/214 (30%), Positives = 113/214 (52%), Gaps = 20/214 (9%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVA 375
++ D ++ K+GQG G VY ++ GQE+A+K+++ + + EL NE+L++
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL-IINEILVMR 71
Query: 376 RLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARG 435
+H N+V L E ++ E++ S+ D + +D I + R
Sbjct: 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMD----EGQIAAVCRE 123
Query: 436 IL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
L +LH + ++IHRD+K+ NILL D K++DFG +QS+ T +VGT
Sbjct: 124 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
+MAPE VTR + K D++S G++ +E++ G+
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 330 NKLGQGGFGAVYK-GRLSHGQEIAVKRLSKNSVQGELEFK---NEVLLVARLQHRNLVRL 385
+G+G FG V K R S G+ + K + ++ E E + +EV ++ L+H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRY 64
Query: 386 LG-FSFEETERLLIY-EFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGGIARGILYLH-- 440
+ L I E+ + + I K R ++ E ++I+ + + H
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
D ++HRDLK +NI LDA+ K+ DFG+A++ + VGT YM+PE +
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI--LGHDSSFAKTYVGTPYYMSPEQL 182
Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
+ KSD++S G L+ E+ +
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-23
Identities = 78/277 (28%), Positives = 143/277 (51%), Gaps = 35/277 (12%)
Query: 332 LGQGGFGAVYKG--RLSHGQE--IAVKRLSKNSVQGE-LEFKNEVLLVARLQHRNLVRLL 386
+G G FG V++G ++ +E +A+K L + + +F +E ++ + H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE-TRYKIIG---GIARGILYLHED 442
G + ++I E++ N ++DK++ D D E + Y+++G GIA G+ YL
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDH------DGEFSSYQLVGMLRGIAAGMKYL--- 123
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--YMAPEYV 500
S + +HRDL A NIL+++++ K+SDFG++R+ E D +G + G + APE +
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560
F+ SDV+SFG+++ E++S + + + K N+G L P
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE------VMKAINDGFRL----PAP 232
Query: 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597
+ S+ + L C Q++ A RP +V +L+
Sbjct: 233 MDCPSA----VYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 8e-23
Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 34/215 (15%)
Query: 330 NKLGQGGFGAVYKG-RLSHGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRNLVRLL 386
NK+G G FG VY L G+ +AVK R+ N + E +E+ ++ L+H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 387 GFSFEETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWET---RYKIIGGIARGILYLHED 442
G E++ I+ E+ + + + ++ ++ E Y + + G+ YLH
Sbjct: 66 GVEVHR-EKVYIFMEYCSGGT----LEELLEHGRILDEHVIRVYTL--QLLEGLAYLHSH 118
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMA--------RLFEMDQSQGDTSRIVGTFGY 494
I+HRD+K +NI LD + + K+ DFG A + E QS + GT Y
Sbjct: 119 ---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS------LAGTPAY 169
Query: 495 MAPEYVTRGHFSIK---SDVFSFGVLVLEIISGQK 526
MAPE +T G +D++S G +VLE+ +G++
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 76/303 (25%), Positives = 137/303 (45%), Gaps = 51/303 (16%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR---LSHGQE---IAVKRLSKN-SVQGELEFKNEVLLVAR 376
NN +GQG FG V++ R L + +AVK L + S + +F+ E L+A
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFD-------------------AIKR 417
H N+V+LLG L++E++ +++F+ +
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 418 VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LF 476
+ L + I +A G+ YL E + +HRDL N L+ +M+ KI+DFG++R ++
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEA 536
D + + + +M PE + ++ +SDV+++GV++ EI S + G
Sbjct: 182 SADYYKASENDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY--GMAH 238
Query: 537 EDLLTYAWKNWNEGTALNLIDPTLRNGSSSEI---MRCVHIGLLCVQENVANRPTMASVV 593
E+++ Y +G L+ D E+ MR LC + ++RP+ AS+
Sbjct: 239 EEVIYYV----RDGNVLSCPD-----NCPLELYNLMR------LCWSKLPSDRPSFASIN 283
Query: 594 VML 596
+L
Sbjct: 284 RIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 69/214 (32%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 331 KLGQGGFGAVYKGRL-----SHGQEIAVKRLSK-NSVQGELEFKNEVLLVARLQHRNLVR 384
+LG+ FG +YKG L H Q +A+K L N+ Q EF+ E L+A L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIF--------------DAIKRVQLDWETRYKIIG 430
LLG +E +++E++ + +F+ D + LD I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIV 489
IA G+ YL S +H+DL A NIL+ + KISD G++R ++ D + ++
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+M PE + G FS SD++SFGV++ EI S
Sbjct: 189 -PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 60/202 (29%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 326 FSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHRNLV 383
F+ +G+G FG VYK Q +A+K + + E+E E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
+ G SF + +L +I E+ S D +K +LD I+ + G+ YLHE+
Sbjct: 63 KYYG-SFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
IHRD+KA+NILL + K++DFG++ S+ +T VGT +MAPE + +
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQ 172
Query: 503 GHFSIKSDVFSFGVLVLEIISG 524
+ K+D++S G+ +E+ G
Sbjct: 173 SGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 69/234 (29%), Positives = 115/234 (49%), Gaps = 30/234 (12%)
Query: 331 KLGQGGFGAVYKGRLSH---GQE---IAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
+LG+G FG V+ + Q+ +AVK L + S +F+ E L+ LQH+++VR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKF---------IFDAIKRV---QLDWETRYKIIGGI 432
G E L+++E++ + +++F I + V QL I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG-- 490
A G++YL + L +HRDL N L+ ++ KI DFGM+R D D R+ G
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRT 184
Query: 491 --TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGE-EAEDLLT 541
+M PE + F+ +SD++SFGV++ EI + K +++ EA + +T
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 56/202 (27%), Positives = 107/202 (52%), Gaps = 17/202 (8%)
Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQHRNLVRLLG 387
++G+G G V+K + G+ +A+K+++ ++G + E+ + QH +V+LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 388 FSFEETERLLIYEFVPN--SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445
+ +L+ E++P+ S V + + Q+ R + +G+ Y+H
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRM-----LLKGVAYMHA---N 118
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE--YVTRG 503
I+HRDLK +N+L+ AD + KI+DFG+ARLF ++ + + + V T Y APE Y R
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPELLYGAR- 176
Query: 504 HFSIKSDVFSFGVLVLEIISGQ 525
+ D+++ G + E+++G
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 63/205 (30%), Positives = 111/205 (54%), Gaps = 11/205 (5%)
Query: 325 NFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKR--LSKNSVQGELEFKNEVLLVARLQHRN 381
+F NK+G+G FG V+K R + + A+K+ LSK + + E +E ++A+L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 382 LVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
++R SF + +L ++ E+ N + K + R L + ++ I G+ +LH
Sbjct: 61 IIRYYE-SFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLH 118
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
+I+HRD+K+ N+ LDA KI D G+A+L + + +T IVGT Y++PE
Sbjct: 119 SK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELC 173
Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
++ KSDV++ GV++ E +G+
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 60/201 (29%), Positives = 107/201 (53%), Gaps = 10/201 (4%)
Query: 330 NKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEF-KNEVLLVARLQHRNLVRLLG 387
+G G VY L + +++A+KR+ Q ++ + EV +++ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
SF + L L+ ++ S+ + + R LD ++ + +G+ YLH + +
Sbjct: 67 -SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 447 IIHRDLKASNILLDADMIPKISDFGM-ARLFE-MDQSQGDTSRIVGTFGYMAPEYVTRGH 504
IHRD+KA NILL D KI+DFG+ A L + D+++ VGT +MAPE + + H
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 505 -FSIKSDVFSFGVLVLEIISG 524
+ K+D++SFG+ +E+ +G
Sbjct: 183 GYDFKADIWSFGITAIELATG 203
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 3e-22
Identities = 62/211 (29%), Positives = 112/211 (53%), Gaps = 11/211 (5%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELE-FKNEVLLVARLQ 378
D F+ ++G+G FG VYKG + +E+ A+K + + E+E + E+ ++++
Sbjct: 1 DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
+ R G + T+ +I E++ S D +K L+ I+ I +G+ Y
Sbjct: 61 SPYITRYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDY 116
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
LH + R IHRD+KA+N+LL K++DFG+A ++ +Q + VGT +MAPE
Sbjct: 117 LHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPE 171
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529
+ + + K+D++S G+ +E+ G+ NS
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQE------IAVKRLSKNSVQG-ELEFKNEVLLVARL 377
N LG+G FG V+ + +E + VK L K + + EF+ E+ + +L
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKIIGG 431
H+N+VRLLG E +I E+ + +F+ + +K L + + +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
IA G+ +L S R +HRDL A N L+ + K+S +++ D + ++
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK----DVYNSEYYKLRNA 178
Query: 492 FG---YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
++APE V FS KSDV+SFGVL+ E+ +
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 6e-22
Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSK------NSVQGELEFKNEVLLVARL 377
+F +G+G FG V + +++ A+K ++K SV+ L NE ++ L
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL---NERRILQEL 57
Query: 378 QHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
H LV L +SF++ E + L+ + + + + ++V+ E I I +
Sbjct: 58 NHPFLVNLW-YSFQDEENMYLVVDLLLGGDLR---YHLSQKVKFSEEQVKFWICEIVLAL 113
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
YLH IIHRD+K NILLD I+DF +A D TS GT GYMA
Sbjct: 114 EYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMA 167
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
PE + R +S+ D +S GV E + G
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 7e-22
Identities = 63/212 (29%), Positives = 108/212 (50%), Gaps = 23/212 (10%)
Query: 332 LGQGGFGAVYKGRLSHG----QEIAVKRLS-KNSVQGELE-FKNEVLLVARLQHRNLVRL 385
LG+G FG+V +G+LS ++AVK + E+E F +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 386 LGFSFEETER------LLIYEFVPNSSVDKFIFD---AIKRVQLDWETRYKIIGGIARGI 436
+G FE + ++I F+ + + F+ +L +T K + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMD-QSQGDTSRIVGTFGY 494
YL S IHRDL A N +L DM ++DFG+++ ++ D QG +++ +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 181
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQ 525
+A E + ++ KSDV++FGV + EI + GQ
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 9e-22
Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKR------LSKNSVQGELEFKNEVLLVA 375
NF + K+G+G F VYK L G+ +A+K+ + + Q L+ E+ L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLK 57
Query: 376 RLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI--FDAIKRVQLDWETRYKIIGGIA 433
+L H N+++ L E E ++ E + + I F KR+ + T +K +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTIWKYFVQLC 116
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
+ ++H RI+HRD+K +N+ + A + K+ D G+ R F + + +VGT
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 171
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
YM+PE + ++ KSD++S G L+ E+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 68/215 (31%), Positives = 106/215 (49%), Gaps = 29/215 (13%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRL--------SKNSVQGELEFKNEV 371
N+ LGQG FG VY L + G+E+AVK++ +K V + E+
Sbjct: 2 TNWRRGKLLGQGAFGRVY---LCYDVDTGRELAVKQVPFDPDSPETKKEVN---ALECEI 55
Query: 372 LLVARLQHRNLVRLLGFSFEETERLLIY-EFVPNSSVDKFIFDAIKRV-QLDWETRYKII 429
L+ LQH +V+ G + E L I+ E++P SV D +K L K
Sbjct: 56 QLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVK----DQLKAYGALTETVTRKYT 110
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA-RLFEMDQSQGDTSRI 488
I G+ YLH + I+HRD+K +NIL D+ K+ DFG + RL + S +
Sbjct: 111 RQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV 167
Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
GT +M+PE ++ + K+DV+S G V+E+++
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
LG+G +G VY R LS IA+K + + + E+ L + L+HRN+V+ LG S
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG-SD 74
Query: 391 EETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
E I+ E VP S+ + ++ + +T I G+ YLH+ +I+H
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVH 131
Query: 450 RDLKASNILLDA-DMIPKISDFGMA-RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH--F 505
RD+K N+L++ + KISDFG + RL ++ T GT YMAPE + +G +
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYMAPEVIDKGPRGY 188
Query: 506 SIKSDVFSFGVLVLEIISGQ 525
+D++S G ++E+ +G+
Sbjct: 189 GAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 70/240 (29%), Positives = 104/240 (43%), Gaps = 42/240 (17%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRL----SKNSVQG----ELEFKNEVLLVA 375
++LG+G G+V K RL + I + +Q ELE
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC---- 56
Query: 376 RLQHRNLVRLLGFSFEETERLL--IYEFVPNSSVDKFIFDAIKRV-QLDWETRYKIIGGI 432
+ +V+ G +E+ + E+ S+D K+V + K++G I
Sbjct: 57 --KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY----KKVKKRGGRIGEKVLGKI 110
Query: 433 ARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
A +L YLH +IIHRD+K SNILL K+ DFG++ E+ S T
Sbjct: 111 AESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGT--F 163
Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAE------DLLTY 542
GT YMAPE + +SI SDV+S G+ +LE+ N F E E +LL+Y
Sbjct: 164 TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVA----QNRFPFPPEGEPPLGPIELLSY 219
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 65/217 (29%), Positives = 115/217 (52%), Gaps = 28/217 (12%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQE---IAVKRLSKNSVQGEL-EFKNEVLLVA 375
DA+ + +G G FG V GRL G+ +A+K L + + +F +E ++
Sbjct: 2 DASC-IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60
Query: 376 RLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI------FDAIKRVQLDWETRYKII 429
+ H N++ L G + +++ E++ N S+D F+ F I+ V ++
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLV--------GML 112
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
GIA G+ YL S + +HRDL A NIL++++++ K+SDFG++R+ E D T+R
Sbjct: 113 RGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-- 167
Query: 490 G---TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
G + APE + F+ SDV+S+G+++ E++S
Sbjct: 168 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 66/193 (34%), Positives = 103/193 (53%), Gaps = 13/193 (6%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE 391
+G+G FG V G G ++AVK + KN + F E ++ +L+H NLV+LLG E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 392 ETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
E L I E++ S+ ++ + R L + K + + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSD 510
DL A N+L+ D + K+SDFG+ + E +Q DT ++ + APE + FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK--EASSTQ-DTGKL--PVKWTAPEALREKKFSTKSD 181
Query: 511 VFSFGVLVLEIIS 523
V+SFG+L+ EI S
Sbjct: 182 VWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 71/217 (32%), Positives = 112/217 (51%), Gaps = 38/217 (17%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---------EVLLV 374
+++ K+G+G +G VYKGR GQ +A+K++ LE + E+ L+
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-------RLESEEEGVPSTAIREISLL 53
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD-KFIFDAIKRVQ-LDWETRYKIIGGI 432
LQH N+V L +E+ LI+EF+ S+D K D++ + Q +D E + I
Sbjct: 54 KELQHPNIVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQI 110
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI---- 488
+GIL+ H R++HRDLK N+L+D + K++DFG+AR F G R+
Sbjct: 111 LQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF------GIPVRVYTHE 161
Query: 489 VGTFGYMAPEYVTRG--HFSIKSDVFSFGVLVLEIIS 523
V T Y APE V G +S D++S G + E+ +
Sbjct: 162 VVTLWYRAPE-VLLGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 3e-21
Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 28/210 (13%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLS----KNSVQGEL--EFKNEVLLVARLQHRNLVR 384
LG G F + Y+ R + G +AVK+++ +S Q E+ + E+ L+ARL H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFI--FDAIKRVQLDWETRYKIIGGIARGILYLHED 442
+LG + E++ L E++ SV + + A K + Y + RG+ YLHE+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI---INY--TEQLLRGLSYLHEN 122
Query: 443 SRLRIIHRDLKASNILLDAD-MIPKISDFGMA-----RLFEMDQSQGDTSRIVGTFGYMA 496
+IIHRD+K +N+L+D+ +I+DFG A + + QG +++GT +MA
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176
Query: 497 PEYVTRGH-FSIKSDVFSFGVLVLEIISGQ 525
PE V RG + DV+S G +++E+ + +
Sbjct: 177 PE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNS-VQGELE--FKNEVLLVARLQHRNLVRLLG 387
LG GGFG V ++ S + A+K + K V+ + +E ++ H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAI-KRVQLD-WETRYKIIGGIARGILYLHEDSR 444
+F++ + + ++ E+ ++ + R D + R+ I + YLH
Sbjct: 61 -TFKDKKYIYMLMEYCLG----GELWTILRDRGLFDEYTARF-YIACVVLAFEYLH---N 111
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
II+RDLK N+LLD++ K+ DFG A+ +S T GT Y+APE +
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPEIILNKG 168
Query: 505 FSIKSDVFSFGVLVLEIISG 524
+ D +S G+L+ E+++G
Sbjct: 169 YDFSVDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 4e-21
Identities = 69/276 (25%), Positives = 128/276 (46%), Gaps = 40/276 (14%)
Query: 332 LGQGGFG-AVYKGRLSHGQEIAVKR--LSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
LG+G FG A R + K L++ S + + NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN- 66
Query: 389 SFEETERLLI-YEFVPNSSVDKFIFDAIKRVQ---LDWETRYKIIGGIARGILYLHEDSR 444
F + LLI E+ + ++D I R + + E + I + Y+H+
Sbjct: 67 HFMDDNTLLIEMEYANGGT----LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG- 121
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
I+HRD+K NI L + K+ DFG++++ + S +T +VGT YM+PE
Sbjct: 122 --ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVK 177
Query: 505 FSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWK----NWNEGTALNLIDPTL 560
++ KSD+++ G ++ E+++ ++ +F +A + L K N+
Sbjct: 178 YNFKSDIWALGCVLYELLTLKR--TF----DATNPLNLVVKIVQGNYTPV---------- 221
Query: 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVML 596
+ SSE++ VH +Q++ RPT V+
Sbjct: 222 VSVYSSELISLVH---SLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 4e-21
Identities = 59/209 (28%), Positives = 110/209 (52%), Gaps = 10/209 (4%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR 376
+I D ++ K+GQG G V+ ++ GQE+A+K+++ + NE+L++
Sbjct: 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
L++ N+V L E ++ E++ S+ D + +D + + +
Sbjct: 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQAL 128
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
+LH + ++IHRD+K+ N+LL D K++DFG +QS+ T +VGT +MA
Sbjct: 129 EFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
PE VTR + K D++S G++ +E++ G+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-21
Identities = 72/265 (27%), Positives = 119/265 (44%), Gaps = 25/265 (9%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
+LG G FG V G+ ++A+K + + S+ E EF E ++ +L H LV+L G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
++ ++ E++ N + ++ + KR Q ++ + G+ YL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTRGHFSIK 508
DL A N L+D K+SDFG++R D+ TS + F + PE + FS K
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 509 SDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEI 568
SDV++FGVL+ E+ + +G+ + + L L P L + I
Sbjct: 182 SDVWAFGVLMWEV--------YSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAI 233
Query: 569 MRCVHIGLLCVQENVANRPTMASVV 593
M C E RPT ++
Sbjct: 234 MYS------CWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 6e-21
Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 30/226 (13%)
Query: 331 KLGQGGFGAVYKGR---LSHGQE---IAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
+LG+G FG V+ LS ++ +AVK L ++ +F+ E L+ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIF----DAIKRV---------QLDWETRYKIIGG 431
G + ++++E++ + ++KF+ DA+ V +L I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG- 490
IA G++YL + +HRDL N L+ A+++ KI DFGM+R D D R+ G
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGH 184
Query: 491 ---TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIG 533
+M PE + F+ +SDV+SFGV++ EI + K F++
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 7e-21
Identities = 67/203 (33%), Positives = 98/203 (48%), Gaps = 19/203 (9%)
Query: 326 FSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLS---KNSVQGELEFKNEVLLVARLQHRN 381
F+ ++G G FGAVY R E+ A+K++S K S + + EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
+ G E L+ E+ S+ D I + K+ + E I G +G+ YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQEVEIA-AICHGALQGLAYLHS 133
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV- 500
R IHRD+KA NILL K++DFG A L S VGT +MAPE +
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAPEVIL 184
Query: 501 --TRGHFSIKSDVFSFGVLVLEI 521
G + K DV+S G+ +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 25/203 (12%)
Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---------EVLLVARLQHR 380
K+G+G +G VYK R G+ +A+K++ LE ++ E+ L+ L H
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKI-------RLETEDEGVPSTAIREISLLKELNHP 58
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
N+VRLL E + L++EF+ + + K++ D+ LD + + +GI Y H
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCH 116
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
S R++HRDLK N+L+D + K++DFG+AR F + + T +V T Y APE +
Sbjct: 117 --SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEIL 171
Query: 501 TRG-HFSIKSDVFSFGVLVLEII 522
+S D++S G + E++
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 9e-21
Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 27/203 (13%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV--QGELE-FKNEVLLVARLQHRNLVRLLG 387
LG G FG V R + A+K LSK + ++E NE ++ ++H LV L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQ---LDWETRYKIIGGIARGILYLHEDS 443
SF++ L L+ E+VP +F +++ Y + + YLH
Sbjct: 69 -SFQDDSNLYLVMEYVPGGE----LFSHLRKSGRFPEPVARFY--AAQVVLALEYLH--- 118
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV-TR 502
L I++RDLK N+LLD+D KI+DFG A+ + G T + GT Y+APE + ++
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK-----GRTYTLCGTPEYLAPEIILSK 173
Query: 503 GH-FSIKSDVFSFGVLVLEIISG 524
G+ ++ D ++ G+L+ E+++G
Sbjct: 174 GYGKAV--DWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 63/193 (32%), Positives = 99/193 (51%), Gaps = 7/193 (3%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG-ELEFKNEVLLVARLQHRNLVRLLGFSF 390
LG+G FG V+KG L +AVK ++ Q +++F +E ++ + H N+V+L+G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
+ ++ E VP D F K+ +L + K A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSD 510
DL A N L+ + + KISDFGM+R E D + + APE + G +S +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 511 VFSFGVLVLEIIS 523
V+S+G+L+ E S
Sbjct: 177 VWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 37/223 (16%)
Query: 331 KLGQGGFGAVY---------------KGRLSHGQE--IAVKRLSKNSVQGEL-EFKNEVL 372
KLG+G FG V+ + +AVK L ++ +F EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI--------FDAIKRVQLDWET 424
+++RL N+ RLLG + +I E++ N +++F+ A L + T
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
+ IA G+ YL L +HRDL N L+ + KI+DFGM+R + D
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSSD 184
Query: 485 TSRIVGT----FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
R+ G +MA E V G F+ KSDV++FGV + EI++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 59/209 (28%), Positives = 109/209 (52%), Gaps = 10/209 (4%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR 376
++ D ++ K+GQG G VY ++ GQE+A+++++ + NE+L++
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
++ N+V L E ++ E++ S+ D + +D + + +
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 129
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
+LH + ++IHRD+K+ NILL D K++DFG +QS+ S +VGT +MA
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMA 184
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
PE VTR + K D++S G++ +E+I G+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 59/209 (28%), Positives = 109/209 (52%), Gaps = 10/209 (4%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR 376
++ D ++ K+GQG G VY ++ GQE+A+K+++ + NE+L++
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
++ N+V L E ++ E++ S+ D + +D + + +
Sbjct: 73 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 128
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
+LH + ++IHRD+K+ NILL D K++DFG +QS+ T +VGT +MA
Sbjct: 129 DFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
PE VTR + K D++S G++ +E++ G+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 2e-20
Identities = 81/341 (23%), Positives = 156/341 (45%), Gaps = 27/341 (7%)
Query: 268 IIVVSTSTFIIALVALITCVFLRRRKKKQKQNLRKADEINTVESLQFDFS---TIRDATN 324
I + F++ + VF+R R + + + D ++ S TI D +
Sbjct: 631 YITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILS 690
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSK-NSVQGELEFKNEVLLVARLQHRNL 382
+ +N + +G GA YKG+ + +G + VK ++ NS+ +E+ + +LQH N+
Sbjct: 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNI 745
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
V+L+G E LI+E++ ++ + + + L WE R KI GIA+ + +LH
Sbjct: 746 VKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCR 799
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
++ +L I++D P + + L D +S Y+APE
Sbjct: 800 CSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRET 852
Query: 503 GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562
+ KSD++ FG++++E+++G+ G ++ +A +++ IDP++R
Sbjct: 853 KDITEKSDIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYCYSDCHLDMWIDPSIRG 911
Query: 563 GSSS---EIMRCVHIGLLCVQENVANRPTMASVVVMLNSSS 600
S EI+ +++ L C + RP V+ L S+S
Sbjct: 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952
|
Length = 968 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 65/227 (28%), Positives = 108/227 (47%), Gaps = 31/227 (13%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQ------EIAVKRLSKNSVQGEL-EFKNEVLLVARL 377
N LG+G FG V K + +AVK L +N+ EL + +E L+ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIK-------------RVQLDWET 424
H ++++L G ++ LLI E+ S+ F+ ++ K LD
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 425 RYKIIGG--------IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476
+ G I+RG+ YL E ++++HRDL A N+L+ KISDFG++R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+ S S+ +MA E + ++ +SDV+SFGVL+ EI++
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 57/196 (29%), Positives = 102/196 (52%), Gaps = 7/196 (3%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
+LG G FG V+ G+ ++A+K +++ ++ E +F E ++ +L H LV+L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-DFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450
++ ++ EF+ N + ++ ++ +L + + + G+ YL +S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSD 510
DL A N L+ + + K+SDFGM R + +D +S + PE +S KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 511 VFSFGVLVLEIISGQK 526
V+SFGVL+ E+ + K
Sbjct: 184 VWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 24/222 (10%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARL- 377
D T F +G+G +G VYK R GQ +A+K + + E E K E ++ +
Sbjct: 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE-EIKEEYNILRKYS 60
Query: 378 QHRNLVRLLGFSF------EETERLLIYEFVPNSSVD---KFIFDAIKRVQLDWETRYKI 428
H N+ G + + L+ E SV K + KR++ +W Y I
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-IAY-I 118
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
+ RG+ YLHE+ ++IHRD+K NILL + K+ DFG++ ++D + G +
Sbjct: 119 LRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTF 173
Query: 489 VGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQ 525
+GT +MAPE + + +SDV+S G+ +E+ G+
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 59/211 (27%), Positives = 113/211 (53%), Gaps = 11/211 (5%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELE-FKNEVLLVARLQ 378
D F+ K+G+G FG V+KG + Q++ A+K + + E+E + E+ ++++
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
+ + G ++T+ +I E++ S D ++ LD I+ I +G+ Y
Sbjct: 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDY 116
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
LH + + IHRD+KA+N+LL K++DFG+A ++ +Q + VGT +MAPE
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPE 171
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529
+ + + K+D++S G+ +E+ G+ +S
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLG 387
LG+GGFG V ++ G+ A K+L K + +GE NE ++ ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRLR 446
++FE + L + + N K+ + E R I G+ +LH + R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP-EARAIFYAAQIICGLEHLH---QRR 115
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
I++RDLK N+LLD +ISD G+A E+ + R GT GYMAPE + +
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGR-AGTPGYMAPEVLQGEVYD 172
Query: 507 IKSDVFSFGVLVLEIISGQ 525
D F+ G + E+I+G+
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 7e-20
Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 332 LGQGGFGAVYKGRLS-----HGQEIAVKRL-SKNSVQGELEFKNEVLLVARLQHRNLVRL 385
LG+G FG V G+ +AVK L + Q +K E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
G E+ + LI E+VP S+ ++ + +L+ I G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMAR------LFEMDQSQGDTSRIVGTFGYMAP 497
IHRDL A N+LLD D + KI DFG+A+ + + GD+ F Y A
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP----VFWY-AV 179
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
E + FS SDV+SFGV + E+++
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 7e-20
Identities = 57/196 (29%), Positives = 102/196 (52%), Gaps = 10/196 (5%)
Query: 331 KLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
K+G+G G V R H G+++AVK + Q NEV+++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
E ++ EF+ ++ D + + +L+ E + + + + YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKS 509
RD+K+ +ILL D K+SDFG D + +VGT +MAPE ++R + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 510 DVFSFGVLVLEIISGQ 525
D++S G++V+E++ G+
Sbjct: 199 DIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 8e-20
Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 18/210 (8%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQG-ELEFKNEVLLVARLQ 378
D + K+G+G G V S G+++AVK++ Q EL F NEV+++ Q
Sbjct: 16 DPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-NEVVIMRDYQ 74
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
H N+V + E ++ EF+ ++ D + +++ E + + + + +
Sbjct: 75 HPNIVEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSF 130
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR---IVGTFGYM 495
LH +IHRD+K+ +ILL +D K+SDFG Q + R +VGT +M
Sbjct: 131 LHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC-----AQVSKEVPRRKSLVGTPYWM 182
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
APE ++R + + D++S G++V+E++ G+
Sbjct: 183 APEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 64/204 (31%), Positives = 110/204 (53%), Gaps = 24/204 (11%)
Query: 332 LGQGGFGAVYKGRLSHGQE-----IAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRL 385
LG G FG VYKG E +A+K L +N S + E +E ++A + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKIIGGIARGILYLHE 441
LG T +L + + +P + ++ + R+ L+W + IA+G+ YL E
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ--GDTSRIVGTFGYMAPEY 499
+R++HRDL A N+L+ + KI+DFG+ARL ++D+++ D ++ +MA E
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALES 182
Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS 523
+ F+ +SDV+S+GV V E+++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 17/198 (8%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLGFS 389
LG G FG VYK + G A K + S + ELE F E+ +++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
F E + ++ EF ++D I ++R + + RY + + + +LH ++IH
Sbjct: 72 FYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIH 126
Query: 450 RDLKASNILLDADMIPKISDFGM-ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS-- 506
RDLKA NILL D K++DFG+ A+ Q + +GT +MAPE V F
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR---DTFIGTPYWMAPEVVACETFKDN 183
Query: 507 ---IKSDVFSFGVLVLEI 521
K+D++S G+ ++E+
Sbjct: 184 PYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 60/204 (29%), Positives = 109/204 (53%), Gaps = 25/204 (12%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQH---RNLVRLL 386
+G+G +GAVY+G+ + G+ +A+K ++ ++ ++ + + EV L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 387 GFSFEETERLLIYEFVPNSSVDKFI-FDAIKRVQLDWETRYKIIGGIARGIL----YLHE 441
G + +I E+ SV + I K I I R +L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAE---------KYISVIIREVLVALKYIHK 119
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
+IHRD+KA+NIL+ K+ DFG+A L +Q+ S VGT +MAPE +T
Sbjct: 120 VG---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVIT 174
Query: 502 RG-HFSIKSDVFSFGVLVLEIISG 524
G ++ K+D++S G+ + E+ +G
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---EVLLVARLQHRNLVRLL 386
K+G+G +G VYK R G+ +A+K++ + E K E+ L+ L H N+++LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKL-RFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
+ + L++EF+ ++ + K I D + L + + +G+ + H
Sbjct: 65 DVFRHKGDLYLVFEFM-DTDLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCH---SHG 118
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE-YVTRGHF 505
I+HRDLK N+L++ + + K++DFG+AR F + V T Y APE + +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGDKGY 176
Query: 506 SIKSDVFSFGVLVLEIISGQ 525
S D++S G + E++S +
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 332 LGQGGFGAVYKGRLSH---GQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQH-RNLVRLL 386
+G+G FG V K H G +AVKR+ + E ++ +V R +V+
Sbjct: 12 IGRGAFGTVNKML--HKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 387 GFSFEETERLLIYEFVPNSSVDKF--IFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
G F E + + E + + S+DKF + + + E KI + + YL E+
Sbjct: 70 GALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE-- 126
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV---T 501
L+IIHRD+K SNILLD + K+ DFG++ ++ +R G YMAPE +
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSA 183
Query: 502 RGHFSIKSDVFSFGVLVLEIISG 524
R + ++SDV+S G+ + E+ +G
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 66/204 (32%), Positives = 110/204 (53%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRL 385
LG+G FG V R + G+++AVK L S + + K E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 386 LGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
G E+ LI EF+P+ S+ +++ ++ L + +Y + I +G+ YL S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYL--GS 127
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS----QGDTSRIVGTFGYMAPEY 499
R + +HRDL A N+L++++ KI DFG+ + E D+ + D V F Y APE
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV--FWY-APEC 183
Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS 523
+ + F I SDV+SFGV + E+++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-19
Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 27/229 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR---LSHGQE---IAVKRLSKNSVQGELEFKNEVLLVARL 377
+N +LG+G FG V+ L Q+ +AVK L S +F E L+ L
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIF----DAI------KRVQLDWETRYK 427
QH ++V+ G E ++++E++ + ++KF+ DA+ + +L
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
I IA G++YL + +HRDL N L+ +++ KI DFGM+R D D R
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYR 177
Query: 488 IVG----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRI 532
+ G +M PE + F+ +SDV+S GV++ EI + K +++
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 66/204 (32%), Positives = 108/204 (52%), Gaps = 11/204 (5%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFK-NEVLLVARLQHRNL 382
NF KLG+G + VYKGR EI A+K + ++ +G E+ L+ L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
VRL E + +L++E++ + K++ R LD T + +GI + HE+
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKD-LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
R++HRDLK N+L++ K++DFG+AR F + + S V T Y AP+ V
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEVVTLWYRAPD-VLL 173
Query: 503 GH--FSIKSDVFSFGVLVLEIISG 524
G +S D++S G ++ E+I+G
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 6e-19
Identities = 57/211 (27%), Positives = 111/211 (52%), Gaps = 11/211 (5%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELE-FKNEVLLVARLQ 378
D F+ ++G+G FG V+KG + Q++ A+K + + E+E + E+ ++++
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
+ + G + T+ +I E++ S D ++ D ++ I +G+ Y
Sbjct: 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDY 116
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
LH + + IHRD+KA+N+LL K++DFG+A ++ +Q + VGT +MAPE
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPE 171
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529
+ + + K+D++S G+ +E+ G+ NS
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 21/201 (10%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLGFS 389
+LG G FG VYK + +A ++ + + ELE + E+ ++A H +V+LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL----YLHEDSRL 445
+ + + ++ EF P +VD + ++LD I I R +L YLH +
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIM------LELDRGLTEPQIQVICRQMLEALQYLHS---M 129
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV----- 500
+IIHRDLKA N+LL D K++DFG++ + D+ +GT +MAPE V
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETM 187
Query: 501 TRGHFSIKSDVFSFGVLVLEI 521
+ K+D++S G+ ++E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 9e-19
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE--FKNEVLLVARLQHRNLVRLLGF 388
++G+G FG V+ GRL + + ++ +L+ F E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRII 448
++ ++ E V F+ R+++ + +++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKV--KELIQMVENAAAGMEYLESKH---CI 116
Query: 449 HRDLKASNILLDADMIPKISDFGMARLFE--MDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
HRDL A N L+ + KISDFGM+R E + S G +I + APE + G +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174
Query: 507 IKSDVFSFGVLVLEIIS 523
+SDV+SFG+L+ E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 55/196 (28%), Positives = 101/196 (51%), Gaps = 10/196 (5%)
Query: 331 KLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
K+G+G G V H G+++AVK++ Q NEV+++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
E ++ EF+ ++ D + +++ E + + R + YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKS 509
RD+K+ +ILL +D K+SDFG ++ + +VGT +MAPE ++R + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 510 DVFSFGVLVLEIISGQ 525
D++S G++V+E+I G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN----EVLLVARLQ 378
N + +G+G +G V K R + G+ +A+K+ K S E + K EV ++ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDE-DVKKTALREVKVLRQLR 58
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQ--LDWETRYKIIGGIARG 435
H N+V L F RL L++E+V + + + ++ L + I + +
Sbjct: 59 HENIVNLKEA-FRRKGRLYLVFEYVERT-----LLELLEASPGGLPPDAVRSYIWQLLQA 112
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
I Y H IIHRD+K NIL+ + K+ DFG AR + T V T Y
Sbjct: 113 IAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-YVATRWYR 168
Query: 496 APE-YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
APE V ++ DV++ G ++ E++ G+
Sbjct: 169 APELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 27/211 (12%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFK---NE--VLLVARL 377
+F ++GQGG+G V+ + EI A+KR+ K+ + E + E +L +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK- 59
Query: 378 QHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
LV+LL ++F++ E L L E+VP + + V + R+ + +
Sbjct: 60 -SEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFE-AV 114
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR---IVGTFG 493
LH L IHRDLK N L+DA K++DFG+ S+G + +VG+
Sbjct: 115 DALH---ELGYIHRDLKPENFLIDASGHIKLTDFGL--------SKGIVTYANSVVGSPD 163
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
YMAPE + + D +S G ++ E + G
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 66/203 (32%), Positives = 109/203 (53%), Gaps = 19/203 (9%)
Query: 332 LGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLL 386
+G+G FG VY G L S GQ+I AVK L++ + E+E F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 387 GFSF-EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG---GIARGILYLHED 442
G E L++ ++ + + FI R + T +IG +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFI-----RSETHNPTVKDLIGFGLQVAKGMEYLASK 117
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMD-QSQGDTSRIVGTFGYMAPEYV 500
+ +HRDL A N +LD K++DFG+AR +++ + S + + +MA E +
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
F+ KSDV+SFGVL+ E+++
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 66/203 (32%), Positives = 112/203 (55%), Gaps = 19/203 (9%)
Query: 330 NKLGQGGFGAVYKGR-LSHGQEIAVKRLS-KNSVQG-ELEFKNEVLLVARLQ---HRNLV 383
++G+G +G VYK R L+ G+ +A+K++ S +G L E+ L+ +L+ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 384 RLLG-FSFEETER----LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
RLL T+R L++E V + + ++ K L ET ++ + RG+ +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPG-LPPETIKDLMRQLLRGVDF 122
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
LH RI+HRDLK NIL+ +D KI+DFG+AR++ + + TS +V T Y APE
Sbjct: 123 LHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--TS-VVVTLWYRAPE 176
Query: 499 YVTRGHFSIKSDVFSFGVLVLEI 521
+ + ++ D++S G + E+
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 59/206 (28%), Positives = 107/206 (51%), Gaps = 16/206 (7%)
Query: 326 FSTDNKLGQGGFGAVYKGR-LSHGQEI----AVKRLSK-NSVQGELEFKNEVLLVARLQH 379
F LG G FG VYKG + G+++ A+K L + S + E +E ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
++ RLLG T +L I + +P + ++ + + + + + IA+G+ YL
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV--QIAKGMNYL 125
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS--QGDTSRIVGTFGYMAP 497
E R++HRDL A N+L+ KI+DFG+A+L D+ + ++ +MA
Sbjct: 126 EER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PIKWMAL 180
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
E + ++ +SDV+S+GV V E+++
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 21/207 (10%)
Query: 331 KLGQGGFGAVYKGRLSHG-------QEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNL 382
+LGQG FG VY+G ++ G +A+K +++ S++ +EF NE ++ ++
Sbjct: 13 ELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ----LDWETRYKII---GGIARG 435
VRLLG + L+I E + + ++ ++ + K+I G IA G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGTFGY 494
+ YL+ + + +HRDL A N ++ D KI DFGM R ++E D + ++ +
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-PVRW 187
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEI 521
M+PE + G F+ SDV+SFGV++ EI
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-18
Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 332 LGQGGFGAVYKGR----LSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRL 385
LGQG FG V+ R GQ A+K L K + V+ + K E ++A + H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 386 LGFSFEETERL-LIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDS 443
++F+ +L LI +F+ + F + K V E + +A + +LH
Sbjct: 64 -HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH--- 115
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
L II+RDLK NILLD + K++DFG+++ E + GT YMAPE V R
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRR 173
Query: 504 HFSIKSDVFSFGVLVLEIISG 524
+ +D +SFGVL+ E+++G
Sbjct: 174 GHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEF-KNEVLLVARLQHRNLVRLLGF 388
++G G +G VYK R E+ ++ K + E + E+ ++ +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG- 67
Query: 389 SFEETERLLI-YEFVPNSSVD---KFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
S+ ++L I E+ S+ + + +Q+ + R + +G+ YLHE
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYLHE--- 119
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV---T 501
IHRD+K +NILL D K++DFG++ ++ + +GT +MAPE
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSA--QLTATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 502 RGHFSIKSDVFSFGVLVLEIISGQ 525
+G + K D+++ G+ +E+ Q
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 20/202 (9%)
Query: 332 LGQGGFGAVYKG-RLSHGQEI----AVKRL-SKNSVQGELEFKNEVLLVARLQHRNLVRL 385
LG G FG V+KG + G I A+K + ++ Q E + +L + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIF---DAIK-RVQLDWETRYKIIGGIARGILYLHE 441
LG L+ + P S+ + D++ + L+W + IA+G+ YL E
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
R++HR+L A NILL +D I +I+DFG+A L D + S +MA E +
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
G ++ +SDV+S+GV V E++S
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 61/209 (29%), Positives = 110/209 (52%), Gaps = 26/209 (12%)
Query: 325 NFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKR--LSKNSVQGELEFKNEVLLVARLQHR 380
+ K+G+G FG +Y K + S + +K L+K V+ + K EV+L+A+++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 381 NLVRLLGFSFEETERLLI-YEFVPNSSVDKFIFDAIKRVQLDWETRY---KIIG---GIA 433
N+V SF+E RL I E+ D +KR+ + +I+ I+
Sbjct: 60 NIVTFFA-SFQENGRLFIVMEYCDGG-------DLMKRINRQRGVLFSEDQILSWFVQIS 111
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARLFEMDQSQGDTSRIVGTF 492
G+ ++H+ +I+HRD+K+ NI L + M+ K+ DFG+AR +++ S VGT
Sbjct: 112 LGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDSMELAYTCVGTP 166
Query: 493 GYMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
Y++PE ++ K+D++S G ++ E+
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 5e-18
Identities = 55/199 (27%), Positives = 103/199 (51%), Gaps = 17/199 (8%)
Query: 332 LGQGGFGAVY--KGRLSHG----QEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385
+G+G FG V+ + + ++I V++++K+ L +NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE---RLAAQNECQVLKLLSHPNIIEY 64
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445
E+ +++ E+ P ++ ++I LD +T I+ + +L LH
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDT---ILHFFVQILLALHHVHTK 120
Query: 446 RIIHRDLKASNILLDA-DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
I+HRDLK NILLD M+ KI DFG++++ S+ +VGT Y++PE
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISPELCEGKP 177
Query: 505 FSIKSDVFSFGVLVLEIIS 523
++ KSD+++ G ++ E+ S
Sbjct: 178 YNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 6e-18
Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 22/207 (10%)
Query: 331 KLGQGGFGAVYKG--RLSHGQ-EIAVKRLSKNSVQGELEFKNEVLLVARLQHR----NLV 383
+LG G FG V KG ++ Q ++A+K L + E ++E++ A + H+ +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIV 58
Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
R++G E E L L+ E ++KF+ + K+ ++ +++ ++ G+ YL
Sbjct: 59 RMIGVC--EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGK 114
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYV 500
+ +HRDL A N+LL KISDFG+++ D S +R G + + APE +
Sbjct: 115 N---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-KARSAGKWPLKWYAPECI 170
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS-GQK 526
FS +SDV+S+G+ + E S GQK
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 63/200 (31%), Positives = 92/200 (46%), Gaps = 34/200 (17%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKR-LSKNSVQG-ELEFKNEVLLVARLQ 378
++ KLG+G FG VYK R + G+ +A+K+ L N G + E+ ++ +L+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 379 HRNLVRLLGFSFEETE-----RLLIYEFVP-----------NSSVDKFIFDAIKRVQLDW 422
H N+V L+ + E + R +Y P N SV K IK L
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV-KLTESQIKCYMLQ- 123
Query: 423 ETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482
+ GI YLHE+ I+HRD+KA+NIL+D I KI+DFG+AR ++
Sbjct: 124 ---------LLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171
Query: 483 GDTSRIVGTFGYMAPEYVTR 502
GT Y VTR
Sbjct: 172 PKGGGGGGTRKY-TNLVVTR 190
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLG 387
LG+GGFG V ++ + G+ A K+L K ++ GE NE ++ ++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
+++E + L + + N KF + + I G+ LH++ RI
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RI 123
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
++RDLK NILLD +ISD G+A + + Q R VGT GYMAPE V ++
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYMAPEVVKNERYTF 180
Query: 508 KSDVFSFGVLVLEIISGQ 525
D ++ G L+ E+I+GQ
Sbjct: 181 SPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 38/208 (18%)
Query: 313 QFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKR-LSKNSVQG-ELEFKN 369
Q++F + + + K+GQG FG V+K R Q +A+K+ L +N +G +
Sbjct: 2 QYEFPFCDE-VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR 60
Query: 370 EVLLVARLQHRNLVRLL--------GFSFEETERLLIYEF--------VPNSSVDKFIFD 413
E+ ++ L+H N+V L+ ++ + L++EF + N +V KF
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV-KFTLS 119
Query: 414 AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473
IK+V + + G+ Y+H R +I+HRD+KA+NIL+ D I K++DFG+A
Sbjct: 120 EIKKV----------MKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA 166
Query: 474 RLF---EMDQSQGDTSRIVGTFGYMAPE 498
R F + + T+R+V T Y PE
Sbjct: 167 RAFSLSKNSKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 7e-18
Identities = 69/215 (32%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 332 LGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRN 381
LG+G FG V K R +AVK L N+ +L + +E+ L+ + +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFI-----------FDAIK--RVQLDWETRYKI 428
++ LLG +E +I E+ ++ +F+ FD K QL ++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
+ARG+ YL +SR R IHRDL A N+L+ D + KI+DFG+AR TS
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+MAPE + ++ +SDV+SFG+L+ EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 71/287 (24%), Positives = 122/287 (42%), Gaps = 42/287 (14%)
Query: 331 KLGQGGFGAVYKGRLSHGQE---------------IAVKRLSKNSVQ-GELEFKNEVLLV 374
KLG+G FG V+ E +AVK L + + +F E+ ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQL---------DWETR 425
+RL++ N++RLLG + +I E++ N +++F+
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485
+ IA G+ YL + L +HRDL N L+ KI+DFGM+R + GD
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR----NLYSGDY 184
Query: 486 SRIVG----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLT 541
RI G +MA E + G F+ SDV++FGV + E+ + K + + + + +
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244
Query: 542 YAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPT 588
N+G + L L ++M + C ++ +RPT
Sbjct: 245 TGEFFRNQGRQIYLSQTPLCPSPVFKLM------MRCWSRDIKDRPT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 8e-18
Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 20/219 (9%)
Query: 319 IRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL 377
+RD F +G G +G VYKGR + GQ A+K + + E E K E+ ++ +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKKY 59
Query: 378 -QHRNLVRLLGFSFEET------ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
HRN+ G ++ + L+ EF SV I + K L E I
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICR 118
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
I RG+ +LH+ ++IHRD+K N+LL + K+ DFG++ ++D++ G + +G
Sbjct: 119 EILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIG 173
Query: 491 TFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISG 524
T +MAPE + + KSD++S G+ +E+ G
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 51/240 (21%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV--QGE-LEFKNEVLLVARLQH 379
++F +G+G FG V+ R ++ A+K L K+ + + + + E ++A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 380 RNLVRLLGFSFEETERL-LIYEFVP-----NSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
+V+L +SF++ E L L+ E++P N + K +F + Y IA
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETARFY-----IA 108
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA--------RLFEMDQSQGDT 485
+L L +L IHRD+K NIL+DAD K++DFG+ R + ++ S
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 486 SR-------------------IVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQ 525
R VGT Y+APE V RG + ++ D +S GV++ E++ G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEMLYGF 227
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 60/224 (26%), Positives = 113/224 (50%), Gaps = 16/224 (7%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLS---KNSVQGELEFKNEVLLVARLQHR 380
NF + K+G+G F VY+ L + +A+K++ + + E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE-TRYKIIGGIARGILYL 439
N+++ L E+ E ++ E + + I K+ +L E T +K + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
H SR R++HRD+K +N+ + A + K+ D G+ R F + + +VGT YM+PE
Sbjct: 123 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 500 VTRGHFSIKSDVFSFGVLVLEIIS------GQKNNSFRIGEEAE 537
+ ++ KSD++S G L+ E+ + G K N F + ++ E
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE 221
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 56/207 (27%), Positives = 106/207 (51%), Gaps = 12/207 (5%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLS---KNSVQGELEFKNEVLLVARLQHR 380
NF + K+G+G F VY+ L G +A+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFI--FDAIKRVQLDWETRYKIIGGIARGILY 438
N+++ E+ E ++ E + + I F KR+ + +T +K + + +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTVWKYFVQLCSALEH 121
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
+H SR R++HRD+K +N+ + A + K+ D G+ R F + + +VGT YM+PE
Sbjct: 122 MH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 176
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
+ ++ KSD++S G L+ E+ + Q
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEF---KNEVLLVARLQHRNLVRLLG 387
+ +G +G V+ + S G A+K + K + + + E ++++ Q +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 388 FSFEETERL-LIYEFVPNSSVDKFI--FDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
+SF+ + L L+ E++P + + + LD + I I + YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGS-----LDEDVARIYIAEIVLALEYLH---S 111
Query: 445 LRIIHRDLKASNILLDADMIPKISDFG------MARLFEMDQSQGDTSRIVGTFGYMAPE 498
IIHRDLK NIL+D++ K++DFG + R ++ + + RIVGT Y+APE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISG 524
+ S D +S G ++ E + G
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 66/199 (33%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLG 387
LG+GGFG V ++ + G+ A K+L K ++ GE NE ++ ++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
+++E + L + + N KF + D E I G+ LH R RI
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERI 123
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMAPEYVTRGHFS 506
++RDLK NILLD +ISD G+A ++ +G+T R VGT GYMAPE V ++
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGYMAPEVVKNERYT 179
Query: 507 IKSDVFSFGVLVLEIISGQ 525
D + G L+ E+I G+
Sbjct: 180 FSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 80/279 (28%), Positives = 129/279 (46%), Gaps = 41/279 (14%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---EVLLVAR 376
D FS ++G G FGAVY R + + + +A+K++S + Q ++++ EV + +
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
L+H N ++ G E L+ E+ S+ D + + K+ + E + G +G+
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA-AVTHGALQGL 128
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
YLH + +IHRD+KA NILL + K+ DFG A + VGT +MA
Sbjct: 129 AYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMA 179
Query: 497 PEYV---TRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553
PE + G + K DV+S G+ +E + E L N N +AL
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIE-----------LAERKPPLF-----NMNAMSAL 223
Query: 554 NLI----DPTLRNGSSSEIMRCVHIGLLCVQENVANRPT 588
I P L++G SE R + C+Q+ +RPT
Sbjct: 224 YHIAQNESPALQSGHWSEYFR--NFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 15/209 (7%)
Query: 332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLG 387
LG+GGFG V ++ + G+ A KRL K ++ GE NE ++ ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
+++E + L + + N KF + + E I G+ LH ++
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---T 123
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMAPEYVTRGHFS 506
++RDLK NILLD +ISD G+A + +G++ R VGT GYMAPE + ++
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLA----VKIPEGESIRGRVGTVGYMAPEVLNNQRYT 179
Query: 507 IKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
+ D + G L+ E+I GQ + FR +E
Sbjct: 180 LSPDYWGLGCLIYEMIEGQ--SPFRGRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 59/198 (29%), Positives = 101/198 (51%), Gaps = 15/198 (7%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLGFS 389
+LG G FG VYK + +A ++ + ELE + E+ ++A H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII-GGIARGILYLHEDSRLRII 448
+ E ++ EF +VD + + + + E + +++ + YLHE+ +II
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHEN---KII 125
Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV-----TRG 503
HRDLKA NIL D K++DFG++ + D+ +GT +MAPE V
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDR 183
Query: 504 HFSIKSDVFSFGVLVLEI 521
+ K+DV+S G+ ++E+
Sbjct: 184 PYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 81/279 (29%), Positives = 127/279 (45%), Gaps = 41/279 (14%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKN---EVLLVAR 376
D F+ ++G G FGAVY R E+ A+K++S + Q ++++ EV + R
Sbjct: 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQR 81
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
++H N + G E L+ E+ S+ D + + K+ + E I G +G+
Sbjct: 82 IKHPNSIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA-AITHGALQGL 138
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
YLH + +IHRD+KA NILL K++DFG A + S VGT +MA
Sbjct: 139 AYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMA 189
Query: 497 PEYV---TRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553
PE + G + K DV+S G+ +E + E L N N +AL
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIE-----------LAERKPPLF-----NMNAMSAL 233
Query: 554 NLI----DPTLRNGSSSEIMRCVHIGLLCVQENVANRPT 588
I PTL++ S+ R + C+Q+ +RPT
Sbjct: 234 YHIAQNESPTLQSNEWSDYFR--NFVDSCLQKIPQDRPT 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 29/212 (13%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN-----EVLLVARLQ 378
+ KLG+G + VYK R G+ +A+K++ + + N E+ L+ L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYK-IIGGIARGI 436
H N++ LL F + L++EF+ + ++K I D + K + RG+
Sbjct: 61 HPNIIGLLDV-FGHKSNINLVFEFME-TDLEKVIKDKSIVLT---PADIKSYMLMTLRGL 115
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI----VGTF 492
YLH I+HRDLK +N+L+ +D + K++DFG+AR F G +R V T
Sbjct: 116 EYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF------GSPNRKMTHQVVTR 166
Query: 493 GYMAPE--YVTRGHFSIKSDVFSFGVLVLEII 522
Y APE + R H+ + D++S G + E++
Sbjct: 167 WYRAPELLFGAR-HYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLG 387
LG+GGFG V ++ + G+ A K+L K ++ GE NE ++ ++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
+++E + L + + N KF + D + + G+ L R RI
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERI 123
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMAPEYVTRGHFS 506
++RDLK NILLD +ISD G+A + +G+T R VGT GYMAPE + ++
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINNEKYT 179
Query: 507 IKSDVFSFGVLVLEIISGQ 525
D + G L+ E+I GQ
Sbjct: 180 FSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 329 DNKLGQGGFGAVYKG--RLSHGQEI--AVKRLSKNSVQGELE-FKNEVLLVARLQHRNLV 383
+G+G FG VY+G ++I AVK + E F E ++ + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
+L+G E ++ E P + ++ + + LD + ++ + YL
Sbjct: 71 KLIGV-ITENPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES-- 125
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
R +HRD+ A N+L+ + K+ DFG++R E D+S S+ +MAPE +
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFR 183
Query: 504 HFSIKSDVFSFGVLVLEIIS-------GQKNN 528
F+ SDV+ FGV + EI+ G KNN
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPFQGVKNN 215
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 66/228 (28%), Positives = 111/228 (48%), Gaps = 30/228 (13%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLL 373
D S +RD F +G G +G VYKGR + GQ A+K + + E E K E+ +
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE-EIKLEINM 65
Query: 374 VARL-QHRNLVRLLGFSFEET------ERLLIYEFVPNSSVDKFIFDAIKR-----VQLD 421
+ + HRN+ G +++ + L+ EF SV D +K ++ D
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVT----DLVKNTKGNALKED 121
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
W I I RG+ +LH ++IHRD+K N+LL + K+ DFG++ ++D++
Sbjct: 122 WIAY--ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRT 174
Query: 482 QGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISG 524
G + +GT +MAPE + + +SD++S G+ +E+ G
Sbjct: 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 61/200 (30%), Positives = 103/200 (51%), Gaps = 19/200 (9%)
Query: 332 LGQGGFGAVYK-GRLSHGQEIAVKRL---SKNSVQGELEFKNEVLLVARLQHRNLVRLLG 387
LG G G+V K + G +A K + +K+SV+ ++ + +++ R + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY--IVSFYG 70
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRV--QLDWETRYKIIGGIARGILYLHEDSRL 445
E + EF+ D D I + + E KI + G+ YL+
Sbjct: 71 AFLNENNICMCMEFM-----DCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VH 123
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
RI+HRD+K SNIL+++ K+ DFG++ E+ S DT VGT YM+PE + G +
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSG--ELINSIADT--FVGTSTYMSPERIQGGKY 179
Query: 506 SIKSDVFSFGVLVLEIISGQ 525
++KSDV+S G+ ++E+ G+
Sbjct: 180 TVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 53/196 (27%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 331 KLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
K+G+G G V + S G+ +AVK++ Q NEV+++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
E ++ EF+ ++ D + +++ E + + + + LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKS 509
RD+K+ +ILL D K+SDFG ++ + +VGT +MAPE ++R + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 510 DVFSFGVLVLEIISGQ 525
D++S G++V+E++ G+
Sbjct: 198 DIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 78/285 (27%), Positives = 137/285 (48%), Gaps = 41/285 (14%)
Query: 331 KLGQGGFGAVYKG---RLSHGQ---EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLV 383
+LGQG FG VY+G + G+ +AVK ++++ S++ +EF NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE--------TRYKII---GGI 432
RLLG + L++ E + + + ++ + ++ + E T ++I I
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGT 491
A G+ YL+ + +HRDL A N ++ D KI DFGM R ++E D + ++
Sbjct: 129 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL-P 184
Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGT 551
+MAPE + G F+ SD++SFGV++ EI S + E+ L+ NE
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--------LAEQPYQGLS------NEQV 230
Query: 552 ALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVML 596
++D + + R + +C Q N RPT +V +L
Sbjct: 231 LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 11/203 (5%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRN 381
NF K+G+G +G VYK R G+ +A+K RL + E+ L+ L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
+V+LL E + L++EF+ + + KF+ DA + + + +G+ + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
R++HRDLK N+L++ + K++DFG+AR F + + T +V T Y APE +
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILL 173
Query: 502 RGHF-SIKSDVFSFGVLVLEIIS 523
+ S D++S G + E+++
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKN---EVLLVARLQHRNLVRL 385
+++G G FGAVY SH E+ AVK++S + Q ++++ EV + +L+H N +
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445
G +E L+ E+ S+ D + + K+ + E I G +G+ YLH +
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA-AITHGALQGLAYLHSHN-- 141
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV---TR 502
+IHRD+KA NILL K++DFG A S VGT +MAPE +
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAMDE 194
Query: 503 GHFSIKSDVFSFGVLVLEI 521
G + K DV+S G+ +E+
Sbjct: 195 GQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 7e-17
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 45/215 (20%)
Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN---EVLLVARLQHRNLVRLLG 387
+G G +G V + G+++A+K+LS+ Q + K E+ L+ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSR-PFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 388 FSFEETERLLIYEFVPNSSVDKF--------IFDA-----IKRVQL-DWETRYKIIGGIA 433
F P SS++ F + A +K +L D ++ ++ I
Sbjct: 82 V------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQIL 128
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL--FEMDQSQGDTSRIVGT 491
RG+ Y+H IIHRDLK SNI ++ D KI DFG+AR EM V T
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG-------YVAT 178
Query: 492 FGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
Y APE + H++ D++S G ++ E+++G+
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-17
Identities = 62/223 (27%), Positives = 106/223 (47%), Gaps = 34/223 (15%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHG---QEIAVKRLSKNSVQGE-LEFKNEVLLVARL-Q 378
N+ + +G+G FG V K R+ + A+KR+ + + + + +F E+ ++ +L
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-----------FDAIKRV--QLDWETR 425
H N++ LLG L E+ P+ ++ F+ F L +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485
+ARG+ YL S+ + IHRDL A NIL+ + + KI+DFG++R G
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQE 175
Query: 486 SRIVGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+ T G +MA E + ++ SDV+S+GVL+ EI+S
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR---LSHGQ---EIAVKRLSKNSVQGELE-FKNEVLLVAR 376
NN S LG G FG V + LS ++AVK L + E E +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 377 L-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARG 435
L H N+V LLG L+I E+ + F+ + L E +A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKG 153
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ---SQGDTSRIVGTF 492
+ +L + IHRDL A N+LL I KI DFG+AR D +G+ V
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV--- 207
Query: 493 GYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+MAPE + ++ +SDV+S+G+L+ EI S
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 331 KLGQGGFGAVYKGRLSH-GQEIAVKRL---SKNSVQGELEFKNEVLLVARLQHRNLVRLL 386
+G+G +G V K + GQ +A+K+ + + ++ + E+ ++ +L+H NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLI 66
Query: 387 GFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQ--LDWETRYKIIGGIARGILYLHEDS 443
F +RL L++EFV D + D +++ LD K + I RGI + H +
Sbjct: 67 EV-FRRKKRLYLVFEFV-----DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY-VTR 502
IIHRD+K NIL+ + K+ DFG AR + + V T Y APE V
Sbjct: 121 ---IIHRDIKPENILVSQSGVVKLCDFGFART--LAAPGEVYTDYVATRWYRAPELLVGD 175
Query: 503 GHFSIKSDVFSFGVLVLEIISGQ 525
+ D+++ G LV E+++G+
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 62/211 (29%), Positives = 108/211 (51%), Gaps = 22/211 (10%)
Query: 332 LGQGGFGAVYKGRLSHGQEI---AVKRLS-KNSVQGELE-FKNEVLLVARLQHRNLVRLL 386
LG+G FG+V +G+L+ I AVK + + E+E F +E + + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 387 GFSFEETER------LLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYKIIGGIARGIL 437
G + E ++I F+ + + F+ + L + K + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA-RLFEMD-QSQGDTSRIVGTFGYM 495
YL S IHRDL A N +L+ +M ++DFG++ +++ D QG +++ ++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKWI 181
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIIS-GQ 525
A E + ++ KSDV+SFGV + EI + GQ
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQ 212
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 28/208 (13%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRL--SKNSVQGELEFKNEVLLVARLQH-RNLVRLLG 387
LG+G +G V K R + G +AVKR+ + NS Q + ++ + R V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFYG 67
Query: 388 FSFEETERLLIYEFVPNSSVDKF---IFDAIKRVQLDWETRYKIIGGIARGIL----YLH 440
F E + + E V ++S+DKF ++D + D I+G IA I+ YLH
Sbjct: 68 ALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPED------ILGKIAVSIVKALEYLH 120
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
+L +IHRD+K SN+L++ + K+ DFG++ + S T G YMAPE +
Sbjct: 121 S--KLSVIHRDVKPSNVLINRNGQVKLCDFGISG--YLVDSVAKTIDA-GCKPYMAPERI 175
Query: 501 ----TRGHFSIKSDVFSFGVLVLEIISG 524
+ + +KSDV+S G+ ++E+ +G
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 12/198 (6%)
Query: 331 KLGQGGFGAVYKGRLSHGQE-IAVK--RLSKNSVQGELEFKNEVLLVARLQHRNLVRLLG 387
K+G+G +G VYK R E IA+K RL + E+ L+ +QH N+VRL
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
E L++E++ + + K + D+ + + I RGI Y H S R+
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHM-DSSPDFAKNPRLIKTYLYQILRGIAYCH--SH-RV 123
Query: 448 IHRDLKASNILLD-ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HF 505
+HRDLK N+L+D K++DFG+AR F + + T +V T Y APE + H+
Sbjct: 124 LHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-TLWYRAPEILLGSRHY 181
Query: 506 SIKSDVFSFGVLVLEIIS 523
S D++S G + E+++
Sbjct: 182 STPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 18/206 (8%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIA---VKRL-SKNSVQGELEFKNEVLLVARLQHRNLVRL 385
+++G G FG V G G A VK L + + +L F EV L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRY--KIIGGIARGILYLHEDS 443
LG E LL+ EF P + ++ V + ++ +A G+L+LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--- 117
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMA-RLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
+ IH DL N L AD+ KI D+G+A + D V ++APE V
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEI 176
Query: 503 GHFSI-------KSDVFSFGVLVLEI 521
+ KS+++S GV + E+
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 61/223 (27%), Positives = 109/223 (48%), Gaps = 34/223 (15%)
Query: 327 STDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-Q 378
+ LG+G FG V K + +AVK L ++ + +L + +E+ ++ + +
Sbjct: 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 74
Query: 379 HRNLVRLLGFSFEETERLLIYEFV-------------PNSSVDKFIFDAIKRVQLDWETR 425
H+N++ LLG +E ++ E+ P L T+
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL---TQ 131
Query: 426 YKIIG---GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQS 481
++ +ARG+ +L S+ + IHRDL A N+L+ D + KI+DFG+AR + +D
Sbjct: 132 KDLVSFAYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 482 QGDTS-RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+ T+ R+ +MAPE + ++ +SDV+SFGVL+ EI +
Sbjct: 189 RKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 68/234 (29%), Positives = 110/234 (47%), Gaps = 51/234 (21%)
Query: 331 KLGQGGFGAVYKGRLSHGQE-----------------IAVKRL----SKNSVQGELEFKN 369
KLG+G FG V+ + + Q+ +AVK L +KN+ +F
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN---DFLK 68
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI----------------FD 413
EV +++RL+ N++RLLG +E +I E++ N +++F+
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 414 AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473
A + + + + IA G+ YL S L +HRDL N L+ ++ KI+DFGM+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 474 RLFEMDQSQGDTSRIVG----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
R + GD RI G +MA E + G F+ SDV++FGV + EI+
Sbjct: 186 R----NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 9/197 (4%)
Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLGF 388
LG+GGFG V ++ + G+ A K+L K ++ + K +L L+ N + L +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRII 448
+FE L + + N K+ + L+ E I GIL+LH + I+
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIV 117
Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIK 508
+RD+K N+LLD ++SD G+A E+ + T R GT GYMAPE + +S
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQR-AGTNGYMAPEILKEEPYSYP 174
Query: 509 SDVFSFGVLVLEIISGQ 525
D F+ G + E+++G+
Sbjct: 175 VDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 5e-16
Identities = 61/199 (30%), Positives = 104/199 (52%), Gaps = 15/199 (7%)
Query: 332 LGQGGFGAVYKG--RLSHGQE--IAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLL 386
LG G FG + +G +L +E +A+ L S + F E L + + H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
G +++ E++ N ++D F+ QL ++ G+A G+ YL E +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLSE---MG 127
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG--TFGYMAPEYVTRGH 504
+H+ L A +L+++D++ KIS F RL E D+S+ + + G + APE + H
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR--RLQE-DKSEAIYTTMSGKSPVLWAAPEAIQYHH 184
Query: 505 FSIKSDVFSFGVLVLEIIS 523
FS SDV+SFG+++ E++S
Sbjct: 185 FSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 54/183 (29%), Positives = 88/183 (48%), Gaps = 19/183 (10%)
Query: 331 KLGQGGFGAVYKGRL---SHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQHRNLVR 384
+G+G +G VYK + G+E A+K+ + Q E+ L+ L+H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 385 LLGFSFEETERL--LIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
L+ E ++ L++++ + + KF A KRV + ++ I G+ YLH
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQA-KRVSIPPSMVKSLLWQILNGVHYLH 125
Query: 441 EDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLF-EMDQSQGDTSRIVGTFGYM 495
+ ++HRDLK +NIL+ + KI D G+ARLF + D +V T Y
Sbjct: 126 SN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYR 182
Query: 496 APE 498
APE
Sbjct: 183 APE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 325 NFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELE-----FKNEVLLVARLQ 378
N+ LGQG FG VY G+E+AVK++ + E + E+ L+ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 379 HRNLVRLLGFSFEETERLL--IYEFVPNSSVDKFIFDAIKRV-QLDWETRYKIIGGIARG 435
H +V+ G + ER L E +P S+ D +K L K I G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEG 118
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA-RLFEMDQSQGDTSRIVGTFGY 494
+ YLH + I+HRD+K +NIL D+ K+ DFG + RL + S + GT +
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
M+PE ++ + K+D++S G V+E+++
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 56/205 (27%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 334 QGGFGAVYKGRLSHG-----QEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLG 387
+G FG ++ G L +E+ VK + ++ + ++ E L+ L H+N++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 388 FSFEETER-LLIYEFVPNSSVDKFIFD---AIKRVQLDWETRYKIIGG--IARGILYLHE 441
E+ E ++Y ++ ++ F+ T+ + IA G+ YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMD-QSQGDT-SRIVGTFGYMAPE 498
+ +IH+D+ A N ++D ++ KI+D ++R LF MD GD +R V +MA E
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---WMALE 189
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIIS 523
+ +S SDV+SFGVL+ E+++
Sbjct: 190 SLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 331 KLGQGGFGAVYKGRLSH-GQEIAVK--RLSKNSVQGELEFKNEVLLVARLQ---HRNLVR 384
++G G +G VYK R H G +A+K R+ N L EV L+ RL+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 385 LLGF-----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
L+ + ET+ L++E V + D + L ET ++ RG+ +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDL--RTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
H + I+HRDLK NIL+ + K++DFG+AR++ Q + +V T Y APE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178
Query: 500 VTRGHFSIKSDVFSFGVLVLEI 521
+ + ++ D++S G + E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-16
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 331 KLGQGGFGAVYKGRLSHG---QEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLL 386
++G G FG V G ++ G ++ VK L + SVQ +++F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFD--AIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
G E T LL+ EF P + ++ + + D T ++ IA G+L+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
IH DL N LL AD+ KI D+G++ + ++ ++APE V H
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 505 FSI-------KSDVFSFGVLVLEI 521
++ +S+V+S GV + E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 22/207 (10%)
Query: 331 KLGQGGFGAVYKG--RLSHGQEIAVKRLSKNSVQGELEFKNEVL----LVARLQHRNLVR 384
+LG G FG V KG ++ ++ ++ KN K+E+L ++ +L + +VR
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDP-ALKDELLREANVMQQLDNPYIVR 60
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
++G E +L+ E ++KF+ K + + +++ ++ G+ YL E +
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN- 115
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMD----QSQGDTSRIVGTFGYMAPEYV 500
+HRDL A N+LL KISDFG+++ D +++ V + APE +
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPV---KWYAPECM 170
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS-GQK 526
FS KSDV+SFGVL+ E S GQK
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 65/214 (30%), Positives = 110/214 (51%), Gaps = 15/214 (7%)
Query: 332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN---EVLLVARLQHRNLVRLLG 387
LG+GGFG V ++ + G+ A K+L+K ++ ++ E ++A++ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVS-LA 59
Query: 388 FSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRL 445
++F+ +T+ L+ + + I++ + E R I G+ +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
RII+RDLK N+LLD D +ISD G+A E+ Q T GT G+MAPE + +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEEY 174
Query: 506 SIKSDVFSFGVLVLEIISGQKNNSFRI-GEEAED 538
D F+ GV + E+I+ + FR GE+ E+
Sbjct: 175 DFSVDYFALGVTLYEMIAAR--GPFRARGEKVEN 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 29/202 (14%)
Query: 334 QGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL--------V 383
+G FG+VY K R + G A+K L K+ + KN+V V + + + V
Sbjct: 6 KGAFGSVYLAKKRST-GDYFAIKVLKKSD----MIAKNQVTNV-KAERAIMMIQGESPYV 59
Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
L +SF+ + L L+ E++ I + + DW +Y I + G+ LH+
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQY--IAEVVLGVEDLHQR 116
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
IIHRD+K N+L+D K++DFG++R ++ + VGT Y+APE +
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILG 167
Query: 503 GHFSIKSDVFSFGVLVLEIISG 524
SD +S G ++ E + G
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 58/190 (30%), Positives = 94/190 (49%), Gaps = 35/190 (18%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKN--EVLLVARLQHRN 381
F N++G+G +G VY+ R + EI A+K++ ++ + + + E+ L+ L+H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDW------------ETRYK-I 428
+V L E V +D IF ++ + D E++ K +
Sbjct: 68 IVELK-------------EVVVGKHLDS-IFLVMEYCEQDLASLLDNMPTPFSESQVKCL 113
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
+ + RG+ YLHE+ IIHRDLK SN+LL KI+DFG+AR + + T ++
Sbjct: 114 MLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM-TPKV 169
Query: 489 VGTFGYMAPE 498
V T Y APE
Sbjct: 170 V-TLWYRAPE 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 25/206 (12%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR--NLVRLLGF 388
+G G G VYK R G +AVK++ + + E + L V H +V+ G+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL----YLHEDSR 444
+++ + E + ++ +DK + KR+Q I+G + I+ YL E
Sbjct: 83 FITDSDVFICMELM-STCLDKLL----KRIQGPIPED--ILGKMTVAIVKALHYLKEKHG 135
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMA-RLFEMDQSQGDTSRIVGTFGYMAPEYVT-- 501
+IHRD+K SNILLDA K+ DFG++ RL + S+ T R G YMAPE +
Sbjct: 136 --VIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKT-RSAGCAAYMAPERIDPP 189
Query: 502 --RGHFSIKSDVFSFGVLVLEIISGQ 525
+ I++DV+S G+ ++E+ +GQ
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELE-----FKNEVLLVARLQHRNLVRL 385
LGQG FG VY + G+E+A K++ + E + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 386 LGFSFEETERLL--IYEFVPNSSVDKFIFDAIKRV-QLDWETRYKIIGGIARGILYLHED 442
G + E+ L E++P SV D +K L K I G+ YLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMAPEYVT 501
I+HRD+K +NIL D+ K+ DFG ++ + G R + GT +M+PE ++
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
+ K+DV+S G V+E+++
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 22/204 (10%)
Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSK--NSVQGELEFKNEVLLVARLQ-HRNLVRLL 386
+LG G FG+VY R G+ +A+K++ K S + + + EV + +L H N+V+L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-EVKSLRKLNEHPNIVKLK 64
Query: 387 GFSFEETERL-LIYEFVPNSSVDKFIFDAIKR---VQLDWETRYKIIGGIARGILYLHED 442
F E + L ++E++ + ++ +K II I +G+ ++H
Sbjct: 65 E-VFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH-- 116
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
+ HRDLK N+L+ + KI+DFG+AR E+ +S+ + V T Y APE + R
Sbjct: 117 -KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EI-RSRPPYTDYVSTRWYRAPEILLR 172
Query: 503 -GHFSIKSDVFSFGVLVLEIISGQ 525
+S D+++ G ++ E+ + +
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 15/199 (7%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEV----LLVARLQHRNLVRLL 386
+G+G FG V + + G+ AVK L K ++ + E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRL 445
+SF+ ++L FV + +F ++R + E R + IA + YLH L
Sbjct: 62 HYSFQTADKLY---FVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS---L 115
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
II+RDLK NILLD+ ++DFG+ + E + TS GT Y+APE + + +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 506 SIKSDVFSFGVLVLEIISG 524
D + G ++ E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 63/223 (28%), Positives = 107/223 (47%), Gaps = 37/223 (16%)
Query: 331 KLGQGGFGAVY----KGRLSHGQE-------------IAVKRLSKNSVQ-GELEFKNEVL 372
KLG+G FG V+ +G + +AVK L +++ + +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI--------FDAIKRVQLDWET 424
+++RL+ N++RLL +I E++ N +++F+ + V + + T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
+ IA G+ YL S L +HRDL N L+ + KI+DFGM+R + GD
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSGD 184
Query: 485 TSRIVG----TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
RI G +M+ E + G F+ SDV++FGV + EI++
Sbjct: 185 YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 22/203 (10%)
Query: 330 NKLGQGGFGAVYKGR-LSHGQEIAVKRLSK--NSVQGELEFKNEVLLVARLQ-HRNLVRL 385
K+G+G F V K + G+ A+K + K S++ E+ + RL H N++RL
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRL 63
Query: 386 LGFSFEE-TERL-LIYEFVPNSSVDKFIFDAIK-RVQLDWETRYK-IIGGIARGILYLHE 441
+ F+ T RL L++E + D +++ IK R + E R K + + + + ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH- 117
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE-YV 500
R I HRD+K NIL+ D++ K++DFG R + T I T Y APE +
Sbjct: 118 --RNGIFHRDIKPENILIKDDIL-KLADFGSCR--GIYSKPPYTEYI-STRWYRAPECLL 171
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
T G++ K D+++ G + EI+S
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 58/203 (28%), Positives = 108/203 (53%), Gaps = 20/203 (9%)
Query: 331 KLGQGGFGAVYKGR--LSHGQEIAVKRLS-KNSVQG-ELEFKNEVLLVARLQ---HRNLV 383
++G+G +G V+K R + G+ +A+KR+ + +G L EV ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 384 RLLGF-----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
RL + ET+ L++E V + + ++ D + + ET ++ + RG+ +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
LH R++HRDLK NIL+ + K++DFG+AR++ Q + +V T Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPE 179
Query: 499 YVTRGHFSIKSDVFSFGVLVLEI 521
+ + ++ D++S G + E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 67/203 (33%), Positives = 104/203 (51%), Gaps = 21/203 (10%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFK---NE--VLLVARLQHRNLVRL 385
LG+G FG V L E+ AVK L K+ + + + + E VL +A +H L +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQL 61
Query: 386 LGFS-FEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHED 442
S F+ +RL + E+V + +F + + D E R + I G+ +LHE
Sbjct: 62 --HSCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFD-EPRARFYAAEIVLGLQFLHER 115
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
II+RDLK N+LLD++ KI+DFGM + E TS GT Y+APE ++
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSY 170
Query: 503 GHFSIKSDVFSFGVLVLEIISGQ 525
+ D ++ GVL+ E+++GQ
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 9e-15
Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 332 LGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFK-----NEVLLVARLQHRNLVRL 385
LG+G FG V RL G+ AVK L K+ + + + + +L +AR H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 386 LGFSFEETERLL-IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDS 443
F+ +RL + EFV + +F K + D E R + I +++LH+
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-EARARFYAAEITSALMFLHDKG 116
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
II+RDLK N+LLD + K++DFGM + E + TS GT Y+APE +
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEM 171
Query: 504 HFSIKSDVFSFGVLVLEIISGQ 525
+ D ++ GVL+ E++ G
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGH 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 9e-15
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 31/212 (14%)
Query: 332 LGQGGFGAVYKG-RLSHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
LG G G VYK L + +AVK + + +V+ + + +E+ ++ + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA----RGILYLHEDSRL 445
F E + EF+ S+D + + ++G IA +G+ YL L
Sbjct: 69 FVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS---L 114
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
+I+HRD+K SN+L++ K+ DFG++ ++ S T VGT YMAPE ++ +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVST--QLVNSIAKT--YVGTNAYMAPERISGEQY 170
Query: 506 SIKSDVFSFGVLVLEIISG-------QKNNSF 530
I SDV+S G+ +E+ G QKN
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGS 202
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 43/149 (28%), Positives = 81/149 (54%), Gaps = 9/149 (6%)
Query: 331 KLGQGGFGAVYKGRLSHGQEI-AVKRLS-KNSVQGELEFK-NEVLLVARLQHRNLVRLLG 387
K+G+G +G V+K + EI A+KR+ + +G E+ L+ L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
+ + L++E+ + + K+ FD+ +D E + + +G+ + H +
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FDSC-NGDIDPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLF 476
+HRDLK N+L++ + K++DFG+AR F
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 34/95 (35%), Positives = 58/95 (61%), Gaps = 5/95 (5%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
I RG+ YLH I+HRD+K N+L++++ + KI DFG+AR+ E D+S+ T +V
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 492 FGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
+ Y APE + H++ D++S G + E++ +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 18/202 (8%)
Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN----EVLLVARLQHRNLVRL 385
K+G+G +G V+K R GQ +A+K+ ++ + + K E+ ++ +L+H NLV L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVES--EDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 386 LGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
+ F +L L++E+ ++ +++ + R + KII + + + H +
Sbjct: 66 IEV-FRRKRKLHLVFEYCDHTVLNEL--EKNPR-GVPEHLIKKIIWQTLQAVNFCH---K 118
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY-VTRG 503
IHRD+K NIL+ K+ DFG AR+ + D + V T Y APE V
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 504 HFSIKSDVFSFGVLVLEIISGQ 525
+ DV++ G + E+++GQ
Sbjct: 177 QYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 29/206 (14%)
Query: 331 KLGQGGFGAVY---------KGRLSHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHR 380
+LG+G FG VY + RL +EI V L+ N +VQ E + L+++L H
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQ----LLSKLDHP 62
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWET--RYKIIGGIAR---G 435
+V+ E +I E+ +D ++ ++ +T ++ + G
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLD----CKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
+ Y+H+ RI+HRDLKA NI L +++ KI DFG++RL M T+ GT YM
Sbjct: 119 VHYMHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLL-MGSCDLATT-FTGTPYYM 172
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEI 521
+PE + + KSD++S G ++ E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 28/216 (12%)
Query: 332 LGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRN 381
LG+G FG V K + +AVK L ++ + +L + +E+ ++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFI-----------FDAIKRV---QLDWETRYK 427
++ LLG ++ +I E+ ++ +++ +D I RV Q+ ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD-IARVPDEQMTFKDLVS 141
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
+ARG+ YL + + IHRDL A N+L+ + + KI+DFG+AR T+
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+MAPE + ++ +SDV+SFGVL+ EI +
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 31/209 (14%)
Query: 330 NKLGQGGFGAVYKGR-LSHGQEIAVKRLSKN---SVQGELEFKNEVLLVARLQHRNLVRL 385
N++G G G VYK G+ A+K + N +V+ ++ + E+L H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV--NHPNVVKC 137
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR----GILYLHE 441
E ++ EF+ S++ + + ++ + +AR GI YLH
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSLEG------THI---ADEQF--LADVARQILSGIAYLH- 185
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV- 500
R I+HRD+K SN+L+++ KI+DFG++R+ + Q+ + VGT YM+PE +
Sbjct: 186 --RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTIAYMSPERIN 241
Query: 501 ---TRGHFS-IKSDVFSFGVLVLEIISGQ 525
G + D++S GV +LE G+
Sbjct: 242 TDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 62/220 (28%), Positives = 109/220 (49%), Gaps = 27/220 (12%)
Query: 326 FSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSK--NSVQGELEFKNEVLLVARLQH 379
F+ LG+G FG+V + +L Q++AVK L S EF E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 380 RNLVRLLGFSFEETER------LLIYEFVPNSSVDKFIFDAIKRV-----QLDWETRYKI 428
N+++L+G S + ++I F+ + + F+ + R+ L +T +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL--MSRIGEEPFTLPLQTLVRF 118
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMD-QSQGDTS 486
+ IA G+ YL S IHRDL A N +L+ +M ++DFG+++ ++ D QG S
Sbjct: 119 MIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQ 525
++ ++A E + ++ SDV++FGV + EI++ GQ
Sbjct: 176 KL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 21/229 (9%)
Query: 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYK-GRLSHGQEIAVKRLSKNS-VQGELEF 367
S ++ D T+ + +G+G +G VYK G AVK L S V E+E
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA 67
Query: 368 KNEVLLVARLQHRNLVRLLGFSFEETERL------LIYEFVPNSSVDKFIFDAIKRVQ-L 420
+ +L H N+V+ G F + ++L L+ E SV + + + Q L
Sbjct: 68 EYNILQSLP-NHPNVVKFYGM-FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRL 125
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
D I+ G G+ +LH + RIIHRD+K +NILL + K+ DFG++ +
Sbjct: 126 DEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182
Query: 481 SQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISG 524
+ +TS VGT +MAPE + + + DV+S G+ +E+ G
Sbjct: 183 LRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 61/216 (28%), Positives = 112/216 (51%), Gaps = 28/216 (12%)
Query: 332 LGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRN 381
LG+G FG V K + + +AVK L ++ +L + +E+ ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFI-----------FDAIK--RVQLDWETRYKI 428
++ LLG ++ ++ E+ ++ +++ FD K QL ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSR 487
+ARG+ YL + + IHRDL A N+L+ D + KI+DFG+AR + +D + T+
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+ +MAPE + ++ +SDV+SFGVL+ EI +
Sbjct: 197 RL-PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 42/111 (37%), Positives = 63/111 (56%), Gaps = 10/111 (9%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVG 490
IA G+ +LH II+RDLK N++LDA+ KI+DFGM + G T+R G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG---GKTTRTFCG 163
Query: 491 TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLT 541
T Y+APE + + D ++FGVL+ E+++GQ F GE+ ++L
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP--PFD-GEDEDELFQ 211
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 17/209 (8%)
Query: 325 NFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRL-----SKNSVQGELEFKNEVLLVARLQ 378
N+ LG+G FG VY G+E+AVK++ S+ + + + E+ L+ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 379 HRNLVRLLGFSFEETERLL--IYEFVPNSSVDKFIFDAIKRV-QLDWETRYKIIGGIARG 435
H +V+ G + E+ L E++P S+ D +K L + I +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQG 118
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA-RLFEMDQSQGDTSRIVGTFGY 494
+ YLH + I+HRD+K +NIL D+ K+ DFG + R+ + S + GT +
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
M+PE ++ + K+DV+S V+E+++
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 60/217 (27%), Positives = 113/217 (52%), Gaps = 30/217 (13%)
Query: 332 LGQGGFGAVY--------KGRLSHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRN 381
LG+G FG V K + + ++AVK L ++ + +L + +E+ ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIF-------------DAIKRVQLDWETRYKI 428
++ LLG ++ +I E+ ++ +++ + QL ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTS- 486
+ARG+ YL + + IHRDL A N+L+ D + KI+DFG+AR + +D + T+
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
R+ +MAPE + ++ +SDV+SFGVL+ EI +
Sbjct: 203 RL--PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 5e-14
Identities = 57/206 (27%), Positives = 113/206 (54%), Gaps = 15/206 (7%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR-NL 382
++F ++LG G G V K + I ++L ++ + +N+++ ++ H N
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAI--RNQIIRELQVLHECNS 62
Query: 383 VRLLGFS---FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
++GF + + E + E + S+D+ + +A KR+ E K+ + RG+ YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA-KRIP--EEILGKVSIAVLRGLAYL 119
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
E + +I+HRD+K SNIL+++ K+ DFG++ ++ S ++ VGT YM+PE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYMSPER 173
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
+ H+S++SD++S G+ ++E+ G+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 325 NFSTDNKLGQGGFGAVY----KGRLSHGQEIAVKRLSKNSV---QGELEF-KNEVLLVAR 376
NF LG G +G V+ G G+ A+K L K ++ E + E ++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 377 LQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIAR 434
++ + L ++F+ +L LI ++V +F + + + E+ ++ I I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGE----LFTHLYQREHFTESEVRVYIAEIVL 116
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
+ +LH+ L II+RD+K NILLD++ ++DFG+++ F ++ + S GT Y
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEY 172
Query: 495 MAPEYV---TRGHFSIKSDVFSFGVLVLEIISG 524
MAPE + + GH D +S GVL E+++G
Sbjct: 173 MAPEVIRGGSGGHDKA-VDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 64/199 (32%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLL 386
LG+G FG V+ L Q A+K L K+ V E + +L +H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
+F+ E L N F + + L T Y I G+ +LH
Sbjct: 63 -CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYA--AEIICGLQFLHSKG--- 116
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
I++RDLK NILLD D KI+DFGM + E T GT Y+APE + ++
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKYN 174
Query: 507 IKSDVFSFGVLVLEIISGQ 525
D +SFGVL+ E++ GQ
Sbjct: 175 TSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-14
Identities = 37/106 (34%), Positives = 59/106 (55%), Gaps = 22/106 (20%)
Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG--------MARLFEM 478
KI + RG+ YL E + +I+HRD+K SNIL+++ K+ DFG MA F
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-- 158
Query: 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
VGT YM+PE + H++++SD++S G+ ++E+ G
Sbjct: 159 ----------VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 17/200 (8%)
Query: 332 LGQGGFGAVY-KGRLSHGQEIAVKRLSKNSVQGELEFKNEV----LLVARLQHRNLVRLL 386
+G+G FG V R S G AVK L K ++ + E + + +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 387 GFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSR 444
+SF+ E+L + ++V +F ++R + E R + +A I YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGE----LFFHLQRERCFLEPRARFYAAEVASAIGYLHS--- 114
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
L II+RDLK NILLD+ ++DFG+ + E + + TS GT Y+APE + +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 505 FSIKSDVFSFGVLVLEIISG 524
+ D + G ++ E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRN-LVRLL 386
K+G+G +G VYK R + G+ +A+K RL + E+ L+ L +VRLL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 387 GFSFEETER-------LLIYEFVPNSSVDKFIFDAIKRVQ---LDWETRYKIIGGIARGI 436
E E L++E++ +S + KF+ D+ R L +T + + +G+
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 437 LYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
+ H + ++HRDLK N+L+D + KI+D G+ R F + + T IV T Y
Sbjct: 124 AHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIV-TLWYR 178
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
APE + H+S D++S G + E+ Q
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 58/218 (26%), Positives = 107/218 (49%), Gaps = 38/218 (17%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQHR 380
+ N++ +G +G VY+ R G+ +A+K+L K + E + E+ ++ +LQH
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLREINILLKLQHP 64
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG--------- 431
N+V + E V S++DK I+ ++ V+ D ++ + +
Sbjct: 65 NIVT-------------VKEVVVGSNLDK-IYMVMEYVEHDLKSLMETMKQPFLQSEVKC 110
Query: 432 ----IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
+ G+ +LH++ I+HRDLK SN+LL+ I KI DFG+AR + ++
Sbjct: 111 LMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG--SPLKPYTQ 165
Query: 488 IVGTFGYMAPE-YVTRGHFSIKSDVFSFGVLVLEIISG 524
+V T Y APE + +S D++S G + E+++
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 33/217 (15%)
Query: 331 KLGQGGFGAVYKGRLSHG---QEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL-- 385
K+G+G +G VYK + G +E A+K++ + + E+ L+ L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIALQK 65
Query: 386 -----------LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
L F + E + I +F S +K K +QL ++ I
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANK------KPMQLPRSMVKSLLYQILD 119
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEMD-QSQGDTSRIV 489
GI YLH + ++HRDLK +NIL+ + KI+D G ARLF + D +V
Sbjct: 120 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 490 GTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
TF Y APE + H++ D+++ G + E+++ +
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 29/206 (14%)
Query: 331 KLGQGGFG-AVYKGRLSHGQEIAVKRL--SKNSVQGELEFKNEVLLVARLQHRNLVRLLG 387
K+G+G FG A+ G++ +K + SK S + E + EV +++ ++H N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 388 FSFEETERLLI----------YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
SFEE L I Y+ + F D I LDW + I +
Sbjct: 67 -SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI----LDWFVQ------ICLALK 115
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
++H+ +I+HRD+K+ NI L D K+ DFG+AR+ T +GT Y++P
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC--IGTPYYLSP 170
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
E ++ KSD+++ G ++ E+ +
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 27/208 (12%)
Query: 332 LGQGGFGAVYKGRLSHG-------QEIAV--------KRLSKNSVQGELEFKNEVLLV-A 375
LG G FG VYK R + +EI V KR S+ + +EV ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIG---DIVSEVTIIKE 64
Query: 376 RLQHRNLVRLLGFSFEETERL-LIYEFVPNSSV-DKFIFDAIKRVQLDWETRYKIIGGIA 433
+L+H N+VR +F E +RL ++ + + + + + F K+ + E + I +
Sbjct: 65 QLRHPNIVRYYK-TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
+ YLH++ R I+HRDL +NI+L D I+DFG+A+ Q + + +VGT
Sbjct: 124 LALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTIL 178
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
Y PE V + K+DV++FG ++ ++
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSK---NSVQGELEFKNEV 371
F T+ + TN + +G G FG V R GQ +A+K++ K V + ++ E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-EL 60
Query: 372 LLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG 431
L+ L+H N++ L E + + + + + + Q Y+I+
Sbjct: 61 KLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQIL-- 118
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
RG+ Y+H ++HRDLK SNIL++ + KI DFG+AR+ + Q G V T
Sbjct: 119 --RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD-PQMTG----YVST 168
Query: 492 FGYMAPE-YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
Y APE +T + ++ D++S G + E++ G+
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEF------KNEVLLVARLQHRNLVR 384
LG+G FG V G+ A+K L K + E K +H LV
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 385 LLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDW--ETRYKIIGG-IARGILYLH 440
L F+ + + + E+ D + + D E R + G+ YLH
Sbjct: 67 LFA-CFQTEDHVCFVMEYAAGG-------DLMMHIHTDVFSEPRAVFYAACVVLGLQYLH 118
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD-TSRIVGTFGYMAPEY 499
E+ +I++RDLK N+LLD + KI+DFG L + GD TS GT ++APE
Sbjct: 119 EN---KIVYRDLKLDNLLLDTEGFVKIADFG---LCKEGMGFGDRTSTFCGTPEFLAPEV 172
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDL 539
+T ++ D + GVL+ E++ G+ + F G++ E++
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGE--SPFP-GDDEEEV 209
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 56/217 (25%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLS-KNSVQGELEF-KNEVLLVARLQHRNLVRLLGF 388
+G+G +G V R + G++ +K+L+ +N+ + E + + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV----- 62
Query: 389 SFEET---ERLLIY--------------------EFVPNSSVDKFIFDAIKRVQLDWETR 425
++ E+ E L+Y + +P + V ++W +
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQV------------VEWFVQ 110
Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD- 484
IA + YLHE I+HRDLK N+ L I K+ D G+AR+ E +Q D
Sbjct: 111 ------IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE---NQCDM 158
Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
S ++GT YM+PE + ++ KSDV++ G V E+
Sbjct: 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 67/274 (24%), Positives = 126/274 (45%), Gaps = 36/274 (13%)
Query: 330 NKLGQGGFGAVYKGRLS-HGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHR----NL 382
++LG+G +G+VYK G +A+K RL + E +F N++++ + H+ +
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD----ESKF-NQIIMELDILHKAVSPYI 61
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
V G F E + E++ S+DK + + + +I + +G+ +L E+
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT- 501
IIHRD+K +N+L++ + K+ DFG++ ++ + +G YMAPE +
Sbjct: 122 --HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPERIKS 175
Query: 502 -----RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556
++++SDV+S G+ +LE+ G+ + E + +G
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGR----YPYPPETYANIFAQLSAIVDGDP---- 227
Query: 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMA 590
PTL +G S + V C+ + RPT A
Sbjct: 228 -PTLPSGYSDDAQDFVA---KCLNKIPNRRPTYA 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 77/272 (28%), Positives = 118/272 (43%), Gaps = 62/272 (22%)
Query: 325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKN------EVLLVARL 377
+F LG G FG V + G+ A+K L K + L+ K E ++ L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI---LKMKQVQHVAQEKSILMEL 75
Query: 378 QHRNLVRLLGFSFEETERL-LIYEFVPNS-------SVDKFIFDAIK----RVQLDWETR 425
H +V ++ SF++ R+ + EFV +F D K + L +E
Sbjct: 76 SHPFIVNMMC-SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE-- 132
Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485
YLH II+RDLK N+LLD K++DFG A+ + T
Sbjct: 133 ------------YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRT 172
Query: 486 SRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ----KNNSFRIGEEAEDLL 540
+ GT Y+APE + ++GH D ++ GVL+ E I+G + FRI E+ +L
Sbjct: 173 FTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK---IL 228
Query: 541 T--YAWKNWNEGTALNLI------DPTLRNGS 564
+ NW +G A +L+ D T R G+
Sbjct: 229 AGRLKFPNWFDGRARDLVKGLLQTDHTKRLGT 260
|
Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEF-----KNEVLLVARLQHRNLVRL 385
LG+G FG V L E+ A+K L K+ + + + + +L +A +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 386 LGFSFEETERLL-IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDS 443
F+ +RL + E+V + +F + + D E R + + +++LH
Sbjct: 62 HC-CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFD-EPRSRFYAAEVTLALMFLHRHG 116
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
+I+RDLK NILLDA+ K++DFGM + E + T+ GT Y+APE +
Sbjct: 117 ---VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQEL 171
Query: 504 HFSIKSDVFSFGVLVLEIISGQ 525
+ D ++ GVL+ E+++GQ
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 23/228 (10%)
Query: 326 FSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLS-KNSVQG-ELEFKNEVLLVARLQHRNL 382
F ++G+G +G VYK R G+ +A+K++ N +G + E+ ++ +L HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 383 VRL----------LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI 432
V L L F ++ L++E++ + D V + + +
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH---DLMGLLESGLVHFSEDHIKSFMKQL 125
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF 492
G+ Y H+ + L HRD+K SNILL+ K++DFG+ARL+ ++S+ T++++ T
Sbjct: 126 LEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TL 181
Query: 493 GYMAPEYVT-RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDL 539
Y PE + + DV+S G ++ E+ + K F+ +E L
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFT--KKPIFQANQELAQL 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 68/204 (33%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELE--------FKNEVLLVARLQHRNL 382
LG+G FG V L E A+K L K+ V LE + VL +A +H L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVV---LEDDDVECTMVERRVLALA-WEHPFL 58
Query: 383 VRLLGFSFEETERLL-IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
L +F+ E L + E++ N F + R Y I G+ +LH+
Sbjct: 59 THLF-CTFQTKEHLFFVMEYL-NGGDLMFHIQSSGRFDEARARFYA--AEIICGLQFLHK 114
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
II+RDLK N+LLD D KI+DFGM + M +G S GT Y+APE +
Sbjct: 115 KG---IIYRDLKLDNVLLDKDGHIKIADFGMCKE-NM-NGEGKASTFCGTPDYIAPEILK 169
Query: 502 RGHFSIKSDVFSFGVLVLEIISGQ 525
++ D +SFGVL+ E++ GQ
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 41/213 (19%)
Query: 332 LGQGGFGAV---YKGRLSHGQEIAVKRLSK--NSVQGELEFKNEVLLVARLQHRNLVRLL 386
+G G +G+V Y RL Q++AVK+LS+ S+ E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 387 GFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLDWETRYKIIGGIA 433
F P +S++ F + + +K +L E +I +
Sbjct: 81 DV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
RG+ Y+H IIHRDLK SN+ ++ D +I DFG+AR Q+ + + V T
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRW 180
Query: 494 YMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
Y APE + H++ D++S G ++ E++ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 17/200 (8%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKNEV----LLVARLQHRNLVRLL 386
+G+G FG V R ++ AVK L K ++ + E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 387 GFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSR 444
FSF+ ++L + +++ +F ++R + E R + IA + YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGE----LFYHLQRERCFLEPRARFYAAEIASALGYLHS--- 114
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
L I++RDLK NILLD+ ++DFG+ + E + G TS GT Y+APE + +
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 505 FSIKSDVFSFGVLVLEIISG 524
+ D + G ++ E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 33/217 (15%)
Query: 331 KLGQGGFGAVYKGRLSHGQE---IAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL-- 385
K+G+G +G VYK + G++ A+K++ + + E+ L+ L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQK 65
Query: 386 -----------LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
L F + E + I +F S +K K VQL ++ I
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANK------KPVQLPRGMVKSLLYQILD 119
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEMD-QSQGDTSRIV 489
GI YLH + ++HRDLK +NIL+ + KI+D G ARLF + D +V
Sbjct: 120 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 490 GTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
TF Y APE + H++ D+++ G + E+++ +
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 48/208 (23%), Positives = 100/208 (48%), Gaps = 16/208 (7%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ 378
R+ +F ++G G +G VYK R ++ G+ A+K + + + E++++ +
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKF--IFDAIKRVQLDWETRYKIIGGIARGI 436
H N+V G + + EF S+ + + Q+ + +R + +G+
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGL 119
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
YLH + +HRD+K +NILL + K++DFG++ ++ + +GT +MA
Sbjct: 120 YYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMA 174
Query: 497 PEYVT---RGHFSIKSDVFSFGVLVLEI 521
PE +G ++ D+++ G+ +E+
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVYKGRLSHGQE----IAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLV 383
LG+GG+G V++ R G + A+K L K ++ + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWE-TRYKIIGGIARGILYLHE 441
L+ ++F+ +L LI E++ +F ++R + E T + I+ + +LH
Sbjct: 64 DLI-YAFQTGGKLYLILEYLSGGE----LFMHLEREGIFMEDTACFYLSEISLALEHLH- 117
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
+ II+RDLK NILLDA K++DFG+ + E T GT YMAPE +
Sbjct: 118 --QQGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 502 RGHFSIKSDVFSFGVLVLEIISGQ 525
R D +S G L+ ++++G
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGA 197
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 6e-13
Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 65/227 (28%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---------EVLLVARLQHRN 381
+G G +G V G+++A+K++S F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKF--------IFDA-----IK-RVQLDWETRYK 427
++ LL + + S + F + + IK L + +
Sbjct: 61 IIGLL-------------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLT-DDHIQ 106
Query: 428 -IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD-- 484
+ I RG+ YLH + +IHRDLK SNIL++++ KI DFG+AR + D+ +
Sbjct: 107 YFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 485 TSRIVGTFGYMAPE-------YVTRGHFSIKSDVFSFGVLVLEIISG 524
T +V T Y APE Y +I D++S G + E+++
Sbjct: 164 TEYVV-TRWYRAPELLLSSSRY----TKAI--DIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 42/197 (21%)
Query: 348 GQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN 404
GQ +A+K+LS+ N + ++ E++L+ + H+N++ LL F P
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLNV------------FTPQ 87
Query: 405 SSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDL 452
S+++F + DA + ++ LD E ++ + GI +LH IIHRDL
Sbjct: 88 KSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 144
Query: 453 KASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIK 508
K SNI++ +D KI DFG+AR F M T +V T Y APE + +
Sbjct: 145 KPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVV-TRYYRAPEVILGMGYKEN 197
Query: 509 SDVFSFGVLVLEIISGQ 525
D++S G ++ E+I G
Sbjct: 198 VDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 38/220 (17%)
Query: 329 DNKLGQGGFGAVYKGRLSHG---QEIAVKRLSKNSVQGE-LEFKNEVLLVARL-QHRNLV 383
++ +G+G FG V + + A+K L + + + + +F E+ ++ +L H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRV---------------QLDWETRYKI 428
LLG + E+ P ++ F+ + RV L + +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKS--RVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
+A G+ YL E + IHRDL A N+L+ ++ KI+DFG++R G+ +
Sbjct: 125 ASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--------GEEVYV 173
Query: 489 VGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
T G +MA E + ++ KSDV+SFGVL+ EI+S
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 30/208 (14%)
Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRN--LVRL 385
+G+GGFG VY R + G+ A+K L K + QGE NE ++++ + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE-------TRYKIIGGIARGILY 438
+ ++F ++L FI D + L + + ++ A IL
Sbjct: 62 MSYAFHTPDKL------------SFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILG 109
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
L +++RDLK +NILLD +ISD G+A D S+ VGT GYMAPE
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPE 165
Query: 499 YVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
+ +G + +D FS G ++ +++ G
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-12
Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 20/191 (10%)
Query: 348 GQEIAVKRLSKNSVQGELE---FKNEVLLVARLQHRNLVRLLGFSFEETERLL-IYEFVP 403
G E+A+K L ++ + E + F+ E L ARL H N+V LL L ++E+VP
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 404 NSSV-DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA- 461
++ + D L +++ + + H I+HRDLK NI++
Sbjct: 63 GRTLREVLAADGA----LPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQT 115
Query: 462 DMIP--KISDFGMARLF----EMDQSQGD-TSRIVGTFGYMAPEYVTRGHFSIKSDVFSF 514
+ P K+ DFG+ L + D + T+ ++GT Y APE + + SD++++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 515 GVLVLEIISGQ 525
G++ LE ++GQ
Sbjct: 176 GLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 42/95 (44%), Positives = 59/95 (62%), Gaps = 9/95 (9%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS---QGDTSRI 488
+ARG+ +L SR + IHRDL A NILL + + KI DFG+AR D +GD +R+
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD-ARL 237
Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+MAPE + ++ +SDV+SFGVL+ EI S
Sbjct: 238 --PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 59/217 (27%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSK--NSVQGELEFKNEVLLV 374
TI + + + +G G +G+V G +AVK+LS+ S+ E+ L+
Sbjct: 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 375 ARLQHRNLVRLLGF-----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
++H N++ LL S EE + + + + ++ + +K +L + +I
Sbjct: 71 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLI 126
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
I RG+ Y+H IIHRDLK SN+ ++ D KI DFG+AR + + + V
Sbjct: 127 YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYV 178
Query: 490 GTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
T Y APE + H++ D++S G ++ E+++G+
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 53/209 (25%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEF-KNEVLLVARLQ 378
R+ +++ ++G G +G VYK R H E+A ++ K + + E+ +V +
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK 64
Query: 379 HRNLVRLLGFSFEETERLLI-YEFVPNSSVDKF--IFDAIKRVQLDWETRYKIIGGIARG 435
H N+V G S+ E+L I E+ S+ + + +Q+ + R + +G
Sbjct: 65 HCNIVAYFG-SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QG 118
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
+ YLH ++ HRD+K +NILL + K++DFG+A ++ + +GT +M
Sbjct: 119 LAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWM 173
Query: 496 APEYVT---RGHFSIKSDVFSFGVLVLEI 521
APE G ++ D+++ G+ +E+
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 39/212 (18%)
Query: 332 LGQGGFGAV-YKGRLSHGQEIAVKRLSKNSVQGELEFKN---EVLLVARLQHRNLVRLLG 387
+G G +G V G ++A+K+L + Q EL K E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHENVIGLLD 81
Query: 388 FSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLDWETRYKIIGGIAR 434
F P+ S+D+F + +K +L + ++ + +
Sbjct: 82 V------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLK 129
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
G+ Y+H IIHRDLK N+ ++ D KI DFG+AR Q+ + + V T Y
Sbjct: 130 GLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWY 181
Query: 495 MAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
APE + H++ D++S G ++ E+++G+
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSV---QGELEFKNEVLLVARLQHR 380
+ +G G FG V+ R + A+K ++ V + E NE ++ + H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
++RL ++ ++ E+VP + ++ ++ + T I + YLH
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYLH 118
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
I++RDLK NILLD + K++DFG A+ + + T + GT Y+APE +
Sbjct: 119 S---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPEVI 170
Query: 501 -TRGHFSIKSDVFSFGVLVLEIISG 524
++GH + D ++ G+L+ E++ G
Sbjct: 171 QSKGH-NKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 66/200 (33%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLL 386
LG+G FG V L G+ AVK L K+ V E + +L ++ L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 387 GFSFEETERLL-IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445
+F+ E L + EF+ + I D R L T Y I G+ +LH
Sbjct: 63 C-TFQTKEHLFFVMEFLNGGDLMFHIQDK-GRFDLYRATFYA--AEIVCGLQFLHSKG-- 116
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
II+RDLK N++LD D KI+DFGM + E S GT Y+APE + +
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKY 173
Query: 506 SIKSDVFSFGVLVLEIISGQ 525
+ D +SFGVL+ E++ GQ
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 34/215 (15%)
Query: 332 LGQGGFGAVYKGRLSHG---QEIAVKRLSKNSVQGE-LEFKNEVLLVARL-QHRNLVRLL 386
+G+G FG V K R+ + A+KR+ + + + + +F E+ ++ +L H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFD--------AIKRVQ-----LDWETRYKIIGGIA 433
G L E+ P+ ++ F+ A L + +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
RG+ YL + + IHRDL A NIL+ + + KI+DFG++R G + T G
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTMG 171
Query: 494 -----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+MA E + ++ SDV+S+GVL+ EI+S
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 63/243 (25%), Positives = 106/243 (43%), Gaps = 27/243 (11%)
Query: 288 FLRRRKKKQKQNLRKADEINTVESLQF-DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLS 346
FL+ + +K++ E +++ DF+ IR LG G FG V
Sbjct: 3 FLKNLQLHKKKDSDSTKEPKRKNKMKYEDFNFIR----------TLGTGSFGRVILATYK 52
Query: 347 HGQ--EIAVKRLSKNSVQGELEFK---NEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401
+ +A+KR K+ + + + +E ++ + H V L G +E+ L+ EF
Sbjct: 53 NEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEF 112
Query: 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 461
V F+ KR D Y A+ +L L I++RDLK N+LLD
Sbjct: 113 VIGGEFFTFLRRN-KRFPNDVGCFYA-----AQIVLIFEYLQSLNIVYRDLKPENLLLDK 166
Query: 462 DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
D K++DFG A++ + T + GT Y+APE + +D ++ G+ + EI
Sbjct: 167 DGFIKMTDFGFAKVVDT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221
Query: 522 ISG 524
+ G
Sbjct: 222 LVG 224
|
Length = 340 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 62/210 (29%), Positives = 110/210 (52%), Gaps = 26/210 (12%)
Query: 330 NKLGQGGFGAVYKGR-LSHGQEIAVKRLS---KNSVQGELEFKNEVLLVARL-QHRNLVR 384
KLG+G +G V+K + +A+K++ +N+ + F+ E++ + L H N+V+
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVK 71
Query: 385 LLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQL-DWETRYKIIGGIARGILYLHE 441
LL E ++ L++E++ + + I+ L D RY I+ + + + Y+H
Sbjct: 72 LLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMYQLLKALKYIH- 124
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLF---EMDQSQGDTSRIVGTFGYMAPE 498
S +IHRDLK SNILL++D K++DFG+AR E + + V T Y APE
Sbjct: 125 -SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182
Query: 499 YV---TRGHFSIKSDVFSFGVLVLEIISGQ 525
+ TR + D++S G ++ E++ G+
Sbjct: 183 ILLGSTRYTKGV--DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGELEF----KNEVLLVAR 376
NF LG G +G V+ R G + A+K L K ++ + + + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 377 LQHRNLVRLLGFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARG 435
++ + L ++F+ +T+ LI +++ + + +R + + G I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIVLA 117
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
+ +LH +L II+RD+K NILLD++ ++DFG+++ F D+ + S GT YM
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEYM 173
Query: 496 APEYVTRGH--FSIKSDVFSFGVLVLEIISG 524
AP+ V G D +S GVL+ E+++G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 44/215 (20%)
Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRN--LVRL 385
+G+GGFG VY R + G+ A+K L K + QGE NE ++++ + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDW-----------ETRY---KIIGG 431
+ ++F ++L FI D + L + E R+ +II G
Sbjct: 62 MTYAFHTPDKLC------------FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILG 109
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
+ H +R +++RDLK +NILLD +ISD G+A D S+ VGT
Sbjct: 110 LE------HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGT 158
Query: 492 FGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
GYMAPE + +G + +D FS G ++ +++ G
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGH 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGELEFKN---EVLL 373
T+ + +++ ++G G +G+V G+++A+K+LS+ Q E+ K E+ L
Sbjct: 9 TVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTL 67
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEF---VPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
+ +QH N++ LL +F +P D I L + ++
Sbjct: 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVY 124
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
+ G+ Y+H IIHRDLK N+ ++ D KI DFG+AR + + + V
Sbjct: 125 QMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVV 176
Query: 491 TFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
T Y APE + H++ D++S G ++ E+++G+
Sbjct: 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 57/196 (29%), Positives = 95/196 (48%), Gaps = 42/196 (21%)
Query: 348 GQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN 404
G +AVK+LS+ N + ++ E++L+ + H+N++ LL F P
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNV------------FTPQ 92
Query: 405 SSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDL 452
S+++F + DA + ++LD E ++ + GI +LH IIHRDL
Sbjct: 93 KSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 149
Query: 453 KASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIK 508
K SNI++ +D KI DFG+AR F M T +V + Y APE + +
Sbjct: 150 KPSNIVVKSDCTLKILDFGLARTACTNFMM------TPYVVTRY-YRAPEVILGMGYKEN 202
Query: 509 SDVFSFGVLVLEIISG 524
D++S G ++ E++ G
Sbjct: 203 VDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 53/228 (23%), Positives = 103/228 (45%), Gaps = 41/228 (17%)
Query: 329 DNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN--------------EVLL 373
LG+G +G V K G+ +A+K++ + ++ E+ +
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
+ ++H N++ L+ E L+ + + S + K + D +++L I+ I
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVDR--KIRLTESQVKCILLQIL 129
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD--------- 484
G+ LH+ +HRDL +NI +++ I KI+DFG+AR +
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 485 ----TSRIVGTFGYMAPEYV---TRGHFSIKSDVFSFGVLVLEIISGQ 525
TS++V T Y APE + + HF++ D++S G + E+++G+
Sbjct: 187 REEMTSKVV-TLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 9/154 (5%)
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
E +L+ + H +++R+ ++ +P+ S D + + + L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
I G+ YLH RIIHRD+K NI ++ I D G A+ + +
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLA 217
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
GT APE + R ++ K+D++S G+++ E+++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 57/169 (33%), Positives = 87/169 (51%), Gaps = 24/169 (14%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF--EMDQSQGDTSRIV 489
+ARG+ +L SR + IHRDL A NILL + + KI DFG+AR + D + ++R+
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS--GQKNNSFRIGEEAEDLLTYAWKNW 547
+MAPE + ++ +SDV+SFGVL+ EI S +I EE +
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-------FCQRL 290
Query: 548 NEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVML 596
+GT + + + EI R I L C Q + RPT +++V +L
Sbjct: 291 KDGTRMRAPENA-----TPEIYR---IMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 54/210 (25%), Positives = 113/210 (53%), Gaps = 23/210 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR-NL 382
++F ++LG G G V+K I ++L ++ + +N+++ ++ H N
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAI--RNQIIRELQVLHECNS 62
Query: 383 VRLLGFS---FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA----RG 435
++GF + + E + E + S+D+ + A + + +I+G ++ +G
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKVSIAVIKG 115
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
+ YL E + +I+HRD+K SNIL+++ K+ DFG++ ++ S ++ VGT YM
Sbjct: 116 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANS--FVGTRSYM 169
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
+PE + H+S++SD++S G+ ++E+ G+
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 42/221 (19%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKN----EVLLVARLQH 379
N F +G+G +G V K R +EI + K+S + E E K E+ ++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQ 59
Query: 380 RNLVRL-----------LGFSFEETERLLIYEFVPNSS----VDKFIFDAIKRVQLDWET 424
N+V L L F + E L + E +PN V +I+ IK
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIK-------- 111
Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
I + H++ I+HRD+K N+L+ + + K+ DFG AR + S +
Sbjct: 112 ----------AIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNAN 157
Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
+ V T Y +PE + + D++S G ++ E+ GQ
Sbjct: 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKN---EVLLVARLQHRNLVRLLG 387
LG+G FG V R + A+K L K + + E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-K 61
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRL 445
+SF+ +RL + E+ +F + R ++ E R + G I + YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGE----LFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD-- 115
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT-SRIVGTFGYMAPEYVTRGH 504
+++RDLK N++LD D KI+DFG+ + S G T GT Y+APE +
Sbjct: 116 -VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 505 FSIKSDVFSFGVLVLEIISGQ 525
+ D + GV++ E++ G+
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 36/95 (37%), Positives = 58/95 (61%), Gaps = 7/95 (7%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVG 490
I+ G+ +LH II+RDLK N++LD++ KI+DFGM + +D G T+R G
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---GVTTRTFCG 163
Query: 491 TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
T Y+APE + + D +++GVL+ E+++GQ
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 61/225 (27%), Positives = 107/225 (47%), Gaps = 25/225 (11%)
Query: 316 FSTIRDATNNFSTDNKLGQGGFGAVYK-GRLSHGQEIAVKRLSK-NSVQGELEFKNEVLL 373
F + D ++ + +G+G +G V+K +G + AVK L + + E+E + +L
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNIL- 68
Query: 374 VARLQHRNLVRLLGFSFEETER-----LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI 428
A H N+V+ G +++ + L+ E SV + +KR + E I
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP---I 125
Query: 429 IGGIAR----GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
I I G+ +LH + + IHRD+K +NILL + K+ DFG++ + + +
Sbjct: 126 IAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 182
Query: 485 TSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISG 524
TS VGT +MAPE + + + DV+S G+ +E+ G
Sbjct: 183 TS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 17/200 (8%)
Query: 332 LGQGGFGAVY-KGRLSHGQEIAVKRLSKNSVQGELEFKNEV----LLVARLQHRNLVRLL 386
+G+G FG V R G+ AVK L K V E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 387 GFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLHEDSR 444
+SF+ TE+L + +FV +F ++R + E R + IA + YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGE----LFFHLQRERSFPEPRARFYAAEIASALGYLHS--- 114
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
+ I++RDLK NILLD+ ++DFG+ + E T+ GT Y+APE + +
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 505 FSIKSDVFSFGVLVLEIISG 524
+ D + G ++ E++ G
Sbjct: 173 YDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 42/95 (44%), Positives = 60/95 (63%), Gaps = 9/95 (9%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS---QGDTSRI 488
+A+G+ +L SR + IHRDL A NILL + + KI DFG+AR D +GD +R+
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD-ARL 243
Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+MAPE + ++I+SDV+SFGVL+ EI S
Sbjct: 244 --PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 52/216 (24%), Positives = 99/216 (45%), Gaps = 34/216 (15%)
Query: 332 LGQGGFGAVYKGRLSH-GQEIAVKRLS---KNSVQGELEFKNEVLLVARLQHRNLVRLLG 387
LG G G V+ S + +AVK++ SV+ L E+ ++ RL H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALR---EIKIIRRLDHDNIVKVYE 69
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII---GGIA----------- 433
L +++ VQ ET + G ++
Sbjct: 70 VLGPSGSDL------TEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQL 123
Query: 434 -RGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEMDQS-QGDTSRIVG 490
RG+ Y+H + ++HRDLK +N+ ++ D++ KI DFG+AR+ + S +G S +
Sbjct: 124 LRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 491 TFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQ 525
T Y +P + +++ D+++ G + E+++G+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 22/199 (11%)
Query: 332 LGQGGFG-AVYKGRLSHGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
+G+G FG A+ ++ Q+ A+K RL K+S E K VLL A+++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLL-AKMKHPNIVAFKE- 65
Query: 389 SFEETERL-LIYEFVPNSSVDKFIFDAIKRV-----QLDWETRYKIIGGIARGILYLHED 442
SFE L ++ E+ + + I ++ L W + + G+ ++HE
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEK 119
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
R++HRD+K+ NI L + K+ DFG ARL + T VGT Y+ PE
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWEN 174
Query: 503 GHFSIKSDVFSFGVLVLEI 521
++ KSD++S G ++ E+
Sbjct: 175 MPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 67/250 (26%), Positives = 112/250 (44%), Gaps = 42/250 (16%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNS-VQGEL---EFKNEVLLVAR 376
NF LG G +G V+ R G + A+K L K + VQ + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 377 LQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARG 435
++ + L ++F+ +L LI ++V +F + + E + G
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGE----MFTHLYQRDNFSEDEVRFYSG--EI 114
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
IL L +L I++RD+K NILLD++ ++DFG+++ F + + + T GT YM
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCGTIEYM 173
Query: 496 APEYV--TRGHFSIKSDVFSFGVLVLEIIS--------GQKNN-------------SF-- 530
APE + GH D +S G+L+ E+++ G++N F
Sbjct: 174 APEIIRGKGGHGKA-VDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS 232
Query: 531 RIGEEAEDLL 540
IG EA+DLL
Sbjct: 233 FIGPEAQDLL 242
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---EVLLVARLQHRNLVRLLG 387
LG+G FG V R + G+ A+K L K + + E + E ++ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-K 61
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRL 445
+SF+ +RL + E+V +F + R ++ E R + G I + YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGE----LFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG--- 114
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
+I++RDLK N++LD D KI+DFG+ + D + T GT Y+APE + +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDNDY 172
Query: 506 SIKSDVFSFGVLVLEIISGQ 525
D + GV++ E++ G+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 6e-11
Identities = 47/178 (26%), Positives = 88/178 (49%), Gaps = 17/178 (9%)
Query: 353 VKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD---- 408
+ + K + ++ +NE+L + RL H N++++ EE R ++ D
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKI-----EEILRSEANTYMITQKYDFDLY 250
Query: 409 KFIFDAI---KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465
F++D K L +TR I+ + + Y+H+ ++IHRD+K NI L+ D
Sbjct: 251 SFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKI 306
Query: 466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+ DFG A FE ++ D VGT +PE + + +D++S G+++L+++S
Sbjct: 307 VLGDFGTAMPFEKEREAFDYG-WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 34/89 (38%), Positives = 56/89 (62%), Gaps = 2/89 (2%)
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGY 494
+L +H +IHRD+K++NILL ++ + K+ DFG ++++ S D R GT Y
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS-DDVGRTFCGTPYY 211
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+APE R +S K+D+FS GVL+ E+++
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLT 240
|
Length = 496 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 39/212 (18%)
Query: 331 KLGQGGFGAVYKG--RLSHGQEIAVKRLSKNSVQGELEFK--NEVLLVARLQHRNLVRLL 386
KLG+G + VYKG R++ GQ +A+K +S + +G + F E L+ L+H N+V
Sbjct: 12 KLGEGSYATVYKGISRIN-GQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIV--- 66
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI------------AR 434
L+++ + F+F+ + + ++ GG+ R
Sbjct: 67 ----------LLHDIIHTKETLTFVFEYMHTDLAQYMIQHP--GGLHPYNVRLFMFQLLR 114
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
G+ Y+H I+HRDLK N+L+ K++DFG+AR + SQ +S +V T Y
Sbjct: 115 GLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVV-TLWY 169
Query: 495 MAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
P+ + +S D++ G + +E++ GQ
Sbjct: 170 RPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 8e-11
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 325 NFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLSKNSVQGE-LEFKNEVLLVARLQHRNL 382
+ + +G+G +G V G ++A+K++S Q E+ ++ R +H N+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 383 VRLLGF----SFEE-TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
+ +L SFE + ++ E + ++ IK L + + I RG+
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQILRGLK 120
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI----VGTFG 493
Y+H + ++HRDLK SN+LL+ + KI DFG+AR+ + D + V T
Sbjct: 121 YIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI---ADPEHDHTGFLTEYVATRW 174
Query: 494 YMAPE-YVTRGHFSIKSDVFSFGVLVLEIISG 524
Y APE + ++ D++S G ++ E++S
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 44/212 (20%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
QG A Y L + +A+K+LS+ N + ++ E++L+ + H+N++ LL
Sbjct: 36 AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNV- 91
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
F P S+++F + DA + +++LD E ++ + GI
Sbjct: 92 -----------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL----FEMDQSQGDTSRIVGTFG 493
+LH IIHRDLK SNI++ +D KI DFG+AR F M T +V +
Sbjct: 141 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TPYVVTRY- 190
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
Y APE + + D++S G ++ E+I G
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 37/95 (38%), Positives = 57/95 (60%), Gaps = 7/95 (7%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVG 490
IA G+ +LH II+RDLK N++LD++ KI+DFGM + D G T++ G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD---GVTTKTFCG 163
Query: 491 TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
T Y+APE + + D ++FGVL+ E+++GQ
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 10/96 (10%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI--- 488
+ RG+ Y+H + +IHRDLK SN+L++ D +I DFGMAR + S +
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR--GLSSSPTEHKYFMTE 170
Query: 489 -VGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEII 522
V T Y APE + + ++ D++S G + E++
Sbjct: 171 YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 36/205 (17%)
Query: 333 GQGGFGAVYKGRLSHGQEIAVKRLSK---NSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
QG A Y L + +A+K+LS+ N + ++ E++L+ + H+N++ LL
Sbjct: 29 AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNV- 84
Query: 390 FEETERLLIYEFVPNSSVDKF--------IFDA----IKRVQLDWETRYKIIGGIARGIL 437
F P S+++F + DA + +++LD E ++ + GI
Sbjct: 85 -----------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 133
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
+LH IIHRDLK SNI++ +D KI DFG+AR S T +V + Y AP
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRY-YRAP 187
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEII 522
E + + D++S G ++ E++
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEF---KNEVLLVARLQHRNLVRLLG 387
+G+G + V RL +I A+K + K V + + + E + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
F+ T RL L+ E+V + +F ++ +L E I + +LHE
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHERG--- 116
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
II+RDLK N+LLDAD K++D+GM + E TS GT Y+APE + +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 507 IKSDVFSFGVLVLEIISGQ 525
D ++ GVL+ E+++G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 23/204 (11%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGE-----LEFKNEVLLVARLQHRNLVRL 385
+G+G + V L + I A+K + K V + ++ + V A H LV L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS-NHPFLVGL 61
Query: 386 LGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
F+ RL + EFV + +F ++ +L E I+ + +LHE
Sbjct: 62 HS-CFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNFLHERG- 116
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
II+RDLK N+LLDA+ K++D+GM + E + TS GT Y+APE + RG
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPE-ILRGE 171
Query: 505 ---FSIKSDVFSFGVLVLEIISGQ 525
FS+ D ++ GVL+ E+++G+
Sbjct: 172 DYGFSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKN---EVLLVARLQHRNLVRLLG 387
+G+G FG V + R Q I A+K + K + E + E ++A++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
FSF+ E+L L+ F+ +F ++R +R + A + L +
Sbjct: 60 FSFQSPEKLYLVLAFINGGE----LFHHLQREGRFDLSRARFY--TAELLCALENLHKFN 113
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
+I+RDLK NILLD + DFG+ +L D + +T GT Y+APE + ++
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPELLLGHGYT 171
Query: 507 IKSDVFSFGVLVLEIISG 524
D ++ GVL+ E+++G
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 332 LGQGGFGAVYKGRL---------SHGQEIAV--KRLSKNSVQGELEFKNEVLLVARLQHR 380
LGQG F +YKG L GQE++V K L + L F L+++L H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHK 61
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
+LV+L G + E +++ E+V +D F+ V L W + + +A + YL
Sbjct: 62 HLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 441 EDSRLRIIHRDLKASNILL-----DADMIP--KISDFGMARLFEMDQSQGDTSRIVGTFG 493
+ +++H ++ NIL+ + +P K+SD G+ + V
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI------TVLSREERVERIP 169
Query: 494 YMAPEYVTRGHFSIKS--DVFSFGVLVLEIISGQK 526
++APE + G S+ D +SFG +LEI S +
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 330 NKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSVQGE-LEFKNEVLLVARLQHRNLVRLLG 387
KLG+G + V+KGR + +A+K + +G EV L+ L+H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFD-----AIKRVQLDWETRYKIIGGIARGILYLHED 442
+ L++E++ + + +++ D ++ V++ + I RG+ Y H
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKI-------FLYQILRGLAYCH-- 121
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT- 501
R +++HRDLK N+L++ K++DFG+AR + S V T Y P+ +
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLG 178
Query: 502 RGHFSIKSDVFSFGVLVLEIISGQ 525
+S + D++ G + E+ SG+
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 330 NKLGQGGFGAVYKGRLSHGQE-IAVKRLSKNSVQGE-LEFKNEVLLVARLQHRNLVRLLG 387
+KLG+G + VYKGR +A+K + +G EV L+ L+H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
E L++E++ + + +++ D + + + + RG+ Y H R ++
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINM--HNVKLFLFQLLRGLNYCH---RRKV 125
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-RGHFS 506
+HRDLK N+L++ K++DFG+AR + S V T Y P+ + +S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYS 183
Query: 507 IKSDVFSFGVLVLEIISGQ 525
+ D++ G + E+ +G+
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 45/156 (28%), Positives = 82/156 (52%), Gaps = 2/156 (1%)
Query: 368 KNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYK 427
++E+ +A H +V+ + + LLI E+ ++K I +K L ++ Y+
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKE-HLPFQ-EYE 170
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
+ + +L L E +++HRDLK++NI L I K+ DFG ++ + S S
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
GT Y+APE R +S K+D++S GV++ E+++
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 34/210 (16%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEF-----KNEVLLVARLQHRNLVRL 385
+G+G FG VY+ R + I A+K LSK + + E + +L+ L +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDW---------ETRYKIIGGIARGI 436
L FSF+ L + D + +L W E R K IA +
Sbjct: 61 LKFSFQTDSDLY------------LVTDYMSGGELFWHLQKEGRFSEDRAKFY--IAELV 106
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYM 495
L L + I++RDLK NILLDA + DFG+++ + + T+ GT Y+
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEYL 163
Query: 496 APE-YVTRGHFSIKSDVFSFGVLVLEIISG 524
APE + ++ D +S GVLV E+ G
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 63/235 (26%), Positives = 104/235 (44%), Gaps = 47/235 (20%)
Query: 331 KLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFK--NEVLLVARLQHRNLVRLLG 387
KLG+G + VYKGR GQ +A+K + +G F E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHD 70
Query: 388 FSFEETERLLIYEFV-----------PN----SSVDKFIFDAIKRVQLDWETRYKIIGGI 432
+ L++E++ +V F+F QL
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLF------QL------------ 112
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF 492
RG+ Y H + R++HRDLK N+L+ K++DFG+AR + S+ ++ +V T
Sbjct: 113 LRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSV-PSKTYSNEVV-TL 167
Query: 493 GYMAPEYVTRG--HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWK 545
Y P+ V G +S D++ G + E+ +G+ F + ED L ++
Sbjct: 168 WYRPPD-VLLGSTEYSTSLDMWGVGCIFYEMATGRP--LFPGSTDVEDQLHKIFR 219
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLGF 388
LG+G FG V + + G+ A+K L K + + E + + LQ+ + L +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRLRI 447
SF+ +RL FV + +F + R ++ E R + G I + YLH S +
Sbjct: 63 SFQTHDRLC---FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH--SEKNV 117
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
++RDLK N++LD D KI+DFG+ + E + GT Y+APE + +
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 508 KSDVFSFGVLVLEIISGQ 525
D + GV++ E++ G+
Sbjct: 176 AVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLGF 388
LG+G FG V R + G+ A+K L K + + E + V LQ+ + L +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRLRI 447
+F+ +RL FV + +F + R ++ E R + G I + YLH +
Sbjct: 63 AFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---V 116
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
++RD+K N++LD D KI+DFG+ + D + T GT Y+APE + +
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDYGR 174
Query: 508 KSDVFSFGVLVLEIISGQ 525
D + GV++ E++ G+
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 9/95 (9%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS---QGDTSRI 488
+A+G+ +L + IHRDL A NILL I KI DFG+AR D + +G+
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
V +MAPE + ++ +SDV+S+G+L+ EI S
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 38/95 (40%), Positives = 54/95 (56%), Gaps = 9/95 (9%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ---SQGDTSRI 488
+ARG+ +L + +HRDL A N+LL I KI DFG+AR D S+G T
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
V +MAPE + ++ SDV+S+G+L+ EI S
Sbjct: 303 V---KWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 52/199 (26%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE----FKNEVLLVARLQHRNLVRLLG 387
+G+G + V RL + I ++ K + + E + E + + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 388 FSFEETERLL-IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
F+ RL + E+V + +F ++ +L E I+ + YLHE
Sbjct: 63 SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNYLHERG--- 116
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
II+RDLK N+LLD++ K++D+GM + E + TS GT Y+APE + +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 507 IKSDVFSFGVLVLEIISGQ 525
D ++ GVL+ E+++G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 10/157 (6%)
Query: 370 EVLLVARLQHRNLVRLLG-FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI 428
E ++ + H ++++L G F++ + L++ P D + + A KR + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL----PRYKTDLYCYLAAKR-NIAICDILAI 187
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
+ R I YLHE+ RIIHRD+KA NI ++ + DFG A F +D +
Sbjct: 188 ERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGW 243
Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
GT APE + R + D++S G+++ E+ +
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 32/83 (38%), Positives = 50/83 (60%), Gaps = 6/83 (7%)
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQS---QGDTSRIVGTFGYMAPEYVTRGH 504
IHRD+ A N+LL + KI DFG+AR D + +G+ V +MAPE +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV---KWMAPESIFDCV 290
Query: 505 FSIKSDVFSFGVLVLEIISGQKN 527
++++SDV+S+G+L+ EI S K+
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 56/218 (25%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN-EVLLVARL 377
R ++ N +G G FG VY+ + +++A+K++ ++ ++KN E+L++ L
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNL 116
Query: 378 QHRNLVRLLGFSFEETERL--------LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
H N++ L + + E + ++ EF+P + V K++ + K+
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQT-VHKYMKHYARNNHALPLFLVKLY 175
Query: 430 G-GIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSR 487
+ R + Y+H I HRDLK N+L+D + K+ DFG A+ + Q S
Sbjct: 176 SYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NLLAGQRSVSY 230
Query: 488 IVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISG 524
I F Y APE + +++ D++S G ++ E+I G
Sbjct: 231 ICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-09
Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 43/227 (18%)
Query: 331 KLGQGGFGAVYKGRLSH----GQEIAVKRLSKNSVQGEL---EFKNEVLLVARLQHRNLV 383
+G+GG G VY L++ + +A+K++ ++ + L F E + A L H +V
Sbjct: 9 LIGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 384 RLLGFSFEETERLLIYE--FVPNSSVDKFIFDAIKRVQLDWETRYK--------IIGGIA 433
+ +S + Y ++ ++ + ++ L E K I I
Sbjct: 66 PV--YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS-QGDTS------ 486
I Y+H S+ ++HRDLK NILL I D+G A ++++ D
Sbjct: 124 ATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 487 ---------RIVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIIS 523
+IVGT YMAPE + G S +D+++ GV++ ++++
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERL-LGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 30/213 (14%)
Query: 331 KLGQGGFGAV----YKGRLSHGQEIAVKRLSKNSVQGELEFKN---EVLLVARLQ-HRNL 382
+LGQG +G V S + +A+K+++ N ++ K E+ L+ + H+N+
Sbjct: 7 ELGQGAYGIVCSARNAET-SEEETVAIKKIT-NVFSKKILAKRALRELKLLRHFRGHKNI 64
Query: 383 VRLLGF------SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYK-IIGGIARG 435
L +F E L +YE + + + + I + Q + ++ I I G
Sbjct: 65 TCLYDMDIVFPGNFNE---LYLYEELMEADLHQII----RSGQPLTDAHFQSFIYQILCG 117
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD--QSQGDTSRIVGTFG 493
+ Y+H + ++HRDLK N+L++AD KI DFG+AR F + ++ G + V T
Sbjct: 118 LKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174
Query: 494 YMAPEYVTRGHFSIKS-DVFSFGVLVLEIISGQ 525
Y APE + K+ DV+S G ++ E++ +
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELE---FKNE--VLLVARL 377
++F +G+G FG V ++ H + I A+K L+K + E F+ E VL+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 378 QHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
Q + L ++F++ L L+ ++ + + R+ D Y IA +
Sbjct: 61 Q---WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEMV 112
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
L +H +L +HRD+K N+LLD + +++DFG L +S VGT Y++
Sbjct: 113 LAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC-LKMNQDGTVQSSVAVGTPDYIS 171
Query: 497 PEYVT-----RGHFSIKSDVFSFGVLVLEIISGQ 525
PE + G + + D +S GV + E++ G+
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 63/251 (25%), Positives = 104/251 (41%), Gaps = 66/251 (26%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSVQGELEFKNEV-------- 371
++F + +G+G FG V RL G A+K+L K+ E+ K +V
Sbjct: 1 DDFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLRKS----EMLEKEQVAHVRAERD 53
Query: 372 LLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQL-DWETRYKII 429
+L V L +SF++ L LI E++P + + +K+ + ETR+ I
Sbjct: 54 ILAE--ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLL---MKKDTFTEEETRFYI- 107
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE----------MD 479
A IL + +L IHRD+K N+LLDA K+SDFG+ + +
Sbjct: 108 ---AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164
Query: 480 QSQGDTSR--------------------------IVGTFGYMAPEYVTRGHFSIKSDVFS 513
+ VGT Y+APE + ++ + D +S
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS 224
Query: 514 FGVLVLEIISG 524
GV++ E++ G
Sbjct: 225 LGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 62/262 (23%), Positives = 102/262 (38%), Gaps = 79/262 (30%)
Query: 324 NNFSTDNKLGQGGFGAV-YKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
+F T +G+G FG V + G+ A+K L K+ + FK + L + + L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-----FKKDQLAHVKAERDVL 55
Query: 383 -------VRLLGFSFEETERL-LIYEFVPNSSV-------DKFIFDAIKRVQLDWETRYK 427
V L +SF++ + L LI EF+P + D F D TR+
Sbjct: 56 AESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---------TRFY 106
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA-------------R 474
+ A +L + +L IHRD+K NIL+D K+SDFG++ +
Sbjct: 107 M----AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQK 162
Query: 475 LFEMDQSQGDTS---------------------------RI-----VGTFGYMAPEYVTR 502
L + ++ R+ VGT Y+APE +
Sbjct: 163 LLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222
Query: 503 GHFSIKSDVFSFGVLVLEIISG 524
+ + D +S G ++ E + G
Sbjct: 223 QGYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 2e-08
Identities = 51/204 (25%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGE-LEFKNEVLLVARLQHRN 381
+++ KLG+G + VYKG+ +G+ +A+K + +G E L+ L+H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
+V L + L++E+V ++ + +++ + + + + + RG+ Y+H+
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLF--LFQLLRGLSYIHQ 121
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
I+HRDLK N+L+ K++DFG+AR + S ++ +V T Y P+ +
Sbjct: 122 RY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVV-TLWYRPPDVLL 176
Query: 502 -RGHFSIKSDVFSFGVLVLEIISG 524
+S D++ G + +E+I G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 13/200 (6%)
Query: 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGE-LEFKNEVLLVARLQHRNLVRLLG 387
+KLG+G + V+KGR +A+K + +G EV L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLHEDSRLR 446
E L++E++ +S + +++ + + + KI + + RG+ Y H + +
Sbjct: 71 IIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMH---NVKIFMFQLLRGLSYCH---KRK 123
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-RGHF 505
I+HRDLK N+L++ K++DFG+AR + S V T Y P+ + +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSTEY 181
Query: 506 SIKSDVFSFGVLVLEIISGQ 525
S D++ G ++ E+ +G+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 52/213 (24%), Positives = 101/213 (47%), Gaps = 18/213 (8%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELE---FKNEVLLVARLQH 379
+F + +G+G FG V R +I A+K + K+ + + F+ E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
+ +L ++F++ + L L+ E+ P + + + D Y +A +L
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-----LAELVLA 114
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
+H ++ +HRD+K N+L+D K++DFG A ++ VGT Y+APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP-VGTPDYIAPE 173
Query: 499 YVT------RGHFSIKSDVFSFGVLVLEIISGQ 525
+T +G + ++ D +S GV+ E+I G+
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 62/246 (25%), Positives = 113/246 (45%), Gaps = 31/246 (12%)
Query: 292 RKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEI 351
RK K N +N E + ++ ++ +G+G FG V R Q++
Sbjct: 16 RKNKNIDNF-----LNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKV 70
Query: 352 -AVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSV 407
A+K LSK + + + F E + + V L +F++ + L ++ E++P +
Sbjct: 71 YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL 130
Query: 408 DKFI--FDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465
+ +D ++ W Y A +L L + +IHRD+K N+LLD
Sbjct: 131 VNLMSNYDVPEK----WAKFYT-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHL 181
Query: 466 KISDFGMARLFEMDQS---QGDTSRIVGTFGYMAPEYVTR----GHFSIKSDVFSFGVLV 518
K++DFG +MD++ + DT+ VGT Y++PE + G++ + D +S GV +
Sbjct: 182 KLADFGTC--MKMDETGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237
Query: 519 LEIISG 524
E++ G
Sbjct: 238 FEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 59/245 (24%), Positives = 98/245 (40%), Gaps = 63/245 (25%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLG 387
+G G FG V R + A+K L K V K E ++A + +V+L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 388 FSFEETERL-LIYEFVPNSS-----VDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
+SF++ + L + +++P + IF+ D Y I + I +H
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEE------DLARFY--IAELTCAIESVH- 118
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLF--------------------EMDQS 481
++ IHRD+K NIL+D D K++DFG+ F E +
Sbjct: 119 --KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176
Query: 482 QGDTSR---------------------IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLE 520
+ R +VGT Y+APE + R ++ D +S GV++ E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
Query: 521 IISGQ 525
++ GQ
Sbjct: 237 MLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
+A G+ +L + +HRDL A N+L+ + KI DFG+AR D +
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+MAPE + ++ SDV+SFG+L+ EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 36/101 (35%), Positives = 55/101 (54%), Gaps = 18/101 (17%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
+ RG+ Y+H + ++HRDLK SN+LL+A+ KI DFG+AR ++ T +V T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVV-T 171
Query: 492 FGYMAPE-------YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
Y APE Y T +I DV+S G + E++ +
Sbjct: 172 RWYRAPELLLNCSEYTT----AI--DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 63/244 (25%), Positives = 107/244 (43%), Gaps = 27/244 (11%)
Query: 292 RKKKQKQNL--RKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQ 349
RK K N R D IN + L R ++ +G+G FG V R +
Sbjct: 16 RKNKNIDNFLNRYKDTINKIRDL-------RMKAEDYEVVKVIGRGAFGEVQLVRHKSTR 68
Query: 350 EI-AVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNS 405
++ A+K LSK + + + F E + + V L ++F++ L ++ E++P
Sbjct: 69 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 128
Query: 406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465
+ + + V W Y A +L L + IHRD+K N+LLD
Sbjct: 129 DLVNLMSNY--DVPEKWARFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL 181
Query: 466 KISDFGMARLFEMD-QSQGDTSRIVGTFGYMAPEYVTR----GHFSIKSDVFSFGVLVLE 520
K++DFG + + DT+ VGT Y++PE + G++ + D +S GV + E
Sbjct: 182 KLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239
Query: 521 IISG 524
++ G
Sbjct: 240 MLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 28/99 (28%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
+A +L + +L +HRD+K N+LLD + +++DFG L + ++ VGT
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSC-LRLLADGTVQSNVAVGT 166
Query: 492 FGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQ 525
Y++PE + +G + + D +S GV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 35/213 (16%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIA---VKRLSKNSVQGELEFKNEVLLVAR----LQHRNLV 383
++G G FG V + +A VK L N+ E +NE L LQH N++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE---QNEFLQQGDPYRILQHPNIL 58
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETR-------YKIIGGIARGI 436
+ LG E LL++E+ + ++ Q W R ++ IA G+
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMACEIAAGV 112
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA-RLFEMDQSQGDTSRIVGTFGYM 495
++H + +H DL N L +D+ K+ D+G+ ++ D + + + V ++
Sbjct: 113 THMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWL 168
Query: 496 APEYVTRGHFSI-------KSDVFSFGVLVLEI 521
APE V H + S+V++ GV + E+
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 61/249 (24%), Positives = 111/249 (44%), Gaps = 25/249 (10%)
Query: 286 CVFLRRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL 345
C RK K N ++ E + +R +F +G+G FG V R
Sbjct: 10 CDIPALRKNKNIDNF-----LSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRH 64
Query: 346 SHGQEI-AVKRLSKNSVQGELE---FKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYE 400
+++ A+K LSK + + F E ++A +V+L ++F++ + L ++ E
Sbjct: 65 KSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH-YAFQDDKYLYMVME 123
Query: 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 460
++P + + + + W Y A +L L + IHRD+K N+LLD
Sbjct: 124 YMPGGDLVNLMSNY--DIPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLD 176
Query: 461 ADMIPKISDFGMA-RLFEMDQSQGDTSRIVGTFGYMAPEYVTR----GHFSIKSDVFSFG 515
K++DFG ++ + DT+ VGT Y++PE + G++ + D +S G
Sbjct: 177 KSGHLKLADFGTCMKMDANGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234
Query: 516 VLVLEIISG 524
V + E++ G
Sbjct: 235 VFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 49/210 (23%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 332 LGQGGFGAVYKGRLS--------HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
LGQG F ++KG H E+ +K L K+ F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
G E +++ E+V S+D ++ + + W + ++ +A + +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 444 RLRIIHRDLKASNILL-----DADMIP---KISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
+ H ++ A N+LL P K+SD G++ + + RI ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERI----PWV 171
Query: 496 APEYVTRG-HFSIKSDVFSFGVLVLEIISG 524
PE + + S+ +D +SFG + EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 50/211 (23%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELE---FKNEVLLVARLQHR 380
+F +G+G FG V +L + ++ A+K L+K + E F+ E ++ ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 381 NLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
+ L ++F++ L L+ ++ + + R+ D Y +A ++ +
Sbjct: 62 -WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVIAI 115
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
+L +HRD+K NIL+D + +++DFG L M+ +S VGT Y++PE
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC-LKLMEDGTVQSSVAVGTPDYISPEI 174
Query: 500 VT-----RGHFSIKSDVFSFGVLVLEIISGQ 525
+ +G + + D +S GV + E++ G+
Sbjct: 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL-FEMDQSQGDTSRIVGTF 492
R + Y+H + + HRDLK NIL +AD KI DFG+AR+ F + + V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 493 GYMAPEYVTRGHFSIKS----DVFSFGVLVLEIISGQ 525
Y APE G F K D++S G + E+++G+
Sbjct: 171 WYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 49/236 (20%)
Query: 314 FDFSTIRDATNNFSTDNKLGQGGFGAVY--KGRLSHGQEIAVKRLSKNSVQGELEFKNEV 371
DF TI+ +N G +GAVY + + + Q A+K+++K + L +N++
Sbjct: 1 EDFETIKLISN----------GAYGAVYLVRHKETR-QRFAMKKINKQN----LILRNQI 45
Query: 372 --LLVAR----LQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWET 424
+ V R V + SFE L ++ E+V + I + +D
Sbjct: 46 QQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLL-KNIGALPVDMAR 104
Query: 425 RYKIIGGIARGIL---YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL------ 475
Y A +L YLH I+HRDLK N+L+ + K++DFG++++
Sbjct: 105 MY-----FAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156
Query: 476 -------FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
E D + ++ GT Y+APE + R + D ++ G+++ E + G
Sbjct: 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 62/250 (24%), Positives = 100/250 (40%), Gaps = 57/250 (22%)
Query: 326 FSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRN 381
F LG G FG V R + A+K L K V K E ++A +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 382 LVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
+VRL +SF++ + L + +++P + + R+ + E + IA +
Sbjct: 63 VVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLI----RMGIFPEDLARFY--IAELTCAVE 115
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE------------------MDQSQ 482
++ IHRD+K NIL+D D K++DFG+ F MD S
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 483 --GDTSR-------------------------IVGTFGYMAPEYVTRGHFSIKSDVFSFG 515
GD + +VGT Y+APE + R ++ D +S G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235
Query: 516 VLVLEIISGQ 525
V++ E++ GQ
Sbjct: 236 VILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 48/212 (22%), Positives = 91/212 (42%), Gaps = 32/212 (15%)
Query: 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGE--LEFKNEVLLVARLQHRNLVRLLGFS 389
+ K + + +AVK+++ +S E + E++ +LQH N++ + S
Sbjct: 10 FEDLMIVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-TS 67
Query: 390 FEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDW--ET--RYKIIGGIARGILYLHEDSR 444
F L ++ + S + D +K + E + I+ + + Y+H
Sbjct: 68 FIVDSELYVVSPLMAYGSCE----DLLKTHFPEGLPELAIAF-ILKDVLNALDYIH---S 119
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG--------YMA 496
IHR +KAS+ILL D +S G+ M G R+V F +++
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMI-KHGKRQRVVHDFPKSSVKNLPWLS 176
Query: 497 PEYVT---RGHFSIKSDVFSFGVLVLEIISGQ 525
PE + +G ++ KSD++S G+ E+ +G
Sbjct: 177 PEVLQQNLQG-YNEKSDIYSVGITACELANGH 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 59/244 (24%), Positives = 101/244 (41%), Gaps = 57/244 (23%)
Query: 332 LGQGGFGAV-YKGRLSHGQEIAVKRLSKNSVQGELEF---KNEVLLVARLQHRNLVRLLG 387
LG G FG V ++ A+K L K V + K E ++A + +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLY- 67
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
+SF++ + L + +++P + + R+++ E + IA L + ++
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLI----RMEVFPEVLARFY--IAELTLAIESVHKMG 121
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFE------------------MDQSQ------ 482
IHRD+K NIL+D D K++DFG+ F M+ S
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 483 ----GD-----------------TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
GD +VGT Y+APE + R ++ D +S GV++ E+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 522 ISGQ 525
+ GQ
Sbjct: 242 LVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 31/108 (28%), Positives = 62/108 (57%), Gaps = 16/108 (14%)
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
I+ G RG+ YLH++ IHR++KAS+IL+ D + +S G++ L+ + G ++
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLS--GLSHLYSL-VRNGQKAK 159
Query: 488 IVGTFG--------YMAPEYVTRG--HFSIKSDVFSFGVLVLEIISGQ 525
+V F +++PE + + +++KSD++S G+ E+ +G+
Sbjct: 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (116), Expect = 7e-06
Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 42/243 (17%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQE------IAVKRLSKNSVQGELEFKNEVLLVARL 377
N + K+G G FG V+ + QE I+ + L K + +L EV ++ L
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVI--EVNVMREL 69
Query: 378 QHRNLVRLLG-FSFEETERLLI-YEFVPNSSVDKFIFDAIKRV-QLDWETRYKIIGGIAR 434
+H+N+VR + F + ++L I EF + + I K +++ I +
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 435 GILYLHE----DSRLRIIHRDLKASNILLDADM-----------------IPKISDFGMA 473
+ Y H + R++HRDLK NI L + I KI DFG++
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQ----KN 527
+ ++ VGT Y +PE + + KSD+++ G ++ E+ SG+ K
Sbjct: 190 KNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246
Query: 528 NSF 530
N+F
Sbjct: 247 NNF 249
|
Length = 1021 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 63/247 (25%), Positives = 102/247 (41%), Gaps = 61/247 (24%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNSVQGELEFKNEVLLVARLQH 379
++F + +G+G FG V RL G A+K L K + + E + R +
Sbjct: 1 DDFESLKVIGRGAFGEV---RLVQKKDTGHIYAMKILRKADM-----LEKEQVAHIRAER 52
Query: 380 RNLVRLLG-------FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG 431
LV G +SF++ L LI EF+P + + K + T++ I
Sbjct: 53 DILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYI--- 107
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM------------------- 472
A +L + +L IHRD+K N+LLDA K+SDFG+
Sbjct: 108 -AETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 473 ---------------ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
A ++ ++ Q S VGT Y+APE + ++ D +S GV+
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYS-TVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225
Query: 518 VLEIISG 524
+ E++ G
Sbjct: 226 MYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 53/242 (21%)
Query: 325 NFSTDNKLGQGGFGAV---YKGRLSHGQEIAVKR----LSKNSVQGELEFKNEVLLVARL 377
+F + +G+G FG V K H + + R L K V G + + ++L+ A
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQV-GHIRAERDILVEA-- 58
Query: 378 QHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
+V++ +SF++ L LI EF+P + + K + ET++ I A +
Sbjct: 59 DSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYI----AETV 111
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM------------------------ 472
L + +L IHRD+K N+LLD+ K+SDFG+
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 473 ----------ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEII 522
A ++ ++ Q S VGT Y+APE + ++ D +S GV++ E++
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFS-TVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 523 SG 524
G
Sbjct: 231 IG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 53/234 (22%)
Query: 331 KLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGE-----LEFKNEVLLVARLQHRNLVR 384
LG+G G V+ RL G+ A+K L K + + + E+L A L H L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL--ATLDHPFLPT 65
Query: 385 LLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL----YL 439
L SF+ L L+ ++ P + + Q ++ A +L YL
Sbjct: 66 LYA-SFQTETYLCLVMDYCPGGE-----LFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL------FEMDQSQGDTSR------ 487
H L I++RDLK NILL +SDF +++ + + R
Sbjct: 120 H---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 488 ---------------IVGTFGYMAPEYVT-RGH-FSIKSDVFSFGVLVLEIISG 524
VGT Y+APE ++ GH ++ D ++ G+L+ E++ G
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 30/153 (19%), Positives = 56/153 (36%), Gaps = 17/153 (11%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV-RLLGFS 389
L G VY + +K + E + +L + + V ++L
Sbjct: 5 LLKGGLTNRVYLLGTKDE-DYVLKINPSREKGADREREVAILQLLA-RKGLPVPKVLASG 62
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
+ L+ E++ ++D ++ E + I +A + LH+ L + H
Sbjct: 63 ESDGWSYLLMEWIEGETLD----------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCH 112
Query: 450 RDLKASNILLDADMIPKISDFGMA----RLFEM 478
DL NIL+D I I D+ A F++
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGYGPPAFDL 145
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 32/211 (15%)
Query: 332 LGQGGFGAVYKGRL-----------SHGQEIAV--KRLSKNSVQGELEFKNEVLLVARLQ 378
LG+G +Y G L S+ +EI V K L + L F ++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
H+++V L G + E +++ EFV +D F+ + W ++K+ +A + Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 439 LHEDSRLRIIHRDLKASNILL-----DADMIP--KISDFGMARLFEMDQSQGDTSRIVGT 491
L ED L +H ++ NILL D + P K+SD G+ + Q RI
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--ITVLSRQECVERI--- 172
Query: 492 FGYMAPEYVT-RGHFSIKSDVFSFGVLVLEI 521
++APE V + SI +D +SFG + EI
Sbjct: 173 -PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 40/168 (23%), Positives = 73/168 (43%), Gaps = 17/168 (10%)
Query: 370 EVLLVARLQHRNLVRLL-GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ-LDWETRYK 427
E+ ++ + HR ++ L+ + ++ T +++ P D F + + R L E
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVM----PKYKCDLFTY--VDRSGPLPLEQAIT 189
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
I + + YLH IIHRD+K NI LD + DFG A +
Sbjct: 190 IQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEI------ISGQKNNS 529
GT +PE + + K+D++S G+++ E+ + G++ S
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS 294
|
Length = 392 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 38/150 (25%), Positives = 69/150 (46%), Gaps = 17/150 (11%)
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ-LDW-ETRYKIIGGIARGI 436
+ N ++L +LI +++ D +FD +K+ L E + KII + +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAEVK-KIIRQLVEAL 122
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
LH + IIH D+K N+L D + D+G+ + G S GT Y
Sbjct: 123 NDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK------IIGTPSCYDGTLDYF 173
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
+PE + ++ + D ++ GVL E+++G+
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 46/184 (25%), Positives = 73/184 (39%), Gaps = 48/184 (26%)
Query: 325 NFSTDNKLGQGGFGAVYKG-----RLSHGQEIAVKRLSKNSVQGELE-FKNEVLL----- 373
+F KLG+G FG VYK + + +K+ ++ G +E + NE +
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATE---YGAVEIWMNERVRRACPN 189
Query: 374 -VARLQHRNLVRLLGF-----SFEETERLLIYEFVPNSS-------------VDKFIFDA 414
A + GF S +E E L++ + S+ V+ ++
Sbjct: 190 SCADFVY-------GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGK 242
Query: 415 IKRVQLDWETRYKIIGGIARGILY----LHEDSRLRIIHRDLKASNILLDADMIP-KISD 469
++ + E KII I R IL+ LH I+HRD+K NI+ KI D
Sbjct: 243 VQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIID 299
Query: 470 FGMA 473
G A
Sbjct: 300 LGAA 303
|
Length = 566 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 44/223 (19%)
Query: 332 LGQGGFGAVYKGRL-----------------------SHGQEIAV--KRLSKNSVQGELE 366
LGQG +Y GRL ++G+E+ V K L + L
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 367 FKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRY 426
F L++++ H +L + G +E +++ EFV + +D + RV + W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNIL-----LDADMIP--KISDFGMARLFEMD 479
+ +A + YL ED L +H ++ A NIL L P K+SD G++ F
Sbjct: 121 TVAQQLASALSYL-EDKNL--VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTAL 175
Query: 480 QSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEI 521
+ RI ++APE V G S +D +SFG +LEI
Sbjct: 176 SREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 36/195 (18%), Positives = 90/195 (46%), Gaps = 22/195 (11%)
Query: 340 VYKGRLSHGQEIAVKRLSK--NSVQGELE-FKNEVLLVARLQHRNLVRLLGFSFEETERL 396
+YKG + +E+ ++ K + ++ +NE+ + R+ N++++ GF + + L
Sbjct: 36 IYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 397 ----LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE-DSRLRIIHRD 451
LI E+ + + + K L ++T+ + +G+ L++ ++ +++
Sbjct: 95 PRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKN 148
Query: 452 LKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR--GHFSIKS 509
L + + L+ + KI G+ ++ + V Y + + + ++IK
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKN-----VNFMVYFSYKMLNDIFSEYTIKD 203
Query: 510 DVFSFGVLVLEIISG 524
D++S GV++ EI +G
Sbjct: 204 DIYSLGVVLWEIFTG 218
|
Length = 283 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 24/109 (22%), Positives = 39/109 (35%), Gaps = 19/109 (17%)
Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI 432
L+ARL H L + RL + + A R + E ++
Sbjct: 101 LLARL-HSVPPEALPLARRLRRRLKLLRQL----------AAALRRLVAAELLDRLAELW 149
Query: 433 ARGILYLHE---DSRLRIIHRDLKASNILLDADMIPKIS---DFGMARL 475
R + L L ++H DL N+L+D +++ DF A L
Sbjct: 150 ERLLAALLALLPALPLVLVHGDLHPGNLLVDPG--GRVTGVIDFEDAGL 196
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 36.9 bits (86), Expect = 0.001
Identities = 19/54 (35%), Positives = 26/54 (48%), Gaps = 7/54 (12%)
Query: 598 SSSLSLPLPSQPAFFMH-STMEQDNLEFTSSDQSKSGSIHFTVNEVTISELDPR 650
S + +P P QP F + S E T S S +TVN+VT+S +D R
Sbjct: 1 SETTEIPQPKQPGFCVGRSPYE------TDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 21/55 (38%), Positives = 32/55 (58%), Gaps = 3/55 (5%)
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475
D E K I +A + YLH IIHRDLK N+L+ + K++DFG++++
Sbjct: 102 DEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 429 IGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484
+ +AR +L Y+H + IIHRD+K N+L++ + DFG A S
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLE 520
I GT APE + ++ D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 44/194 (22%), Positives = 87/194 (44%), Gaps = 27/194 (13%)
Query: 348 GQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFVPNS 405
G+ + V+R++ + E+ F L V++L H N+V + E ++ F+
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84
Query: 406 SVDKFI----FDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 461
S I D + + + + I+ G+ + + Y+H + +HR +KAS+IL+
Sbjct: 85 SAKDLICTHFMDGMSELAIAY-----ILQGVLKALDYIHH---MGYVHRSVKASHILISV 136
Query: 462 DMIPKISDFGMARLFEMDQSQGDTSRIVGTF--------GYMAPEYVTRG--HFSIKSDV 511
D K+ G+ M + G R+V F +++PE + + + KSD+
Sbjct: 137 D--GKVYLSGLRSNLSM-INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 193
Query: 512 FSFGVLVLEIISGQ 525
+S G+ E+ +G
Sbjct: 194 YSVGITACELANGH 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 650 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.98 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.79 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.74 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.62 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.44 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.42 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.41 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.3 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.25 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.11 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.06 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.05 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.03 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.0 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.95 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.94 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.79 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.75 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.62 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.62 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.55 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.43 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.35 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.25 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.11 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.98 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 96.92 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.84 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.81 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.79 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.76 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.59 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.47 | |
| PLN02236 | 344 | choline kinase | 96.32 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.3 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.18 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.13 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.97 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.85 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.72 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.07 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.98 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.85 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.81 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.62 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.61 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.54 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.46 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.39 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-57 Score=472.82 Aligned_cols=287 Identities=46% Similarity=0.755 Sum_probs=254.3
Q ss_pred cccccChhhHHhhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeeccee
Q 006317 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389 (650)
Q Consensus 310 ~~~~~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 389 (650)
....|++.+++.+|++|...++||+|+||.||+|.+.+|+.||||++.....+...+|.+|+.++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34569999999999999999999999999999999999999999998776543145699999999999999999999999
Q ss_pred ecCC-eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEe
Q 006317 390 FEET-ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS 468 (650)
Q Consensus 390 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 468 (650)
.+.+ +.+||||||++|+|+++|+..... .++|..|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9998 599999999999999999864333 89999999999999999999999988899999999999999999999999
Q ss_pred eeecccccccCCCCCcccee-ecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhc
Q 006317 469 DFGMARLFEMDQSQGDTSRI-VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNW 547 (650)
Q Consensus 469 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 547 (650)
|||+++..... ....... .||.+|++||++..+..+.|+|||||||+|+||+||+++.+.........+..|+++.+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999654421 1111112 79999999999999999999999999999999999999887665555666999999999
Q ss_pred cCCCcccccCccCC-CCCh--HHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 548 NEGTALNLIDPTLR-NGSS--SEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 548 ~~~~~~~~id~~l~-~~~~--~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
..+...+++|+.+. .... .++.++..++++|++.+|++||+|.||+++|+..
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 99999999999987 4444 6889999999999999999999999999999543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=390.08 Aligned_cols=254 Identities=30% Similarity=0.524 Sum_probs=205.0
Q ss_pred CcCCcccccCceeEEEeeccCCcceeEeeccccCchh--HHHHHHHHHHHhhCCCCceeeecceeecCC-eeEEEEecCC
Q 006317 327 STDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQHRNLVRLLGFSFEET-ERLLIYEFVP 403 (650)
Q Consensus 327 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~~~ 403 (650)
...+.||+|+||+||+|.+.....||||++....... ..+|.+|+.+|.+++|||||+++|+|.+.. ..++||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3446699999999999999543449999998754333 458999999999999999999999999988 7999999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC-CeEEeeeecccccccCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~~~~~~ 482 (650)
+|+|.++|+.. .+..+++..+++++.|||+||+|||+++. ||||||||+||||+.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 99999999864 46789999999999999999999999863 99999999999999998 99999999998654322
Q ss_pred CccceeecCccccChhccc--cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 483 GDTSRIVGTFGYMAPEYVT--RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~--~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
.......||+.|||||++. ...|+.|+|||||||++|||+||+.||..... ...+....... ..+.+
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~-----~Rp~~ 267 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGG-----LRPPI 267 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcC-----CCCCC
Confidence 2233368999999999999 66999999999999999999999999874322 11111111111 12223
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
....+..+ ..++.+||+.||+.||++.+++.+|+..
T Consensus 268 p~~~~~~l---~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 268 PKECPPHL---SSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred CccCCHHH---HHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 33344444 4555579999999999999999999753
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=390.09 Aligned_cols=253 Identities=30% Similarity=0.503 Sum_probs=204.9
Q ss_pred CCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCC
Q 006317 326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS 405 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 405 (650)
+...+.||+|.||+||.|.++....||+|.++..... ..+|.+|+.+|++|+|+|||+++|+|..++..+||||||++|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3456899999999999999987779999999876443 347889999999999999999999999999999999999999
Q ss_pred ChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCcc
Q 006317 406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485 (650)
Q Consensus 406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 485 (650)
+|.+||.. ..+..++..+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||||++....+... ..
T Consensus 287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~-~~ 361 (468)
T KOG0197|consen 287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT-AS 361 (468)
T ss_pred cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee-ec
Confidence 99999986 35677999999999999999999999987 999999999999999999999999999954433322 22
Q ss_pred ceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCC
Q 006317 486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGS 564 (650)
Q Consensus 486 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 564 (650)
....-+..|.|||.+..+.|+.|||||||||+||||+| |+.|+.... ..+.+....+..+.. .| ...
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms---n~ev~~~le~GyRlp------~P---~~C 429 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS---NEEVLELLERGYRLP------RP---EGC 429 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC---HHHHHHHHhccCcCC------CC---CCC
Confidence 22234668999999999999999999999999999999 777765322 222222222221111 11 124
Q ss_pred hHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 565 SSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 565 ~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
++++ .+|+..||+.+|++|||++.+...|+..
T Consensus 430 P~~v---Y~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 430 PDEV---YELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CHHH---HHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 4444 4566689999999999999999888754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=360.96 Aligned_cols=250 Identities=27% Similarity=0.392 Sum_probs=205.1
Q ss_pred CCCcCCcccccCceeEEEeeccC-CcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCC-eeEEEEec
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEET-ERLLIYEF 401 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~ 401 (650)
+++..+.||+|..|+|||++++. ++.+|+|.+.... ....+++.+|++++++.+||+||+++|.|.... +..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 45566899999999999999764 7789999995543 334568999999999999999999999999988 59999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
|++|||++++.. .+.+++...-+|+.+|++||.|||+.. +||||||||+||||+..|.+||+|||.++.+...
T Consensus 160 MDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999873 367999999999999999999999632 4999999999999999999999999999876533
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCC--CcccchhHHHHHHhccCCCcccccCcc
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRI--GEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~--~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.... .....+++.+.-.. -.|.
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~---------ppP~ 301 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE---------PPPR 301 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC---------CCCC
Confidence 3456789999999999999999999999999999999999999987541 12223333332211 1233
Q ss_pred CCCC-ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 560 LRNG-SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 560 l~~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
++.. ..+|+..+ +-.||++||.+||++.|+++.
T Consensus 302 lP~~~fS~ef~~F---V~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 302 LPEGEFSPEFRSF---VSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCcccCCHHHHHH---HHHHhcCCcccCCCHHHHhcC
Confidence 4443 55555554 457999999999999999854
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=395.68 Aligned_cols=260 Identities=28% Similarity=0.449 Sum_probs=211.7
Q ss_pred ccCCCcCCcccccCceeEEEeecc------CCcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeecCCee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETER 395 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 395 (650)
..+....+.||+|.||+||+|+.. +.+.||||.++..... ...+|++|++++..++|||||+|+|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 455667789999999999999853 2456999999887655 777999999999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHHhhh-------c----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC
Q 006317 396 LLIYEFVPNSSVDKFIFDAI-------K----RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI 464 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~ 464 (650)
+||+|||..|+|.+||.... . ..+|+..+.+.|+.|||.||+||-++. +|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 99999999999999997521 1 234889999999999999999999887 999999999999999999
Q ss_pred eEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHH
Q 006317 465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYA 543 (650)
Q Consensus 465 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~ 543 (650)
+||+||||+|-....+.........-+.+|||||.++.++||.+||||||||+|||++| |+.|+..-..++..+.+.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~-- 719 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR-- 719 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH--
Confidence 99999999996655444443333445789999999999999999999999999999999 888876433333222221
Q ss_pred HHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCC
Q 006317 544 WKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSS 600 (650)
Q Consensus 544 ~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~ 600 (650)
.+..+.. .+..+ .++..|++.||+.+|++||+++||-..|+...
T Consensus 720 -----~g~lL~~-----Pe~CP---~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 720 -----AGQLLSC-----PENCP---TEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred -----cCCcccC-----CCCCC---HHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 2222111 11233 34567788999999999999999999998643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=365.58 Aligned_cols=199 Identities=30% Similarity=0.538 Sum_probs=180.1
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeecccc--CchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
-.+|...+.||+|.||+||+|+++ ++..||||.+.+. ..+..+.+..|+.+|+.++|||||++++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 367888899999999999999975 4889999999876 4445556889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC------CCeEEeeeecc
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD------MIPKISDFGMA 473 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~------~~~kl~DFGla 473 (650)
|||.+|+|.+||+ +++.+++.....++.|||.||++||+++ ||||||||.||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999998 4568999999999999999999999998 9999999999999875 45899999999
Q ss_pred cccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCC
Q 006317 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF 530 (650)
Q Consensus 474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~ 530 (650)
+.+.. .......+|++.|||||++...+|+.|+|+||+|++||+|++|+.||..
T Consensus 163 R~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 163 RFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 98763 3345568999999999999999999999999999999999999999863
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=378.90 Aligned_cols=248 Identities=26% Similarity=0.436 Sum_probs=209.5
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
..|...+.||+|||..||+++. ..|+.||+|++.+... ...+.+.+||++.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688999999999999999997 7799999999987533 33456889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
|+|++++|.+++. .++.+++.++..++.||+.||.|||+++ |+|||||..|+||++++++||+|||||..++.+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999887 5788999999999999999999999987 999999999999999999999999999987744
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
. ......+||+-|+|||++.....+..+||||+||+||-|+.|++||+...-.+....+. .-+..
T Consensus 172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik-------------~~~Y~ 236 (592)
T KOG0575|consen 172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK-------------LNEYS 236 (592)
T ss_pred c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH-------------hcCcc
Confidence 3 34556899999999999999999999999999999999999999997443222211111 11222
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
++.....+.. +|+..+|+.||.+|||+++|+.-
T Consensus 237 ~P~~ls~~A~---dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 237 MPSHLSAEAK---DLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cccccCHHHH---HHHHHHhcCCcccCCCHHHHhcC
Confidence 2223333333 55668999999999999999943
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=356.18 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=200.9
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCch-------hHHHHHHHHHHHhhCCCCceeeecceeecCC
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ-------GELEFKNEVLLVARLQHRNLVRLLGFSFEET 393 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 393 (650)
..+.|...+.||+|+||.|-+|+. ++|+.||||++++.... ......+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346678889999999999999985 46999999999875322 1224579999999999999999999999999
Q ss_pred eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC---CCeEEeee
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDF 470 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DF 470 (650)
..||||||+.+|.|.+++- ..+.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ -.+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999987 4566888888899999999999999998 9999999999999876 67999999
Q ss_pred ecccccccCCCCCccceeecCccccChhccccCCC---CccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhc
Q 006317 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF---SIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNW 547 (650)
Q Consensus 471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 547 (650)
|+|+... ....+...+||+.|.|||++.++.. ..+.|+||+||+||-++||.+||+...++. .+.+...+
T Consensus 324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~~-- 396 (475)
T KOG0615|consen 324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQILK-- 396 (475)
T ss_pred chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHhc--
Confidence 9999765 3345667899999999999987643 348899999999999999999997544332 11111111
Q ss_pred cCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 548 NEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 548 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
+.. .+-|.. ...-..+.++++-+||..||++|||+.|+++
T Consensus 397 --G~y--~f~p~~---w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 --GRY--AFGPLQ---WDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred --Ccc--cccChh---hhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 110 011111 1112244556777999999999999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=339.48 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=205.2
Q ss_pred cCCCcCCcccccCceeEEEee-ccCCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecce-eecCCe-eEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGF-SFEETE-RLLI 398 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~-~~~~~~-~~lv 398 (650)
.+|++.++||+|.||+|||+. +.+|..+|.|.+.... .+...++..|+.+|++|+|||||+++++ +.++.+ ..||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468888999999999999997 5689999999997543 3445578999999999999999999994 444445 7899
Q ss_pred EecCCCCChhHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCC-CcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 399 YEFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGGIARGILYLHEDSR-LRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
||+|..|+|..++....+ +..+++..+|+++.|++.||..+|++-+ ..|+||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999977443 5569999999999999999999998421 23999999999999999999999999999988
Q ss_pred ccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
.... ......+||+.||+||.+.+..|+.||||||+||++|||..-+.||..+ +++....+.. .+..
T Consensus 179 ~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~-qgd~---- 245 (375)
T KOG0591|consen 179 SSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIE-QGDY---- 245 (375)
T ss_pred cchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHH-cCCC----
Confidence 7443 2345679999999999999999999999999999999999999998632 3333332221 1110
Q ss_pred CccCC-CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 557 DPTLR-NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 557 d~~l~-~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+.+. .....+ +..|+..|+..||+.||+...++..+.+
T Consensus 246 -~~~p~~~YS~~---l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 -PPLPDEHYSTD---LRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -CCCcHHHhhhH---HHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1122 123344 4456668999999999996666655544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=380.98 Aligned_cols=253 Identities=28% Similarity=0.452 Sum_probs=208.4
Q ss_pred CCCcCCcccccCceeEEEeeccC----CcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
...+.++||.|.||+|++|+++- ...||||.++... .+...+|..|..+|.+++||||++|.|+.......++|+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 34567899999999999999753 3469999998764 345568999999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
|||+||+|+.||+. +.+++++.++.-++++||.||+||-+.+ +|||||.++||||+.+..+|++||||+|.++.+
T Consensus 710 EyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999999987 4567999999999999999999999887 999999999999999999999999999988655
Q ss_pred CCCCc-cceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 480 QSQGD-TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 480 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
..... +..-.-+.+|.|||.+...+++.+||||||||+|||.++ |.+|+.... .+...+.|+
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS----------------NQdVIkaIe 848 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS----------------NQDVIKAIE 848 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc----------------hHHHHHHHH
Confidence 42221 111223578999999999999999999999999999888 888874222 122222233
Q ss_pred ccCCCC-ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 558 PTLRNG-SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 558 ~~l~~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
..++-. +.+-...+.+|++.|||+|-.+||++.+|+.+|++
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 333222 22233456789999999999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=348.64 Aligned_cols=266 Identities=27% Similarity=0.420 Sum_probs=201.1
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHh--hCCCCceeeecceeecCC----eeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVA--RLQHRNLVRLLGFSFEET----ERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~~----~~~l 397 (650)
...+..++||+|+||.||||++. ++.||||++... ....|++|-++.+ .++|+||+++++.-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34566789999999999999994 599999999654 3445666666554 568999999999877655 8999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhc------CCCcEEecCCCCCceEeCCCCCeEEeeee
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED------SRLRIIHRDLKASNILLDADMIPKISDFG 471 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~~~iiHrDlk~~NILl~~~~~~kl~DFG 471 (650)
|+||.++|+|.+||. ...++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999996 45799999999999999999999975 46789999999999999999999999999
Q ss_pred cccccccCCCCCccceeecCccccChhccccCC-CC-----ccccccchhHHHHHHHhCCCCCCC--------CCCccc-
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH-FS-----IKSDVFSFGVLVLEIISGQKNNSF--------RIGEEA- 536 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~~sDV~S~Gvll~elltG~~p~~~--------~~~~~~- 536 (650)
||..+............+||.+|||||++.+.- +. .+.||||+|.|||||++.-..... +.+.+.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999998887777777789999999999997642 22 468999999999999997543311 000000
Q ss_pred -chhHHHHHHhccCCCcccccCccCCCC--ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCC
Q 006317 537 -EDLLTYAWKNWNEGTALNLIDPTLRNG--SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSL 601 (650)
Q Consensus 537 -~~l~~~~~~~~~~~~~~~~id~~l~~~--~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~ 601 (650)
.--++.-+... ..+...|.+++. ....+.-+.+.+..||+.||+.|-|+.=|-+.+.....
T Consensus 442 ~hPt~e~mq~~V----V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 442 NHPTLEEMQELV----VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CCCCHHHHHHHH----HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 00011111111 111122333222 11334445577889999999999999888877765443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=344.23 Aligned_cols=202 Identities=26% Similarity=0.401 Sum_probs=181.6
Q ss_pred hccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
..++|++.++||+|+||+||.++.++ ++-+|+|.+++... .......+|..+|.+++||.||++.-.+++.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 35789999999999999999998654 88899999987643 234568899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
|+||+.||.|..+|. +.+.+++..+.-++.+|+.||.|||+++ ||||||||+|||||++|+++|+||||++...
T Consensus 103 Vld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999997 5678999999999999999999999998 9999999999999999999999999998544
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCC
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR 531 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~ 531 (650)
.. ...+..++||+.|||||++.+..++..+|+||+|+++|||++|.+||...
T Consensus 177 ~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~ 228 (357)
T KOG0598|consen 177 KD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE 228 (357)
T ss_pred cC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence 32 23455589999999999999999999999999999999999999999743
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=346.44 Aligned_cols=262 Identities=24% Similarity=0.392 Sum_probs=203.2
Q ss_pred cCCCcCCcccccCceeEEEee-ccCCcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeecC--CeeEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERLLI 398 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv 398 (650)
+.|+.+++||+|.||.|||++ ..+|+.||+|++.....+ ...-..+||.+|++|+||||++|.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 457778999999999999998 456999999999876533 334567999999999999999999998876 689999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
+|||++ +|..++.. ....++..++..++.||+.||+|||+.+ |+|||||.+|||||++|.+||+|||||+++..
T Consensus 197 FeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999988 78777764 3557999999999999999999999998 99999999999999999999999999999887
Q ss_pred CCCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHh--------ccC
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKN--------WNE 549 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~--------~~~ 549 (650)
......+. .+-|++|.|||.+.+. .|+.+.|+||.||||.||+.|++.+..... .+.+...++. |..
T Consensus 271 ~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE---veQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 271 SGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE---VEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred CCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH---HHHHHHHHHHhCCCChhcccc
Confidence 66555444 4569999999999874 799999999999999999999987753322 2222222222 111
Q ss_pred CC--cccccCccCCCC-ChHH-----HHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 550 GT--ALNLIDPTLRNG-SSSE-----IMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 550 ~~--~~~~id~~l~~~-~~~~-----~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.. ....+.+.-.-. ...| ....++|+..+|..||.+|.|+.++++-
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 11 111222211100 0111 1234567778899999999999998754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=340.43 Aligned_cols=256 Identities=28% Similarity=0.404 Sum_probs=201.5
Q ss_pred cCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCC--eeEEEEe
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET--ERLLIYE 400 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~e 400 (650)
.++...+.||+|.||.||++...+ |...|||.+..........+.+|+.+|.+++|||||+++|.....+ ...++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 457778999999999999998654 8999999997764444556899999999999999999999855444 6889999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC-CCCeEEeeeecccccccC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEMD 479 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~~~~ 479 (650)
|+++|+|.+++... +..|++..+..+..||++||+|||+++ |+|+||||+||||+. ++.+||+|||+++.....
T Consensus 97 y~~~GsL~~~~~~~--g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRY--GGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 99999999999753 227999999999999999999999988 999999999999999 799999999999876531
Q ss_pred -CCCCccceeecCccccChhccccCC-CCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 480 -QSQGDTSRIVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 480 -~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
..........||+.|||||++..+. ...++|||||||++.||+||++||... .+...+........ .-
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~-----~~ 241 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED-----SL 241 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC-----CC
Confidence 1122344578999999999999643 345999999999999999999998732 11111112221111 11
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
|.+....+.+.. +++..|++.||++|||++++++-..
T Consensus 242 P~ip~~ls~~a~---~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 242 PEIPDSLSDEAK---DFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCCCcccCHHHH---HHHHHHhhcCcccCcCHHHHhhChh
Confidence 233333444444 4555899999999999999997643
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=350.91 Aligned_cols=257 Identities=27% Similarity=0.462 Sum_probs=201.7
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+.+.+.+.||+|.||+||+|+|. -.||||++..... +..+.|++|+..+++-+|.||+-+.|+|..... .+|+.|
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred HHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 44566789999999999999984 4699999987633 345579999999999999999999999999887 999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
|++.+|..+|+. .+..++..+.+.|++||++||.|||.++ |||||||+.||+|.+++.+||+||||+..-..-..
T Consensus 469 CeGsSLY~hlHv--~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 469 CEGSSLYTHLHV--QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred ccCchhhhhccc--hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 999999999986 4467899999999999999999999998 99999999999999999999999999864322211
Q ss_pred CCccceeecCccccChhccccC---CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRG---HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
........|...|||||++... +|+..+||||||+++|||+||..|+.....+.. .|. .+.-.-..|.
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI------ifm---VGrG~l~pd~ 614 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI------IFM---VGRGYLMPDL 614 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe------EEE---ecccccCccc
Confidence 2223334578899999998753 689999999999999999999999873222211 111 1111111122
Q ss_pred cCC-CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCC
Q 006317 559 TLR-NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSS 600 (650)
Q Consensus 559 ~l~-~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~ 600 (650)
... ...+.++. +|+..||..++++||.+.+|+.+|+...
T Consensus 615 s~~~s~~pk~mk---~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 615 SKIRSNCPKAMK---RLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred hhhhccCHHHHH---HHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 111 12334444 5666899999999999999999886543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=353.27 Aligned_cols=260 Identities=28% Similarity=0.410 Sum_probs=201.1
Q ss_pred hccCCCcCCcccccCceeEEEeec------cCCcceeEeeccccCc-hhHHHHHHHHHHHhhC-CCCceeeecceeecC-
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFSFEE- 392 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~- 392 (650)
..++|++.++||+|+||.||+|.. ..++.||||++..... .....+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346789999999999999999963 2356799999975432 2345688999999999 899999999988764
Q ss_pred CeeEEEEecCCCCChhHHHHhhhc--------------------------------------------------------
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAIK-------------------------------------------------------- 416 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 416 (650)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 457899999999999999974211
Q ss_pred ---cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccceeecCcc
Q 006317 417 ---RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493 (650)
Q Consensus 417 ---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 493 (650)
...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134888999999999999999999987 99999999999999999999999999986543322222223456778
Q ss_pred ccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHH
Q 006317 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCV 572 (650)
Q Consensus 494 y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~ 572 (650)
|+|||++.+..++.++|||||||++|||++ |+.||......+ ... .....+.. .......+ ..+.
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~----~~~~~~~~-----~~~~~~~~---~~l~ 307 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFC----QRLKDGTR-----MRAPENAT---PEIY 307 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHH----HHHhcCCC-----CCCCCCCC---HHHH
Confidence 999999999999999999999999999997 988886432211 111 11111111 11111122 3456
Q ss_pred HHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 573 HIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 573 ~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+|+.+||+.||++|||+.||+++|+.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHH
Confidence 78889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=350.33 Aligned_cols=252 Identities=29% Similarity=0.447 Sum_probs=207.0
Q ss_pred hccCCCcCCcccccCceeEEEee-ccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
....|....+||+|..|.||.++ ...++.||||++.......++-+.+|+.+|+..+|+|||+++..+..++++|+|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 34578888999999999999997 45688999999988776677778999999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
||++|+|.+.+. ...+++.++..|..+++.||+|||.++ |+|||||.+|||++.+|.+||+|||++..+....
T Consensus 351 ym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 351 YMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred ecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999999875 345999999999999999999999998 9999999999999999999999999998776554
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
. .....+||+.|||||++....|..|.||||||++++||+-|.+|+-.... +...+.....+. |.+
T Consensus 424 ~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lrAlyLIa~ng~------P~l 489 (550)
T KOG0578|consen 424 S--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNGT------PKL 489 (550)
T ss_pred C--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HHHHHHHhhcCC------CCc
Confidence 4 44567999999999999999999999999999999999999999864211 111111111111 111
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.. ...-...+.+++.+||+.|+++||++.|+|+-
T Consensus 490 k~-~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 KN-PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CC-ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11 11111233455668999999999999999853
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=378.41 Aligned_cols=258 Identities=31% Similarity=0.490 Sum_probs=205.7
Q ss_pred ccCCCcCCcccccCceeEEEeeccC--Cc----ceeEeecccc-CchhHHHHHHHHHHHhhCCCCceeeecceeecCCee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH--GQ----EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETER 395 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~--g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 395 (650)
..+....+.||+|.||.||.|...+ |. .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3456667899999999999998643 33 3899999876 455667899999999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHHhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeee
Q 006317 396 LLIYEFVPNSSVDKFIFDAIK----RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 471 (650)
++++|||++|+|..||++... ...|+..+.+.++.|||+|+.||++++ +|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999987421 456899999999999999999999987 9999999999999999999999999
Q ss_pred cccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCC
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEG 550 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 550 (650)
||+.+...+.......-.-..+|||||.+..+.|+.|+|||||||+|||++| |..|+......+ ....+. ..+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---v~~~~~---~gg 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---VLLDVL---EGG 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---HHHHHH---hCC
Confidence 9995443333333333334568999999999999999999999999999999 677765332221 111111 111
Q ss_pred CcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 551 TALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 551 ~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.+-.| ...++ ++.+|+..||+.+|++||++..|++.+..
T Consensus 922 ---RL~~P---~~CP~---~ly~lM~~CW~~~pe~RP~F~~i~~q~~~ 960 (1025)
T KOG1095|consen 922 ---RLDPP---SYCPE---KLYQLMLQCWKHDPEDRPSFRTIVEQDPA 960 (1025)
T ss_pred ---ccCCC---CCCCh---HHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence 11111 11333 34578889999999999999999998764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.27 Aligned_cols=264 Identities=26% Similarity=0.407 Sum_probs=211.3
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchh-HHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG-ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
.+...+.++||+|.||+|.+.....+..||||+++...... ..+|.+|+++|.+++|||||+++|+|..++..++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34567789999999999999999888999999998875554 47899999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
|++|+|..||..... ..+.-....+|+.||+.||+||.+.+ +|||||.++|+|++.++++||+|||++|-+...+.
T Consensus 617 mEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 999999999975421 22455667789999999999999887 99999999999999999999999999997766666
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHh--CCCCCCCCCCcccchhHHHHHHhccCCCcc-cccCc
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS--GQKNNSFRIGEEAEDLLTYAWKNWNEGTAL-NLIDP 558 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-~~id~ 558 (650)
.....+.+-+.+|||||.+..++++.++|||+|||.+||+++ ...|++....++ .++-.-.....+... -+..|
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCcceeccCC
Confidence 655666677899999999999999999999999999999876 456665322222 222222222222111 11111
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
. ..+ ..+.++++.||..+.++||+++++...|...
T Consensus 770 ~---~cp---~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 770 P---ACP---QGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred C---cCc---HHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1 122 3456889999999999999999999888653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=323.78 Aligned_cols=262 Identities=20% Similarity=0.321 Sum_probs=201.9
Q ss_pred cCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
+.|+...++|+|+||.|||.+.++ |+-||||++...... -.+-..+|+++|++++|||+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 457788899999999999999765 999999999765432 22346799999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
||+..-|++.-+ ....++.+.+.+++.|+++|+.|+|+++ +|||||||+||||+.++.+||||||+|+.+..
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-- 153 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-- 153 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence 999866665432 2345899999999999999999999998 99999999999999999999999999998763
Q ss_pred CCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHH--------HhccCCC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAW--------KNWNEGT 551 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~~ 551 (650)
.....+..+.|.+|.|||.+.+ .+|....|||++||++.||++|.+-|...++-+...++.... ..+....
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 2233455678999999999988 689999999999999999999998776443322222221111 1111111
Q ss_pred cc-cccCccC------CCCChHHHHHHHHHHhcccccCCCCCCCHHHHH
Q 006317 552 AL-NLIDPTL------RNGSSSEIMRCVHIGLLCVQENVANRPTMASVV 593 (650)
Q Consensus 552 ~~-~~id~~l------~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl 593 (650)
.. .+.-|.. +...+.-..-+++++-.||+.||.+|++-++++
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 11 1111111 111222233456788899999999999999998
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=313.84 Aligned_cols=274 Identities=26% Similarity=0.406 Sum_probs=213.1
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchh--HHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
.+|...++||+|.||.||+|+. +.|+.||||+++.....+ .....+|++.|+.++|+||+.+++++...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677789999999999999984 569999999998764332 3467899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
||+. +|+..+++ +...++..++..++.++++||+|||++. |+||||||.|+|++++|.+||+|||+++.+....
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9976 89999876 5667999999999999999999999998 9999999999999999999999999999887544
Q ss_pred CCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcc---c--
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL---N-- 554 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---~-- 554 (650)
..... .+-|.+|.|||.+.+ ..|+...|+||.|||+.||+-|.+-+. ++...+.+......+...... +
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp---G~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP---GDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC---CCchHHHHHHHHHHcCCCCcccCcccc
Confidence 33222 267899999999987 479999999999999999999986554 233334444433332211110 1
Q ss_pred -c--------c-CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCCCCCCCCCCc
Q 006317 555 -L--------I-DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSLPLPSQPA 610 (650)
Q Consensus 555 -~--------i-d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~~~~~p~~p~ 610 (650)
+ + .+.+..-.+......++++..++..||.+|.|+.|.+++=...+ .|.|+.|.
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~--~P~pt~~~ 294 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS--LPLPTPPS 294 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc--CCCCCChh
Confidence 1 1 11111112233344577888999999999999999998754433 45555443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=333.47 Aligned_cols=262 Identities=23% Similarity=0.340 Sum_probs=204.5
Q ss_pred ccCCCcCCcccccCceeEEEee-ccCCcceeEeeccccCchhH-HHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE-LEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
.+.|+..+.||.|..++||+|+ .+.++.||||++.-...... ..+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4678999999999999999998 45688999999987655444 678999999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
||.+||+.++++..... .+++..+..|++++++||.|||+++ .||||||+.||||+.+|.+||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999875443 4999999999999999999999998 9999999999999999999999999987544332
Q ss_pred CC-Cc-cceeecCccccChhcccc--CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 481 SQ-GD-TSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 481 ~~-~~-~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
.. .. ....+||+.|||||+++. ..|+.|+||||||+...||.+|..||....... .+....+.-..-.....+
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk---vLl~tLqn~pp~~~t~~~ 257 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK---VLLLTLQNDPPTLLTSGL 257 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH---HHHHHhcCCCCCcccccC
Confidence 21 11 256789999999999765 468999999999999999999999986322111 111111110000000011
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
+..- ....-..+.+++..||+.||++|||++++++
T Consensus 258 ~~d~---~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 258 DKDE---DKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ChHH---hhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1110 1111224556777899999999999999984
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=344.66 Aligned_cols=254 Identities=28% Similarity=0.448 Sum_probs=205.2
Q ss_pred ccccChhhHHhhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceee
Q 006317 311 SLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390 (650)
Q Consensus 311 ~~~~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 390 (650)
..++.|++|. .++-||.|..|.||+|++ .++.||||+++.-. ..+|+-|++|+||||+.+.|+|.
T Consensus 118 ~WeiPFe~Is-------ELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCt 182 (904)
T KOG4721|consen 118 LWEIPFEEIS-------ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCT 182 (904)
T ss_pred hccCCHHHhh-------hhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeec
Confidence 3456666654 458899999999999999 46899999986432 34788899999999999999999
Q ss_pred cCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeee
Q 006317 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF 470 (650)
Q Consensus 391 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 470 (650)
...-++||||||..|-|...|+ .+..++......|..+||.||.|||.+. |||||||+-||||..+..+||+||
T Consensus 183 qsPcyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDF 256 (904)
T KOG4721|consen 183 QSPCYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDF 256 (904)
T ss_pred CCceeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccc
Confidence 9999999999999999999997 4667899999999999999999999987 999999999999999999999999
Q ss_pred ecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC
Q 006317 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG 550 (650)
Q Consensus 471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 550 (650)
|-++..... .....+.||..|||||++...+.+.|.||||||||||||+||..|+..-+.. ...|.. ..
T Consensus 257 GTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss------AIIwGV--Gs 325 (904)
T KOG4721|consen 257 GTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS------AIIWGV--GS 325 (904)
T ss_pred cchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh------eeEEec--cC
Confidence 999865432 3445678999999999999999999999999999999999999987522111 011211 11
Q ss_pred CcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCCC
Q 006317 551 TALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLS 602 (650)
Q Consensus 551 ~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~~ 602 (650)
+.+.+ ......++.+.-+++ +||+..|..||++.+|+.-|+-....
T Consensus 326 NsL~L---pvPstcP~GfklL~K---qcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 326 NSLHL---PVPSTCPDGFKLLLK---QCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred Ccccc---cCcccCchHHHHHHH---HHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 12222 222335555554444 79999999999999999998754443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=340.31 Aligned_cols=254 Identities=26% Similarity=0.353 Sum_probs=207.4
Q ss_pred hhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchh---HHHHHHHHHHHhhC-CCCceeeecceeecCCee
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQG---ELEFKNEVLLVARL-QHRNLVRLLGFSFEETER 395 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 395 (650)
...++|..++.||+|.|++|++++.. .++++|||++.+.-.-. ..-+..|-..|.+| .||.|++|+-.|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34578999999999999999999854 58999999997763322 22366788889999 899999999999999999
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
|+|+||+++|+|.++|. +-+.|++.....++.+|+.||+|||+.+ ||||||||+|||||+||++||+|||-|+.
T Consensus 150 YFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999998 4578999999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCC---------Cc--cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHH
Q 006317 476 FEMDQSQ---------GD--TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAW 544 (650)
Q Consensus 476 ~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~ 544 (650)
+...... .. ...++||..|.+||++..+..+..+|+|+|||+||+|+.|++||.... +...+..+.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N---eyliFqkI~ 300 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN---EYLIFQKIQ 300 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc---HHHHHHHHH
Confidence 7643322 11 245899999999999999999999999999999999999999986321 111111111
Q ss_pred HhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHh
Q 006317 545 KNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVML 596 (650)
Q Consensus 545 ~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L 596 (650)
-++..+....++.+..++ ..-|..||.+|+|..+|-+-.
T Consensus 301 ----------~l~y~fp~~fp~~a~dLv---~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 301 ----------ALDYEFPEGFPEDARDLI---KKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ----------HhcccCCCCCCHHHHHHH---HHHHccCccccccHHHHhhCc
Confidence 123444444555555544 467899999999999998654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=339.36 Aligned_cols=263 Identities=25% Similarity=0.374 Sum_probs=199.9
Q ss_pred cCCCcCCcccccCceeEEEeeccC-----------------CcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeee
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-----------------GQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRL 385 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l 385 (650)
++|.+.++||+|+||.||++.+++ +..||+|.+..... ....++.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999997532 33699999876532 334578999999999999999999
Q ss_pred cceeecCCeeEEEEecCCCCChhHHHHhhh----------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEe
Q 006317 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAI----------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449 (650)
Q Consensus 386 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 449 (650)
++++.+.+..++||||+++|+|.+++.... ....++|..+++++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999986421 1134788999999999999999999987 999
Q ss_pred cCCCCCceEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCC--CC
Q 006317 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ--KN 527 (650)
Q Consensus 450 rDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~--~p 527 (650)
|||||+|||+++++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||+++. .|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999998654332222223345578899999999889999999999999999999854 44
Q ss_pred CCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 528 NSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 528 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
+..... ................. +........+ ..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 242 ~~~~~~---~~~~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTD---EQVIENAGEFFRDQGRQ--VYLFRPPPCP---QGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCH---HHHHHHHHHHhhhcccc--ccccCCCCCC---HHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 432211 12222221111111000 0000111122 34567888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=388.68 Aligned_cols=260 Identities=25% Similarity=0.485 Sum_probs=213.1
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
....|...+.||+|+||.||+|+. .++..||||++...... ..+|++.+++++|||||+++|++.+.+..++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 345678889999999999999986 46889999998654322 2346889999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++|+|.++++ .++|..+.+++.||++||+|||....++|+||||||+||+++.++.+++. ||........
T Consensus 764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 999999999985 38999999999999999999997656679999999999999999988875 6665432211
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
....||..|+|||++.+..++.++|||||||++|||+||+.|+....+ ....+..|.+...........+|+.+
T Consensus 836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccc
Confidence 123678999999999999999999999999999999999999854322 23455566655554445556667766
Q ss_pred CCC---ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 561 RNG---SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 561 ~~~---~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
... ..++..++.+++.+||+.+|++||||.||+++|+..
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 433 446677888999999999999999999999999864
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.08 Aligned_cols=259 Identities=28% Similarity=0.439 Sum_probs=203.2
Q ss_pred ccCCCcCCcccccCceeEEEeeccC--C---cceeEeecccc---CchhHHHHHHHHHHHhhCCCCceeeecceeecCCe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH--G---QEIAVKRLSKN---SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE 394 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~--g---~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 394 (650)
+++....++||+|.||.||+|++.. + ..||||..+.. ......+|.+|.++|++++|||||+++|++..+..
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 4455566999999999999998654 2 22899998752 34566789999999999999999999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.++|||+|.||+|+++|... ...++..++++++.+.|.||+|||+++ +|||||.++|+|++.++.+||+||||++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 99999999999999999852 336999999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHH-HHhccCCCc
Q 006317 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYA-WKNWNEGTA 552 (650)
Q Consensus 475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~-~~~~~~~~~ 552 (650)
.-.. .........-+.+|+|||.+..+.|+.++|||||||++||+++ |..|+.... ..+...++ ...++
T Consensus 311 ~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~---~~~v~~kI~~~~~r---- 381 (474)
T KOG0194|consen 311 AGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK---NYEVKAKIVKNGYR---- 381 (474)
T ss_pred CCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC---HHHHHHHHHhcCcc----
Confidence 5431 1111111134678999999999999999999999999999999 777775322 22222222 11111
Q ss_pred ccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCCCC
Q 006317 553 LNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSL 603 (650)
Q Consensus 553 ~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~~~ 603 (650)
.......+.++.. +...||..+|++||+|.++.+.|+......
T Consensus 382 -----~~~~~~~p~~~~~---~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 382 -----MPIPSKTPKELAK---VMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred -----CCCCCCCHHHHHH---HHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 1111234444444 445899999999999999999998654443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=339.86 Aligned_cols=266 Identities=23% Similarity=0.323 Sum_probs=205.8
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHH-HHHHHHHHHhhCC-CCceeeecceeecCC-eeEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQ-HRNLVRLLGFSFEET-ERLL 397 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~-~~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~l 397 (650)
..++|...++||.|.||.||+|+. ..|..||||++++.....++ .=.+|+..|++|+ |||||++..++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 346788899999999999999984 56889999999876444322 2468999999998 999999999999888 9999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
|||||+. +|.+++++ ++..+++..+..|+.||++||+|+|.+| +.||||||+|||+..+..+||+||||||...
T Consensus 88 VfE~Md~-NLYqLmK~--R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhhh-hHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 9999976 89998876 4778999999999999999999999998 9999999999999999999999999999765
Q ss_pred cCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHH-----HHhccCC-
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYA-----WKNWNEG- 550 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~-----~~~~~~~- 550 (650)
.. .-.+..+.|.+|.|||++.. +-|+.+.|+|++|||++|+.+-++-|....+-+....+-.+ +..|.++
T Consensus 162 Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 33 23445678999999998764 68899999999999999999998777533222111111111 1112221
Q ss_pred CcccccCccC---CCC-----ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHh
Q 006317 551 TALNLIDPTL---RNG-----SSSEIMRCVHIGLLCVQENVANRPTMASVVVML 596 (650)
Q Consensus 551 ~~~~~id~~l---~~~-----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L 596 (650)
.....+.-.+ ... .+....++++++..|+++||.+|||+.|.+++-
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 0111111111 111 122345677888899999999999999999774
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=350.78 Aligned_cols=259 Identities=27% Similarity=0.382 Sum_probs=200.7
Q ss_pred ccCCCcCCcccccCceeEEEeec------cCCcceeEeeccccC-chhHHHHHHHHHHHhhC-CCCceeeecceeecCCe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETE 394 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 394 (650)
.++|+..++||+|+||.||++++ ..+..||||+++... ......+.+|+.++..+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34789999999999999999963 235679999997543 23345688999999999 89999999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhc----------------------------------------------------------
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIK---------------------------------------------------------- 416 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 416 (650)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864211
Q ss_pred --------------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 417 --------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 417 --------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
...++|..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 125789999999999999999999987 999999999999999999999999999865433221
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
.......++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ....... ..+.. +...
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~----~~~~~-----~~~~ 339 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMI----KEGYR-----MLSP 339 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHH----HhCcc-----CCCC
Confidence 11222345668999999999999999999999999999998 77776432111 1111111 11110 0011
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
...+ .++.+|+.+||+.||++||++.||+++|+.
T Consensus 340 ~~~~---~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 340 ECAP---SEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1122 345678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=330.21 Aligned_cols=245 Identities=16% Similarity=0.292 Sum_probs=195.0
Q ss_pred CCcccccCceeEEEeeccCCcceeEeeccccCchh---HHHHHHHHHHHhhCCCCceeeecceeec----CCeeEEEEec
Q 006317 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG---ELEFKNEVLLVARLQHRNLVRLLGFSFE----ETERLLIYEF 401 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~ 401 (650)
...||+|++|.||+|++ +|+.||||+++...... ...+.+|+.+|.+++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36899999999999998 68999999997653332 3567899999999999999999999876 3467899999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++|+|.+++.. ...+++...++++.+++.||.|||+.. +++||||||+|||+++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999999973 457899999999999999999999852 27899999999999999999999999998654221
Q ss_pred CCccceeecCccccChhcccc--CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 482 QGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..++....... +. .+.
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~---~~~~~~~i~~~---~~-----~~~ 242 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT---TKEIYDLIINK---NN-----SLK 242 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhc---CC-----CCC
Confidence 12457889999999976 689999999999999999999999986322 12222221111 00 111
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+....+. .+.+++.+||+.||++|||+.||++.|+.
T Consensus 243 ~~~~~~~---~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 243 LPLDCPL---EIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred CCCcCcH---HHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1112233 34567779999999999999999999865
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=336.84 Aligned_cols=250 Identities=23% Similarity=0.375 Sum_probs=203.3
Q ss_pred hhccCCCcCCcccccCceeEEEeec-cCCcceeEeecccc----Cc-hhHHHHHHHHHHHhhCC-CCceeeecceeecCC
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN----SV-QGELEFKNEVLLVARLQ-HRNLVRLLGFSFEET 393 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 393 (650)
...++|...+.||+|.||+|++|.. .++..||+|++.+. .. .....+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999975 45899999987664 11 23445778999999999 999999999999999
Q ss_pred eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC-CCeEEeeeec
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGM 472 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGl 472 (650)
..++||||+.+|+|.+++.+ .+.+.+....+++.||+.|++|||+.+ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999974 577899999999999999999999998 9999999999999999 9999999999
Q ss_pred ccccccCCCCCccceeecCccccChhccccCC-CC-ccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH-FS-IKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG 550 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 550 (650)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.. ....+..... .+
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~---~~~~l~~ki~----~~ 238 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS---NVPNLYRKIR----KG 238 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc---cHHHHHHHHh----cC
Confidence 98774 1223455678999999999999977 86 8899999999999999999999741 1111111110 10
Q ss_pred CcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHH
Q 006317 551 TALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVV 593 (650)
Q Consensus 551 ~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl 593 (650)
. ..++.... ..++..++.+|++.||.+|+|+.+|+
T Consensus 239 ~------~~~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 E------FKIPSYLL--SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred C------ccCCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0 01111110 34556777899999999999999999
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=345.88 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=200.2
Q ss_pred ccCCCcCCcccccCceeEEEeecc------CCcceeEeeccccCc-hhHHHHHHHHHHHhhC-CCCceeeecceeecCCe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETE 394 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 394 (650)
.++|+..+.||+|+||.||+++.. ++..||||+++.... .....+.+|+.+++.+ +|+||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457889999999999999998732 245799999976533 2344688999999999 89999999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhc----------------------------------------------------------
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIK---------------------------------------------------------- 416 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 416 (650)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999864211
Q ss_pred ---------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccce
Q 006317 417 ---------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487 (650)
Q Consensus 417 ---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 487 (650)
...+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 124788999999999999999999987 99999999999999999999999999976543221111122
Q ss_pred eecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChH
Q 006317 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSS 566 (650)
Q Consensus 488 ~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~ 566 (650)
..++..|+|||++.+..++.++|||||||++|||++ |+.||....... ..... .... ..+......+
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~----~~~~-----~~~~~~~~~~- 341 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKM----VKRG-----YQMSRPDFAP- 341 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHH----HHcc-----cCccCCCCCC-
Confidence 335668999999998999999999999999999998 999886332111 11111 1110 0111111122
Q ss_pred HHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 567 EIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 567 ~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.++.+++.+||+.||++||++.+|+++|+.
T Consensus 342 --~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 342 --PEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred --HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 345567779999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.85 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=197.9
Q ss_pred CCCcCCcccccCceeEEEeec-cCCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
.|+..+.||+|+||.||++.. .+|+.||||.+..... .....+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999986 4689999999875432 233457889999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++|+|..++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999999888642 2346899999999999999999999987 9999999999999999999999999997653221
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
......||..|+|||++.+..++.++|||||||++|||++|+.||...........+. ....... ...
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~~~~------~~~ 224 (285)
T cd05631 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---RRVKEDQ------EEY 224 (285)
T ss_pred ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---HHhhccc------ccC
Confidence 1233568999999999999999999999999999999999999987433221111111 1110000 011
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCC-----HHHHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPT-----MASVVV 594 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~evl~ 594 (650)
...... .+.+++..||+.||++||+ ++++++
T Consensus 225 ~~~~s~---~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 225 SEKFSE---DAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CccCCH---HHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 112223 3456777999999999997 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=310.33 Aligned_cols=197 Identities=30% Similarity=0.423 Sum_probs=180.1
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|+..+.||.|+||.|.+++.+ +|..+|+|++++... +..++..+|..+|+.+.||+++++.+.+.+....+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 57888999999999999999965 477899999987643 34456789999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|.|..+|+ +.+.+++....-++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS-- 195 (355)
T ss_pred eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec--
Confidence 9999999999997 5678999999999999999999999988 9999999999999999999999999998654
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCC
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR 531 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~ 531 (650)
..+...+||+.|+|||++..+.+...+|+|+|||++|||+.|..||...
T Consensus 196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 3467789999999999999999999999999999999999999998643
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=330.74 Aligned_cols=245 Identities=26% Similarity=0.386 Sum_probs=204.0
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
...|...++||+|.||.||||... .++.||+|++.-...+ ...++++|+.++.+++++||.+++|.+..+..++++||
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 345777899999999999999864 4788999999766444 34578999999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
||.+|++.+.|. ....+++..+.-+++++..||.|||.++ .+|||||+.||||..+|.+||+|||++.......
T Consensus 92 y~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 92 YCGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HhcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999886 3445588888899999999999999998 9999999999999999999999999998766443
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc----
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI---- 556 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i---- 556 (650)
.. ...++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+ .+.+-+|
T Consensus 166 ~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------------mrvlflIpk~~ 227 (467)
T KOG0201|consen 166 KR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------------MRVLFLIPKSA 227 (467)
T ss_pred hc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------------ceEEEeccCCC
Confidence 32 3668999999999999988999999999999999999999999863222 2222222
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.|.+.+.....+. +++..||++||+.||++.++++
T Consensus 228 PP~L~~~~S~~~k---EFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 228 PPRLDGDFSPPFK---EFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCccccccCHHHH---HHHHHHhhcCcccCcCHHHHhh
Confidence 2334333333344 4555899999999999999984
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.25 Aligned_cols=247 Identities=27% Similarity=0.379 Sum_probs=203.4
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
++|...+.||+|.||.||||+-+ +.+.||+|.+.+... +..+.+.+|++++++++|||||.++.+|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46788899999999999999855 478899999977543 344568899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+.+ +|..+|. ..+.++++.+..++.+++.||.|||+.. |+|||+||.||||+..+.+|++|||+++.+..+
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~- 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN- 153 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence 9987 9999997 4577999999999999999999999987 999999999999999999999999999976542
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
......+.||+.|||||.+.++.|+..+|+||+||++|||++|++||... ++...+..... |+..
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~--------d~v~ 218 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILK--------DPVK 218 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhc--------CCCC
Confidence 23455678999999999999999999999999999999999999998521 22222222111 1111
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
. +......++.++-.-|++||..|-|..+++.-
T Consensus 219 ~--p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 P--PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred C--cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1 11223344556667899999999999999843
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=334.21 Aligned_cols=200 Identities=26% Similarity=0.382 Sum_probs=175.0
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
.++|+..+.||+|+||.||+++.. ++..+|+|.+..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367899999999999999999865 478899999876532 234568999999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999863 456899999999999999999999853 4999999999999999999999999998755322
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR 531 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~ 531 (650)
......||..|+|||++.+..++.++|||||||++|||++|+.|+...
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 223356899999999999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=336.66 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=200.9
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|++.+.||+|+||.||+++.. +++.||||+++.... .....+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999875 488999999976422 23446889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999986 3457899999999999999999999987 99999999999999999999999999975432
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+......+ ..... ..+.. ... .+.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~i-~~~~~--~~~--~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---TWENL-KYWKE--TLQ--RPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---HHHHH-Hhccc--ccc--CCC
Confidence 2234578999999999999999999999999999999999999986432221 11111 11110 000 011
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..........++.+++..||+.+|.+||++.++++.
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 110001112344567778999999999999999966
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=325.84 Aligned_cols=257 Identities=30% Similarity=0.471 Sum_probs=203.0
Q ss_pred cCCCcCCcccccCceeEEEeeccC------CcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 396 (650)
++|+..+.||+|+||.||+|.... ...|++|.+..... .....+.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998643 25699999875432 33456899999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHHhhhc-------------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC
Q 006317 397 LIYEFVPNSSVDKFIFDAIK-------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM 463 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~ 463 (650)
++|||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999975311 145889999999999999999999987 99999999999999999
Q ss_pred CeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHH
Q 006317 464 IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTY 542 (650)
Q Consensus 464 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~ 542 (650)
.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+...... +....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999986543322222333456889999999998899999999999999999998 98887532221 12111
Q ss_pred HHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 543 AWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 543 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+..+... ......+ .++.+|+.+||+.||.+||++.||++.|++
T Consensus 239 ----i~~~~~~-----~~~~~~~---~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 ----IRSRQLL-----PCPEDCP---ARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHcCCcC-----CCcccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111111 1111223 345567789999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=323.99 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=200.1
Q ss_pred ccCCCcCCcccccCceeEEEeecc----CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS----HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
.++|++.+.||+|+||.||+|.+. .+..||+|.++.... .....+.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888999999999999999753 356899999976532 334568899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999874 2357899999999999999999999887 9999999999999999999999999876432
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... +.+... ..+.
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~----~~~~----- 225 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAV----EDGF----- 225 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH----HCCC-----
Confidence 2111 11112335678999999999999999999999999999875 99888533211 111111 1110
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
........+ ..+.+++..||+.+|++||++.+|++.|+.
T Consensus 226 ~~~~~~~~~---~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 226 RLPAPRNCP---NLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred CCCCCCCCC---HHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 011111122 235567789999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=330.04 Aligned_cols=250 Identities=32% Similarity=0.551 Sum_probs=190.7
Q ss_pred cCCcccccCceeEEEeecc-----CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 328 TDNKLGQGGFGAVYKGRLS-----HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 328 ~~~~LG~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
..+.||.|.||.||+|.+. .+..|+||.++.... .....+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999876 256799999965433 3467899999999999999999999999988889999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++|+|.++|... ....+++..++.|+.||++||.|||+.+ ++|+||+++||||++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999863 2467999999999999999999999987 99999999999999999999999999986632222
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
........+...|+|||.+....++.++||||||+++|||++ |+.|+... ...+..... ..+.... .
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~~~~----~~~~~~~-----~ 226 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEIIEKL----KQGQRLP-----I 226 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHHHHH----HTTEETT-----S
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccc----cccccce-----e
Confidence 222233456778999999999999999999999999999999 67776422 112222221 1111111 1
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHh
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVML 596 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L 596 (650)
....+.. +.+++..||..+|++||++.+|++.|
T Consensus 227 ~~~~~~~---~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 PDNCPKD---IYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp BTTSBHH---HHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccchhHH---HHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1122333 44677799999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=322.74 Aligned_cols=252 Identities=27% Similarity=0.449 Sum_probs=200.8
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
++|+..+.||+|+||.||++.++++..+|+|.+..... ...++.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 45778899999999999999988888899999865432 34578899999999999999999999999999999999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
+|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 99999998642 346899999999999999999999887 999999999999999999999999998754322111
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .+.+........ ...+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~~~~~------~~~~~--- 224 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMISRGFR------LYRPK--- 224 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCCC------CCCCC---
Confidence 1112235668999999998889999999999999999999 8888753221 122222211110 00111
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
... ..+.+++.+||+.+|.+||++.+++++|.
T Consensus 225 ~~~---~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 LAS---MTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCC---HHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112 34567888999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=336.09 Aligned_cols=252 Identities=28% Similarity=0.441 Sum_probs=203.6
Q ss_pred CCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCC
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
+....++||-|.||.||.|+|+. ...||||.++.+..+ .++|..|..+|+.++|||+|+|+|+|..+...|||+|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 45566899999999999999976 567999999876554 4589999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
+|+|.+||++. .+..++-..++.++.||+.||+||..++ +|||||.++|+||.++..+||+||||++++..+.. .
T Consensus 347 yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY-T 421 (1157)
T KOG4278|consen 347 YGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY-T 421 (1157)
T ss_pred CccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce-e
Confidence 99999999875 4556888889999999999999999887 99999999999999999999999999998875432 2
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
.+....-...|.|||-+....++.|+|||+|||+||||.| |..|+..-+ +. .++..+..+-.++ -..
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lS-qVY~LLEkgyRM~-----~Pe 489 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LS-QVYGLLEKGYRMD-----GPE 489 (1157)
T ss_pred cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HH-HHHHHHhcccccc-----CCC
Confidence 2222334678999999999999999999999999999999 767765221 11 1222211111110 011
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
..+ .++.+|++.||+++|.+||++.|+.+.++
T Consensus 490 GCP---pkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 490 GCP---PKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred CCC---HHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 233 34566777999999999999999987664
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=326.41 Aligned_cols=257 Identities=22% Similarity=0.262 Sum_probs=202.6
Q ss_pred HhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch---hHHHHHHHHHHHhhCCCCceeeecceeecCCee
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFSFEETER 395 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 395 (650)
+...++|+.+..||+|+||.||+++.+ .|..+|+|++++.... ....+..|-.+|....+|.||+|+..|.+.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 345689999999999999999999865 4899999999887544 334578899999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
||||||++||++..+|. +...|++.....++.+++.|++-||+.| +|||||||+|+|||..|++||+||||+.-
T Consensus 217 YLiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999987 5678999999999999999999999998 99999999999999999999999999853
Q ss_pred cccC---------------C------CCC-----c-------------------cceeecCccccChhccccCCCCcccc
Q 006317 476 FEMD---------------Q------SQG-----D-------------------TSRIVGTFGYMAPEYVTRGHFSIKSD 510 (650)
Q Consensus 476 ~~~~---------------~------~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~s~~sD 510 (650)
+... . ... . ....+||+.|||||++.+..|+...|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 3210 0 000 0 01157999999999999999999999
Q ss_pred ccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCC--
Q 006317 511 VFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPT-- 588 (650)
Q Consensus 511 V~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-- 588 (650)
+||||||+||||.|-+||......+.-..+......|.-.. ......+ ..+++.+|+. ||++|--
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~---------~~~~s~e---A~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE---------EVDLSDE---AKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC---------cCcccHH---HHHHHHHHhc-CHHHhcCcc
Confidence 99999999999999999986554443222221111121110 0112233 3456667777 9999965
Q ss_pred -HHHHHHH
Q 006317 589 -MASVVVM 595 (650)
Q Consensus 589 -~~evl~~ 595 (650)
+.||-+.
T Consensus 438 G~~EIK~H 445 (550)
T KOG0605|consen 438 GAEEIKKH 445 (550)
T ss_pred cHHHHhcC
Confidence 6666544
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=324.59 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=203.7
Q ss_pred cCCCcCCcccccCceeEEEeeccC------CcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeecCCeeE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 396 (650)
++|.+.+.||+|+||.||+|+..+ +..||||+++..... ....+.+|++++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468888999999999999998643 467999999765444 4567999999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHHhhh-----------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCe
Q 006317 397 LIYEFVPNSSVDKFIFDAI-----------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 465 (650)
+||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999997531 1345889999999999999999999987 9999999999999999999
Q ss_pred EEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHH
Q 006317 466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAW 544 (650)
Q Consensus 466 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~ 544 (650)
||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.|+.....+ .......
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHH
Confidence 9999999975433222122223345778999999999999999999999999999999 99887533221 2222211
Q ss_pred HhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 545 KNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 545 ~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.+... ......+ ..+.+++..||+.||++||++.||+++|+.
T Consensus 239 ----~~~~~-----~~~~~~~---~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 ----QGRLL-----QRPRTCP---SEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----cCCcC-----CCCCCCC---HHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11110 0011122 345577889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.38 Aligned_cols=260 Identities=25% Similarity=0.422 Sum_probs=206.2
Q ss_pred cCCCcCCcccccCceeEEEeecc------CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
.+|...+.||+|+||.||+++.. ++..+++|.+..........+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777899999999999999742 345689999877666666679999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhh-------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC
Q 006317 398 IYEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI 464 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~ 464 (650)
||||+++++|.+++.... ....+++..+++++.||+.||+|||+.+ ++||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999997532 1245899999999999999999999987 999999999999999999
Q ss_pred eEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHH
Q 006317 465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYA 543 (650)
Q Consensus 465 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~ 543 (650)
+||+|||++................++..|+|||.+.+..++.++||||||+++|||+| |+.|+...... .....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIEC- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH-
Confidence 99999999975543222222233456788999999999999999999999999999999 88887532221 11111
Q ss_pred HHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCC
Q 006317 544 WKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSL 601 (650)
Q Consensus 544 ~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~ 601 (650)
...+.... .....+ ..+.+++.+||+.+|++||++.+|+++|+....
T Consensus 238 ---~~~~~~~~-----~~~~~~---~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ---ITQGRVLE-----RPRVCP---KEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ---HhCCCCCC-----CCccCC---HHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11111111 011112 345678889999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=340.67 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=202.6
Q ss_pred hccCCCcCCcccccCceeEEEeecc------CCcceeEeeccccCc-hhHHHHHHHHHHHhhCC-CCceeeecceeecCC
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQ-HRNLVRLLGFSFEET 393 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 393 (650)
..++|.+.++||+|+||.||+|+.. .+..||||++..... .....+.+|+.+++++. ||||+++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4568889999999999999999752 134699999975433 33456899999999996 999999999999999
Q ss_pred eeEEEEecCCCCChhHHHHhhhc---------------------------------------------------------
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIK--------------------------------------------------------- 416 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 416 (650)
..+|||||+++|+|.++|.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999999875311
Q ss_pred ------------------------------------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC
Q 006317 417 ------------------------------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 460 (650)
Q Consensus 417 ------------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~ 460 (650)
...+++..++.++.||++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 124788999999999999999999987 99999999999999
Q ss_pred CCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchh
Q 006317 461 ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDL 539 (650)
Q Consensus 461 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l 539 (650)
+++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+....... ..
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~ 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TF 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HH
Confidence 999999999999986543322222333456788999999998899999999999999999997 888875321111 11
Q ss_pred HHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 540 LTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 540 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+.....+.. .......+ ..+.+++.+||+.+|++||++.+|+++|+.
T Consensus 350 ----~~~~~~~~~-----~~~~~~~~---~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 350 ----YNKIKSGYR-----MAKPDHAT---QEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred ----HHHHhcCCC-----CCCCccCC---HHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 111111100 11111122 345678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=330.56 Aligned_cols=254 Identities=25% Similarity=0.420 Sum_probs=198.5
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCc----ceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQ----EIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
.+|+..+.||+|+||.||+|++. +++ .||+|.++... .....++.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46899999999999999999864 333 38999987543 33455788999999999999999999998765 5679
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999875 2346899999999999999999999987 9999999999999999999999999998765
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
............++..|++||++.+..++.++||||||+++|||++ |+.|+..... .++.... .....
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~---~~~~~~~----~~~~~---- 229 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSIL----EKGER---- 229 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH----hCCCC----
Confidence 4332222222334678999999999999999999999999999998 8888753211 1111111 11100
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
....... ...+.+++..||+.+|.+||++.+++..|..
T Consensus 230 -~~~~~~~---~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~ 267 (316)
T cd05108 230 -LPQPPIC---TIDVYMIMVKCWMIDADSRPKFRELIIEFSK 267 (316)
T ss_pred -CCCCCCC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 0001111 2345678889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=323.91 Aligned_cols=259 Identities=26% Similarity=0.443 Sum_probs=201.0
Q ss_pred hccCCCcCCcccccCceeEEEeecc------CCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE 394 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 394 (650)
.+++|+..+.||+|+||.||+|... .+..||||++.... .....++.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999998753 24579999986543 2344568899999999999999999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhc-------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEE
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIK-------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 467 (650)
.++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999865221 234688999999999999999999887 999999999999999999999
Q ss_pred eeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHh
Q 006317 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKN 546 (650)
Q Consensus 468 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 546 (650)
+|||+++...............++..|+|||++.++.++.++||||||+++|||++ |..|+..... ........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~~~~-- 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLRFVM-- 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH--
Confidence 99999875543222111222345778999999998899999999999999999999 6777653221 11111111
Q ss_pred ccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 547 WNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 547 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.... +......+ ..+.+++.+||+.+|++|||+.|++++|+.
T Consensus 236 --~~~~-----~~~~~~~~---~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 --EGGL-----LDKPDNCP---DMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred --cCCc-----CCCCCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1110 01111122 245678889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=321.70 Aligned_cols=255 Identities=29% Similarity=0.492 Sum_probs=202.0
Q ss_pred cCCCcCCcccccCceeEEEeeccC----CcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
++|+..+.||+|+||.||+|++.. ...||||.++.... ....++.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578899999999999999998743 34799999876533 3445788999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++++|.+++.. ....+++..+++++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999875 2347899999999999999999999987 99999999999999999999999999987652
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
...........++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ..........+..
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~-------- 227 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVEDGYRL-------- 227 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCCCC--------
Confidence 222112222345678999999999999999999999999999998 8888742211 1111111111000
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+. ....+ ..+.+++.+||+.+|++||++.||+++|+.
T Consensus 228 ~~-~~~~~---~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 228 PP-PMDCP---SALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred CC-CCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 00 11122 345678889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=319.72 Aligned_cols=255 Identities=28% Similarity=0.452 Sum_probs=204.3
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
.++|+..++||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++|+||+++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 357888999999999999999988888999999865432 3457899999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999998653 3456899999999999999999999887 999999999999999999999999999865432211
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
......++..|+|||++..+.++.++||||||+++|||+| |+.|+..... ..........+. ....
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~~---------~~~~ 226 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSALQRGYR---------MPRM 226 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCCC---------CCCC
Confidence 1122345678999999998899999999999999999999 8888753221 112221111110 0111
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
...+ ..+.+++.+|++.+|++||++++++++|+.
T Consensus 227 ~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 ENCP---DELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCC---HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122 245577889999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=334.25 Aligned_cols=243 Identities=24% Similarity=0.308 Sum_probs=198.3
Q ss_pred hccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCch---hHHHHHHHHHHHhhC-CCCceeeecceeecCCeeE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQ---GELEFKNEVLLVARL-QHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 396 (650)
.-++|...++||+|.||+|+++..+. ++.+|||.+++...- ..+..+.|.+++... +||.|++++.++...++.+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 34689999999999999999998754 778999999987543 334567787777766 5999999999999999999
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
+||||+.||++..+. ....+++..+.-++..|+.||.|||+++ ||+||||.+|||||.+|++||+||||++.-
T Consensus 446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999955443 4567999999999999999999999998 999999999999999999999999999843
Q ss_pred ccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
. .....+..++||+.|||||++.+..|+...|+|||||+||||+.|+.||..++.+ ++.+.... .
T Consensus 519 m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---e~FdsI~~----------d 583 (694)
T KOG0694|consen 519 M--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---EVFDSIVN----------D 583 (694)
T ss_pred C--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHhc----------C
Confidence 2 1234677899999999999999999999999999999999999999999744333 23222111 1
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCH
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTM 589 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~ 589 (650)
|+..+.....|. +.|+.+.+..||++|--+
T Consensus 584 ~~~yP~~ls~ea---~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 EVRYPRFLSKEA---IAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCcccHHH---HHHHHHHhccCcccccCC
Confidence 233333334443 455668899999999876
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.46 Aligned_cols=245 Identities=22% Similarity=0.281 Sum_probs=197.7
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|+..+.||+|+||.||+++.. +++.||+|++..... .....+.+|+.++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999865 588999999865422 23446889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~- 153 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD- 153 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC-
Confidence 99999999999863 457899999999999999999999987 99999999999999999999999999976532
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ......... .. ..
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~~~~~i~~----~~------~~ 216 (291)
T cd05612 154 ----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---FGIYEKILA----GK------LE 216 (291)
T ss_pred ----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh----CC------cC
Confidence 12235689999999999998999999999999999999999999863321 111111110 00 01
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCC-----HHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPT-----MASVVVM 595 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~evl~~ 595 (650)
+..... ..+.+++.+||+.||.+||+ ++|+++.
T Consensus 217 ~~~~~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 FPRHLD---LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCccCC---HHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111122 23456777999999999995 8887744
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=332.75 Aligned_cols=242 Identities=21% Similarity=0.246 Sum_probs=193.7
Q ss_pred CcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCC
Q 006317 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS 405 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 405 (650)
+.||+|+||.||+++.. +|+.||||++++... .....+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 588999999976432 22345778999999999999999999999999999999999999
Q ss_pred ChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCcc
Q 006317 406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485 (650)
Q Consensus 406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 485 (650)
+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~ 152 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence 9999886 3457899999999999999999999987 999999999999999999999999998743211 1223
Q ss_pred ceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCCh
Q 006317 486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSS 565 (650)
Q Consensus 486 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~ 565 (650)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+...... . +..+.....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~~~~---~-------~~~~p~~~~ 219 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILM---E-------EIRFPRTLS 219 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHHHHHc---C-------CCCCCCCCC
Confidence 346799999999999999999999999999999999999999853221 111111110 0 011112223
Q ss_pred HHHHHHHHHHhcccccCCCCCC-----CHHHHHHH
Q 006317 566 SEIMRCVHIGLLCVQENVANRP-----TMASVVVM 595 (650)
Q Consensus 566 ~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~~ 595 (650)
. ++.+++.+||+.||++|| ++.++++.
T Consensus 220 ~---~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 220 P---EAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred H---HHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 3 345677799999999999 79998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=322.84 Aligned_cols=256 Identities=28% Similarity=0.453 Sum_probs=208.2
Q ss_pred hccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
...+|+..++||.|+||.||+|+..+++.+++|.+.........++.+|+.+++.++||||+++++++......++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45678899999999999999999888899999999877665566789999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++... ....+++..++.++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999753 3456899999999999999999999987 99999999999999999999999999976543211
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
. .....++..|++||.+.+..++.++||||||+++|+|++ |+.|+.... ..+.+........ +..
T Consensus 160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~~---------~~~ 225 (261)
T cd05148 160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQITAGYR---------MPC 225 (261)
T ss_pred c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHHhCCc---------CCC
Confidence 1 112345678999999998899999999999999999999 788875332 1122222211100 111
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
....+ ..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 226 ~~~~~---~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 226 PAKCP---QEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11122 345578889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=319.52 Aligned_cols=267 Identities=25% Similarity=0.382 Sum_probs=201.0
Q ss_pred HHhhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHh--hCCCCceeeecceeecCC---
Q 006317 319 IRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVA--RLQHRNLVRLLGFSFEET--- 393 (650)
Q Consensus 319 ~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~~--- 393 (650)
.+.........+.||+|.||+||+|+| .|+.||||++.... +..+.+|.++.. .|+|+||+.+++.-..+.
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 344557788889999999999999999 58999999996543 334566666654 469999999998765543
Q ss_pred -eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhh-----cCCCcEEecCCCCCceEeCCCCCeEE
Q 006317 394 -ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE-----DSRLRIIHRDLKASNILLDADMIPKI 467 (650)
Q Consensus 394 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~iiHrDlk~~NILl~~~~~~kl 467 (650)
+++||++|.++|||.|||. +..++....++++..+|.||++||. +++|.|.|||||+.||||..++.+.|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 6899999999999999995 4689999999999999999999995 47899999999999999999999999
Q ss_pred eeeecccccccCCC--CCccceeecCccccChhccccC----CC--CccccccchhHHHHHHHhCC----------CCCC
Q 006317 468 SDFGMARLFEMDQS--QGDTSRIVGTFGYMAPEYVTRG----HF--SIKSDVFSFGVLVLEIISGQ----------KNNS 529 (650)
Q Consensus 468 ~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~----~~--s~~sDV~S~Gvll~elltG~----------~p~~ 529 (650)
+|+|||.....+.. ....+..+||.+|||||++... .+ -..+||||||+|+||+...- .|+.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 99999987654422 2235567899999999998653 22 24699999999999987532 2322
Q ss_pred CCCCcccchhHHHHHHhccCCCcccccCccCCCC--ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 530 FRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNG--SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 530 ~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~--~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
...+.+. + ...+.+-.=.+.+.|.+++. +.+.+..+.+|+..||..||.-|-|+-.|-+.|.+.
T Consensus 438 d~Vp~DP-s-----~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 438 DVVPSDP-S-----FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred cCCCCCC-C-----HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 1000000 0 00011111112234444433 456677788999999999999999998888777653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=332.34 Aligned_cols=247 Identities=26% Similarity=0.365 Sum_probs=205.1
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCch---hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
+-|+.++.||.|+-|.|-+|++ .+|+.+|||++.+.... ....+.+|+.+|+.+.|||++++++++.+..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4578889999999999999986 46999999999776321 2235789999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|-|.++|. .++.+++.+..+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||+|.+-..+
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999987 6788999999999999999999999987 999999999999999999999999999764322
Q ss_pred CCCCccceeecCccccChhccccCCCC-ccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFS-IKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
.-....+|.+.|.+||++++.+|. .++||||.|||||-|+||+.||+ ++....++..+.+.. .+
T Consensus 166 ---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV~~G~-----f~---- 230 (786)
T KOG0588|consen 166 ---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKVQRGV-----FE---- 230 (786)
T ss_pred ---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHHHcCc-----cc----
Confidence 233456899999999999999885 89999999999999999999997 333333443333221 11
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
++.....+ +.+|+.+|+..||++|-|+.||++-
T Consensus 231 -MPs~Is~e---aQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 231 -MPSNISSE---AQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -CCCcCCHH---HHHHHHHHhccCccccccHHHHhhC
Confidence 11223333 4456678999999999999999976
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=322.24 Aligned_cols=264 Identities=19% Similarity=0.248 Sum_probs=198.4
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
++|++.+.||+|+||.||+++.+ +++.||||++..... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999975 478899999875422 233467889999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|++++++..+.. ....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999987765543 2456899999999999999999999887 9999999999999999999999999998654322
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHH--------HHhc-cCCC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYA--------WKNW-NEGT 551 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~--------~~~~-~~~~ 551 (650)
........|+..|+|||++.+..++.++|||||||++|||++|+.||......+........ ++.+ ....
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 -NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred -cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 11223457899999999999989999999999999999999999988643221111000000 0000 0000
Q ss_pred cccccCccCCCCC-------hHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 552 ALNLIDPTLRNGS-------SSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 552 ~~~~id~~l~~~~-------~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
......+...... ......+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000001110000 001134667888999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=329.65 Aligned_cols=200 Identities=25% Similarity=0.381 Sum_probs=174.3
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
.++|+..++||+|+||.||+++.. ++..+|+|++..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999875 477899998876432 234568899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++|+|.+++.. ...+++.....++.+++.||.|||+.+ +++||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999863 456899999999999999999999753 3999999999999999999999999998755322
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR 531 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~ 531 (650)
......|+..|+|||++.+..++.++|||||||++|||++|+.|+...
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 122346899999999999889999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=333.76 Aligned_cols=245 Identities=24% Similarity=0.295 Sum_probs=197.7
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|.+.+.||+|+||.||+++.. +++.||||++..... .....+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999875 478999999875422 23346889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999873 456899999999999999999999987 999999999999999999999999999865321
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...... ...+. ..
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~----i~~~~------~~ 233 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---FRIYEK----ILAGR------LK 233 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---HHHHHH----HhcCC------cC
Confidence 2235789999999999999999999999999999999999999853211 111111 11111 00
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCC-----HHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPT-----MASVVVM 595 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~evl~~ 595 (650)
+...... ++.+++..||+.||++||+ +.+++..
T Consensus 234 ~p~~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 FPNWFDG---RARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCCCH---HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111222 3456777999999999997 6777744
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=319.73 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=202.9
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
.++|+..+.||+|++|.||+|...+++.||+|.++.... ...++.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 456888999999999999999987788899999876442 3457889999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 999999998753 2346899999999999999999999987 999999999999999999999999999876522111
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
.......+..|+|||++.+..++.++||||||+++|||++ |+.|+.... ...+...... .. .....
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~----~~-----~~~~~ 226 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT---NAEVLQQVDQ----GY-----RMPCP 226 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHc----CC-----CCCCC
Confidence 1111223457999999998899999999999999999999 888775221 1111111111 10 00011
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
... ...+.+++.+|++.+|.+||++.++++.|+.
T Consensus 227 ~~~---~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 PGC---PKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CcC---CHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 111 2345678889999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=321.48 Aligned_cols=257 Identities=30% Similarity=0.442 Sum_probs=200.4
Q ss_pred cCCCcCCcccccCceeEEEeec-----cCCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
++|++.+.||+|+||.||+|.. ..+..|++|.+.... ......+.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577889999999999999974 245789999997543 3334578899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhh--------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC
Q 006317 398 IYEFVPNSSVDKFIFDAI--------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM 463 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~ 463 (650)
||||+++++|.+++.... ....+++...+.++.||+.||+|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999986321 1235889999999999999999999987 99999999999999999
Q ss_pred CeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHH
Q 006317 464 IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTY 542 (650)
Q Consensus 464 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~ 542 (650)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+..... ......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 999999999986543322222233445778999999998899999999999999999999 8777642211 111111
Q ss_pred HHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 543 AWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 543 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
... .... ......+. ++.+++.+||+.+|++||++.+|+++|..
T Consensus 239 ~~~----~~~~-----~~~~~~~~---~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRK----RQLL-----PCSEDCPP---RMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHc----CCcC-----CCCCCCCH---HHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111 1100 11111223 45567779999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=328.75 Aligned_cols=242 Identities=21% Similarity=0.259 Sum_probs=190.7
Q ss_pred ccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCCCh
Q 006317 332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSV 407 (650)
Q Consensus 332 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 407 (650)
||+|+||.||+++.. +++.||+|++.... ......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999865 47889999986532 23344678899999999999999999999999999999999999999
Q ss_pred hHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccce
Q 006317 408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487 (650)
Q Consensus 408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 487 (650)
.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 999863 456899999999999999999999987 9999999999999999999999999997543221 22334
Q ss_pred eecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHH
Q 006317 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSE 567 (650)
Q Consensus 488 ~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~ 567 (650)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...... ...... ..+......
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~---~~~~~~---~~~~~~-------~~~~~~~~~- 218 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN---VNEMYR---KILQEP-------LRFPDGFDR- 218 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC---HHHHHH---HHHcCC-------CCCCCcCCH-
Confidence 679999999999999999999999999999999999999986321 111111 111110 111112223
Q ss_pred HHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 568 IMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 568 ~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
.+.+++..||+.||++||++.++.+.|.
T Consensus 219 --~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 219 --DAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred --HHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 3456777999999999986544444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=324.47 Aligned_cols=258 Identities=25% Similarity=0.415 Sum_probs=203.4
Q ss_pred cCCCcCCcccccCceeEEEeecc------CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888899999999999999742 245689999877655556679999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhh----------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEE
Q 006317 398 IYEFVPNSSVDKFIFDAI----------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 467 (650)
||||+++++|.+++.... ....+++..++.++.||+.+|+|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999987421 1235899999999999999999999987 999999999999999999999
Q ss_pred eeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHh
Q 006317 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKN 546 (650)
Q Consensus 468 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 546 (650)
+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .+......
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~~~i~-- 236 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECIT-- 236 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH--
Confidence 99999976543222122223345778999999998899999999999999999999 8887753221 11111111
Q ss_pred ccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 547 WNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 547 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
.+... ......+ ..+.+++.+||+.||.+|||+.||++.|+..
T Consensus 237 --~~~~~-----~~~~~~~---~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 237 --QGRVL-----QRPRTCP---KEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred --cCCcC-----CCCCCCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11110 0111122 3466788899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=347.29 Aligned_cols=252 Identities=21% Similarity=0.272 Sum_probs=201.4
Q ss_pred CCCcCCcccccCceeEEEeecc-C-CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-H-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
.|...+.||+|+||.||++... + ++.||+|.+..........+.+|+.+++.++||||+++++++..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888899999999999999743 3 5678899876555455556788999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 403 PNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 403 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
++|+|.++|.+.. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 9999999987532 3456899999999999999999999987 99999999999999999999999999987653332
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ..+...... +. .++ +.
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~~~~~~~~----~~----~~~-~~ 292 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---REIMQQVLY----GK----YDP-FP 292 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh----CC----CCC-CC
Confidence 2233456799999999999999999999999999999999999999853221 111111111 00 001 11
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.... ..+.+++..||+.+|++||++.+++.
T Consensus 293 ~~~s---~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 CPVS---SGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ccCC---HHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1122 24556777999999999999999874
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=318.65 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=200.1
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
++|...+.||+|+||.||+++..++..+|+|.+..... ...++.+|+.++.+++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 45778899999999999999987777899999875433 34578999999999999999999999999889999999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
+|+|.+++... ...+++..+++++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||+++....... .
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T 156 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence 99999998642 336899999999999999999999987 99999999999999999999999999876543221 1
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
......++..|++||.+.+..++.++||||||+++|||++ |+.|+...... +...... .... +....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~-----~~~~~ 224 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVEKVS----QGLR-----LYRPH 224 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHh----cCCC-----CCCCC
Confidence 1112235678999999998889999999999999999999 88887532211 1111111 1100 00011
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
.. ...+.+++.+||+.+|.+||++.+|++.|+
T Consensus 225 ~~---~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 LA---SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CC---CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11 245667888999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=331.71 Aligned_cols=259 Identities=28% Similarity=0.390 Sum_probs=200.6
Q ss_pred ccCCCcCCcccccCceeEEEeecc------CCcceeEeeccccCc-hhHHHHHHHHHHHhhC-CCCceeeecceeec-CC
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFSFE-ET 393 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~-~~ 393 (650)
.++|++.+.||+|+||.||+|+.. .++.||+|+++.... .....+.+|+.++.++ +|+||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457899999999999999999642 246899999875432 2334678899999999 89999999998865 45
Q ss_pred eeEEEEecCCCCChhHHHHhhhc---------------------------------------------------------
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIK--------------------------------------------------------- 416 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 416 (650)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999999864211
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccceeecCcccc
Q 006317 417 -RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495 (650)
Q Consensus 417 -~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 495 (650)
...++|..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 136899999999999999999999887 9999999999999999999999999998664333222233345677899
Q ss_pred ChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHH
Q 006317 496 APEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHI 574 (650)
Q Consensus 496 aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l 574 (650)
|||++.+..++.++|||||||++|||++ |+.|+......+ . ........... ..... ...++.++
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~---~~~~~~~~~~~-----~~~~~---~~~~~~~l 308 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---E---FCRRLKEGTRM-----RAPEY---ATPEIYSI 308 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---H---HHHHHhccCCC-----CCCcc---CCHHHHHH
Confidence 9999999999999999999999999998 988875322111 1 11111111110 11111 12356678
Q ss_pred HhcccccCCCCCCCHHHHHHHhcC
Q 006317 575 GLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 575 ~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+.+||+.+|++||++.||+++|+.
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHH
Confidence 889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=328.10 Aligned_cols=242 Identities=22% Similarity=0.254 Sum_probs=192.3
Q ss_pred CcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCC
Q 006317 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS 405 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 405 (650)
+.||+|+||.||+++.. +|+.||+|++..... .....+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 588999999976422 23345778999999999999999999999999999999999999
Q ss_pred ChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCcc
Q 006317 406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485 (650)
Q Consensus 406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 485 (650)
+|..++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 9998886 3457899999999999999999999987 9999999999999999999999999987532211 122
Q ss_pred ceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCCh
Q 006317 486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSS 565 (650)
Q Consensus 486 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~ 565 (650)
....||..|+|||++.+..++.++|||||||++|||++|+.|+.....+ ....... .. +..+.....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~~~---~~-------~~~~p~~~~ 219 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELIL---ME-------EIRFPRTLS 219 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHh---cC-------CCCCCCCCC
Confidence 3457899999999999999999999999999999999999998632211 1111111 00 011112223
Q ss_pred HHHHHHHHHHhcccccCCCCCC-----CHHHHHHH
Q 006317 566 SEIMRCVHIGLLCVQENVANRP-----TMASVVVM 595 (650)
Q Consensus 566 ~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~~ 595 (650)
.+ +.+++.+||+.||++|| ++.++++.
T Consensus 220 ~~---~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 220 PE---AKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HH---HHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 33 44667789999999998 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=321.12 Aligned_cols=263 Identities=24% Similarity=0.357 Sum_probs=198.6
Q ss_pred cCCCcCCcccccCceeEEEeeccC---------------CcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecc
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH---------------GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLG 387 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~---------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g 387 (650)
++|++.++||+|+||.||+++... ...||+|.++... ......+.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578899999999999999987532 1248999987653 233456899999999999999999999
Q ss_pred eeecCCeeEEEEecCCCCChhHHHHhhhc---------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceE
Q 006317 388 FSFEETERLLIYEFVPNSSVDKFIFDAIK---------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 458 (650)
Q Consensus 388 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 458 (650)
++......++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999864211 124789999999999999999999987 999999999999
Q ss_pred eCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhC--CCCCCCCCCccc
Q 006317 459 LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG--QKNNSFRIGEEA 536 (650)
Q Consensus 459 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG--~~p~~~~~~~~~ 536 (650)
+++++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||+++ ..|+.....+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-- 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-- 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence 999999999999999765432222222233457789999999989999999999999999999995 4454422211
Q ss_pred chhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 537 EDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 537 ~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
..+......+......... ...... ...+.+++.+||+.+|++||++.+|+++|.
T Consensus 240 -~~~~~~~~~~~~~~~~~~~--~~~~~~---~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 -QVIENTGEFFRNQGRQIYL--SQTPLC---PSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred -HHHHHHHHhhhhccccccC--CCCCCC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111111111000000 001111 235668888999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=316.08 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=193.3
Q ss_pred CcccccCceeEEEeecc-CCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCCCh
Q 006317 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSV 407 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 407 (650)
+.||+|+||.||+++.. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999864 68899999886543 33445789999999999999999999999999999999999999999
Q ss_pred hHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccce
Q 006317 408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487 (650)
Q Consensus 408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 487 (650)
.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999864 3346899999999999999999999887 99999999999999999999999999875432111111111
Q ss_pred eecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChH
Q 006317 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSS 566 (650)
Q Consensus 488 ~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~ 566 (650)
..++..|+|||.+.++.++.++||||||+++|||++ |..|+...... ........ . .........+
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~~~~~----~-----~~~~~~~~~~- 222 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTREAIEQ----G-----VRLPCPELCP- 222 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHHHHHc----C-----CCCCCcccCC-
Confidence 123457999999999999999999999999999998 77776532211 11111111 0 0011111122
Q ss_pred HHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 567 EIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 567 ~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
..+.+++.+|++.+|++|||+.+|+++|+
T Consensus 223 --~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 223 --DAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred --HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 34567788999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.80 Aligned_cols=254 Identities=29% Similarity=0.406 Sum_probs=197.1
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCc----ceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQ----EIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
++|+..+.||+|+||.||+|++. +++ .+++|.+..... ....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46788899999999999999864 344 478888754432 233467888889999999999999998754 55789
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
++||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999974 3457899999999999999999999987 9999999999999999999999999998664
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
............++..|++||.+.++.++.++||||||+++|||++ |+.|+...... ...... ..+... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~~----~~~~~~--~ 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EVPDLL----EKGERL--A 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH----HCCCcC--C
Confidence 3332222334557788999999998999999999999999999998 88887532211 111111 111100 0
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.+ .... ..+..++.+||+.+|++|||+.|+++.|..
T Consensus 232 ~~---~~~~---~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 232 QP---QICT---IDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred CC---CCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 11 1112 234567779999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=313.27 Aligned_cols=247 Identities=22% Similarity=0.396 Sum_probs=206.7
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHH---HHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGEL---EFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~---~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
..+|++.+.||+|.||+|-+++. ..|+.||||.+++...+.+. .+.+|+++|..|+||||+.++.+|+..+...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35788889999999999999985 56999999999888666554 477999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||..+|.|.+|+. .++.|++.+...++.||..|+.|+|.+. ++|||||.+|||||.++++||+||||+.++..
T Consensus 132 MEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999998 5678999999999999999999999887 99999999999999999999999999987753
Q ss_pred CCCCCccceeecCccccChhccccCCC-CccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
. .....++|++-|.+||++.+.+| .+..|-|||||+||-|+.|.-||+.. +...++... ..+...+
T Consensus 206 ~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~---Dhk~lvrQI----s~GaYrE--- 272 (668)
T KOG0611|consen 206 K---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR---DHKRLVRQI----SRGAYRE--- 272 (668)
T ss_pred c---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc---hHHHHHHHh----hcccccC---
Confidence 3 33456899999999999999888 48999999999999999999998632 222233222 1222111
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
...+.+. .-|+.|||..||++|.|+.+|..-
T Consensus 273 ----P~~PSdA---~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 273 ----PETPSDA---SGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ----CCCCchH---HHHHHHHHhcCcccchhHHHHhhh
Confidence 1122222 246679999999999999999865
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.93 Aligned_cols=192 Identities=21% Similarity=0.276 Sum_probs=166.9
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
.+|+..++||+|+||.||+++.. .++.||+|.... ..+.+|+.++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 57999999999999999999864 578899997542 24678999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
. ++|..++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..... ..
T Consensus 166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~~ 237 (391)
T PHA03212 166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NA 237 (391)
T ss_pred C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc-cc
Confidence 5 688888763 456899999999999999999999987 999999999999999999999999999753321 11
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~ 529 (650)
.......||+.|+|||++.+..++.++|||||||++|||++|+.|+.
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 22334579999999999999999999999999999999999998764
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=322.88 Aligned_cols=263 Identities=21% Similarity=0.317 Sum_probs=196.9
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
++|...++||+|+||.||+++.. +++.||+|+++.... .....+.+|+.++++++||||+++++++..+...++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999865 578999999875432 2334678999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 975 89888764 2345789999999999999999999987 9999999999999999999999999997543221
Q ss_pred CCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHH--------HHHhccC-CC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTY--------AWKNWNE-GT 551 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~-~~ 551 (650)
.......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....... .|..... ..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 12233467999999998875 5689999999999999999999999864332221111110 0111100 00
Q ss_pred cccccCccCCCCC-----hHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 552 ALNLIDPTLRNGS-----SSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 552 ~~~~id~~l~~~~-----~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
......+...... .....++++++.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0111111111000 011134567888999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=347.10 Aligned_cols=262 Identities=22% Similarity=0.314 Sum_probs=205.1
Q ss_pred hhhHHhhccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecC
Q 006317 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE 392 (650)
Q Consensus 316 ~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 392 (650)
..+.+...++|.+.++||+|+||+||+++. .+|+.||||++.... ......+.+|+..+..++|+|++++...+...
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 344555668999999999999999999985 468999999986543 23345688999999999999999998876543
Q ss_pred C--------eeEEEEecCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC
Q 006317 393 T--------ERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM 463 (650)
Q Consensus 393 ~--------~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~ 463 (650)
. ..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+||||+.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNG 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCC
Confidence 2 3679999999999999997532 2356899999999999999999999987 99999999999999999
Q ss_pred CeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHH
Q 006317 464 IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYA 543 (650)
Q Consensus 464 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~ 543 (650)
.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+...
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---~~~~~~-- 255 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---MEEVMH-- 255 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHH--
Confidence 999999999987654333333445679999999999999999999999999999999999999986322 111111
Q ss_pred HHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 544 WKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 544 ~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
... .+. .++ +....+. ++.+++..||+.||.+||++.+++..
T Consensus 256 -~~~-~~~----~~~-~~~~~~~---~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 -KTL-AGR----YDP-LPPSISP---EMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -HHh-cCC----CCC-CCCCCCH---HHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 010 111 1122223 45567779999999999999999864
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=315.98 Aligned_cols=252 Identities=26% Similarity=0.414 Sum_probs=199.1
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
.+|++.+.||+|+||.||++.++++..+|+|++..... ....+.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35778899999999999999987777899999865432 34468889999999999999999999999999999999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
+++|.+++... ...+++..+++++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++....... .
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~ 156 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-T 156 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-c
Confidence 99999998742 346899999999999999999999987 99999999999999999999999999876532211 1
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... +...... .. .......
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~----~~-----~~~~~~~ 224 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVESVS----AG-----YRLYRPK 224 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHHHHH----cC-----CcCCCCC
Confidence 1111223457999999999999999999999999999999 78777532211 1111111 11 0111111
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
..+ .++.+++.+||+.+|++|||+.||+++|.
T Consensus 225 ~~~---~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 225 LAP---TEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCC---HHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 122 34667888999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=328.52 Aligned_cols=242 Identities=22% Similarity=0.250 Sum_probs=193.3
Q ss_pred CcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCC
Q 006317 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS 405 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 405 (650)
+.||+|+||.||+++.. +++.||||++.+.. ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999854 58899999997642 223346788999999999999999999999999999999999999
Q ss_pred ChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCcc
Q 006317 406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485 (650)
Q Consensus 406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 485 (650)
+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~ 152 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATM 152 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccc
Confidence 9998886 3457999999999999999999999987 999999999999999999999999998753221 1223
Q ss_pred ceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCCh
Q 006317 486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSS 565 (650)
Q Consensus 486 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~ 565 (650)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... ... +..+.....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~~~---~~~-------~~~~p~~~~ 219 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELI---LME-------DIKFPRTLS 219 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHHHh---ccC-------CccCCCCCC
Confidence 3457999999999999999999999999999999999999998632211 111111 100 111122223
Q ss_pred HHHHHHHHHHhcccccCCCCCC-----CHHHHHHH
Q 006317 566 SEIMRCVHIGLLCVQENVANRP-----TMASVVVM 595 (650)
Q Consensus 566 ~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~~ 595 (650)
. ++.+++.+||+.||++|| ++.|+++.
T Consensus 220 ~---~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 220 A---DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred H---HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 3 345667799999999997 89998854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=317.49 Aligned_cols=254 Identities=28% Similarity=0.436 Sum_probs=200.9
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
.+|...++||+|+||.||+|... .++.||+|++.... ....++.+|+.++++++||||+++++++..+...++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35777899999999999999865 47889999987543 33457889999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~- 159 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 159 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee-
Confidence 999999998643 2356899999999999999999999887 99999999999999999999999999986543221
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
.......++..|+|||.+.+..++.++||||||+++|||++ |..|+..... .+.... .... ..+...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~----~~~~-----~~~~~~ 227 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYEL----LEKG-----YRMERP 227 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----HHCC-----CCCCCC
Confidence 11112234568999999999999999999999999999999 8888753221 111111 1111 011111
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
...+ ..+.+++.+||+.+|++||++.+++++|+.
T Consensus 228 ~~~~---~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 228 EGCP---PKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CCCC---HHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 1222 345567779999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=317.70 Aligned_cols=264 Identities=26% Similarity=0.390 Sum_probs=203.0
Q ss_pred ccCCCcCCcccccCceeEEEeeccC-----------------CcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH-----------------GQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVR 384 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~ 384 (650)
.++|++.+.||+|+||.||++...+ +..||+|.+..... ....++.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578899999999999999987543 24589999876533 34557889999999999999999
Q ss_pred ecceeecCCeeEEEEecCCCCChhHHHHhhh--------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCc
Q 006317 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAI--------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 456 (650)
Q Consensus 385 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~N 456 (650)
+++++..+...+++|||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999997532 1126899999999999999999999887 9999999999
Q ss_pred eEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh--CCCCCCCCCCc
Q 006317 457 ILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS--GQKNNSFRIGE 534 (650)
Q Consensus 457 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt--G~~p~~~~~~~ 534 (650)
|++++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999976543322222334456788999999998899999999999999999999 455553211
Q ss_pred ccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 535 EAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 535 ~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
..+.+......+........... ....+ .++.+++.+||+.+|++|||+.||++.|+
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~--~~~~~---~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 -DQQVIENAGHFFRDDGRQIYLPR--PPNCP---KDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred -hHHHHHHHHhccccccccccCCC--ccCCC---HHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 12222222222111111111100 01112 35677888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=330.04 Aligned_cols=261 Identities=21% Similarity=0.297 Sum_probs=193.7
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeecccc--CchhHHHHHHHHHHHhhCCCCceeeecceeecC-----CeeE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-----TERL 396 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~ 396 (650)
+|+..++||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999854 5889999998643 223344688999999999999999999988643 2479
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
+||||+. ++|.+++. ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 68888876 3456999999999999999999999987 999999999999999999999999999854
Q ss_pred ccCCC-CCccceeecCccccChhcccc--CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHH--------
Q 006317 477 EMDQS-QGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWK-------- 545 (650)
Q Consensus 477 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~-------- 545 (650)
..... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.....
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~ 230 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPSPE 230 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCHH
Confidence 32221 112234578999999999876 678999999999999999999999986432111 1111100
Q ss_pred ---hccCCCcccc---cCccCCCC----ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 546 ---NWNEGTALNL---IDPTLRNG----SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 546 ---~~~~~~~~~~---id~~l~~~----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+......+. +.+..... .+.....+.+++..||+.||++|||++|+++.
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000 00000000 00111345678889999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=320.91 Aligned_cols=262 Identities=25% Similarity=0.438 Sum_probs=198.3
Q ss_pred cCCCcCCcccccCceeEEEeec-----cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeec--CCeeE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE--ETERL 396 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 396 (650)
++|++.+.||+|+||.||++.. .++..||+|++..........+.+|+.++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688889999999999999974 2477899999987665566678999999999999999999998754 34678
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
+||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999864 2356899999999999999999999987 999999999999999999999999999866
Q ss_pred ccCCCCC-ccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCc---
Q 006317 477 EMDQSQG-DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA--- 552 (650)
Q Consensus 477 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--- 552 (650)
....... ......++..|+|||++.+..++.++||||||+++|||++|..++...... . .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~----~~~~~~~~~~~~ 230 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----F----MRMMGNDKQGQM 230 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----h----hhhccccccccc
Confidence 4322211 111122345699999999889999999999999999999987664321100 0 000000000
Q ss_pred -----ccccCccCC-CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 553 -----LNLIDPTLR-NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 553 -----~~~id~~l~-~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.+.+..... .........+.+++.+||+.+|++|||+.||+.+|+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 000100000 0011112346678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=316.61 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=198.1
Q ss_pred CCcCCcccccCceeEEEeeccC----CcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCe-----
Q 006317 326 FSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE----- 394 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 394 (650)
|.+.+.||+|+||.||+|.+.. +..||+|+++... ......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999998643 3679999987543 2334578999999999999999999998876554
Q ss_pred -eEEEEecCCCCChhHHHHhhh---ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeee
Q 006317 395 -RLLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF 470 (650)
Q Consensus 395 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 470 (650)
.+++|||+++|+|..++.... ....+++...+.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999986532 2246899999999999999999999987 999999999999999999999999
Q ss_pred ecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccC
Q 006317 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNE 549 (650)
Q Consensus 471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 549 (650)
|+++...............++..|+|||.+....++.++||||||+++|||++ |..|+.... ...........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~---~~~~~~~~~~~--- 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE---NHEIYDYLRHG--- 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcC---
Confidence 99986643332222222345678999999988899999999999999999999 777764321 12222222111
Q ss_pred CCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 550 GTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 550 ~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.. ....... ..++.+++.+||+.||.+||++.||++.|+.
T Consensus 232 -~~-----~~~~~~~---~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 232 -NR-----LKQPEDC---LDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred -CC-----CCCCcCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 11 1111112 2355677789999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=318.85 Aligned_cols=265 Identities=26% Similarity=0.369 Sum_probs=197.3
Q ss_pred CCcCCcccccCceeEEEeec-----cCCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecC--CeeEE
Q 006317 326 FSTDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERLL 397 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 397 (650)
|...+.||+|+||+||++.. .+++.||+|.++.... .....+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988642 3577899999876532 3445788999999999999999999988654 35789
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||+++++|.+++.. ..+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999853 35999999999999999999999987 9999999999999999999999999998654
Q ss_pred cCCCCC-ccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 478 MDQSQG-DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 478 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
...... ......++..|+|||.+.+..++.++||||||+++|||+||+.|+...... ..+...............+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhh
Confidence 322111 111223566799999999889999999999999999999999887532211 111111111111111111111
Q ss_pred CccCCCC-ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 557 DPTLRNG-SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 557 d~~l~~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+...... .......+.+++..||+.+|++|||+++|+++|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 1111111 11112345667889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.59 Aligned_cols=248 Identities=25% Similarity=0.348 Sum_probs=191.4
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
++|+..++||+|+||.||+++.. +++.||||++..... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45677889999999999999864 588999999865432 2345688999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++|+|... ...++..+..++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGT-------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999998653 23567788899999999999999987 99999999999999999999999999986543221
Q ss_pred CCccceeecCccccChhcccc-----CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 482 QGDTSRIVGTFGYMAPEYVTR-----GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
......||..|+|||++.. ...+.++|||||||++|||++|+.||......+...+...... . .
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~---~-~----- 292 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM---S-Q----- 292 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc---c-C-----
Confidence 1233578999999998743 2345689999999999999999999873322211111111000 0 0
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+....... .++.+++.+||+.||++||++.||++.
T Consensus 293 ~~~~~~~~~---~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 PPEAPATAS---REFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCCccC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111122 345667779999999999999999864
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=330.31 Aligned_cols=245 Identities=24% Similarity=0.297 Sum_probs=197.3
Q ss_pred cCCCcCCcccccCceeEEEeeccC--CcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH--GQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~--g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
++|...+.||+|+||.||+|+... +..||+|++.... ......+.+|+.++..++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 568889999999999999998543 3579999986542 22334678899999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999873 457899999999999999999999987 99999999999999999999999999986532
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
......||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ....... ..+. .
T Consensus 184 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~~~~i----~~~~------~ 245 (340)
T PTZ00426 184 -----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP---LLIYQKI----LEGI------I 245 (340)
T ss_pred -----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH---HHHHHHH----hcCC------C
Confidence 12345799999999999988899999999999999999999999863221 1111111 1111 0
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCC-----CHHHHHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRP-----TMASVVVM 595 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~~ 595 (650)
.+......+ +.+++.+|++.+|++|+ +++++++.
T Consensus 246 ~~p~~~~~~---~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 YFPKFLDNN---CKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCCHH---HHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111122233 44677799999999995 89998865
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=322.45 Aligned_cols=260 Identities=27% Similarity=0.389 Sum_probs=202.8
Q ss_pred hhccCCCcCCcccccCceeEEEeeccC------CcceeEeeccccC-chhHHHHHHHHHHHhhC-CCCceeeecceeecC
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEE 392 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 392 (650)
...++|+..+.||+|+||.||++.... ...+|+|.+.... .....++.+|+.++.++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 344678889999999999999998642 3578999987643 23345688999999999 899999999999999
Q ss_pred CeeEEEEecCCCCChhHHHHhh-------------hccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe
Q 006317 393 TERLLIYEFVPNSSVDKFIFDA-------------IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 459 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl 459 (650)
+..+++|||+++|+|..++... .....+++..+++++.||+.||+|||+.+ |+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999998642 12356899999999999999999999887 9999999999999
Q ss_pred CCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccch
Q 006317 460 DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAED 538 (650)
Q Consensus 460 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~ 538 (650)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+..... .+
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~ 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EE 242 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---HH
Confidence 9999999999999986653322222222345678999999988899999999999999999998 8887653211 11
Q ss_pred hHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 539 LLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 539 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
..... ..+.... ........+.+++.+|++.+|++|||+.||++.|+.
T Consensus 243 ~~~~~----~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 243 LFKLL----KEGYRME--------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred HHHHH----HcCCcCC--------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 11111 1111000 011122356678889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=321.40 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=199.1
Q ss_pred CCCcCCcccccCceeEEEeecc------CCcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
+|...++||+|+||.||+|... .++.||+|+++..... ....+.+|+.++.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667789999999999999853 2467999999765433 23468899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhh-------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC
Q 006317 398 IYEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI 464 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~ 464 (650)
++||+++++|.+++.... ....+++..+++++.|++.||.|||+.+ ++||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985311 1235889999999999999999999887 999999999999999999
Q ss_pred eEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHH
Q 006317 465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYA 543 (650)
Q Consensus 465 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~ 543 (650)
+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..|+.... ..+.....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~~i 239 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVIEMI 239 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH
Confidence 99999999886543322222233446778999999998899999999999999999998 766664221 11222111
Q ss_pred HHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 544 WKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 544 ~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
. .... .......+.+ +.+++..||+.+|++||++.+|+..|+.
T Consensus 240 ~----~~~~-----~~~~~~~~~~---~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 R----NRQV-----LPCPDDCPAW---VYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H----cCCc-----CCCCCCCCHH---HHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 1110 0111223333 4567789999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=320.25 Aligned_cols=262 Identities=23% Similarity=0.330 Sum_probs=195.7
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
.++|+..++||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999865 588999999875432 223457789999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|++ ++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 577777754 3456899999999999999999999987 9999999999999999999999999987543211
Q ss_pred CCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC--------C
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG--------T 551 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--------~ 551 (650)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..+.+.......... .
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchh
Confidence 12233568899999999875 4578999999999999999999999863221 111111111110000 0
Q ss_pred cccccCcc-CC---CCC-hH------HHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 552 ALNLIDPT-LR---NGS-SS------EIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 552 ~~~~id~~-l~---~~~-~~------~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.....++. .. ... .. ....+.+++..||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000 00 000 00 0123557778999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.83 Aligned_cols=259 Identities=24% Similarity=0.341 Sum_probs=191.4
Q ss_pred cCCCcCCcccccCceeEEEeecc--CCcceeEeeccccCch--hHHHHHHHHHHHhhC---CCCceeeecceeec-----
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS--HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARL---QHRNLVRLLGFSFE----- 391 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~g~~~~----- 391 (650)
++|+..+.||+|+||.||+++.. +++.||||+++..... ....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999853 4678999998654322 233566777777665 69999999998852
Q ss_pred CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeee
Q 006317 392 ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471 (650)
Q Consensus 392 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 471 (650)
....++||||++ ++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 456889999996 5898888643 2345899999999999999999999987 9999999999999999999999999
Q ss_pred cccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhcc---
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWN--- 548 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~--- 548 (650)
+++..... .......||..|+|||.+.+..++.++|||||||++|||++|+.|+...... +.+........
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~---~~~~~i~~~~~~~~ 229 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPG 229 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCCCC
Confidence 99865432 2233456899999999999889999999999999999999999988643221 11111111100
Q ss_pred CCCc-------ccccCccCCCCChH-----HHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 549 EGTA-------LNLIDPTLRNGSSS-----EIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 549 ~~~~-------~~~id~~l~~~~~~-----~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.... ...+.+.- ....+ ....+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKS-AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCC-CCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 00000000 00011 1123457888999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=324.17 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=196.0
Q ss_pred CCCcCCcccccCceeEEEeec----cCCcceeEeeccccCc----hhHHHHHHHHHHHhhC-CCCceeeecceeecCCee
Q 006317 325 NFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSV----QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETER 395 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 395 (650)
+|++.++||+|+||.||+++. .+++.||+|++.+... .....+.+|+.++.++ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999875 3578899999865321 2234577899999999 599999999999999999
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++||||+++|+|.+++. .+..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999986 3456899999999999999999999987 99999999999999999999999999986
Q ss_pred cccCCCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
+..... .......||..|+|||++.+. .++.++|||||||++|||++|+.||...........+. .....
T Consensus 155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~~------ 225 (332)
T cd05614 155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRILK------ 225 (332)
T ss_pred ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHhc------
Confidence 543222 223345799999999998865 47899999999999999999999986433222111111 11100
Q ss_pred ccCccCCCCChHHHHHHHHHHhcccccCCCCCC-----CHHHHHHH
Q 006317 555 LIDPTLRNGSSSEIMRCVHIGLLCVQENVANRP-----TMASVVVM 595 (650)
Q Consensus 555 ~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~~ 595 (650)
.++.+......+ +.+++.+||+.||++|| ++.++++.
T Consensus 226 -~~~~~~~~~~~~---~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 -CDPPFPSFIGPE---AQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -CCCCCCCCCCHH---HHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 112222222333 44667799999999999 67777754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=319.49 Aligned_cols=256 Identities=28% Similarity=0.380 Sum_probs=199.9
Q ss_pred CCCcCCcccccCceeEEEeecc------CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
+|+..+.||+|+||.||+|+.. ....+++|.+..... .....+.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4678899999999999999753 235689998876543 334568899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhh---------------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCc
Q 006317 398 IYEFVPNSSVDKFIFDAI---------------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 456 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~N 456 (650)
+|||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986421 1235889999999999999999999887 9999999999
Q ss_pred eEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcc
Q 006317 457 ILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEE 535 (650)
Q Consensus 457 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~ 535 (650)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 9999999999999999986543322222223345778999999988889999999999999999999 8888753221
Q ss_pred cchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 536 AEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 536 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
..+.... .... ......... .++.+++.+||+.+|++||++.|+++.|+.
T Consensus 236 -~~~~~~~----~~~~-----~~~~~~~~~---~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~ 285 (290)
T cd05045 236 -ERLFNLL----KTGY-----RMERPENCS---EEMYNLMLTCWKQEPDKRPTFADISKELEK 285 (290)
T ss_pred -HHHHHHH----hCCC-----CCCCCCCCC---HHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1111111 1110 011111122 345678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=293.54 Aligned_cols=265 Identities=23% Similarity=0.270 Sum_probs=208.4
Q ss_pred HhhccCCCcCCcccccCceeEEEee-ccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecC-----C
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-----T 393 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~ 393 (650)
....++|.+.++||+|||..||+++ +.++..+|+|++...+.++.+..++|++..++++||||++++.+...+ .
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3456789999999999999999998 567889999999988878888899999999999999999999987543 3
Q ss_pred eeEEEEecCCCCChhHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeec
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 472 (650)
+.||+++|...|+|.+.+..... +..+++.+.++|+.+|++||++||+.. ++++||||||.|||+.+++.++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 58999999999999999976443 447999999999999999999999985 5799999999999999999999999999
Q ss_pred ccccccCCCCC-------ccceeecCccccChhccc---cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHH
Q 006317 473 ARLFEMDQSQG-------DTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTY 542 (650)
Q Consensus 473 a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~ 542 (650)
+......-... ......-|..|.|||.+. +...+.++|||||||+||+|+-|..||+...+... +
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-S---- 250 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-S---- 250 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-e----
Confidence 87543211110 111223588999999885 45678999999999999999999999974332111 0
Q ss_pred HHHhccCCCcccccCccCCC-CChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 543 AWKNWNEGTALNLIDPTLRN-GSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 543 ~~~~~~~~~~~~~id~~l~~-~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
..+.+..+.+.- ........+.+++-+|+|.||.+||++.+++..++.
T Consensus 251 --------laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 251 --------LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred --------EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 011111111110 111133455677779999999999999999988864
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=319.03 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=200.9
Q ss_pred cCCCcCCcccccCceeEEEeecc------CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
.+|...++||+|+||.||++... ++..+++|.+..........+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999632 355789999887666666689999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhc------------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCe
Q 006317 398 IYEFVPNSSVDKFIFDAIK------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 465 (650)
+|||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999875311 135899999999999999999999887 9999999999999999999
Q ss_pred EEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHH
Q 006317 466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAW 544 (650)
Q Consensus 466 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~ 544 (650)
||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+..... .+......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~ 238 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---TEAIECIT 238 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---HHHHHHHH
Confidence 9999999975543222122223345678999999999999999999999999999999 8887742211 11111111
Q ss_pred HhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 545 KNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 545 ~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
. .... ......+ ..+.+++.+||+.||.+||++.||++.|+
T Consensus 239 ~----~~~~-----~~~~~~~---~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 Q----GREL-----ERPRTCP---PEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred c----CccC-----CCCCCCC---HHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0 0000 0011122 23557788999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=328.48 Aligned_cols=201 Identities=25% Similarity=0.347 Sum_probs=173.7
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|+..+.||+|+||+||+++.. +++.||||++.+... .....+.+|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999864 588999999976432 22345788999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999873 467999999999999999999999987 999999999999999999999999998754321
Q ss_pred CCC---------------------------------CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCC
Q 006317 480 QSQ---------------------------------GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK 526 (650)
Q Consensus 480 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~ 526 (650)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCC
Q 006317 527 NNSF 530 (650)
Q Consensus 527 p~~~ 530 (650)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=293.47 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=205.6
Q ss_pred cCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|++++.||+|.||.||.|+.+. +--||+|++.+... +-+.++.+|+++-..|+||||+++++++.++...||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 679999999999999999998654 66789999976543 23457899999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||.++|+|...|.+. ...++++.....++.|+|.||.|+|..+ ||||||||+|+|++.++..||+|||.+..-.
T Consensus 102 Eya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 999999999999753 4567999999999999999999999887 9999999999999999999999999986432
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
.......+||..|.+||...+...+...|+|++||+.||++.|.+||+.... .+......+ .++.+|
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---~etYkrI~k-------~~~~~p- 242 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---SETYKRIRK-------VDLKFP- 242 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---HHHHHHHHH-------ccccCC-
Confidence 3445668999999999999999999999999999999999999999974432 122221111 112222
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..... ...+++..|+..+|.+|.+..|++.-
T Consensus 243 --~~is~---~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 --STISG---GAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --cccCh---hHHHHHHHHhccCccccccHHHHhhh
Confidence 22223 34467779999999999999999753
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=331.41 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=199.5
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|.+.+.||+|+||.||+++.. +++.||||++..... .....+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999865 588999999975422 23446889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999999874 367999999999999999999999987 999999999999999999999999999865433
Q ss_pred C---------------------------CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCC
Q 006317 480 Q---------------------------SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRI 532 (650)
Q Consensus 480 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~ 532 (650)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0012234568999999999999999999999999999999999999986432
Q ss_pred CcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCC-HHHHHHH
Q 006317 533 GEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPT-MASVVVM 595 (650)
Q Consensus 533 ~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-~~evl~~ 595 (650)
... ...... .+... ..-+. ....+.+ +.+++..|++ +|.+||+ ++++++.
T Consensus 235 ~~~---~~~~i~-~~~~~----~~~p~-~~~~~~~---~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQE---TYNKII-NWKES----LRFPP-DPPVSPE---AIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHH---HHHHHh-ccCCc----ccCCC-CCCCCHH---HHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111 111000 00000 00000 0112333 4456668887 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=325.50 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=205.9
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCe-eEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE-RLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lv~ 399 (650)
++|...+++|+|+||.++..+.+ +++.+++|++.... ........+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888999999999999998865 47789999986543 3334467899999999999999999999999888 99999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
+|++||+|.+.|... ++..++++.+++|+.||+.|+.|||++. |+|||||+.||+++.++.+||+|||+++.+...
T Consensus 84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999998764 3577999999999999999999999776 999999999999999999999999999987754
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
. ......+||+.||.||++.+.+|..|+|||||||++|||++-+++|...+ +.....+.. ...-..
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~------m~~Li~ki~------~~~~~P 225 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN------MSELILKIN------RGLYSP 225 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc------hHHHHHHHh------hccCCC
Confidence 3 24456899999999999999999999999999999999999999886322 111221111 111122
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+......+ +..++..|++.+|+.||++.+++.+
T Consensus 226 lp~~ys~e---l~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 LPSMYSSE---LRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCccccHH---HHHHHHHHhhcCCccCCCHHHHhhC
Confidence 22333444 4455668999999999999999966
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.55 Aligned_cols=242 Identities=25% Similarity=0.328 Sum_probs=192.0
Q ss_pred CcccccCceeEEEeec----cCCcceeEeeccccCc----hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 330 NKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
++||+|+||.||+++. ..++.||||+++.... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 3477899999875422 2234577899999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++. ....+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 99999999886 3456889999999999999999999987 9999999999999999999999999987533221
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .... +. ..+.
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~~~~---~~~~-~~------~~~~ 220 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KTID---KILK-GK------LNLP 220 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---HHHH---HHHc-CC------CCCC
Confidence 2223457899999999999888999999999999999999999998632211 1111 1111 10 1111
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCC-----CHHHHHHH
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRP-----TMASVVVM 595 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~~ 595 (650)
..... .+.+++.+||+.+|++|| ++.++++-
T Consensus 221 ~~~~~---~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 221 PYLTP---EARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCH---HHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 12222 345677799999999999 78888753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=318.39 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=199.1
Q ss_pred HhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch--------------hHHHHHHHHHHHhhCCCCceee
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--------------GELEFKNEVLLVARLQHRNLVR 384 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--------------~~~~~~~E~~~l~~l~H~niv~ 384 (650)
+..-++|++.+.||+|.||.|-+++.. +++.||||++.+.... ..+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 344578999999999999999999854 5889999999765321 1236789999999999999999
Q ss_pred ecceeec--CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC
Q 006317 385 LLGFSFE--ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD 462 (650)
Q Consensus 385 l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~ 462 (650)
|+.+..+ .+..|||+|||..|.+...-- ....++..+.++++.++..||+|||.++ ||||||||+|+||+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 9999865 567899999999998765321 2223999999999999999999999998 9999999999999999
Q ss_pred CCeEEeeeecccccccCCCC---CccceeecCccccChhccccCC----CCccccccchhHHHHHHHhCCCCCCCCCCcc
Q 006317 463 MIPKISDFGMARLFEMDQSQ---GDTSRIVGTFGYMAPEYVTRGH----FSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535 (650)
Q Consensus 463 ~~~kl~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~S~Gvll~elltG~~p~~~~~~~~ 535 (650)
|++||+|||.+..+...... ......+||+.|+|||...++. .+.+.||||+||.||.|+-|+.||-.. .
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~---~ 323 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD---F 323 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc---h
Confidence 99999999999876432211 1233478999999999987743 357899999999999999999998521 1
Q ss_pred cchhHHHHHHhccCCCcccccCccCC-CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHh
Q 006317 536 AEDLLTYAWKNWNEGTALNLIDPTLR-NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVML 596 (650)
Q Consensus 536 ~~~l~~~~~~~~~~~~~~~~id~~l~-~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L 596 (650)
..++.+ +++...|. ...++.-..+-.|+.++|++||+.|-+..+|..-.
T Consensus 324 ~~~l~~------------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 324 ELELFD------------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHHHHH------------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 111111 22222332 22333444555788899999999999999997554
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=315.85 Aligned_cols=257 Identities=27% Similarity=0.447 Sum_probs=203.0
Q ss_pred ccCCCcCCcccccCceeEEEeeccC------CcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETER 395 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 395 (650)
.++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578888999999999999998643 3679999987553 23445788999999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHHhhhc-------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEe
Q 006317 396 LLIYEFVPNSSVDKFIFDAIK-------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS 468 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 468 (650)
++||||+++|+|.+++..... ...++|..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999975321 234789999999999999999999887 9999999999999999999999
Q ss_pred eeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhc
Q 006317 469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNW 547 (650)
Q Consensus 469 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 547 (650)
|||+++...............++..|+|||.+.++.++.++||||||+++|||+| |+.|+..... ........
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~~--- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFVI--- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHHh---
Confidence 9999986543322222233456789999999998899999999999999999999 8887753221 12222111
Q ss_pred cCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 548 NEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 548 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
..... ...... ...+.+++..||+.+|++|||+.++++.|+
T Consensus 236 -~~~~~-----~~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -DGGHL-----DLPENC---PDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -cCCCC-----CCCCCC---CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11111 111112 234557888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=329.13 Aligned_cols=255 Identities=25% Similarity=0.342 Sum_probs=194.8
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
.|...+.||+|+||+||+++.. +++.||||++..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999854 578899999976432 234468899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999999863 456899999999999999999999987 9999999999999999999999999976432110
Q ss_pred CC---------------------------------------------CccceeecCccccChhccccCCCCccccccchh
Q 006317 481 SQ---------------------------------------------GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFG 515 (650)
Q Consensus 481 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~G 515 (650)
.. .......||..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 00 001235799999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 516 VLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 516 vll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
|++|||++|+.||......+. ... ...+.. .... + .......+...++.- +.|+..+|..||++.|++..
T Consensus 236 ~il~elltG~~Pf~~~~~~~~--~~~--i~~~~~--~~~~--~-~~~~~s~~~~dli~~-ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTET--QLK--VINWEN--TLHI--P-PQVKLSPEAVDLITK-LCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHH--HHH--HHcccc--ccCC--C-CCCCCCHHHHHHHHH-HccCcccccCCCCHHHHhcC
Confidence 999999999999864322111 000 000100 0000 0 001123344444332 23777888889999999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.91 Aligned_cols=257 Identities=23% Similarity=0.298 Sum_probs=206.3
Q ss_pred HhhccCCCcCCcccccCceeEEEeeccCC-cceeEeeccccCchhHHHHHHHHHHHhhCC-CCceeeecc-eeec-----
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRLSHG-QEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLG-FSFE----- 391 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g-~~~~----- 391 (650)
.....++++.+.|.+|||+.||++....+ .++|+|++-.........+.+||++|++|+ |+|||.+++ ....
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34556778889999999999999998776 999999998777777788999999999997 999999999 3322
Q ss_pred -CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeee
Q 006317 392 -ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF 470 (650)
Q Consensus 392 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 470 (650)
.-+.+|+||||++|+|-+++....... |++.++++|+.++++|+++||... ++|||||||-+||||+.+++.|||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence 236789999999999999998765544 999999999999999999999984 78999999999999999999999999
Q ss_pred ecccccccCCC-CCc------cceeecCccccChhcc---ccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhH
Q 006317 471 GMARLFEMDQS-QGD------TSRIVGTFGYMAPEYV---TRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL 540 (650)
Q Consensus 471 Gla~~~~~~~~-~~~------~~~~~gt~~y~aPE~~---~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~ 540 (650)
|.+.-...... ... .-...-|+.|.+||.+ .+..+++|+|||+|||+||-|+-...||+..
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s--------- 261 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES--------- 261 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC---------
Confidence 99863322211 100 1112358999999977 4678899999999999999999999999721
Q ss_pred HHHHHhccCCCcccccCccCCCC-ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 541 TYAWKNWNEGTALNLIDPTLRNG-SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 541 ~~~~~~~~~~~~~~~id~~l~~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
..+.+++-...-. .+....++..||..||+.||.+||++-+|+..+.
T Consensus 262 ----------g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 262 ----------GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred ----------cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 1222333322211 2455566677888999999999999999997764
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=317.59 Aligned_cols=258 Identities=31% Similarity=0.501 Sum_probs=200.0
Q ss_pred hccCCCcCCcccccCceeEEEeeccC------CcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE 394 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 394 (650)
.+++|...+.||+|++|.||+|.+.. +..|++|.+.... ...+..+.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678899999999999999998753 4578999886543 3344568999999999999999999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC---CeEE
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIK----RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM---IPKI 467 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl 467 (650)
.++||||+++++|.+++..... ...++|..+++++.||+.||+|||+.+ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999875321 135899999999999999999999987 99999999999998765 5999
Q ss_pred eeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHh
Q 006317 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKN 546 (650)
Q Consensus 468 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 546 (650)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||.....+ .........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~~~~ 237 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFVTGG 237 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHcC
Confidence 99999986532221111222233568999999999999999999999999999997 88887532221 122111110
Q ss_pred ccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 547 WNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 547 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
.. . ......+ ..+.+++.+|++.+|++||++.+|++.|+
T Consensus 238 ---~~-~-----~~~~~~~---~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 ---GR-L-----DPPKGCP---GPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---Cc-C-----CCCCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00 0 0111122 34557788999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.43 Aligned_cols=264 Identities=25% Similarity=0.378 Sum_probs=199.4
Q ss_pred ccCCCcCCcccccCceeEEEeecc-----------------CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-----------------HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVR 384 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-----------------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~ 384 (650)
.++|++.++||+|+||.||++... ++..+|+|++..... ....++.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999998532 234689999876532 34457899999999999999999
Q ss_pred ecceeecCCeeEEEEecCCCCChhHHHHhhhc--------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCc
Q 006317 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIK--------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 456 (650)
Q Consensus 385 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~N 456 (650)
+++++...+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999875321 134788999999999999999999987 9999999999
Q ss_pred eEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh--CCCCCCCCCCc
Q 006317 457 ILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS--GQKNNSFRIGE 534 (650)
Q Consensus 457 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt--G~~p~~~~~~~ 534 (650)
||+++++.++|+|||+++.+.............++..|++||....+.++.++||||||+++|||++ |..|+......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999986543322222222344678999999888899999999999999999999 55665422211
Q ss_pred ccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 535 EAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 535 ~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
+........+.... .....+. ....+ ..+.+++.+||+.||++||++.||++.|+
T Consensus 241 ---~~~~~~~~~~~~~~-~~~~~~~-~~~~~---~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 ---QVIENTGEFFRDQG-RQVYLPK-PALCP---DSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ---HHHHHHHHHHhhcc-ccccCCC-CCCCC---HHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11111111111110 0000111 01112 45567888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=321.89 Aligned_cols=240 Identities=26% Similarity=0.330 Sum_probs=186.7
Q ss_pred CcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhh-CCCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVAR-LQHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
+.||+|+||.||+++.. +++.||||.++.... .....+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999865 477899999876422 222345556666654 4899999999999999999999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999998863 456899999999999999999999987 9999999999999999999999999997543222 22
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGS 564 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 564 (650)
.....||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+..... .. .+.+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i~----~~------~~~~~~~~ 219 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSIL----ND------RPHFPRWI 219 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHHH----cC------CCCCCCCC
Confidence 3346799999999999999999999999999999999999999863221 11111111 00 11112222
Q ss_pred hHHHHHHHHHHhcccccCCCCCCCHH-HHH
Q 006317 565 SSEIMRCVHIGLLCVQENVANRPTMA-SVV 593 (650)
Q Consensus 565 ~~~~~~~~~l~~~Cl~~~p~~RPt~~-evl 593 (650)
..+ +.+++..||+.+|++||++. +++
T Consensus 220 ~~~---~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 220 SKE---AKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CHH---HHHHHHHHccCCHHHcCCChHHHH
Confidence 333 34566789999999999876 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=313.37 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=194.6
Q ss_pred CCcCCcccccCceeEEEeeccCCc---ceeEeecccc--CchhHHHHHHHHHHHhhCCCCceeeecceeecC------Ce
Q 006317 326 FSTDNKLGQGGFGAVYKGRLSHGQ---EIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------TE 394 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~~g~---~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 394 (650)
|.+.++||+|+||.||+|++.... .+|+|.++.. .......+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356789999999999999875432 5899988654 233345788999999999999999999987532 24
Q ss_pred eEEEEecCCCCChhHHHHhhh---ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeee
Q 006317 395 RLLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 471 (650)
.+++|||+++|+|.+++.... ....+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999885321 2245899999999999999999999987 9999999999999999999999999
Q ss_pred cccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCC
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEG 550 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 550 (650)
+++...............++..|++||.+.+..++.++||||||+++|||++ |+.|+.... ...+..... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~~----~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE---NSEIYDYLR----QG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHH----cC
Confidence 9986543222111222345678999999999999999999999999999999 777775321 112222111 11
Q ss_pred CcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 551 TALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 551 ~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.... ...... ..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 231 ~~~~-----~~~~~~---~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRLK-----QPPDCL---DGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCC-----CCCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1110 111122 235678889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=337.37 Aligned_cols=252 Identities=30% Similarity=0.469 Sum_probs=207.2
Q ss_pred CCcCCcccccCceeEEEeec-cCCc----ceeEeecccc-CchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 326 FSTDNKLGQGGFGAVYKGRL-SHGQ----EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~-~~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
....++||+|.||+||||.+ ++|+ +||+|++... ..+...++.+|+..|.+++||||++++|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 44568999999999999985 3443 6899998765 4456678999999999999999999999998776 78999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
+||+.|+|.+|++. .+..+..+..+.|..|||+||.|||++. ++||||.++||||.+...+||.|||+++.+..+
T Consensus 777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999999986 5667889999999999999999999886 999999999999999999999999999998876
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
...-......-...|||-|.+....++.++|||||||.+||++| |..|++....++..+++.. +..
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~-------geR------ 918 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK-------GER------ 918 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc-------ccc------
Confidence 65555555555778999999999999999999999999999999 8888765444443333321 111
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
| ..++.-...+..++..||..|+..||+++++...+..
T Consensus 919 -L-sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 919 -L-SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred -C-CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 1 1122333455667788999999999999999977653
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=319.38 Aligned_cols=260 Identities=27% Similarity=0.448 Sum_probs=201.5
Q ss_pred hccCCCcCCcccccCceeEEEeeccC------CcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE 394 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 394 (650)
..++|++.++||+|+||.||+|..++ +..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999997532 4579999986543 2334468899999999999999999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhc-------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEE
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIK-------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 467 (650)
.++||||+++|+|.+++..... ...+++..+.+++.||+.||.|||+.+ ++||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999975321 234678889999999999999999887 999999999999999999999
Q ss_pred eeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHh
Q 006317 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKN 546 (650)
Q Consensus 468 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 546 (650)
+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |..|+..... .+.......
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~- 236 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVLKFVMD- 236 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc-
Confidence 99999986543222222222345678999999999999999999999999999999 6767642211 112211111
Q ss_pred ccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 547 WNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 547 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
+... ...... ...+.+++.+|++.+|++|||+.++++.|+..
T Consensus 237 ---~~~~-----~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 237 ---GGYL-----DQPDNC---PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ---CCCC-----CCCCCC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1000 011111 23566788899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=321.84 Aligned_cols=248 Identities=23% Similarity=0.304 Sum_probs=191.7
Q ss_pred CcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
+.||+|+||.||+++.. +++.||+|++++... .....+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999865 478899999976422 2334577888888776 899999999999999999999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~~ 152 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CCc
Confidence 99998876 3457999999999999999999999987 999999999999999999999999998753211 122
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcc--cchhHHHHHHhccCCCcccccCccCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE--AEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
.....||..|+|||++.+..++.++||||||+++|||++|+.||....... ......+.+....... ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------~~~p~ 226 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------IRIPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC------CCCCC
Confidence 334678999999999999999999999999999999999999986322111 1111222222211111 11111
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCC------HHHHHH
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPT------MASVVV 594 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt------~~evl~ 594 (650)
... ..+.+++.+||+.||++||+ +.++++
T Consensus 227 ~~~---~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 227 SLS---VKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCC---HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 222 33456777999999999998 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=318.62 Aligned_cols=258 Identities=27% Similarity=0.467 Sum_probs=201.0
Q ss_pred ccCCCcCCcccccCceeEEEeecc------CCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETER 395 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 395 (650)
.++|+..+.||+|+||.||++... ++..||+|++.... .....++.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999853 36789999987653 23445788999999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHHhhh-------------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCc
Q 006317 396 LLIYEFVPNSSVDKFIFDAI-------------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 456 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~N 456 (650)
++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999997421 1134788999999999999999999887 9999999999
Q ss_pred eEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcc
Q 006317 457 ILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEE 535 (650)
Q Consensus 457 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~ 535 (650)
||+++++.+||+|||+++................+..|+|||.+.+..++.++|||||||++|||++ |..|+.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999876543222111222334667999999998899999999999999999998 7777642211
Q ss_pred cchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 536 AEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 536 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.+..... ..+.... ..... ..++.+++.+||+.+|++|||+.||++.|+.
T Consensus 239 -~~~~~~~----~~~~~~~-----~~~~~---~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 -EEVIYYV----RDGNVLS-----CPDNC---PLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -HHHHHHH----hcCCCCC-----CCCCC---CHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111111 1111110 11111 2346678889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=310.66 Aligned_cols=259 Identities=22% Similarity=0.389 Sum_probs=203.9
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|++.+.||+|+||.||+|+.. +++.||||.+.... ......+.+|+.+++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47889999999999999999864 68899999876432 233446889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 400 EFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998865322 345899999999999999999999987 99999999999999999999999999886543
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
... ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+..... +........ .... .+
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~-~~~~-----~~ 226 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKI-EQCD-----YP 226 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHH-hcCC-----CC
Confidence 221 12234678899999999988899999999999999999999999753211 111111111 0000 11
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
.+. .......+.+++.+||+.+|++||++.+|++.|++.
T Consensus 227 ~~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 PLP--TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCC--hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111 111123455777799999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=309.33 Aligned_cols=254 Identities=29% Similarity=0.430 Sum_probs=192.1
Q ss_pred CcccccCceeEEEeeccC---CcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCC
Q 006317 330 NKLGQGGFGAVYKGRLSH---GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS 405 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 405 (650)
+.||+|+||.||+|.+.+ +..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998643 3568999987653 234457889999999999999999999999999999999999999
Q ss_pred ChhHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 406 SVDKFIFDAIK--RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 406 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
+|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975322 235678888999999999999999987 9999999999999999999999999987543222212
Q ss_pred ccceeecCccccChhccccC-------CCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 484 DTSRIVGTFGYMAPEYVTRG-------HFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~-------~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
......++..|+|||++.+. .++.++||||||+++|||++ |+.|+...... +...... .+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~~~----~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE---QVLTYTV----REQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHh----hcccCCC
Confidence 22334578889999988642 35789999999999999997 99888643221 1111111 1111222
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
.++.+.....+++ .+++..|+ .+|++|||++||+..|+
T Consensus 231 ~~~~~~~~~~~~~---~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLPLSDRW---YEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCCCChHH---HHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 3333332333433 34556788 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=320.67 Aligned_cols=242 Identities=24% Similarity=0.298 Sum_probs=191.3
Q ss_pred CcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
++||+|+||.||+|+.. +++.||||+++.... .....+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 478899999876422 2234567788888866 799999999999999999999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 99998886 3456899999999999999999999987 9999999999999999999999999987533221 22
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGS 564 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 564 (650)
.....||..|+|||++.+..++.++||||||+++|||++|+.||..... ......... .. .......
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~~~~~~i~~---~~-------~~~p~~~ 219 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDLFESILH---DD-------VLYPVWL 219 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---HHHHHHHHc---CC-------CCCCCCC
Confidence 3345789999999999998999999999999999999999999864321 122211111 10 0111112
Q ss_pred hHHHHHHHHHHhcccccCCCCCC-------CHHHHHHH
Q 006317 565 SSEIMRCVHIGLLCVQENVANRP-------TMASVVVM 595 (650)
Q Consensus 565 ~~~~~~~~~l~~~Cl~~~p~~RP-------t~~evl~~ 595 (650)
.. .+.+++..||+.||++|| ++.++++.
T Consensus 220 ~~---~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 220 SK---EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CH---HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 22 345677799999999999 78888744
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=326.27 Aligned_cols=242 Identities=21% Similarity=0.246 Sum_probs=191.9
Q ss_pred CcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCC
Q 006317 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS 405 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 405 (650)
+.||+|+||.||+++.. +|+.||+|++++... .....+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999854 588999999976422 23345778999999999999999999999999999999999999
Q ss_pred ChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
+|..++. ....+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 9998886 34578999999999999999999997 55 9999999999999999999999999987532211 12
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGS 564 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 564 (650)
.....||..|+|||++.+..++.++|||||||++|||++|+.||.....+ ........ . ...+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~~i~~---~-------~~~~p~~~ 219 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILM---E-------EIRFPRTL 219 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHHHHhc---C-------CCCCCCCC
Confidence 23456999999999999999999999999999999999999998632211 11111110 0 01111222
Q ss_pred hHHHHHHHHHHhcccccCCCCCC-----CHHHHHHH
Q 006317 565 SSEIMRCVHIGLLCVQENVANRP-----TMASVVVM 595 (650)
Q Consensus 565 ~~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~~ 595 (650)
.. .+.+++.+||+.||++|+ ++.++++.
T Consensus 220 ~~---~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 220 SP---EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CH---HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 33 345667799999999996 89999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=311.75 Aligned_cols=246 Identities=28% Similarity=0.418 Sum_probs=192.2
Q ss_pred cccccCceeEEEeec---cCCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCC
Q 006317 331 KLGQGGFGAVYKGRL---SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS 405 (650)
Q Consensus 331 ~LG~G~~g~Vy~~~~---~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 405 (650)
.||+|+||.||+|.+ .++..+|+|+++.... ....++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 3467899999865432 23457889999999999999999999875 45678999999999
Q ss_pred ChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC-c
Q 006317 406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG-D 484 (650)
Q Consensus 406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~ 484 (650)
+|.+++.. ...+++..+.+++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++......... .
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999863 456899999999999999999999987 9999999999999999999999999998654332211 1
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNG 563 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 563 (650)
.....++..|+|||.+....++.++||||||+++|||++ |+.||..... ........ .+.. +.....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i~----~~~~-----~~~~~~ 222 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMIE----SGER-----MECPQR 222 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH----CCCC-----CCCCCC
Confidence 112234578999999988889999999999999999998 8888863221 12222111 1111 111122
Q ss_pred ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 564 SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 564 ~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.+. ++.+++.+||+.||++||++.+|+++|++
T Consensus 223 ~~~---~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 223 CPP---EMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCH---HHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 233 34567889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=311.46 Aligned_cols=253 Identities=27% Similarity=0.455 Sum_probs=200.2
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
++|++.++||+|+||.||++..+++..+|+|.+..... ....+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 56888999999999999999988888999999876443 3457899999999999999999999875 456899999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
+++|.+++... ....+++..++.++.+++.||+|||+.+ ++||||||+||++++++.++|+|||++..+......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 99999998742 2345899999999999999999999987 999999999999999999999999999865432211
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ..+......... ......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~---------~~~~~~ 226 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN---NREVLEQVERGY---------RMPCPQ 226 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCC---------CCCCCC
Confidence 1112235668999999988899999999999999999999 777775321 112222111100 011111
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.. ...+.+++.+|++.+|++|||+.++++.|+.
T Consensus 227 ~~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 227 DC---PISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred cC---CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 12 2345678889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=323.93 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=196.4
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|...+.||+|+||.||+++.. +++.||+|+++.... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999864 588999999976432 23446888999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998742 357999999999999999999999987 999999999999999999999999999865432
Q ss_pred CCCCccceeecCccccChhccc------cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVT------RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 553 (650)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ... ..........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~---~~i~~~~~~~ 228 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA---KTY---NNIMNFQRFL 228 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH---HHH---HHHHcCCCcc
Confidence 221 222346899999999986 456789999999999999999999998632211 111 1111111111
Q ss_pred cccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 554 NLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 554 ~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.. + .......+ +.+++..|++ +|++||++.+++.-
T Consensus 229 ~~--~-~~~~~~~~---~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 KF--P-EDPKVSSD---FLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CC--C-CCCCCCHH---HHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 10 0 00112333 4455567887 99999999999853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=315.43 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=203.6
Q ss_pred hccCCCcCCcccccCceeEEEeeccC-----CcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeec-CCe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSH-----GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFE-ETE 394 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~ 394 (650)
..++|...+.||+|+||.||+|...+ +..|++|++.... ......+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34678889999999999999998765 6789999987543 3344568899999999999999999998876 467
Q ss_pred eEEEEecCCCCChhHHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEee
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKR-----VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD 469 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 469 (650)
.++++||+++++|.+++...... ..+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998753222 46899999999999999999999887 99999999999999999999999
Q ss_pred eecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhcc
Q 006317 470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWN 548 (650)
Q Consensus 470 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 548 (650)
||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.|+.... ..++..+...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~~--- 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID---PFEMAAYLKD--- 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC---HHHHHHHHHc---
Confidence 999986543322212222346778999999998889999999999999999999 988875321 1122221111
Q ss_pred CCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 549 EGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 549 ~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
+. ........++ .+.+++.+||+.+|++|||+.+|+++|+..
T Consensus 235 -~~-----~~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 235 -GY-----RLAQPINCPD---ELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred -CC-----CCCCCCcCCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 10 0001111222 456788899999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=311.41 Aligned_cols=255 Identities=23% Similarity=0.339 Sum_probs=199.3
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45789999999999999999986 45788999998765444455688999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 999999998863 456899999999999999999999887 9999999999999999999999999998654221
Q ss_pred CCccceeecCccccChhccc---cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 482 QGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
.......|+..|+|||.+. ...++.++||||||+++|||++|+.|+........ .. .+... ....+
T Consensus 161 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~-----~~~~~---~~~~~ 229 (267)
T cd06646 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LF-----LMSKS---NFQPP 229 (267)
T ss_pred -cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--he-----eeecC---CCCCC
Confidence 1223346888999999884 34578899999999999999999998742211110 00 00000 00001
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHh
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVML 596 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L 596 (650)
.... .......+.+++.+||+.+|++||++++|++.|
T Consensus 230 ~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD-KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc-ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1110 111123455777899999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=330.38 Aligned_cols=253 Identities=24% Similarity=0.319 Sum_probs=195.3
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|+..++||+|+||.||+++.. +++.||||++.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999865 58899999997542 223345788999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999999873 456999999999999999999999987 999999999999999999999999998754321
Q ss_pred CCCC------------------------------------ccceeecCccccChhccccCCCCccccccchhHHHHHHHh
Q 006317 480 QSQG------------------------------------DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523 (650)
Q Consensus 480 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt 523 (650)
.... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112469999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCC---HHHHHHH
Q 006317 524 GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPT---MASVVVM 595 (650)
Q Consensus 524 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt---~~evl~~ 595 (650)
|+.||...... ....... .+.. .... +. .....++.. +++..|+. +|.+|++ +.|++..
T Consensus 235 G~~Pf~~~~~~---~~~~~i~-~~~~--~~~~--~~-~~~~s~~~~---~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQ---ETYRKII-NWKE--TLQF--PD-EVPLSPEAK---DLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHH---HHHHHHH-cCCC--ccCC--CC-CCCCCHHHH---HHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99998633211 1111110 1110 0000 00 001233333 45556776 8999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.17 Aligned_cols=252 Identities=26% Similarity=0.327 Sum_probs=197.9
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch---hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
+|+..++||+|+||.||++... +++.||||++...... ....+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3778899999999999999864 5889999998754322 23457789999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++|+|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999888642 2346899999999999999999999987 9999999999999999999999999997654222
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
......|+..|+|||++.+..++.++||||||+++|||++|+.||........ ........... ....
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~~------~~~~ 224 (285)
T cd05605 157 ---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKED------QEEY 224 (285)
T ss_pred ---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhhc------cccc
Confidence 12234689999999999988999999999999999999999999864322111 11111110000 0111
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCC-----CHHHHHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRP-----TMASVVVM 595 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~~ 595 (650)
..... ..+.+++..||+.||++|| +++++++.
T Consensus 225 ~~~~~---~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 225 SEKFS---EAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred CcccC---HHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11122 3345677899999999999 88888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=331.64 Aligned_cols=260 Identities=24% Similarity=0.354 Sum_probs=200.5
Q ss_pred hccCCCcCCcccccCceeEEEeecc------CCcceeEeeccccCch-hHHHHHHHHHHHhhCC-CCceeeecceeecCC
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQ-HRNLVRLLGFSFEET 393 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~ 393 (650)
..++|...++||+|+||.||+|++. .+..||||+++..... ....+.+|+.++.++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 4456788899999999999999853 2457999999765333 2346889999999997 999999999999999
Q ss_pred eeEEEEecCCCCChhHHHHhhhc---------------------------------------------------------
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIK--------------------------------------------------------- 416 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 416 (650)
..++||||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999974211
Q ss_pred --------------------------------------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceE
Q 006317 417 --------------------------------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 458 (650)
Q Consensus 417 --------------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 458 (650)
...+++..+++++.||+.||+|||+.+ ++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 124678889999999999999999876 999999999999
Q ss_pred eCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccc
Q 006317 459 LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAE 537 (650)
Q Consensus 459 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~ 537 (650)
+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+......+
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-- 349 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-- 349 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--
Confidence 99999999999999986543222112223356788999999998889999999999999999998 888875322111
Q ss_pred hhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 538 DLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 538 ~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
........ +.. +....... ..+.+++..||+.+|.+||+++||++.|+.
T Consensus 350 ~~~~~~~~----~~~-----~~~p~~~~---~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 350 QFYNAIKR----GYR-----MAKPAHAS---DEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred HHHHHHHc----CCC-----CCCCCCCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11111111 100 11111122 345567779999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=312.21 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=199.5
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
.++|.+.++||+|+||.||+|+..++..||+|+++.... ....+.+|+.++++++||||+++++++. +...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 356889999999999999999987777899999975432 3457899999999999999999999874 45679999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++|+|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999742 2346899999999999999999999987 999999999999999999999999999865432211
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
......++..|+|||++.+..++.++||||||+++|||+| |+.|+..... ......... .. .....
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~~~~~~~~~----~~-----~~~~~ 225 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVER----GY-----RMPCP 225 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---HHHHHHHhc----CC-----CCCCc
Confidence 1222346778999999998899999999999999999999 7777653221 111111110 00 00111
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
......+.+++.+|++.+|++||++.+++++|+.
T Consensus 226 ---~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 226 ---PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred ---cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 1122345678889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=309.37 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=201.2
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeecccc--CchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+|...+.||+|++|.||++... +++.|++|.+... .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677899999999999999865 5889999998653 233455788999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++... ....+++..+++++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999999753 3457999999999999999999999887 99999999999999999999999999886543221
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
......|+..|+|||++.+..++.++||||||+++|||++|+.|+..... ........ .+. . +.+.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~----~~~----~-~~~~ 222 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALILKII----RGV----F-PPVS 222 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH----cCC----C-CCCc
Confidence 22334688899999999999999999999999999999999999864321 11111111 000 0 1111
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
. .....+.+++.+||+.+|++||++.++++.
T Consensus 223 ~---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 Q---MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred c---ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1 122345678889999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.52 Aligned_cols=238 Identities=29% Similarity=0.337 Sum_probs=189.6
Q ss_pred CcccccCceeEEEeec----cCCcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCC
Q 006317 330 NKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
+.||+|+||.||+++. .+|+.||+|++...... ....+.+|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 35789999999764322 33457789999999999999999999999999999999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
+|+|.+++. +...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 999999886 3456899999999999999999999987 9999999999999999999999999987543221 2
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNG 563 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 563 (650)
......||..|+|||.+.+..++.++||||||+++|||++|+.|+..... ......... . . ..+...
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~~i~~---~-~------~~~p~~ 220 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETMTMILK---A-K------LGMPQF 220 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHHHHHHHc---C-C------CCCCCC
Confidence 23345789999999999988899999999999999999999999863221 111111111 0 0 011112
Q ss_pred ChHHHHHHHHHHhcccccCCCCCCCHHH
Q 006317 564 SSSEIMRCVHIGLLCVQENVANRPTMAS 591 (650)
Q Consensus 564 ~~~~~~~~~~l~~~Cl~~~p~~RPt~~e 591 (650)
... .+.+++.+||+.||++||++.+
T Consensus 221 ~~~---~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 221 LSP---EAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCH---HHHHHHHHHhhcCHhHcCCCCC
Confidence 223 3446777999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=313.07 Aligned_cols=256 Identities=28% Similarity=0.489 Sum_probs=200.7
Q ss_pred ccCCCcCCcccccCceeEEEeeccC-Cc---ceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQ---EIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~-g~---~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
.++|+..+.||+|+||.||+|+... +. .+++|.+.... ......+.+|++++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3567888999999999999998753 33 68999987653 3344578899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999864 3457899999999999999999999987 9999999999999999999999999997654
Q ss_pred cCCCCCc-cceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 478 MDQSQGD-TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 478 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
....... ......+..|+|||++....++.++||||||+++|||++ |+.|+..... .+..... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i----~~~~---- 227 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAI----NDGF---- 227 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHH----hcCC----
Confidence 3221111 111223457999999998899999999999999999998 9998853221 1111111 1110
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
..+. .......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 228 ~~~~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 228 RLPA----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred CCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0010 11112345688889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=313.16 Aligned_cols=247 Identities=25% Similarity=0.303 Sum_probs=192.3
Q ss_pred ccccCceeEEEeecc-CCcceeEeeccccCch---hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCCCh
Q 006317 332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSV 407 (650)
Q Consensus 332 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 407 (650)
||+|+||+||++... +++.||+|.+...... ....+..|+.++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999864 5889999998754322 224577899999999999999999999999999999999999999
Q ss_pred hHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccc
Q 006317 408 DKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486 (650)
Q Consensus 408 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 486 (650)
..++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 98886432 3456999999999999999999999987 99999999999999999999999999976543222 223
Q ss_pred eeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChH
Q 006317 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSS 566 (650)
Q Consensus 487 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~ 566 (650)
...||+.|+|||++.+..++.++||||||+++|||++|+.||........ ......... ... ..+....+
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~-~~~------~~~~~~~~- 225 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRIL-NDS------VTYPDKFS- 225 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhc-ccC------CCCcccCC-
Confidence 35789999999999999999999999999999999999999864322111 000000000 000 01111122
Q ss_pred HHHHHHHHHhcccccCCCCCC-----CHHHHHHH
Q 006317 567 EIMRCVHIGLLCVQENVANRP-----TMASVVVM 595 (650)
Q Consensus 567 ~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~~ 595 (650)
..+.+++..||+.||++|| +++++++.
T Consensus 226 --~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 226 --PASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred --HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 3445677799999999999 67777753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.37 Aligned_cols=248 Identities=23% Similarity=0.290 Sum_probs=192.6
Q ss_pred CcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
+.||+|+||.||+++.. +++.||||++++... .....+..|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865 578899999976422 2234577899999888 799999999999999999999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
|+|.+++. ....+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++.... ....
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~ 152 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccccc--CCCc
Confidence 99998886 3457999999999999999999999987 99999999999999999999999999874221 1122
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcc--cchhHHHHHHhccCCCcccccCccCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE--AEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
.....||..|+|||++.+..++.++|||||||++|||++|+.||......+ ......+......... ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~p~ 226 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ------IRIPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC------CCCCC
Confidence 334679999999999999999999999999999999999999986422111 1111122222111111 11111
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCC------HHHHHH
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPT------MASVVV 594 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt------~~evl~ 594 (650)
... .++.+++.+||+.||++||+ +.++++
T Consensus 227 ~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 227 SLS---VKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCC---HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 222 23456777999999999997 667763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=307.98 Aligned_cols=247 Identities=27% Similarity=0.393 Sum_probs=195.7
Q ss_pred CcccccCceeEEEeeccCCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCCChh
Q 006317 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD 408 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 408 (650)
++||+|+||.||+|...+++.+|+|.+..... .....+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47999999999999988888999999876543 23446889999999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCcccee
Q 006317 409 KFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488 (650)
Q Consensus 409 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 488 (650)
+++.. ....+++..++.++.|++.+|.|||+.+ ++||||||+||++++++.+||+|||++........ ......
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 154 (250)
T cd05085 81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLK 154 (250)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCC
Confidence 98864 3356899999999999999999999887 99999999999999999999999999875432211 111122
Q ss_pred ecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHH
Q 006317 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSE 567 (650)
Q Consensus 489 ~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~ 567 (650)
.++..|+|||++....++.++||||||+++|||++ |..|+...... ........ ... .......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~~~~----~~~-----~~~~~~~--- 219 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQVEK----GYR-----MSCPQKC--- 219 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHHc----CCC-----CCCCCCC---
Confidence 34567999999998899999999999999999999 88887532111 11111111 100 0111111
Q ss_pred HHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 568 IMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 568 ~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
...+.+++.+|++.+|++||++.|++++|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 235567888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=330.43 Aligned_cols=248 Identities=28% Similarity=0.389 Sum_probs=199.8
Q ss_pred CcCCcccccCceeEEEeeccC--Cc--ceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 327 STDNKLGQGGFGAVYKGRLSH--GQ--EIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 327 ~~~~~LG~G~~g~Vy~~~~~~--g~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
...++||+|.||.|++|.|.. |+ .||||.++..... ...+|.+|+.+|.+|+|||+++|+|+..+ ....||||.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 456899999999999999864 44 5899999877655 55689999999999999999999999998 778899999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
++.|+|.+.|++ ..+..|-......++.|||.||.||.++. +|||||..+|+||-....+||+||||.+.+..+..
T Consensus 192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999999987 46677889999999999999999999987 99999999999999999999999999998765443
Q ss_pred CC-ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 482 QG-DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 482 ~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
.- ......-...|.|||.+....|+.++|||+|||.||||+| |..||..-. .. .+++.||..
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~---g~-------------qIL~~iD~~ 331 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR---GI-------------QILKNIDAG 331 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC---HH-------------HHHHhcccc
Confidence 22 1222234668999999999999999999999999999999 456654221 11 122223321
Q ss_pred CCCC-ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 560 LRNG-SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 560 l~~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
-+-. ...-.+++.+++..||..+|++|||+..|.+.
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 1111 22223456678889999999999999999744
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=319.41 Aligned_cols=258 Identities=27% Similarity=0.369 Sum_probs=200.4
Q ss_pred ccCCCcCCcccccCceeEEEeecc------CCcceeEeeccccCc-hhHHHHHHHHHHHhhC-CCCceeeecceeecCCe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETE 394 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 394 (650)
.++|...+.||+|+||.||++... .+..||||+++.... .....+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357889999999999999999641 245799999876532 3345688999999999 79999999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.++||||+++|+|.+++... ....+++.++..++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999998642 2234899999999999999999999987 9999999999999999999999999997
Q ss_pred ccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcc
Q 006317 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553 (650)
Q Consensus 475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 553 (650)
...............++..|+|||.+.+..++.++|||||||++|||++ |+.|+...... ......... +.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~~~~~----~~-- 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYKLIKE----GY-- 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHHHHHc----CC--
Confidence 6543221111222345678999999999999999999999999999998 88887532211 111111111 10
Q ss_pred cccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 554 NLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 554 ~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.+......+ .++.+++.+|++.+|++||++.||++.|..
T Consensus 262 ---~~~~~~~~~---~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 262 ---RMAQPEHAP---AEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ---cCCCCCCCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 000111112 345678889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=307.12 Aligned_cols=259 Identities=23% Similarity=0.402 Sum_probs=204.9
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|+..+.||+|+||.||+|... +|+.||+|.++... ......+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999876 68999999886432 223457889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 400 EFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
||+++++|..++.... ....+++..++.++.+|+.||.|||+.+ ++||||||+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986532 2456899999999999999999999987 99999999999999999999999999876543
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.... .+..... .....+. . +
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~-~~~~~~~----~-~ 226 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLC-KKIEKCD----Y-P 226 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHH-hhhhcCC----C-C
Confidence 221 1223468889999999998899999999999999999999999875322 1111111 1111110 0 1
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
.+.. ......+.+++.+||+.+|++||++.+|+++|+..
T Consensus 227 ~~~~--~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 227 PLPA--DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCh--hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1111 01123455778899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=310.56 Aligned_cols=254 Identities=29% Similarity=0.469 Sum_probs=201.5
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
.++|++.++||+|+||.||++..++++.||+|.+..... ...++.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 467888999999999999999988899999999876543 3457889999999999999999998864 45689999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++++|.+++... ....+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY- 157 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence 999999988643 3457899999999999999999999887 99999999999999999999999999976542221
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
.......++..|+|||++....++.++||||||+++|||++ |+.|+..... .+..... .... .....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~----~~~~-----~~~~~ 225 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNL----ERGY-----RMPRP 225 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHH----HcCC-----CCCCC
Confidence 11122345678999999998899999999999999999999 8888853221 1111111 1110 01111
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
...+ .++.+++.+|++.+|++||++++++..|+.
T Consensus 226 ~~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 DNCP---EELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCC---HHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1122 245677889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=329.41 Aligned_cols=201 Identities=25% Similarity=0.332 Sum_probs=171.9
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|...++||+|+||.||+++.. +++.||||++.+... .....+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888999999999999999854 588999999865422 23346788999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999999863 456899999999999999999999987 999999999999999999999999999643211
Q ss_pred CCC------------C---------------------------------ccceeecCccccChhccccCCCCccccccch
Q 006317 480 QSQ------------G---------------------------------DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSF 514 (650)
Q Consensus 480 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~ 514 (650)
... . ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 0012469999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCC
Q 006317 515 GVLVLEIISGQKNNSF 530 (650)
Q Consensus 515 Gvll~elltG~~p~~~ 530 (650)
||++|||++|+.||..
T Consensus 235 Gvil~elltG~~Pf~~ 250 (377)
T cd05629 235 GAIMFECLIGWPPFCS 250 (377)
T ss_pred chhhhhhhcCCCCCCC
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=305.81 Aligned_cols=250 Identities=33% Similarity=0.494 Sum_probs=200.8
Q ss_pred CcccccCceeEEEeeccC----CcceeEeeccccCchh-HHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNSVQG-ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
++||+|+||.||++.... +..|++|.+....... ...+.+|++.+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998754 7789999997764433 56789999999999999999999999999999999999999
Q ss_pred CChhHHHHhhhc------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 405 SSVDKFIFDAIK------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 405 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999975311 367999999999999999999999987 99999999999999999999999999987654
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
...........++..|+|||.+....++.++||||||+++|||++ |..|+..... .++..... .+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~----~~~~----- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLR----KGYR----- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHH----cCCC-----
Confidence 332223334567889999999998899999999999999999999 5888764321 11111111 1110
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
....... ..++.+++.+||+.+|++||++.|+++.|+
T Consensus 226 ~~~~~~~---~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 LPKPEYC---PDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCccC---ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111111 234567778999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=312.57 Aligned_cols=254 Identities=27% Similarity=0.472 Sum_probs=198.5
Q ss_pred CCCcCCcccccCceeEEEeeccC-C---cceeEeecccc-CchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLSH-G---QEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~~-g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
.|+..+.||+|+||.||+|++.. + ..||||.++.. ......+|..|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778999999999999998653 3 35999998764 2334557999999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++++|.+++.. ....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 85 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999864 3456899999999999999999999987 999999999999999999999999998765432
Q ss_pred CCCCccce-ee--cCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 480 QSQGDTSR-IV--GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 480 ~~~~~~~~-~~--gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
........ .. .+..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .+........+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~~~-------- 228 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQDY-------- 228 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHcCC--------
Confidence 22111111 11 2457999999999999999999999999999987 9888753221 12222111110
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
........+ ..+.+++..||+.+|.+||++.+|+.+|+.
T Consensus 229 -~~~~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 229 -RLPPPMDCP---TALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred -cCCCcccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 000111122 234577889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=320.45 Aligned_cols=237 Identities=24% Similarity=0.288 Sum_probs=185.5
Q ss_pred CcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHH-HHhhCCCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVL-LVARLQHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
+.||+|+||+||+++.. +|+.||||++.+... ....++.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999865 588999999875422 12234445544 56789999999999999999999999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence 999998863 457899999999999999999999987 999999999999999999999999998753221 122
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGS 564 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 564 (650)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ..... . ..+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~---~i~~~-~------~~~~~~~ 219 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---AEMYD---NILNK-P------LRLKPNI 219 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH---HHHHH---HHHcC-C------CCCCCCC
Confidence 3345799999999999999999999999999999999999999863221 11111 11110 0 1111122
Q ss_pred hHHHHHHHHHHhcccccCCCCCCCHH
Q 006317 565 SSEIMRCVHIGLLCVQENVANRPTMA 590 (650)
Q Consensus 565 ~~~~~~~~~l~~~Cl~~~p~~RPt~~ 590 (650)
. ..+.+++.+||+.||++||++.
T Consensus 220 ~---~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 220 S---VSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C---HHHHHHHHHHhhcCHHhCCCCC
Confidence 2 3455677799999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=310.51 Aligned_cols=250 Identities=24% Similarity=0.351 Sum_probs=195.7
Q ss_pred CCCcCCcccccCceeEEEeec-cCCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
+|+..++||+|+||.||+++. .+++.||+|++.... .....++.+|+.++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577889999999999999985 458889999986552 334457889999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 999987542 4788899999999999999999987 999999999999999999999999999755322
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
......||..|+|||++.+..++.++||||||+++|||++|+.|+....................... .+.+..
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 222 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVLPV 222 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCCCC
Confidence 22335789999999999998999999999999999999999999864322111110000011111110 111111
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
. ....++.+++.+|++.+|++||+++|+++.
T Consensus 223 ~--~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 G--QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred C--cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1 112345677889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.47 Aligned_cols=255 Identities=26% Similarity=0.420 Sum_probs=197.9
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCc----ceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQ----EIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
++|+..++||+|+||.||+|++. +++ .||+|.++... .....++.+|+.++..++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 56888899999999999999853 444 37999987543 3345578899999999999999999999875 45789
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
++||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 ~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999874 2456899999999999999999999987 9999999999999999999999999998765
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
............++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ..+...... ....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~----~~~~--- 230 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLLEK----GERL--- 230 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHC----CCcC---
Confidence 3322211222334678999999998899999999999999999999 8888753221 111111111 1000
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
....... ..+.+++..||+.||++||++.++++.|...
T Consensus 231 --~~~~~~~---~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 231 --PQPPICT---IDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred --CCCccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 0011122 3455778899999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=322.24 Aligned_cols=236 Identities=26% Similarity=0.326 Sum_probs=187.1
Q ss_pred CcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
++||+|+||.||+++.+ +++.||||++.+... .....+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999865 478899999875422 2334567788888776 699999999999999999999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCc
Confidence 999998863 456999999999999999999999987 999999999999999999999999998753221 122
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGS 564 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 564 (650)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+..... ... ..+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i~----~~~------~~~~~~~ 219 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---DDLFEAIL----NDE------VVYPTWL 219 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHHHh----cCC------CCCCCCC
Confidence 3345799999999999999999999999999999999999999863321 11111111 110 0111112
Q ss_pred hHHHHHHHHHHhcccccCCCCCCCH
Q 006317 565 SSEIMRCVHIGLLCVQENVANRPTM 589 (650)
Q Consensus 565 ~~~~~~~~~l~~~Cl~~~p~~RPt~ 589 (650)
.. .+.+++.+||+.||++||++
T Consensus 220 ~~---~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 220 SQ---DAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CH---HHHHHHHHHcccCHHHCCCC
Confidence 23 34567779999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=310.89 Aligned_cols=246 Identities=24% Similarity=0.312 Sum_probs=190.8
Q ss_pred ccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCCCh
Q 006317 332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSV 407 (650)
Q Consensus 332 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 407 (650)
||+|+||.||+++.+ +|+.+|+|++..... .....+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 588999999865322 1233456799999999999999999999999999999999999999
Q ss_pred hHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccce
Q 006317 408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487 (650)
Q Consensus 408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 487 (650)
.+++... ....+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.++|+|||++....... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 9888643 3345899999999999999999999987 9999999999999999999999999987654321 1223
Q ss_pred eecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHH
Q 006317 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSE 567 (650)
Q Consensus 488 ~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~ 567 (650)
..|+..|+|||++.+..++.++|||||||++|||++|+.|+........ ............ +.. .......
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~-----~~~-~~~~~~~- 224 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLEDE-----VKF-EHQNFTE- 224 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhccc-----ccc-ccccCCH-
Confidence 4689999999999998999999999999999999999999863222111 111111111110 000 0011223
Q ss_pred HHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 568 IMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 568 ~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
++.+++..||+.||++||++.|+++.
T Consensus 225 --~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 225 --ESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred --HHHHHHHHHhccCHhhCCCCccchhh
Confidence 34567778999999999999877644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=313.33 Aligned_cols=239 Identities=24% Similarity=0.339 Sum_probs=186.1
Q ss_pred cccccCceeEEEeeccC-------------------------CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeee
Q 006317 331 KLGQGGFGAVYKGRLSH-------------------------GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRL 385 (650)
Q Consensus 331 ~LG~G~~g~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l 385 (650)
+||+|+||.||+|.+.. ...|++|++.........++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 12489999876544445578899999999999999999
Q ss_pred cceeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC--
Q 006317 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-- 463 (650)
Q Consensus 386 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~-- 463 (650)
++++.+....++||||+++|+|+.++.. ....+++..+.+++.||++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999864 3457899999999999999999999887 99999999999998654
Q ss_pred -----CeEEeeeecccccccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHH-hCCCCCCCCCCccc
Q 006317 464 -----IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEII-SGQKNNSFRIGEEA 536 (650)
Q Consensus 464 -----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~ell-tG~~p~~~~~~~~~ 536 (650)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+......+
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE- 229 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence 3899999998643211 12356788999998875 56899999999999999995 6888775322211
Q ss_pred chhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 537 EDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 537 ~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
........ ..+..... ..+.+++.+||+.+|++||++.+|++.|.
T Consensus 230 --~~~~~~~~-----------~~~~~~~~---~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 --KERFYEKK-----------HRLPEPSC---KELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHHHHHhc-----------cCCCCCCC---hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111100 00111111 24567888999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.90 Aligned_cols=240 Identities=24% Similarity=0.357 Sum_probs=186.9
Q ss_pred CcccccCceeEEEeeccC-------------CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeE
Q 006317 330 NKLGQGGFGAVYKGRLSH-------------GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 396 (650)
+.||+|+||.||+|++.. ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2248899887655555557888999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC-------eEEee
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI-------PKISD 469 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~-------~kl~D 469 (650)
+||||+++|+|+.++.. ....+++..+++++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999998764 3456899999999999999999999987 999999999999987664 89999
Q ss_pred eecccccccCCCCCccceeecCccccChhccc-cCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhc
Q 006317 470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNW 547 (650)
Q Consensus 470 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 547 (650)
||++...... ....++..|+|||.+. +..++.++|||||||++|||++ |+.|+......+ ... .+.
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~-~~~-- 223 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE---KER-FYE-- 223 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH---HHH-HHh--
Confidence 9998654321 2245788999999887 4678999999999999999985 766654221111 100 000
Q ss_pred cCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 548 NEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 548 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
.. .. +.... ...+.+|+.+||+.||.+||++.+|++.|+
T Consensus 224 -~~--~~-----~~~~~---~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 -GQ--CM-----LVTPS---CKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -cC--cc-----CCCCC---hHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 00 00 11111 234567788999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=308.15 Aligned_cols=258 Identities=22% Similarity=0.373 Sum_probs=203.4
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|+..+.||+|+||.||+++. .+++.++||.+.... .....++.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999985 468899999886532 223457889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 400 EFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999986432 2456899999999999999999999987 99999999999999999999999999876543
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
... ......|+..|+|||.+.+..++.++||||||+++|||++|..|+..... +...... .. .....+
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~----~~-----~~~~~~ 226 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCK----KI-----EQCDYP 226 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-hHHHHhh----hh-----hcCCCC
Confidence 221 12234688899999999988899999999999999999999999753211 1111111 00 011111
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.+... .....+.+++.+||+.+|++||||.+|+++++.
T Consensus 227 ~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 227 PLPSD--HYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCCcc--cccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 11111 122345577789999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=319.00 Aligned_cols=242 Identities=26% Similarity=0.295 Sum_probs=191.5
Q ss_pred CcccccCceeEEEeeccC-CcceeEeeccccCc---hhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
+.||+|+||.||+++... ++.||||++++... .....+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999998754 77899999976422 2334567888888877 799999999999999999999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVT 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC--CCc
Confidence 999988863 457999999999999999999999987 999999999999999999999999998643211 122
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGS 564 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 564 (650)
.....||..|+|||++.+..++.++|||||||++|||++|+.||..... ........ ... .......
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~~~i~----~~~------~~~~~~~ 219 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELFQSIL----EDE------VRYPRWL 219 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHHHHHH----cCC------CCCCCcC
Confidence 3345789999999999999999999999999999999999999863221 11111111 110 1111112
Q ss_pred hHHHHHHHHHHhcccccCCCCCCCH-----HHHHHH
Q 006317 565 SSEIMRCVHIGLLCVQENVANRPTM-----ASVVVM 595 (650)
Q Consensus 565 ~~~~~~~~~l~~~Cl~~~p~~RPt~-----~evl~~ 595 (650)
+. .+.+++.+||+.||.+||++ .++++.
T Consensus 220 ~~---~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 220 SK---EAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CH---HHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 23 34567779999999999999 888754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=308.14 Aligned_cols=254 Identities=25% Similarity=0.365 Sum_probs=187.6
Q ss_pred CcccccCceeEEEeeccC---CcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCC
Q 006317 330 NKLGQGGFGAVYKGRLSH---GQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS 405 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~---g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 405 (650)
+.||+|+||.||+|...+ ...+++|.+..... .....+.+|+..++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 34688888765432 33456889999999999999999999999999999999999999
Q ss_pred ChhHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 406 SVDKFIFDAIK--RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 406 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
+|.+++..... ....++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999975322 233578888999999999999999987 9999999999999999999999999986543222111
Q ss_pred ccceeecCccccChhcccc-------CCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 484 DTSRIVGTFGYMAPEYVTR-------GHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~-------~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
......++..|+|||++.. ..++.++||||||+++|||++ |..|+..... .+.+.... .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~----~~~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD---EQVLKQVV----REQDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHh----hccCccC
Confidence 1223345778999998743 356889999999999999999 6667643211 11111111 1111222
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
.++.+......+.. +++..|+ .||++|||+++|+++|.
T Consensus 231 ~~~~~~~~~~~~~~---~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDLKYSDRWY---EVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccccCCHHHH---HHHHHHh-cCcccccCHHHHHHHhc
Confidence 22333323333333 4555677 59999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=329.15 Aligned_cols=202 Identities=25% Similarity=0.363 Sum_probs=172.4
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|++.+.||+|+||.||+++.. +++.||||++.+... .....+.+|+.++++++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999854 488999999865422 22345789999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999863 456889999999999999999999987 999999999999999999999999997533110
Q ss_pred CC-----------------------------------------CCccceeecCccccChhccccCCCCccccccchhHHH
Q 006317 480 QS-----------------------------------------QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLV 518 (650)
Q Consensus 480 ~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll 518 (650)
.. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00 0001234799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCC
Q 006317 519 LEIISGQKNNSFR 531 (650)
Q Consensus 519 ~elltG~~p~~~~ 531 (650)
|||++|+.||...
T Consensus 235 yell~G~~Pf~~~ 247 (376)
T cd05598 235 YEMLVGQPPFLAD 247 (376)
T ss_pred eehhhCCCCCCCC
Confidence 9999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=326.11 Aligned_cols=260 Identities=24% Similarity=0.345 Sum_probs=195.0
Q ss_pred CCCcCCcccccCceeEEEeec-cCCcceeEeecccc--CchhHHHHHHHHHHHhhCCCCceeeecceeecCC-----eeE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET-----ERL 396 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 396 (650)
+|+..++||+|+||.||++.. .+++.||||++... .......+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999985 46889999998653 2233456889999999999999999999998766 789
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
+||||+. ++|.+++. ....+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 57777765 3457999999999999999999999987 999999999999999999999999999865
Q ss_pred ccCCCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcc--
Q 006317 477 EMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL-- 553 (650)
Q Consensus 477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-- 553 (650)
..... .......++..|+|||++.+. .++.++|||||||++|||++|+.||......+ .+.............
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ---QLDLITDLLGTPSLEAM 229 (372)
T ss_pred ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCHHHH
Confidence 43222 122234678899999998874 57899999999999999999999986433211 111111100000000
Q ss_pred --------ccc-----Cc-c---CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 554 --------NLI-----DP-T---LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 554 --------~~i-----d~-~---l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..+ .+ . +.........++.+++.+||+.||++|||+.|++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000 00 0 000001112345678889999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=317.47 Aligned_cols=248 Identities=23% Similarity=0.288 Sum_probs=193.2
Q ss_pred CcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
++||+|+||.||+++.. +++.||+|++++... .....+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999865 478899999976532 2234578899999888 699999999999999999999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDT 152 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCc
Confidence 99998876 3457999999999999999999999987 999999999999999999999999998743211 122
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGS 564 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 564 (650)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.............+.+....... ..+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~p~~~ 226 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP------IRIPRFL 226 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC------CCCCCCC
Confidence 3346799999999999999999999999999999999999999964333222222222222221111 0111112
Q ss_pred hHHHHHHHHHHhcccccCCCCCCCH------HHHHH
Q 006317 565 SSEIMRCVHIGLLCVQENVANRPTM------ASVVV 594 (650)
Q Consensus 565 ~~~~~~~~~l~~~Cl~~~p~~RPt~------~evl~ 594 (650)
. .++.+++.+||+.||++||++ .++++
T Consensus 227 ~---~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 259 (327)
T cd05617 227 S---VKASHVLKGFLNKDPKERLGCQPQTGFSDIKS 259 (327)
T ss_pred C---HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence 2 234567779999999999984 56654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=320.04 Aligned_cols=259 Identities=27% Similarity=0.397 Sum_probs=198.0
Q ss_pred ccCCCcCCcccccCceeEEEeec------cCCcceeEeeccccCc-hhHHHHHHHHHHHhhC-CCCceeeecceeecC-C
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFSFEE-T 393 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~ 393 (650)
.++|++.++||+|+||.||+|+. .+++.||||+++.... .....+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35789999999999999999963 3467899999976432 2344688999999999 689999999988654 4
Q ss_pred eeEEEEecCCCCChhHHHHhhhc---------------------------------------------------------
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIK--------------------------------------------------------- 416 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 416 (650)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999864210
Q ss_pred -------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccceee
Q 006317 417 -------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489 (650)
Q Consensus 417 -------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 489 (650)
...+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124788899999999999999999987 9999999999999999999999999998653322222222234
Q ss_pred cCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHH
Q 006317 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEI 568 (650)
Q Consensus 490 gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~ 568 (650)
++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ..... ....+.... ......
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~----~~~~~~~~~-----~~~~~~--- 308 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCR----RLKEGTRMR-----APDYTT--- 308 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHH----HHhccCCCC-----CCCCCC---
Confidence 5678999999998899999999999999999997 88887532211 11111 111111110 011111
Q ss_pred HHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 569 MRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 569 ~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.++.+++..||+.+|++||++.||++.|+.
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 245678889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=304.70 Aligned_cols=263 Identities=24% Similarity=0.342 Sum_probs=201.1
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCch--hHHHHHHHHHHHhhCCCCc-eeeecceeecCC------
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRN-LVRLLGFSFEET------ 393 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------ 393 (650)
..|...++||+|.||+||+|+. .+|+.||+|++.-.... ......+|+.++++++|+| ||++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4566778999999999999985 45889999999765432 2234689999999999999 999999998877
Q ss_pred eeEEEEecCCCCChhHHHHhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeec
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 472 (650)
..+||+||+.. +|..++...... ..++...+..++.||+.||+|||+++ |+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 78899999965 899998764322 45777899999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhcc---
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWN--- 548 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~--- 548 (650)
|+.+.... ......++|..|.|||++.+. .|+...||||+|||+.||++++.-|..... .+.+...+....
T Consensus 167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTPN 241 (323)
T ss_pred HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCCC
Confidence 99765332 224456789999999999986 799999999999999999998876653322 333333332221
Q ss_pred -----CCCcccccCccCCCC-----C----hHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 549 -----EGTALNLIDPTLRNG-----S----SSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 549 -----~~~~~~~id~~l~~~-----~----~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
......-.+...... . +......++++.+||+.+|.+|.|++..+.+
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111111111111110 0 1111356678889999999999999999876
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=321.78 Aligned_cols=241 Identities=25% Similarity=0.286 Sum_probs=190.4
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCC-ceeeecceeecCCeeEEEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHR-NLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~ 399 (650)
+|++.+.||+|+||.||+|+.. +++.||||++.+.. ......+..|..++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999865 46789999987642 22334577899999999765 5888989999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999886 3456899999999999999999999987 999999999999999999999999998643211
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
........||..|+|||++.+..++.++|||||||++|||+||+.|+.... .......... . ...
T Consensus 155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~----~------~~~ 219 (324)
T cd05587 155 --GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQSIME----H------NVS 219 (324)
T ss_pred --CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHc----C------CCC
Confidence 122334579999999999999999999999999999999999999986322 1122221111 0 011
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTM 589 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~ 589 (650)
+...... ++.+++.+||+.||++||+.
T Consensus 220 ~~~~~~~---~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 YPKSLSK---EAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCH---HHHHHHHHHhhcCHHHcCCC
Confidence 1112222 34567779999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.39 Aligned_cols=247 Identities=26% Similarity=0.416 Sum_probs=191.1
Q ss_pred cccccCceeEEEeecc---CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCCC
Q 006317 331 KLGQGGFGAVYKGRLS---HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSS 406 (650)
Q Consensus 331 ~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 406 (650)
.||+|+||.||+|.+. .+..||+|++..... .....+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 355699999876533 23456899999999999999999999875 457899999999999
Q ss_pred hhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC-cc
Q 006317 407 VDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG-DT 485 (650)
Q Consensus 407 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~ 485 (650)
|.+++.. ....+++..+++++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++......... ..
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999864 3457899999999999999999999987 9999999999999999999999999998654332211 11
Q ss_pred ceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCC
Q 006317 486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGS 564 (650)
Q Consensus 486 ~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 564 (650)
....++..|+|||.+....++.++||||||+++|||++ |+.|+...... +..... ..+.. +......
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~----~~~~~-----~~~~~~~ 223 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMSFI----EQGKR-----LDCPAEC 223 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH----HCCCC-----CCCCCCC
Confidence 11223578999999988889999999999999999997 98887532211 111111 11110 1111122
Q ss_pred hHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 565 SSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 565 ~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
. .++.+++..||+.+|++||++.+|.+.|+.
T Consensus 224 ~---~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 224 P---PEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred C---HHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 3 344467779999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=319.10 Aligned_cols=258 Identities=26% Similarity=0.379 Sum_probs=199.4
Q ss_pred ccCCCcCCcccccCceeEEEeecc--------CCcceeEeeccccC-chhHHHHHHHHHHHhhC-CCCceeeecceeecC
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS--------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEE 392 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 392 (650)
.++|.+.+.||+|+||.||+++.. ++..+|+|.+.... .....++.+|+.++.++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357899999999999999999742 23469999997643 23445688899999999 799999999999999
Q ss_pred CeeEEEEecCCCCChhHHHHhhhc-------------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAIK-------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 459 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl 459 (650)
+..++||||+++|+|.+++..... ...+++.++++++.||+.||+|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999975321 235899999999999999999999887 9999999999999
Q ss_pred CCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccch
Q 006317 460 DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAED 538 (650)
Q Consensus 460 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~ 538 (650)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ..+
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~---~~~ 250 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---VEE 250 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC---HHH
Confidence 9999999999999876542221111222234568999999998889999999999999999999 777764321 111
Q ss_pred hHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 539 LLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 539 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+..... ..... ....... ..+.+++..||+.+|.+||++.+|++.|+.
T Consensus 251 ~~~~~~----~~~~~-----~~~~~~~---~~~~~li~~~l~~~p~~Rps~~evl~~l~~ 298 (307)
T cd05098 251 LFKLLK----EGHRM-----DKPSNCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLDR 298 (307)
T ss_pred HHHHHH----cCCCC-----CCCCcCC---HHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 111111 11100 0111122 345567889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=305.68 Aligned_cols=248 Identities=28% Similarity=0.400 Sum_probs=195.6
Q ss_pred CcccccCceeEEEeeccCCcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCCChh
Q 006317 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD 408 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 408 (650)
++||+|+||.||++...+++.|++|++...... ....+.+|+.++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765443 4557899999999999999999999999999999999999999999
Q ss_pred HHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCcccee
Q 006317 409 KFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488 (650)
Q Consensus 409 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 488 (650)
+++.. ....+++..++.++.+++.+|+|||+.+ ++||||||+|||++.++.+||+|||+++..............
T Consensus 81 ~~l~~--~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99864 2346899999999999999999999887 999999999999999999999999999755422111111122
Q ss_pred ecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHH
Q 006317 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSE 567 (650)
Q Consensus 489 ~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~ 567 (650)
.++..|+|||.+.++.++.++||||||+++|||+| |..|+...... ........ .. ........+
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~~~~~~----~~-----~~~~~~~~~-- 221 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRERIES----GY-----RMPAPQLCP-- 221 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHHHHHhc----CC-----CCCCCccCC--
Confidence 33567999999998899999999999999999999 77776432211 11111110 00 000111122
Q ss_pred HHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 568 IMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 568 ~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
..+.+++.+|++.+|.+|||+.||++.|+
T Consensus 222 -~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 -EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 34567888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=316.77 Aligned_cols=259 Identities=25% Similarity=0.378 Sum_probs=201.0
Q ss_pred hccCCCcCCcccccCceeEEEeecc--------CCcceeEeeccccC-chhHHHHHHHHHHHhhC-CCCceeeecceeec
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS--------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFE 391 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 391 (650)
..++|.+.+.||+|+||.||+++.. ++..||+|.+.... .....++.+|+.++..+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3467888899999999999999631 24469999987543 23445788999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCChhHHHHhhh-------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceE
Q 006317 392 ETERLLIYEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 458 (650)
Q Consensus 392 ~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 458 (650)
....++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 999999999999999999997531 1245889999999999999999999987 999999999999
Q ss_pred eCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccc
Q 006317 459 LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAE 537 (650)
Q Consensus 459 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~ 537 (650)
+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.... ..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~ 246 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VE 246 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---HH
Confidence 99999999999999986643322222333345678999999988889999999999999999999 666664221 11
Q ss_pred hhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 538 DLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 538 ~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
++..... ...... .....+ ..+.+++.+||+.+|.+||++.||++.|+.
T Consensus 247 ~~~~~~~----~~~~~~-----~~~~~~---~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 247 ELFKLLK----EGHRMD-----KPANCT---NELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred HHHHHHH----cCCcCC-----CCCCCC---HHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 2221111 111100 011122 345567779999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=324.22 Aligned_cols=254 Identities=20% Similarity=0.255 Sum_probs=196.5
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
..++|+..++||+|+||.||+++.. +++.||+|++.+.. ......+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4568899999999999999999865 57889999986532 2233457789999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998853 35888899999999999999999987 9999999999999999999999999997654
Q ss_pred cCCCCCccceeecCccccChhccccC----CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcc
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRG----HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 553 (650)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .... .........
T Consensus 194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~---~i~~~~~~~ 266 (370)
T cd05596 194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYS---KIMDHKNSL 266 (370)
T ss_pred CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---HHHH---HHHcCCCcC
Confidence 2211 122345799999999998653 4789999999999999999999998633211 1111 111111000
Q ss_pred cccCccCCCCChHHHHHHHHHHhcccccCCCC--CCCHHHHHHH
Q 006317 554 NLIDPTLRNGSSSEIMRCVHIGLLCVQENVAN--RPTMASVVVM 595 (650)
Q Consensus 554 ~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~--RPt~~evl~~ 595 (650)
.. +. ...... .+.+++..||+.+|.+ ||++.|++..
T Consensus 267 ~~--~~-~~~~s~---~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TF--PD-DIEISK---QAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CC--CC-cCCCCH---HHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 00 001223 3445667899999988 9999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=327.63 Aligned_cols=200 Identities=26% Similarity=0.367 Sum_probs=171.4
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
.|+..++||+|+||.||+++.. +++.||+|++.+... .....+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999864 578899999875432 233468899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999998863 356889999999999999999999987 9999999999999999999999999975332100
Q ss_pred C---------------------------------------------CCccceeecCccccChhccccCCCCccccccchh
Q 006317 481 S---------------------------------------------QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFG 515 (650)
Q Consensus 481 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~G 515 (650)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0001234699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCC
Q 006317 516 VLVLEIISGQKNNSF 530 (650)
Q Consensus 516 vll~elltG~~p~~~ 530 (650)
|++|||++|+.||..
T Consensus 236 vil~elltG~~Pf~~ 250 (382)
T cd05625 236 VILYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=320.60 Aligned_cols=245 Identities=24% Similarity=0.296 Sum_probs=190.4
Q ss_pred CCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHH---hhCCCCceeeecceeecCCeeEEE
Q 006317 326 FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLV---ARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
|++.+.||+|+||.||++... +++.||||++++... .....+.+|+.++ ..++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999864 588999999975421 2223456665554 567899999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++++|..++. ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988774 356999999999999999999999987 99999999999999999999999999874322
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
. ........|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .+....... .. +
T Consensus 154 ~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~~~~~~i~~----~~------~ 218 (324)
T cd05589 154 F--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---EEVFDSIVN----DE------V 218 (324)
T ss_pred C--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHh----CC------C
Confidence 1 1223346799999999999999999999999999999999999999863321 111111111 00 1
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCC-----CHHHHHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRP-----TMASVVVM 595 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~~ 595 (650)
......+. .+.+++.+||+.||.+|| ++.++++.
T Consensus 219 ~~p~~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 RYPRFLSR---EAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCCCCCH---HHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 11112223 345677799999999999 56666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.22 Aligned_cols=240 Identities=26% Similarity=0.332 Sum_probs=188.5
Q ss_pred CcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
++||+|+||.||+++.. +|+.||+|+++.... .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999865 478899999976421 2233466777777654 899999999999999999999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCc
Confidence 999998863 456899999999999999999999987 999999999999999999999999998743211 122
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGS 564 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 564 (650)
.....||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+...... . .+.+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~~~~----~------~~~~~~~~ 219 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESIRV----D------TPHYPRWI 219 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHh----C------CCCCCCCC
Confidence 3346789999999999999999999999999999999999999863221 112111110 0 11111222
Q ss_pred hHHHHHHHHHHhcccccCCCCCCCHH-HHH
Q 006317 565 SSEIMRCVHIGLLCVQENVANRPTMA-SVV 593 (650)
Q Consensus 565 ~~~~~~~~~l~~~Cl~~~p~~RPt~~-evl 593 (650)
.. ++.+++.+||+.||++||++. +++
T Consensus 220 ~~---~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 220 TK---ESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CH---HHHHHHHHHccCCHHHcCCChHHHH
Confidence 23 344677799999999999984 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=314.33 Aligned_cols=262 Identities=25% Similarity=0.392 Sum_probs=198.4
Q ss_pred cCCCcCCcccccCceeEEEeec-----cCCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecC--Cee
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TER 395 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 395 (650)
..|+..+.||+|+||.||+++. .++..||+|.++... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3468889999999999999974 347789999987553 33345789999999999999999999998775 567
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++||||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 899999999999999864 2346899999999999999999999987 99999999999999999999999999986
Q ss_pred cccCCCC-CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCc--------ccchhHHHHHHh
Q 006317 476 FEMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGE--------EAEDLLTYAWKN 546 (650)
Q Consensus 476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~--------~~~~l~~~~~~~ 546 (650)
+...... .......++..|+|||++.+..++.++||||||+++|||++++.|....... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 5432221 1122345677899999998889999999999999999999987654311100 000000111111
Q ss_pred ccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 547 WNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 547 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
...+.. ..... .....+.+++.+||+.+|.+||++.++++.|+.
T Consensus 239 ~~~~~~-----~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 239 LEEGKR-----LPRPP---NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHcCcc-----CCCCC---CCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 111100 00011 122456678889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=316.72 Aligned_cols=255 Identities=26% Similarity=0.402 Sum_probs=196.6
Q ss_pred cCCCcCCcccccCceeEEEeeccC-Cc--ceeEeecccc-CchhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQ--EIAVKRLSKN-SVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 398 (650)
++|++.+.||+|+||.||+|+..+ +. .+++|.++.. .......+.+|+.++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468889999999999999998754 33 4688888753 233445788999999999 799999999999999999999
Q ss_pred EecCCCCChhHHHHhhh-------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCe
Q 006317 399 YEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 465 (650)
|||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996421 1135889999999999999999999987 9999999999999999999
Q ss_pred EEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHH
Q 006317 466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAW 544 (650)
Q Consensus 466 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~ 544 (650)
||+|||++...... ........+..|+|||++....++.++|||||||++|||++ |+.||..... .++....
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~~~~~- 231 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AELYEKL- 231 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH-
Confidence 99999998642211 01111223557999999998889999999999999999998 9888753221 1111111
Q ss_pred HhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 545 KNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 545 ~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
..+ ..+......+ ..+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 232 ---~~~-----~~~~~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 232 ---PQG-----YRMEKPRNCD---DEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred ---hcC-----CCCCCCCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111 0111111122 3455778899999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=306.42 Aligned_cols=249 Identities=31% Similarity=0.450 Sum_probs=197.0
Q ss_pred CcccccCceeEEEeeccC--Cc--ceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLSH--GQ--EIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~--g~--~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
++||+|++|.||+|.+.+ ++ .||||.+..... .....+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998643 32 589999987766 556679999999999999999999999988 889999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC-C
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-G 483 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 483 (650)
++|.+++.+... ..+++...+.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999975322 56899999999999999999999987 999999999999999999999999999876542221 1
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .+....... ..... ....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~---~~~~~-----~~~~ 224 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILKKIDK---EGERL-----ERPE 224 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHh---cCCcC-----CCCc
Confidence 1223456789999999998899999999999999999999 9998752211 111111111 00000 0011
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
..+ ..+.+++.+|++.+|++||++.+|++.|.
T Consensus 225 ~~~---~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 ACP---QDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCC---HHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 112 34567888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=297.46 Aligned_cols=274 Identities=23% Similarity=0.321 Sum_probs=201.7
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchh--HHHHHHHHHHHhhCCCCceeeecceeecC--CeeEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERLLI 398 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv 398 (650)
+.|+.+++|++|.||.||+|+.+ +++.||+|+++...... -..-.+|+.+|.+.+|||||.+-.+.... +..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 46888999999999999999865 47889999998654221 22457899999999999999998887643 578999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
||||++ +|...+... ..++...+..-+..|+++|++|||... |+|||||++|+|+++.|.+||+||||||.+..
T Consensus 156 Me~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999987 888888753 357899999999999999999999998 99999999999999999999999999998864
Q ss_pred CCCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC-------
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG------- 550 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------- 550 (650)
.. ...+..+-|++|.|||.+.+. .|+...|+||+|||+.||+++++-+... ...+.+...++.+..+
T Consensus 230 p~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~---sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 230 PL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK---SEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred Cc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC---chHHHHHHHHHHhCCCccccCCC
Confidence 42 334556779999999999874 6899999999999999999999877533 2333333332222111
Q ss_pred -CcccccC-cc--------CCCCChHH--HHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCCCCCCCCCCc
Q 006317 551 -TALNLID-PT--------LRNGSSSE--IMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSLPLPSQPA 610 (650)
Q Consensus 551 -~~~~~id-~~--------l~~~~~~~--~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~~~~~p~~p~ 610 (650)
.....+. .. ++...... ...-.+++-..+..||++|-|++|-++-=-. ...|.|.-|.
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F--~e~P~p~~P~ 374 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYF--RETPLPIDPS 374 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccc--ccCCCCCChh
Confidence 1111110 00 01100000 0122345556788999999999998754221 2445554443
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.56 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=199.3
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
++|++.++||+|+||.||+++.. ++..+|+|.+..... ....++.+|++++.+++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999865 477889998865422 2344688999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++.. ...+++..+..++.||++||.|||+.. +++|+||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 999999999873 356899999999999999999999742 3999999999999999999999999998754321
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCc---------
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA--------- 552 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--------- 552 (650)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+........................
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 122356889999999998888999999999999999999999998643322111111100000000000
Q ss_pred --------cccc-------CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHh
Q 006317 553 --------LNLI-------DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVML 596 (650)
Q Consensus 553 --------~~~i-------d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L 596 (650)
.+.. .+.+... .....+.+++.+||+.+|++||++.+|+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSG--AFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCc--ccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000 0001000 0123466888899999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=310.62 Aligned_cols=255 Identities=26% Similarity=0.455 Sum_probs=199.8
Q ss_pred cCCCcCCcccccCceeEEEeeccC----CcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
.+|++.+.||+|+||.||+|+... +..+|+|.++.... .....+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 467888999999999999998642 33699999875432 3345789999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++++|.+++.. ....+++.+++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999864 2356899999999999999999999987 99999999999999999999999999986643
Q ss_pred CCCCC-ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 479 DQSQG-DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 479 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
..... ......++..|++||.+.+..++.++||||||+++||+++ |+.|+...... +........+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~~-------- 227 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIEEGYR-------- 227 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHhCCCc--------
Confidence 22211 1112233568999999998899999999999999999887 99887532211 12211111100
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.......+ ..+.+++.+|++.+|.+||+|.++++.|+.
T Consensus 228 -~~~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 228 -LPAPMDCP---AALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred -CCCCCCCC---HHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 00111112 345578889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=320.13 Aligned_cols=246 Identities=24% Similarity=0.275 Sum_probs=192.8
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 399 (650)
+|...+.||+|+||.||+++.. +++.||||++.+... .....+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999865 467899999876432 2223466777887777 5899999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999988863 456899999999999999999999987 999999999999999999999999998743221
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ..+...... .. ..
T Consensus 155 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~----~~------~~ 219 (323)
T cd05616 155 --GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIME----HN------VA 219 (323)
T ss_pred --CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHHHh----CC------CC
Confidence 1123345789999999999999999999999999999999999999863321 222221111 00 11
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCH-----HHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTM-----ASVVV 594 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~-----~evl~ 594 (650)
+..... .++.+++.+|++.+|++|++. .++.+
T Consensus 220 ~p~~~s---~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 220 YPKSMS---KEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred CCCcCC---HHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 111222 344567779999999999984 56653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=303.76 Aligned_cols=265 Identities=23% Similarity=0.338 Sum_probs=201.4
Q ss_pred hhccCCCcCCcccccCceeEEEeec-cCCcceeEeeccc--cCchhHHHHHHHHHHHhhCCCCceeeecceeec-----C
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSK--NSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE-----E 392 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~ 392 (650)
.....|...+.||+|.||.|..++. .+|+.||||++.. ...-..+...+|+.+++.++|+||+.++..+.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 3456677789999999999999985 4589999999973 333445567899999999999999999998765 3
Q ss_pred CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeec
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 472 (650)
+..|+|+|+| ..+|...++ .+..|+......++.||++||.|+|+.+ |+||||||+|+|++.+...||+||||
T Consensus 99 ~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 5789999999 458888876 3445999999999999999999999988 99999999999999999999999999
Q ss_pred ccccccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC-
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG- 550 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~- 550 (650)
|+...........+..+.|.+|.|||++.. ..|+...||||.|||+.||++|+.-|...+.-. .+.........+
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~---Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH---QLQLILELLGTPS 248 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH---HHHHHHHhcCCCC
Confidence 998765423334466788999999998754 689999999999999999999998776433222 222221111111
Q ss_pred ----------CcccccC--ccCCCC-----ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 551 ----------TALNLID--PTLRNG-----SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 551 ----------~~~~~id--~~l~~~-----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.....+. +..... .+......++|+.+||..||.+|+|++|.++-
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111111 001111 11112345677789999999999999999865
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=315.82 Aligned_cols=258 Identities=28% Similarity=0.400 Sum_probs=199.7
Q ss_pred cCCCcCCcccccCceeEEEeecc--------CCcceeEeeccccC-chhHHHHHHHHHHHhhC-CCCceeeecceeecCC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS--------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEET 393 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 393 (650)
++|.+.++||+|+||.||+++.. ....+|+|.++... .....++.+|+.+++++ +||||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57888999999999999999742 24468999987543 23345688999999999 6999999999999999
Q ss_pred eeEEEEecCCCCChhHHHHhhh-------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 460 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~ 460 (650)
..++||||+++|+|.+++.... ....+++.++.+++.||+.||.|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999997532 1245899999999999999999999887 99999999999999
Q ss_pred CCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchh
Q 006317 461 ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDL 539 (650)
Q Consensus 461 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l 539 (650)
+++.+||+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.|+.... ..+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~---~~~~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP---VEEL 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC---HHHH
Confidence 999999999999986543222111222234567999999998899999999999999999999 777774322 1122
Q ss_pred HHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 540 LTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 540 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
..... .....+ .....+ .++.+++.+||+.+|++||++.|+++.|...
T Consensus 246 ~~~~~----~~~~~~-----~~~~~~---~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 246 FKLLR----EGHRMD-----KPSNCT---HELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HHHHH----cCCCCC-----CCCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 22111 111111 111122 2455778899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.38 Aligned_cols=250 Identities=28% Similarity=0.452 Sum_probs=201.8
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
.++|+..+.||.|+||.||++... |+.||+|.+..... ...++.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888899999999999999874 78999999976654 4567899999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 999999998743 2236999999999999999999999987 99999999999999999999999999986532211
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
...++..|+|||.+..+.++.++||||||+++|||++ |+.|+.... ..++.......+ . ....
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~~~----~-----~~~~ 221 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPHVEKGY----R-----MEAP 221 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHhcCC----C-----CCCc
Confidence 2234568999999998899999999999999999998 888875321 112222111111 0 0111
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
...+ ..+.+++.+||+.+|++||+++|++.+|+.
T Consensus 222 ~~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 EGCP---PEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cCCC---HHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1122 345577889999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=304.24 Aligned_cols=252 Identities=27% Similarity=0.380 Sum_probs=198.3
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch-----hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ-----GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
++|...+.||+|++|.||++... +++.+++|.+...... ....+.+|+.++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999854 5889999998654221 23468889999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999998863 456899999999999999999999987 9999999999999999999999999997654
Q ss_pred cCCCCC-ccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 478 MDQSQG-DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 478 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
...... ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~----- 224 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPT----- 224 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCC-----
Confidence 221111 112345788999999999988999999999999999999999987522111 11111111100
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+.+...... .+.+++..||+.+|.+|||+.++++.
T Consensus 225 ~~~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 NPQLPSHVSP---DARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCccCCH---HHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111112223 34567779999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=305.14 Aligned_cols=248 Identities=30% Similarity=0.452 Sum_probs=194.1
Q ss_pred CcccccCceeEEEeeccC----CcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
++||+|+||.||+|++.. +..+|+|.+...... ...++.+|+.+++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 267999999766542 4557899999999999999999999876 4568999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC-
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG- 483 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~- 483 (650)
|+|.+++.. ...+++..++.++.|++.+|+|||+.+ ++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999974 347899999999999999999999887 9999999999999999999999999998664332211
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .+........ ... ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~----~~~-----~~~~ 221 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESG----ERL-----PRPE 221 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcC----CcC-----CCCC
Confidence 1111224567999999998999999999999999999998 8888753322 2222222111 100 0111
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
..+ ..+.+++.+||+.+|++||++.+|++.|+..
T Consensus 222 ~~~---~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 222 ECP---QEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCC---HHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 112 3455788899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=306.29 Aligned_cols=252 Identities=28% Similarity=0.494 Sum_probs=200.4
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
.+|+..+.||+|+||.||++.+.++..+|+|++..... ...++.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 45777899999999999999987788999999875433 34578999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
+++|.+++.. ....+++..++.++.+++.+|+|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 9999999864 2346899999999999999999999887 999999999999999999999999998755322111
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
......++.+|+|||.+.++.++.++||||||+++|||++ |+.|+..... ..++... ..+ .....+.+
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~----~~~--~~~~~~~~-- 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETI----NAG--FRLYKPRL-- 225 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHH----hCC--CCCCCCCC--
Confidence 1112234678999999998899999999999999999998 8888753221 1111111 111 01111111
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
. ...+.+++.+||+.+|++||++.||+++|.
T Consensus 226 -~---~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 -A---SQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -C---CHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1 245667888999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=307.38 Aligned_cols=253 Identities=28% Similarity=0.466 Sum_probs=198.1
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
++|...++||+|++|.||++....+..+|+|++..... ....+.+|+.++++++|||++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 45788899999999999999987777899998865432 3456889999999999999999998875 456889999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++....... .
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~ 158 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-T 158 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-c
Confidence 99999998753 2345899999999999999999999887 99999999999999999999999999976543221 1
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ........... .+....
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~---------~~~~~~ 226 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQVERGY---------RMPCPQ 226 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCC---------CCCCCc
Confidence 1122345678999999998899999999999999999999 8887753211 11111111100 011111
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
..+ ..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 227 ~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 227 GCP---ESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ccC---HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 122 345567779999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=307.82 Aligned_cols=254 Identities=28% Similarity=0.410 Sum_probs=197.1
Q ss_pred HhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceeecC-----
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEE----- 392 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----- 392 (650)
+++++.|+..+.||+|+||.||+|+.. +++.||+|++.... .....+.+|+.++.++ +||||+++++++...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 456788999999999999999999865 47889999986543 3345788999999998 799999999998753
Q ss_pred -CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeee
Q 006317 393 -TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471 (650)
Q Consensus 393 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 471 (650)
...++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence 4578999999999999998752 3356899999999999999999999987 9999999999999999999999999
Q ss_pred cccccccCCCCCccceeecCccccChhccc-----cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHh
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKN 546 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~ 546 (650)
++....... .......|+..|+|||++. +..++.++|||||||++|||++|+.|+...... .... ..
T Consensus 157 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~~-~~ 228 (272)
T cd06637 157 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALF-LI 228 (272)
T ss_pred Cceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHH-HH
Confidence 997653221 2233457899999999986 345788999999999999999999988522111 1111 11
Q ss_pred ccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 547 WNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 547 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
... ..... .....+. .+.+++.+||+.+|.+|||+.++++
T Consensus 229 ~~~-~~~~~----~~~~~~~---~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PRN-PAPRL----KSKKWSK---KFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hcC-CCCCC----CCCCcCH---HHHHHHHHHcCCChhhCCCHHHHhh
Confidence 110 00000 1111222 4557778999999999999999974
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.46 Aligned_cols=240 Identities=23% Similarity=0.290 Sum_probs=186.8
Q ss_pred CcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHH-HHhhCCCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVL-LVARLQHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
+.||+|+||.||+++.. +|+.+|+|++.+... .....+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999854 588999999875421 22334555554 46779999999999999999999999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
|+|..++. +...+++..+..++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence 99998886 3457899999999999999999999987 999999999999999999999999998743211 122
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGS 564 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 564 (650)
.....||..|+|||++.+..++.++|||||||++|||++|+.||..... ..+.. ...... ..+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~---~~~~~~-------~~~~~~~ 219 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV---AEMYD---NILHKP-------LVLRPGA 219 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH---HHHHH---HHHcCC-------ccCCCCC
Confidence 3345799999999999999999999999999999999999999863221 11111 111110 0111112
Q ss_pred hHHHHHHHHHHhcccccCCCCCCCHHHHH
Q 006317 565 SSEIMRCVHIGLLCVQENVANRPTMASVV 593 (650)
Q Consensus 565 ~~~~~~~~~l~~~Cl~~~p~~RPt~~evl 593 (650)
. ..+.+++..|++.+|++||++.+.+
T Consensus 220 ~---~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 220 S---LTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred C---HHHHHHHHHHhccCHHhcCCCCCCH
Confidence 2 3345677789999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=313.09 Aligned_cols=270 Identities=26% Similarity=0.401 Sum_probs=201.2
Q ss_pred cCCCcCCcccccCceeEEEeecc-----CCcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeec--CCee
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-----HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFE--ETER 395 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 395 (650)
+.|+..+.||+|+||.||++++. .+..+|||.+...... ....+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45677899999999999999853 3678999999766443 45679999999999999999999999877 5678
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999742 336999999999999999999999987 99999999999999999999999999987
Q ss_pred cccCCCC-CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 476 FEMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
....... .......++..|++||.+....++.++||||||+++|||++|+.|+......... ...............+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQGQMIVTRLLE 237 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-ccccccccccHHHHHH
Confidence 6522211 1111234456799999998889999999999999999999999886532211100 0000000000000000
Q ss_pred ccCccCCCC-ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 555 LIDPTLRNG-SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 555 ~id~~l~~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
.+....... ......++.+++.+||+.+|++|||+.||+++|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111100000 011114566788899999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.79 Aligned_cols=241 Identities=26% Similarity=0.327 Sum_probs=188.9
Q ss_pred CcccccCceeEEEeeccC-CcceeEeeccccCc---hhHHHHHHHHHHHhh-CCCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVAR-LQHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
+.||+|+||.||+|+... ++.||||+++.... .....+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999998654 77899999876421 223345667777775 4899999999999999999999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCc
Confidence 999998863 456899999999999999999999987 999999999999999999999999998743221 122
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGS 564 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 564 (650)
.....||..|+|||++.+..++.++|||||||++|||++|+.|+..... ..+..... .. .+.+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i~----~~------~~~~~~~~ 219 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIR----MD------NPCYPRWL 219 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHH----hC------CCCCCccC
Confidence 3345789999999999999999999999999999999999999863321 12221111 00 11111112
Q ss_pred hHHHHHHHHHHhcccccCCCCCCCHH-HHHH
Q 006317 565 SSEIMRCVHIGLLCVQENVANRPTMA-SVVV 594 (650)
Q Consensus 565 ~~~~~~~~~l~~~Cl~~~p~~RPt~~-evl~ 594 (650)
.. .+.+++.+||+.||++||++. ++.+
T Consensus 220 ~~---~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 220 TR---EAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CH---HHHHHHHHHhccCHhhcCCChHHHHc
Confidence 22 345677799999999999997 6643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.13 Aligned_cols=203 Identities=22% Similarity=0.299 Sum_probs=173.5
Q ss_pred HhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCee
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETER 395 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 395 (650)
....++|+..++||+|+||.||+++.. +++.+|+|++.+.. ......+.+|+.+++.++||||+++++++.++...
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344578999999999999999999865 47889999986532 22334578899999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999998853 35889999999999999999999987 99999999999999999999999999986
Q ss_pred cccCCCCCccceeecCccccChhccccC----CCCccccccchhHHHHHHHhCCCCCCC
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRG----HFSIKSDVFSFGVLVLEIISGQKNNSF 530 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~S~Gvll~elltG~~p~~~ 530 (650)
..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 192 ~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 192 MDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred cccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 54221 1122345799999999998754 378999999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=327.66 Aligned_cols=194 Identities=23% Similarity=0.278 Sum_probs=167.3
Q ss_pred ccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
..+|.+.+.||+|+||.||+++... ++.||||.... ..+.+|+.++++++|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3478899999999999999998754 77899996432 2356899999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+. ++|.+++.. ....++|..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 688888764 2346999999999999999999999987 99999999999999999999999999986643322
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNN 528 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~ 528 (650)
........||..|+|||++.+..++.++|||||||+||||++|..++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 22233457999999999999999999999999999999999988654
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=304.29 Aligned_cols=255 Identities=29% Similarity=0.468 Sum_probs=203.5
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
.++|.+.++||+|+||.||++..++++.+|||.+..... ...++.+|+.++++++|+||+++++++..+...++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 467889999999999999999988888899999876443 3457899999999999999999999999989999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++++|.+++... ....+++..+..++.+|+.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+.....
T Consensus 84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (261)
T cd05034 84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY- 158 (261)
T ss_pred CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence 999999998753 2346899999999999999999999987 99999999999999999999999999986543211
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ............ .....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~~~~~~---------~~~~~ 226 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT---NREVLEQVERGY---------RMPRP 226 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCC---------CCCCC
Confidence 11112234568999999998899999999999999999999 888875321 112222111110 00111
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
...+ ..+.+++.+|++.+|++||+++++++.|+.
T Consensus 227 ~~~~---~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCP---EELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCC---HHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1122 345677889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=316.88 Aligned_cols=237 Identities=23% Similarity=0.281 Sum_probs=184.7
Q ss_pred CcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHH-HHhhCCCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVL-LVARLQHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
++||+|+||.||+++.. +++.||+|++.+... .....+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999865 578899999875432 22234555554 57889999999999999999999999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EET 152 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCc
Confidence 99988876 3456889999999999999999999887 999999999999999999999999998743211 122
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGS 564 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 564 (650)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.... .... ..+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i---~~~~-------~~~~~~~ 219 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---VSQMYDNI---LHKP-------LQLPGGK 219 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC---HHHHHHHH---hcCC-------CCCCCCC
Confidence 334578999999999999899999999999999999999999986322 11111111 1110 0111112
Q ss_pred hHHHHHHHHHHhcccccCCCCCCCHH
Q 006317 565 SSEIMRCVHIGLLCVQENVANRPTMA 590 (650)
Q Consensus 565 ~~~~~~~~~l~~~Cl~~~p~~RPt~~ 590 (650)
...+.+++.+||+.+|.+||+..
T Consensus 220 ---~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 220 ---TVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---CHHHHHHHHHHccCCHhhcCCCC
Confidence 23455677799999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=312.84 Aligned_cols=254 Identities=27% Similarity=0.464 Sum_probs=196.8
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCc----ceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQ----EIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
++|+..+.||+|+||.||+|++. +|. .||+|.+..... ....++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 56778899999999999999864 344 478898875533 2334688999999999999999999998754 4679
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
++||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999864 2346899999999999999999999987 9999999999999999999999999998664
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
............++..|++||.+.+..++.++||||||+++|||++ |+.|+.... ......+.. .+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~~~~~~~----~~~~~--- 230 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TREIPDLLE----KGERL--- 230 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH----CCCCC---
Confidence 3322222223345778999999998899999999999999999998 888875321 111111111 11100
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
...... ...+..++..||..+|++||++.+++++|..
T Consensus 231 --~~~~~~---~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~ 267 (303)
T cd05110 231 --PQPPIC---TIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267 (303)
T ss_pred --CCCCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 001111 2345678889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=317.53 Aligned_cols=250 Identities=25% Similarity=0.408 Sum_probs=199.5
Q ss_pred CCCcCCcccccCceeEEEeeccC---Cc--ceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLSH---GQ--EIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~~---g~--~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
.....++||+|-||.||+|...+ |. .||||..+.+.. ...+.|..|..+|++++|||||+++|+|.+. ..|+|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence 34456789999999999998533 33 489999987533 3456799999999999999999999999865 67999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
||.++-|.|..||.. ++..|+......++.||..+|.|||+.. +|||||..+||||...--+||+||||+|.++.
T Consensus 469 mEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 469 MELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999986 4567899999999999999999999987 99999999999999999999999999998875
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
+..... +...-+..|||||.+...+++.+||||.|||++||+++ |.+||..-...+ ..-.+.
T Consensus 544 ~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI~~iE 606 (974)
T KOG4257|consen 544 DAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VIGHIE 606 (974)
T ss_pred cchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eEEEec
Confidence 543332 24445678999999999999999999999999999988 888886321111 111111
Q ss_pred ccCCCC-ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 558 PTLRNG-SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 558 ~~l~~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
..-+.. ++.-...+..|..+||..+|.+||++.|+...|.
T Consensus 607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 111111 2223345567888999999999999999986663
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=310.46 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=202.6
Q ss_pred hhccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
....+|+..+.||+|+||.||+|+. .+++.|++|.+..........+.+|+.+++.++||||+++++.+..+...++||
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 3446889999999999999999985 458899999998766555667889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++++|.+++.+ ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 97 e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 97 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred cccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 99999999998853 35899999999999999999999987 999999999999999999999999998765432
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
.. ......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ......+ .... +.
T Consensus 170 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~---~~~~~~~---~~~~------~~ 235 (296)
T cd06654 170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYLIA---TNGT------PE 235 (296)
T ss_pred cc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH---HhHHHHh---cCCC------CC
Confidence 21 122346888999999999888999999999999999999999998633211 1111111 0100 00
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+. ........+.+++.+||+.+|++||++.||+..
T Consensus 236 ~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 236 LQ-NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CC-CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 10 011112345577889999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=304.98 Aligned_cols=238 Identities=24% Similarity=0.407 Sum_probs=187.0
Q ss_pred CcccccCceeEEEeeccCCc-----------ceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 330 NKLGQGGFGAVYKGRLSHGQ-----------EIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999976432 4788877654433 5678999999999999999999999988 778999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC-------CeEEeeee
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-------IPKISDFG 471 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~-------~~kl~DFG 471 (650)
|||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999998752 237899999999999999999999887 99999999999999888 79999999
Q ss_pred cccccccCCCCCccceeecCccccChhccccC--CCCccccccchhHHHHHHHhC-CCCCCCCCCcccchhHHHHHHhcc
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG--HFSIKSDVFSFGVLVLEIISG-QKNNSFRIGEEAEDLLTYAWKNWN 548 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~S~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~ 548 (650)
++..... .....++..|+|||++... .++.++||||||+++|||++| ..|+....... ... .+.
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~-~~~--- 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KER-FYQ--- 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHH-HHh---
Confidence 9975432 1223567789999999876 789999999999999999995 55554322111 111 010
Q ss_pred CCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 549 EGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 549 ~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
... .+.... ...+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 221 ~~~-------~~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 DQH-------RLPMPD---CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred cCC-------CCCCCC---chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 000111 145667888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=303.77 Aligned_cols=258 Identities=24% Similarity=0.353 Sum_probs=196.0
Q ss_pred cCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCC-----eeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET-----ERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~l 397 (650)
-.|...+++|.|.||.||+|++.. ++.||||++..+.... -+|+++|+++.|||||+|+-++.... ...|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 456778999999999999999654 6899999986654322 35899999999999999998886432 2348
Q ss_pred EEecCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC-CCeEEeeeecccc
Q 006317 398 IYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARL 475 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGla~~ 475 (650)
||||||. +|.++++... .+..++...+.-+..||.+||.|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999987 8888887532 3566888888889999999999999977 9999999999999987 8999999999998
Q ss_pred cccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcc-
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL- 553 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~- 553 (650)
+..+..+ ....-|..|.|||.+.+ ..|+.+.||||.||++.||+-|+.-|.. +...+.+....+.+.-....
T Consensus 176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG---~s~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG---DSSVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC---CCHHHHHHHHHHHhCCCCHHH
Confidence 8755433 23345889999999887 5799999999999999999999987764 33334333333333222111
Q ss_pred ---------cccCccCCCCC------hHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 554 ---------NLIDPTLRNGS------SSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 554 ---------~~id~~l~~~~------~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+.-.+.+.... ...-.+.++++.++++.+|.+|.++.|++..
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11122222111 1122456677889999999999999999854
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.15 Aligned_cols=254 Identities=28% Similarity=0.429 Sum_probs=196.3
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCc--ceeEeeccccC-chhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQ--EIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 398 (650)
++|++.+.||+|+||.||+|.+. ++. .+++|.++... ......+.+|+.++.++ +||||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888899999999999999864 344 45788776532 33445788999999999 899999999999999999999
Q ss_pred EecCCCCChhHHHHhhh-------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCe
Q 006317 399 YEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 465 (650)
|||+++++|.+++.... ....+++.+++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999997532 1235889999999999999999999887 9999999999999999999
Q ss_pred EEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHH
Q 006317 466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAW 544 (650)
Q Consensus 466 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~ 544 (650)
||+|||+++..... .......++..|+|||++.+..++.++||||||+++|||+| |..||..... .+......
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~~~ 237 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLP 237 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---HHHHHHHh
Confidence 99999998642211 11111234667999999988889999999999999999998 8888753221 11111111
Q ss_pred HhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 545 KNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 545 ~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.... .......+ ..+.+++.+||+.+|++||++.+++.+|+.
T Consensus 238 ----~~~~-----~~~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 238 ----QGYR-----LEKPLNCD---DEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred ----cCCc-----CCCCCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1000 00011112 245678889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=303.75 Aligned_cols=257 Identities=25% Similarity=0.381 Sum_probs=198.5
Q ss_pred HhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
+.+++++.....||+|+||.||+|+.. ++..|++|.+..........+.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 445677777789999999999999854 4778999998876666667899999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC-CCCeEEeeeecccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFE 477 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~~ 477 (650)
+||+++++|.+++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999999975322112388889999999999999999887 999999999999986 6799999999987553
Q ss_pred cCCCCCccceeecCccccChhccccCC--CCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGH--FSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
... .......|+..|+|||++.... ++.++||||||+++|||++|+.|+....... ...+..... .
T Consensus 161 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~-------~ 228 (268)
T cd06624 161 GIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMF-------K 228 (268)
T ss_pred cCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhh-------c
Confidence 222 1122345788999999986643 7899999999999999999999875321110 000000000 0
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
..+.+..... .++.+++.+||+.+|.+|||+.||+.
T Consensus 229 ~~~~~~~~~~---~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 IHPEIPESLS---AEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cCCCCCcccC---HHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 1111222222 33456777999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=314.83 Aligned_cols=264 Identities=21% Similarity=0.339 Sum_probs=196.3
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
++|...++||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999865 477899999875432 2334577899999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 158 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT- 158 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-
Confidence 985 78877754 2345899999999999999999999987 9999999999999999999999999997543221
Q ss_pred CCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHH--------HHHhccCCCc
Q 006317 482 QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTY--------AWKNWNEGTA 552 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~~~ 552 (650)
.......++..|+|||.+.+ ..++.++||||||+++|||+||+.||......+....... .|..+.....
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 12223467899999998865 4688999999999999999999999864332221111111 1111110000
Q ss_pred ccccC-ccCCC-----CChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 553 LNLID-PTLRN-----GSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 553 ~~~id-~~l~~-----~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
....+ +.... ....-...+.+++.+||+.||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000 00000 000111245578889999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=303.36 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=200.8
Q ss_pred ccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
.++|+..++||+|+||.||+++..+ ++.+++|.+..... ..++.+|++++++++||||+++++++......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3678899999999999999999765 78899999875532 56799999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999999864 3457899999999999999999999987 99999999999999999999999999986543221
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
......|+..|+|||++.+..++.++||||||+++|||++|+.|+........ ... ... ...+.+.
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~~-----~~~-----~~~~~~~ 220 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IFM-----IPN-----KPPPTLS 220 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hhh-----hcc-----CCCCCCC
Confidence 22334578899999999988999999999999999999999999863221110 000 000 0001110
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
........+.+++.+||+.+|++|||+.||++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 -DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 01111134567778999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=305.74 Aligned_cols=254 Identities=27% Similarity=0.442 Sum_probs=200.7
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
.++|...++||+|+||.||++...++..+++|.+.... .....+.+|+.++++++|+||+++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 46788899999999999999998778889999887543 234578899999999999999999999887 7789999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++++|.+++... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 157 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 157 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence 999999998643 3456899999999999999999999887 99999999999999999999999999976543221
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
.......++..|+|||++..+.++.++||||||+++|||+| |+.|+..... .++..... ..... ...
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~----~~~~~-----~~~ 225 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALE----RGYRM-----PRP 225 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHh----CCCCC-----CCc
Confidence 11222345678999999998899999999999999999999 8888753221 11111111 11000 011
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
...+ ..+.+++.+|++.+|++||++.+++++|+.
T Consensus 226 ~~~~---~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ENCP---EELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ccCC---HHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1122 345677889999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.47 Aligned_cols=252 Identities=28% Similarity=0.474 Sum_probs=198.6
Q ss_pred CCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHH--HHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 326 FSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
|+..+.||+|+||+||+++... ++.+|+|++......... ...+|+.++.+++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999998654 668999999877544332 3456999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++++|.+++. ....+++..++.++.||++||++||+.+ ++|+||||+||++++++.++|+|||++.... ...
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence 9999999997 4567899999999999999999999987 9999999999999999999999999987541 222
Q ss_pred CccceeecCccccChhccc-cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 483 GDTSRIVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
.......++..|+|||++. +..++.++||||+|+++|+|++|+.|+......+........... . ......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~-------~-~~~~~~ 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR-------P-LPSSSQ 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT-------H-HHHHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc-------c-cccccc
Confidence 3344567899999999998 788999999999999999999999988743111111111111000 0 000000
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
........+.+++..||+.||++||++.++++
T Consensus 225 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 -QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp -SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred -ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001156677888999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=322.86 Aligned_cols=259 Identities=18% Similarity=0.236 Sum_probs=198.1
Q ss_pred ccCCCcCCcccccCceeEEEeecc---CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS---HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
..+|.+.++||+|+||.||++... .+..|++|.+.... ...+|+.++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999998743 35679999886532 3467999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
|++. ++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 57888874 4567999999999999999999999987 999999999999999999999999999765543
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCc-------
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA------- 552 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------- 552 (650)
..........||..|+|||++.+..++.++|||||||++|||++|+.|+...........+....+.......
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 3333334567999999999999999999999999999999999999998643332221211111111100000
Q ss_pred ---------------c-cccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 553 ---------------L-NLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 553 ---------------~-~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
. ..+.+.+... .....+..++.+||+.||++|||+.|++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKY--GMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhcc--CcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0000000000 011244567789999999999999999866
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=303.59 Aligned_cols=254 Identities=22% Similarity=0.328 Sum_probs=188.3
Q ss_pred CcccccCceeEEEeeccCCc---ceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCC
Q 006317 330 NKLGQGGFGAVYKGRLSHGQ---EIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS 405 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~g~---~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 405 (650)
+.||+|+||.||+|...++. .+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999754433 45677665443 334567899999999999999999999999999999999999999
Q ss_pred ChhHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 406 SVDKFIFDAIK-RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 406 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
+|.+++..... ...+++..++.++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999975322 234677788899999999999999887 99999999999999999999999999864322111112
Q ss_pred cceeecCccccChhcccc-------CCCCccccccchhHHHHHHHhC-CCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 485 TSRIVGTFGYMAPEYVTR-------GHFSIKSDVFSFGVLVLEIISG-QKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~-------~~~s~~sDV~S~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+.... ..+...... .+......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~---~~~~~~~~~----~~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS---DREVLNHVI----KDQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHH----hhcccccC
Confidence 233567889999998753 2457899999999999999985 44553211 111222111 12223344
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
++.+.....+.+ .+++..|| .+|.+||++++|++.|.
T Consensus 231 ~~~~~~~~~~~~---~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPYSERW---YEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCCcHHH---HHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 454443334443 34556788 57999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=308.32 Aligned_cols=240 Identities=22% Similarity=0.350 Sum_probs=187.6
Q ss_pred CcccccCceeEEEeeccC--------CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 330 NKLGQGGFGAVYKGRLSH--------GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+.||+|+||.||+|.... ...+++|.+..........+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999997532 235889988765555556788999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC--------eEEeeeecc
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI--------PKISDFGMA 473 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~--------~kl~DFGla 473 (650)
+++|+|..++.. .+..+++..+++++.||+.||+|||+.+ |+||||||+|||++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKK--NKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999874 2346899999999999999999999987 999999999999988765 599999988
Q ss_pred cccccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCC-CCCCCCCcccchhHHHHHHhccCCC
Q 006317 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQK-NNSFRIGEEAEDLLTYAWKNWNEGT 551 (650)
Q Consensus 474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~ 551 (650)
..... .....++..|+|||++.+ ..++.++||||||+++|||++|.. |+..... ....... . .
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~---~~~~~~~-~---~-- 220 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS---QKKLQFY-E---D-- 220 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH---HHHHHHH-H---c--
Confidence 64432 223467889999999986 457999999999999999999964 4331111 1111100 0 0
Q ss_pred cccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 552 ALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 552 ~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
...+... ...++.+++..||+.+|++|||+++|++.|+
T Consensus 221 -----~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 -----RHQLPAP---KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----cccCCCC---CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0011111 1234567888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=305.24 Aligned_cols=250 Identities=27% Similarity=0.354 Sum_probs=196.0
Q ss_pred CCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCC
Q 006317 326 FSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
|++.+.||+|+||.||++.... +..+++|.+..........+.+|+++++.++||||+++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5677899999999999998754 778899998766655566789999999999999999999999999999999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
++|..++.. ....+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~ 159 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 159 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence 999988764 3457999999999999999999999987 9999999999999999999999999987543221 12
Q ss_pred cceeecCccccChhccc-----cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 485 TSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
.....++..|+|||++. +..++.++|||||||++|||++|+.|+..... ......... . .......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~---~-~~~~~~~-- 230 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRVLLKIAK---S-EPPTLAQ-- 230 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHHHHHHhh---c-CCCCCCC--
Confidence 23356899999999984 34578899999999999999999998753211 111111000 0 0000000
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
....+ ..+.+++.+||+.+|.+||++.++++.
T Consensus 231 -~~~~~---~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 231 -PSRWS---SEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -ccccC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122 244567779999999999999998744
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=307.40 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=196.4
Q ss_pred CCcCCcccccCceeEEEeecc-CCcceeEeeccccCch---hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 326 FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
|+..+.||+|+||.||++... +++.||||.+...... ....+.+|+.++++++|+|++++++.+..++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999865 5889999998654322 234577899999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 9999999988643 3346899999999999999999999887 9999999999999999999999999987543222
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
......|+..|+|||++.+..++.++||||||+++|||++|+.||.................. ......
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---------~~~~~~ 225 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---------VQEEYS 225 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---------hhhhcC
Confidence 122346899999999999999999999999999999999999998643221111111110000 001111
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCC-----HHHHHHH
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPT-----MASVVVM 595 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~evl~~ 595 (650)
..... .+.+++..||+.||++||| +.|+++.
T Consensus 226 ~~~~~---~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 226 EKFSP---DARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ccCCH---HHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 12222 3456677899999999999 7888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=302.61 Aligned_cols=250 Identities=25% Similarity=0.387 Sum_probs=190.1
Q ss_pred CcccccCceeEEEeeccC----CcceeEeecccc-CchhHHHHHHHHHHHhhCCCCceeeecceee-cCCeeEEEEecCC
Q 006317 330 NKLGQGGFGAVYKGRLSH----GQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSF-EETERLLIYEFVP 403 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lv~e~~~ 403 (650)
+.||+|+||.||+|.+.+ ...+|+|++... .......+.+|+.+++.++||||+++++++. .+...++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 478999999999998532 356999998643 2334457889999999999999999999876 4556789999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC--
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS-- 481 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~-- 481 (650)
+|+|.+++.. ....+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRS--ETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999874 2345788889999999999999999887 99999999999999999999999999975432211
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCC-CCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKN-NSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
........++..|+|||.+.+..++.++||||||+++|||++|+.| +... ...++....+.. .. +..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~---~~~~~~~~~~~~---~~------~~~ 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---DSFDITVYLLQG---RR------LLQ 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHhcC---CC------CCC
Confidence 1111233457789999999888999999999999999999996554 4311 112222222111 00 000
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
....+ ..+.+++..||+.+|++||++.||+..|+..
T Consensus 224 ~~~~~---~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 224 PEYCP---DPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CCcCC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11112 2456788899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=307.15 Aligned_cols=250 Identities=30% Similarity=0.465 Sum_probs=194.5
Q ss_pred CcccccCceeEEEeeccC-------CcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 330 NKLGQGGFGAVYKGRLSH-------GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~-------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+.||+|+||.||+|+..+ ++.+++|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998643 2578999886543 23455788999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhh----ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC-----CeEEeeeec
Q 006317 402 VPNSSVDKFIFDAI----KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-----IPKISDFGM 472 (650)
Q Consensus 402 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~-----~~kl~DFGl 472 (650)
+++++|.+++.... ....+++.+++.++.||+.||+|||+.+ ++|+||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 1234889999999999999999999887 99999999999999887 899999999
Q ss_pred ccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCC
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGT 551 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 551 (650)
++...............++..|+|||++.++.++.++||||||+++|||+| |+.|+..... .+...... .+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~----~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVT----AGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHh----cCC
Confidence 975543222222223345778999999999999999999999999999998 8888753221 11111111 110
Q ss_pred cccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 552 ALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 552 ~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
.. ......+ ..+.+++.+||+.+|.+||++.+|+++|+
T Consensus 231 ~~-----~~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 RL-----QKPENCP---DKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cc-----CCcccch---HHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00 0111122 34557788999999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=340.87 Aligned_cols=259 Identities=20% Similarity=0.301 Sum_probs=198.7
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|+..++||+|+||.||+|+.. .|+.||||++..... .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47889999999999999999865 488999999975422 23446889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhc--------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeee
Q 006317 400 EFVPNSSVDKFIFDAIK--------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 471 (650)
||+++|+|.+++..... ...+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 234677888999999999999999987 9999999999999999999999999
Q ss_pred cccccccCCCC----------------CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcc
Q 006317 472 MARLFEMDQSQ----------------GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535 (650)
Q Consensus 472 la~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~ 535 (650)
+++........ .......||+.|+|||++.+..++.++|||||||++|||+||+.|+.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99865211100 01123569999999999999999999999999999999999999986422211
Q ss_pred cchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCC-CHHHHHHHhcC
Q 006317 536 AEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRP-TMASVVVMLNS 598 (650)
Q Consensus 536 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RP-t~~evl~~L~~ 598 (650)
.. .. ...... ... .+ ....+ ..+.+++.+|++.||++|| +++++++.|+.
T Consensus 239 ---i~-~~-~~i~~P--~~~-~p--~~~iP---~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 ---IS-YR-DVILSP--IEV-AP--YREIP---PFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred ---hh-hh-hhccCh--hhc-cc--cccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 10 00 000000 000 00 01112 2345678899999999995 56667666653
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=305.87 Aligned_cols=251 Identities=23% Similarity=0.364 Sum_probs=198.1
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
.++|...++||+|+||.||+++.. +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888899999999999999864 5888999998766544455688999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++. ....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd06645 88 CGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-- 159 (267)
T ss_pred cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence 99999999886 3457999999999999999999999987 999999999999999999999999998755322
Q ss_pred CCccceeecCccccChhccc---cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 482 QGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
........|+..|+|||++. ...++.++|||||||++|||++|+.|+....... ........... .+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~~~~~~~~~~--------~~ 229 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFLMTKSNFQ--------PP 229 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hHHhhhccCCC--------CC
Confidence 12223456899999999874 4568899999999999999999999875322111 11110000000 01
Q ss_pred cCCC--CChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 559 TLRN--GSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 559 ~l~~--~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.... ..+ ..+.+++.+|++.+|++||++++|++
T Consensus 230 ~~~~~~~~~---~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 230 KLKDKMKWS---NSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccccCCCC---HHHHHHHHHHccCCchhCcCHHHHhc
Confidence 1110 112 23457788999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=305.06 Aligned_cols=253 Identities=26% Similarity=0.359 Sum_probs=199.3
Q ss_pred ccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
.+.|++.++||+|+||.||+|+... ++.+++|.+..........+.+|+.++++++||||+++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 3678899999999999999998754 889999999876666666788999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|..++.. ....+++..++.++.||+.+|+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 91 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-- 163 (292)
T cd06644 91 CPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-- 163 (292)
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence 999999988764 2456899999999999999999999887 999999999999999999999999998754321
Q ss_pred CCccceeecCccccChhccc-----cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 482 QGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
........++..|+|||++. ...++.++|||||||++|||++|+.|+...... ....... ...
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~-~~~----- 231 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIA-KSE----- 231 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHh-cCC-----
Confidence 12223456888999999985 345688999999999999999999987532210 1111110 000
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+.+.. ......++.+++.+||+.+|++||++.+|++.
T Consensus 232 ~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 232 PPTLSQ-PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CccCCC-CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 011100 11112345567789999999999999999753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=302.62 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=202.3
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
.++|+..+.||+|+||.||++... +++.+++|.+..........+.+|+.++++++||||+++++++..+...+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357888999999999999999864 4778999999876555566789999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 999999998864 2357999999999999999999999987 9999999999999999999999999987654321
Q ss_pred CCccceeecCccccChhccccC---CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRG---HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
.......++..|+|||.+... .++.++||||||+++|||++|+.|+....... ......... +.+
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~~~~~~---------~~~ 223 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFLISKSN---------FPP 223 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcc---------CCC
Confidence 122335678899999998776 88999999999999999999999885322111 111100000 011
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
............+.+++.+||+.+|.+|||+.+|+.
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 010111222345678888999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.68 Aligned_cols=240 Identities=23% Similarity=0.281 Sum_probs=185.6
Q ss_pred CcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHH-HHHhhCCCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEV-LLVARLQHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
+.||+|+||.||+++.. +++.||+|++..... .....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 467899999875422 2223344444 456788999999999999999999999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
|+|.+++.. ...+.+.....++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCC
Confidence 999998863 456888899999999999999999987 999999999999999999999999998753221 122
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGS 564 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 564 (650)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... .. ..+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~---~~-------~~~~~~~ 219 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNILN---KP-------LQLKPNI 219 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---HHHHHHHHh---CC-------cCCCCCC
Confidence 3346799999999999999999999999999999999999999863221 111111111 00 0111122
Q ss_pred hHHHHHHHHHHhcccccCCCCCCCHHHHH
Q 006317 565 SSEIMRCVHIGLLCVQENVANRPTMASVV 593 (650)
Q Consensus 565 ~~~~~~~~~l~~~Cl~~~p~~RPt~~evl 593 (650)
.. .+.+++..|++.+|.+||++.+.+
T Consensus 220 ~~---~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 220 TN---SARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CH---HHHHHHHHHcccCHHHCCCCCCCH
Confidence 23 344667789999999999987544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=306.32 Aligned_cols=255 Identities=26% Similarity=0.423 Sum_probs=199.6
Q ss_pred cCCCcCCcccccCceeEEEeeccC-Cc----ceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQ----EIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
.+|+..+.||+|+||.||+|.+++ |. .+|+|.+..... ....++.+|+.++.+++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567888999999999999998643 33 589998876543 344578899999999999999999999987 78899
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999875 3446899999999999999999999976 9999999999999999999999999998765
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
............++..|+|||.+....++.++||||||+++|||++ |+.|+..... .++...... ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~----~~~---- 229 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---VEIPDLLEK----GER---- 229 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhC----CCC----
Confidence 3322111112223568999999988899999999999999999999 9998763321 112111111 100
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
........ ..+..++..||..+|.+||++.++++.|+..
T Consensus 230 -~~~~~~~~---~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 230 -LPQPPICT---IDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred -CCCCCCCC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00011111 3455677899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.53 Aligned_cols=257 Identities=21% Similarity=0.278 Sum_probs=194.5
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|++.+.||+|+||.||+++.. +++.||+|++.+.. ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999865 48899999987532 223345788999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999864 2456899999999999999999999987 999999999999999999999999998765432
Q ss_pred CCCCccceeecCccccChhcccc-----CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTR-----GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
.. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .+... ..........
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~---~~~~~---~i~~~~~~~~ 228 (331)
T cd05597 156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYG---KIMNHKEHFQ 228 (331)
T ss_pred CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH---HHHHH---HHHcCCCccc
Confidence 21 12223569999999999863 4578899999999999999999999853221 11111 1111111111
Q ss_pred ccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 555 LIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 555 ~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+.+. ....+++...+++-+ .|...++..||++.++++.
T Consensus 229 -~~~~-~~~~~~~~~~li~~l-l~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 -FPPD-VTDVSEEAKDLIRRL-ICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -CCCc-cCCCCHHHHHHHHHH-ccCcccccCCCCHHHHhcC
Confidence 1111 112344555544422 2556666668999999866
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=309.31 Aligned_cols=262 Identities=26% Similarity=0.373 Sum_probs=194.6
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+|+..+.||+|++|.||+|+.. +++.||||+++.... .....+.+|+.++.+++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999865 588999999865422 2235688999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
++ ++|.+++........+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 688888865434467999999999999999999999987 9999999999999999999999999997554221
Q ss_pred CCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHH----------HHHhccCC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTY----------AWKNWNEG 550 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~----------~~~~~~~~ 550 (650)
.......++..|+|||++.+. .++.++||||||+++|||+||+.|+....... ..... .|+.+...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhh
Confidence 112233568899999988654 57899999999999999999998886322111 11100 00000000
Q ss_pred -CcccccC----ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 551 -TALNLID----PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 551 -~~~~~id----~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.....++ ..+......-..++.+++.+||+.||++|||+.+|+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 0000000001134457788999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=315.60 Aligned_cols=258 Identities=26% Similarity=0.382 Sum_probs=199.5
Q ss_pred cCCCcCCcccccCceeEEEeeccC--------CcceeEeeccccC-chhHHHHHHHHHHHhhC-CCCceeeecceeecCC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH--------GQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEET 393 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 393 (650)
.+|.+.+.||+|+||.||+++... +..||+|.++... .....++.+|+.++.++ +||||+++++++..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468889999999999999997421 2368999887543 23445789999999999 8999999999999999
Q ss_pred eeEEEEecCCCCChhHHHHhhh-------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 460 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~ 460 (650)
..+++|||+++|+|.+++.... ....++|..++.++.||+.||+|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999987521 2345889999999999999999999987 99999999999999
Q ss_pred CCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchh
Q 006317 461 ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDL 539 (650)
Q Consensus 461 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l 539 (650)
+++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+.... ..+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~ 245 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---VEEL 245 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHH
Confidence 999999999999976543222222222334567999999999999999999999999999999 777764221 1111
Q ss_pred HHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 540 LTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 540 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
.... ....... ...... ..+.+++.+||+.+|++||++.|+++.|...
T Consensus 246 ~~~~----~~~~~~~-----~~~~~~---~~l~~li~~cl~~~p~~Rps~~ell~~l~~~ 293 (334)
T cd05100 246 FKLL----KEGHRMD-----KPANCT---HELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293 (334)
T ss_pred HHHH----HcCCCCC-----CCCCCC---HHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1111 1111111 111122 3455778899999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=307.67 Aligned_cols=250 Identities=25% Similarity=0.334 Sum_probs=195.0
Q ss_pred CCcCCcccccCceeEEEeecc-CCcceeEeeccccCch---hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 326 FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
|+..++||+|+||+||++... +++.+|+|.+...... ....+.+|+.++++++|+||+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999864 5889999998654322 233577899999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 9999999888643 2346999999999999999999999887 9999999999999999999999999987543221
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
......|+..|+|||++.+..++.++||||||+++|||++|+.||........... ........ .....
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~~~~------~~~~~ 225 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRVLET------EEVYS 225 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhhcc------ccccC
Confidence 12234689999999999988999999999999999999999999863321111111 11110000 01111
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCC-----HHHHHH
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPT-----MASVVV 594 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~evl~ 594 (650)
..... .+.+++..|++.||++||+ +.+++.
T Consensus 226 ~~~~~---~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 226 AKFSE---EAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCCH---HHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 12222 3456777899999999999 566664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=305.28 Aligned_cols=249 Identities=29% Similarity=0.457 Sum_probs=196.6
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch---------hHHHHHHHHHHHhhCCCCceeeecceeecCCe
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---------GELEFKNEVLLVARLQHRNLVRLLGFSFEETE 394 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 394 (650)
+|...+.||+|++|.||+|... +++.+|+|.+...... ....+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677899999999999999864 5788999988654221 12457889999999999999999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999863 456899999999999999999999887 9999999999999999999999999998
Q ss_pred ccccCCCC----CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC
Q 006317 475 LFEMDQSQ----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG 550 (650)
Q Consensus 475 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 550 (650)
........ .......|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... .. .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~---~~~~~--- 225 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QA---IFKIG--- 225 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HH---HHHHh---
Confidence 66532111 1122345788999999999889999999999999999999999998632111 11 11100
Q ss_pred CcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 551 TALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 551 ~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
....+.+....+. .+.+++.+||+.+|.+||++.||++
T Consensus 226 ---~~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 ---ENASPEIPSNISS---EAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---ccCCCcCCcccCH---HHHHHHHHHccCCchhCcCHHHHhh
Confidence 0111222222233 3446667999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=303.82 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=191.8
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-----hhHHHHHHHHHHHhhCCCCceeeecceeec--CCee
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-----QGELEFKNEVLLVARLQHRNLVRLLGFSFE--ETER 395 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 395 (650)
.+|...+.||+|+||.||++... .+..|++|++..... .....+.+|+.++++++||||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999864 588999998864321 223458889999999999999999998875 3567
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++++||+++++|.+++.. ...+++...+.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999863 346899999999999999999999887 99999999999999999999999999876
Q ss_pred cccCCC-CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 476 FEMDQS-QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 476 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~---- 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQP---- 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCC----
Confidence 532111 1112234578899999999988999999999999999999999999853211 11111110000
Q ss_pred ccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 555 LIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 555 ~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
..+.+.....+.+. .+ ++||..+|++||+++||++
T Consensus 226 -~~~~~~~~~~~~~~---~l-i~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 -TNPQLPSHISEHAR---DF-LGCIFVEARHRPSAEELLR 260 (266)
T ss_pred -CCCCCchhcCHHHH---HH-HHHhcCChhhCcCHHHHhc
Confidence 11222211222222 23 3688899999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=317.70 Aligned_cols=260 Identities=21% Similarity=0.250 Sum_probs=197.0
Q ss_pred hhHHhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecC
Q 006317 317 STIRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE 392 (650)
Q Consensus 317 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 392 (650)
..+....++|+..+.||+|+||.||+++.. +++.+|+|++.+.. ......+.+|+.+++.++||||+++++.+.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344455689999999999999999999865 47889999986532 12234577899999999999999999999999
Q ss_pred CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeec
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 472 (650)
...++||||+++|+|.+++.. ..++...+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 999999999999999998853 35888999999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCCCCccceeecCccccChhccccC----CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhcc
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG----HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWN 548 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 548 (650)
++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .........
T Consensus 189 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~ 261 (371)
T cd05622 189 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMN 261 (371)
T ss_pred eeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHc
Confidence 986542211 122345799999999998754 378999999999999999999999863221 111111111
Q ss_pred CCCcccccCccCCCCChHHHHHHHHHHhcccccCCCC--CCCHHHHHHHh
Q 006317 549 EGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVAN--RPTMASVVVML 596 (650)
Q Consensus 549 ~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~--RPt~~evl~~L 596 (650)
........+ ......+ +.+++..|++.++.+ ||++.|+++..
T Consensus 262 ~~~~~~~~~---~~~~s~~---~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 262 HKNSLTFPD---DNDISKE---AKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCcccCCC---cCCCCHH---HHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111111110 1112333 345566788744433 78999998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=306.00 Aligned_cols=248 Identities=28% Similarity=0.450 Sum_probs=191.2
Q ss_pred CcccccCceeEEEeeccC-Cc--ceeEeeccccC-chhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLSH-GQ--EIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~-g~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
+.||+|+||.||+|++.+ +. .+++|.++... ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999998754 33 46888887543 33445788999999999 899999999999999999999999999
Q ss_pred CChhHHHHhhh-------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeee
Q 006317 405 SSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471 (650)
Q Consensus 405 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 471 (650)
|+|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999987531 1235889999999999999999999887 9999999999999999999999999
Q ss_pred cccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCC
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEG 550 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 550 (650)
+++..... ........+..|+|||++....++.++||||||+++|||++ |+.||.... ..+..... ..+
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~---~~~~~~~~----~~~ 227 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKL----PQG 227 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC---HHHHHHHH----hCC
Confidence 98632211 11111223567999999988889999999999999999997 888875321 11111111 111
Q ss_pred CcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 551 TALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 551 ~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
...+ ...... ..+.+++.+|++.+|.+|||+.+++..|+.
T Consensus 228 ~~~~-----~~~~~~---~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 228 YRLE-----KPLNCD---DEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred CCCC-----CCCcCC---HHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 0000 111112 245678889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=317.16 Aligned_cols=198 Identities=28% Similarity=0.371 Sum_probs=166.8
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeecccc--CchhHHHHHHHHHHHhhCCCCceeeecceeecCC-----
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET----- 393 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 393 (650)
..++|+..+.||+|+||.||+++.. .|+.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999864 5889999998654 2233456789999999999999999999886543
Q ss_pred -eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeec
Q 006317 394 -ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472 (650)
Q Consensus 394 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 472 (650)
..++||||+++ +|...+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999976 5555543 24888999999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCC
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR 531 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~ 531 (650)
++..... .......||..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 170 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 170 ARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 9754322 1223357899999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=308.02 Aligned_cols=257 Identities=25% Similarity=0.345 Sum_probs=201.6
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
++|+..++||+|+||+||++... +++.||+|++.... ......+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56788899999999999999864 58889999886543 23456789999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++.. .+.+++.....++.+++.+|.|||+.. +++||||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 999999998763 456899999999999999999999742 3999999999999999999999999998654321
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcc-----cchhHHHHHHhccCCCccccc
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE-----AEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~-----~~~l~~~~~~~~~~~~~~~~i 556 (650)
......|+..|+|||++.+..++.++|||||||++|||++|+.|+......+ ...............
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 229 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------ 229 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------
Confidence 1224578999999999988899999999999999999999999987433211 111112111111110
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
.+.+... .....+.+++.+|++.||++|||+.||++++.
T Consensus 230 ~~~~~~~--~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 230 PPRLPSS--DFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CCCCCch--hcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0111111 11234556777999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=303.11 Aligned_cols=250 Identities=21% Similarity=0.301 Sum_probs=198.7
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
+|+..++||+|+||.||+++.. +++.+|+|.++... ......+.+|+.++++++||||+++++.+..+...++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4678899999999999999864 58889999986432 334456888999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++++|.+++... ....+++...+.++.||+.||.|||+.+ ++|+||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-- 154 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-- 154 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--
Confidence 999999988642 3445889999999999999999999987 9999999999999999999999999997654322
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.|+..... .... .... .+... .+..
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~---~~~~---~~~~-~~~~~-----~~~~ 222 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW---KNLI---LKVC-QGSYK-----PLPS 222 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH---HHHH---HHHh-cCCCC-----CCCc
Confidence 122335688899999999988899999999999999999999999863221 1111 1111 11100 0111
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
... ..+.+++.+||+.||++||++.+|+..
T Consensus 223 ~~~---~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 HYS---YELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccC---HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 112 234567789999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=311.63 Aligned_cols=196 Identities=28% Similarity=0.469 Sum_probs=160.5
Q ss_pred CCcccccCceeEEEeecc---CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeec--CCeeEEEEecCC
Q 006317 329 DNKLGQGGFGAVYKGRLS---HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE--ETERLLIYEFVP 403 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~ 403 (650)
.++||+|+||.||+++.. +++.+|+|.+..... ...+.+|+.++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 457899999865432 2357789999999999999999998854 456789999986
Q ss_pred CCChhHHHHhhh------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe----CCCCCeEEeeeecc
Q 006317 404 NSSVDKFIFDAI------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DADMIPKISDFGMA 473 (650)
Q Consensus 404 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGla 473 (650)
+ +|.+++.... +...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 7877765321 1235899999999999999999999987 9999999999999 45678999999999
Q ss_pred cccccCCC-CCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCC
Q 006317 474 RLFEMDQS-QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF 530 (650)
Q Consensus 474 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~ 530 (650)
+.+..... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 87653321 122334678999999999877 4589999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=317.31 Aligned_cols=192 Identities=22% Similarity=0.337 Sum_probs=165.1
Q ss_pred hccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
...+|.+.+.||+|+||.||+|+... ++.||+|+..... ...|+.++++++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 34579999999999999999998654 6789999754432 3468999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
++. ++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 995 588888764 3457999999999999999999999987 999999999999999999999999999743221
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNN 528 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~ 528 (650)
.......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456899999999999999999999999999999999976654
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=308.31 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=190.0
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch--hHHHHHHHHHHHhhC---CCCceeeecceeec-----CC
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARL---QHRNLVRLLGFSFE-----ET 393 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~g~~~~-----~~ 393 (650)
+|+..+.||+|+||.||+++.. +++.||+|.++..... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999865 5889999998754222 223456677776655 79999999998764 24
Q ss_pred eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecc
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 473 (650)
..++||||+++ +|.+++... ....+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57899999985 888887642 2345899999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHh-------
Q 006317 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKN------- 546 (650)
Q Consensus 474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~------- 546 (650)
+...... ......||..|+|||++.+..++.++|||||||++|||++|+.|+......+ .+......
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~ 229 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPED 229 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHHHHHHhCCCChh
Confidence 8654221 2233568899999999999899999999999999999999998875332211 11111110
Q ss_pred -ccCCC--cccccCccCCCC----ChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 547 -WNEGT--ALNLIDPTLRNG----SSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 547 -~~~~~--~~~~id~~l~~~----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
|.... ....+.+..... .+.....+.+++.+||+.||++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 000011100000 0111234567888999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=307.42 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=197.0
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
.|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4566788999999999999864 47789999987543 233456889999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++++|.+++. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence 9999999875 346899999999999999999999887 9999999999999999999999999997654321
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
.......|+..|+|||++.+..++.++||||||+++|||++|+.|+....... .... .... ..+.+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~----~~~~-----~~~~~~~ 223 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLFL----IPKN-----SPPTLEG 223 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHhh----hhcC-----CCCCCCc
Confidence 12223467889999999998899999999999999999999999875222111 1100 0000 0111111
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
. ....+.+++.+||+.+|.+||++.+|+..
T Consensus 224 ~---~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 224 Q---YSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred c---cCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1 22345677889999999999999999975
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.67 Aligned_cols=201 Identities=22% Similarity=0.313 Sum_probs=172.1
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|...+.||+|+||.||+++.. +++.||+|++.+.. ......+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999865 47789999986532 122335788999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999974 2456899999999999999999999987 999999999999999999999999999765432
Q ss_pred CCCCccceeecCccccChhcccc-----CCCCccccccchhHHHHHHHhCCCCCCC
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTR-----GHFSIKSDVFSFGVLVLEIISGQKNNSF 530 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvll~elltG~~p~~~ 530 (650)
.. .......||+.|+|||++.+ +.++.++|||||||++|||++|+.||..
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 21 12233569999999999875 5678999999999999999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=326.41 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=190.2
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecC--------
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-------- 392 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 392 (650)
..++|...++||+|+||.||+|+.. .++.||||++..... ...+|+.++++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4567999999999999999999864 588999998865322 345799999999999999999876432
Q ss_pred CeeEEEEecCCCCChhHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC-CeEEeee
Q 006317 393 TERLLIYEFVPNSSVDKFIFDA-IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDF 470 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DF 470 (650)
...++||||+++ +|.+++... .....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 235689999985 677766542 23467999999999999999999999987 99999999999999765 7999999
Q ss_pred ecccccccCCCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccC
Q 006317 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNE 549 (650)
Q Consensus 471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 549 (650)
|+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +.+.........
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~---~~~~~i~~~~~~ 289 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV---DQLVRIIQVLGT 289 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCC
Confidence 9998654322 22235689999999998764 6899999999999999999999988643221 111111111110
Q ss_pred CC----------cccccCccCCCCC------hHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 550 GT----------ALNLIDPTLRNGS------SSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 550 ~~----------~~~~id~~l~~~~------~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.. ..++--+...... .....++.+++.+||+.||.+|||+.|++..
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 0000000000000 0011345678889999999999999999844
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=301.54 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=200.2
Q ss_pred CCCcCCcccccCceeEEEeec-cCCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+|+..+.||.|+||.||.++. .+++.+++|.+.... .....++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999875 458889999986542 33445788999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++... ....+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999998753 2456899999999999999999999887 99999999999999999999999999986543321
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+..... .+. ..... .+... +. .
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~~~---~~~~~-~~~~~----~~-~ 222 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNL---VVKIV-QGNYT----PV-V 222 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH---HHH---HHHHH-cCCCC----CC-c
Confidence 22335689999999999888899999999999999999999998753221 111 11111 11110 00 0
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHh
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVML 596 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L 596 (650)
.... .++.+++.+||+.+|.+||++.++++.+
T Consensus 223 ~~~~---~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 SVYS---SELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cccC---HHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1122 3455677799999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.44 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=197.7
Q ss_pred CCCcCCcccccCceeEEEeeccCCcceeEeeccccCc------hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV------QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
+|...+.||+|+||.||+|...+++.+|||.+..... .....+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999987889999998864321 1224588999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999863 356899999999999999999999887 99999999999999999999999999876432
Q ss_pred CCC----CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 479 DQS----QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 479 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
... ........|+..|+|||++.+..++.++||||||+++|||++|+.|+...... ...... . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~~---~-~~~---- 224 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL--AAMFYI---G-AHR---- 224 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH--HHHHHh---h-hcc----
Confidence 111 11122346889999999999888999999999999999999999998532211 111100 0 000
Q ss_pred ccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 555 LIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 555 ~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
...+.+......+ +..++.+||+.+|.+||++.|++.
T Consensus 225 ~~~~~~~~~~~~~---~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 GLMPRLPDSFSAA---AIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCCCCCHH---HHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111222223333 456777999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=304.03 Aligned_cols=263 Identities=24% Similarity=0.353 Sum_probs=201.8
Q ss_pred cChhhHHhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceee-
Q 006317 314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSF- 390 (650)
Q Consensus 314 ~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~- 390 (650)
+.++.+..+.++|++.+.||+|+||.||+++.. +++.+|+|++.... ....++.+|+.++.++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 445667788899999999999999999999864 47889999886532 2234678899999999 6999999999874
Q ss_pred ----cCCeeEEEEecCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCe
Q 006317 391 ----EETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465 (650)
Q Consensus 391 ----~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 465 (650)
.++..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 3456899999999999999886432 3456899999999999999999999987 9999999999999999999
Q ss_pred EEeeeecccccccCCCCCccceeecCccccChhcccc-----CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhH
Q 006317 466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-----GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL 540 (650)
Q Consensus 466 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~ 540 (650)
||+|||+++...... .......|+..|+|||++.. ..++.++|||||||++|||++|+.|+...... ..+.
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~--~~~~ 239 (286)
T cd06638 164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM--RALF 239 (286)
T ss_pred EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh--HHHh
Confidence 999999987654322 12223468999999998753 45788999999999999999999987532111 1110
Q ss_pred HHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 541 TYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 541 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
. ..........++. ... ..+..++.+||+.+|++|||+.||++.
T Consensus 240 ----~-~~~~~~~~~~~~~---~~~---~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 ----K-IPRNPPPTLHQPE---LWS---NEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ----h-ccccCCCcccCCC---CcC---HHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 0001001111111 112 245577889999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=315.06 Aligned_cols=241 Identities=24% Similarity=0.295 Sum_probs=189.5
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCC-CCceeeecceeecCCeeEEEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 399 (650)
+|+..+.||+|+||.||+++.. +|+.||+|++.+... .....+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677899999999999999864 588999999876422 22345777888888885 577888999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999886 3456999999999999999999999987 999999999999999999999999998753321
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
. .......||..|+|||++.+..++.++|||||||++|||++|+.|+..... ..+....... . ..
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~~~----~------~~ 219 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSIMEH----N------VS 219 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhC----C------CC
Confidence 1 122345689999999999999999999999999999999999999863321 1222211110 0 01
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTM 589 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~ 589 (650)
+..... ..+.+++.+||+.+|.+|++.
T Consensus 220 ~p~~~~---~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 YPKSLS---KEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCccCC---HHHHHHHHHHcccCHhhCCCC
Confidence 111122 244567779999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.23 Aligned_cols=248 Identities=27% Similarity=0.430 Sum_probs=195.7
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceee-cCCeeEEEEecC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF-EETERLLIYEFV 402 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lv~e~~ 402 (650)
++|...+.||+|+||.||++.. .|..+++|.++... ....+.+|+.++++++|+|++++++++. .++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4678889999999999999986 47889999986543 2446889999999999999999999765 456789999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++++|.+++... ....+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999998753 2345899999999999999999999987 9999999999999999999999999987543221
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
....++..|+|||++.+..++.++||||||+++|||++ |+.|+.... ..++.......+ .+...
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~---~~~~~~~~~~~~---------~~~~~ 221 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRVEKGY---------KMDAP 221 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhcCC---------CCCCC
Confidence 12234568999999998899999999999999999998 888875321 111211111110 01111
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
...+ ..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 222 ~~~~---~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 222 DGCP---PVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCC---HHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1122 345567779999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.07 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=197.6
Q ss_pred CCCcCCcccccCceeEEEeeccC--CcceeEeeccccC----------chhHHHHHHHHHHHhh-CCCCceeeecceeec
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLSH--GQEIAVKRLSKNS----------VQGELEFKNEVLLVAR-LQHRNLVRLLGFSFE 391 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~~--g~~vavK~l~~~~----------~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 391 (650)
+|+..+.||+|+||.||+|.... ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999765 6789999875321 1223356778888865 799999999999999
Q ss_pred CCeeEEEEecCCCCChhHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeee
Q 006317 392 ETERLLIYEFVPNSSVDKFIFDA-IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF 470 (650)
Q Consensus 392 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 470 (650)
++..++||||+++++|.+++... .....+++..+++++.|++.+|.|||+.. +++|+||+|+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988653 23456899999999999999999999632 3999999999999999999999999
Q ss_pred ecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC
Q 006317 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG 550 (650)
Q Consensus 471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 550 (650)
|++....... ......|+..|++||.+.+..++.++||||||+++|||++|+.|+...... ...... ...
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~~~~~----~~~ 228 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SLATKI----VEA 228 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HHHHHH----hhc
Confidence 9998654322 233456889999999999988999999999999999999999987532111 111110 011
Q ss_pred CcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 551 TALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 551 ~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
.. .+....... ..+.+++.+||+.||++||++.||..+++
T Consensus 229 ~~----~~~~~~~~~---~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VY----EPLPEGMYS---EDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cC----CcCCcccCC---HHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00 011111122 34556777999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=308.38 Aligned_cols=248 Identities=24% Similarity=0.368 Sum_probs=197.8
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
+.|.....||+|+||.||++... ++..||||.+..........+.+|+..+++++|+||+++++.+...+..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 34455578999999999999864 57899999987655555667899999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++++|.+++. ...+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 102 ~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-- 172 (292)
T cd06658 102 EGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-- 172 (292)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence 9999999874 346899999999999999999999987 9999999999999999999999999987543222
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... ........ .+.+.+..
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~---------~~~~~~~~ 240 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMRRIRD---------NLPPRVKD 240 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh---------cCCCcccc
Confidence 2223456899999999998889999999999999999999999998632211 11111111 11111111
Q ss_pred --CChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 563 --GSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 563 --~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.... .+..++..|++.+|++|||+.|+++.
T Consensus 241 ~~~~~~---~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSS---VLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCH---HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1222 34456678999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=320.06 Aligned_cols=201 Identities=26% Similarity=0.360 Sum_probs=173.0
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|+..+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999865 58899999987532 223346788999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++. +...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999986 3457899999999999999999999987 999999999999999999999999998754321
Q ss_pred CCC---------------------------------CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCC
Q 006317 480 QSQ---------------------------------GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK 526 (650)
Q Consensus 480 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~ 526 (650)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00123479999999999999999999999999999999999999
Q ss_pred CCCC
Q 006317 527 NNSF 530 (650)
Q Consensus 527 p~~~ 530 (650)
||..
T Consensus 235 Pf~~ 238 (360)
T cd05627 235 PFCS 238 (360)
T ss_pred CCCC
Confidence 9864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=306.30 Aligned_cols=263 Identities=22% Similarity=0.318 Sum_probs=197.4
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
++|+..+.||+|++|.||+++.. +++.||+|++..... .....+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999876 488999999865422 233457899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++++|..++. ....+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998888765 3446899999999999999999999987 9999999999999999999999999998654322
Q ss_pred CCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHH--------HhccCCC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAW--------KNWNEGT 551 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~~ 551 (650)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+......... ..+....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223457889999999876 467899999999999999999999886433211111100000 0000000
Q ss_pred cc-cccCccCCCC-C-----hHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 552 AL-NLIDPTLRNG-S-----SSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 552 ~~-~~id~~l~~~-~-----~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.. ....+..... . ......+.+++.+||+.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 0000100000 0 011234667888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=330.61 Aligned_cols=263 Identities=19% Similarity=0.226 Sum_probs=190.0
Q ss_pred HHhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCC------Cceeeecceeec
Q 006317 319 IRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH------RNLVRLLGFSFE 391 (650)
Q Consensus 319 ~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~~~ 391 (650)
+...+++|++.++||+|+||+||++... .++.||||+++.... ...++..|+.++.+++| .+++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3445688999999999999999999864 478899999865322 22345667777766654 458888888875
Q ss_pred C-CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEecCCCCCceEeCCCC------
Q 006317 392 E-TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDADM------ 463 (650)
Q Consensus 392 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlk~~NILl~~~~------ 463 (650)
+ ...++|||++ +++|.+++. +...+++..+..++.||+.||+|||++ + |+||||||+||||+.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence 4 5788999988 678888876 345799999999999999999999974 5 99999999999998765
Q ss_pred ----------CeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCC
Q 006317 464 ----------IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIG 533 (650)
Q Consensus 464 ----------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~ 533 (650)
.+||+|||++.... .......||..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred cccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 49999999875322 123346799999999999999999999999999999999999999864332
Q ss_pred cccchhHHHH-------HHh-ccCCCccccc------CccCCC---------C---ChHHHHHHHHHHhcccccCCCCCC
Q 006317 534 EEAEDLLTYA-------WKN-WNEGTALNLI------DPTLRN---------G---SSSEIMRCVHIGLLCVQENVANRP 587 (650)
Q Consensus 534 ~~~~~l~~~~-------~~~-~~~~~~~~~i------d~~l~~---------~---~~~~~~~~~~l~~~Cl~~~p~~RP 587 (650)
.+....+... |.. +......+++ ++.... . ...+...+.+++..||+.||++||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 2111111110 000 0000000000 000000 0 001123456888999999999999
Q ss_pred CHHHHHH
Q 006317 588 TMASVVV 594 (650)
Q Consensus 588 t~~evl~ 594 (650)
|++|+++
T Consensus 431 ta~e~L~ 437 (467)
T PTZ00284 431 NARQMTT 437 (467)
T ss_pred CHHHHhc
Confidence 9999985
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=317.80 Aligned_cols=197 Identities=26% Similarity=0.347 Sum_probs=166.4
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecC------
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------ 392 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 392 (650)
..++|...+.||+|+||.||+++.. .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4478999999999999999999854 58889999987542 22344678899999999999999999987643
Q ss_pred CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeec
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 472 (650)
...++||||+++ +|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 356899999976 5666553 24889999999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCC
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF 530 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~ 530 (650)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 166 ~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred cccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9754322 122335789999999999998999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.23 Aligned_cols=256 Identities=27% Similarity=0.394 Sum_probs=199.4
Q ss_pred cCCCcCCcccccCceeEEEeecc------CCcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeecCCeeE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 396 (650)
++|+..+.||+|+||.||+++.+ +.+.|++|.+...... ...++.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999854 2457999988765443 3457899999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHHhhhcc------CCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeee
Q 006317 397 LIYEFVPNSSVDKFIFDAIKR------VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF 470 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 470 (650)
+||||+++|+|.+++...... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999753321 26899999999999999999999987 999999999999999999999999
Q ss_pred ecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccC
Q 006317 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNE 549 (650)
Q Consensus 471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 549 (650)
|+++...... ........++..|+|||.+.+..++.++||||||+++|||++ |..|+..... ...+.. ...
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~----~~~ 233 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNR----LQA 233 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHH----HHc
Confidence 9987543221 112223456778999999988889999999999999999999 6667642111 111111 111
Q ss_pred CCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 550 GTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 550 ~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
..... ......+ ..+.+++.+||+.+|++||++.|++.+|.
T Consensus 234 ~~~~~----~~~~~~~---~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLEL----PVPEGCP---SRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCC----CCCCCCC---HHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11100 0111122 24557888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.54 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=201.9
Q ss_pred hhccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
...++|+..+.||+|+||.||+++. .+++.||+|.+..........+.+|+.+++.++||||+++++++..++..++||
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 3447899999999999999999985 468999999997765555667889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 96 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred cccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999999998853 45899999999999999999999987 999999999999999999999999998765432
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
.. ......++..|+|||.+.+..++.++|||||||++|+|++|+.|+........ +. .....+ .+.
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~----~~~~~~------~~~ 234 (297)
T cd06656 169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LY----LIATNG------TPE 234 (297)
T ss_pred cc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--ee----eeccCC------CCC
Confidence 21 12234688899999999998999999999999999999999999853221110 00 000000 000
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+. ........+.+++.+||+.+|++||++.+|++.
T Consensus 235 ~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 235 LQ-NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CC-CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 001111234567789999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=304.91 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=196.6
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeecccc-CchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
++|+..+.||+|+||.||+++.. .++.||+|.+... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35788899999999999999875 5889999988654 223345788999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|..++........+++..+..++.+|+.||.|||+.. +++|+||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999998875322447999999999999999999999742 3999999999999999999999999998755322
Q ss_pred CCccceeecCccccChhccccC------CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRG------HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ........ ....
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~-~~~~---- 226 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAI-VDGD---- 226 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHH-hhcC----
Confidence 12234578899999998554 35789999999999999999999985322111 11111100 0000
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+.+... ....+..++.+||+.+|++||++.+++..
T Consensus 227 -~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 -PPTLPSG---YSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -CCCCCcc---cCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1111111 22344567779999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=315.29 Aligned_cols=197 Identities=27% Similarity=0.354 Sum_probs=166.8
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecC------
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------ 392 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 392 (650)
..++|...+.||+|+||.||+++.. .++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3478999999999999999999854 47889999997542 23345678899999999999999999987543
Q ss_pred CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeec
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 472 (650)
...++||||+++ +|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999975 6666653 24889999999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCC
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF 530 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~ 530 (650)
++..... .......||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 173 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 173 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred ccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 9764322 122335689999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=304.43 Aligned_cols=254 Identities=22% Similarity=0.368 Sum_probs=197.8
Q ss_pred cCCCcCCcccccCceeEEEeeccCC----cceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHG----QEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
++|...++||+|+||.||+|...+. ..|+||...... ......+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4678889999999999999986432 468999887654 3445578999999999999999999998875 557899
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++|+|.+++.. ....+++..++.++.+++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQV--NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999864 2346899999999999999999999887 99999999999999999999999999976543
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
..... .....++..|+|||.+....++.++||||||+++|||++ |+.||...... +...... .+..
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~----~~~~----- 226 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIE----NGER----- 226 (270)
T ss_pred cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH----cCCc-----
Confidence 32111 112234568999999988889999999999999999996 99888533211 1111111 1110
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
.......+. .+.+++.+|+..+|.+|||+.+++..|+..
T Consensus 227 ~~~~~~~~~---~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 227 LPMPPNCPP---TLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred CCCCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011122223 455677799999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.72 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=201.3
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
..+|+..+.||.|++|.||+|+. .+++.|++|.+..........+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 35688999999999999999985 46889999999766555566788999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++.. ..+++.++..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999998853 35899999999999999999999987 99999999999999999999999999876543322
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
......|+..|+|||.+.+..++.++|||||||++|||++|+.|+....... ... ..... . ..... ..
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~--~~~-~~~~~---~-~~~~~---~~ 238 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALY-LIATN---G-TPELQ---NP 238 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH-HHHhc---C-CcccC---Cc
Confidence 1223468889999999998889999999999999999999999986432211 111 11110 0 00000 00
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.... ..+.+++.+||+.+|++||++.+|+..
T Consensus 239 ~~~~---~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 239 EKLS---PIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ccCC---HHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1112 234567789999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=300.21 Aligned_cols=255 Identities=28% Similarity=0.411 Sum_probs=195.7
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch----------hHHHHHHHHHHHhhCCCCceeeecceeecCC
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ----------GELEFKNEVLLVARLQHRNLVRLLGFSFEET 393 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~----------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 393 (650)
+|...+.||+|+||.||+|+.. +|+.+|+|.++..... ..+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677899999999999999854 5889999988542111 1235788999999999999999999999999
Q ss_pred eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecc
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 473 (650)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999999874 357899999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCCccceeecCccccChhccccCC--CCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCC
Q 006317 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH--FSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGT 551 (650)
Q Consensus 474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 551 (650)
+...............|+..|+|||.+.... ++.++||||||+++|||++|+.|+..... ......... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~-~~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGN-KR 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhc-cc
Confidence 7654322222233456888999999987654 78999999999999999999998752111 111111111 11
Q ss_pred cccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 552 ALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 552 ~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
....+.+....... ..+.+++..||+.+|.+||++.+|++.
T Consensus 229 ~~~~~~~~~~~~~~---~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPIPPDVSMNLS---PVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcCCccccccCC---HHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11111111111122 345567779999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.55 Aligned_cols=257 Identities=20% Similarity=0.272 Sum_probs=192.5
Q ss_pred cCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|+..++||+|+||.||+++.+. ++.+|+|++.+... .....+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 368889999999999999998754 67899999865321 22334788999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999974 2456899999999999999999999987 999999999999999999999999998754322
Q ss_pred CCCCccceeecCccccChhccc-----cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||..... .... ...........
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~---~~~~---~~i~~~~~~~~ 228 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL---VETY---GKIMNHKERFQ 228 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH---HHHH---HHHhCCCcccc
Confidence 21 1223357999999999986 34688999999999999999999999863221 1111 11111111000
Q ss_pred ccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 555 LIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 555 ~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+ +........++..+++-+ .|...++..||++.|+++.
T Consensus 229 -~-p~~~~~~s~~~~~li~~l-l~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 -F-PAQVTDVSEDAKDLIRRL-ICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -C-CCccccCCHHHHHHHHHH-ccChhhhcCCCCHHHHhCC
Confidence 0 111112234444444321 2445556668999999865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=299.60 Aligned_cols=256 Identities=25% Similarity=0.386 Sum_probs=202.3
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
++|+..+.||.|+||.||+|... ++..+++|++..... .....+.+|+..++.++|+||+++++.+..++..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999854 578899999875432 3455789999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++........+++.....++.||+.||+|||+.+ ++||||||+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999975433457899999999999999999999887 99999999999999999999999999986654332
Q ss_pred CC--ccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 482 QG--DTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 482 ~~--~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
.. ......|+..|++||++... .++.++||||||+++|||++|+.|+....... ...+..... .+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~------~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQND------PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCC------CC
Confidence 21 22345688999999998877 78999999999999999999999986332211 111111110 11
Q ss_pred cCCCCC--hHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 559 TLRNGS--SSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 559 ~l~~~~--~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.+.... ..-...+.+++..||+.||++||++.+|++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111110 111244567788999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.65 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=200.0
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
++|+..+.||.|++|.||+|+.. +++.||+|++.... ......+.+|+.++++++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999865 58899999987653 33445688999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999998863 27899999999999999999999987 9999999999999999999999999998765332
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
.......++..|+|||.+.+..++.++||||||+++|||+||+.|+..... .......... ..+.+.
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~---------~~~~~~ 219 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRVLFLIPKN---------NPPSLE 219 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHHHHHhhhc---------CCCCCc
Confidence 122335678899999999998899999999999999999999999853221 1111111111 111111
Q ss_pred CC-ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 562 NG-SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 562 ~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.. .+ ..+.+++..||+.+|++|||++++++.
T Consensus 220 ~~~~~---~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 220 GNKFS---KPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ccccC---HHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11 22 235567779999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=298.22 Aligned_cols=270 Identities=20% Similarity=0.255 Sum_probs=211.4
Q ss_pred cCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhH---HHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
+.|+..+.||+|.-|+||++++.+ +..+|+|++.+...... ...+.|-++|+.++||.++.|++.+..++..+|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 457778999999999999999865 57899999988754433 34677999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc-
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM- 478 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~- 478 (650)
|||+||+|...++. ...+.+++..+.-++.+++.||+|||-.| ||.|||||+||||.++|++-|+||.|+.....
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999987654 45677999999999999999999999988 99999999999999999999999999754311
Q ss_pred --------------------------------CCC---------------------CCccceeecCccccChhccccCCC
Q 006317 479 --------------------------------DQS---------------------QGDTSRIVGTFGYMAPEYVTRGHF 505 (650)
Q Consensus 479 --------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 505 (650)
... ......++||..|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 011233689999999999999999
Q ss_pred CccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC-CChHHHHHHHHHHhcccccCCC
Q 006317 506 SIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN-GSSSEIMRCVHIGLLCVQENVA 584 (650)
Q Consensus 506 s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~-~~~~~~~~~~~l~~~Cl~~~p~ 584 (650)
+.++|+|.|||++|||+.|..||.....++ ...+++...+.- +.+.....+.+||...|.+||+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~---------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchh---------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 999999999999999999999996433222 122222222221 1223345566788889999999
Q ss_pred CCCC----HHHHHHH--hcCCCCCCCCCCCCccc
Q 006317 585 NRPT----MASVVVM--LNSSSLSLPLPSQPAFF 612 (650)
Q Consensus 585 ~RPt----~~evl~~--L~~~~~~~~~p~~p~~~ 612 (650)
+|-- +.||-+- .++.++.+..-..|+++
T Consensus 378 kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~i 411 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEI 411 (459)
T ss_pred hhhccccchHHhhcCccccCCChhheeccCCCcC
Confidence 9988 7777644 45555555544444443
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.49 Aligned_cols=260 Identities=24% Similarity=0.349 Sum_probs=196.5
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch-----hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ-----GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
+|+..+.||+|++|.||+|... +++.|+||++...... ....+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999864 5889999999765432 234567899999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+ +++|.+++... ...+++..++.++.||++||.|||+.+ ++|+||||+|||++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 89999998642 236999999999999999999999987 99999999999999999999999999986543
Q ss_pred CCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC-------
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG------- 550 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------- 550 (650)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|..++...... +.+..........
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhhhhh
Confidence 221 1222356788999998865 46789999999999999999997666532221 1111111100000
Q ss_pred --CcccccCcc------CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 551 --TALNLIDPT------LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 551 --~~~~~id~~------l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
......... +..........+.+++.+||+.+|++|||+.||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000 000011123456788889999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=299.96 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=196.9
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeec-CCeeEEEEe
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFE-ETERLLIYE 400 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e 400 (650)
+|++.+.||+|++|.||+++.. +++.+|+|++.... ......+.+|++++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999864 47789999986543 2334568899999999999999999988764 446789999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++++|.+++... ....+++.+++.++.+++.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999998753 3446899999999999999999999987 9999999999999999999999999998664322
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
.......+++.|+|||++.+..++.++||||||++++||++|+.|+..... ... ...... +.. +.+
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---~~~---~~~~~~-~~~-----~~~ 222 (257)
T cd08223 157 --DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---NSL---VYRIIE-GKL-----PPM 222 (257)
T ss_pred --CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HHH---HHHHHh-cCC-----CCC
Confidence 122345688999999999999999999999999999999999998753221 111 111111 110 111
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
... ....+.+++.+|++.+|++||++.++++.
T Consensus 223 ~~~---~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 PKD---YSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ccc---cCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111 22345678889999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.69 Aligned_cols=264 Identities=22% Similarity=0.327 Sum_probs=195.6
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
++|...++||+|+||.||+++.. +++.||+|.+..... .....+.+|+.++++++||||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888999999999999999865 578899999865432 2334577899999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
++ ++|..++.. ....+++..+..++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~- 158 (301)
T cd07873 86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 158 (301)
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-
Confidence 97 588888864 3456899999999999999999999987 9999999999999999999999999997543221
Q ss_pred CCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHH--------HHHHhccCCCc
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLT--------YAWKNWNEGTA 552 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~~~~~ 552 (650)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.||......+...... ..|..+.....
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 112234568899999988754 57889999999999999999999886433211111000 01111111000
Q ss_pred ccccC-ccCCCC-----ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 553 LNLID-PTLRNG-----SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 553 ~~~id-~~l~~~-----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
....+ +..... ...-...+.+++.+||+.||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 110000 00011234578889999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=307.51 Aligned_cols=263 Identities=23% Similarity=0.334 Sum_probs=196.5
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
++|+..++||+|+||.||++..+ +++.||+|++...... ....+.+|+++++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999975 4889999998654322 34468899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++++|..+.. ....+++..++.++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999988765 2345899999999999999999999987 9999999999999999999999999987654322
Q ss_pred CCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccC--------CC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNE--------GT 551 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--------~~ 551 (650)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.|+......+....+......+.. ..
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 22223457889999999875 45788999999999999999999887533211100000000000000 00
Q ss_pred c-ccccCccCCCC------ChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 552 A-LNLIDPTLRNG------SSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 552 ~-~~~id~~l~~~------~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
. .....+..... .+.....+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 00000000000 0111244667888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=302.14 Aligned_cols=251 Identities=26% Similarity=0.375 Sum_probs=199.5
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
.++|++.+.||.|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467889999999999999999874 5788999999766555566788999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 156 (280)
T cd06611 84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-- 156 (280)
T ss_pred cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc--
Confidence 999999999864 2356999999999999999999999987 999999999999999999999999998754322
Q ss_pred CCccceeecCccccChhccc-----cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 482 QGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
........|+..|++||.+. ...++.++||||||+++|||++|+.|+...... ...... .....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~~~-----~~~~~---- 225 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLLKI-----LKSEP---- 225 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHHHH-----hcCCC----
Confidence 12223456899999999875 345678999999999999999999987532211 111111 00000
Q ss_pred CccCC--CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 557 DPTLR--NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 557 d~~l~--~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+.+. ..... .+.+++..||+.+|.+||++.+|++-
T Consensus 226 -~~~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 -PTLDQPSKWSS---SFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -CCcCCcccCCH---HHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1111 11222 34567779999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=298.48 Aligned_cols=253 Identities=25% Similarity=0.424 Sum_probs=198.0
Q ss_pred CCCcCCcccccCceeEEEeec-cCCcceeEeeccccCc------hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV------QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
+|+..+.||+|++|.||++.. .+++.||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 5688999999865431 123568899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC-CeEEeeeeccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLF 476 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~ 476 (650)
||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999863 356899999999999999999999987 99999999999998876 5999999998766
Q ss_pred ccCCCC--CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 477 EMDQSQ--GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 477 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
...... .......|+..|+|||.+.+..++.++||||+|+++|||++|+.|+........ ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~----- 226 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASA----- 226 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhcc-----
Confidence 433111 112235688999999999888899999999999999999999998853322111 1111111000
Q ss_pred ccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 555 LIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 555 ~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
...+.. .......+.+++.+|++.+|.+||++.++++
T Consensus 227 ~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 TTAPSI---PEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCC---chhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 001111 1112245667888999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=308.81 Aligned_cols=196 Identities=28% Similarity=0.469 Sum_probs=159.9
Q ss_pred CCcccccCceeEEEeeccC---CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeec--CCeeEEEEecCC
Q 006317 329 DNKLGQGGFGAVYKGRLSH---GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE--ETERLLIYEFVP 403 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~---g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~ 403 (650)
..+||+|+||.||+++..+ +..||+|.+..... ...+.+|+.++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3689999999999998643 46899999875432 2357889999999999999999998854 457789999987
Q ss_pred CCChhHHHHhhh------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe----CCCCCeEEeeeecc
Q 006317 404 NSSVDKFIFDAI------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DADMIPKISDFGMA 473 (650)
Q Consensus 404 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGla 473 (650)
+ +|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 6777664211 1235889999999999999999999987 9999999999999 56679999999999
Q ss_pred cccccCCCC-CccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCC
Q 006317 474 RLFEMDQSQ-GDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF 530 (650)
Q Consensus 474 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~ 530 (650)
+........ .......||..|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 876433221 22334578999999999876 4579999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.37 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=195.9
Q ss_pred CCcCCcccccCceeEEEeecc----CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCC------
Q 006317 326 FSTDNKLGQGGFGAVYKGRLS----HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEET------ 393 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 393 (650)
|.+.+.||+|+||.||+|.+. .++.||||++.... .....++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999853 36789999987642 234456889999999999999999999886532
Q ss_pred eeEEEEecCCCCChhHHHHhhh---ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeee
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF 470 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 470 (650)
..++++||+++|+|.+++.... ....+++...++++.||+.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998876421 1235789999999999999999999887 999999999999999999999999
Q ss_pred ecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccC
Q 006317 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNE 549 (650)
Q Consensus 471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 549 (650)
|+++...............++..|++||.+....++.++||||||+++|||++ |+.|+.... ..++..+....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~---~~~~~~~~~~~--- 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE---NSEIYNYLIKG--- 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC---HHHHHHHHHcC---
Confidence 99986543322222223345678999999998889999999999999999999 777764221 12222222111
Q ss_pred CCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 550 GTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 550 ~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.... . .......+.+++.+|++.+|++||++.+|+..|+.
T Consensus 232 -~~~~-----~---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 232 -NRLK-----Q---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred -CcCC-----C---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 1000 0 01122456778889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=301.33 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=198.8
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
..|+..++||.|+||.||+|... .++.||+|.+.... ......+.+|+.++++++||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777899999999999999865 47899999987543 33455788999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998852 46899999999999999999999887 99999999999999999999999999976543221
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
......++..|+|||++.+..++.++||||||+++|||++|+.|+....... ..... ... ..+.+
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~----~~~-----~~~~~- 221 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VLFLI----PKN-----NPPTL- 221 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---Hhhhh----hcC-----CCCCC-
Confidence 1223467889999999998889999999999999999999999875322111 00000 000 01111
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.......+.+++..||+.+|++||++.+++..
T Consensus 222 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 --TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11223456678889999999999999999755
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=296.81 Aligned_cols=247 Identities=29% Similarity=0.438 Sum_probs=196.6
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccC-----chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-----VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+....+.+|+.++++++|+||+++++++..+...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677899999999999999876 68899999986543 22345688999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999863 346899999999999999999999987 99999999999999999999999999876543
Q ss_pred CCCCCccceeecCccccChhccccCC-CCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
.. ......|+..|++||.+.... ++.++|+||||+++|+|++|+.|+.... . ....+....... .
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--~----~~~~~~~~~~~~-~---- 220 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--G----VAAVFKIGRSKE-L---- 220 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--H----HHHHHHHHhccc-C----
Confidence 22 223456888999999987776 8999999999999999999999975322 1 111111100000 0
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
+.+.... ...+.+++.+||+.+|.+||++.+++.
T Consensus 221 ~~~~~~~---~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 PPIPDHL---SDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCcCCCc---CHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1111111 234456777999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=298.57 Aligned_cols=251 Identities=33% Similarity=0.523 Sum_probs=197.6
Q ss_pred CCcCCcccccCceeEEEeeccC-----CcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 326 FSTDNKLGQGGFGAVYKGRLSH-----GQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
|++.+.||.|+||.||+++..+ +..||+|++...... ....+.+|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999998754 378999999766443 4567899999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999999987521 122899999999999999999999987 999999999999999999999999999866543
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
...... ...++..|+|||.+....++.++||||+|++++||++ |+.|+... ........... ....
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~---~~~~~~~~~~~----~~~~----- 223 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM---SNEEVLEYLKK----GYRL----- 223 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHhc----CCCC-----
Confidence 222111 2336789999999988889999999999999999999 66666431 11122221111 1100
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHh
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVML 596 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L 596 (650)
......+ .++.+++.+|++.+|++|||+.|++++|
T Consensus 224 ~~~~~~~---~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PKPENCP---PEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCcCC---HHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111122 3455677899999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=308.94 Aligned_cols=198 Identities=19% Similarity=0.279 Sum_probs=164.2
Q ss_pred cCCccccc--CceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 328 TDNKLGQG--GFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 328 ~~~~LG~G--~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
+.++||+| +|++||+++.. +|+.||+|++..... .....+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78899999864 588999999976432 23346778999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC-
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS- 481 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~- 481 (650)
++|+|.+++... ....+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999998643 2345899999999999999999999987 99999999999999999999999987543221110
Q ss_pred ----CCccceeecCccccChhcccc--CCCCccccccchhHHHHHHHhCCCCCC
Q 006317 482 ----QGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQKNNS 529 (650)
Q Consensus 482 ----~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvll~elltG~~p~~ 529 (650)
........++..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 211 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 001122356778999999876 468999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=299.55 Aligned_cols=247 Identities=28% Similarity=0.465 Sum_probs=194.8
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
++|++.+.||+|+||.||++.. .++.||+|.++... ....+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999975 67889999986543 234688999999999999999999998654 4799999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
+++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 99999998753 2346899999999999999999999887 999999999999999999999999998754321
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
......+..|+|||.+.++.++.++||||||+++|||++ |+.|+..... ......... +.. .+ ...
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~----~~~---~~--~~~ 220 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL---KEVKECVEK----GYR---ME--PPE 220 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH---HHHHHHHhC----CCC---CC--CCC
Confidence 112234567999999998899999999999999999998 8888753221 111111111 100 01 111
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
..+ ..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 221 ~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 GCP---ADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred cCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 122 344577789999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=311.49 Aligned_cols=239 Identities=23% Similarity=0.271 Sum_probs=183.1
Q ss_pred ccccCceeEEEeecc-CCcceeEeeccccCch---hHHHHHHHHHHHhhC---CCCceeeecceeecCCeeEEEEecCCC
Q 006317 332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLVARL---QHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 332 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
||+|+||+||+++.. +++.||||++.+.... ....+..|..++... +||||++++.++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999865 5889999998654322 222345566666655 699999999999999999999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
|+|.+++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 99998886 3567999999999999999999999987 9999999999999999999999999987533221 22
Q ss_pred cceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC-
Q 006317 485 TSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN- 562 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~- 562 (650)
.....||..|+|||++.+. .++.++|||||||++|||++|+.||..... ..+.. ....+. ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---~~~~~----~i~~~~------~~~~~~ 219 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---QQMYR----NIAFGK------VRFPKN 219 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---HHHHH----HHHcCC------CCCCCc
Confidence 3345799999999998764 479999999999999999999999853221 11111 111111 01111
Q ss_pred CChHHHHHHHHHHhcccccCCCCCC----CHHHHHH
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRP----TMASVVV 594 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RP----t~~evl~ 594 (650)
.... .+.+++.+||+.||.+|| ++.++++
T Consensus 220 ~~~~---~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 VLSD---EGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cCCH---HHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1222 334667799999999998 5666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=339.43 Aligned_cols=254 Identities=23% Similarity=0.366 Sum_probs=194.8
Q ss_pred hccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeec--CCeeE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFE--ETERL 396 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 396 (650)
..++|.+.++||+|+||.||+++... +..||+|.+.... ......+..|+.++.+++|||||++++++.. ....+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 44689999999999999999998654 6788999886542 2234568899999999999999999998854 35689
Q ss_pred EEEecCCCCChhHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCC----CcEEecCCCCCceEeCC----------
Q 006317 397 LIYEFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGGIARGILYLHEDSR----LRIIHRDLKASNILLDA---------- 461 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~iiHrDlk~~NILl~~---------- 461 (650)
|||||+++|+|.++|..... ...+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 99999999999999975322 3569999999999999999999998541 34999999999999964
Q ss_pred -------CCCeEEeeeecccccccCCCCCccceeecCccccChhcccc--CCCCccccccchhHHHHHHHhCCCCCCCCC
Q 006317 462 -------DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQKNNSFRI 532 (650)
Q Consensus 462 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvll~elltG~~p~~~~~ 532 (650)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+||||+||+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 2358999999997654221 2234578999999999864 458899999999999999999999985321
Q ss_pred CcccchhHHHHHHhccCCCcccccCccCC-CCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 533 GEEAEDLLTYAWKNWNEGTALNLIDPTLR-NGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 533 ~~~~~~l~~~~~~~~~~~~~~~~id~~l~-~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
....++.. .... +.+. .... ..+.+|+..||+.+|.+||++.|++.
T Consensus 248 --~~~qli~~----lk~~-------p~lpi~~~S---~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 --NFSQLISE----LKRG-------PDLPIKGKS---KELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred --cHHHHHHH----HhcC-------CCCCcCCCC---HHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 11111111 1110 1111 1122 34556777999999999999999984
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=298.99 Aligned_cols=250 Identities=21% Similarity=0.336 Sum_probs=198.1
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+|+..++||+|+||.||+++.. +|+.||+|++.... .....++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999854 58899999986532 23345789999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++... ....+++..+++++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999988642 2345889999999999999999999987 99999999999999999999999999976543211
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
......|+..|+|||++.+..++.++||||||++++||++|+.|+..... .+.. ..... +.. +...
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~~~~---~~~~~-~~~-----~~~~ 222 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---KNLV---LKIIR-GSY-----PPVS 222 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH---HHHH---HHHhc-CCC-----CCCc
Confidence 12234578899999999988999999999999999999999998753211 1111 11111 100 1111
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
... ...+.+++.+||+.+|.+||++.+|++.
T Consensus 223 ~~~---~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 223 SHY---SYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ccC---CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 112 2345567779999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=295.53 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=204.2
Q ss_pred cCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
++|+..+.||+|++|.||+++... ++.|+||++..... .....+.+|+..+.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 367888999999999999998764 88999999877644 3456789999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
+++++|.+++.. ...+++..+++++.||+++|+|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999874 3678999999999999999999998 76 9999999999999999999999999998664332
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
.. .....++..|+|||.+....++.++||||||+++|||++|+.|+.........++...... . ..+.+
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----~-----~~~~~ 223 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD----G-----PPPSL 223 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc----C-----CCCCC
Confidence 21 2245688899999999999999999999999999999999999864332122222222111 0 11111
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
... .....+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~--~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAE--EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred Ccc--cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 012345567778999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=282.43 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=199.3
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeecccc--CchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
.++.|++.+.||+|.|+.||+... ..|+.+|+|++... +..+.+++.+|+.+.+.|+||||+++...+.++...+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 356788889999999999999864 56999999998643 334566789999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC---CCeEEeeeecccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARL 475 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGla~~ 475 (650)
+|+|.+++|-.-+- .+.-+++...-..++||+++|.|+|..+ |||||+||.|+||-.. .-+||+|||++..
T Consensus 89 Fe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999865443 3456788889999999999999999998 9999999999999543 3589999999986
Q ss_pred cccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
+. ........+||++|||||++...+|+..+|||+.||+||-|+.|..||... +...+.+...+..- +
T Consensus 163 l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~---~~~rlye~I~~g~y-----d- 230 (355)
T KOG0033|consen 163 VN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYEQIKAGAY-----D- 230 (355)
T ss_pred eC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc---cHHHHHHHHhcccc-----C-
Confidence 65 333455678999999999999999999999999999999999999998632 23333333322110 0
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHH
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVV 593 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl 593 (650)
+++..-+...++. .+|+.+||..||++|-|+.|.+
T Consensus 231 ~~~~~w~~is~~A---k~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 231 YPSPEWDTVTPEA---KSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred CCCcccCcCCHHH---HHHHHHHhccChhhhccHHHHh
Confidence 1111111122333 3566689999999999999887
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.29 Aligned_cols=258 Identities=23% Similarity=0.308 Sum_probs=193.2
Q ss_pred hhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecC-----
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEE----- 392 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----- 392 (650)
...++|...+.||+|+||.||++... +++.||||++..... .....+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999854 578899999875422 2334577899999999999999999987543
Q ss_pred -CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeee
Q 006317 393 -TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471 (650)
Q Consensus 393 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 471 (650)
...++++|++ +++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3568999988 778888764 356999999999999999999999987 9999999999999999999999999
Q ss_pred cccccccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhc---
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNW--- 547 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~--- 547 (650)
+++.... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||...... +.+.......
T Consensus 164 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~ 235 (343)
T cd07878 164 LARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI---DQLKRIMEVVGTP 235 (343)
T ss_pred cceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHhCCC
Confidence 9986432 1223568999999999877 57899999999999999999999988532211 1111110000
Q ss_pred --------cCCCcccccCccCCCCChH--------HHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 548 --------NEGTALNLIDPTLRNGSSS--------EIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 548 --------~~~~~~~~id~~l~~~~~~--------~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
........+. .+...... ....+.+++.+|++.||.+|||+.|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 00000000 01235678889999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=294.16 Aligned_cols=247 Identities=24% Similarity=0.396 Sum_probs=202.2
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
+-|++.++||+|.||.|||+.++ .|+.+|||.+.... ..+++..|+.+|.+.+.|++|+++|.+.....+|+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34677899999999999999875 48999999987654 3457889999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
..|+..++++- ++++|++.++..++...++||+|||... -||||||+.||||+.+|.+||+|||++..+....
T Consensus 111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-- 183 (502)
T KOG0574|consen 111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-- 183 (502)
T ss_pred CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--
Confidence 99999999874 6788999999999999999999999875 7999999999999999999999999997664322
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
.....+.||+.|||||++..-.|..++||||||+...||..|++|+..-... +..-++......
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----------------RAIFMIPT~PPP 247 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM----------------RAIFMIPTKPPP 247 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc----------------ceeEeccCCCCC
Confidence 2345578999999999999999999999999999999999999998621111 111111111111
Q ss_pred C--ChHH-HHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 563 G--SSSE-IMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 563 ~--~~~~-~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
. .+++ ..++-+.+..||-++|++|-|+.++++-
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 0 1222 2334456668999999999999988753
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.55 Aligned_cols=265 Identities=21% Similarity=0.321 Sum_probs=198.6
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
++|+..++||+|+||.||++... +++.|+||+++... ......+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999875 47889999986542 2234578899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|++++.+..++. +...+++..++.++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999877776554 3456899999999999999999999987 9999999999999999999999999998665432
Q ss_pred CCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHH--------hccCCC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWK--------NWNEGT 551 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~--------~~~~~~ 551 (650)
. .......++..|+|||++.+. .++.++||||||+++|||++|+.|+......+........+. .+....
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 2 122335678899999999888 889999999999999999999988763322111000000000 000000
Q ss_pred cc---cccCccCC----CCChH-HHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 552 AL---NLIDPTLR----NGSSS-EIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 552 ~~---~~id~~l~----~~~~~-~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.. +..+.... ...+. ...++.+++.+||+.+|++||+++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 00000000 00001 13456678889999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=304.04 Aligned_cols=262 Identities=25% Similarity=0.382 Sum_probs=201.8
Q ss_pred cChhhHHhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceeec
Q 006317 314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFE 391 (650)
Q Consensus 314 ~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 391 (650)
+....+..++++|...+.||+|+||.||++... +++.+|+|.+..... ....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 455677778899999999999999999999864 588899999865432 234677899999998 89999999999875
Q ss_pred C-----CeeEEEEecCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCe
Q 006317 392 E-----TERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465 (650)
Q Consensus 392 ~-----~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 465 (650)
. ...++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 3 35799999999999999886432 3457899999999999999999999887 9999999999999999999
Q ss_pred EEeeeecccccccCCCCCccceeecCccccChhccccC-----CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhH
Q 006317 466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-----HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL 540 (650)
Q Consensus 466 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~ 540 (650)
||+|||+++....... ......|+..|+|||.+... .++.++|||||||++|||++|+.|+..... ...+.
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~--~~~~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTLF 243 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--HHHHH
Confidence 9999999876542221 12234678899999988643 368999999999999999999998753221 11111
Q ss_pred HHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 541 TYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 541 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
... ......+.++ ......+.+++.+||+.+|++||++.|+++
T Consensus 244 ~~~-----~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 KIP-----RNPPPTLLHP------EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHh-----cCCCCCCCcc------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 110 0111111111 111234667888999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=296.98 Aligned_cols=249 Identities=22% Similarity=0.375 Sum_probs=197.0
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+|+..+.||+|+||.||++... +++.+|||.+.... ......+.+|+.++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 57889999986543 23345788999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC-CeEEeeeecccccccCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQ 480 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~~~~ 480 (650)
+++++|.+++... ....+++..+.+++.+++.+|+|||+.+ ++|+||||+||++++++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999999753 2345899999999999999999999987 99999999999998654 68999999998654321
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ......... ... ..+
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~----~~~-----~~~ 221 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKIMS----GTF-----API 221 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHHHh----cCC-----CCC
Confidence 22235688899999999988899999999999999999999998753221 111111110 000 011
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.... ...+.+++.+||+.+|++|||+.|++..
T Consensus 222 ~~~~---~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 SDRY---SPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCc---CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111 2345577789999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=301.92 Aligned_cols=260 Identities=22% Similarity=0.318 Sum_probs=193.1
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+|+..+.||+|+||.||+++.. +|+.+|+|++...... ....+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999865 5889999998654222 234577899999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++ +|.+++.. ....+++..++.++.||++||.|||+.+ ++||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 974 78777754 2456999999999999999999999987 9999999999999999999999999998654322
Q ss_pred CCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCC------ccc
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGT------ALN 554 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~ 554 (650)
.......++..|+|||.+.+. .++.++|||||||++|||+||+.|+..... ....+........... ...
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCCChHHhHHhhh
Confidence 112234578899999998765 468999999999999999999988642221 1111111111000000 000
Q ss_pred ccC----ccCCCC------ChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 555 LID----PTLRNG------SSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 555 ~id----~~l~~~------~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
..+ +..... .+....++.+++.+||+.||.+|||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 000000 0111234557788999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=296.04 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=191.9
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC-----chhHHHHHHHHHHHhhCCCCceeeecceeecC--Cee
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-----VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TER 395 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 395 (650)
.+|+..++||+|+||.||+++.. ++..||||.+.... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999864 48899999885321 12234688899999999999999999988764 457
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++||||+++++|.+++.. ...+++...++++.|++.+|+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999999863 345889999999999999999999987 99999999999999999999999999976
Q ss_pred cccCCC-CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 476 FEMDQS-QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 476 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
...... ........|+..|+|||.+.+..++.++||||||+++|||++|+.|+..... .... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~~-~~~~~~~---- 225 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----MAAI-FKIATQP---- 225 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----HHHH-HHHhcCC----
Confidence 542211 1122334688999999999888899999999999999999999999853211 1111 1110000
Q ss_pred ccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 555 LIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 555 ~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
..+... ......+..++..|+. +|++||+++||++
T Consensus 226 -~~~~~~---~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 -TNPVLP---PHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -CCCCCc---hhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 011111 1222344556667874 8999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=303.35 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=196.7
Q ss_pred CCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCC
Q 006317 326 FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
|+...+||+|+||.||++... +++.||+|.+..........+.+|+.++..++||||+++++++..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 344568999999999999864 5889999998765555556788999999999999999999999999999999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
++|..++. ...+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++..+.... ..
T Consensus 103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~ 173 (297)
T cd06659 103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PK 173 (297)
T ss_pred CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--cc
Confidence 99998774 346899999999999999999999987 9999999999999999999999999987554322 12
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGS 564 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 564 (650)
.....|+..|+|||++.+..++.++||||||+++|||++|+.|+...... ........ ..... .......
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~----~~~~~---~~~~~~~ 243 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLRD----SPPPK---LKNAHKI 243 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhc----cCCCC---ccccCCC
Confidence 23356899999999999889999999999999999999999998632211 11111110 00000 0000111
Q ss_pred hHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 565 SSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 565 ~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
. ..+.+++..||+.+|++||++++|++.
T Consensus 244 ~---~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 S---PVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred C---HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 2 234567779999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=300.89 Aligned_cols=261 Identities=21% Similarity=0.323 Sum_probs=198.5
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+|++.+.||+|++|.||+|+.. +|+.|++|++..... .....+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999864 588999999876542 2345788999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+ +++|.+++.. ....+++..++.++.||+++|+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRD--EERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 9999999865 2356999999999999999999999987 99999999999999999999999999986643321
Q ss_pred CCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC----------
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG---------- 550 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---------- 550 (650)
.......|+..|+|||.+.+. .++.++||||+|++++||++|+.++..... ...+..........
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccC
Confidence 122335688999999998654 468999999999999999999766643221 11111111111100
Q ss_pred --CcccccCccCC-----CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 551 --TALNLIDPTLR-----NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 551 --~~~~~id~~l~-----~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
....+..+... ....+....+.+++.+||+.+|++||++++++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0001122556678889999999999999999854
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=302.13 Aligned_cols=258 Identities=19% Similarity=0.257 Sum_probs=199.9
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|+..+.||+|+||.||++... .++.|++|.+..... .....+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999865 478899999876532 23346789999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999864 356899999999999999999999987 999999999999999999999999998742111
Q ss_pred CC-------------CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHh
Q 006317 480 QS-------------QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKN 546 (650)
Q Consensus 480 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~ 546 (650)
.. ........|+..|+|||.+.+..++.++||||||+++|||++|+.|+.... ...+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~---~~~~~~~~~~- 230 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT---PEELFGQVIS- 230 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHh-
Confidence 00 001112457889999999998889999999999999999999999985221 1111111110
Q ss_pred ccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCC
Q 006317 547 WNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSS 600 (650)
Q Consensus 547 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~ 600 (650)
+ ....+......+. .+.+++.+||+.+|++||++.++.+.|+...
T Consensus 231 ---~---~~~~~~~~~~~~~---~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 231 ---D---DIEWPEGDEALPA---DAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred ---c---ccCCCCccccCCH---HHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 0 0011111111223 3456777999999999999887877777643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=296.69 Aligned_cols=254 Identities=25% Similarity=0.375 Sum_probs=200.4
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
++|+..+.||+|++|.||++... +++.+++|++..... ....++.+|++++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778899999999999999875 588899999876543 3445788999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
+++++|.+++... ...+++..+..++.|++.+|+|||+ .+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999998742 2678999999999999999999998 66 9999999999999999999999999987553221
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
. ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... ............... .+.+
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~------~~~~ 224 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEP------PPRL 224 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCC------CCCC
Confidence 1 1256888999999999999999999999999999999999998643211 111111111111110 1111
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
... .....+.+++..||..+|++|||+.+++..
T Consensus 225 ~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 PSG--KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred Chh--hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111 012335577779999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=306.96 Aligned_cols=252 Identities=25% Similarity=0.347 Sum_probs=205.2
Q ss_pred hccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchh---HHHHHHHHHHHhhCC-CCceeeecceeecCCeeE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQG---ELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERL 396 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 396 (650)
....|+..+.||+|.||.||+++.+. |+.+|+|.+.+..... ...+.+|+.+|+++. |||||.+.+.+.+....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45678888999999999999998765 9999999998775543 357899999999998 999999999999999999
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC----CCeEEeeeec
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD----MIPKISDFGM 472 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~----~~~kl~DFGl 472 (650)
+|||++.+|.|.+.+... .+++.....++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999998753 3999999999999999999999987 9999999999999644 4799999999
Q ss_pred ccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCc
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA 552 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 552 (650)
+..... .......+||+.|+|||++....|+...||||+||++|.|++|..||.......... ... .+..
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--~i~-----~~~~ 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--AIL-----RGDF 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--HHH-----cCCC
Confidence 987764 345667899999999999999999999999999999999999999987443222111 111 1111
Q ss_pred ccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 553 LNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 553 ~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+.-++.. ....+.. -.++..++..||.+|+|+.++++-
T Consensus 256 -~f~~~~w-~~is~~a---kd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -DFTSEPW-DDISESA---KDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -CCCCCCc-cccCHHH---HHHHHHhcccCcccCCCHHHHhcC
Confidence 1111111 1122233 345668999999999999999873
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=300.78 Aligned_cols=258 Identities=28% Similarity=0.438 Sum_probs=199.2
Q ss_pred ChhhHHhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceeec-
Q 006317 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFE- 391 (650)
Q Consensus 315 ~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~- 391 (650)
++.++..+.+.|+..+.||.|+||.||+|+.. +++.+|+|++.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45566677889999999999999999999864 57889999986543 2334678899999998 69999999998853
Q ss_pred -----CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeE
Q 006317 392 -----ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPK 466 (650)
Q Consensus 392 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~k 466 (650)
....+++|||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ ++|+||||+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 45779999999999999988653 3345889999999999999999999987 99999999999999999999
Q ss_pred EeeeecccccccCCCCCccceeecCccccChhccc-----cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHH
Q 006317 467 ISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLT 541 (650)
Q Consensus 467 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~ 541 (650)
|+|||++....... .......|+..|+|||.+. ...++.++|||||||++|||++|+.|+....... ....
T Consensus 162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~--~~~~ 237 (282)
T cd06636 162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR--ALFL 237 (282)
T ss_pred EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh--hhhh
Confidence 99999987553221 1223456899999999876 3467889999999999999999999885321110 0000
Q ss_pred HHHHhccCCCcccccCccCC-CCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 542 YAWKNWNEGTALNLIDPTLR-NGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 542 ~~~~~~~~~~~~~~id~~l~-~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
. .....+.+. ...+ ..+.+++..||+.||.+||++.||++
T Consensus 238 -~---------~~~~~~~~~~~~~~---~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 -I---------PRNPPPKLKSKKWS---KKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -H---------hhCCCCCCcccccC---HHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 000011111 1122 34566777999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=294.88 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=198.3
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeec--CCeeEEEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFE--ETERLLIY 399 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~ 399 (650)
+|+..+.||.|+||.||++... +++.+|+|++.... ......+.+|+.++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999854 57889999987543 2334468889999999999999999997754 45678999
Q ss_pred ecCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcC--CCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 400 EFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
||+++++|.+++.... ....+++..++.++.||+.||.|||..+ ..+++|+||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999987532 2467999999999999999999999332 234999999999999999999999999999876
Q ss_pred ccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
..... ......|+..|+|||.+....++.++||||||+++|+|++|+.|+..... ..+..... ...
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~----~~~----- 226 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASKIK----EGK----- 226 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHHHh----cCC-----
Confidence 53321 12234689999999999998899999999999999999999999864331 11111111 111
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+.+.. .....+.+++.+|++.+|++||++.+|++.
T Consensus 227 ~~~~~~---~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 FRRIPY---RYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCCcc---ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011111 122355678889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=300.14 Aligned_cols=261 Identities=24% Similarity=0.358 Sum_probs=195.2
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
++|+..+.||+|++|.||+|+.+ +++.||||.+...... ....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999865 5789999998654322 233567899999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++ +|.+++... ...+++.....++.||++||.|||+.+ ++||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 157 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS- 157 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC-
Confidence 985 899888642 346899999999999999999999987 9999999999999999999999999987543211
Q ss_pred CCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcc-------
Q 006317 482 QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL------- 553 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------- 553 (650)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..... ..+.+...+..+......
T Consensus 158 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred -ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhhh
Confidence 11122346788999998875 4578999999999999999999998853321 111111111111110000
Q ss_pred -----c----cc-CccCCCC--ChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 554 -----N----LI-DPTLRNG--SSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 554 -----~----~i-d~~l~~~--~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
. .. ...+... .......+.+++..||+.+|++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00 0000000 0011245667888999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=282.88 Aligned_cols=253 Identities=24% Similarity=0.379 Sum_probs=198.4
Q ss_pred HhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc----h----hHHHHHHHHHHHhhC-CCCceeeeccee
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV----Q----GELEFKNEVLLVARL-QHRNLVRLLGFS 389 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----~----~~~~~~~E~~~l~~l-~H~niv~l~g~~ 389 (650)
+..-+.|...+.||.|..+.|-+...+ .|+++|+|++..... + -.+.-.+|+.+|+++ .||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 344567888899999999999888754 588999999854321 1 122356799999998 699999999999
Q ss_pred ecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEee
Q 006317 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD 469 (650)
Q Consensus 390 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 469 (650)
......++|+|.|+.|.|.++|. ....++++...+|+.|+.+|++|||..+ |+||||||+|||+|++.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 99999999999999999999997 4567999999999999999999999987 99999999999999999999999
Q ss_pred eecccccccCCCCCccceeecCccccChhccc------cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHH
Q 006317 470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT------RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYA 543 (650)
Q Consensus 470 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~ 543 (650)
||++..++... .....+||++|+|||.+. ...|+...|+|+.||++|-|+.|.+||.... .++..
T Consensus 167 FGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----QmlML- 237 (411)
T KOG0599|consen 167 FGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----QMLML- 237 (411)
T ss_pred cceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----HHHHH-
Confidence 99998776433 345579999999999885 3468899999999999999999999984211 11100
Q ss_pred HHhccCCCcccccCccCCC-CChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 544 WKNWNEGTALNLIDPTLRN-GSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 544 ~~~~~~~~~~~~id~~l~~-~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
+...++.. .... +..+.....-+|+.+||+.||.+|-|.+|.+.
T Consensus 238 -R~ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 238 -RMIMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred -HHHHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11111110 1111 11122233446778999999999999999984
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=309.79 Aligned_cols=243 Identities=29% Similarity=0.422 Sum_probs=195.9
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
+.|..++.||.|+||.||.++.. +.+.||||+++... .+.+.++..|+..|.+++|||+|.+-|+|..+...||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 34677789999999999999854 56789999997653 344567999999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
|||-| |-.++|.- .++++-+.++..|..+.+.||+|||+.+ .||||||+.||||++.|.+||+|||.+.+..+
T Consensus 106 EYClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 106 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred HHHhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 99965 77777653 4567999999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCCccceeecCccccChhccc---cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
...++||+.|||||++. .+.|+-|+||||||+...||.-.++|...... .+.+-..... -
T Consensus 179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA---MSALYHIAQN---------e 241 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQN---------E 241 (948)
T ss_pred -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH---HHHHHHHHhc---------C
Confidence 33578999999999874 58999999999999999999999988642211 1111111111 1
Q ss_pred CccCCCC-ChHHHHHHHHHHhcccccCCCCCCCHHHHH
Q 006317 557 DPTLRNG-SSSEIMRCVHIGLLCVQENVANRPTMASVV 593 (650)
Q Consensus 557 d~~l~~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl 593 (650)
.|.|... ..+.+..+++ .||++-|.+|||.++++
T Consensus 242 sPtLqs~eWS~~F~~Fvd---~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 242 SPTLQSNEWSDYFRNFVD---SCLQKIPQERPTSEELL 276 (948)
T ss_pred CCCCCCchhHHHHHHHHH---HHHhhCcccCCcHHHHh
Confidence 2334322 4445555444 79999999999999987
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=296.18 Aligned_cols=259 Identities=25% Similarity=0.319 Sum_probs=199.6
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecC--CeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~ 399 (650)
++|+..+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999974 578899999875433 3455789999999999999999999988654 4689999
Q ss_pred ecCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 400 EFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999876432 3456899999999999999999999987 99999999999999999999999999875432
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCC--cccchhHHHHHHhccCCCccccc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIG--EEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
.. .....++..|++||.+.+..++.++||||||+++|||++|+.|+..... ....++..+... .....+
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~- 228 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPEL- 228 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhh-
Confidence 21 1234578899999999989999999999999999999999999874422 111222222111 011111
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
...... ...-...+.+++.+||+.+|++|||+.||+..
T Consensus 229 ~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 229 KDEPGN-GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ccCCCC-CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 110100 01122456688889999999999999999864
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=304.50 Aligned_cols=204 Identities=27% Similarity=0.455 Sum_probs=168.6
Q ss_pred CCCcCCcccccCceeEEEeeccC---CcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecC--CeeE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLSH---GQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERL 396 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~~---g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 396 (650)
+|+..++||+|+||.||+|+... ++.||+|.+.... ......+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788999999999999998654 7899999997743 22334678899999999999999999999988 7899
Q ss_pred EEEecCCCCChhHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC----CCCeEEeee
Q 006317 397 LIYEFVPNSSVDKFIFDAIK--RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA----DMIPKISDF 470 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~----~~~~kl~DF 470 (650)
+||||+++ +|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 66666643222 236899999999999999999999987 999999999999999 999999999
Q ss_pred ecccccccCCC-CCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCC
Q 006317 471 GMARLFEMDQS-QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRI 532 (650)
Q Consensus 471 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~ 532 (650)
|++........ ........++..|+|||.+.+. .++.++||||||++++||++|+.|+....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99986543322 1223345678899999988764 57899999999999999999999986443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.05 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=191.5
Q ss_pred CCcCCcccccCceeEEEeecc-CCcceeEeecccc----CchhHHHHHHHHHHHhhCCCCceeeecceeecCCe--eEEE
Q 006317 326 FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN----SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE--RLLI 398 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lv 398 (650)
.+...+||+|.|-+||||... +|.+||--.++.. +......|..|+.+|+.|+|||||+++..+.+... .-+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 345679999999999999864 3777765444322 22233579999999999999999999999987655 7799
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC-CCeEEeeeecccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARLFE 477 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGla~~~~ 477 (650)
+|.+..|+|..|+. +.+.++...+.+|++||++||.|||++. |+|||||||-.||+|+.+ |.+||+|+|||....
T Consensus 122 TEL~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 122 TELFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eecccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999997 4567899999999999999999999985 789999999999999865 799999999998765
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
.. ....+.||+.|||||... ..|....||||||++++||+|+..|+.- -.....+...+..........++
T Consensus 198 ~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE--C~n~AQIYKKV~SGiKP~sl~kV-- 268 (632)
T KOG0584|consen 198 KS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE--CTNPAQIYKKVTSGIKPAALSKV-- 268 (632)
T ss_pred cc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh--hCCHHHHHHHHHcCCCHHHhhcc--
Confidence 32 233479999999999876 7899999999999999999999998751 11111122211111111111111
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
. ..++.+++..|+.. .++|||+.|+|.-
T Consensus 269 ------~---dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 269 ------K---DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ------C---CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1 23445677799999 9999999999954
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=298.76 Aligned_cols=263 Identities=22% Similarity=0.306 Sum_probs=195.2
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++++|...+.||+|+||.||+|... +++.||+|++...... ....+.+|+.+++.++|+||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999864 5889999998654322 2345778999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+. ++|..++.. ....+++..+..++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 677766653 2345788999999999999999999987 999999999999999999999999998754322
Q ss_pred CCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC--------
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG-------- 550 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-------- 550 (650)
. .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+..... ..+.+...|..+...
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 S--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred C--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhhhh
Confidence 1 112234578899999998764 578899999999999999999999863322 112222222211100
Q ss_pred ----CcccccC-----ccCCC--CChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 551 ----TALNLID-----PTLRN--GSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 551 ----~~~~~id-----~~l~~--~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
....... ..+.. ........+.+++.+|++.||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000 00000 00011234557778999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=311.99 Aligned_cols=245 Identities=27% Similarity=0.444 Sum_probs=198.2
Q ss_pred cccccCceeEEEeeccC-CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCCChhH
Q 006317 331 KLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDK 409 (650)
Q Consensus 331 ~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 409 (650)
+||+|.||+||.|+..+ ...+|||.+........+.+.+|+.+.++|+|+|||+++|.+.+++..-+.||-++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999765 44689999987766666678999999999999999999999999999999999999999999
Q ss_pred HHHhhhccCCC--CHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC-CCCeEEeeeecccccccCCCCCccc
Q 006317 410 FIFDAIKRVQL--DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEMDQSQGDTS 486 (650)
Q Consensus 410 ~l~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~ 486 (650)
+|.. +-+++ ++.+.-.+.+||++||.|||++. |||||||-.||||+. .|.+||+|||-++.+.. -+.-+.
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence 9986 55666 78888899999999999999987 999999999999975 68999999999986642 233455
Q ss_pred eeecCccccChhccccC--CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCC
Q 006317 487 RIVGTFGYMAPEYVTRG--HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGS 564 (650)
Q Consensus 487 ~~~gt~~y~aPE~~~~~--~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 564 (650)
.+.||+.|||||++..+ .|..++|||||||.+.||.||++||.--. .... .++.-+ +-.+.|.++
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg-spqA-------AMFkVG--myKvHP~iP--- 801 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG-SPQA-------AMFKVG--MYKVHPPIP--- 801 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC-ChhH-------hhhhhc--ceecCCCCc---
Confidence 67899999999999876 48899999999999999999999985211 1100 011000 111223222
Q ss_pred hHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 565 SSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 565 ~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+-..++...+++|+.++|.+||++.++++-
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 2223455678889999999999999999954
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=300.03 Aligned_cols=261 Identities=21% Similarity=0.321 Sum_probs=193.9
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+|+..+.||.|++|.||+++.. +++.||||++..... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999864 588999999865432 2234688999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+. ++|..++... ....+++..++.++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~- 154 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 154 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence 96 6888887643 3456899999999999999999999887 9999999999999999999999999987654321
Q ss_pred CCccceeecCccccChhccccCC-CCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccC-CC--------
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNE-GT-------- 551 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~-------- 551 (650)
.......++..|+|||.+.+.. ++.++||||||+++|||+||+.|+...... ..........-.. ..
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHH
Confidence 1122335688999999887654 588999999999999999999988643211 1111111000000 00
Q ss_pred ------cccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 552 ------ALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 552 ------~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
........+......-...+.+++.+|++.||++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000000001123457888999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.43 Aligned_cols=251 Identities=27% Similarity=0.409 Sum_probs=200.8
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
.++|...+.||+|+||.||++... +++.|++|.+..........+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 368889999999999999999853 5788999998765555556788999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998853 35889999999999999999999987 99999999999999999999999999875543222
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
......|+..|++||.+.+..++.++||||||+++|||++|+.||........ +.... ..+. +...
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~---~~~~~---~~~~------~~~~ 236 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLIA---TNGT------PELQ 236 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh---eeehh---cCCC------CCCC
Confidence 22334688899999999888899999999999999999999999863322110 00000 0000 0010
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
........+.+++.+||+.+|++||++.+++..
T Consensus 237 -~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 -NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011112345567889999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=294.94 Aligned_cols=252 Identities=26% Similarity=0.421 Sum_probs=198.3
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+|+..+.||+|+||.||+|... +++.|++|.++..... ....+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 5889999998765443 556789999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999863 345889999999999999999999987 99999999999999999999999999986543322
Q ss_pred CCc--cceeecCccccChhccccCC---CCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 482 QGD--TSRIVGTFGYMAPEYVTRGH---FSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 482 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
... .....++..|++||++.... .+.++||||||+++|||++|+.|+...... ......... . .
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~-----~ 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHVGA-G-----H 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHHhc-C-----C
Confidence 111 22356788999999998766 889999999999999999999998532211 111111100 0 0
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.+.+.... .....+.+++.+||+.+|.+||++.+++.
T Consensus 224 ~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPIPDSL-QLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCccc-ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111 01233456777999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=298.33 Aligned_cols=249 Identities=23% Similarity=0.358 Sum_probs=205.9
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
.+-|+..+.||+|.|..|-++++ -.|..||||++.+.... ...++.+|++.|+.++|||||+|+.+......+|||.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45688889999999999999974 36999999999877544 3446889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC-CCCCeEEeeeeccccccc
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPKISDFGMARLFEM 478 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~~~~~ 478 (650)
|.-.+|+|.+||-. ....+++....+++.||+.|+.|+|+.+ +|||||||+||.+- .-|-+||.|||++..|.+
T Consensus 97 ELGD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999975 3456899999999999999999999887 99999999998774 568899999999987765
Q ss_pred CCCCCccceeecCccccChhccccCCCC-ccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFS-IKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
.+ .....+|.+.|-|||++.+..|+ ++.||||||||||.|++|+.||....+.+. +.-++|
T Consensus 172 G~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImD 233 (864)
T KOG4717|consen 172 GK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMD 233 (864)
T ss_pred cc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhc
Confidence 43 34457899999999999999986 789999999999999999999974332221 111222
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
-.. .-+..-..+|.+|+..||+.||.+|.+.+||+..
T Consensus 234 CKY-tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 234 CKY-TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ccc-cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 111 1122334567788889999999999999999854
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=289.62 Aligned_cols=251 Identities=26% Similarity=0.412 Sum_probs=201.9
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecC--CeeEEEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERLLIY 399 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~ 399 (650)
+|...+.||+|++|.||+|... +++.|++|++..... .....+.+|+.++++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999976 588999999876543 3455789999999999999999999999988 8899999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++++|.+++.. ...+++..++.++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999874 338999999999999999999999977 999999999999999999999999999876543
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
..........++..|++||.+.....+.++||||||+++++|++|+.|+.... +.....+........ +.
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~-----~~ 224 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEP-----PE 224 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCC-----cC
Confidence 32111334568889999999998889999999999999999999999986433 111222221110111 11
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
+.... ...+.+++.+|++.+|.+||++.+++.
T Consensus 225 ~~~~~---~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 IPEHL---SEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCccc---CHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11112 234556777999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=297.23 Aligned_cols=256 Identities=28% Similarity=0.419 Sum_probs=198.4
Q ss_pred HhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceeecCC----
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEET---- 393 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~---- 393 (650)
..++++|+..+.||+|++|.||+|... +++.+++|++..... ....+.+|+.+++++ +|+||+++++++....
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 346789999999999999999999975 477899999876543 345789999999999 7999999999997644
Q ss_pred --eeEEEEecCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeee
Q 006317 394 --ERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF 470 (650)
Q Consensus 394 --~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 470 (650)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCC
Confidence 4899999999999999986532 2457899999999999999999999987 999999999999999999999999
Q ss_pred ecccccccCCCCCccceeecCccccChhcccc-----CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHH
Q 006317 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-----GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWK 545 (650)
Q Consensus 471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~ 545 (650)
|++....... .......|+..|+|||.+.. ..++.++||||||+++|||++|+.|+..... ...+..
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~---- 229 (275)
T cd06608 158 GVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--MRALFK---- 229 (275)
T ss_pred ccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--HHHHHH----
Confidence 9987543221 12233568899999998753 3467899999999999999999999852211 111111
Q ss_pred hccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 546 NWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 546 ~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.. ... .+.+.. .......+.+++.+||..||++|||+.+|++
T Consensus 230 ~~-~~~-----~~~~~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IP-RNP-----PPTLKS-PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hh-ccC-----CCCCCc-hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 10 000 011110 1112234567888999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.11 Aligned_cols=194 Identities=25% Similarity=0.371 Sum_probs=166.9
Q ss_pred CCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCC-C-----CceeeecceeecCCeeEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-H-----RNLVRLLGFSFEETERLL 397 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 397 (650)
+|.+.+.||+|.||.|.++.. .+++.||||++++..... .+-..|+.+|..|+ | -|+|++++++...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~-~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFL-RQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHH-HHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788899999999999999975 458999999998764332 34567999999996 4 389999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC--CeEEeeeecccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM--IPKISDFGMARL 475 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~--~~kl~DFGla~~ 475 (650)
|+|.+.. +|.++|+.+ +...++...+..++.||+.||.+||+.+ |||+||||+||||.+.. .+||+|||.+..
T Consensus 266 VfELL~~-NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhhh-hHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999955 999999865 3455999999999999999999999887 99999999999997755 699999999986
Q ss_pred cccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCC
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~ 529 (650)
.... .. ...-+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.
T Consensus 341 ~~q~----vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 341 ESQR----VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred cCCc----ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 4322 12 4566789999999999999999999999999999999976554
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=296.83 Aligned_cols=247 Identities=26% Similarity=0.391 Sum_probs=196.6
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
-|+..++||+|+||.||+|... ++..||+|.+..... .....+.+|+.++.+++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3677889999999999999864 578899999865432 33456889999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++++|.+++. ...+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence 9999999885 346899999999999999999999987 9999999999999999999999999987654221
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
.......++..|+|||.+.+..++.++|||||||++|||++|..|+..... ..... .. .... .+.+..
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~---~~-~~~~-----~~~~~~ 223 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLF---LI-PKNN-----PPTLEG 223 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHH---HH-hcCC-----CCCCCc
Confidence 112234678899999999888899999999999999999999998753211 11111 10 0000 011111
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..+ ..+.+++.+||+.+|.+||++.+++..
T Consensus 224 ~~~---~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 NYS---KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ccC---HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 122 345567789999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=295.54 Aligned_cols=250 Identities=22% Similarity=0.362 Sum_probs=196.7
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+|...+.||+|+||.||++..+ +|..+|+|.+.... ......+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999875 47889999986542 23345688999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC-eEEeeeecccccccCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI-PKISDFGMARLFEMDQ 480 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~-~kl~DFGla~~~~~~~ 480 (650)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999998642 2345899999999999999999999987 999999999999998864 6999999997654322
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
. ......|+..|+|||++.+..++.++||||||+++|||++|+.|+..... ......... .. +.+ .
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~----~~~-~ 222 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQ-GY----FAP-I 222 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-cc----CCC-C
Confidence 1 12234588899999999888899999999999999999999998753211 111111111 11 111 1
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..... ..+.+++.+|++.+|++|||+.||+..
T Consensus 223 ~~~~~---~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 SPNFS---RDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCC---HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11122 245567779999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.06 Aligned_cols=263 Identities=22% Similarity=0.320 Sum_probs=195.4
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeecC--CeeEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERLLI 398 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv 398 (650)
++|+..+.||+|+||.||+|..+ +++.+++|.++..... ....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999975 4788999998754322 223567899999999999999999998877 889999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++ +|.+++.. ....+++..++.++.||+.||+|||+.+ ++|+||||+|||+++++.+||+|||+++.+..
T Consensus 85 ~e~~~~-~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMET--MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999975 89888764 2346899999999999999999999987 99999999999999999999999999986653
Q ss_pred CCCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHH--------HHHHhccC
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLT--------YAWKNWNE 549 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~~ 549 (650)
.. .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...........+. ..|..+..
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 22 122234578899999998764 46899999999999999999999886433221111110 01111100
Q ss_pred ------CCcccccCccCCCCChH--HHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 550 ------GTALNLIDPTLRNGSSS--EIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 550 ------~~~~~~id~~l~~~~~~--~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
....+.....+....+. ....+.+++..||+.+|++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000011111111 1234557788999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=295.22 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=190.6
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHH-HhhCCCCceeeecceeecCCeeEEEEe
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLL-VARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
++|++.+.||+|+||.||+++.. +|+.||+|+++.... ....++..|+.. ++.++||||+++++++..+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999865 589999999876532 233455566665 566789999999999999999999999
Q ss_pred cCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 401 FVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
|++ |+|.+++.... ....+++..++.++.||+.||+|||++. +++||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 68888876532 3356899999999999999999999862 3999999999999999999999999999865322
Q ss_pred CCCCccceeecCccccChhcccc----CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTR----GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
. ......|+..|+|||.+.+ ..++.++|+||||+++|||++|+.|+..... ....+. ... .+
T Consensus 158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~---~~~-~~----- 223 (283)
T cd06617 158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLK---QVV-EE----- 223 (283)
T ss_pred c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHH---HHH-hc-----
Confidence 1 1223467889999998865 4568899999999999999999999752111 111111 110 00
Q ss_pred cCccCCC-CChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 556 IDPTLRN-GSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 556 id~~l~~-~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
..+.+.. ..+. .+.+++..||+.+|.+||++.+|++
T Consensus 224 ~~~~~~~~~~~~---~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 PSPQLPAEKFSP---EFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCCCccccCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111 1222 3556777999999999999999985
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=296.20 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=196.0
Q ss_pred CCCcCCcccccCceeEEEeec-cCCcceeEeeccccC-chhHHHHHHHHHHHhhCC---CCceeeecceeecCCeeEEEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQ---HRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~ 399 (650)
.|+..+.||+|+||.||+|.. .+++.+++|.+.... .....++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477789999999999999986 468899999987543 233456888999999996 999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++++|.+++.. ..+++...+.++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998753 37899999999999999999999987 999999999999999999999999999866533
Q ss_pred CCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
. .......|+..|+|||.+.++ .++.++||||||+++|||++|+.|+....... ... .... ...+
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~-~~~~-----~~~~ 220 (277)
T cd06917 155 S--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMM-LIPK-----SKPP 220 (277)
T ss_pred c--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhh-cccc-----CCCC
Confidence 2 122334688999999988754 46899999999999999999999985322111 100 0000 0111
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+... .....+.+++.+||+.||++||++.|++..
T Consensus 221 ~~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 RLEDN--GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCcc--cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 12111 012345567779999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=296.98 Aligned_cols=264 Identities=25% Similarity=0.368 Sum_probs=196.9
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
+|+..++||+|++|.||+|+.. +|+.||||+++..... ....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999975 5889999998765332 2345778999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++ +|.+++........+++..+.+++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 88888865434456999999999999999999999887 99999999999999999999999999975543211
Q ss_pred CccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhH-HH-------HHHhccCCCcc
Q 006317 483 GDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL-TY-------AWKNWNEGTAL 553 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~-~~-------~~~~~~~~~~~ 553 (650)
......++..|++||.+.+. .++.++||||||+++|||++|+.|+......+..... .. .|+.+......
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 12234568899999988664 5689999999999999999999988643322111100 00 01111100000
Q ss_pred cccCccCCCCC-----hHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 554 NLIDPTLRNGS-----SSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 554 ~~id~~l~~~~-----~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
..--+...... +.....+.+++.+|++.||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000 111234567888999999999999999974
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=300.32 Aligned_cols=244 Identities=25% Similarity=0.322 Sum_probs=196.6
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|...+.||+|+||.||+++.. +++.+|+|.+..... .....+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999865 588999999865422 23456889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||||++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999863 467899999999999999999999987 999999999999999999999999999865432
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
.....|++.|+|||.+.+...+.++||||||+++|||++|+.|+..... ....... ..+. ..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~----~~~~------~~ 216 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQIYEKI----LEGK------VR 216 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH----hcCC------cc
Confidence 2334688999999999888889999999999999999999999863321 1111111 0110 11
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCC-----CHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRP-----TMASVVV 594 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~ 594 (650)
+..... ..+.+++.+||+.||.+|| +++|++.
T Consensus 217 ~~~~~~---~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 217 FPSFFS---PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CCccCC---HHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 111122 3445677799999999999 7777763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=295.69 Aligned_cols=254 Identities=25% Similarity=0.410 Sum_probs=202.4
Q ss_pred hhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
..++.|+..+.||+|++|.||++... +++.+++|.+..... ....+.+|++++++++|+|++++++.+......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 46678899999999999999999976 588899999976544 4557889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQN--FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999999753 237999999999999999999999977 999999999999999999999999998754422
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
.. ......++..|++||.+.+..++.++|||||||++|||++|+.|+...... ....... ........++
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~~~~~~~-----~~~~~~~~~~- 239 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--RALFLIT-----TKGIPPLKNP- 239 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHH-----hcCCCCCcch-
Confidence 11 222345788999999998888999999999999999999999987532211 1111100 0000000000
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
...+ ..+.+++.+|++.+|.+||++.+|+..
T Consensus 240 --~~~~---~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 240 --EKWS---PEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred --hhCC---HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0012 345567889999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.20 Aligned_cols=253 Identities=23% Similarity=0.265 Sum_probs=197.9
Q ss_pred cCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCch---hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|+..+.||+|++|.||++...+ ++.+|+|.+...... ....+.+|++++..++||||+++++.+..+...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999998754 889999999765432 3446889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+.+++|.+++... ....+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988642 3457899999999999999999999987 999999999999999999999999998754322
Q ss_pred CCC---------------------------CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCC
Q 006317 480 QSQ---------------------------GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRI 532 (650)
Q Consensus 480 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~ 532 (650)
... .......||..|+|||++.+..++.++||||||+++|||++|+.|+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 01123468889999999998889999999999999999999999986332
Q ss_pred CcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCC----HHHHHH
Q 006317 533 GEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPT----MASVVV 594 (650)
Q Consensus 533 ~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt----~~evl~ 594 (650)
... .. ....... ..... .......+.+++.+||+.+|++||+ +.|++.
T Consensus 237 ~~~---~~---~~~~~~~-------~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDE---TF---SNILKKE-------VTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHH---HH---HHHhcCC-------ccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 211 11 1111000 00100 1112234557777999999999999 666664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=296.48 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=197.9
Q ss_pred CCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCC
Q 006317 325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
.|...++||+|++|.||++.. .+++.+++|++..........+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 455568999999999999985 4578899999876555555678899999999999999999999999999999999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
+++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 9999998863 46899999999999999999999987 99999999999999999999999999875443221
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNG 563 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 563 (650)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+..... .......... . .+.+...
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---~~~~~~~~~~----~-----~~~~~~~ 238 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAMKRIRDN----L-----PPKLKNL 238 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHhc----C-----CCCCccc
Confidence 12234688999999999888899999999999999999999998753221 1111111111 0 0111111
Q ss_pred ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 564 SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 564 ~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
......+.+++.+||+.+|++||++.++++.
T Consensus 239 -~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 239 -HKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred -ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 1112345677889999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=293.35 Aligned_cols=247 Identities=25% Similarity=0.292 Sum_probs=198.1
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
+|+..+.||.|+||.||+++.. +++.||+|.+.+... .....+.+|++++++++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999875 488999999975432 334578899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999999864 357899999999999999999999887 9999999999999999999999999987654321
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
......|+..|+|||.+....++.++||||||+++|+|++|+.|+............ ..... .. +..
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~--~~----~~~ 221 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----AKQET--AD----VLY 221 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----HHhcc--cc----ccC
Confidence 223356788999999999888999999999999999999999998754432111111 11110 00 111
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCH--HHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTM--ASVV 593 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~--~evl 593 (650)
....+ ..+.+++.+||+.+|.+||++ +|++
T Consensus 222 ~~~~~---~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 222 PATWS---TEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCc---HHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11122 455577789999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=289.41 Aligned_cols=249 Identities=29% Similarity=0.444 Sum_probs=200.6
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCC
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
.|...+.||+|++|.||++... +++.+++|++..........+.+|+.++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677899999999999999975 588899999977655556678999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
+++|.+++... ...+++..+..++.|++.+|.|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 99999998642 257999999999999999999999976 99999999999999999999999999876543321
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNG 563 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 563 (650)
.....++..|++||.+....++.++||||||+++++|++|+.|+...... ........ ..... +...
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~----~~~~~-----~~~~ 220 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALFKIAT----NGPPG-----LRNP 220 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHHh----cCCCC-----cCcc
Confidence 33457889999999999888999999999999999999999987632211 11111110 00001 1111
Q ss_pred ChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 564 SSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 564 ~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
. .-...+.+++.+||+.||++|||+.|+++
T Consensus 221 ~-~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 E-KWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred c-ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 00234567778999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.46 Aligned_cols=260 Identities=24% Similarity=0.357 Sum_probs=193.7
Q ss_pred CCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 326 FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
|+..++||.|++|.||+|... +|+.||+|++..... .....+.+|++++++++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999864 689999999875432 22346888999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
+ ++|.+++... ....+++..+++++.||++||+|||+.+ ++||||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 6899888642 2246899999999999999999999887 99999999999999999999999999976542221
Q ss_pred CccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHH----------HHhccC-C
Q 006317 483 GDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYA----------WKNWNE-G 550 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~----------~~~~~~-~ 550 (650)
......++..|+|||++.+. .++.++||||||+++|||++|+.|+...... ..+.... |..... .
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhch
Confidence 12223568899999988764 5789999999999999999999988633211 1111110 000000 0
Q ss_pred Ccc----cccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 551 TAL----NLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 551 ~~~----~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
... ....+............+.+++.+|++.+|++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 00000000001111245667888999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=300.15 Aligned_cols=263 Identities=22% Similarity=0.316 Sum_probs=194.4
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeecC--CeeEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERLL 397 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 397 (650)
.++|+..+.||+|+||.||+|+.. +|+.||+|+++..... ....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 367899999999999999999864 5889999998654322 223467899999999999999999998765 46899
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||+.+ +|.+++.. ....+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDN--MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 78888764 2356999999999999999999999987 9999999999999999999999999998664
Q ss_pred cCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccC-------
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNE------- 549 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------- 549 (650)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+......+ .+.........
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWP 234 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhch
Confidence 3221 1222345788999999865 457899999999999999999999886432211 11111111100
Q ss_pred ----CCccccc--C-ccCC---CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHh
Q 006317 550 ----GTALNLI--D-PTLR---NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVML 596 (650)
Q Consensus 550 ----~~~~~~i--d-~~l~---~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L 596 (650)
......+ . ..+. .........+.+++..|++.||++|||+.|++..-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0000000 0 0000 00001123445688899999999999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=298.50 Aligned_cols=248 Identities=27% Similarity=0.378 Sum_probs=193.6
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
..+.|+..+.||+|+||.||+|+.. +++.||+|.+..... ....++.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 3466888999999999999999865 588999999864322 233468899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.+||+|||++....
T Consensus 93 v~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 93 VMEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred EHHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 999997 577776643 3456999999999999999999999987 9999999999999999999999999987543
Q ss_pred cCCCCCccceeecCccccChhccc---cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
.. ....++..|+|||.+. ...++.++||||||+++|||+||+.|+...... ..... .....
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~---~~~~~--~~~~~----- 230 (307)
T cd06607 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYH--IAQND----- 230 (307)
T ss_pred CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH---HHHHH--HhcCC-----
Confidence 22 2345788999999874 456889999999999999999999987532111 11100 00000
Q ss_pred ccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 555 LIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 555 ~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+.+.. ......+.+++.+||+.+|++||++.+|+..
T Consensus 231 --~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 --SPTLSS--NDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCCCCc--hhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011111 1112345677889999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.70 Aligned_cols=265 Identities=23% Similarity=0.362 Sum_probs=192.9
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCC-------
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEET------- 393 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------- 393 (650)
++|+..++||+|+||.||+++.. +++.||||++..... .....+.+|+.++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 56889999999999999999865 588999999865422 22335678999999999999999999987654
Q ss_pred -eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeec
Q 006317 394 -ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472 (650)
Q Consensus 394 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 472 (650)
..++||||+.+ +|.+++.. ....+++.+++.++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 34999999975 78777753 2346899999999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCCC--CccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccC
Q 006317 473 ARLFEMDQSQ--GDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNE 549 (650)
Q Consensus 473 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 549 (650)
+..+...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...........+.........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9865432221 122234578899999988764 4788999999999999999999887643322221222211111000
Q ss_pred CC-----cccccCc-cCCCC----Ch------HHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 550 GT-----ALNLIDP-TLRNG----SS------SEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 550 ~~-----~~~~id~-~l~~~----~~------~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
+. .....+. .+... .. .+...+.+++.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 0000000 00000 00 01234557888999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=297.48 Aligned_cols=259 Identities=22% Similarity=0.354 Sum_probs=195.1
Q ss_pred CCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecC--CeeEEEEe
Q 006317 326 FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERLLIYE 400 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e 400 (650)
|+..++||+|++|.||+|+.. +++.+|+|++.... ......+.+|+.++++++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999875 47899999998663 23344688999999999999999999999888 88999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++ +|.+++.. ....+++..++.++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 88888764 2257999999999999999999999987 9999999999999999999999999998665332
Q ss_pred CCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccC---CCc----
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNE---GTA---- 552 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~---- 552 (650)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... .+......... ...
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccc
Confidence 1 11223456788999998765 457899999999999999999999886433211 11111111100 000
Q ss_pred ----ccccCcc------CCCCChH-HHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 553 ----LNLIDPT------LRNGSSS-EIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 553 ----~~~id~~------l~~~~~~-~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.....+. +...... ....+.+++.+||+.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000 0000000 1345678888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.74 Aligned_cols=262 Identities=21% Similarity=0.300 Sum_probs=194.0
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecC-----Cee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-----TER 395 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 395 (650)
+++|++.++||+|+||.||+|+.. +|+.||||+++... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999854 58899999986432 22344678899999999999999999987654 357
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++|+||+.+ +|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 7776663 356999999999999999999999987 99999999999999999999999999976
Q ss_pred cccCCCC-CccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC---
Q 006317 476 FEMDQSQ-GDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG--- 550 (650)
Q Consensus 476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--- 550 (650)
....... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.|+..... ..............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~---~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY---LHQLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCCHH
Confidence 5432221 12233568899999998754 5689999999999999999999998853221 11111111111100
Q ss_pred CcccccCcc-------C---CCCC-----hHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 551 TALNLIDPT-------L---RNGS-----SSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 551 ~~~~~id~~-------l---~~~~-----~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
....+.+.. + .... +....++.+++.+||+.+|++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 0 0000 1112346678889999999999999999976
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=294.85 Aligned_cols=256 Identities=21% Similarity=0.285 Sum_probs=190.1
Q ss_pred CCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCC-CCceeeecceeecC--CeeEEEEe
Q 006317 326 FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQ-HRNLVRLLGFSFEE--TERLLIYE 400 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~e 400 (650)
|+..++||+|+||.||++... +++.||+|+++.... .......+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566789999999999999854 588999999876422 22234557888898885 99999999999887 88999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|++ ++|.+++.. ....+++..++.++.||+.||+|||+.+ ++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 578777764 2357899999999999999999999987 999999999999999 999999999998654322
Q ss_pred CCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhc-----------c
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNW-----------N 548 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~-----------~ 548 (650)
. .....++..|+|||.+.. +.++.++|||||||++|||++|+.|+...... +.+....... .
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhhc
Confidence 1 123457889999997654 56789999999999999999999988643221 1111111110 0
Q ss_pred CCCcccccCccCCC-----CChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 549 EGTALNLIDPTLRN-----GSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 549 ~~~~~~~id~~l~~-----~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.........+.... ........+.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000000 00112355678888999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=304.89 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=202.6
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchh--HHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
...|.+...||+|.|++|.+++.. .+.+||||.+.+..... ...+.+|+++|..++|||||+++.+......+++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467889999999999999999864 58999999998875443 345889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+.+|.+.++|. +.+.+.+.....++.|+.++++|||+++ |+|||||++||||+.+.++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999997 4456677888999999999999999998 999999999999999999999999999887632
Q ss_pred CCCCccceeecCccccChhccccCCC-CccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
......+|++.|.|||++.+.++ .++.|+||+||+||-|+.|..||+...-. .+++......+
T Consensus 209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-----------~Lr~rvl~gk~-- 272 (596)
T KOG0586|consen 209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-----------ELRPRVLRGKY-- 272 (596)
T ss_pred ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-----------cccchheeeee--
Confidence 33445789999999999998776 58999999999999999999999732111 11111111100
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+ +.--..+|-+++..+|-.+|.+|++++++.+-
T Consensus 273 rI---p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 273 RI---PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred cc---cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 00 01112345577778999999999999999843
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=294.60 Aligned_cols=254 Identities=26% Similarity=0.369 Sum_probs=191.8
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCC-CCceeeecceeecCCeeEEEEec
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+|...++||+|+||.||+++.. +++.+|+|++..... .....+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4566789999999999999864 478999999875432 34457889999999996 99999999999999999999999
Q ss_pred CCCCChhHHHHh--hhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 402 VPNSSVDKFIFD--AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 402 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
+.. +|.++... ......+++....+++.+++.||+|||+.. +++||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 55554321 113457999999999999999999999752 3999999999999999999999999999765422
Q ss_pred CCCCccceeecCccccChhccccC---CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRG---HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
. ......|+..|+|||.+... .++.++||||||+++|||++|+.|+.... ............ .
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~-~----- 227 (288)
T cd06616 162 I---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG-D----- 227 (288)
T ss_pred C---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC-C-----
Confidence 2 11233578899999998776 68999999999999999999999986322 111111111110 0
Q ss_pred CccCCCC-ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 557 DPTLRNG-SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 557 d~~l~~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+.+... .......+.+++.+||+.+|++|||+.+|+..
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 11122345677889999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=296.07 Aligned_cols=264 Identities=22% Similarity=0.332 Sum_probs=194.5
Q ss_pred hhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCC----
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEET---- 393 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 393 (650)
...++|++.+.||+|+||.||+|..+ +|+.||+|+++.... .....+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999975 478999999875432 23346788999999999999999999987654
Q ss_pred ------eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEE
Q 006317 394 ------ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467 (650)
Q Consensus 394 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 467 (650)
..++|+||+++ +|..++.. ....+++..++.++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 67666653 2346899999999999999999999987 999999999999999999999
Q ss_pred eeeecccccccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHh
Q 006317 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKN 546 (650)
Q Consensus 468 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~ 546 (650)
+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.|+...... ..+......
T Consensus 158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~ 233 (302)
T cd07864 158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRL 233 (302)
T ss_pred CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHH
Confidence 99999986643321 11222346778999998865 35789999999999999999999888633221 111111111
Q ss_pred ccCC---Ccccc--------cCc------cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 547 WNEG---TALNL--------IDP------TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 547 ~~~~---~~~~~--------id~------~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.... ....+ .++ .+..........+.+++..||+.+|.+||++.+|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1000 00000 000 000000001234567888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=293.56 Aligned_cols=258 Identities=22% Similarity=0.331 Sum_probs=196.4
Q ss_pred CCcCCcccccCceeEEEeecc-CCcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 326 FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
|+..+.||+|++|.||+++.. +++.+++|++...... ....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 556789999999999999865 5888999998765332 3456888999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++ +|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 75 88887764 2357999999999999999999999987 9999999999999999999999999998665432
Q ss_pred CccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC---CcccccC-
Q 006317 483 GDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG---TALNLID- 557 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~id- 557 (650)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+......+. .......+... ......+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhh
Confidence 122234578889999998876 789999999999999999999988854332111 11111100000 0000000
Q ss_pred -------------ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 558 -------------PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 558 -------------~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
............++.+++..||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000001112345668888999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=296.30 Aligned_cols=262 Identities=23% Similarity=0.320 Sum_probs=192.5
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
++|+..+.||+|++|.||+|+.. +|+.||+|++..... .....+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999865 588999999865432 223468899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC-CCCeEEeeeecccccccC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEMD 479 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~~~~ 479 (650)
|++ ++|.+++... ....+++.....++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 4777776532 2334688889999999999999999987 999999999999985 557999999999765432
Q ss_pred CCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC--Ccc---
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG--TAL--- 553 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--~~~--- 553 (650)
. .......++..|+|||++.+. .++.++||||||+++|||+||+.|+......+ .+......+..+ ...
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID---ELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChhhcccc
Confidence 1 112234568899999988764 57899999999999999999999886432211 111111110000 000
Q ss_pred ------cccCccCCC-----CChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 554 ------NLIDPTLRN-----GSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 554 ------~~id~~l~~-----~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
...-+.... ..+....++.+++.+|++.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 011112345678889999999999999999863
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=296.12 Aligned_cols=262 Identities=23% Similarity=0.325 Sum_probs=192.0
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch--hHHHHHHHHHHHhhCC-CCceeeecceeecCCe-----
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQ-HRNLVRLLGFSFEETE----- 394 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~----- 394 (650)
++|+..+.||+|+||.||+|... +++.||||.+...... ....+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888999999999999999865 5889999988654322 2346788999999995 6999999999877665
Q ss_pred eEEEEecCCCCChhHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC-CCCeEEeeee
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIK--RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFG 471 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFG 471 (650)
.++||||+++ +|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 78888765322 346899999999999999999999987 999999999999999 8899999999
Q ss_pred cccccccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG 550 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 550 (650)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|+.|+..... ...+... ...+...
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~~~~-~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE--LQQLLHI-FKLLGTP 231 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHH-HHHhCCC
Confidence 9976532211 1122356788999998865 4578999999999999999999988863221 1111111 0110000
Q ss_pred C--c-cccc-------CccCCCC-----ChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 551 T--A-LNLI-------DPTLRNG-----SSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 551 ~--~-~~~i-------d~~l~~~-----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
. . .... -+..... .+....++.+++..||+.||.+||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0 0000 0000000 0111244567888999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=295.19 Aligned_cols=246 Identities=24% Similarity=0.347 Sum_probs=194.9
Q ss_pred cCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCCC
Q 006317 328 TDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSS 406 (650)
Q Consensus 328 ~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 406 (650)
...+||+|+||.||++... +++.||||++..........+.+|+.+++.++|+||+++++++...+..++||||+++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 3468999999999999864 688999999866555556678999999999999999999999999999999999999999
Q ss_pred hhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccc
Q 006317 407 VDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486 (650)
Q Consensus 407 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 486 (650)
|.+++. ...+++.....++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||++....... ....
T Consensus 104 L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~ 174 (292)
T cd06657 104 LTDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRK 174 (292)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--cccc
Confidence 998874 345899999999999999999999987 9999999999999999999999999987543221 1223
Q ss_pred eeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChH
Q 006317 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSS 566 (650)
Q Consensus 487 ~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~ 566 (650)
...|+..|++||.+.+..++.++||||||+++|||++|+.|+...... .......... .+.+.. ...
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~~---------~~~~~~-~~~ 241 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDNL---------PPKLKN-LHK 241 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhhC---------CcccCC-ccc
Confidence 356889999999998888999999999999999999999997632211 1111111110 011100 001
Q ss_pred HHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 567 EIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 567 ~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
....+.+++.+||+.+|.+||++.+++..
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 11234567779999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=286.81 Aligned_cols=242 Identities=23% Similarity=0.301 Sum_probs=191.8
Q ss_pred ccccCceeEEEeeccC-CcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCCCh
Q 006317 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSV 407 (650)
Q Consensus 332 LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 407 (650)
||.|++|.||+++... ++.+++|++.+... .....+.+|+.++++++||||+++++.+.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999754 88999999876432 2345689999999999999999999999999999999999999999
Q ss_pred hHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccce
Q 006317 408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487 (650)
Q Consensus 408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 487 (650)
.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999863 346899999999999999999999987 9999999999999999999999999998654322 2223
Q ss_pred eecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHH
Q 006317 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSE 567 (650)
Q Consensus 488 ~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~ 567 (650)
..|+..|++||.+....++.++|+||||+++|||++|+.|+.....+ ....... ...... ........
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~---~~~~~~-----~~~~~~~~--- 219 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PMEIYND---ILKGNG-----KLEFPNYI--- 219 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HHHHHHH---HhccCC-----CCCCCccc---
Confidence 46788999999998888999999999999999999999998643321 1111111 100000 01111111
Q ss_pred HHHHHHHHhcccccCCCCCCC-----HHHHHH
Q 006317 568 IMRCVHIGLLCVQENVANRPT-----MASVVV 594 (650)
Q Consensus 568 ~~~~~~l~~~Cl~~~p~~RPt-----~~evl~ 594 (650)
...+.+++..||+.+|++||+ +.|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 235567788999999999999 667664
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=290.55 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=195.3
Q ss_pred ccccCceeEEEeeccC-CcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCCCh
Q 006317 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSV 407 (650)
Q Consensus 332 LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 407 (650)
||.|+||.||+++... |+.+++|.+..... .....+.+|+.++++++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 88999999876543 3445688999999999999999999999999999999999999999
Q ss_pred hHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC------
Q 006317 408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS------ 481 (650)
Q Consensus 408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~------ 481 (650)
.+++.. ...+++..++.++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999874 347899999999999999999999887 99999999999999999999999999875433211
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
........++..|++||.+.....+.++||||||+++|||++|+.|+.....+ .... .... +.. . ..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~---~~~~-~~~----~--~~ 221 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQ---NILN-GKI----E--WP 221 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHhc-CCc----C--CC
Confidence 11223456788999999998888999999999999999999999998633211 1111 1100 000 0 00
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
... .....+..++..||+.+|++|||+.++.+.|+..
T Consensus 222 ~~~-~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~ 258 (265)
T cd05579 222 EDV-EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP 258 (265)
T ss_pred ccc-cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence 000 0123445677799999999999997777777654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=295.05 Aligned_cols=248 Identities=27% Similarity=0.381 Sum_probs=192.8
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
.|...+.||+|+||.||+++.. ++..+|+|++..... .....+.+|+.++++++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4777889999999999999864 578999999865422 233468889999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9974 77777653 3456899999999999999999999987 99999999999999999999999999865432
Q ss_pred CCCccceeecCccccChhccc---cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
.....|+..|+|||++. .+.++.++|||||||++|||++|+.|+..... ......... ...
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~---~~~------ 241 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQ---NES------ 241 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHh---ccC------
Confidence 12346788999999874 45789999999999999999999998753211 111111000 000
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+... .......+.+++.+||+.+|.+||++.+|++.+..
T Consensus 242 ~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 242 PTLQ--SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred CCCC--CccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 0011 11112345577889999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=302.99 Aligned_cols=266 Identities=22% Similarity=0.298 Sum_probs=195.4
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeecccc--CchhHHHHHHHHHHHhhC-CCCceeeecceeecC--Cee
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN--SVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEE--TER 395 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~ 395 (650)
..++|+..+.||+|+||.||+|... +++.+|||++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467889999999999999999865 5788999988543 223334577899999999 999999999988653 467
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++||||++ ++|..++.. ..++|..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 588887753 27899999999999999999999987 99999999999999999999999999986
Q ss_pred cccCCCC---CccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHH--------
Q 006317 476 FEMDQSQ---GDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYA-------- 543 (650)
Q Consensus 476 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~-------- 543 (650)
....... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.|+...............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 5433221 22334568999999998765 46789999999999999999999988543221111000000
Q ss_pred HHhccCCCcccccCccC-------CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 544 WKNWNEGTALNLIDPTL-------RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 544 ~~~~~~~~~~~~id~~l-------~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+..+.......+++... ..........+.+++.+||+.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000001111000 00001112456678889999999999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=285.79 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=199.4
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+|+..++||+|+||.||+++.. +++.+++|.+.... .....++.+|+.++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999754 57889999987543 23344678899999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 402 VPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 402 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999987532 2456899999999999999999999987 999999999999999999999999999876543
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
......++..|++||.+.+..++.++|+||||+++|||++|+.|+...... .+.... ..... +.+
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~----~~~~~-----~~~ 221 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRYKV----QRGKY-----PPI 221 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH----hcCCC-----CCC
Confidence 122245788999999999989999999999999999999999998633211 111111 01100 011
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.......+.+++.+|++.+|++||++.++++
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 222 ---PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ---chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1122345667888999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=301.45 Aligned_cols=261 Identities=20% Similarity=0.289 Sum_probs=195.2
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeecccc--CchhHHHHHHHHHHHhhCCCCceeeecceeecC-----Ce
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-----TE 394 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 394 (650)
.++|...+.||+|+||.||+++.. +++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457889999999999999999854 5889999998753 222344677899999999999999999987654 34
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.++||||+. ++|.+++. ....+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 68888876 3457999999999999999999999987 9999999999999999999999999998
Q ss_pred ccccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhc------
Q 006317 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNW------ 547 (650)
Q Consensus 475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~------ 547 (650)
...... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||...... ..........
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV---HQLKLITELLGSPSEE 231 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCChH
Confidence 654321 12223467889999998865 46899999999999999999999998643211 1111111110
Q ss_pred -----cCCCccccc-------CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 548 -----NEGTALNLI-------DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 548 -----~~~~~~~~i-------d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
......+.+ ++......+....++.+++.+||+.+|++|||+.|+++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000000 000000011122456678889999999999999999866
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=289.16 Aligned_cols=242 Identities=24% Similarity=0.317 Sum_probs=184.0
Q ss_pred cccccCceeEEEeecc-CCcceeEeeccccCch---hHHHHHHHHHHH---hhCCCCceeeecceeecCCeeEEEEecCC
Q 006317 331 KLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLV---ARLQHRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 331 ~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
.||+|+||.||++... +++.+|+|.+.+.... ....+.+|..++ ...+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 5889999988654221 122344444433 33479999999999999999999999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999998863 456999999999999999999999987 9999999999999999999999999987543221
Q ss_pred ccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
.....|+..|+|||.+.. ..++.++|||||||++|||++|+.||..........+ .... ......+..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~------~~~~~~~~~ 220 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMT------LTVNVELPD 220 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH----HHHh------hcCCcCCcc
Confidence 123468999999998864 5689999999999999999999999864322221111 1100 001112222
Q ss_pred CChHHHHHHHHHHhcccccCCCCCC-----CHHHHHHH
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRP-----TMASVVVM 595 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~~ 595 (650)
.... ++.+++..||+.||++|| ++.|+++.
T Consensus 221 ~~~~---~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 221 SFSP---ELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccCH---HHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2233 344666799999999999 59999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.48 Aligned_cols=262 Identities=24% Similarity=0.295 Sum_probs=194.6
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeecccc--CchhHHHHHHHHHHHhhCCCCceeeecceeecC------
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------ 392 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 392 (650)
..++|+..+.||+|+||.||+++.. +++.||||++... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3478999999999999999999854 6889999998653 223344677899999999999999999987643
Q ss_pred CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeec
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 472 (650)
...++||||+.+ +|.+.+.. .+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 356999999964 77777642 2889999999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccc------------hh-
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAE------------DL- 539 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~------------~l- 539 (650)
++...... ......++..|+|||.+.+..++.++||||||+++|+|++|+.|+...+..... ++
T Consensus 165 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98654221 122346788999999999999999999999999999999999988643211100 00
Q ss_pred --HHHHHHhccCC-------CcccccCccCC----CC-ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 540 --LTYAWKNWNEG-------TALNLIDPTLR----NG-SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 540 --~~~~~~~~~~~-------~~~~~id~~l~----~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+......+... ...+.+...+. .. .......+.+++.+||+.||++|||+.|++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000000 00011111110 00 11123445688889999999999999999855
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=296.06 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=199.0
Q ss_pred hhccCCCcCCcccccCceeEEEeeccCCcceeEeecccc--CchhHHHHHHHHHHHhhCC-CCceeeecceeecCCeeEE
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 397 (650)
.....|+++++||+||.+.||++...+.+.+|+|++... ..+....|.+|+.+|.+|+ |.+||+|++|-..++.+||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 344678999999999999999999888888999887543 3344556999999999995 9999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||= .-+|..+|... .....+| .+..+..||+.++.++|+++ |||.||||.|+|+- .|.+||+|||+|..+.
T Consensus 438 vmE~G-d~DL~kiL~k~-~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKK-KSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeecc-cccHHHHHHhc-cCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 99986 44899999752 2222335 77888999999999999998 99999999999986 4799999999999887
Q ss_pred cCCCCCccceeecCccccChhccccC-----------CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHh
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRG-----------HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKN 546 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~ 546 (650)
.+.........+||+-||+||.+... +.+.++||||+|||||+|+.|+.||.. .... |.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~--------~~n~-~a- 580 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ--------IINQ-IA- 580 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH--------HHHH-HH-
Confidence 77666666677999999999998532 256899999999999999999999851 1111 11
Q ss_pred ccCCCcccccCccCCCC--ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 547 WNEGTALNLIDPTLRNG--SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 547 ~~~~~~~~~id~~l~~~--~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
++..+.||.-.-+ ...+-.++++++-.||+.||.+||++.|+|+-
T Consensus 581 ----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 ----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1223444422111 11111126677779999999999999999854
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=304.90 Aligned_cols=251 Identities=26% Similarity=0.357 Sum_probs=197.8
Q ss_pred cCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
+.|.++..||.|+||.||+++.++ +-..|.|.+...+.....+|.-|+++|....||+||+|++.|..++.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 457778899999999999998765 4456788888777777788999999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
.||-.+.++.. -...|++.++.-+..|++.||.|||++. |||||||+.|||++-+|.++|+|||++..... ..
T Consensus 112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR 184 (1187)
T ss_pred CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence 99999998875 3567999999999999999999999997 99999999999999999999999999864321 12
Q ss_pred CccceeecCccccChhccc-----cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 483 GDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
.....+.||+.|||||+++ ..+|+.++||||||+.|.||..+.+|..--... .-++.. .+. -.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM--RVllKi-aKS---------eP 252 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLKI-AKS---------EP 252 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH--HHHHHH-hhc---------CC
Confidence 2344578999999999875 468999999999999999999999876411110 001110 000 01
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
|.|... ..=...+-+++-.||..||..||++.++++
T Consensus 253 PTLlqP-S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 253 PTLLQP-SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CcccCc-chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 222111 111123334555799999999999999984
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=286.53 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=201.6
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+|...+.||.|+||.||++... +++.+++|++..... .....+.+|++++++++|||++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999875 588999999976543 4455788999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 402 VPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 402 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999987532 2467999999999999999999999987 9999999999999999999999999998654332
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
.......|+..|+|||.+.+..++.++||||+|+++++|++|+.|+.... ........ . ... .+.+
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~---~-~~~-----~~~~ 223 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKI---L-KGQ-----YPPI 223 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHHHH---h-cCC-----CCCC
Confidence 12233568889999999998889999999999999999999999875332 11111111 1 110 0111
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..... ..+.+++.+||+.+|++||++.|+++.
T Consensus 224 ~~~~~---~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 PSQYS---SELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCC---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11222 345567779999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=285.98 Aligned_cols=247 Identities=28% Similarity=0.439 Sum_probs=198.9
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+|+..+.||+|++|.||+++.. +++.|++|.+..... .....+.+|++++++++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999865 578899999977654 3445789999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++.. ...+++..++.++.|++.+|.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999999863 367999999999999999999999887 99999999999999999999999999986653322
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
......++..|++||.+.+..++.++||||+|+++|+|++|+.|+.... . ....+.... .. .+.+.
T Consensus 155 --~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~--~----~~~~~~~~~-~~-----~~~~~ 220 (254)
T cd06627 155 --DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN--P----MAALFRIVQ-DD-----HPPLP 220 (254)
T ss_pred --cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc--H----HHHHHHHhc-cC-----CCCCC
Confidence 1233567889999999988888999999999999999999999875322 1 111111110 00 01111
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.... ..+..++.+||+.+|++||++.+++.
T Consensus 221 ~~~~---~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 EGIS---PELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCC---HHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1122 34457778999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=288.74 Aligned_cols=244 Identities=25% Similarity=0.326 Sum_probs=189.3
Q ss_pred ccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCCCh
Q 006317 332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSV 407 (650)
Q Consensus 332 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 407 (650)
||+|+||+||++... +|+.+|+|.+..... .....+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999754 588999999865422 2233567899999999999999999999999999999999999999
Q ss_pred hHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccce
Q 006317 408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487 (650)
Q Consensus 408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 487 (650)
.+++... ....+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++...... .....
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~ 153 (277)
T cd05577 81 KYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG 153 (277)
T ss_pred HHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence 9998753 2246899999999999999999999987 999999999999999999999999998765431 12223
Q ss_pred eecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHH
Q 006317 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSE 567 (650)
Q Consensus 488 ~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~ 567 (650)
..++..|++||.+.+..++.++||||||+++|+|++|+.|+...........+. ..... ....+.....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~------~~~~~~~~~~-- 222 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK---RRTLE------MAVEYPDKFS-- 222 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH---hcccc------ccccCCccCC--
Confidence 457889999999988889999999999999999999999986433211111110 00000 0111111122
Q ss_pred HHHHHHHHhcccccCCCCCC-----CHHHHHH
Q 006317 568 IMRCVHIGLLCVQENVANRP-----TMASVVV 594 (650)
Q Consensus 568 ~~~~~~l~~~Cl~~~p~~RP-----t~~evl~ 594 (650)
..+.+++..||+.+|++|| ++.+++.
T Consensus 223 -~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 223 -PEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred -HHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 3445677799999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=290.99 Aligned_cols=262 Identities=23% Similarity=0.293 Sum_probs=193.9
Q ss_pred CCcCCcccccCceeEEEeeccC-CcceeEeeccccCc-hhHHHHHHHHHHHhhCC-CCceeeecceeecCCeeEEEEecC
Q 006317 326 FSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV-QGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
|.+.+.||+|++|.||+|+..+ ++.|+||++..... .......+|+..+++++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5677899999999999999754 78899999866432 22334567999999999 999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
+|+|.+++... ....+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-- 153 (283)
T cd07830 81 -EGNLYQLMKDR-KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-- 153 (283)
T ss_pred -CCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC--
Confidence 88998888642 2346899999999999999999999987 9999999999999999999999999997654221
Q ss_pred CccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhH-H---------HHHHhccCCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL-T---------YAWKNWNEGT 551 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~-~---------~~~~~~~~~~ 551 (650)
......++..|+|||++.. ..++.++||||||+++|||++|+.|+......+..... . |.........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 1223457889999998754 45789999999999999999999887543221110000 0 0000000000
Q ss_pred cccccCcc----CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 552 ALNLIDPT----LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 552 ~~~~id~~----l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
....+... +..........+.+++.+||+.+|++|||++|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 000011112456788899999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=315.32 Aligned_cols=201 Identities=23% Similarity=0.402 Sum_probs=158.9
Q ss_pred ccCCCcCCcccccCceeEEEeeccC--CcceeEe------------------eccccCchhHHHHHHHHHHHhhCCCCce
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH--GQEIAVK------------------RLSKNSVQGELEFKNEVLLVARLQHRNL 382 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~--g~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~H~ni 382 (650)
.++|++.++||+|+||+||++.++. +...++| .+.. .......+.+|+.++++++||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCc
Confidence 4689999999999999999986532 2122222 1111 11233468899999999999999
Q ss_pred eeecceeecCCeeEEEEecCCCCChhHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC
Q 006317 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIK--RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 460 (650)
Q Consensus 383 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~ 460 (650)
+++++++...+..++|+|++. ++|.+++..... ...........++.||+.||+|||+.+ |+||||||+||||+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999985 467776654211 222345677889999999999999987 99999999999999
Q ss_pred CCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCC
Q 006317 461 ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529 (650)
Q Consensus 461 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~ 529 (650)
.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|+.++.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 999999999999987653222 12223579999999999999999999999999999999999986543
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=297.57 Aligned_cols=263 Identities=22% Similarity=0.324 Sum_probs=193.1
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeecCC------
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEET------ 393 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 393 (650)
.++|...++||+|+||.||+++.. +++.+|||++...... ....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999865 5889999998654322 2235778999999999999999999875433
Q ss_pred --eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeee
Q 006317 394 --ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471 (650)
Q Consensus 394 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 471 (650)
..++||||+.+ +|...+.. ....+++..+..++.||++||.|||+.+ ++|+||||+|||+++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46899999975 66666653 3457999999999999999999999987 9999999999999999999999999
Q ss_pred cccccccCCCC---------CccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHH
Q 006317 472 MARLFEMDQSQ---------GDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLT 541 (650)
Q Consensus 472 la~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~ 541 (650)
+++........ .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~~~ 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---QLH 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---HHH
Confidence 99865432211 112234678889999987654 57899999999999999999998886332221 111
Q ss_pred HHHHhccCC---C------ccc----ccCccCCCC----ChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 542 YAWKNWNEG---T------ALN----LIDPTLRNG----SSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 542 ~~~~~~~~~---~------~~~----~id~~l~~~----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
..+..+... . ... ......... .......+.+++.+||+.+|++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111111000 0 000 000111100 1111245678888999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=285.55 Aligned_cols=245 Identities=20% Similarity=0.279 Sum_probs=186.4
Q ss_pred hhccCCCcCCcc--cccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeE
Q 006317 321 DATNNFSTDNKL--GQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 321 ~~~~~f~~~~~L--G~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 396 (650)
...++|++.+.+ |+|+||.||+++.+ ++..+|+|.+........ |+.....+ +||||+++++.+...+..+
T Consensus 11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 344567777776 99999999999854 578899999865432211 22222222 7999999999999999999
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC-CeEEeeeecccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARL 475 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~ 475 (650)
+||||+++++|.+++.. ...+++..++.++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+++.
T Consensus 86 iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 99999999999999864 347999999999999999999999987 99999999999999998 999999999875
Q ss_pred cccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
.... ....|+..|+|||++.+..++.++||||||+++|||++|+.|+.....+. .+...+.... .....
T Consensus 160 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~---~~~~~- 228 (267)
T PHA03390 160 IGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ---QKKLP- 228 (267)
T ss_pred cCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh---cccCC-
Confidence 4322 12357889999999999899999999999999999999999987332221 1111111111 00000
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCC-HHHHHH
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPT-MASVVV 594 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-~~evl~ 594 (650)
... .....+.+++..||+.+|.+||+ ++|+++
T Consensus 229 ----~~~---~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 229 ----FIK---NVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----ccc---ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 011 12234556777999999999995 688873
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=292.01 Aligned_cols=261 Identities=18% Similarity=0.217 Sum_probs=190.7
Q ss_pred cCCcccccCceeEEEeeccCCcceeEeecccc--CchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCC
Q 006317 328 TDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS 405 (650)
Q Consensus 328 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 405 (650)
+.+.+|.|+++.||++.. +++.||||++... .......+.+|+.++++++||||+++++++.+.+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 345556666666666655 6899999998764 3334457899999999999999999999999999999999999999
Q ss_pred ChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC----
Q 006317 406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS---- 481 (650)
Q Consensus 406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~---- 481 (650)
+|.+++... ....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999998753 2345889999999999999999999987 99999999999999999999999999875432211
Q ss_pred -CCccceeecCccccChhcccc--CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhc----c------
Q 006317 482 -QGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNW----N------ 548 (650)
Q Consensus 482 -~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~----~------ 548 (650)
........++..|+|||++.. ..++.++||||||+++|||++|+.||..... ............ .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA--TQMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCccccccCchhh
Confidence 111223456788999999876 3578999999999999999999999863221 111111110000 0
Q ss_pred -CCCccc----ccCccCCC-----CChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 549 -EGTALN----LIDPTLRN-----GSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 549 -~~~~~~----~id~~l~~-----~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
...... ..++.... .......++.+++.+||+.||++|||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 00000000 011122456678889999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=299.75 Aligned_cols=266 Identities=19% Similarity=0.268 Sum_probs=195.4
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeec----CCee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFE----ETER 395 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 395 (650)
.++|+..+.||+|+||.||++... +|+.||+|++..... .....+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367889999999999999999854 588999999876422 234467789999999999999999998753 3467
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++||||+. ++|.+++. ....+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 58888875 3456999999999999999999999987 99999999999999999999999999976
Q ss_pred cccCCCC--CccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHH--------HH
Q 006317 476 FEMDQSQ--GDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTY--------AW 544 (650)
Q Consensus 476 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~--------~~ 544 (650)
....... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. .+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432211 11223578899999998865 4688999999999999999999999853321111000000 00
Q ss_pred HhccCCCcccccCccC--CCC-----ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 545 KNWNEGTALNLIDPTL--RNG-----SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 545 ~~~~~~~~~~~id~~l--~~~-----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.....+...+.++... ... .......+.+++.+||+.+|++||++++++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000011110000 000 01123456678889999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=290.31 Aligned_cols=256 Identities=17% Similarity=0.225 Sum_probs=181.4
Q ss_pred ccCCCcCCcccccCceeEEEeeccCC----cceeEeeccccCchh--H---------HHHHHHHHHHhhCCCCceeeecc
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHG----QEIAVKRLSKNSVQG--E---------LEFKNEVLLVARLQHRNLVRLLG 387 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g----~~vavK~l~~~~~~~--~---------~~~~~E~~~l~~l~H~niv~l~g 387 (650)
.++|.+.++||+|+||.||+|...++ ..+|+|......... + .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46899999999999999999986543 456666543222111 1 01223344556778999999999
Q ss_pred eeecCC----eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC
Q 006317 388 FSFEET----ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM 463 (650)
Q Consensus 388 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~ 463 (650)
++.... ..++++|++.. ++.+.+.. ....++..+..++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 766543 34678887754 55555542 234678889999999999999999987 99999999999999999
Q ss_pred CeEEeeeecccccccCCCC-----CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccch
Q 006317 464 IPKISDFGMARLFEMDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAED 538 (650)
Q Consensus 464 ~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~ 538 (650)
.++|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~ 241 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--N 241 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--H
Confidence 9999999999876432211 11223469999999999999999999999999999999999999996432111 1
Q ss_pred hHHHH----HHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 539 LLTYA----WKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 539 l~~~~----~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
+.... ......+.. . + ...+. .+.+++..|++.+|++||++.++++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~----~--~-~~~~~---~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGKI----K--I-KNANK---FIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHHHHhhhhhh----c--c-CCCCH---HHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11111 111111100 0 0 11233 3445666899999999999999998774
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=321.39 Aligned_cols=261 Identities=28% Similarity=0.383 Sum_probs=201.2
Q ss_pred HhhccCCCcCCcccccCceeEEEeeccC--------CcceeEeeccccCc-hhHHHHHHHHHHHhhC-CCCceeeeccee
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRLSH--------GQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFS 389 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 389 (650)
+...++..+.+.||+|.||.|++|.... ...||||.++.... .....+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 3344555667799999999999997431 34699999987644 3455799999999998 699999999999
Q ss_pred ecCCeeEEEEecCCCCChhHHHHhhh-----cc--------CCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCc
Q 006317 390 FEETERLLIYEFVPNSSVDKFIFDAI-----KR--------VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 456 (650)
Q Consensus 390 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~N 456 (650)
..++..++|+||+..|+|.+||+... .. ..++..+.+.++.|||.||+||++.. ++||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence 99999999999999999999998643 00 23899999999999999999999887 9999999999
Q ss_pred eEeCCCCCeEEeeeecccccccCCCCCccceee--cCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCC
Q 006317 457 ILLDADMIPKISDFGMARLFEMDQSQGDTSRIV--GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIG 533 (650)
Q Consensus 457 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~ 533 (650)
|||.++..+||+|||+++.......... .... -+..|||||.+....|+.|+|||||||+||||+| |..|+..-
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~-- 525 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI-- 525 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC--
Confidence 9999999999999999986543332221 1111 2456999999999999999999999999999999 55665420
Q ss_pred cccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 534 EEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 534 ~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
....++.. ....+..++. +.... .++.+|+..||+.+|++||++.++++.+..
T Consensus 526 ~~~~~l~~----~l~~G~r~~~-----P~~c~---~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 526 PPTEELLE----FLKEGNRMEQ-----PEHCS---DEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred CcHHHHHH----HHhcCCCCCC-----CCCCC---HHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 01122222 2222221111 11123 345577779999999999999999999876
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=280.36 Aligned_cols=264 Identities=21% Similarity=0.300 Sum_probs=205.5
Q ss_pred hhHHhhccCCCcCCcccccCceeEEEeecc------CCcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeeccee
Q 006317 317 STIRDATNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFS 389 (650)
Q Consensus 317 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~ 389 (650)
+++.....+++...++-+|.||.||.|.|. +.+.|-||.++....+ ....+..|--++..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 444555677888889999999999999764 3456889998766433 334577888899999999999999998
Q ss_pred ecC-CeeEEEEecCCCCChhHHHHh-----hhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC
Q 006317 390 FEE-TERLLIYEFVPNSSVDKFIFD-----AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM 463 (650)
Q Consensus 390 ~~~-~~~~lv~e~~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~ 463 (650)
.++ ...++++.++.-|+|..||.. ......++..+...++.|++.||+|||.++ |||.||.++|++||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 765 567889999999999999983 333455788889999999999999999988 99999999999999999
Q ss_pred CeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHH
Q 006317 464 IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTY 542 (650)
Q Consensus 464 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~ 542 (650)
++||+|=.|+|-+.+.+.+.-......+..||+||.+.+..|+..+|||||||+||||+| |+.|+..-++ .++..+
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP---fEm~~y 510 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP---FEMEHY 510 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH---HHHHHH
Confidence 999999999997665554443333445778999999999999999999999999999999 7887753222 222222
Q ss_pred HHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 543 AWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 543 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
..+..+- .. +...++|+ ..++.-||...|++||++++++.-|..
T Consensus 511 lkdGyRl------aQ---P~NCPDeL---f~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 511 LKDGYRL------AQ---PFNCPDEL---FTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred Hhcccee------cC---CCCCcHHH---HHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 2222111 11 12245554 456668999999999999999987753
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=288.46 Aligned_cols=258 Identities=24% Similarity=0.357 Sum_probs=191.2
Q ss_pred CCcCCcccccCceeEEEeeccC-CcceeEeeccccCch--hHHHHHHHHHHHhhC---CCCceeeecceeecCCe-----
Q 006317 326 FSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQ--GELEFKNEVLLVARL---QHRNLVRLLGFSFEETE----- 394 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 394 (650)
|++.+.||+|+||.||+|+.+. ++.+|+|++...... ....+.+|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999764 889999999754222 223466787777665 69999999999988776
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.+++|||+.+ +|.+++... ....+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 788888642 2346899999999999999999999987 9999999999999999999999999998
Q ss_pred ccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccC-----
Q 006317 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNE----- 549 (650)
Q Consensus 475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----- 549 (650)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... +...........
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA---DQLDKIFDVIGLPSEEE 229 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH---HHHHHHHHHcCCCChHh
Confidence 7643221 12235788999999999999999999999999999999998887632221 111111111000
Q ss_pred ---CCc--ccccCccCCCC----ChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 550 ---GTA--LNLIDPTLRNG----SSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 550 ---~~~--~~~id~~l~~~----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
... ........... .......+.+++.+||+.||++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 00000000000 1112245567888999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=284.66 Aligned_cols=245 Identities=22% Similarity=0.254 Sum_probs=187.6
Q ss_pred CcccccCceeEEEeecc-CCcceeEeeccccCchh---HHHHHHHHHH-HhhCCCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQG---ELEFKNEVLL-VARLQHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~---~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
+.||+|+||.||++... +++.||||.+.+..... ...+..|..+ ....+|+|++++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999864 58899999987643221 2234445444 4455899999999999999999999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999999863 356899999999999999999999987 99999999999999999999999999875432
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGS 564 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 564 (650)
.....|+..|++||.+.+..++.++||||||+++|||++|..|+...... .... ........ .........
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~----~~~~~~~~--~~~~~~~~~ 220 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AVFD----NILSRRIN--WPEEVKEFC 220 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHH----HHHhcccC--CCCcccccC
Confidence 22345788999999998888899999999999999999999998633221 1111 11000000 001111111
Q ss_pred hHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 565 SSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 565 ~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+ ..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 221 ~---~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 221 S---PEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred C---HHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 2 345567779999999999988877777655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=289.75 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=198.7
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCC-CCceeeecceeecCCeeEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv 398 (650)
++|...+.||+|+||.||+++.. +++.|++|++.+.. ......+.+|+.++++++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999865 68899999987642 233456888999999998 99999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999863 447999999999999999999999987 99999999999999999999999999986543
Q ss_pred CCCC------------------CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhH
Q 006317 479 DQSQ------------------GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL 540 (650)
Q Consensus 479 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~ 540 (650)
.... .......++..|++||.+....++.++||||||++++||++|+.|+..... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~ 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTF 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHH
Confidence 2211 222345678899999999888899999999999999999999999864321 1111
Q ss_pred HHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCH----HHHHH
Q 006317 541 TYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTM----ASVVV 594 (650)
Q Consensus 541 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~----~evl~ 594 (650)
..... ....+.... ...+.+++.+||+.+|.+||++ ++++.
T Consensus 232 ~~~~~----------~~~~~~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 QKILK----------LEYSFPPNF---PPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHh----------cCCCCCCcc---CHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11110 001111111 2345677889999999999999 77653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=303.08 Aligned_cols=204 Identities=30% Similarity=0.488 Sum_probs=175.8
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCC------ee
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEET------ER 395 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~ 395 (650)
..|...+.||+|+||.||+|+. ..|+.||||.+..... ...+...+|+++|++++|+|||+++++-.+.. ..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 3456678999999999999995 4699999999987543 34445788999999999999999999866543 56
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC--CCC--CeEEeeee
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--ADM--IPKISDFG 471 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~--~~~--~~kl~DFG 471 (650)
.+|||||.+|||...|.+..+...|++.+.+.++.++..||.|||+++ |+||||||.||++- ++| .-||+|||
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 899999999999999988777788999999999999999999999887 99999999999993 334 46999999
Q ss_pred cccccccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCC
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIG 533 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~ 533 (650)
.|+-.+.+. ....++||..|.+||.... +.|+...|.|||||++||.+||..||....+
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 999765433 4566899999999999984 8899999999999999999999999975443
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=320.62 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=187.3
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeec--------
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFE-------- 391 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------- 391 (650)
-..+|++.+.||+||||.|||++.+ ||+.+|||++.-.. ......+.+|+.++++|+|||||+++..+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3467899999999999999999854 79999999997653 3334468899999999999999998732100
Q ss_pred ---------------------------------------------------------C----------------------
Q 006317 392 ---------------------------------------------------------E---------------------- 392 (650)
Q Consensus 392 ---------------------------------------------------------~---------------------- 392 (650)
+
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred --------------------------------CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhh
Q 006317 393 --------------------------------TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440 (650)
Q Consensus 393 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH 440 (650)
..+|+-||||+..+|++++..+.-. -.....|+++.+|++||.|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHH
Confidence 0146889999998888888642111 146778999999999999999
Q ss_pred hcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc----------------CCCCCccceeecCccccChhccccC-
Q 006317 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM----------------DQSQGDTSRIVGTFGYMAPEYVTRG- 503 (650)
Q Consensus 441 ~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~----------------~~~~~~~~~~~gt~~y~aPE~~~~~- 503 (650)
+++ +|||||||.||+|+++..+||+|||++..... .......+..+||.-|+|||++.+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 998 99999999999999999999999999986210 0111134457899999999999764
Q ss_pred --CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhccccc
Q 006317 504 --HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQE 581 (650)
Q Consensus 504 --~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~ 581 (650)
.|+.|+|+||+|||++||+.- |.. ..+....+ ..++.+...+- +.+ ..++...=.+++.|++++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~yP---F~T--sMERa~iL----~~LR~g~iP~~--~~f---~~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLYP---FGT--SMERASIL----TNLRKGSIPEP--ADF---FDPEHPEEASLIRWLLSH 857 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhcc---CCc--hHHHHHHH----HhcccCCCCCC--ccc---ccccchHHHHHHHHHhcC
Confidence 599999999999999999974 321 11111111 22222221111 111 233344445788899999
Q ss_pred CCCCCCCHHHHHH
Q 006317 582 NVANRPTMASVVV 594 (650)
Q Consensus 582 ~p~~RPt~~evl~ 594 (650)
||.+|||+.|+|.
T Consensus 858 dP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 858 DPSKRPTATELLN 870 (1351)
T ss_pred CCccCCCHHHHhh
Confidence 9999999999973
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=285.04 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=192.3
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeecccc-----CchhHHHHHHHHHHHhhCCCCceeeecceeecC--Cee
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN-----SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TER 395 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 395 (650)
.+|...+.||+|+||.||+++.. +++.|++|++... .......+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999864 5889999987532 122334688999999999999999999998764 457
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++++||+++++|.+++.. ...+++....+++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999998863 345889999999999999999999887 99999999999999999999999999986
Q ss_pred cccCCC-CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 476 FEMDQS-QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 476 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
...... ........|+..|+|||.+.+..++.++||||||+++|||++|+.||.... ...... +.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~----~~~~~~---- 225 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE--AMAAIF----KIATQP---- 225 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC--HHHHHH----HHHcCC----
Confidence 532111 111223568899999999998889999999999999999999999985221 111111 111000
Q ss_pred ccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 555 LIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 555 ~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
..+.+.....++ +.+++..|++ +|..||+..+++.
T Consensus 226 -~~~~~p~~~~~~---~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 -TKPMLPDGVSDA---CRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -CCCCCCcccCHH---HHHHHHHHhc-CcccCccHHHHhc
Confidence 111222222233 4456668998 5799999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=288.15 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=197.5
Q ss_pred CCCcCCcccccCceeEEEeec----cCCcceeEeeccccCc----hhHHHHHHHHHHHhhC-CCCceeeecceeecCCee
Q 006317 325 NFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSV----QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETER 395 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 395 (650)
+|+..+.||+|++|.||+++. .+++.||||.+++... .....+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367789999999999999874 3467899999875322 2234578899999999 599999999999999999
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++||||+++|+|.+++.. ...+++..+..++.|++++|.|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999998863 456899999999999999999999887 99999999999999999999999999876
Q ss_pred cccCCCCCccceeecCccccChhccccCC--CCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcc
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGH--FSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 553 (650)
+...... ......|+..|++||.+.+.. .+.++||||||+++|||++|..|+........ ...........
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~---- 227 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKS---- 227 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHcc----
Confidence 5433211 122346889999999987655 78899999999999999999999853221111 11111111100
Q ss_pred cccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 554 NLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 554 ~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
.+....... ..+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 228 ---~~~~~~~~~---~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 ---KPPFPKTMS---AEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ---CCCCCcccC---HHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 111111122 2345677799999999999999998888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=295.57 Aligned_cols=262 Identities=20% Similarity=0.294 Sum_probs=194.2
Q ss_pred cCCCc-CCcccccCceeEEEeecc-CCcceeEeeccccCchh--------------HHHHHHHHHHHhhCCCCceeeecc
Q 006317 324 NNFST-DNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQG--------------ELEFKNEVLLVARLQHRNLVRLLG 387 (650)
Q Consensus 324 ~~f~~-~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g 387 (650)
++|.. .+.||+|+||.||+++.. .++.||||+++...... ...+.+|+.++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45553 577999999999999864 58899999986543221 124678999999999999999999
Q ss_pred eeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEE
Q 006317 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467 (650)
Q Consensus 388 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 467 (650)
++..++..++||||+. |+|.+++. ....+++.....++.||+.||+|||+.+ ++|+||||+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 58888885 3456899999999999999999999987 999999999999999999999
Q ss_pred eeeecccccccCC------------CCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCc
Q 006317 468 SDFGMARLFEMDQ------------SQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGE 534 (650)
Q Consensus 468 ~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~ 534 (650)
+|||+++...... .........++..|+|||.+.+. .++.++||||||+++|||++|+.|+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999997654111 01112223467889999998764 4689999999999999999999988643322
Q ss_pred ccchhHHHHHHhccCCC---ccc--------ccCccCCC----CChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 535 EAEDLLTYAWKNWNEGT---ALN--------LIDPTLRN----GSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 535 ~~~~l~~~~~~~~~~~~---~~~--------~id~~l~~----~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+.+........... +.. ...+.... ........+.+++..||+.+|++||++.|++..
T Consensus 241 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 ---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred ---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 22222111111000 000 00000000 011112345678889999999999999999965
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=297.78 Aligned_cols=264 Identities=23% Similarity=0.315 Sum_probs=198.5
Q ss_pred CCCcCCcccccCceeEEEeeccC-CcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCC-----eeE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEET-----ERL 396 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 396 (650)
+|++.+.||+|++|.||+++... ++.|+||++.... ......+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47788999999999999999754 8899999987643 334457889999999999999999999988775 789
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
+||||+++ +|.+++.. ...+++..++.++.||+.||+|||+.+ ++||||||.|||+++++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 78888763 347999999999999999999999987 999999999999999999999999999866
Q ss_pred ccCCC-CCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHH--------Hh
Q 006317 477 EMDQS-QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAW--------KN 546 (650)
Q Consensus 477 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~--------~~ 546 (650)
..... ........++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+.... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 53321 1123334678899999999887 78999999999999999999999986433211111110000 00
Q ss_pred ccCCCcccccCccCCC-------CChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 547 WNEGTALNLIDPTLRN-------GSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 547 ~~~~~~~~~id~~l~~-------~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.......+.+...... ........+.+++.+||+.+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0011111111100000 001112345678889999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=286.91 Aligned_cols=252 Identities=25% Similarity=0.411 Sum_probs=190.8
Q ss_pred cCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCc-hhHHHHHHHHHHHhhCC-CCceeeecceeecCCeeEEEEe
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV-QGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e 400 (650)
++|+..+.||+|++|.||+++..+ ++.||||+++.... ....++..|+.++.+.. ||||+++++++.++...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 568888999999999999999865 88999999976432 23345667777776665 9999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++ +|.+++.. ....+++..+..++.||+.||+|||+.. +++||||+|+||++++++.+||+|||++..+....
T Consensus 95 ~~~~-~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccCc-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9854 77776653 2347899999999999999999999742 39999999999999999999999999987654222
Q ss_pred CCCccceeecCccccChhccccCC----CCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGH----FSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.|+..... ..+.+... .... .
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~---~~~~-~---- 236 (296)
T cd06618 170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLTKI---LQEE-P---- 236 (296)
T ss_pred c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHHHH---hcCC-C----
Confidence 1 12235788999999987553 78999999999999999999999853211 11111111 1111 0
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+.+... .....++.+++.+||+.+|.+||++.+++..
T Consensus 237 -~~~~~~-~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 -PSLPPN-EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -CCCCCC-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111100 0112345677789999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=282.90 Aligned_cols=242 Identities=25% Similarity=0.323 Sum_probs=184.5
Q ss_pred cccccCceeEEEeecc-CCcceeEeeccccCch---hHHHHHHHHH---HHhhCCCCceeeecceeecCCeeEEEEecCC
Q 006317 331 KLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVL---LVARLQHRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 331 ~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~---~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
.||+|+||.||+++.. +++.||+|.+.+.... ....+.+|.. .+....||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 4889999998764322 1222334433 4445689999999999999999999999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
+++|.+++. ....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++..+....
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999999886 3457999999999999999999999987 9999999999999999999999999987543221
Q ss_pred ccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
.....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||............ ... . ...+.+..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~~-~------~~~~~~~~ 220 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMT-L------TMAVELPD 220 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HHh-h------ccCCCCCC
Confidence 2234689999999998754 6899999999999999999999998643222111110 000 0 01111221
Q ss_pred CChHHHHHHHHHHhcccccCCCCCC-----CHHHHHHH
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRP-----TMASVVVM 595 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~~ 595 (650)
... ..+.+++.+|++.+|++|| ++.++++.
T Consensus 221 ~~s---~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 221 SFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred cCC---HHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 122 3455667799999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=287.91 Aligned_cols=243 Identities=28% Similarity=0.387 Sum_probs=189.2
Q ss_pred CCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 326 FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
|...++||+|+||.||+|+.. +++.|++|++..... .....+.+|+.++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566688999999999999864 578899999865432 2334678899999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+. |+|.+++.. ....+++..++.++.||+.+|.|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~---- 172 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS---- 172 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC----
Confidence 96 577777653 3456899999999999999999999987 9999999999999999999999999986422
Q ss_pred CCccceeecCccccChhccc---cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 482 QGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
......|+..|+|||++. .+.++.++||||||+++|||++|+.|+..... ..... ..... .. +
T Consensus 173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~---~~~~~---~~~~~-~~-----~ 238 (313)
T cd06633 173 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALY---HIAQN-DS-----P 238 (313)
T ss_pred --CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHH---HHHhc-CC-----C
Confidence 122356888999999974 45688999999999999999999998753211 11111 11000 00 1
Q ss_pred cCCC-CChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 559 TLRN-GSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 559 ~l~~-~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.... ... ..+.+++.+||+.+|.+||++.+++..
T Consensus 239 ~~~~~~~~---~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 TLQSNEWT---DSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCccccC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 112 234567779999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=286.27 Aligned_cols=252 Identities=24% Similarity=0.314 Sum_probs=193.4
Q ss_pred CCCcCCcccccCceeEEEeec----cCCcceeEeeccccCc----hhHHHHHHHHHHHhhC-CCCceeeecceeecCCee
Q 006317 325 NFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSV----QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETER 395 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 395 (650)
+|+..+.||+|+||.||+++. .+|+.||+|++..... .....+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467789999999999999975 3688899999875422 2334678899999999 599999999999999999
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++||||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999863 456889999999999999999999987 99999999999999999999999999986
Q ss_pred cccCCCCCccceeecCccccChhccccC--CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcc
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRG--HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 553 (650)
...... .......|+..|+|||.+... .++.++||||||+++|||++|+.|+....... ............
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~---- 227 (290)
T cd05613 155 FHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS---- 227 (290)
T ss_pred cccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhcc----
Confidence 543221 122345688999999998753 46789999999999999999999986432211 111111111110
Q ss_pred cccCccCCCCChHHHHHHHHHHhcccccCCCCCC-----CHHHHHHH
Q 006317 554 NLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRP-----TMASVVVM 595 (650)
Q Consensus 554 ~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~~ 595 (650)
.+....... ..+..++..||+.+|++|| ++.+++..
T Consensus 228 ---~~~~~~~~~---~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 ---EPPYPQEMS---ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---CCCCCccCC---HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 111111112 2345677799999999997 67777643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=326.44 Aligned_cols=260 Identities=27% Similarity=0.379 Sum_probs=202.3
Q ss_pred hhHHhhccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCC
Q 006317 317 STIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEET 393 (650)
Q Consensus 317 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 393 (650)
+.++..+-+|....+||.|.||.||-+.. .+|.-.|+|.++.... .......+|+.++..++|||+|+++|+-..++
T Consensus 1228 ~~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1228 SSLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE 1307 (1509)
T ss_pred HHhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH
Confidence 34555677889999999999999999984 5588899998865433 23345789999999999999999999999999
Q ss_pred eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecc
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 473 (650)
..+|.||||++|+|.+.+. .+...++.....+..|++.|+.|||+++ ||||||||.||||+.+|.+|++|||.|
T Consensus 1308 kv~IFMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred HHHHHHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccce
Confidence 9999999999999999886 3445677777788899999999999998 999999999999999999999999999
Q ss_pred cccccCC--CCCccceeecCccccChhccccCC---CCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhcc
Q 006317 474 RLFEMDQ--SQGDTSRIVGTFGYMAPEYVTRGH---FSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWN 548 (650)
Q Consensus 474 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 548 (650)
..+.... -........||+.|||||++.+.. -..+.||||+|||++||+||++||.--+. .|..+-
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---------e~aIMy 1452 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---------EWAIMY 1452 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---------hhHHHh
Confidence 8765432 122345578999999999998643 45789999999999999999999963221 111110
Q ss_pred CCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHh
Q 006317 549 EGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVML 596 (650)
Q Consensus 549 ~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L 596 (650)
+-.+.+ .|.++.....+- .+.+..||+.||++|.++.|+++.=
T Consensus 1453 ~V~~gh--~Pq~P~~ls~~g---~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1453 HVAAGH--KPQIPERLSSEG---RDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred HHhccC--CCCCchhhhHhH---HHHHHHHHhcCchhhhHHHHHHHhh
Confidence 000000 122222222222 3456689999999999999888654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=271.64 Aligned_cols=202 Identities=27% Similarity=0.417 Sum_probs=169.2
Q ss_pred cCCCcCCcccccCceeEEEeeccC-----CcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeec-CCee
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-----GQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFE-ETER 395 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 395 (650)
..|+....||+|.||.||++.-.+ ..++|+|+++..... -.....+|+.+++.++||||+.|..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 467888999999999999995322 237999999765332 12356789999999999999999999877 8889
Q ss_pred EEEEecCCCCChhHHHHhh--hccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC----CCeEEee
Q 006317 396 LLIYEFVPNSSVDKFIFDA--IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD----MIPKISD 469 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~----~~~kl~D 469 (650)
+|++||.+. +|.++++-. .+...++...+..|+.||+.|+.|||++- |+||||||.||||..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999988 777777542 23457999999999999999999999998 9999999999999888 8999999
Q ss_pred eecccccccCCCCC-ccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCC
Q 006317 470 FGMARLFEMDQSQG-DTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNS 529 (650)
Q Consensus 470 FGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~ 529 (650)
||++|++...-..- ....++-|..|.|||.+.+. .||.+.|||+.|||+.||+|-++-|.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 99999887543322 44567789999999999874 79999999999999999999876554
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=289.76 Aligned_cols=248 Identities=27% Similarity=0.398 Sum_probs=191.6
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeecccc---CchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN---SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
.+.|+..+.||+|+||.||+|+.. +++.+++|.+... ......++.+|+.+++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 345777789999999999999864 4778999998643 222334678899999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 94 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 99997 578777653 3456899999999999999999999887 99999999999999999999999999875432
Q ss_pred CCCCCccceeecCccccChhccc---cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
. ....|+..|+|||.+. ...++.++|||||||++|||++|+.|+....... ..... . ...
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~--~---~~~---- 230 (308)
T cd06634 168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHI--A---QNE---- 230 (308)
T ss_pred c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--HHHHH--h---hcC----
Confidence 1 2345788999999874 3567889999999999999999998874221110 01110 0 000
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHh
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVML 596 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L 596 (650)
.+.... ......+.+++.+||+.+|++||++.+|+...
T Consensus 231 -~~~~~~--~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 231 -SPALQS--GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -CCCcCc--ccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 011111 11123345677799999999999999999664
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=291.05 Aligned_cols=197 Identities=21% Similarity=0.333 Sum_probs=161.1
Q ss_pred Cccccc--CceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQG--GFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G--~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
..||+| +||+||+++.. .|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456766 89999999864 68999999987543 22345688999999999999999999999999999999999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC-
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG- 483 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~- 483 (650)
++|.+++.... ...+++..+..++.||+.||+|||+.+ ++||||||+|||++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999887532 345899999999999999999999887 9999999999999999999999998654332111110
Q ss_pred ----ccceeecCccccChhccccC--CCCccccccchhHHHHHHHhCCCCCCC
Q 006317 484 ----DTSRIVGTFGYMAPEYVTRG--HFSIKSDVFSFGVLVLEIISGQKNNSF 530 (650)
Q Consensus 484 ----~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~S~Gvll~elltG~~p~~~ 530 (650)
......++..|++||++.+. .++.++||||||+++|||++|+.|+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 01112346679999998764 478999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=294.79 Aligned_cols=265 Identities=21% Similarity=0.284 Sum_probs=191.6
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecC---------
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE--------- 392 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------- 392 (650)
..+|...+.||.|+||.||+|+.. +|+.||+|++..........+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368899999999999999999864 5889999998776555566788999999999999999999876543
Q ss_pred -----CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC-CCCeE
Q 006317 393 -----TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIPK 466 (650)
Q Consensus 393 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~-~~~~k 466 (650)
...++||||++ ++|.+++. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++. ++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 35789999997 58887764 346899999999999999999999987 999999999999974 56789
Q ss_pred EeeeecccccccCCCC-CccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHH
Q 006317 467 ISDFGMARLFEMDQSQ-GDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAW 544 (650)
Q Consensus 467 l~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~ 544 (650)
|+|||+++........ .......++..|+|||.+.. ..++.++|||||||++|||++|+.||................
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999765322111 11122357889999998754 467889999999999999999999986332111100000000
Q ss_pred HhccC---CCcc-----ccc-CccCCCCCh-----HHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 545 KNWNE---GTAL-----NLI-DPTLRNGSS-----SEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 545 ~~~~~---~~~~-----~~i-d~~l~~~~~-----~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..... .... ... +........ ....++.+++..||+.||++|||+.|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000 0000 000 000000000 112345678889999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=286.47 Aligned_cols=261 Identities=26% Similarity=0.374 Sum_probs=195.8
Q ss_pred CCcCCcccccCceeEEEeeccC-CcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 326 FSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
|+..+.||+|++|.||+|+..+ ++.+++|++.... ......+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4567889999999999998754 8899999997653 223346788999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
+ ++|.+++... ...+++..++.++.+++.||+|||+.+ ++||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 5899998742 246999999999999999999999987 99999999999999999999999999976543221
Q ss_pred CccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccch-hH-------HHHHHhccCCCcc
Q 006317 483 GDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAED-LL-------TYAWKNWNEGTAL 553 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~-l~-------~~~~~~~~~~~~~ 553 (650)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+......+... .. ...|..+..-...
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 22223457789999998776 88999999999999999999988875432111100 00 0011111000000
Q ss_pred cccCccCCCC-----ChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 554 NLIDPTLRNG-----SSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 554 ~~id~~l~~~-----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
+..-+..... .+.....+.+++..||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000 1111345678888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=291.33 Aligned_cols=263 Identities=22% Similarity=0.321 Sum_probs=194.8
Q ss_pred HhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeec-CCee
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFE-ETER 395 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 395 (650)
...+++|+..+.||+|+||.||+++.. +++.||||++.+.. ......+.+|+.++.+++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 456788999999999999999999854 68899999886532 2234567889999999999999999998865 5678
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++|+||+ +++|.+++. ...+++.....++.||++||.|||+.+ ++||||+|+|||+++++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 568888774 345888899999999999999999987 99999999999999999999999999875
Q ss_pred cccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHH--------HHHHh
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLT--------YAWKN 546 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~--------~~~~~ 546 (650)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...........+. ..+..
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 4321 123456889999998766 568999999999999999999999886432211100000 00011
Q ss_pred ccCCCcccccCccC-CCC-Ch-----HHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 547 WNEGTALNLIDPTL-RNG-SS-----SEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 547 ~~~~~~~~~id~~l-~~~-~~-----~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+......+.+.... ... .. .....+.+++.+|++.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111111110000 000 00 112456678889999999999999999755
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=277.39 Aligned_cols=241 Identities=23% Similarity=0.259 Sum_probs=194.1
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHH---HHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGEL---EFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~---~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
-++|+.+++||+|.||+|-+.+-+ .++.+|+|++++...-... .-..|-++|...+||.+..+--.+...+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 468999999999999999999854 5889999999987544333 355688999999999999999889999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||..+|.|.-+|. +...+++....-+-.+|+.||.|||+++ ||.||||.+|.|||.+|++||+||||++.-.
T Consensus 247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence 99999999998886 4556888888899999999999999987 9999999999999999999999999997322
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
.....++.++||+.|+|||++....|....|+|.+||++|||++|+.||...+-+. +.....- . |-
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---LFeLIl~-------e---d~ 385 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---LFELILM-------E---DL 385 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---HHHHHHh-------h---hc
Confidence 23345677999999999999999999999999999999999999999986433222 1111110 0 11
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCC
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRP 587 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RP 587 (650)
..+.....+... |+...|.+||.+|-
T Consensus 386 kFPr~ls~eAkt---LLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 KFPRTLSPEAKT---LLSGLLKKDPKKRL 411 (516)
T ss_pred cCCccCCHHHHH---HHHHHhhcChHhhc
Confidence 122223334433 44467889999994
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=282.72 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=191.0
Q ss_pred CCCcCCcccccCceeEEEeeccC-CcceeEeecccc-----CchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKN-----SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
+|.+.++||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998643 445666665432 122334577899999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 399 YEFVPNSSVDKFIFDA-IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
|||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988753 23457999999999999999999999987 999999999999975 569999999987654
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
.... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+.... .......... + ..
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~-~-----~~ 222 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVE-G-----PT 222 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHc-C-----CC
Confidence 3221 2223457889999999988888999999999999999999999875211 1111111110 0 11
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
+.+....+ ..+.+++.+||+.+|++||++.|+++
T Consensus 223 ~~~~~~~~---~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 PSLPETYS---RQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCcchhc---HHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11211122 34556777999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=287.43 Aligned_cols=201 Identities=29% Similarity=0.418 Sum_probs=177.8
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
.+.|..-++||+||||.||-.+.+ +|+-+|.|++.+... +++.-..+|-.++.+++.+.||.+--.++..+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 466888899999999999998755 589999999976543 3444578899999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
+..|.||+|.-+|.+. ....+++....-++.+|+.||++||... ||.|||||+|||||+.|+++|+|.|||.-+..
T Consensus 264 LtlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999999864 3467999999999999999999999987 99999999999999999999999999986654
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCC
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF 530 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~ 530 (650)
.+. ....+||.+|||||++.++.|+...|+||+||+||||+.|+.||..
T Consensus 340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 332 2234899999999999999999999999999999999999999863
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=296.26 Aligned_cols=256 Identities=24% Similarity=0.344 Sum_probs=190.0
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecC------C
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------T 393 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 393 (650)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 468889999999999999999864 58899999986532 12234578999999999999999999988654 3
Q ss_pred eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecc
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 473 (650)
..++|+||+.. +|..++ ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999964 666553 236899999999999999999999987 999999999999999999999999998
Q ss_pred cccccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHh------
Q 006317 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKN------ 546 (650)
Q Consensus 474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~------ 546 (650)
+.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ......+..
T Consensus 165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~ 236 (342)
T cd07879 165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGP 236 (342)
T ss_pred cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCH
Confidence 75432 1223467889999999876 46889999999999999999999998643211 111111110
Q ss_pred -----ccCCCcccccC--ccCCCC-----ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 547 -----WNEGTALNLID--PTLRNG-----SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 547 -----~~~~~~~~~id--~~l~~~-----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+........+. +..... .+.....+.+++.+||+.||++||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000000 000000 01112346678889999999999999999854
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=290.55 Aligned_cols=263 Identities=21% Similarity=0.320 Sum_probs=193.3
Q ss_pred HhhccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCC---
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEET--- 393 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--- 393 (650)
....++|+..+.||+|+||.||++.. .++..||||++.... ......+.+|+.++++++||||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34567899999999999999999985 468899999986532 223346789999999999999999999887543
Q ss_pred ---eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeee
Q 006317 394 ---ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF 470 (650)
Q Consensus 394 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 470 (650)
..++||||+ +++|.+++. ...+++..++.++.||++||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 458999999 678888774 346899999999999999999999987 999999999999999999999999
Q ss_pred ecccccccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCccc-chhHH-------
Q 006317 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEA-EDLLT------- 541 (650)
Q Consensus 471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~-~~l~~------- 541 (650)
|+++..... .....++..|++||.+.+ ..++.++||||||+++|+|++|+.|+........ .....
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 999754321 223457889999999876 4588999999999999999999999863221100 00000
Q ss_pred HHHHhccCCCcccccCc--cCCCC-----ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 542 YAWKNWNEGTALNLIDP--TLRNG-----SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 542 ~~~~~~~~~~~~~~id~--~l~~~-----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..+..+........+.. ..... .......+.+++.+|++.||++|||+.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000000 00000 00112245678889999999999999999854
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=292.52 Aligned_cols=266 Identities=24% Similarity=0.322 Sum_probs=194.9
Q ss_pred hhHHhhccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecC-
Q 006317 317 STIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE- 392 (650)
Q Consensus 317 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~- 392 (650)
.++...+++|...+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++.+++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 44556778999999999999999999985 468899999987542 22345678899999999999999999987543
Q ss_pred -----CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEE
Q 006317 393 -----TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467 (650)
Q Consensus 393 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 467 (650)
...+++++++ +++|.+++. ...+++..++.++.||++||+|||+.+ ++||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 3467888876 778888764 346899999999999999999999987 999999999999999999999
Q ss_pred eeeecccccccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhH-HH---
Q 006317 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL-TY--- 542 (650)
Q Consensus 468 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~-~~--- 542 (650)
+|||+++.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...........+ ..
T Consensus 162 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 162 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred ecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999875432 1223467889999998866 56889999999999999999999988532221110000 00
Q ss_pred ----HHHhccCCCccc---ccCc----cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 543 ----AWKNWNEGTALN---LIDP----TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 543 ----~~~~~~~~~~~~---~id~----~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+..+....... .+.. ............+.+++.+|++.+|.+||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000000000 0000 0000000112345678889999999999999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=293.05 Aligned_cols=261 Identities=22% Similarity=0.281 Sum_probs=189.1
Q ss_pred CCCcCCcccccCceeEEEeeccC---CcceeEeeccccC--chhHHHHHHHHHHHhhC-CCCceeeecceeecC----Ce
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLSH---GQEIAVKRLSKNS--VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEE----TE 394 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~~---g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 394 (650)
+|...+.||+|+||.||+++... +..||+|++.... ......+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 46778899999999999998643 6789999986532 22244678899999999 599999999875432 45
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.++++||+. ++|.+++. ....+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688899886 58888875 3457999999999999999999999987 9999999999999999999999999998
Q ss_pred ccccCCC--CCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHH------
Q 006317 475 LFEMDQS--QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWK------ 545 (650)
Q Consensus 475 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~------ 545 (650)
.+..... ........|+..|+|||.+.+ ..++.++|||||||++|+|++|+.|+...... +.+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~ 230 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV---DQLNQILQVLGTPD 230 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH---HHHHHHHHHhCCCC
Confidence 6543221 112234578999999998765 46899999999999999999999887643211 11111000
Q ss_pred -----hccCCCcccc---cC----ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 546 -----NWNEGTALNL---ID----PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 546 -----~~~~~~~~~~---id----~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+........ .. ..+..........+.+++.+|++.||++|||+.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 00 00000001112345678889999999999999998743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=292.54 Aligned_cols=259 Identities=24% Similarity=0.334 Sum_probs=194.4
Q ss_pred hhccCCCcCCcccccCceeEEEeecc-CCcceeEeecccc--CchhHHHHHHHHHHHhhCCCCceeeecceeecCCe---
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE--- 394 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--- 394 (650)
...++|...+.||+|++|.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999875 4788999998653 22233457789999999999999999998776554
Q ss_pred ---eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeee
Q 006317 395 ---RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471 (650)
Q Consensus 395 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 471 (650)
.++|+||+ +++|.+++. ...+++..++.++.||++||.|||+.+ |+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 568988875 356999999999999999999999987 9999999999999999999999999
Q ss_pred cccccccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHH-----
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWK----- 545 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~----- 545 (650)
++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... ..+.....
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~---~~~~~i~~~~~~~ 235 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI---DQLKRIMNLVGTP 235 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCC
Confidence 99765322 223467889999998865 36789999999999999999999988633221 11111100
Q ss_pred ------hccCCCcccccCccC---CCC----ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 546 ------NWNEGTALNLIDPTL---RNG----SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 546 ------~~~~~~~~~~id~~l---~~~----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+........+.... ... .......+.+++.+||+.+|++|||+.||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000000000 000 00113456788889999999999999999754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=265.38 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=191.4
Q ss_pred CCCcCCcccccCceeEEEeeccC-CcceeEeeccccCc-hhHHHHHHHHHHHhhCC-CCceeeecceeecCCeeEEEEec
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV-QGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+.+.+..||.|..|.||+.+.+. |..+|||.+.+... +..+.+...+.++.+-+ .|.||+.+|+|..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 34456789999999999998654 88899999977643 34456777777776664 89999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
|.. -++.+|.. -.+++++.-+-++...+++||.||.+++ +|+|||+||+|||+|+.|++|++|||++-.+....
T Consensus 173 Ms~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk- 246 (391)
T KOG0983|consen 173 MST-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK- 246 (391)
T ss_pred HHH-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc-
Confidence 843 45565543 3456888888899999999999999876 69999999999999999999999999997765332
Q ss_pred CCccceeecCccccChhcccc---CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 482 QGDTSRIVGTFGYMAPEYVTR---GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
...+..|-+.|||||.+.- ..|+.++||||||+.++||.||+.|+..-.. .-+.+..+... ..|
T Consensus 247 --AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--dFe~ltkvln~---------ePP 313 (391)
T KOG0983|consen 247 --AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--DFEVLTKVLNE---------EPP 313 (391)
T ss_pred --ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--cHHHHHHHHhc---------CCC
Confidence 3445678999999999864 4788999999999999999999999863221 11222222211 113
Q ss_pred cCCCC--ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 559 TLRNG--SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 559 ~l~~~--~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.|+.. ...++ .+++..||++|+.+||...++++.
T Consensus 314 ~L~~~~gFSp~F---~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 314 LLPGHMGFSPDF---QSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCcccCcCHHH---HHHHHHHhhcCcccCcchHHHhcC
Confidence 44332 33344 445557999999999999999854
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=274.62 Aligned_cols=236 Identities=26% Similarity=0.318 Sum_probs=189.3
Q ss_pred ccccCceeEEEeecc-CCcceeEeeccccCch---hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCCCh
Q 006317 332 LGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSV 407 (650)
Q Consensus 332 LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 407 (650)
||+|+||.||++... +++.+++|.+...... ....+.+|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999865 4889999998765332 344688999999999999999999999999999999999999999
Q ss_pred hHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccce
Q 006317 408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487 (650)
Q Consensus 408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 487 (650)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 999864 346899999999999999999999977 9999999999999999999999999997654321 12334
Q ss_pred eecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHH
Q 006317 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSE 567 (650)
Q Consensus 488 ~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~ 567 (650)
..++..|++||.+.+...+.++|+||||+++|||++|+.|+..... ......... . ...+....+
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~----~------~~~~~~~~~-- 217 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILK----D------PLRFPEFLS-- 217 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhc----C------CCCCCCCCC--
Confidence 5678899999999888889999999999999999999999863322 111111110 0 011111112
Q ss_pred HHHHHHHHhcccccCCCCCCCHHH
Q 006317 568 IMRCVHIGLLCVQENVANRPTMAS 591 (650)
Q Consensus 568 ~~~~~~l~~~Cl~~~p~~RPt~~e 591 (650)
..+.+++.+||+.||++||++.+
T Consensus 218 -~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 -PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -HHHHHHHHHHhcCCHhhCCCccc
Confidence 34456777999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-34 Score=268.25 Aligned_cols=256 Identities=25% Similarity=0.344 Sum_probs=191.7
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEEEec
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+.+.+..||.|.||+|+|-.++ .|+..|||+++.... .++.++..|.+...+- +.||||+++|.+..++..|+.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3344578999999999999865 589999999987655 5566788888876655 799999999999999999999999
Q ss_pred CCCCChhHHHHh--hhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 402 VPNSSVDKFIFD--AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 402 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
|.- ||+.+-.. ..++..+++.-+-+|....+.||.||.+.. .|||||+||+||||+..|.+||+|||++-.+...
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 954 77665432 234567888888899999999999998765 6999999999999999999999999998755422
Q ss_pred CCCCccceeecCccccChhcccc--CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
- ..+.-.|-..|||||.+.. ..|+.+|||||||+.|+|+.||+.|+..++. ..+...... .+....+..
T Consensus 222 i---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv-~gdpp~l~~ 292 (361)
T KOG1006|consen 222 I---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVV-IGDPPILLF 292 (361)
T ss_pred H---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHH-cCCCCeecC
Confidence 1 2234568889999998864 3489999999999999999999999863321 222211111 111111111
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+ .+..+....+.+.+-.|+.+|-.+||...++.++
T Consensus 293 ~---~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 D---KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred c---ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1 1112233445556667999999999999999754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=304.88 Aligned_cols=145 Identities=28% Similarity=0.386 Sum_probs=130.1
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|.+.++||+|+||.||+|+.. +++.||||+++.... .....+.+|+.++..++||||+++++++......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999875 588999999975432 22356888999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999863 356889999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=292.24 Aligned_cols=260 Identities=26% Similarity=0.420 Sum_probs=209.8
Q ss_pred ccChhhHHhhccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceee
Q 006317 313 QFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSF 390 (650)
Q Consensus 313 ~~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 390 (650)
..+++.+.+.++-|++.+.||.|.+|.||+++. ++++.+|||++...... .++++.|.++++.+ .|||++.++|++.
T Consensus 8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 356677778889999999999999999999984 46889999998765433 34677888888887 6999999999986
Q ss_pred c-----CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCe
Q 006317 391 E-----ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465 (650)
Q Consensus 391 ~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 465 (650)
. ++++|||||||.+||..|++.... ...+.|..+..|+.+++.||.+||... ++|||||-.||||+.++.+
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~V 162 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEV 162 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcE
Confidence 4 578999999999999999998764 778999999999999999999999886 9999999999999999999
Q ss_pred EEeeeecccccccCCCCCccceeecCccccChhcccc-----CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhH
Q 006317 466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-----GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL 540 (650)
Q Consensus 466 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~ 540 (650)
||.|||++..+.. +........||+.|||||++.- ..|+.++|+||||++..||--|.+|+......
T Consensus 163 KLvDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------ 234 (953)
T KOG0587|consen 163 KLVDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------ 234 (953)
T ss_pred EEeeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh------
Confidence 9999999986653 3345556789999999999864 34778999999999999999999987521110
Q ss_pred HHHHHhccCCCccccc--CccCCCC-ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 541 TYAWKNWNEGTALNLI--DPTLRNG-SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 541 ~~~~~~~~~~~~~~~i--d~~l~~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..+-.| .|...-. +..-..++.+.+..||.+|-+.||++.++++.
T Consensus 235 ----------raLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 235 ----------RALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----------hhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 011111 1111111 23334667788889999999999999998743
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=262.08 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=193.7
Q ss_pred CcccccCceeEEEee-ccCCcceeEeeccccCchhHHHHHHHHHHHhhCC-CCceeeecceeecCCeeEEEEecCCCCCh
Q 006317 330 NKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEFVPNSSV 407 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gsL 407 (650)
+.||+|.|+.|--.+ +.+|.++|||++.+..........+|++++.+.+ |+||++|+.+++++...|||||-|.+|+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 689999999998876 6789999999999887777778999999999985 99999999999999999999999999999
Q ss_pred hHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC---eEEeeeecccccccCC----
Q 006317 408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI---PKISDFGMARLFEMDQ---- 480 (650)
Q Consensus 408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFGla~~~~~~~---- 480 (650)
..+|. ++..+++.++.++..+|+.||.|||.++ |.||||||+|||-.+... +||+||.|..-.....
T Consensus 164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 99987 5677999999999999999999999998 999999999999977654 7999999976432221
Q ss_pred -CCCccceeecCccccChhccc-----cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCc--
Q 006317 481 -SQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA-- 552 (650)
Q Consensus 481 -~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-- 552 (650)
........+|+..|||||+.. ...|+.+.|.||||||||-|++|..||....+++. .|..+..
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC---------GWdrGe~Cr 308 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC---------GWDRGEVCR 308 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC---------CccCCCccH
Confidence 112233467888999999763 23578899999999999999999999976554332 1111111
Q ss_pred ------ccccCccCCCCChHHH----HHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 553 ------LNLIDPTLRNGSSSEI----MRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 553 ------~~~id~~l~~~~~~~~----~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.+.|...-...+..+. .+.-+++...+..++.+|-++.+++.
T Consensus 309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1112111111111111 11223455567799999999988875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-33 Score=262.79 Aligned_cols=266 Identities=22% Similarity=0.417 Sum_probs=196.1
Q ss_pred cCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeec--------C
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFE--------E 392 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~ 392 (650)
+.|....+||+|.||+||+++..+ |+.||+|++-.... .--....+|+.++..|+|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 446667899999999999998654 77899988744221 112346789999999999999999998853 2
Q ss_pred CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeec
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 472 (650)
...+|||++|++ +|..+|.+ ....++..++.++..++..||.|+|... |+|||+|+.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 357999999987 77777764 3456899999999999999999999886 99999999999999999999999999
Q ss_pred ccccccCCC--CCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHH------
Q 006317 473 ARLFEMDQS--QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYA------ 543 (650)
Q Consensus 473 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~------ 543 (650)
++.+..... .......+-|+.|.+||.+.+ .+++++.|||.-||++.||+|+.+-+..........++...
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 987764433 223344566999999998887 57899999999999999999998766533332323333322
Q ss_pred --HHhccCCCccccc--CccCCCC----ChHHHH------HHHHHHhcccccCCCCCCCHHHHHHHh
Q 006317 544 --WKNWNEGTALNLI--DPTLRNG----SSSEIM------RCVHIGLLCVQENVANRPTMASVVVML 596 (650)
Q Consensus 544 --~~~~~~~~~~~~i--d~~l~~~----~~~~~~------~~~~l~~~Cl~~~p~~RPt~~evl~~L 596 (650)
|+....-...+.+ .| +... ..+.+. +..+++..++..||.+|+..++++.--
T Consensus 251 evWP~~d~lpL~~sie~eP-l~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEP-LPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred ccCCCcccchHHHhccCCC-CCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 2222222222222 11 2111 111111 345667788999999999999998653
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=279.31 Aligned_cols=243 Identities=25% Similarity=0.363 Sum_probs=193.5
Q ss_pred CCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCC
Q 006317 329 DNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS 405 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 405 (650)
.+.||.|.||+||-|+.+ +|+.||||++.+... +.+.++.+|+.+|.+++||.||.+.-.|+..+..++|||-+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 478999999999999865 599999999987643 45567999999999999999999999999999999999999776
Q ss_pred ChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC---CCeEEeeeecccccccCCCC
Q 006317 406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGla~~~~~~~~~ 482 (650)
-|+-+|.. .++.|++.....++.||+.||.|||.++ |+|.||||+||||.+. -++||+|||++|++....
T Consensus 649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 66665554 5678999999999999999999999998 9999999999999654 379999999999886432
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
....++||+.|+|||++..+.|...-|+||.|||+|--++|..||. .+++..+.++-+.-++....+.+
T Consensus 722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEdIndQIQNAaFMyPp~PW~e-------- 790 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDEDINDQIQNAAFMYPPNPWSE-------- 790 (888)
T ss_pred -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC--CccchhHHhhccccccCCCchhh--------
Confidence 2345789999999999999999999999999999999999998874 44444454443322222211111
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHH
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVV 593 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl 593 (650)
. ....++++-..||..-++|-+...-+
T Consensus 791 -i---s~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 791 -I---SPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred -c---CHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 1 12334555566777778888877655
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=265.71 Aligned_cols=220 Identities=20% Similarity=0.168 Sum_probs=173.0
Q ss_pred cCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCCChhHHHHh
Q 006317 335 GGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFD 413 (650)
Q Consensus 335 G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 413 (650)
|.+|.||+++.. +++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999864 57899999997653 233455556667899999999999999999999999999999999864
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccceeecCcc
Q 006317 414 AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493 (650)
Q Consensus 414 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 493 (650)
...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++|||++...... .....++..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 345899999999999999999999987 999999999999999999999999988654422 112345678
Q ss_pred ccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHH
Q 006317 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVH 573 (650)
Q Consensus 494 y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~ 573 (650)
|+|||.+.+..++.++||||+|+++|||++|+.|+...... ... .....+..... ..+.+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~-----~~~~~~~~~~~---~~~~~ 207 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INT-----HTTLNIPEWVS---EEARS 207 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------ccc-----ccccCCcccCC---HHHHH
Confidence 99999998888999999999999999999998765421100 000 00001111122 34556
Q ss_pred HHhcccccCCCCCCCHH
Q 006317 574 IGLLCVQENVANRPTMA 590 (650)
Q Consensus 574 l~~~Cl~~~p~~RPt~~ 590 (650)
++.+|++.||++||++.
T Consensus 208 li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 208 LLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHccCCHHHhcCCC
Confidence 77799999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=298.05 Aligned_cols=263 Identities=22% Similarity=0.263 Sum_probs=203.3
Q ss_pred cChhhHHhhccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeeccee
Q 006317 314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFS 389 (650)
Q Consensus 314 ~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~ 389 (650)
-....++-..++|.+.++||+|+||.|..++.+. ++.+|+|++++... ....-|..|-.+|..-+.+=|+++.-.|
T Consensus 65 ~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF 144 (1317)
T KOG0612|consen 65 KKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF 144 (1317)
T ss_pred HHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence 3445666677899999999999999999999754 78899999987422 2334578888899888889999999999
Q ss_pred ecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEee
Q 006317 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD 469 (650)
Q Consensus 390 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 469 (650)
.++..+|+|||||+||+|-.+|.. -..+++..+..++.+|+.||.-||+.| +|||||||.|||||..|++||+|
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeecc
Confidence 999999999999999999998874 236999999999999999999999987 99999999999999999999999
Q ss_pred eecccccccCCCCCccceeecCccccChhccc----c-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHH
Q 006317 470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT----R-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAW 544 (650)
Q Consensus 470 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~ 544 (650)
||-+-.+..+. .......+|||.|++||++. + +.|+...|+||+||++|||+.|..||.. ..++.-.-
T Consensus 219 FGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~ 291 (1317)
T KOG0612|consen 219 FGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYG 291 (1317)
T ss_pred chhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHH
Confidence 99987765433 23345578999999999985 2 5789999999999999999999999863 22332222
Q ss_pred HhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCC---HHHHHHHh
Q 006317 545 KNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPT---MASVVVML 596 (650)
Q Consensus 545 ~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt---~~evl~~L 596 (650)
+...+...+.+-+. ..-+++...++.- +--+|+.|-. ++++-.-.
T Consensus 292 KIm~hk~~l~FP~~---~~VSeeakdLI~~----ll~~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 292 KIMNHKESLSFPDE---TDVSEEAKDLIEA----LLCDREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred HHhchhhhcCCCcc---cccCHHHHHHHHH----HhcChhhhcccccHHHHHhCc
Confidence 33333222222211 1144555555541 2235666666 88887553
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=272.47 Aligned_cols=257 Identities=27% Similarity=0.360 Sum_probs=195.7
Q ss_pred hhccCCCcCCcccccCceeEEEee-ccCCcceeEeeccccC-chhH------HHHHHHHHHHhhCCCCceeeecceee-c
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNS-VQGE------LEFKNEVLLVARLQHRNLVRLLGFSF-E 391 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~-~~~~------~~~~~E~~~l~~l~H~niv~l~g~~~-~ 391 (650)
...++|-.+++||+|||+.|||+. +...+.||||+-..+. +..+ +...+|..+.+.|.||.||++++++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 345678888999999999999997 4457789999865432 2211 23568999999999999999999885 5
Q ss_pred CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC---CCCeEEe
Q 006317 392 ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPKIS 468 (650)
Q Consensus 392 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~ 468 (650)
.+..+-|+|||++.+|+-||.. ...++++++..|+.||+.||.||.+. +++|||-||||.||||-+ -|.+||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cccceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 6678999999999999999984 45789999999999999999999987 478999999999999954 4789999
Q ss_pred eeecccccccCCCCC-----ccceeecCccccChhccccC----CCCccccccchhHHHHHHHhCCCCCCCCCCcccchh
Q 006317 469 DFGMARLFEMDQSQG-----DTSRIVGTFGYMAPEYVTRG----HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDL 539 (650)
Q Consensus 469 DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l 539 (650)
||||+++++.+.... .+....||.+|++||.+.-+ +.+.|.||||.|||+|..+-|++||..... ..++
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdI 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDI 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHH
Confidence 999999987554331 24556899999999987543 578899999999999999999999974322 2233
Q ss_pred HHHHHHhccCCCcccccCccCC--CCChHHHHHHHHHHhcccccCCCCCCCHHHHH
Q 006317 540 LTYAWKNWNEGTALNLIDPTLR--NGSSSEIMRCVHIGLLCVQENVANRPTMASVV 593 (650)
Q Consensus 540 ~~~~~~~~~~~~~~~~id~~l~--~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl 593 (650)
+.+. ..++.-.-.++ ..-..+.. .++.+||+..-++|-..-++.
T Consensus 694 LqeN-------TIlkAtEVqFP~KPvVsseAk---aFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 LQEN-------TILKATEVQFPPKPVVSSEAK---AFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred Hhhh-------chhcceeccCCCCCccCHHHH---HHHHHHHHhhhhhhhhHHHHc
Confidence 3321 11111111111 11223333 456689999999998766653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=268.76 Aligned_cols=209 Identities=27% Similarity=0.348 Sum_probs=174.0
Q ss_pred cCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHHH---HHHHHHHHhhC-CCCceeeecceeecCCeeEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELE---FKNEVLLVARL-QHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~---~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 398 (650)
.+|..+.+||+|+||.|.++.-+. .+.+|||++++...-...+ -+.|-++|+.. +-|.++++..++..-+.+++|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 478889999999999999997654 5679999998874322221 34566667665 567899999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+.+|+|--++.+ -+.+.+..+.-++.+||-||-+||+++ ||.||||..|||||.+|++||+|||+++.--
T Consensus 429 MEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni- 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI- 501 (683)
T ss_pred EEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc-
Confidence 999999999888764 456778888999999999999999998 9999999999999999999999999997321
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHH
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYA 543 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~ 543 (650)
.....+...+||+.|+|||++...+|+...|+|||||+||||+.|+.||+. +++.++....
T Consensus 502 -~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG---eDE~elF~aI 562 (683)
T KOG0696|consen 502 -FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG---EDEDELFQAI 562 (683)
T ss_pred -cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHH
Confidence 123456678999999999999999999999999999999999999999973 4444444433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=282.58 Aligned_cols=241 Identities=23% Similarity=0.298 Sum_probs=188.2
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 399 (650)
.+..|.....+|.|+|+.|-++.. .+++..+||++.+... +-.+|+.++... +||||+++.+.+.+..+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 356788888899999999999875 4588999999987622 234566555554 7999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe-CCCCCeEEeeeeccccccc
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-DADMIPKISDFGMARLFEM 478 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl-~~~~~~kl~DFGla~~~~~ 478 (650)
|.+.++-|.+.+.. ..... ..+..|+.+|+.++.|||+++ ++||||||+|||+ ++.++++|+|||.++..+.
T Consensus 396 e~l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999988776652 22233 777889999999999999988 9999999999999 6999999999999986553
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
. ....+-|..|.|||++....++.++||||||++||+|++|+.|+.....+ .++.. ....+
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~----~i~~~-------- 529 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT----RIQMP-------- 529 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH----hhcCC--------
Confidence 3 22345688999999999999999999999999999999999998754333 11111 11111
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.......++.. +|+.+||+.||.+||+|.++..-
T Consensus 530 ~~s~~vS~~AK---dLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 530 KFSECVSDEAK---DLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ccccccCHHHH---HHHHHhccCChhhCcChhhhccC
Confidence 11111223333 56668999999999999999754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=262.19 Aligned_cols=238 Identities=26% Similarity=0.365 Sum_probs=190.4
Q ss_pred CceeEEEeeccC-CcceeEeeccccCchh-HHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCCChhHHHHh
Q 006317 336 GFGAVYKGRLSH-GQEIAVKRLSKNSVQG-ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFD 413 (650)
Q Consensus 336 ~~g~Vy~~~~~~-g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 413 (650)
+||.||+++... ++.+++|++....... ...+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999764 8899999997765444 56899999999999999999999999999999999999999999999864
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccceeecCcc
Q 006317 414 AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493 (650)
Q Consensus 414 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 493 (650)
...+++..++.++.+++.++.|||+.+ ++|+||+|+||++++++.++|+|||++....... ......++..
T Consensus 81 ---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 ---RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred ---ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 223899999999999999999999987 9999999999999999999999999998665332 2334567889
Q ss_pred ccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHH
Q 006317 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVH 573 (650)
Q Consensus 494 y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~ 573 (650)
|++||.+....++.++||||||+++++|++|..|+... ............ .... . .........++.+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~--~~~~~~~~~~~~----~~~~----~--~~~~~~~~~~~~~ 219 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD--DQLLELFKKIGK----PKPP----F--PPPEWKISPEAKD 219 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHhc----cCCC----C--ccccccCCHHHHH
Confidence 99999999888999999999999999999999887532 111111111111 0000 0 0000001245667
Q ss_pred HHhcccccCCCCCCCHHHHHH
Q 006317 574 IGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 574 l~~~Cl~~~p~~RPt~~evl~ 594 (650)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 888999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=281.57 Aligned_cols=203 Identities=20% Similarity=0.317 Sum_probs=153.8
Q ss_pred hccCCCcCCcccccCceeEEEeec-----------------cCCcceeEeeccccCchhHHH--------------HHHH
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-----------------SHGQEIAVKRLSKNSVQGELE--------------FKNE 370 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~--------------~~~E 370 (650)
..++|++.++||+|+||.||+|.+ .+++.||||++.........+ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999963 235679999986543322222 3347
Q ss_pred HHHHhhCCCCce-----eeecceeec--------CCeeEEEEecCCCCChhHHHHhhh---------------------c
Q 006317 371 VLLVARLQHRNL-----VRLLGFSFE--------ETERLLIYEFVPNSSVDKFIFDAI---------------------K 416 (650)
Q Consensus 371 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~---------------------~ 416 (650)
+.++.+++|.++ ++++++|.. ++..+|||||+++++|.++|+... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778877654 677787753 356899999999999999987421 1
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccceeecCccccC
Q 006317 417 RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496 (650)
Q Consensus 417 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 496 (650)
...++|..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123578889999999999999999987 99999999999999999999999999975432211 11112334789999
Q ss_pred hhccccCCC----------------------CccccccchhHHHHHHHhCCC-CC
Q 006317 497 PEYVTRGHF----------------------SIKSDVFSFGVLVLEIISGQK-NN 528 (650)
Q Consensus 497 PE~~~~~~~----------------------s~~sDV~S~Gvll~elltG~~-p~ 528 (650)
||.+..... ..+.||||+||+++||++|.. |+
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~ 433 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV 433 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 998764321 134799999999999999975 44
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=291.77 Aligned_cols=259 Identities=19% Similarity=0.221 Sum_probs=167.2
Q ss_pred hccCCCcCCcccccCceeEEEeeccC-----CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecce------ee
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSH-----GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF------SF 390 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~ 390 (650)
..++|+..++||+|+||.||+|++.+ +..||||++...... +...+| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999998754 678999998653211 111111 1222223333332222 24
Q ss_pred cCCeeEEEEecCCCCChhHHHHhhhc-----------------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCC
Q 006317 391 EETERLLIYEFVPNSSVDKFIFDAIK-----------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLK 453 (650)
Q Consensus 391 ~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 453 (650)
.+...++||||+++++|.+++..... ........+..++.||+.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56688999999999999998864210 001123345679999999999999987 9999999
Q ss_pred CCceEeCC-CCCeEEeeeecccccccCCCCCccceeecCccccChhccccC----------------------CCCcccc
Q 006317 454 ASNILLDA-DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG----------------------HFSIKSD 510 (650)
Q Consensus 454 ~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~sD 510 (650)
|+||||++ ++.+||+|||+++.+..... .......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 57999999999986543222 123346789999999965322 2345679
Q ss_pred ccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccC----CCcccccCccCCCC-------ChHHHHHHHHHHhccc
Q 006317 511 VFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNE----GTALNLIDPTLRNG-------SSSEIMRCVHIGLLCV 579 (650)
Q Consensus 511 V~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----~~~~~~id~~l~~~-------~~~~~~~~~~l~~~Cl 579 (650)
||||||+||||+++..+... ++.......... ..+...+.+..... ...+.....+++.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS-------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch-------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 99999999999997655331 111110000000 00001111110000 0001122346888999
Q ss_pred ccCCCCCCCHHHHHHH
Q 006317 580 QENVANRPTMASVVVM 595 (650)
Q Consensus 580 ~~~p~~RPt~~evl~~ 595 (650)
+.||++|||+.|+++-
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-32 Score=274.59 Aligned_cols=242 Identities=22% Similarity=0.266 Sum_probs=197.5
Q ss_pred cCCCcCCcccccCceeEEEeeccCCc-ceeEeecccc---CchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQ-EIAVKRLSKN---SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~-~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
.+++....||-|+||.|-+++.+... .+|+|++++. ....++++..|-.+|.+.+.|.||+++.-+.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45566788999999999999875433 4899999775 3344557889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
|-|-+|.|...|. .++.++..+..-++..+.+|++|||+++ ||.|||||+|.+|+.+|-+||.|||+|+.+.
T Consensus 500 EaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~-- 571 (732)
T KOG0614|consen 500 EACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG-- 571 (732)
T ss_pred HhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc--
Confidence 9999999999997 5678999999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
....+..++||+.|.|||++..+..+..+|.||||+++|||++|++||...++....+++-.-...+. +
T Consensus 572 -~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~------~---- 640 (732)
T KOG0614|consen 572 -SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE------F---- 640 (732)
T ss_pred -cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh------c----
Confidence 34567789999999999999999999999999999999999999999986655443333221111110 0
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCC
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPT 588 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt 588 (650)
+..-.....+++...+..+|.+|--
T Consensus 641 ----Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 641 ----PRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ----ccccchhHHHHHHHHHhcCcHhhhc
Confidence 0011122334555667889999976
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=232.50 Aligned_cols=197 Identities=26% Similarity=0.431 Sum_probs=166.1
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+|+..++||+|.||+||+++.. .++.||+|+++-.... -.....+|+-+++.++|+|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4566789999999999999855 4778999998654322 233578999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
|.. +|..|... -++.++.+....++.|+++||.++|+++ +.||||||.|.||+.+|+.|++|||+++.+.....
T Consensus 83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 965 67776543 3567999999999999999999999998 99999999999999999999999999998764321
Q ss_pred CCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNS 529 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~ 529 (650)
-.+..+-|..|.+|+++.+. -|+...|+||-||++.|+....+|..
T Consensus 157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf 203 (292)
T KOG0662|consen 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_pred --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence 12234568999999999885 47899999999999999998666643
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=239.27 Aligned_cols=207 Identities=28% Similarity=0.400 Sum_probs=170.7
Q ss_pred hHHhhccCCCcCCcccccCceeEEEeec-cCCcceeEeecccc-CchhHHHHHHHHHHHhhC-CCCceeeecceeecCCe
Q 006317 318 TIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN-SVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETE 394 (650)
Q Consensus 318 ~~~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 394 (650)
.+....+.......||+|++|.|-+-++ .+|+..|+|++... ..+......+|+.+..+- ..|.+|.++|....+..
T Consensus 40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 3445556667778999999999988875 46899999999765 334455677888876554 79999999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecc
Q 006317 395 RLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 473 (650)
.++.||.|.- ||+.|-.+-. ++..+++..+-+|+..+.+||.|||++- .+||||+||+||||+.+|++||||||++
T Consensus 120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence 9999999955 8888876533 4567899999999999999999999964 6999999999999999999999999999
Q ss_pred cccccCCCCCccceeecCccccChhcccc----CCCCccccccchhHHHHHHHhCCCCCCC
Q 006317 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTR----GHFSIKSDVFSFGVLVLEIISGQKNNSF 530 (650)
Q Consensus 474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDV~S~Gvll~elltG~~p~~~ 530 (650)
-.+...-. .+...|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|++.
T Consensus 197 G~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 197 GYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 76653221 122457789999998753 4789999999999999999999999863
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=247.17 Aligned_cols=251 Identities=22% Similarity=0.256 Sum_probs=189.8
Q ss_pred hccCCCcC-CcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceeec----CCe
Q 006317 322 ATNNFSTD-NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFE----ETE 394 (650)
Q Consensus 322 ~~~~f~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~ 394 (650)
.+++|.+. ++||-|-.|.|-....+ .++.+|+|++.... ...+|+++.-.. .|||||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34555544 68999999999988754 58899999986542 346788876555 69999999998764 456
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC---CCeEEeeee
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFG 471 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFG 471 (650)
+++|||.|+||.|...+.+. ....+++.++-.|+.||..|+.|||+.+ |.||||||+|+|.... -.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 78999999999999888753 4456999999999999999999999987 9999999999999754 468999999
Q ss_pred cccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCC
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGT 551 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 551 (650)
+|+.-. ........+-|+.|.|||++...+|+...|+||+||++|-|++|-+||....+... ..+.
T Consensus 210 FAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-----------spgM 275 (400)
T KOG0604|consen 210 FAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGM 275 (400)
T ss_pred cccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-----------ChhH
Confidence 998533 23444556789999999999999999999999999999999999999864332110 0000
Q ss_pred ccccc--CccCCCCChHHHHH-HHHHHhcccccCCCCCCCHHHHHHH
Q 006317 552 ALNLI--DPTLRNGSSSEIMR-CVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 552 ~~~~i--d~~l~~~~~~~~~~-~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..++. ..........++.+ .-+++...|..+|++|-|+.+++.-
T Consensus 276 k~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 276 KRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 00110 01111111222222 2357778899999999999999754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=280.49 Aligned_cols=247 Identities=26% Similarity=0.366 Sum_probs=187.6
Q ss_pred CCCcCCcccccCcee-EEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEEEecC
Q 006317 325 NFSTDNKLGQGGFGA-VYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
-|...+.+|.|..|+ ||+|.. +|++||||++-.... .-.++|+..++.- +|||||++++.-.++...|+..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 355567889999885 799998 689999999865432 2357899999888 6999999999999999999999999
Q ss_pred CCCChhHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC---C--CCeEEeeeeccccc
Q 006317 403 PNSSVDKFIFDA-IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---D--MIPKISDFGMARLF 476 (650)
Q Consensus 403 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~---~--~~~kl~DFGla~~~ 476 (650)
.. +|++++... ...........+.+..|+++||++||+.+ ||||||||.||||+. + .+++|+|||+++.+
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 65 999999753 11111222456788999999999999976 999999999999976 3 47999999999988
Q ss_pred ccCCCC-CccceeecCccccChhccccCCCCccccccchhHHHHHHHhC-CCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 477 EMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG-QKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 477 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
..+... .......||-+|+|||++....-+..+||||+||++|..++| ++||......+. ..........
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~L~ 733 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYTLV 733 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCcccee
Confidence 765442 335567899999999999998889999999999999999997 788863211110 1111111111
Q ss_pred ccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 555 LIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 555 ~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.+.+ ..+. +..+|+.+|+.++|..||++.+|+.
T Consensus 734 ~L~~------~~d~-eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 HLEP------LPDC-EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eecc------CchH-HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1111 1111 4557888999999999999999983
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=249.90 Aligned_cols=200 Identities=27% Similarity=0.359 Sum_probs=173.2
Q ss_pred ccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCc---hhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 397 (650)
-++|..+++||+|+|.+|..+++.. .+-+|+|++++.-. +.....+.|-.+..+. +||.+|-+..++..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 3678999999999999999998754 67899999987532 2333455666666555 79999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
|.||+++|+|--++. +...|+++.+.-+..+|..||.|||+.+ ||.||||..|||||.+|++||+|+|+.+.-
T Consensus 329 vieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~- 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG- 401 (593)
T ss_pred EEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC-
Confidence 999999999976665 4567999999999999999999999998 999999999999999999999999998732
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCC
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF 530 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~ 530 (650)
-.....++.++||+.|+|||++.+..|....|+|++||+++||+.|+.||+.
T Consensus 402 -l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 402 -LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred -CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 1233456778999999999999999999999999999999999999999985
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=254.61 Aligned_cols=262 Identities=20% Similarity=0.255 Sum_probs=196.3
Q ss_pred hccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHHHHHHHHHHHhhCC-C-C----ceeeecceeecCCe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-H-R----NLVRLLGFSFEETE 394 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-~----niv~l~g~~~~~~~ 394 (650)
.+++|.+..++|+|.||.|-...... +..||||+++.-... .+..+-|++++.++. + | -+|.+.+++.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 37899999999999999999887543 688999999764333 224456899999983 2 2 37788889999999
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC-------------
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA------------- 461 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~------------- 461 (650)
.++|+|.+ |-|+.+||..+ +-.+++...+..|+.|++++++|||+.. ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999988 55899999753 3456889999999999999999999987 999999999999932
Q ss_pred -------CCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCc
Q 006317 462 -------DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGE 534 (650)
Q Consensus 462 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~ 534 (650)
+..+||.|||-+..... ....++.|..|.|||++.+-.++..+||||+||||.|+.||..-|...+..
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 23589999999976432 235678899999999999999999999999999999999998876544322
Q ss_pred ccchhHHHH--------------HHhccCC-------Cc----ccccCccC-----CCCChHHHHHHHHHHhcccccCCC
Q 006317 535 EAEDLLTYA--------------WKNWNEG-------TA----LNLIDPTL-----RNGSSSEIMRCVHIGLLCVQENVA 584 (650)
Q Consensus 535 ~~~~l~~~~--------------~~~~~~~-------~~----~~~id~~l-----~~~~~~~~~~~~~l~~~Cl~~~p~ 584 (650)
+...+-+.. .+....+ .. ....++.. ......+..++.+|+..||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 211111110 0000000 00 00111110 011345667789999999999999
Q ss_pred CCCCHHHHHH
Q 006317 585 NRPTMASVVV 594 (650)
Q Consensus 585 ~RPt~~evl~ 594 (650)
+|+|+.|++.
T Consensus 396 ~RiTl~EAL~ 405 (415)
T KOG0671|consen 396 RRITLREALS 405 (415)
T ss_pred ccccHHHHhc
Confidence 9999999974
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=261.82 Aligned_cols=207 Identities=26% Similarity=0.360 Sum_probs=174.5
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch---hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
..-|..++.||-|.||+|-++... ....+|+|.+.+.... .....+.|-.+|..-..+=||+|+-.|.+.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 356888899999999999999743 4567999999876433 233578899999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||++||++-.+|. +.+.+.+..+..++.++..|+++.|.-| +|||||||.|||||.+|++||+||||+.-+..
T Consensus 708 MdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 99999999998886 4567888888899999999999999887 99999999999999999999999999864421
Q ss_pred CC--------CCC--------------------------------ccceeecCccccChhccccCCCCccccccchhHHH
Q 006317 479 DQ--------SQG--------------------------------DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLV 518 (650)
Q Consensus 479 ~~--------~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll 518 (650)
.. .+. .....+||..|+|||++....++...|+||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 10 000 01125799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCcc
Q 006317 519 LEIISGQKNNSFRIGEE 535 (650)
Q Consensus 519 ~elltG~~p~~~~~~~~ 535 (650)
|||+.|+.||-.....+
T Consensus 862 ~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHhhCCCCccCCCCCc
Confidence 99999999987544433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-28 Score=233.64 Aligned_cols=211 Identities=34% Similarity=0.557 Sum_probs=182.3
Q ss_pred ccccCceeEEEeeccC-CcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCCChhH
Q 006317 332 LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDK 409 (650)
Q Consensus 332 LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 409 (650)
||+|.+|.||++...+ ++.+++|++...... ....+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 889999999766443 34578999999999999999999999999999999999999999999
Q ss_pred HHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC-CCCeEEeeeecccccccCCCCCcccee
Q 006317 410 FIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEMDQSQGDTSRI 488 (650)
Q Consensus 410 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~ 488 (650)
++... ...+++..++.++.+++++|++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKEN--EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 98642 146899999999999999999999987 999999999999999 89999999999986543221 12334
Q ss_pred ecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHH
Q 006317 489 VGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSE 567 (650)
Q Consensus 489 ~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~ 567 (650)
.+...|++||.+... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 577899999999887 888999999999999999
Q ss_pred HHHHHHHHhcccccCCCCCCCHHHHHHHh
Q 006317 568 IMRCVHIGLLCVQENVANRPTMASVVVML 596 (650)
Q Consensus 568 ~~~~~~l~~~Cl~~~p~~RPt~~evl~~L 596 (650)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3556778899999999999999998643
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-29 Score=240.85 Aligned_cols=265 Identities=23% Similarity=0.337 Sum_probs=191.4
Q ss_pred CCCcCCcccccCceeEEEeec-cCCcceeEeecccc--CchhHHHHHHHHHHHhhCCCCceeeecceeecC-----CeeE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-----TERL 396 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~ 396 (650)
+.+..+.||-|.||.||.... ++|+.||+|++..- +....+.+.+|+.++.-++|.|++..++.-.-. .+.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 345668999999999999885 46999999998653 333455788999999999999999998876543 3567
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
+++|.|.. +|.+++- ....++...+.-++.||++||+|||+.+ |.||||||.|.|++.|-.+||+||||++..
T Consensus 134 V~TELmQS-DLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHHh-hhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 88888854 6776664 4556888888889999999999999987 999999999999999999999999999987
Q ss_pred ccCCCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHH--------HHHhc
Q 006317 477 EMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTY--------AWKNW 547 (650)
Q Consensus 477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~--------~~~~~ 547 (650)
+.++....+. .+-|-.|.|||++++. .|+.+.||||.|||+.||+..+.-|.....-+..+++.. ..+..
T Consensus 207 e~d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 207 DQRDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred chhhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 7655443333 3458899999999985 799999999999999999988765543322222222211 11111
Q ss_pred cCCCcccccCccCCCC--------Ch--HHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 548 NEGTALNLIDPTLRNG--------SS--SEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 548 ~~~~~~~~id~~l~~~--------~~--~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
.++....++....+.. .. ..--+.+.+...++..+|.+|-+..+.+.-+.
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1221112221111110 01 11122344556788999999999998886654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-27 Score=231.96 Aligned_cols=197 Identities=32% Similarity=0.506 Sum_probs=172.0
Q ss_pred CCcCCcccccCceeEEEeeccC-CcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCC
Q 006317 326 FSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
|...+.||+|++|.||+++..+ ++.+++|.+...... ....+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999865 889999999876544 56678999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhhccCC-CCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 404 NSSVDKFIFDAIKRVQ-LDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
+++|.+++... .. +++..++.++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~- 153 (225)
T smart00221 81 GGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA- 153 (225)
T ss_pred CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-
Confidence 99999998742 23 899999999999999999999986 99999999999999999999999999987653321
Q ss_pred CccceeecCccccChhcc-ccCCCCccccccchhHHHHHHHhCCCCCC
Q 006317 483 GDTSRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQKNNS 529 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~-~~~~~s~~sDV~S~Gvll~elltG~~p~~ 529 (650)
.......++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 123345678899999998 66778889999999999999999999985
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=223.14 Aligned_cols=193 Identities=20% Similarity=0.404 Sum_probs=164.5
Q ss_pred ccCCCcCCcccccCceeEEEee-ccCCcceeEeeccccCchhHHHHHHHHHHHhhCC-CCceeeecceeecC--CeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEE--TERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lv 398 (650)
.++|++.+++|+|.+++||.|. ..+.+.++||+++.-. ...+.+|+.+|..|+ ||||++++++..+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4688999999999999999998 4567889999997643 336789999999997 99999999998765 456799
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC-CeEEeeeecccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFE 477 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~ 477 (650)
+||+.+.+...+- ..|+..++...+.++++||.|+|+.| |.|||+||.||+||... .++|+|+|||.++.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998766543 35788899999999999999999998 99999999999999765 69999999999887
Q ss_pred cCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCC
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSF 530 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~ 530 (650)
+... .+..+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||..
T Consensus 185 p~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 185 PGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred CCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 6543 334556778899998865 5678899999999999999999999853
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=246.02 Aligned_cols=195 Identities=26% Similarity=0.440 Sum_probs=166.8
Q ss_pred cCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHH--------HHHHHHHHHhhCC---CCceeeecceeec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGEL--------EFKNEVLLVARLQ---HRNLVRLLGFSFE 391 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~--------~~~~E~~~l~~l~---H~niv~l~g~~~~ 391 (650)
.+|...+.+|+|+||.|+++.++. ..+|+||.+.+...-... ..-.|+.+|..++ |+||++++.++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 358888999999999999998754 567999998776432111 2446999999997 9999999999999
Q ss_pred CCeeEEEEecCC-CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeee
Q 006317 392 ETERLLIYEFVP-NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF 470 (650)
Q Consensus 392 ~~~~~lv~e~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 470 (650)
++..+|+||-.. +-+|.+++. .+..+++.+...|+.||+.|+++||+++ |||||||-+||.|+.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999999864 557778775 4677999999999999999999999998 999999999999999999999999
Q ss_pred ecccccccCCCCCccceeecCccccChhccccCCC-CccccccchhHHHHHHHhCCCCC
Q 006317 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNN 528 (650)
Q Consensus 471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~elltG~~p~ 528 (650)
|.+.... ......++||..|.|||++.+.+| ...-|||++|++||-++-...|+
T Consensus 715 gsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 9987643 234567899999999999998877 56789999999999988877665
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=251.32 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=198.0
Q ss_pred hhccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
...++|+....+|.|.||.|||++. ..++..|||.++-.......-+++|+-+++..+|||||.++|-+......++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 3456889999999999999999985 458899999998776666666788999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
|||.+|+|++.-+ ..+.+++.++..+.++..+||+|||+.+ -+|||||-.|||+++.|.+|++|||.+..+..
T Consensus 92 EycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita- 164 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA- 164 (829)
T ss_pred EecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh-
Confidence 9999999999765 5678999999999999999999999998 79999999999999999999999999875542
Q ss_pred CCCCccceeecCccccChhccc---cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
.-.....+.||+.|||||+.. .+.|..++|||+.|+...|+---+.|..--... .+..... ...+
T Consensus 165 -ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm-------r~l~LmT----kS~~ 232 (829)
T KOG0576|consen 165 -TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM-------RALFLMT----KSGF 232 (829)
T ss_pred -hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH-------HHHHHhh----ccCC
Confidence 223345578999999999763 467899999999999999998877664211000 0000000 0111
Q ss_pred Cc-cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 557 DP-TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 557 d~-~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
+| .+++. ..-...+-+++-.|+-++|++||+++.++.
T Consensus 233 qpp~lkDk-~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 233 QPPTLKDK-TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCcccCC-ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 22 22221 111122334555799999999999987763
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=223.55 Aligned_cols=195 Identities=30% Similarity=0.389 Sum_probs=160.7
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeecccc--CchhHHHHHHHHHHHhhCCCCceeeecceeecC------
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------ 392 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 392 (650)
...+|.....+|.|.- .|-.+.. -.++.||+|++... .........+|..++..++|+||++++.++.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 3456777888999888 4444432 24789999998654 223445678999999999999999999998643
Q ss_pred CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeec
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 472 (650)
.+.++|||+|.. +|...+. ..++-+++..+..|++.|++|||+.+ |+||||||+||++..+..+||.|||+
T Consensus 94 ~e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 94 QEVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HhHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence 467999999954 7887775 35788899999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCC
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~ 529 (650)
++.-..+ -..+..+.|..|.|||++.+-.+...+||||.||++.||++|+--|.
T Consensus 165 ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 165 ARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred hcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 9854322 24455678999999999998889999999999999999999986554
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=234.77 Aligned_cols=261 Identities=19% Similarity=0.262 Sum_probs=200.7
Q ss_pred hccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHHHHHHHHHHHhhCC------CCceeeecceeecCCe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQ------HRNLVRLLGFSFEETE 394 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~~~~~~ 394 (650)
...+|.+....|+|-|++|.+|.... |+.||||++..+..-.. .=+.|+++|++|+ --|.++|+-.|...++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~K-tGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHK-TGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhh-hhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 45678888889999999999998654 88999999987643222 3357999999995 3489999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC-CeEEeeeecc
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMA 473 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla 473 (650)
++||+|-+ .-+|.+.|........|....+..++.|+..||..|..-+ |+|.||||.||||++.. .+||||||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999987 4589999987767778999999999999999999999877 99999999999999865 5799999999
Q ss_pred cccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHH--------
Q 006317 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWK-------- 545 (650)
Q Consensus 474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~-------- 545 (650)
.....+. .....-+..|.|||++.+..|+...|+||.||.||||.||+.-|... ...+++.+...
T Consensus 585 ~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~---TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 585 SFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR---TNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred ccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC---CcHHHHHHHHHhcCCCcHH
Confidence 7654322 22233456799999999999999999999999999999999776522 22333332211
Q ss_pred hccCC---------------------------CcccccCc------------cCCCCChHHHHHHHHHHhcccccCCCCC
Q 006317 546 NWNEG---------------------------TALNLIDP------------TLRNGSSSEIMRCVHIGLLCVQENVANR 586 (650)
Q Consensus 546 ~~~~~---------------------------~~~~~id~------------~l~~~~~~~~~~~~~l~~~Cl~~~p~~R 586 (650)
++..+ .++..+.| .+..+....+..+..|+-.|+..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 11110 01111222 2334455566778889999999999999
Q ss_pred CCHHHHHH
Q 006317 587 PTMASVVV 594 (650)
Q Consensus 587 Pt~~evl~ 594 (650)
-|..+.|.
T Consensus 738 it~nqAL~ 745 (752)
T KOG0670|consen 738 ITVNQALK 745 (752)
T ss_pred CCHHHHhc
Confidence 99998763
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-26 Score=217.02 Aligned_cols=254 Identities=19% Similarity=0.317 Sum_probs=185.0
Q ss_pred hccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeeccee-ecCCeeEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFS-FEETERLLI 398 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~-~~~~~~~lv 398 (650)
..+.|.+.+.||+|.||.+-+++++. .+.+++|-+.... ....+|.+|..---.| .|.||+.-+.+- ...+..+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 34678999999999999999999765 6689999886643 3456888887765555 589999988764 455677899
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC--CCCCeEEeeeeccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--ADMIPKISDFGMARLF 476 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~--~~~~~kl~DFGla~~~ 476 (650)
+||+|.|+|..-+. ...+.+....+++.|++.||.|+|+++ +||||||.+||||- +..++||+|||+.+..
T Consensus 101 qE~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999876553 456888889999999999999999998 99999999999993 3458999999998754
Q ss_pred ccCCCCCccceeecCccccChhccccC-----CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCC
Q 006317 477 EMDQSQGDTSRIVGTFGYMAPEYVTRG-----HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGT 551 (650)
Q Consensus 477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 551 (650)
+.. .....-+..|.+||..... ...+.+|||.||++++.++||+.||.... ..+..-|.|..|..+.
T Consensus 174 g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~---~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 174 GTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS---IMDKPYWEWEQWLKRK 245 (378)
T ss_pred Cce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh---ccCchHHHHHHHhccc
Confidence 321 2223345679999976532 34678999999999999999999997332 2233334555555554
Q ss_pred cccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHh
Q 006317 552 ALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVML 596 (650)
Q Consensus 552 ~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L 596 (650)
...+-+. -....+..+++. .+-+.+++++|=...++-+|-
T Consensus 246 ~~~~P~~--F~~fs~~a~r~F---kk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 246 NPALPKK--FNPFSEKALRLF---KKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred CccCchh--hcccCHHHHHHH---HHhcCCcccccchhHHHHHHH
Confidence 4422111 111333444443 367889999995555555553
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=268.52 Aligned_cols=197 Identities=16% Similarity=0.235 Sum_probs=138.8
Q ss_pred hCCC-Cceeeeccee-------ecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcE
Q 006317 376 RLQH-RNLVRLLGFS-------FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447 (650)
Q Consensus 376 ~l~H-~niv~l~g~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 447 (650)
.++| +||+++++++ ......++++||+ +++|.++|.. ....+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3556 6888888877 2234567888987 5599999964 2456999999999999999999999987 9
Q ss_pred EecCCCCCceEeCC-------------------CCCeEEeeeecccccccCCC--------------CCccceeecCccc
Q 006317 448 IHRDLKASNILLDA-------------------DMIPKISDFGMARLFEMDQS--------------QGDTSRIVGTFGY 494 (650)
Q Consensus 448 iHrDlk~~NILl~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y 494 (650)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566667776654221000 0001124578899
Q ss_pred cChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHH
Q 006317 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHI 574 (650)
Q Consensus 495 ~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l 574 (650)
||||++.+..++.++|||||||+||||++|..|+.... ......... .+.+. ......+...+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~---------~~~~~----~~~~~~~~~~~ 244 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHR---------VLPPQ----ILLNWPKEASF 244 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHh---------hcChh----hhhcCHHHHHH
Confidence 99999999999999999999999999999887653110 000000000 01111 11122344567
Q ss_pred HhcccccCCCCCCCHHHHHHH
Q 006317 575 GLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 575 ~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+.+||+++|.+||+|.||++.
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 778999999999999999854
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=223.39 Aligned_cols=201 Identities=24% Similarity=0.392 Sum_probs=167.4
Q ss_pred HHhhccCCCcCCcccccCceeEEEeeccC----CcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceeecCC
Q 006317 319 IRDATNNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEET 393 (650)
Q Consensus 319 ~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 393 (650)
+....+.|...++||+|.|++||++.+.. .+.||+|.+...+... .+.+|+++|..+ -+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~--ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS--RILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch--HHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 44456788999999999999999998543 5689999987654433 478999999999 4999999999999999
Q ss_pred eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC-CCeEEeeeec
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGM 472 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGl 472 (650)
...+|+||+++....+++. .++...+..+++.+..||.++|..+ ||||||||+|+|.+.. ++-.|.||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 9999999999999998876 3778999999999999999999998 9999999999999865 5789999999
Q ss_pred ccccccCC-------------CC-----------------------------CccceeecCccccChhcccc-CCCCccc
Q 006317 473 ARLFEMDQ-------------SQ-----------------------------GDTSRIVGTFGYMAPEYVTR-GHFSIKS 509 (650)
Q Consensus 473 a~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~s~~s 509 (650)
+...+... .. .......||++|.|||++.. ...++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97321100 00 00112469999999999876 4678999
Q ss_pred cccchhHHHHHHHhCCCCCCC
Q 006317 510 DVFSFGVLVLEIISGQKNNSF 530 (650)
Q Consensus 510 DV~S~Gvll~elltG~~p~~~ 530 (650)
||||.|||++.+++++.||..
T Consensus 260 Diws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred ceeeccceeehhhcccccccc
Confidence 999999999999999999853
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=222.35 Aligned_cols=131 Identities=24% Similarity=0.351 Sum_probs=108.5
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCC-----C---Cceeeecceeec---
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-----H---RNLVRLLGFSFE--- 391 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~--- 391 (650)
.+|...++||-|.|++||++.. .+.+.||+|+.+...... +....||++|++++ | ..||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYt-EaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYT-EAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHH-HHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6888999999999999999975 456789999987544333 34678999999883 3 369999999864
Q ss_pred -CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe
Q 006317 392 -ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 459 (650)
Q Consensus 392 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl 459 (650)
+.+.+||+|++ |.+|..+|... .-..++...+.+|+.||+.||.|||.+. +|||-||||+||||
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56889999999 55777777643 3456899999999999999999999987 79999999999999
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=206.94 Aligned_cols=165 Identities=18% Similarity=0.209 Sum_probs=123.5
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
|+|.+++.. .+..++|.+++.++.||++||+|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 689999874 2456999999999999999999999875 999999999999999 99998654321
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGS 564 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~ 564 (650)
..||+.|||||++.+..++.++|||||||++|||+||+.|+..... ....+.......... ++... ..
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~~------~~~~~-~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE--LSAILEILLNGMPAD------DPRDR-SN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch--hcHHHHHHHHHhccC------Ccccc-cc
Confidence 2588999999999999999999999999999999999999853221 111111111111100 00000 11
Q ss_pred hHHH---HHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 565 SSEI---MRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 565 ~~~~---~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.... .++.+++.+||+.+|++||++.|+++.+..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 1222 247788999999999999999999988753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=206.21 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=188.0
Q ss_pred CCcCCcccccCceeEEEeeccCCcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCC
Q 006317 326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
.....+|.+...|+.|+|+++ |..+++|++...... -..+|..|.-.++.+.||||+.++|.|.......++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 344568899999999999994 677888888665333 23478999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
.|+|...|++. ....++..+..+++.+||+|++|||+.. +-|..--|.+..|+||++.+++|+- +-.++.. +
T Consensus 271 ~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kfsf--q--- 342 (448)
T KOG0195|consen 271 FGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF--Q--- 342 (448)
T ss_pred chHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccceeee--e---
Confidence 99999999863 3445788899999999999999999986 3344556899999999999988742 1111110 0
Q ss_pred ccceeecCccccChhccccCCCC---ccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFS---IKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s---~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
.....-.+.||+||.+..++-+ ...|+|||.+++|||.|...||......+.. ....++-+.+.+
T Consensus 343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-----------mkialeglrv~i 410 (448)
T KOG0195|consen 343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-----------MKIALEGLRVHI 410 (448)
T ss_pred -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-----------hhhhhccccccC
Confidence 0112236789999999876554 5799999999999999999998633322211 112233344445
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+......+.++++| |+++||.+||.+..|+-.|+.
T Consensus 411 ppgis~hm~klm~i---cmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 411 PPGISRHMNKLMNI---CMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred CCCccHHHHHHHHH---HhcCCCCcCCCcceehhhHHH
Confidence 55555556666554 999999999999999988875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=218.65 Aligned_cols=171 Identities=19% Similarity=0.201 Sum_probs=132.2
Q ss_pred hhHHhhccCCCcCCcccccCceeEEEeecc--CCcceeEeeccccC-----chhHHHHHHHHHHHhhCCCCceeeeccee
Q 006317 317 STIRDATNNFSTDNKLGQGGFGAVYKGRLS--HGQEIAVKRLSKNS-----VQGELEFKNEVLLVARLQHRNLVRLLGFS 389 (650)
Q Consensus 317 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 389 (650)
+......++|...+.||+|+||+||+|+.. +++.+|||++.... ......+.+|++++.+++|+|+++.+..
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~- 89 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA- 89 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence 344556788999999999999999999864 46778999875331 1234468999999999999999853322
Q ss_pred ecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCC-CCCceEeCCCCCeEEe
Q 006317 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDL-KASNILLDADMIPKIS 468 (650)
Q Consensus 390 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl-k~~NILl~~~~~~kl~ 468 (650)
.+..+|||||+++++|... . .. . ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+
T Consensus 90 --~~~~~LVmE~~~G~~L~~~-~---~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHLA-R---PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred --cCCcEEEEEccCCCCHHHh-C---cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEE
Confidence 2457999999999999632 1 11 1 1467889999999999987 999999 9999999999999999
Q ss_pred eeecccccccCCCCC------ccceeecCccccChhccccC
Q 006317 469 DFGMARLFEMDQSQG------DTSRIVGTFGYMAPEYVTRG 503 (650)
Q Consensus 469 DFGla~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~ 503 (650)
|||+++.+....... ......+++.|++||++...
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999999765432111 12356788899999998654
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=181.00 Aligned_cols=101 Identities=41% Similarity=0.781 Sum_probs=78.4
Q ss_pred CCCCC-C-CCcc-CCCChHHHHHHHHHHHhHhhhcCC--CCceeeecCCCCCceEEEEeccCCCChhhhHHHHHHHHHHH
Q 006317 11 GQTCY-D-TGNF-TTNSTYGKNRDLFLSSLASTVTAN--KGFYTATIGQIPDEVYGLALCRGDSSPESCASCLNFTVLDM 85 (650)
Q Consensus 11 ~~~C~-~-~~~~-~~~s~y~~nl~~ll~~l~~~~~~~--~~f~~~~~g~~~~~vyg~~~C~~D~~~~~C~~Cl~~a~~~~ 85 (650)
|+.|+ | .++| +++++|++||+.||+.|.+.++.. .+|++++.|.++++|||++||++|+++.+|..||+.|+..+
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~ 80 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANI 80 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCH
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHH
Confidence 57898 4 4667 678889999999999999997643 68999999999999999999999999999999999999999
Q ss_pred HhcCCCcccceEecCCCcceEEEecCccc
Q 006317 86 MKNCPNQKEAISWEGMDFPCVVRYSSRSF 114 (650)
Q Consensus 86 ~~~C~~~~~a~~~~~~~~~C~~ry~~~~f 114 (650)
.+.|+++++|+||++ .|+||||+++|
T Consensus 81 ~~~C~~~~g~~v~~~---~C~lRY~~~~F 106 (106)
T PF01657_consen 81 SSCCPGSRGGRVWYD---SCFLRYENYPF 106 (106)
T ss_dssp HHHTTSBSSEEEEES---SEEEEEESS--
T ss_pred HHhCCCCceEEEECC---CEEEEEECCCC
Confidence 999999999999999 99999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-22 Score=207.90 Aligned_cols=257 Identities=20% Similarity=0.253 Sum_probs=189.2
Q ss_pred CCCcCCcccccCceeEEEeeccCC--cceeEeeccccCchhHHHHHHHHHHHhhCCC----Cceeeeccee-ecCCeeEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLSHG--QEIAVKRLSKNSVQGELEFKNEVLLVARLQH----RNLVRLLGFS-FEETERLL 397 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 397 (650)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++.+++... ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999986553 4788888766533322267788888888873 5788888877 47778899
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC-----CCeEEeeeec
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-----MIPKISDFGM 472 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~-----~~~kl~DFGl 472 (650)
||+.+ +.+|.++..... ...++..+.+.|+.|++.+|++||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 679999765432 578999999999999999999999998 9999999999999865 4689999999
Q ss_pred ccccc--cCCCC----C-c-cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccch-hHHHH
Q 006317 473 ARLFE--MDQSQ----G-D-TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAED-LLTYA 543 (650)
Q Consensus 473 a~~~~--~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~-l~~~~ 543 (650)
++.+. ..... . . .....||.+|.+++...+.+.+.+.|+||++.++.|++.|..||.......... .....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98332 22211 1 1 234569999999999999999999999999999999999999985433221111 11111
Q ss_pred HHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 544 WKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 544 ~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
... .... .....+.++..+... +-..+..++|....+...|..
T Consensus 254 ~~~--------~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 254 RKL--------LTDR-FGDLKPEEFAKILEY---IDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred hhh--------cccc-ccCCChHHHHHHHHH---hhccCCcCCCCHHHHHHHHHH
Confidence 110 0110 222234455444443 334788999999999888754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-20 Score=196.58 Aligned_cols=261 Identities=28% Similarity=0.384 Sum_probs=196.0
Q ss_pred CCcCCcccccCceeEEEeeccCCcceeEeeccccCch---hHHHHHHHHHHHhhCCCC-ceeeecceeecCCeeEEEEec
Q 006317 326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHR-NLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~e~ 401 (650)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++..++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566789999999999999876 78899998765433 356799999999999988 799999999777778999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC-CeEEeeeecccccccCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQ 480 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~~~~ 480 (650)
+.++++.+++........+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .+++.|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976653211126889999999999999999999988 99999999999999999 79999999998655433
Q ss_pred CCC----ccceeecCccccChhcccc---CCCCccccccchhHHHHHHHhCCCCCCCCCCc-ccchhHHHHHHhccCCCc
Q 006317 481 SQG----DTSRIVGTFGYMAPEYVTR---GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGE-EAEDLLTYAWKNWNEGTA 552 (650)
Q Consensus 481 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~ 552 (650)
... ......|+..|++||.+.+ ...+...|+||+|++++++++|..|+...... .........+..... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 221 2456789999999999987 57889999999999999999999995433221 111222222221111 00
Q ss_pred ccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 553 LNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 553 ~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.....+.. .......+.+++..|+..+|..|.++.+....
T Consensus 236 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 ASPLSPSN---PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccCccc---cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000 01112345567778899999999999987764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-22 Score=223.72 Aligned_cols=255 Identities=24% Similarity=0.279 Sum_probs=186.2
Q ss_pred CcCCcccccCceeEEEeecc-CCcceeEeecccc--CchhHH----HHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 327 STDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN--SVQGEL----EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 327 ~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~----~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
...+.+|.|.+|.|+..... ....++.|..... ....+. .+..|+.+-..++|||++..+....+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45688999999987776532 2333444433210 111111 2556777788899999999888887777666669
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
|||++ +|..++. ....++..++..++.|+..|+.|||+.+ |.|||||++|++++.+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 9988876 3347889999999999999999999998 999999999999999999999999999877655
Q ss_pred CCC--CccceeecCccccChhccccCCCCc-cccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 480 QSQ--GDTSRIVGTFGYMAPEYVTRGHFSI-KSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 480 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~-~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
.+. ......+|...|+|||.+.+.+|.+ ..||||.|+++..|++|+.||......+... ..... .....+
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~-~~~~~~ 546 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNY-SDQRNI 546 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhhcc-cccccc
Confidence 444 4556688999999999999999875 5899999999999999999997655443321 00000 000000
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
......-....-.+...++.++|+.+|.+|-|+++|++.
T Consensus 547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000000011112345578889999999999999999854
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-21 Score=186.94 Aligned_cols=198 Identities=22% Similarity=0.364 Sum_probs=168.1
Q ss_pred CCCcCCcccccCceeEEEee-ccCCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEEEecC
Q 006317 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
+|.++++||+|.||..+.|+ +-+++.||||.-...+.. -++..|.+..+.| ..++|...+-|-.++....||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 68999999999999999998 557899999986554432 2567788888888 4689999988888888999999998
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC-----CeEEeeeecccccc
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-----IPKISDFGMARLFE 477 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~-----~~kl~DFGla~~~~ 477 (650)
+-||+|+. +. -...++.+++..++.|++.-++|+|++. +|.|||||+|+||...+ .+.|.|||+|+.+.
T Consensus 107 -GPSLEDLF-D~-CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLF-DL-CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHH-HH-hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 66898854 32 4567999999999999999999999998 99999999999996543 58999999999876
Q ss_pred cCCCC-----CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCC
Q 006317 478 MDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF 530 (650)
Q Consensus 478 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~ 530 (650)
...+. .......||.+||+-....+.+.+.+.|+-|+|-+++..+-|..||..
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 55433 235557799999999999999999999999999999999999999963
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-21 Score=168.00 Aligned_cols=102 Identities=35% Similarity=0.675 Sum_probs=76.8
Q ss_pred EEee---ccccCCChHHHHHHHHHHHHHHHHHhccCCCccceeeeeeccCCCcceeEEeecccCCCccchhhHHHHhHhh
Q 006317 125 IAHN---VNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPDISQSDCEFCLRQSMAD 201 (650)
Q Consensus 125 ~~~~---~~~~~~~~~~f~~~~~~l~~~l~~~a~~~~~~~~fa~~~~~~~~~~~vy~laQC~~Dl~~~~C~~CL~~~~~~ 201 (650)
..|+ .++++.+.+.|..++++||+.|+..|+... ..+|+++.. ..+.++||||+||++||++++|+.||..++..
T Consensus 2 ~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~-~~~f~~~~~-~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~ 79 (106)
T PF01657_consen 2 HFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSS-SKGFATGSA-GSGPDTVYGLAQCRGDLSPSDCRACLADAVAN 79 (106)
T ss_dssp --E---SSB----TT-THHHHHHHHHHHHHHHGGGTT--TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCC
T ss_pred CcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhcc-ccCcEEeec-CCCCCeEEEEEEcCCCCChhhhHHHHHHHHHH
Confidence 3455 333422455699999999999999987653 368999986 44678999999999999999999999999999
Q ss_pred hhhccCCCcceEEeCcccccccccCcc
Q 006317 202 VQSCCYGKKGSYIMGPSCIFRWEMYPF 228 (650)
Q Consensus 202 ~~~~c~~~~g~~~~~~~C~lry~~~~f 228 (650)
++.+|+++.||+|++++|+||||.++|
T Consensus 80 ~~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 80 ISSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHHhCCCCceEEEECCCEEEEEECCCC
Confidence 999999999999999999999999987
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-21 Score=180.72 Aligned_cols=200 Identities=21% Similarity=0.309 Sum_probs=167.0
Q ss_pred ccCCCcCCcccccCceeEEEee-ccCCcceeEeeccccCchhHHHHHHHHHHHhhCCC-CceeeecceeecCCeeEEEEe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH-RNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e 400 (650)
.++|...++||.|+||.+|.|. +.+|.+||||.-+...... ++.-|..+...|+| ..|..+..+..++....|||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp--qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP--QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc--chhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3678999999999999999997 5679999999976654333 45678888888876 567778888888889999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC---CCeEEeeeecccccc
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARLFE 477 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGla~~~~ 477 (650)
.+ +-||++...- -...++..+.+-++-|++.-++|+|.++ +|||||||+|+|..-+ ..+.++||||++.+.
T Consensus 92 LL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 88 6689886643 3456889999999999999999999998 9999999999999654 468899999999775
Q ss_pred cCCCC-----CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCC
Q 006317 478 MDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF 530 (650)
Q Consensus 478 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~ 530 (650)
...+. .......||.+|.+-....+.+.+.+.|+-|+|.+|...--|..||..
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQg 223 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQG 223 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccc
Confidence 43322 234456899999999988888889999999999999999999999963
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.3e-21 Score=185.36 Aligned_cols=172 Identities=15% Similarity=0.180 Sum_probs=134.1
Q ss_pred hccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHH---------HHHHHHHHhhCCCCceeeecceeecC
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE---------FKNEVLLVARLQHRNLVRLLGFSFEE 392 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~H~niv~l~g~~~~~ 392 (650)
..++|...++||.|+||.||+... ++..+|||.+.......+.. +.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468899999999999999999765 57789999997553322222 67899999999999999998875532
Q ss_pred --------CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC
Q 006317 393 --------TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI 464 (650)
Q Consensus 393 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~ 464 (650)
...+|||||++|.+|.++.. ++. ....+|+.+|..||+.+ ++|||+||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999988632 222 24568999999999988 99999999999999999
Q ss_pred eEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh
Q 006317 465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523 (650)
Q Consensus 465 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt 523 (650)
++|+|||.......+... ..++....+..++|+|+|||.+.-...
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999999988654321110 113445567789999999999876543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-20 Score=200.28 Aligned_cols=216 Identities=24% Similarity=0.395 Sum_probs=164.0
Q ss_pred HhhCCCCceeeecceeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCC
Q 006317 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLK 453 (650)
Q Consensus 374 l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 453 (650)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....++|.-...++++|++||+|||... --+|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3578999999999999999999999999999999999985 4667999999999999999999999864 23999999
Q ss_pred CCceEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccC-------CCCccccccchhHHHHHHHhCCC
Q 006317 454 ASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-------HFSIKSDVFSFGVLVLEIISGQK 526 (650)
Q Consensus 454 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~sDV~S~Gvll~elltG~~ 526 (650)
++|+++|..+.+||+|||+..+..............-..-|.|||.+... ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998876431111112222234579999998763 14678999999999999999999
Q ss_pred CCCCCCCcc-cchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 527 NNSFRIGEE-AEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 527 p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
||....... ..+++.+..+ .....+.|.+.... +....++.++..||..+|++||++++|-..++..
T Consensus 157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 997533222 2333333332 11122233332211 1122567788899999999999999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=180.97 Aligned_cols=139 Identities=17% Similarity=0.182 Sum_probs=108.9
Q ss_pred CCcccccCceeEEEeeccCCcceeEeeccccCch--h------------------------HHHHHHHHHHHhhCCCCce
Q 006317 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ--G------------------------ELEFKNEVLLVARLQHRNL 382 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~------------------------~~~~~~E~~~l~~l~H~ni 382 (650)
...||+|+||.||+|...+|+.||||+++..... . .....+|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999754211 1 0122459999999988877
Q ss_pred eeecceeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHh-hhcCCCcEEecCCCCCceEeCC
Q 006317 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL-HEDSRLRIIHRDLKASNILLDA 461 (650)
Q Consensus 383 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiHrDlk~~NILl~~ 461 (650)
.....+.. ...+|||||++++++...+. ....+++.....++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333222 23489999999987765432 235689999999999999999999 6776 99999999999998
Q ss_pred CCCeEEeeeeccccc
Q 006317 462 DMIPKISDFGMARLF 476 (650)
Q Consensus 462 ~~~~kl~DFGla~~~ 476 (650)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=174.93 Aligned_cols=140 Identities=22% Similarity=0.276 Sum_probs=111.3
Q ss_pred CCcccccCceeEEEeeccCCcceeEeeccccCch--h------------------------HHHHHHHHHHHhhCCCCce
Q 006317 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ--G------------------------ELEFKNEVLLVARLQHRNL 382 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~------------------------~~~~~~E~~~l~~l~H~ni 382 (650)
...||+|++|.||+|+..+|+.||||+++..... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4789999999999999878999999998764211 0 1124678999999999987
Q ss_pred eeecceeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEecCCCCCceEeCC
Q 006317 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDA 461 (650)
Q Consensus 383 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlk~~NILl~~ 461 (650)
.....+... ..+|||||++++++..... ....++......++.+++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544443332 3489999999886543322 23467888999999999999999999 76 99999999999999
Q ss_pred CCCeEEeeeecccccc
Q 006317 462 DMIPKISDFGMARLFE 477 (650)
Q Consensus 462 ~~~~kl~DFGla~~~~ 477 (650)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-20 Score=209.34 Aligned_cols=249 Identities=18% Similarity=0.217 Sum_probs=180.7
Q ss_pred CCCcCCcccccCceeEEEeeccCCcceeEeeccccC-chhHHHHH---HHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS-VQGELEFK---NEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~---~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
++...+.||.+.|=+|.+++.++|. |+||++-+.. .-....|. .|++ ...++|||.+++..+-..+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5677899999999999999998887 9999986543 22333344 3444 556699999999888777788899999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc-C
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM-D 479 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~-~ 479 (650)
|..+ +|.|.|. .+.-+...+...|+.|++.||..+|..+ |+|||||.+||||+.-..+.|+||.-.+.... .
T Consensus 102 yvkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 9876 7777775 4556788889999999999999999988 99999999999999999999999987764321 2
Q ss_pred CCCCccceeec----CccccChhccccC----------C-CCccccccchhHHHHHHHhC-CCCCCCCCCcccchhHHHH
Q 006317 480 QSQGDTSRIVG----TFGYMAPEYVTRG----------H-FSIKSDVFSFGVLVLEIISG-QKNNSFRIGEEAEDLLTYA 543 (650)
Q Consensus 480 ~~~~~~~~~~g----t~~y~aPE~~~~~----------~-~s~~sDV~S~Gvll~elltG-~~p~~~~~~~~~~~l~~~~ 543 (650)
+.......+.- -..|+|||.+... . .+++-||||+||++.||++- +++|.. ..++.|.
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr 248 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYR 248 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHh
Confidence 22223322222 2469999977431 1 57789999999999999995 555541 2233332
Q ss_pred HHh-ccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 544 WKN-WNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 544 ~~~-~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
... ...+..++.| . ...+.++++.|++.||++|-++++.|+.-.+
T Consensus 249 ~~~~~~~e~~Le~I----e------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 249 SGNADDPEQLLEKI----E------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred ccCccCHHHHHHhC----c------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 210 0011111111 0 1145578889999999999999999987443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.2e-20 Score=194.63 Aligned_cols=185 Identities=28% Similarity=0.362 Sum_probs=154.8
Q ss_pred cccccCceeEEEeec----cCCcceeEeeccccCchh--HHHHHHHHHHHhhCC-CCceeeecceeecCCeeEEEEecCC
Q 006317 331 KLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 331 ~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
.+|+|.||.|++.+. ..|..+|+|.+++..... ......|..++...+ ||.+|++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998752 347778999887653321 114556777888886 9999999999999999999999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
+|.|...+. +...++..........++-+++++|+.+ ++|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 999887775 4456777888888889999999999887 99999999999999999999999999986542221
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~ 529 (650)
.+||..|||||++. ......|.||||++++||+||..|+.
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~ 192 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFG 192 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence 28999999999998 55788999999999999999999886
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=165.52 Aligned_cols=186 Identities=19% Similarity=0.150 Sum_probs=138.9
Q ss_pred CCcCCcccccCceeEEEeeccCCcceeEeeccccCchhH----HHHHHHHHHHhhCC-CCceeeecceeecCCeeEEEEe
Q 006317 326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGE----LEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~----~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e 400 (650)
+.....|++|+||+||.+.- .+.+++.+.+........ ..+.+|+++|++|. |+++++++++ +..+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34568899999999997765 678888888876544222 24789999999995 5789998886 45699999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCC-CCCceEeCCCCCeEEeeeecccccccC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDL-KASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl-k~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
|+.+.+|...+.. ....++.|++.+|+++|+.+ |+|||| ||.|||++.++.++|+|||++......
T Consensus 79 yI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 79 YLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred eecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 9999998654311 11357789999999999998 999999 799999999999999999999854432
Q ss_pred CCC------Cc-----cceeecCccccChhccccC-CCC-ccccccchhHHHHHHHhCCCCCC
Q 006317 480 QSQ------GD-----TSRIVGTFGYMAPEYVTRG-HFS-IKSDVFSFGVLVLEIISGQKNNS 529 (650)
Q Consensus 480 ~~~------~~-----~~~~~gt~~y~aPE~~~~~-~~s-~~sDV~S~Gvll~elltG~~p~~ 529 (650)
... .. ......++.|++|+...-- ..+ ...++++-|.-+|.++|++.+..
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 210 00 1112356777777754322 333 56788999999999999987754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.1e-18 Score=166.13 Aligned_cols=137 Identities=20% Similarity=0.322 Sum_probs=106.8
Q ss_pred CCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhC-----CCCceeeecceeecCC---e-eE
Q 006317 326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-----QHRNLVRLLGFSFEET---E-RL 396 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~ 396 (650)
+...++||+|+||.||. .++....+||++..........+.+|+.+++++ .||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34568999999999996 433333479988765444556799999999999 5799999999998764 3 33
Q ss_pred EEEec--CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHH-HHhhhcCCCcEEecCCCCCceEeCC----CCCeEEee
Q 006317 397 LIYEF--VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI-LYLHEDSRLRIIHRDLKASNILLDA----DMIPKISD 469 (650)
Q Consensus 397 lv~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~iiHrDlk~~NILl~~----~~~~kl~D 469 (650)
+|+|| +++++|.+++.+ ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 668999999963 235555 35677888777 9999988 999999999999974 34799999
Q ss_pred eecc
Q 006317 470 FGMA 473 (650)
Q Consensus 470 FGla 473 (650)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5444
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.3e-18 Score=171.29 Aligned_cols=233 Identities=18% Similarity=0.245 Sum_probs=144.4
Q ss_pred CCCcCCcccccCceeEEEeeccC-CcceeEeeccccC---chhHHHHHHHHHHHhhCCC----------Cceeeeccee-
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNS---VQGELEFKNEVLLVARLQH----------RNLVRLLGFS- 389 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H----------~niv~l~g~~- 389 (650)
.+...+.||.|+++.||.++... |+++|||++.... ....+++++|......+.+ -.++..++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 34556899999999999999754 8999999885443 2234467777665555433 1222212211
Q ss_pred --------ecC---C-----eeEEEEecCCCCChhHHHHhhhcc----CCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEe
Q 006317 390 --------FEE---T-----ERLLIYEFVPNSSVDKFIFDAIKR----VQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449 (650)
Q Consensus 390 --------~~~---~-----~~~lv~e~~~~gsL~~~l~~~~~~----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 449 (650)
... . ..+++|+-+ .++|.+++.-.... ..+....++.+..|+++.+++||+.+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 1 235778877 55888876432111 22445667788899999999999998 999
Q ss_pred cCCCCCceEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccC--------CCCccccccchhHHHHHH
Q 006317 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG--------HFSIKSDVFSFGVLVLEI 521 (650)
Q Consensus 450 rDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~s~~sDV~S~Gvll~el 521 (650)
+||||+|++++.+|.++|+||+.......... ....+..|.+||..... .++.+.|.|++|+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999988764332111 02345679999976442 478899999999999999
Q ss_pred HhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCC
Q 006317 522 ISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANR 586 (650)
Q Consensus 522 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~R 586 (650)
++|..|+.....+...+. .+ ......++.+. .|+..+|+.||++|
T Consensus 244 WC~~lPf~~~~~~~~~~~---------------~f--~~C~~~Pe~v~---~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW---------------DF--SRCRDMPEPVQ---FLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG---------------GG--TTSS---HHHH---HHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc---------------cc--hhcCCcCHHHH---HHHHHHccCCcccC
Confidence 999999875433322111 01 11112333333 46668999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-17 Score=165.96 Aligned_cols=198 Identities=24% Similarity=0.291 Sum_probs=135.8
Q ss_pred CCCceeeecceeecC---------------------------CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHH
Q 006317 378 QHRNLVRLLGFSFEE---------------------------TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG 430 (650)
Q Consensus 378 ~H~niv~l~g~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 430 (650)
+|||||+++++|.++ ...|+||.-.+. +|.++|.. ...+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHH
Confidence 699999999876542 356899988765 88888863 3456667777899
Q ss_pred HHHHHHHHhhhcCCCcEEecCCCCCceEe--CCCC--CeEEeeeecccccccCCCC----CccceeecCccccChhcccc
Q 006317 431 GIARGILYLHEDSRLRIIHRDLKASNILL--DADM--IPKISDFGMARLFEMDQSQ----GDTSRIVGTFGYMAPEYVTR 502 (650)
Q Consensus 431 ~ia~~L~yLH~~~~~~iiHrDlk~~NILl--~~~~--~~kl~DFGla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~ 502 (650)
|+++|+.|||.++ |.|||||++|||| |+|+ ...|+|||++-..+...-+ ...-..-|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 9999999999999 4444 4789999998543321111 11112346667899998764
Q ss_pred CC--C----CccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHh
Q 006317 503 GH--F----SIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGL 576 (650)
Q Consensus 503 ~~--~----s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~ 576 (650)
.+ . -.|+|.|+.|-+.||+++...||.. .++...+...|... --|.+.+..+..+. +++.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~-rGem~L~~r~Yqe~----------qLPalp~~vpp~~r---qlV~ 491 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK-RGEMLLDTRTYQES----------QLPALPSRVPPVAR---QLVF 491 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccc-cchheechhhhhhh----------hCCCCcccCChHHH---HHHH
Confidence 22 1 3689999999999999999988853 23322222222111 11333333333333 5566
Q ss_pred cccccCCCCCCCHHHHHHHhc
Q 006317 577 LCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 577 ~Cl~~~p~~RPt~~evl~~L~ 597 (650)
.-|+.||++||+..-....|+
T Consensus 492 ~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHhcCCccccCCccHHHhHHH
Confidence 789999999999766555543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-18 Score=197.24 Aligned_cols=196 Identities=19% Similarity=0.239 Sum_probs=158.5
Q ss_pred hccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCC---CCceeeecceeecCCeeEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ---HRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv 398 (650)
....|.+.+.||+|+||+||+|...+|+.||+|+-+...... |.==.+++.+|+ -+-|..+...+...+.-+||
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 345788889999999999999998889999999977654331 111123344444 23455555556667788999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC-------CCCeEEeeee
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-------DMIPKISDFG 471 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~-------~~~~kl~DFG 471 (650)
+||.+.|+|.+++. ..+.++|.....++.|+++.++.||..+ |||+||||+|+||.. +.-++|+|||
T Consensus 773 ~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecc
Confidence 99999999999986 5677999999999999999999999988 999999999999942 3458999999
Q ss_pred cccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCC
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK 526 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~ 526 (650)
.+--+..-.........++|-.+-.+|...+..++...|.|.+.-+++-|+-|+.
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9864443333445667788999999999999999999999999999999999974
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.2e-19 Score=183.69 Aligned_cols=124 Identities=26% Similarity=0.459 Sum_probs=109.4
Q ss_pred eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecc
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 473 (650)
..++.|++|...+|.+||.........++...+.++.|++.+++| ++ .+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999866566778999999999999999999 54 999999999999999999999999998
Q ss_pred cccccCC----CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh
Q 006317 474 RLFEMDQ----SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523 (650)
Q Consensus 474 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt 523 (650)
....... ........+||..||+||.+.+..|+.|+|||+||++|+||++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7554333 1224556789999999999999999999999999999999998
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.4e-17 Score=160.61 Aligned_cols=134 Identities=19% Similarity=0.308 Sum_probs=113.7
Q ss_pred CcccccCceeEEEeeccCCcceeEeeccccCch--------hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ--------GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+.||+|++|.||+|+. .|..+++|+....... ....+.+|+.++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 6799999999999987 6788999986543221 123577899999999999988877777778888999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988531 12 88899999999999999987 99999999999999 78999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.2e-17 Score=162.90 Aligned_cols=142 Identities=20% Similarity=0.262 Sum_probs=110.8
Q ss_pred CCCcCCcccccCceeEEEee--ccCCcceeEeeccccCch------------------------hHHHHHHHHHHHhhCC
Q 006317 325 NFSTDNKLGQGGFGAVYKGR--LSHGQEIAVKRLSKNSVQ------------------------GELEFKNEVLLVARLQ 378 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 378 (650)
.|.+.+.||+|+||.||+|. ..+|+.||||++...... ....+.+|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 568999999998753210 0123568999999997
Q ss_pred CCc--eeeecceeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCc
Q 006317 379 HRN--LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 456 (650)
Q Consensus 379 H~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~N 456 (650)
+.+ +.+++++ ...++||||+++++|..++. ....+.......++.||+.+|++||+.+ .++||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 633 3334432 23589999999988876543 2334566677899999999999999875 49999999999
Q ss_pred eEeCCCCCeEEeeeeccccc
Q 006317 457 ILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 457 ILl~~~~~~kl~DFGla~~~ 476 (650)
|+++ ++.++|+|||++...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE-CCCEEEEEChhhhcc
Confidence 9999 889999999998643
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.4e-17 Score=180.66 Aligned_cols=140 Identities=16% Similarity=0.305 Sum_probs=113.2
Q ss_pred HhhccCCCcCCcccccCceeEEEeeccCCcceeEeec-ccc-Cc------hhHHHHHHHHHHHhhCCCCceeeecceeec
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRL-SKN-SV------QGELEFKNEVLLVARLQHRNLVRLLGFSFE 391 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l-~~~-~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 391 (650)
......|...++||+|+||.||+|.+... .+++|+. .+. .. .....+.+|++++.+++|++++....++..
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 33445567789999999999999987543 4444432 221 11 112457899999999999999988888877
Q ss_pred CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeee
Q 006317 392 ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471 (650)
Q Consensus 392 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 471 (650)
....++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCc
Confidence 778899999999999998874 34678999999999999987 9999999999999 67899999999
Q ss_pred cccc
Q 006317 472 MARL 475 (650)
Q Consensus 472 la~~ 475 (650)
+++.
T Consensus 473 la~~ 476 (535)
T PRK09605 473 LGKY 476 (535)
T ss_pred cccc
Confidence 9974
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.4e-17 Score=156.72 Aligned_cols=130 Identities=21% Similarity=0.385 Sum_probs=107.0
Q ss_pred cccccCceeEEEeeccCCcceeEeeccccCch--------hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ--------GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 331 ~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
.||+|+||.||+|.+ +|..+++|........ ....+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 6788999986543211 1245778999999999988766655666677789999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.+++.|||+++.
T Consensus 80 ~g~~l~~~~~~~~---~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN---D-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH---H-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875311 0 78999999999999987 99999999999999 88999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.1e-17 Score=156.32 Aligned_cols=138 Identities=20% Similarity=0.224 Sum_probs=108.8
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCc----------------------hhHHHHHHHHHHHhhCCCCc
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV----------------------QGELEFKNEVLLVARLQHRN 381 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~l~H~n 381 (650)
..|...+.||+|+||.||++...+|+.||||++..... .....+..|..++..+.|++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 34777899999999999999988899999998754320 01123567888999888874
Q ss_pred --eeeecceeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe
Q 006317 382 --LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 459 (650)
Q Consensus 382 --iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl 459 (650)
+.+.++ ....++||||+++++|..+.. ......++.+|+.++.++|+.+ ++||||||+||++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill 158 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILV 158 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEE
Confidence 334333 245689999999999876532 0345678899999999999987 9999999999999
Q ss_pred CCCCCeEEeeeecccccc
Q 006317 460 DADMIPKISDFGMARLFE 477 (650)
Q Consensus 460 ~~~~~~kl~DFGla~~~~ 477 (650)
++++.++|+|||++..+.
T Consensus 159 ~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCcEEEEECCccccCC
Confidence 999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=4e-15 Score=136.92 Aligned_cols=135 Identities=21% Similarity=0.232 Sum_probs=114.7
Q ss_pred cCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCC--CceeeecceeecCCeeEEEEecCCCC
Q 006317 328 TDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH--RNLVRLLGFSFEETERLLIYEFVPNS 405 (650)
Q Consensus 328 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~g 405 (650)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++.+++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999854 7899999866543 4578899999999976 58899988888888899999999988
Q ss_pred ChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 406 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
.+..+ +......++.+++++|++||.....+++|+||+|.||++++.+.+++.|||+++.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 76543 5566778899999999999987555699999999999999999999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.1e-16 Score=170.77 Aligned_cols=210 Identities=22% Similarity=0.293 Sum_probs=136.4
Q ss_pred ccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
..+|+.+++|..|+||.||..+++. .+.+|+|+ .++..- .+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li-----lRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI-----LRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccchh-----hhc--cccccCCccee------------------
Confidence 4678899999999999999998764 66788844 332110 000 12222233333
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
|+=...+.. -+.++. +++.+++|||+.+ |+|||+||.|.||+.-|++|++|||+++..-....
T Consensus 136 ---gDc~tllk~---~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKN---IGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhccc---CCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 222222221 122222 2378899999887 99999999999999999999999999875321110
Q ss_pred -------------CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhcc
Q 006317 482 -------------QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWN 548 (650)
Q Consensus 482 -------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 548 (650)
+-....++||+.|+|||++....|...+|+|++|+|+||.+-|..||..+ ...+++..+....
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd---tpeelfg~visd~- 274 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD---TPEELFGQVISDD- 274 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC---CHHHHHhhhhhhh-
Confidence 01133468999999999999999999999999999999999999998643 2233333322110
Q ss_pred CCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCC
Q 006317 549 EGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPT 588 (650)
Q Consensus 549 ~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt 588 (650)
..+.|- |. ..+.|... ++.+.|+.+|.+|--
T Consensus 275 -i~wpE~-de----a~p~Ea~d---li~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 275 -IEWPEE-DE----ALPPEAQD---LIEQLLRQNPLCRLG 305 (1205)
T ss_pred -cccccc-Cc----CCCHHHHH---HHHHHHHhChHhhcc
Confidence 011111 11 13344443 444678899999953
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.2e-15 Score=142.80 Aligned_cols=136 Identities=22% Similarity=0.262 Sum_probs=96.9
Q ss_pred CCcccccCceeEEEeeccCCcceeEeeccccCchh--HHH----------------------HHHHHHHHhhCCCCc--e
Q 006317 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG--ELE----------------------FKNEVLLVARLQHRN--L 382 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~--~~~----------------------~~~E~~~l~~l~H~n--i 382 (650)
.+.||+|+||.||++...+|+.||||++....... ... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 47899999999999998889999999986542211 111 134555555554332 3
Q ss_pred eeecceeecCCeeEEEEecCCCCChhHH-HHhhhccCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEecCCCCCceEeC
Q 006317 383 VRLLGFSFEETERLLIYEFVPNSSVDKF-IFDAIKRVQLDWETRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLD 460 (650)
Q Consensus 383 v~l~g~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlk~~NILl~ 460 (650)
.+.+++ ...++||||++++.+... +.+. . .. .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-h---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence 333332 346899999999554321 1111 0 11 6678899999999999998 65 99999999999999
Q ss_pred CCCCeEEeeeecccccc
Q 006317 461 ADMIPKISDFGMARLFE 477 (650)
Q Consensus 461 ~~~~~kl~DFGla~~~~ 477 (650)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999996443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.6e-14 Score=143.97 Aligned_cols=135 Identities=21% Similarity=0.263 Sum_probs=104.7
Q ss_pred CCccc-ccCceeEEEeeccCCcceeEeeccccCc-------------hhHHHHHHHHHHHhhCCCCce--eeecceeecC
Q 006317 329 DNKLG-QGGFGAVYKGRLSHGQEIAVKRLSKNSV-------------QGELEFKNEVLLVARLQHRNL--VRLLGFSFEE 392 (650)
Q Consensus 329 ~~~LG-~G~~g~Vy~~~~~~g~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~ 392 (650)
...|| .||.|+||+.... +..++||++..... .....+.+|+.++.+++|++| ++.+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999998874 77899998754211 122357889999999998885 6677664432
Q ss_pred C----eeEEEEecCCC-CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEE
Q 006317 393 T----ERLLIYEFVPN-SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467 (650)
Q Consensus 393 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 467 (650)
. ..++|||++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+||||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 689888753 334443 3568999999999998 999999999999999999999
Q ss_pred eeeecccc
Q 006317 468 SDFGMARL 475 (650)
Q Consensus 468 ~DFGla~~ 475 (650)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=5.7e-16 Score=172.60 Aligned_cols=256 Identities=21% Similarity=0.311 Sum_probs=186.0
Q ss_pred ccCCCcCCcccccCceeEEEeeccCC--cceeEeeccccC--chhHHHHHHHHHHHhhCC-CCceeeecceeecCCeeEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHG--QEIAVKRLSKNS--VQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g--~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 397 (650)
...|...+.||+|.|+.|-....... ..+|+|.+.... .........|..+-..+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 34577778899999999988775433 346777665543 222233445777777776 9999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhh-hcCCCcEEecCCCCCceEeCCCC-CeEEeeeecccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH-EDSRLRIIHRDLKASNILLDADM-IPKISDFGMARL 475 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~ 475 (650)
+.+|..++++.+.+... .....+.......+.|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||++..
T Consensus 99 ~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999999988877311 2224666777788999999999999 666 99999999999999999 999999999987
Q ss_pred ccc-CCCCCccceeec-CccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCc
Q 006317 476 FEM-DQSQGDTSRIVG-TFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA 552 (650)
Q Consensus 476 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 552 (650)
+.. ...........| ++.|+|||...+. ......|+||.|+++.-+++|..|+......... .. .|.+...
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~-----~~~~~~~ 248 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YS-----SWKSNKG 248 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ce-----eeccccc
Confidence 765 444444555678 9999999999884 4568899999999999999999999866544311 11 1111110
Q ss_pred ccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHH
Q 006317 553 LNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVV 593 (650)
Q Consensus 553 ~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl 593 (650)
. .....-.... .....+...++..+|..|.+.+++-
T Consensus 249 ~--~~~~~~~~~~---~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 249 R--FTQLPWNSIS---DQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred c--cccCccccCC---hhhhhcccccccCCchhcccccccc
Confidence 0 0000001111 1233455578889999999998875
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.1e-13 Score=136.00 Aligned_cols=202 Identities=22% Similarity=0.293 Sum_probs=139.7
Q ss_pred HHHHhhCCCCceeeecceeecC-----CeeEEEEecCCCCChhHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 006317 371 VLLVARLQHRNLVRLLGFSFEE-----TERLLIYEFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGGIARGILYLHEDSR 444 (650)
Q Consensus 371 ~~~l~~l~H~niv~l~g~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 444 (650)
..-+-++.|-|||++..|+.+. ....++.|||..|+|..||+...+ ...+......+|+-||..||.|||+- .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 3445667899999999998654 356899999999999999987543 45688888899999999999999987 4
Q ss_pred CcEEecCCCCCceEeCCCCCeEEeeeecccccccC---CCCCccceeecCccccChhccccCCCCccccccchhHHHHHH
Q 006317 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMD---QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEI 521 (650)
Q Consensus 445 ~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~el 521 (650)
|+|+|+++..+-|++..++-+||+--- ....... ..........+.++|.+||+-.....+..+|||+||...+||
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 789999999999999999999985311 1111000 001112234567899999987777788899999999999999
Q ss_pred HhCCCCCCC-CCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHH
Q 006317 522 ISGQKNNSF-RIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVV 593 (650)
Q Consensus 522 ltG~~p~~~-~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl 593 (650)
.-+..-... ........... ..+ ..+.+. +. ...+..|++..|..||+|.+++
T Consensus 276 ailEiq~tnseS~~~~ee~ia------------~~i-~~len~----lq--r~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIA------------NVI-IGLENG----LQ--RGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HHheeccCCCcceeehhhhhh------------hhe-eeccCc----cc--cCcCcccccCCCCCCcchhhhh
Confidence 888542111 00000000000 000 011111 00 1234479999999999999987
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=4e-13 Score=145.35 Aligned_cols=144 Identities=24% Similarity=0.333 Sum_probs=102.3
Q ss_pred CCCcCCcccccCceeEEEeeccCCcceeEeeccccCchh----------------------------------------H
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG----------------------------------------E 364 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~----------------------------------------~ 364 (650)
.|+ .+.||.|++|.||+|++++|+.||||+.+...... +
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 36899999999999999999999999986542110 0
Q ss_pred HHHHHHHHHHhhC----CCCceeeecceee-cCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHH-HHHH
Q 006317 365 LEFKNEVLLVARL----QHRNLVRLLGFSF-EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR-GILY 438 (650)
Q Consensus 365 ~~~~~E~~~l~~l----~H~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~y 438 (650)
.+|.+|...+.++ +|.+-+.+-.++. .....+|||||+++++|.+++... .... .+.+++..++. .+..
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~--~~~~---~~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD--EAGL---DRKALAENLARSFLNQ 272 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH--hcCC---CHHHHHHHHHHHHHHH
Confidence 1244555555554 2333344444433 345679999999999999876531 1122 23456666665 4678
Q ss_pred hhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 439 LH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
+|..+ ++|+|+||.||++++++++++.|||++..+.
T Consensus 273 l~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 273 VLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 88877 9999999999999999999999999987553
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=6.3e-12 Score=118.58 Aligned_cols=130 Identities=22% Similarity=0.167 Sum_probs=97.0
Q ss_pred CCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceee-ecceeecCCeeEEEEecCCCCCh
Q 006317 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR-LLGFSFEETERLLIYEFVPNSSV 407 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lv~e~~~~gsL 407 (650)
.+.|+.|.++.||+++.. +..+++|....... ....+..|+..+..+.+.++++ ++.+ .....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence 467899999999999874 77899999765432 2234678999999887655543 4433 33346899999999887
Q ss_pred hHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcC--CCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.... .....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.+++.|||.+.
T Consensus 79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6420 011245678999999999876 23469999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.4e-12 Score=134.77 Aligned_cols=250 Identities=22% Similarity=0.281 Sum_probs=177.5
Q ss_pred cCCCcCCcccc--cCceeEEEeec---cCCcceeEeeccccCc--hhHHHHHHHHHHHhhC-CCCceeeecceeecCCee
Q 006317 324 NNFSTDNKLGQ--GGFGAVYKGRL---SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETER 395 (650)
Q Consensus 324 ~~f~~~~~LG~--G~~g~Vy~~~~---~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 395 (650)
..|.....+|. |.+|.||.+.. .++..+|+|+-+.... .....=.+|+...+++ .|+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45667788999 99999999986 3577899998433222 2222335677777777 599999999999999999
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHH----HHHHhhhcCCCcEEecCCCCCceEeCCC-CCeEEeee
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR----GILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDF 470 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DF 470 (650)
++-+|++. .+|..+.+. ....++....+....+... ||.++|+.. ++|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999986 678877764 2333667777788888888 999999987 9999999999999999 88999999
Q ss_pred ecccccccCCCCCc---cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhc
Q 006317 471 GMARLFEMDQSQGD---TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNW 547 (650)
Q Consensus 471 Gla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 547 (650)
|+...+....-... .....|...|++||.+. +-++..+|+|++|.+++|..+|.......... .|...
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~~~ 338 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWSQL 338 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC--------Ccccc
Confidence 99987764432221 12235777899999764 56789999999999999999997655432100 11111
Q ss_pred cCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 548 NEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 548 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+.. . +...+.... ..++..+..++++.+|..|++...+...
T Consensus 339 r~~---~-ip~e~~~~~---s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 339 RQG---Y-IPLEFCEGG---SSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ccc---c-CchhhhcCc---chhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 111 0 101111111 1222236678999999999998887643
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=6e-12 Score=137.77 Aligned_cols=142 Identities=19% Similarity=0.275 Sum_probs=94.9
Q ss_pred ccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchh----------------------------------H---
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQG----------------------------------E--- 364 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~----------------------------------~--- 364 (650)
...|+. +.||.|++|.||++++++ |++||||++++...+. .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 789999999999999987 9999999997542110 0
Q ss_pred ---HHHHHHHHHHhhC----CCCceeeecceeec-CCeeEEEEecCCCCChhHHHHhhhccCCCC-----HHHHHHHHHH
Q 006317 365 ---LEFKNEVLLVARL----QHRNLVRLLGFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLD-----WETRYKIIGG 431 (650)
Q Consensus 365 ---~~~~~E~~~l~~l----~H~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~-----~~~~~~i~~~ 431 (650)
.++.+|...+.++ .+.+.+.+-.++.+ ....+|||||++|+.+.++..- .....+ ......++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l--~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL--RAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH--HhcCCCHHHHHHHHHHHHHHH
Confidence 1233444444443 24444444444433 4567899999999999875321 111222 2222233333
Q ss_pred HHHHHHHhhhcCCCcEEecCCCCCceEeCCCC----CeEEeeeecccccc
Q 006317 432 IARGILYLHEDSRLRIIHRDLKASNILLDADM----IPKISDFGMARLFE 477 (650)
Q Consensus 432 ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFGla~~~~ 477 (650)
++..+ ++|+|+||.||+++.++ ++++.|||+...+.
T Consensus 276 -------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 -------VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 33455 99999999999999988 99999999997664
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.3e-10 Score=125.32 Aligned_cols=166 Identities=16% Similarity=0.208 Sum_probs=125.5
Q ss_pred ccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHH
Q 006317 345 LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWET 424 (650)
Q Consensus 345 ~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~ 424 (650)
..++.+|.|+..+...........+-++.|+.++||||++++..+..++..|||+|-+. .|..++.+ +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 34678888888876655334456778899999999999999999999999999999985 45666653 33566
Q ss_pred HHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCC
Q 006317 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504 (650)
Q Consensus 425 ~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 504 (650)
....+.||+.||.|||+.+ .++|++|.-..|+|+..|..||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 6777899999999999776 599999999999999999999999998764332111 111111122466666543222
Q ss_pred CCccccccchhHHHHHHHhC
Q 006317 505 FSIKSDVFSFGVLVLEIISG 524 (650)
Q Consensus 505 ~s~~sDV~S~Gvll~elltG 524 (650)
-..|.|-||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 456999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.5e-10 Score=107.21 Aligned_cols=136 Identities=17% Similarity=0.154 Sum_probs=97.3
Q ss_pred CCcccccCceeEEEeeccC-------CcceeEeeccccC--ch--------------------hHHH----HHHHHHHHh
Q 006317 329 DNKLGQGGFGAVYKGRLSH-------GQEIAVKRLSKNS--VQ--------------------GELE----FKNEVLLVA 375 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~-------g~~vavK~l~~~~--~~--------------------~~~~----~~~E~~~l~ 375 (650)
...||.|.-+.||.|...+ +..+|||+.+... .+ .... ..+|+..|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998543 4789999865321 00 0112 237888888
Q ss_pred hCCC--CceeeecceeecCCeeEEEEecCCCCChhH-HHHhhhccCCCCHHHHHHHHHHHHHHHHHh-hhcCCCcEEecC
Q 006317 376 RLQH--RNLVRLLGFSFEETERLLIYEFVPNSSVDK-FIFDAIKRVQLDWETRYKIIGGIARGILYL-HEDSRLRIIHRD 451 (650)
Q Consensus 376 ~l~H--~niv~l~g~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiHrD 451 (650)
++.. -++.+.+.+ ...+|||||+.+..+.. .| +...++..+...+..+++.+|..| |..+ ++|+|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 8853 355555543 56789999998754322 12 222355566778889999999999 7766 99999
Q ss_pred CCCCceEeCCCCCeEEeeeeccccc
Q 006317 452 LKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 452 lk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
|++.|||++ ++.+.|+|||.+...
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999997 468999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.6e-10 Score=110.59 Aligned_cols=141 Identities=17% Similarity=0.280 Sum_probs=108.2
Q ss_pred CcccccCceeEEEeeccCCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCC--ceeeecceeecC---CeeEEEEecCC
Q 006317 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHR--NLVRLLGFSFEE---TERLLIYEFVP 403 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lv~e~~~ 403 (650)
+.|+.|..+.||++...+|..+++|....... .....+..|..++..+++. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 67899999999999887778999999765432 1344688999999999763 456677666553 25689999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------------
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS---------------------------------------- 443 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------- 443 (650)
+.++.+.+. ...++..++..++.++++.|..||+..
T Consensus 84 G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 998876542 134677777788888888888888521
Q ss_pred -------------CCcEEecCCCCCceEeCC--CCCeEEeeeeccc
Q 006317 444 -------------RLRIIHRDLKASNILLDA--DMIPKISDFGMAR 474 (650)
Q Consensus 444 -------------~~~iiHrDlk~~NILl~~--~~~~kl~DFGla~ 474 (650)
...++|+|+++.||++++ ++.+.|.||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 245899999999999998 6678999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.4e-11 Score=125.74 Aligned_cols=248 Identities=21% Similarity=0.222 Sum_probs=172.2
Q ss_pred hhccCCCcCCcccccCceeEEEeecc--CCcceeEeeccccCchhHHH--HHHHHHHHhhC-CCCceeeecceeecCCee
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRLS--HGQEIAVKRLSKNSVQGELE--FKNEVLLVARL-QHRNLVRLLGFSFEETER 395 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 395 (650)
....+|..+..||.|.|+.|++...+ ++..+++|.+.+.......+ -..|+.+...+ .|.++++....+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567889999999999999987643 57789999987764332222 23466666555 589999988888877788
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC-CCeEEeeeeccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMAR 474 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGla~ 474 (650)
++--||+.++++...+. -...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||+..
T Consensus 342 ~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 89999999999887663 3445788889999999999999999876 9999999999999987 788999999986
Q ss_pred ccccCCCCCccceeecCcccc--ChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCc
Q 006317 475 LFEMDQSQGDTSRIVGTFGYM--APEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA 552 (650)
Q Consensus 475 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 552 (650)
.+... .......-+++ +|+......+-.+.|++|||.-+.|.++|..-.+... . |.....+
T Consensus 416 ~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-----~-----~~~i~~~-- 478 (524)
T KOG0601|consen 416 RLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-----Q-----SLTIRSG-- 478 (524)
T ss_pred cccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc-----c-----ceeeecc--
Confidence 42211 11112233444 5555556677899999999999999999964322100 0 0000000
Q ss_pred ccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 553 LNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 553 ~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.-+.+.... .+.+.+.+ .+..+++..||.+.++..+...
T Consensus 479 ---~~p~~~~~~-~~~q~~~k---v~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 479 ---DTPNLPGLK-LQLQVLLK---VMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ---cccCCCchH-Hhhhhhhh---hhcCCccccchhhhhhcccchh
Confidence 111111112 33333333 4778999999999888765543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.7e-09 Score=99.61 Aligned_cols=131 Identities=20% Similarity=0.334 Sum_probs=100.9
Q ss_pred CcccccCceeEEEeeccCCcceeEeeccccCc--h------hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV--Q------GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
..+++|+-..+|.+.+. |.++++|.=.+... . ......+|..++.+++--.|..-+-+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999774 44566664322211 1 112366899999998776666666677788888999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
+++..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888642 2556777778888899988 99999999999998876 89999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.7e-09 Score=96.92 Aligned_cols=143 Identities=27% Similarity=0.344 Sum_probs=106.4
Q ss_pred cCCcccccCceeEEEeeccCCcceeEee-ccccCc-------hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 328 TDNKLGQGGFGAVYKGRLSHGQEIAVKR-LSKNSV-------QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 328 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~-l~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
....|-+|+-+.|+++.+ .|+...||. +.+.-. -.....++|.+++.+++--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999998 567666664 333211 12335778999999887656655555667777778999
Q ss_pred ecCCC-CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC---CeEEeeeecccc
Q 006317 400 EFVPN-SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM---IPKISDFGMARL 475 (650)
Q Consensus 400 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~DFGla~~ 475 (650)
||+++ .++.+++....... ........++..|-+.+.-||..+ |+|+||..+||+|..++ .+.+.|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 57888887643322 233334778889999999999987 99999999999997665 358999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.6e-09 Score=109.38 Aligned_cols=170 Identities=20% Similarity=0.322 Sum_probs=129.6
Q ss_pred CceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceee----cCCeeEEEEecCCC-CChhH
Q 006317 336 GFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF----EETERLLIYEFVPN-SSVDK 409 (650)
Q Consensus 336 ~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lv~e~~~~-gsL~~ 409 (650)
.-.+.||+.. .+|..+++|++.............-++.++++.|+|||++..++. .+...+|||+|.|+ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3456788864 479999999995554433333445688999999999999999876 34578999999985 57776
Q ss_pred HHHhhh------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 410 FIFDAI------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 410 ~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
+-+... .+...++..+|.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 655321 2234778999999999999999999998 8889999999999999999999988876554
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCC
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKN 527 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p 527 (650)
.+.. |-+. --.+-|.=.||.+++-|.||...
T Consensus 445 ~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 3320 1111 12467888999999999999654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.5e-08 Score=99.54 Aligned_cols=140 Identities=18% Similarity=0.153 Sum_probs=100.3
Q ss_pred CcccccCceeEEEeeccCCcceeEeeccccCch-----------hHHHHHHHHHHHhhCCCCce--eeecceeec-----
Q 006317 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ-----------GELEFKNEVLLVARLQHRNL--VRLLGFSFE----- 391 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~----- 391 (650)
+.+-.-....|.+..+ +|+.+.||+....... ....+.+|...+.++...+| .+.+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3344344445667666 5778999976443311 11147789998888854443 344555433
Q ss_pred CCeeEEEEecCCCC-ChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC-------CC
Q 006317 392 ETERLLIYEFVPNS-SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-------DM 463 (650)
Q Consensus 392 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~-------~~ 463 (650)
....+||||++++. +|.+++.+.. ....+...+..++.+++..+.-||..+ |+|+||+++|||++. ++
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 23578999999986 8999875422 234566778899999999999999998 999999999999985 46
Q ss_pred CeEEeeeeccc
Q 006317 464 IPKISDFGMAR 474 (650)
Q Consensus 464 ~~kl~DFGla~ 474 (650)
.+.++||+.++
T Consensus 183 ~~~LIDl~r~~ 193 (268)
T PRK15123 183 KLSVIDLHRAQ 193 (268)
T ss_pred eEEEEECCccc
Confidence 89999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.4e-09 Score=120.39 Aligned_cols=205 Identities=18% Similarity=0.196 Sum_probs=144.5
Q ss_pred hhccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeE
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 396 (650)
...+.|.+.+-+-.|.++.++...-.. |...+.|....... ........+-.++...+||-+++..--+.......
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 355677888888999999998876322 33333333322111 01111122222333345677776665556677889
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
|+++|..+++|...|+. .+..+.+-....+..+...++|||... +.|+|++|.|.|+..++..+++|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 99999999999988874 334565566666777889999999875 899999999999999999999999843321
Q ss_pred ccC-------------------------CC----CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCC
Q 006317 477 EMD-------------------------QS----QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKN 527 (650)
Q Consensus 477 ~~~-------------------------~~----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p 527 (650)
..- .. ........||+.|.+||.+.+......+|+|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 00 0112335789999999999999999999999999999999999998
Q ss_pred CCCC
Q 006317 528 NSFR 531 (650)
Q Consensus 528 ~~~~ 531 (650)
+...
T Consensus 1035 ~na~ 1038 (1205)
T KOG0606|consen 1035 FNAE 1038 (1205)
T ss_pred CCCc
Confidence 8643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.3e-08 Score=94.09 Aligned_cols=124 Identities=25% Similarity=0.319 Sum_probs=80.3
Q ss_pred eEEEeeccCCcceeEeeccccC--ch------------------------hHHHHHHHHHHHhhCCCC--ceeeecceee
Q 006317 339 AVYKGRLSHGQEIAVKRLSKNS--VQ------------------------GELEFKNEVLLVARLQHR--NLVRLLGFSF 390 (650)
Q Consensus 339 ~Vy~~~~~~g~~vavK~l~~~~--~~------------------------~~~~~~~E~~~l~~l~H~--niv~l~g~~~ 390 (650)
.||.|...+|..+|||+.+... .+ ......+|.+.|.++..- ++.+.+.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899988889999999865321 00 112367899999999766 45555543
Q ss_pred cCCeeEEEEecCC--CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHH-hhhcCCCcEEecCCCCCceEeCCCCCeEE
Q 006317 391 EETERLLIYEFVP--NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY-LHEDSRLRIIHRDLKASNILLDADMIPKI 467 (650)
Q Consensus 391 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~iiHrDlk~~NILl~~~~~~kl 467 (650)
....|||||++ +..+..+... .++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999998 5555443221 12234456677777776555 46666 9999999999999988 9999
Q ss_pred eeeecccc
Q 006317 468 SDFGMARL 475 (650)
Q Consensus 468 ~DFGla~~ 475 (650)
+|||.+..
T Consensus 148 IDf~qav~ 155 (188)
T PF01163_consen 148 IDFGQAVD 155 (188)
T ss_dssp --GTTEEE
T ss_pred EecCccee
Confidence 99998753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.3e-07 Score=95.06 Aligned_cols=192 Identities=16% Similarity=0.170 Sum_probs=127.0
Q ss_pred CcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeeccee------ecCC-eeEEE
Q 006317 327 STDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFS------FEET-ERLLI 398 (650)
Q Consensus 327 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~------~~~~-~~~lv 398 (650)
...+.||+|+-+.+|-.- .-...+.|+..........+. +..|... .||-+-.-+.+= -++. ...++
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 446789999999999532 112245577665433322222 2233333 566443322221 1122 25677
Q ss_pred EecCCCCC-hhHHHHh---hhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 399 YEFVPNSS-VDKFIFD---AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 399 ~e~~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
|..+++-- ...++.. ...-...+|.-.++++..++.+.+-||..+ .+-+|+.++|+|+++++.+.|.|=....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 87776542 2222221 112235889999999999999999999998 8899999999999999999998854333
Q ss_pred ccccCCCCCccceeecCccccChhccc-----cCCCCccccccchhHHHHHHHhC-CCCCC
Q 006317 475 LFEMDQSQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISG-QKNNS 529 (650)
Q Consensus 475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~elltG-~~p~~ 529 (650)
+. .........+|...|.+||... +-.-+..+|.|.+||++++++.| ++|+.
T Consensus 166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys 223 (637)
T COG4248 166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS 223 (637)
T ss_pred ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence 22 2223344467888999999765 33456789999999999999987 88886
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.1e-07 Score=91.07 Aligned_cols=133 Identities=22% Similarity=0.280 Sum_probs=93.5
Q ss_pred CCcCCcccccCceeEEEeeccCCcceeEeeccccC----------c------------hhHHHHHHHHHHHhhCCCC--c
Q 006317 326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS----------V------------QGELEFKNEVLLVARLQHR--N 381 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~----------~------------~~~~~~~~E~~~l~~l~H~--n 381 (650)
..++++||.|.-+.||.|..++|.++|||.=+... . -.....++|.+.|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45568999999999999999999999999532210 0 0122467899999988655 5
Q ss_pred eeeecceeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC
Q 006317 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 461 (650)
Q Consensus 382 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~ 461 (650)
+.+.+++ +...+||||+++-.|... .++.+..-.++..|++-+.-+-..+ |||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~--------r~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRL--------RLDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecc--------cCcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 6666543 456899999988665432 1223333344444444444444444 999999999999999
Q ss_pred CCCeEEeeeecc
Q 006317 462 DMIPKISDFGMA 473 (650)
Q Consensus 462 ~~~~kl~DFGla 473 (650)
+|.+.+.||--+
T Consensus 238 dg~~~vIDwPQ~ 249 (304)
T COG0478 238 DGDIVVIDWPQA 249 (304)
T ss_pred CCCEEEEeCccc
Confidence 999999999544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=5.1e-07 Score=98.62 Aligned_cols=141 Identities=20% Similarity=0.276 Sum_probs=94.3
Q ss_pred CcccccCceeEEEeeccCCcceeEeeccccCchhH----------------------------------------HHHHH
Q 006317 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGE----------------------------------------LEFKN 369 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~----------------------------------------~~~~~ 369 (650)
+.|+.++-|.||+|++++|+.||||+....-.+.. .++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999999999999999876532110 01233
Q ss_pred HHHHHhhC----CCCceeeecceee-cCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 006317 370 EVLLVARL----QHRNLVRLLGFSF-EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444 (650)
Q Consensus 370 E~~~l~~l----~H~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 444 (650)
|..-+.++ ++..-+++=.++. -.....|+|||++|-.+.++..- +...++.+.+.....++. +..+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l--~~~g~d~k~ia~~~~~~f--~~q~~~dg- 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL--KSAGIDRKELAELLVRAF--LRQLLRDG- 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH--HhcCCCHHHHHHHHHHHH--HHHHHhcC-
Confidence 43333333 2222233333343 35678999999999999888532 234455444443333332 22222234
Q ss_pred CcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 445 ~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
++|.|.+|.||+++.++++-+.|||+...+.
T Consensus 286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred --ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999987654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=8.1e-07 Score=86.59 Aligned_cols=105 Identities=28% Similarity=0.328 Sum_probs=82.7
Q ss_pred HHHHHHHHHHhhCCCCc--eeeecceeecC----CeeEEEEecCCCC-ChhHHHHhhhccCCCCHHHHHHHHHHHHHHHH
Q 006317 365 LEFKNEVLLVARLQHRN--LVRLLGFSFEE----TERLLIYEFVPNS-SVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437 (650)
Q Consensus 365 ~~~~~E~~~l~~l~H~n--iv~l~g~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~ 437 (650)
....+|...+..+.... ..+.+++.... ...+||+|++++. +|.+++... ..++......++.++++.+.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHHH
Confidence 35778888888775433 45556655542 2458999999984 899988642 22667778899999999999
Q ss_pred HhhhcCCCcEEecCCCCCceEeCCCC---CeEEeeeecccc
Q 006317 438 YLHEDSRLRIIHRDLKASNILLDADM---IPKISDFGMARL 475 (650)
Q Consensus 438 yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~DFGla~~ 475 (650)
-||+.+ |+|+|+++.|||++.+. .+.++||+-++.
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999998 99999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=2e-06 Score=82.38 Aligned_cols=137 Identities=18% Similarity=0.227 Sum_probs=101.6
Q ss_pred ccccCceeEEEeeccCCcceeEeecccc---C---chhHHHHHHHHHHHhhCCCCc--eeeecceee-c----CCeeEEE
Q 006317 332 LGQGGFGAVYKGRLSHGQEIAVKRLSKN---S---VQGELEFKNEVLLVARLQHRN--LVRLLGFSF-E----ETERLLI 398 (650)
Q Consensus 332 LG~G~~g~Vy~~~~~~g~~vavK~l~~~---~---~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~-~----~~~~~lv 398 (650)
-|+||-+.|++-.+ +|+.+-+|+-... + ..++..|.+|+..+.+|...+ +.+.+ ++. . .-..+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46788888998776 4457889987522 1 125567999999999985433 44444 332 1 1246799
Q ss_pred EecCCC-CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC--eEEeeeeccc
Q 006317 399 YEFVPN-SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI--PKISDFGMAR 474 (650)
Q Consensus 399 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~--~kl~DFGla~ 474 (650)
+|-+++ -+|.+++.+. ...+.+...+..++.+++..+.-||+.+ +.|+|+.+.|||++.++. +++.||--++
T Consensus 104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997763 5888887542 2235677888999999999999999998 999999999999987777 8999997654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.2e-07 Score=103.13 Aligned_cols=155 Identities=23% Similarity=0.354 Sum_probs=100.4
Q ss_pred HHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC-------CccceeecCccccChhcccc
Q 006317 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-------GDTSRIVGTFGYMAPEYVTR 502 (650)
Q Consensus 430 ~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~ 502 (650)
.+++.||.|+|... .+||++|.|++|.++.++..||+.|+.+......... ....-..-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34559999999865 6999999999999999999999999987654331110 01111223457999999999
Q ss_pred CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccC
Q 006317 503 GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQEN 582 (650)
Q Consensus 503 ~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~ 582 (650)
...+.++|+||+|+++|-+..|..+.....+ ..+.+.......+.... ......+.|+.+.++ +.+..+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~----~~~~~~~~~~~~~~~~~----~~s~~~p~el~~~l~---k~l~~~ 252 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANG----GLLSYSFSRNLLNAGAF----GYSNNLPSELRESLK---KLLNGD 252 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccC----Ccchhhhhhcccccccc----cccccCcHHHHHHHH---HHhcCC
Confidence 8889999999999999999965544321111 11111111111111001 111234455555443 578899
Q ss_pred CCCCCCHHHHHHHhc
Q 006317 583 VANRPTMASVVVMLN 597 (650)
Q Consensus 583 p~~RPt~~evl~~L~ 597 (650)
+.-||++.++.....
T Consensus 253 ~~~rp~~~~l~~~~f 267 (700)
T KOG2137|consen 253 SAVRPTLDLLLSIPF 267 (700)
T ss_pred cccCcchhhhhcccc
Confidence 999998888775543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.2e-06 Score=83.52 Aligned_cols=139 Identities=14% Similarity=0.191 Sum_probs=85.2
Q ss_pred CcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCc--eeeecceeecCCeeEEEEecCCCCC-
Q 006317 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLGFSFEETERLLIYEFVPNSS- 406 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~gs- 406 (650)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999983 25568888876533 2335688999998886443 4667777777777889999999863
Q ss_pred hhHHHH--------------hh---hcc---CCCCHHHHHH-HHH----------HHHH-HHHHhhh-cCCCcEEecCCC
Q 006317 407 VDKFIF--------------DA---IKR---VQLDWETRYK-IIG----------GIAR-GILYLHE-DSRLRIIHRDLK 453 (650)
Q Consensus 407 L~~~l~--------------~~---~~~---~~l~~~~~~~-i~~----------~ia~-~L~yLH~-~~~~~iiHrDlk 453 (650)
+...+. .. ... .......... +.. .+.. ...+|.. ...+.++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 221110 00 000 0111111100 000 0011 1122221 123457999999
Q ss_pred CCceEeCCCCCeEEeeeeccc
Q 006317 454 ASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 454 ~~NILl~~~~~~kl~DFGla~ 474 (650)
|.||++++++ +.|.||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999988 9999998874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.7e-07 Score=100.83 Aligned_cols=197 Identities=20% Similarity=0.188 Sum_probs=142.4
Q ss_pred cChhhHHhhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCc-eeeecceeecC
Q 006317 314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN-LVRLLGFSFEE 392 (650)
Q Consensus 314 ~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~ 392 (650)
|+.-.+++.+..+...+-+++|.+++++|.+-...+...++.+... ....-++++|.+++||| .++.++-+..+
T Consensus 232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E 306 (829)
T KOG0576|consen 232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGE 306 (829)
T ss_pred CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcc
Confidence 3444455666667777889999999999987544444445555332 34556889999999999 77777777778
Q ss_pred CeeEEEEecCCCC--ChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeee
Q 006317 393 TERLLIYEFVPNS--SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF 470 (650)
Q Consensus 393 ~~~~lv~e~~~~g--sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 470 (650)
...+++++++..+ +..... .....+...+...+...-.+++++||+.. =+|+| ||+..+ +..|..||
T Consensus 307 ~~~~i~~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~ 375 (829)
T KOG0576|consen 307 DYLWIPMRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDF 375 (829)
T ss_pred cccchhhhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccc
Confidence 8889999999877 211111 01122334445566667788999999864 48998 777766 67899999
Q ss_pred ecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCC
Q 006317 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529 (650)
Q Consensus 471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~ 529 (650)
+....+.... ......+|..|+|||+.....+..+.|+|+.|+--.+|--|-+|-.
T Consensus 376 ~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 376 AVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 9987655332 2345678999999999999999999999999998888877766543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.25 E-value=9.4e-06 Score=78.15 Aligned_cols=137 Identities=15% Similarity=0.162 Sum_probs=92.2
Q ss_pred hccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHH---------HHHHHHHHhhCCCC---ceeeeccee
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE---------FKNEVLLVARLQHR---NLVRLLGFS 389 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~H~---niv~l~g~~ 389 (650)
..++|...+++-......|.+-.. +|+.+++|..+......++. ..+++..+.+++.. ....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 356777778888777777877776 57889999887654333332 22344444444322 222322222
Q ss_pred e-----cCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC
Q 006317 390 F-----EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI 464 (650)
Q Consensus 390 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~ 464 (650)
. .....+|+|||++|..|.++.. ++. .+...|.+.+.-||+.| ++|+|..|+|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 2 2345679999999988776532 222 24456778899999998 99999999999999655
Q ss_pred eEEeeeeccc
Q 006317 465 PKISDFGMAR 474 (650)
Q Consensus 465 ~kl~DFGla~ 474 (650)
+++.||+..+
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 8999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.1e-05 Score=77.89 Aligned_cols=143 Identities=20% Similarity=0.214 Sum_probs=84.4
Q ss_pred CCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCC--ceeeecceeec---CCeeEEEEecCC
Q 006317 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR--NLVRLLGFSFE---ETERLLIYEFVP 403 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~---~~~~~lv~e~~~ 403 (650)
.+.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.+++.+... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999866 68999997554 4455677888888887533 34566654432 334689999999
Q ss_pred CCChhH----------------HHHhh--h--ccCCCCHHH---------HHHH------------HHHHHH-HHHHhhh
Q 006317 404 NSSVDK----------------FIFDA--I--KRVQLDWET---------RYKI------------IGGIAR-GILYLHE 441 (650)
Q Consensus 404 ~gsL~~----------------~l~~~--~--~~~~l~~~~---------~~~i------------~~~ia~-~L~yLH~ 441 (650)
+..+.. ++... . ....+.+.. .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11110 0 001111110 0000 111222 3333332
Q ss_pred ----cCCCcEEecCCCCCceEeC-CCCCeEEeeeeccc
Q 006317 442 ----DSRLRIIHRDLKASNILLD-ADMIPKISDFGMAR 474 (650)
Q Consensus 442 ----~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~ 474 (650)
.....++|+|+.+.|||++ +++.+.|.||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2345699999999999999 66666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.7e-05 Score=77.06 Aligned_cols=140 Identities=16% Similarity=0.212 Sum_probs=84.7
Q ss_pred cccccCc-eeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCC-CCceeeecceeecCCeeEEEEecCCCCChh
Q 006317 331 KLGQGGF-GAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEFVPNSSVD 408 (650)
Q Consensus 331 ~LG~G~~-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 408 (650)
.|-.|.. ..||+.... +..+.||+..... ..++.+|+.++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3445555 788998764 4788888876543 234677888888774 344556777776666789999999998876
Q ss_pred HHHH---------h---------hhc--cCCCC--HHHHHHHHH--------------------HHHHHHHHhhh----c
Q 006317 409 KFIF---------D---------AIK--RVQLD--WETRYKIIG--------------------GIARGILYLHE----D 442 (650)
Q Consensus 409 ~~l~---------~---------~~~--~~~l~--~~~~~~i~~--------------------~ia~~L~yLH~----~ 442 (650)
.... . ... ...+. ......... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4320 0 000 00111 000010000 01111222211 1
Q ss_pred CCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 443 SRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 443 ~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
..+.++|+|+.|.|||++++....|.||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 23569999999999999998888999998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.3e-05 Score=76.62 Aligned_cols=104 Identities=24% Similarity=0.220 Sum_probs=82.4
Q ss_pred HHHHHHHhhCCC-CceeeecceeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCc
Q 006317 368 KNEVLLVARLQH-RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446 (650)
Q Consensus 368 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 446 (650)
.+|..++..+++ +++.+++|.| ..++|.||...+++...-.....-...+|..+.+|+.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888876 6999999998 34789999987765421000001234789999999999999999999865445
Q ss_pred EEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 447 IIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 447 iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
+...|++++|+-+++++++|+.|...+-.
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 99999999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.03 E-value=3.2e-05 Score=84.41 Aligned_cols=141 Identities=20% Similarity=0.285 Sum_probs=93.8
Q ss_pred CcccccCceeEEEeeccCCcceeEeeccccCchh-------------------------------------HHHHHHHHH
Q 006317 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG-------------------------------------ELEFKNEVL 372 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-------------------------------------~~~~~~E~~ 372 (650)
+.||.-..|.||++++++|+.||||+-+..-... +.+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999876542111 112334443
Q ss_pred HHhh----CCCCce---eeecceeec-CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 006317 373 LVAR----LQHRNL---VRLLGFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444 (650)
Q Consensus 373 ~l~~----l~H~ni---v~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 444 (650)
-..+ +.|-++ |.+=.++.+ ...+.|+||||+|..+.+... ..+..++...+..-+.++..-+-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~--i~~~gi~~~~i~~~l~~~~~~qIf~~---- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA--IDKRGISPHDILNKLVEAYLEQIFKT---- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH--HHHcCCCHHHHHHHHHHHHHHHHHhc----
Confidence 3322 344451 222233333 457899999999998887633 34455666655555544433333333
Q ss_pred CcEEecCCCCCceEeCC----CCCeEEeeeecccccc
Q 006317 445 LRIIHRDLKASNILLDA----DMIPKISDFGMARLFE 477 (650)
Q Consensus 445 ~~iiHrDlk~~NILl~~----~~~~kl~DFGla~~~~ 477 (650)
+++|.|=+|.||++.. ++.+.+-|||+.....
T Consensus 321 -GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 -GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred -CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 3999999999999984 6689999999987543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.00 E-value=1.3e-05 Score=78.04 Aligned_cols=152 Identities=20% Similarity=0.254 Sum_probs=95.1
Q ss_pred ChhhHHhhccCCCcCCc---ccccCceeEEEeeccCCcceeEeeccccCchhHH------------------------HH
Q 006317 315 DFSTIRDATNNFSTDNK---LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGEL------------------------EF 367 (650)
Q Consensus 315 ~~~~~~~~~~~f~~~~~---LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~------------------------~~ 367 (650)
+.+.+.....+..+... |+.|.-..||+|...++..+|||+.+........ ..
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 34455555555555554 5567777899998878999999998654321110 12
Q ss_pred HHHHHHHhhCC--CCceeeecceeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 006317 368 KNEVLLVARLQ--HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445 (650)
Q Consensus 368 ~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 445 (650)
.+|+.-|.++. +-.+.+-+++ ....|||||+.... +-....+...+...+...+..++++.+.-|-...
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 23444454442 2222222222 23479999996541 1111112223333356777788888888887643
Q ss_pred cEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 446 RIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 446 ~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
++||+||+.=|||+. ++.+.|+|||-+...
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECcccccc
Confidence 499999999999999 889999999987643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00011 Score=70.49 Aligned_cols=130 Identities=18% Similarity=0.278 Sum_probs=91.4
Q ss_pred CcCCcccccCceeEEEeeccCCcceeEeeccccC----------------chhHHHHHHHHHHHhhCC------CCceee
Q 006317 327 STDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS----------------VQGELEFKNEVLLVARLQ------HRNLVR 384 (650)
Q Consensus 327 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~ 384 (650)
+....||+|+.-.||. +++.....||++.... .....+..+|+.-...+. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 3457899999999996 5566778889887665 112335566666555554 889999
Q ss_pred ecceeecCCeeEEEEecCCC--C----ChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceE
Q 006317 385 LLGFSFEETERLLIYEFVPN--S----SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 458 (650)
Q Consensus 385 l~g~~~~~~~~~lv~e~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 458 (650)
++|+...+....+|+|.+.+ | +|.+++. ...++. ...+.+.++. .||-+.+ |+.+||+|.||+
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~~f~---~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALDEFK---RYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHHHHH---HHHHHcC---CeecCCCcccEE
Confidence 99999999999999998753 3 5666663 345665 4444444444 4555554 999999999999
Q ss_pred eCCCC----CeEEee
Q 006317 459 LDADM----IPKISD 469 (650)
Q Consensus 459 l~~~~----~~kl~D 469 (650)
+.... .+.|.|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 96433 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.94 E-value=7.8e-05 Score=87.87 Aligned_cols=79 Identities=11% Similarity=0.276 Sum_probs=57.7
Q ss_pred CCcccccCceeEEEeeccCC---cceeEeeccccC-chhHHHHHHHHHHHhhCC-CCce--eeecceeecC---CeeEEE
Q 006317 329 DNKLGQGGFGAVYKGRLSHG---QEIAVKRLSKNS-VQGELEFKNEVLLVARLQ-HRNL--VRLLGFSFEE---TERLLI 398 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lv 398 (650)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999876553 367888765432 223346889999999995 6664 7777777664 467899
Q ss_pred EecCCCCCh
Q 006317 399 YEFVPNSSV 407 (650)
Q Consensus 399 ~e~~~~gsL 407 (650)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00014 Score=72.39 Aligned_cols=74 Identities=16% Similarity=0.217 Sum_probs=45.6
Q ss_pred CCcccccCce-eEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCC---ceeeecceeecC---CeeEEEEec
Q 006317 329 DNKLGQGGFG-AVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR---NLVRLLGFSFEE---TERLLIYEF 401 (650)
Q Consensus 329 ~~~LG~G~~g-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~---~~~~lv~e~ 401 (650)
.+.|+.|+.. .||+. +..+++|..... .....+.+|.+++..+... .+.+.++..... ...+++|++
T Consensus 2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 2 IEPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ceeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 3567777776 48875 345778875442 2334688899999887532 233333333221 234889999
Q ss_pred CCCCChh
Q 006317 402 VPNSSVD 408 (650)
Q Consensus 402 ~~~gsL~ 408 (650)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00035 Score=72.07 Aligned_cols=78 Identities=14% Similarity=0.071 Sum_probs=56.6
Q ss_pred CcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCC---Cceeeecceeec---CCeeEEEEe
Q 006317 327 STDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH---RNLVRLLGFSFE---ETERLLIYE 400 (650)
Q Consensus 327 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~---~~~~~lv~e 400 (650)
...+.||.|..+.||+....++ .+++|..+.. .....+..|...++.|.. -.+.++++++.. .+..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3457899999999999876555 4677774331 123468889999988853 357788877754 356899999
Q ss_pred cCCCCCh
Q 006317 401 FVPNSSV 407 (650)
Q Consensus 401 ~~~~gsL 407 (650)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00034 Score=66.68 Aligned_cols=125 Identities=26% Similarity=0.378 Sum_probs=88.6
Q ss_pred cCCCcCCcccccCc-eeEEEeeccCCcceeEeeccccC----------ch-----------hHHHHHHHHHHHhhCC---
Q 006317 324 NNFSTDNKLGQGGF-GAVYKGRLSHGQEIAVKRLSKNS----------VQ-----------GELEFKNEVLLVARLQ--- 378 (650)
Q Consensus 324 ~~f~~~~~LG~G~~-g~Vy~~~~~~g~~vavK~l~~~~----------~~-----------~~~~~~~E~~~l~~l~--- 378 (650)
.+++..+.||.|.- |.|||+++ +|+.+|+|.+.... .. ....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888899999999 99999998 67899999932210 00 0124778888887774
Q ss_pred CCce--eeecceeecC------------------CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHH
Q 006317 379 HRNL--VRLLGFSFEE------------------TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438 (650)
Q Consensus 379 H~ni--v~l~g~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y 438 (650)
+.++ |+++||..-. ....||.||++... .+. .+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 4566 9999987321 12357888876543 122 2234566777888
Q ss_pred hhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecc
Q 006317 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473 (650)
Q Consensus 439 LH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 473 (650)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99887 999999999985 4589999853
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00028 Score=71.28 Aligned_cols=138 Identities=15% Similarity=0.118 Sum_probs=78.6
Q ss_pred cccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCcee-eecceeecCCeeEEEEecCCCCChhH
Q 006317 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV-RLLGFSFEETERLLIYEFVPNSSVDK 409 (650)
Q Consensus 331 ~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~~gsL~~ 409 (650)
.+..|-...+|+... ++..+++|........-..+..+|..+++.+....++ ++++.. ..++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 456678889998873 5678889876543222112457788888888644333 333332 2368999999876542
Q ss_pred H-------H----------Hhhh-ccCCCCHHHH-HHHHHH---------HHHHHHHhhhc-----CCCcEEecCCCCCc
Q 006317 410 F-------I----------FDAI-KRVQLDWETR-YKIIGG---------IARGILYLHED-----SRLRIIHRDLKASN 456 (650)
Q Consensus 410 ~-------l----------~~~~-~~~~l~~~~~-~~i~~~---------ia~~L~yLH~~-----~~~~iiHrDlk~~N 456 (650)
- + +... ....++.... .....+ +...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 1 1100 0111222211 111111 11112222111 13458999999999
Q ss_pred eEeCCCCCeEEeeeeccc
Q 006317 457 ILLDADMIPKISDFGMAR 474 (650)
Q Consensus 457 ILl~~~~~~kl~DFGla~ 474 (650)
|++++++ +.|.||..+.
T Consensus 158 il~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEEeCCC-CEEEeccccC
Confidence 9999887 7899998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00042 Score=68.91 Aligned_cols=74 Identities=18% Similarity=0.252 Sum_probs=48.5
Q ss_pred CcccccCceeEEEeeccC--CcceeEeeccccCchhHHHHHHHHHHHhhCCCCcee-eecceeecCCeeEEEEecCCCCC
Q 006317 330 NKLGQGGFGAVYKGRLSH--GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV-RLLGFSFEETERLLIYEFVPNSS 406 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~~gs 406 (650)
+.|..|-...+|+....+ +..+++|+...... ...+..+|+.++..+...+++ ++++... ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567788888999988654 57888997754322 122345788888888544443 3333222 248999999877
Q ss_pred hh
Q 006317 407 VD 408 (650)
Q Consensus 407 L~ 408 (650)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00077 Score=78.18 Aligned_cols=197 Identities=19% Similarity=0.219 Sum_probs=133.9
Q ss_pred HHHHHHHHhhCCCCceeeecceeecCCeeE----EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhc
Q 006317 367 FKNEVLLVARLQHRNLVRLLGFSFEETERL----LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442 (650)
Q Consensus 367 ~~~E~~~l~~l~H~niv~l~g~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~ 442 (650)
..-|...+.++.|+|++.+++|..++...- +..|++..-++...+. ....++....+.+..++.+||.|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 345777888899999999999987654433 3456777777777765 345688888989999999999999987
Q ss_pred CCCcEEecCCCCC---ceEeCCCCCeEEe--eeecccccccCCCCCccceeecCccccChhccccCCCC--ccccccchh
Q 006317 443 SRLRIIHRDLKAS---NILLDADMIPKIS--DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS--IKSDVFSFG 515 (650)
Q Consensus 443 ~~~~iiHrDlk~~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s--~~sDV~S~G 515 (650)
. +.|.-|..+ +.-++.++...++ ||+.++.+..... .....-+..|.+||......+. ...|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHH
Confidence 5 555555555 5556677777777 8888875543221 1112234567888877766554 447999999
Q ss_pred HHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 516 VLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 516 vll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.++..+..|..+..... ....+++. .... ........|+..++++|++..+++..
T Consensus 380 ll~~~~~~~~~i~~~~~------------------~~~~~l~~----~~~~---~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSA------------------VPVSLLDV----LSTS---ELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHHhhhhhcCccccccc------------------chhhhhcc----ccch---hhhhhhhhhcchhhhhccchhhhhhc
Confidence 99999999976543110 00011111 1111 22344557999999999999999977
Q ss_pred hc
Q 006317 596 LN 597 (650)
Q Consensus 596 L~ 597 (650)
..
T Consensus 435 ~f 436 (1351)
T KOG1035|consen 435 PF 436 (1351)
T ss_pred hh
Confidence 53
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.001 Score=61.53 Aligned_cols=129 Identities=20% Similarity=0.282 Sum_probs=83.9
Q ss_pred CCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceee-ecceeecCCeeEEEEecCCC
Q 006317 326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR-LLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lv~e~~~~ 404 (650)
....+.|++|++|.||+|.+. |.++|+|+-..++ ....+..|.+++..+.-.++-+ ++.|- +..+.|||+.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G 96 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDG 96 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcC
Confidence 345578999999999999995 5588888865543 3346788999998887666543 33222 22345999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCC-CCceEeCCCCCeEEeeeeccc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLK-ASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk-~~NILl~~~~~~kl~DFGla~ 474 (650)
-.|.++-.. .+-+.+.. +++.---|-..+ |-|+.|. |...+|-+++.+.|+||.-|.
T Consensus 97 ~~L~~~~~~------~~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 97 RPLGKLEIG------GDRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred cchhhhhhc------ccHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 888775431 12333333 333322333333 8888886 444444445599999999886
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0046 Score=65.94 Aligned_cols=75 Identities=13% Similarity=0.172 Sum_probs=51.9
Q ss_pred CcccccCceeEEEeeccCC-cceeEeecccc------C-chhHHHHHHHHHHHhhCC---CCceeeecceeecCCeeEEE
Q 006317 330 NKLGQGGFGAVYKGRLSHG-QEIAVKRLSKN------S-VQGELEFKNEVLLVARLQ---HRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~g-~~vavK~l~~~------~-~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv 398 (650)
+.||.|.+..||++...+| +.++||.-... . ......+..|.+.|..+. ..++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5789999999999998777 48999985321 1 112334566777777652 2456666665 44567899
Q ss_pred EecCCCCC
Q 006317 399 YEFVPNSS 406 (650)
Q Consensus 399 ~e~~~~gs 406 (650)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0048 Score=63.64 Aligned_cols=142 Identities=19% Similarity=0.180 Sum_probs=85.2
Q ss_pred CCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCc--eeeecce------eecCCeeEEEEe
Q 006317 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLGF------SFEETERLLIYE 400 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lv~e 400 (650)
.+.|..|....+|+....+ ..+++|+... .....+..|+.++..+.+.+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4677888888999987644 4788898764 22345667888887775433 3444431 123445689999
Q ss_pred cCCCCChhH----HH----------Hhhhcc--------CCCCHHHHH----------HHHHHHHHHHHHhhh----cCC
Q 006317 401 FVPNSSVDK----FI----------FDAIKR--------VQLDWETRY----------KIIGGIARGILYLHE----DSR 444 (650)
Q Consensus 401 ~~~~gsL~~----~l----------~~~~~~--------~~l~~~~~~----------~i~~~ia~~L~yLH~----~~~ 444 (650)
|++|..+.. .. +..... ....|.... .....+...+.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877532 11 110000 111222211 011123344455443 122
Q ss_pred CcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 445 LRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 445 ~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
..++|+|+.|.|||+++++.+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 459999999999999998778899998774
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.018 Score=60.19 Aligned_cols=142 Identities=16% Similarity=0.187 Sum_probs=76.9
Q ss_pred CCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCc--eeeecc------eeecCCeeEEEEe
Q 006317 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLG------FSFEETERLLIYE 400 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g------~~~~~~~~~lv~e 400 (650)
.+.|+.|....+|+....+| .+++|+.... .......|+.++..|...+ +.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35677787789999876555 6889987521 2223344555555553222 223221 1122456789999
Q ss_pred cCCCCChhH-----H------H---Hhhhcc--------CCCCH-HHHHH------------HH-HHHHHHHHHhhhc--
Q 006317 401 FVPNSSVDK-----F------I---FDAIKR--------VQLDW-ETRYK------------II-GGIARGILYLHED-- 442 (650)
Q Consensus 401 ~~~~gsL~~-----~------l---~~~~~~--------~~l~~-~~~~~------------i~-~~ia~~L~yLH~~-- 442 (650)
|++|..+.. + | +..... ..+.| ..... .+ ..+...++.+.+.
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999875421 1 1 110000 01112 11111 11 1111222333211
Q ss_pred --CCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 443 --SRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 443 --~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
-...++|+|+.+.|||++++...-|.||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23469999999999999977666899998874
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.00082 Score=48.01 Aligned_cols=45 Identities=40% Similarity=0.618 Sum_probs=33.4
Q ss_pred CCCCCCCCCCCccccccCcccCcccccccCCCCC--CCcccccCcccccccccC
Q 006317 599 SSLSLPLPSQPAFFMHSTMEQDNLEFTSSDQSKS--GSIHFTVNEVTISELDPR 650 (650)
Q Consensus 599 ~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 650 (650)
+...||.|.+|.|+..+.......+ +++. .. .|+|+||+|.|++|
T Consensus 2 e~~~LP~PKqPgF~~~r~~~e~~sS-----ss~~~~~~--~SvNevTiT~l~~R 48 (48)
T PF11883_consen 2 ETATLPQPKQPGFFTGRSPSETDSS-----SSKQRDES--CSVNEVTITMLEAR 48 (48)
T ss_pred CcccCCCCCCCCEEeEcCCCCcCCC-----cccccCCC--CCeeeEEEEeEecC
Confidence 4568999999999988886554322 1111 23 78999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.022 Score=59.12 Aligned_cols=143 Identities=20% Similarity=0.219 Sum_probs=81.8
Q ss_pred CCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCc--eeeecce------eecCCeeEEEEe
Q 006317 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLGF------SFEETERLLIYE 400 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lv~e 400 (650)
.+.++.|....+|+....+| .+++|+..... ...+...|+.++..|.... +.+.+.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677787789999876444 67788765432 1234455667776664222 3344331 122456789999
Q ss_pred cCCCCChhH----H----------HHhhhccC---------CCCHHHHH------------HHHHHHHHHHHHhhh----
Q 006317 401 FVPNSSVDK----F----------IFDAIKRV---------QLDWETRY------------KIIGGIARGILYLHE---- 441 (650)
Q Consensus 401 ~~~~gsL~~----~----------l~~~~~~~---------~l~~~~~~------------~i~~~ia~~L~yLH~---- 441 (650)
|++|..+.. . ++...... .-.|.... .....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 998865321 0 11100100 01121111 001123344555542
Q ss_pred cCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 442 ~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.....++|+|+++.||++++++...|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223569999999999999998877899998773
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0081 Score=61.39 Aligned_cols=75 Identities=17% Similarity=0.273 Sum_probs=47.3
Q ss_pred CcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCC---CCceeeecceeecCCeeEEEEecCC
Q 006317 327 STDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ---HRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 327 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
+..+.|+.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. --.+.+++++....+..+|||||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 344678889999999987 4678899998762 22235777888777773 4457788888877777899999998
Q ss_pred CC
Q 006317 404 NS 405 (650)
Q Consensus 404 ~g 405 (650)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.011 Score=60.96 Aligned_cols=135 Identities=19% Similarity=0.303 Sum_probs=77.6
Q ss_pred eEEEeeccCCcceeEeeccc--cCchhHHHHHHHHHHHhhCCC--CceeeecceeecCC--eeEEEEecCCCCChhHHH-
Q 006317 339 AVYKGRLSHGQEIAVKRLSK--NSVQGELEFKNEVLLVARLQH--RNLVRLLGFSFEET--ERLLIYEFVPNSSVDKFI- 411 (650)
Q Consensus 339 ~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lv~e~~~~gsL~~~l- 411 (650)
.+|.... .++.++++ ... ..........+|..+|+.+.- --+.+.+++|.++. ..+.||+|+++..+...+
T Consensus 40 ~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~ 117 (321)
T COG3173 40 DTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP 117 (321)
T ss_pred ceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence 3444333 26778888 331 233344456788888887743 34456677777666 679999999884322211
Q ss_pred ---------H--------hhh-----------------ccCCCCHHHHHHHH--------HHHHHHHHHhhhc-----CC
Q 006317 412 ---------F--------DAI-----------------KRVQLDWETRYKII--------GGIARGILYLHED-----SR 444 (650)
Q Consensus 412 ---------~--------~~~-----------------~~~~l~~~~~~~i~--------~~ia~~L~yLH~~-----~~ 444 (650)
. ... .++--.|...++.+ -....-..||+++ +.
T Consensus 118 ~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~ 197 (321)
T COG3173 118 PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGP 197 (321)
T ss_pred cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCC
Confidence 1 000 00000111111100 0112223444433 34
Q ss_pred CcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 445 LRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 445 ~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
+.++|+|+++.|++++++.-+=|.||+++.+
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 5699999999999999999899999999864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0083 Score=62.09 Aligned_cols=140 Identities=25% Similarity=0.329 Sum_probs=82.0
Q ss_pred CcccccCceeEEEeeccC-------CcceeEeeccccCchhHHHHHHHHHHHhhCCCCcee-eecceeecCCeeEEEEec
Q 006317 330 NKLGQGGFGAVYKGRLSH-------GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV-RLLGFSFEETERLLIYEF 401 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~ 401 (650)
+.|..|-...+|+....+ ++.+++|+..... ....+..+|..++..+....+. ++++++. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 455667777899887654 4788999875543 2223567788888887543333 4444443 2368999
Q ss_pred CCCCChhHH-------H----------HhhhccC------C--CCHHHHHH--------------------------HHH
Q 006317 402 VPNSSVDKF-------I----------FDAIKRV------Q--LDWETRYK--------------------------IIG 430 (650)
Q Consensus 402 ~~~gsL~~~-------l----------~~~~~~~------~--l~~~~~~~--------------------------i~~ 430 (650)
++|..+... + +...... . .-|....+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988776431 1 1100000 0 00111111 111
Q ss_pred HHHHHHHHhhh------cCCCcEEecCCCCCceEeCCC----CCeEEeeeeccc
Q 006317 431 GIARGILYLHE------DSRLRIIHRDLKASNILLDAD----MIPKISDFGMAR 474 (650)
Q Consensus 431 ~ia~~L~yLH~------~~~~~iiHrDlk~~NILl~~~----~~~kl~DFGla~ 474 (650)
.+..-+.+|.. .....++|+|+.+.|||++++ +.+++.||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22233344432 234579999999999999985 889999998874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.017 Score=58.83 Aligned_cols=31 Identities=29% Similarity=0.504 Sum_probs=25.8
Q ss_pred CCcEEecCCCCCceEeCCCCC-eEEeeeeccc
Q 006317 444 RLRIIHRDLKASNILLDADMI-PKISDFGMAR 474 (650)
Q Consensus 444 ~~~iiHrDlk~~NILl~~~~~-~kl~DFGla~ 474 (650)
.+.++|+|+++.|||++++++ .-|.||+.+.
T Consensus 184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred CCeeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 345999999999999998555 5699999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.0036 Score=63.29 Aligned_cols=145 Identities=20% Similarity=0.260 Sum_probs=96.3
Q ss_pred ccChhhHHhhcc---CCCcCCcccccCceeEEEeeccCCcceeEeecccc--C---c-----------------hhHHHH
Q 006317 313 QFDFSTIRDATN---NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKN--S---V-----------------QGELEF 367 (650)
Q Consensus 313 ~~~~~~~~~~~~---~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~--~---~-----------------~~~~~~ 367 (650)
-+++-.|+...+ -+..++.||-|.-+.||.+...+|++.++|.-.-. + . .+....
T Consensus 78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa 157 (465)
T KOG2268|consen 78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA 157 (465)
T ss_pred cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence 355555555443 35778999999999999999999999998853211 0 0 011235
Q ss_pred HHHHHHHhhCCC-C-ceeeecceeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 006317 368 KNEVLLVARLQH-R-NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445 (650)
Q Consensus 368 ~~E~~~l~~l~H-~-niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 445 (650)
.+|+..|+.|.. . -+.+.+ +.+..++|||++.+-.|...- ...+..++..- +..-+--|..++
T Consensus 158 ~kEfafmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~---lm~~Iv~la~~G-- 222 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVR------HVEDPPTLYDD---LMGLIVRLANHG-- 222 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeee------ecCChHHHHHH---HHHHHHHHHHcC--
Confidence 578888887743 2 233333 345678999999887765532 12233333333 333344555566
Q ss_pred cEEecCCCCCceEeCCCCCeEEeeeecc
Q 006317 446 RIIHRDLKASNILLDADMIPKISDFGMA 473 (650)
Q Consensus 446 ~iiHrDlk~~NILl~~~~~~kl~DFGla 473 (650)
+||+|..-=||+|++++.++++||--.
T Consensus 223 -lIHgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 223 -LIHGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred -ceecccchheeEEecCCCEEEeechHh
Confidence 999999999999999999999999643
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.019 Score=60.52 Aligned_cols=140 Identities=18% Similarity=0.212 Sum_probs=79.8
Q ss_pred CcccccCceeEEEeeccC-----CcceeEeeccccCchhHHHHHHHHHHHhhCCCCcee-eecceeecCCeeEEEEecCC
Q 006317 330 NKLGQGGFGAVYKGRLSH-----GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV-RLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~ 403 (650)
+.|-.|-.-.+|+..+.+ ++.+++|+..... ....+..+|..++..+..-++. ++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-CeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345556777888876532 3578888876543 2222346788888888654443 444544322 5899998
Q ss_pred CCChhHH-------H----------Hhhh-cc-C-CCCHHHHHHHHHHH-----------------HHHHHHh----hh-
Q 006317 404 NSSVDKF-------I----------FDAI-KR-V-QLDWETRYKIIGGI-----------------ARGILYL----HE- 441 (650)
Q Consensus 404 ~gsL~~~-------l----------~~~~-~~-~-~l~~~~~~~i~~~i-----------------a~~L~yL----H~- 441 (650)
+.+|..- + |... .. . ...|.+..++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7776421 1 1100 00 0 11233333333221 1112222 22
Q ss_pred cCCCcEEecCCCCCceEeCC-CCCeEEeeeeccc
Q 006317 442 DSRLRIIHRDLKASNILLDA-DMIPKISDFGMAR 474 (650)
Q Consensus 442 ~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~ 474 (650)
.....++|+|+++.|||+++ ++.+.+.||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 22346899999999999986 4689999998875
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.0012 Score=78.21 Aligned_cols=158 Identities=11% Similarity=-0.041 Sum_probs=112.5
Q ss_pred HHHHHHhhCCCCceeeecceee--cCCeeEEEEecCCCCChhHHHHhhhcc-CCCCHHHHHHHHHHHHHHHHHhhhcC--
Q 006317 369 NEVLLVARLQHRNLVRLLGFSF--EETERLLIYEFVPNSSVDKFIFDAIKR-VQLDWETRYKIIGGIARGILYLHEDS-- 443 (650)
Q Consensus 369 ~E~~~l~~l~H~niv~l~g~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~-- 443 (650)
.|....++..|+++.....-.. +..+.+.+++|+..|.+...|....++ ..++..-....-.+......-+|+..
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 3444556678998877655443 345678999999999999988764433 23333333333333355555555442
Q ss_pred CCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh
Q 006317 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523 (650)
Q Consensus 444 ~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt 523 (650)
..-.+|++||+-|.+|..+.++|++++|+.++..+. ........+++.|+.|++...-.++.++|+|..|..+|+.--
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 234799999999999999999999999999843321 122334567888999999888889999999999999999988
Q ss_pred CCCCC
Q 006317 524 GQKNN 528 (650)
Q Consensus 524 G~~p~ 528 (650)
|..++
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 87655
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.069 Score=56.92 Aligned_cols=73 Identities=12% Similarity=0.082 Sum_probs=47.5
Q ss_pred CCcccccCceeEEEeeccCCcceeEeeccccCc-------hhHHHHHHHHHHHhhCC---CCceeeecceeecCCeeEEE
Q 006317 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV-------QGELEFKNEVLLVARLQ---HRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv 398 (650)
.+.||.|....||+... ++..++||+-..... .....-..|...|..+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46789999999999876 456799998652111 01112233455555443 346777887776 456789
Q ss_pred EecCCC
Q 006317 399 YEFVPN 404 (650)
Q Consensus 399 ~e~~~~ 404 (650)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.059 Score=56.40 Aligned_cols=73 Identities=16% Similarity=0.181 Sum_probs=44.7
Q ss_pred cccccCceeEEEeeccCC-cceeEeecccc------Cc-hhHHHHHHHHHHHhhCC--CCc-eeeecceeecCCeeEEEE
Q 006317 331 KLGQGGFGAVYKGRLSHG-QEIAVKRLSKN------SV-QGELEFKNEVLLVARLQ--HRN-LVRLLGFSFEETERLLIY 399 (650)
Q Consensus 331 ~LG~G~~g~Vy~~~~~~g-~~vavK~l~~~------~~-~~~~~~~~E~~~l~~l~--H~n-iv~l~g~~~~~~~~~lv~ 399 (650)
.||.|....||++..++| +.|+||.-... +. -......-|...|+... -|. +.+++ +.+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence 579999999999998655 58999974321 11 11223334666665542 243 33343 34556667999
Q ss_pred ecCCCC
Q 006317 400 EFVPNS 405 (650)
Q Consensus 400 e~~~~g 405 (650)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.033 Score=57.54 Aligned_cols=138 Identities=20% Similarity=0.251 Sum_probs=94.8
Q ss_pred CCcccccCceeEEEeeccCCcceeEeeccccCc--hh-------H-----------------HHHHHHHHHHhhCCCCce
Q 006317 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV--QG-------E-----------------LEFKNEVLLVARLQHRNL 382 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~-------~-----------------~~~~~E~~~l~~l~H~ni 382 (650)
...|..|.-..||.+.-.+|..+|||+.+.... .. + .....|++-|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 456788999999999999999999998764311 10 0 123456666666654442
Q ss_pred eeecceeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC
Q 006317 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD 462 (650)
Q Consensus 383 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~ 462 (650)
.-.--... ....|||+|+.. +.|-....+...++...+..+-.+++.-|.-|.+.+ ++||.||.-=|+|+- +
T Consensus 229 P~PePIlL--k~hVLVM~FlGr---dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGR---DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-D 300 (520)
T ss_pred CCCCceee--ecceEeeeeccC---CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-C
Confidence 21111111 234799999953 233333345566887888888899999999998887 599999999999885 4
Q ss_pred CCeEEeeeeccc
Q 006317 463 MIPKISDFGMAR 474 (650)
Q Consensus 463 ~~~kl~DFGla~ 474 (650)
|.+.|+|-+-+.
T Consensus 301 G~lyiIDVSQSV 312 (520)
T KOG2270|consen 301 GKLYIIDVSQSV 312 (520)
T ss_pred CEEEEEEccccc
Confidence 678888876553
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.11 Score=53.77 Aligned_cols=29 Identities=28% Similarity=0.306 Sum_probs=25.1
Q ss_pred CcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 445 LRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 445 ~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
..++|+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 46999999999999998 678899998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.05 Score=57.64 Aligned_cols=74 Identities=11% Similarity=0.173 Sum_probs=46.3
Q ss_pred CCcccccCceeEEEeeccC-CcceeEeecccc-----Cc-hhHHHHHHHHHHHhhCC--CCc-eeeecceeecCCeeEEE
Q 006317 329 DNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKN-----SV-QGELEFKNEVLLVARLQ--HRN-LVRLLGFSFEETERLLI 398 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~-----~~-~~~~~~~~E~~~l~~l~--H~n-iv~l~g~~~~~~~~~lv 398 (650)
.+.||.|.-.-||++...+ ++.|+||.-... +. -......-|.+.|+... -|. +.+++ +.+.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy--~~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVY--LFDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEE--EECcHHhhHH
Confidence 4678999999999998743 567999974321 11 12223444666666542 343 44444 3455566789
Q ss_pred EecCCC
Q 006317 399 YEFVPN 404 (650)
Q Consensus 399 ~e~~~~ 404 (650)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.032 Score=54.42 Aligned_cols=30 Identities=40% Similarity=0.532 Sum_probs=21.2
Q ss_pred CcEEecCCCCCceEe-CCCCCeEEeeeeccc
Q 006317 445 LRIIHRDLKASNILL-DADMIPKISDFGMAR 474 (650)
Q Consensus 445 ~~iiHrDlk~~NILl-~~~~~~kl~DFGla~ 474 (650)
..+.|.||.+.|||+ +.++.++++||..+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 358899999999999 889999999998774
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.089 Score=55.20 Aligned_cols=140 Identities=15% Similarity=0.220 Sum_probs=78.4
Q ss_pred CcccccCceeEEEeeccC----CcceeEeeccccCchhHHHHHHHHHHHhhCCCCcee-eecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV-RLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~~ 404 (650)
+.|..|-.-.+|+....+ +..|++|+...... ...+-.+|..+++.+..-++- ++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 445556677788876433 23788888765432 223446788888888655553 4555442 22 58999977
Q ss_pred CChhH-------HH----------Hhhh-c-cC-CCCHHHHHHHHHHH----------------------HHHHH----H
Q 006317 405 SSVDK-------FI----------FDAI-K-RV-QLDWETRYKIIGGI----------------------ARGIL----Y 438 (650)
Q Consensus 405 gsL~~-------~l----------~~~~-~-~~-~l~~~~~~~i~~~i----------------------a~~L~----y 438 (650)
..|.. .+ +... . .. .--|..+.++..++ ..-+. +
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 66532 11 1100 0 00 11233333332221 11111 2
Q ss_pred hhh-cCCCcEEecCCCCCceEeCC-CCCeEEeeeeccc
Q 006317 439 LHE-DSRLRIIHRDLKASNILLDA-DMIPKISDFGMAR 474 (650)
Q Consensus 439 LH~-~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~ 474 (650)
+.. .....+.|.||.+.|||+++ ++.++++||..+.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 211 12235899999999999975 5789999998874
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.37 Score=50.21 Aligned_cols=140 Identities=20% Similarity=0.292 Sum_probs=81.2
Q ss_pred cccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCce------eeecc----eeecCCeeEEEEe
Q 006317 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL------VRLLG----FSFEETERLLIYE 400 (650)
Q Consensus 331 ~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni------v~l~g----~~~~~~~~~lv~e 400 (650)
.|.+ .-..+|+....+|+. ++|+.... ....++..|+..|..|.-.+| ..+=| ........+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 456788888877666 88888765 344466677777777732221 11111 1112236778999
Q ss_pred cCCCCChhH-H----H----------Hhhhcc---------CCCCHHH-------------HHHHHHHHHHHHHHhhhc-
Q 006317 401 FVPNSSVDK-F----I----------FDAIKR---------VQLDWET-------------RYKIIGGIARGILYLHED- 442 (650)
Q Consensus 401 ~~~~gsL~~-~----l----------~~~~~~---------~~l~~~~-------------~~~i~~~ia~~L~yLH~~- 442 (650)
|++|..+.. . + +...++ ....|.. ......++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988772 1 1 110010 1233430 011223334444444432
Q ss_pred ---CC---CcEEecCCCCCceEeCCCCC-eEEeeeeccc
Q 006317 443 ---SR---LRIIHRDLKASNILLDADMI-PKISDFGMAR 474 (650)
Q Consensus 443 ---~~---~~iiHrDlk~~NILl~~~~~-~kl~DFGla~ 474 (650)
-. ..+||+|+.|.|||++.+.. +-+.||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 11 22899999999999999985 8899998764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.31 Score=50.55 Aligned_cols=31 Identities=26% Similarity=0.295 Sum_probs=27.7
Q ss_pred CCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 444 RLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 444 ~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
+..++|+|+.+.|||+++++.+.|.||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 3469999999999999999999999998775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.34 Score=58.54 Aligned_cols=140 Identities=21% Similarity=0.297 Sum_probs=77.1
Q ss_pred cccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhC-------CCCceeeec-ce----eec-CC--ee
Q 006317 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-------QHRNLVRLL-GF----SFE-ET--ER 395 (650)
Q Consensus 331 ~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-------~H~niv~l~-g~----~~~-~~--~~ 395 (650)
.|+ |..-.+|+....+|..+++|+...... ......|...|..| .-|.+++.. |- ... ++ ..
T Consensus 32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 32 PLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred ecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 453 345678888877788999999876432 22334455555444 223444332 11 111 22 45
Q ss_pred EEEEecCCCCChhHH-------H----------Hhhh-------ccCCCCHHH-----------------HHHHHHHHHH
Q 006317 396 LLIYEFVPNSSVDKF-------I----------FDAI-------KRVQLDWET-----------------RYKIIGGIAR 434 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~-------l----------~~~~-------~~~~l~~~~-----------------~~~i~~~ia~ 434 (650)
+-+++|++|..|.+. + +... ....+.|.. ...++.++.+
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 678999999877651 1 1000 011233321 1122223332
Q ss_pred HHH-----HhhhcCCCcEEecCCCCCceEeCCCC--CeE-Eeeeeccc
Q 006317 435 GIL-----YLHEDSRLRIIHRDLKASNILLDADM--IPK-ISDFGMAR 474 (650)
Q Consensus 435 ~L~-----yLH~~~~~~iiHrDlk~~NILl~~~~--~~k-l~DFGla~ 474 (650)
... .|.+ -...+||+|+.+.|||++.++ ++. |.|||-+.
T Consensus 189 ~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 189 RFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 222 1211 234599999999999999875 554 99999874
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.11 Score=53.88 Aligned_cols=72 Identities=19% Similarity=0.163 Sum_probs=56.2
Q ss_pred eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecc
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 473 (650)
..+++|++. ++++.- ...-.|++.+.++.+.+..+.-+..+- +.-|||+.-.||||+ +|++-|+||-++
T Consensus 300 y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence 345667765 334332 234578999999999888888887654 689999999999999 999999999999
Q ss_pred ccc
Q 006317 474 RLF 476 (650)
Q Consensus 474 ~~~ 476 (650)
|+-
T Consensus 369 Rl~ 371 (488)
T COG5072 369 RLS 371 (488)
T ss_pred ecc
Confidence 853
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.54 E-value=0.22 Score=48.10 Aligned_cols=154 Identities=18% Similarity=0.230 Sum_probs=92.5
Q ss_pred cCceeEEEeeccCCcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCCChhHHHHh
Q 006317 335 GGFGAVYKGRLSHGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFD 413 (650)
Q Consensus 335 G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 413 (650)
++..+.-+|+.+-| +..+|++...... ...-|.++.+++++++ .|+++..= ......++.|+|-.-..
T Consensus 73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 34455555544333 3455655444333 4445778888888774 56666621 33355688998843210
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccceeecCcc
Q 006317 414 AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493 (650)
Q Consensus 414 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 493 (650)
. ..-.|..+ .+.|.-.|+.. ...+|+|-.|+||+-|..|.+||.|=+... + + +.-
T Consensus 142 -------~--~~N~i~ag-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~----~--------~V~ 196 (308)
T PF07387_consen 142 -------N--FSNFITAG-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--E----N--------QVN 196 (308)
T ss_pred -------c--hhHHHHHh-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhh--h----h--------eee
Confidence 0 01111222 35677888653 469999999999999999999999976542 1 0 111
Q ss_pred ccChhccccCCCCccccccchhHHHHHHHhCCCC
Q 006317 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKN 527 (650)
Q Consensus 494 y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p 527 (650)
|.--| ....++++.+-+|=.-++++....+.
T Consensus 197 ~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~~~ 227 (308)
T PF07387_consen 197 MVNIE---YESLTQEAEVKVFVKSCLKLVEKQRS 227 (308)
T ss_pred EEeee---ccccChHHHHHHHHHHHHHHHHHHhc
Confidence 22211 23457788888888888888776543
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.46 E-value=0.6 Score=48.85 Aligned_cols=71 Identities=14% Similarity=0.131 Sum_probs=44.0
Q ss_pred cCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCC--ceeeec---c--eeecCCeeEEEEecCCCCC
Q 006317 335 GGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR--NLVRLL---G--FSFEETERLLIYEFVPNSS 406 (650)
Q Consensus 335 G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~---g--~~~~~~~~~lv~e~~~~gs 406 (650)
+.-..||+....++..+++|+..... ....++..|+..+..|... .++..+ | +...++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 44567999888778889999875432 2344566777777766321 122211 2 1223456778999988764
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.39 E-value=0.39 Score=46.69 Aligned_cols=76 Identities=14% Similarity=0.230 Sum_probs=50.8
Q ss_pred CCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCC---CCceeeecceeecCCeeEEEEecCCCC
Q 006317 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ---HRNLVRLLGFSFEETERLLIYEFVPNS 405 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~e~~~~g 405 (650)
.+.+.-|.--..|.... ...++.||+=.. .....|..|+.-|..|. .-++.+++.+-.+..+.++|+||++-|
T Consensus 21 r~~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 21 REEVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred ccccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 34555555555565443 456788887432 22335777776666654 455777777778889999999999987
Q ss_pred Chh
Q 006317 406 SVD 408 (650)
Q Consensus 406 sL~ 408 (650)
.++
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 776
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 650 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-52 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-51 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-41 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-38 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-23 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-22 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-22 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-21 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-21 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-20 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-20 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-20 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-20 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-20 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-20 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-20 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-20 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-20 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-20 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-20 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-20 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-20 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-20 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-19 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-19 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-17 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-14 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-12 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 8e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 9e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 440 bits (1133), Expect = e-152
Identities = 110/309 (35%), Positives = 164/309 (53%), Gaps = 18/309 (5%)
Query: 305 EINTVESLQFDFSTIRDATNNFS------TDNKLGQGGFGAVYKGRLSHGQEIAVKRLSK 358
E++ F F +++ TNNF NK+G+GGFG VYKG ++ +AVK+L+
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAA 64
Query: 359 ----NSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDA 414
+ + + +F E+ ++A+ QH NLV LLGFS + + L+Y ++PN S+ +
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 415 IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474
L W R KI G A GI +LHE+ IHRD+K++NILLD KISDFG+AR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGE 534
E TSRIVGT YMAPE + G + KSD++SFGV++LEII+G
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH--R 238
Query: 535 EAEDLLTYAWKNWNEGTAL-NLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVV 593
E + LL + +E + + ID + + S+ + + C+ E RP + V
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQ 298
Query: 594 VMLNSSSLS 602
+L + S
Sbjct: 299 QLLQEMTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 418 bits (1077), Expect = e-143
Identities = 118/293 (40%), Positives = 176/293 (60%), Gaps = 6/293 (2%)
Query: 314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG-ELEFKNEVL 372
F ++ A++NFS N LG+GGFG VYKGRL+ G +AVKRL + QG EL+F+ EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGG 431
+++ HRNL+RL GF TERLL+Y ++ N SV + + + + LDW R +I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
ARG+ YLH+ +IIHRD+KA+NILLD + + DFG+A+L + + T+ + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGT 198
Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKN--NSFRIGEEAEDLLTYAWKNWNE 549
G++APEY++ G S K+DVF +GV++LE+I+GQ+ + ++ LL + E
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 550 GTALNLIDPTLR-NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSL 601
L+D L+ N E+ + + + LLC Q + RP M+ VV ML L
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 367 bits (944), Expect = e-123
Identities = 101/296 (34%), Positives = 167/296 (56%), Gaps = 7/296 (2%)
Query: 304 DEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG 363
+ ES + + +ATNNF +G G FG VYKG L G ++A+KR + S QG
Sbjct: 19 SYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG 78
Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ-LDW 422
EF+ E+ ++ +H +LV L+GF E E +LIY+++ N ++ + ++ + + W
Sbjct: 79 IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSW 138
Query: 423 ETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF-EMDQS 481
E R +I G ARG+ YLH + IIHRD+K+ NILLD + +PKI+DFG+++ E+DQ+
Sbjct: 139 EQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195
Query: 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLT 541
T + GT GY+ PEY +G + KSDV+SFGV++ E++ + + E +L
Sbjct: 196 HLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254
Query: 542 YAWKNWNEGTALNLIDPTLRNG-SSSEIMRCVHIGLLCVQENVANRPTMASVVVML 596
+A ++ N G ++DP L + + + + C+ + +RP+M V+ L
Sbjct: 255 WAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 292 bits (748), Expect = 5e-94
Identities = 72/318 (22%), Positives = 125/318 (39%), Gaps = 35/318 (11%)
Query: 307 NTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE 366
+ + + + +G FG V+K +L + +AVK Q +
Sbjct: 7 HHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-Q 64
Query: 367 FKNEVLLVARLQHRNLVRLLGFSFE----ETERLLIYEFVPNSSVDKFIFDAIKRVQLDW 422
+ EV + ++H N+++ +G + + LI F S+ F+ K + W
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSW 120
Query: 423 ETRYKIIGGIARGILYLHED-------SRLRIIHRDLKASNILLDADMIPKISDFGMARL 475
I +ARG+ YLHED + I HRD+K+ N+LL ++ I+DFG+A
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180
Query: 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGH-----FSIKSDVFSFGVLVLEIISGQKNNSF 530
FE +S GDT VGT YMAPE + ++ D+++ G+++ E+ S
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD- 239
Query: 531 RIGEEAEDLLTYAWKNWNEGT--------ALNLIDPTLRNG-SSSEIMRCV-HIGLLCVQ 580
G E +L + + + P LR+ M + C
Sbjct: 240 --GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD 297
Query: 581 ENVANRPTMASVVVMLNS 598
+ R + V +
Sbjct: 298 HDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 245 bits (626), Expect = 8e-76
Identities = 70/339 (20%), Positives = 123/339 (36%), Gaps = 42/339 (12%)
Query: 312 LQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEV 371
++ S +N +G+G +GAVYKG L + +AVK S + Q + K +
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NI 58
Query: 372 LLVARLQHRNLVRLLGFSFE-----ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRY 426
V ++H N+ R + E LL+ E+ PN S+ K++ DW +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSC 114
Query: 427 KIIGGIARGILYLHED------SRLRIIHRDLKASNILLDADMIPKISDFGMARLF---- 476
++ + RG+ YLH + + I HRDL + N+L+ D ISDFG++
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 477 --EMDQSQGDTSRIVGTFGYMAPEY-------VTRGHFSIKSDVFSFGVLVLEIISGQKN 527
+ VGT YMAPE + D+++ G++ EI
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR-CT 233
Query: 528 NSFRIGEEAEDLLTYAWKNWNEGTALNLID--------PTLRNG-SSSEIMRCVHIGLL- 577
+ F E + + + N T ++ P + + +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 578 -CVQENVANRPTMASVVVMLNSSSLSLPLPSQPAFFMHS 615
C ++ R T + + + H
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-63
Identities = 79/331 (23%), Positives = 143/331 (43%), Gaps = 35/331 (10%)
Query: 290 RRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQ 349
++ + + ++ D I + + K+G G FG V++ HG
Sbjct: 5 HHHHPMSDYDIPTTENLYFQGAMDGDDMDIP--WCDLNIKEKIGAGSFGTVHRAEW-HGS 61
Query: 350 EIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSV 407
++AVK L + E EF EV ++ RL+H N+V +G + ++ E++ S+
Sbjct: 62 DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL 121
Query: 408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467
+ + + R QLD R + +A+G+ YLH I+HR+LK+ N+L+D K+
Sbjct: 122 YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKV 180
Query: 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQK 526
DFG++R + + GT +MAPE V R + KSDV+SFGV++ E+ + Q
Sbjct: 181 CDFGLSR--LKASTFLSSKSAAGTPEWMAPE-VLRDEPSNEKSDVYSFGVILWELATLQ- 236
Query: 527 NNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLL-----CVQE 581
+ W ++ EI R ++ + C
Sbjct: 237 ------------------QPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTN 278
Query: 582 NVANRPTMASVVVMLNS-SSLSLPLPSQPAF 611
RP+ A+++ +L ++P P++
Sbjct: 279 EPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 3e-61
Identities = 71/318 (22%), Positives = 124/318 (38%), Gaps = 42/318 (13%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
+ +G+G FG V K + +++A+K++ S + F E+ ++R+ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKA--FIVELRQLSRVNHPNIV 64
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
+L G L+ E+ S+ + A ++G+ YLH
Sbjct: 65 KLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 444 RLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
+IHRDLK N+LL A + KI DFG A Q + G+ +MAPE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEVFEG 177
Query: 503 GHFSIKSDVFSFGVLVLEIISGQ------KNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556
++S K DVFS+G+++ E+I+ + +FRI + GT LI
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV-----------HNGTRPPLI 226
Query: 557 D---PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSLPLPSQPAFFM 613
+ +M C ++ + RP+M +V ++ P +P +
Sbjct: 227 KNLPKPIE-----SLMTR------CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275
Query: 614 HSTMEQDNLEFTSSDQSK 631
+
Sbjct: 276 CQHSLPPGEDGRVEPYVD 293
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 8e-60
Identities = 71/300 (23%), Positives = 121/300 (40%), Gaps = 43/300 (14%)
Query: 330 NKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
LG+G FG K G+ + +K L + + + F EV ++ L+H N+++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRII 448
+++ I E++ ++ I Q W R IA G+ YLH + II
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNII 130
Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR------------IVGTFGYMA 496
HRDL + N L+ + ++DFG+ARL +++Q + R +VG +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556
PE + + K DVFSFG+++ EII A ++ T +
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN----------------ADPDYLPRTMDFGL 234
Query: 557 DPTLRNGSSSEIMRCVHIGLL-----CVQENVANRPTMASVVVMLNS--SSLSLPLPSQP 609
+ +R C + RP+ + L + L+ LP P
Sbjct: 235 N--VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGP 292
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-57
Identities = 72/286 (25%), Positives = 121/286 (42%), Gaps = 45/286 (15%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRL----SKNSVQGELEFKNEVLLVARLQHRNLVRL 385
+G GGFG VY+ G E+AVK ++ Q + E L A L+H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 386 LGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445
G +E L+ EF + + ++ + IARG+ YLH+++ +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPL----NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 446 RIIHRDLKASNILLDADMIP--------KISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
IIHRDLK+SNIL+ + KI+DFG+AR + G + +MAP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWMAP 183
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557
E + FS SDV+S+GVL+ E+++G+ ++ + +
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEV----------------PFRGIDGLAVAYGV- 226
Query: 558 PTLRNGSSSEIMRCVHIGLL-----CVQENVANRPTMASVVVMLNS 598
N + I C + +RP+ +++ L +
Sbjct: 227 --AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-56
Identities = 77/292 (26%), Positives = 134/292 (45%), Gaps = 53/292 (18%)
Query: 330 NKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL-------EFKNEVLLVARLQHRN 381
++G+GGFG V+KGR + +A+K L +GE EF+ EV +++ L H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 382 LVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
+V+L G ++ EFVP + + D K + W + +++ IA GI Y+
Sbjct: 85 IVKLYGLM---HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 441 EDSRLRIIHRDLKASNILLD-----ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
+ I+HRDL++ NI L A + K++DFG+++ QS S ++G F +M
Sbjct: 140 -NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWM 193
Query: 496 APE--YVTRGHFSIKSDVFSFGVLVLEIISGQK----NNSFRIGEEAEDLLTYAWKNWNE 549
APE ++ K+D +SF +++ I++G+ + +I + E
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI--------KFINMIREE 245
Query: 550 GTALNL---IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598
G + P LRN ++ LC + RP + +V L+
Sbjct: 246 GLRPTIPEDCPPRLRN-----VIE------LCWSGDPKKRPHFSYIVKELSE 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 5e-55
Identities = 59/283 (20%), Positives = 108/283 (38%), Gaps = 45/283 (15%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRNLVRLLG 387
KL + G ++KGR G +I VK L +F E + H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 388 FSFEETERLL--IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRL 445
I ++P S+ + + +D K +ARG+ +LH L
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-- 503
I L + ++++D DM +IS + F+ + ++APE +
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------MYAPAWVAPE-ALQKKP 184
Query: 504 --HFSIKSDVFSFGVLVLEIISGQ---KNNSFRIGEEAEDLLTYAWKNWNEGTALNL--- 555
+D++SF VL+ E+++ + + S + K EG +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFADLSN---------MEIGMKVALEGLRPTIPPG 235
Query: 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598
I P + +M+ +C+ E+ A RP +V +L
Sbjct: 236 ISPHVSK-----LMK------ICMNEDPAKRPKFDMIVPILEK 267
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-54
Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 13/201 (6%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRNLVRLLG 387
++G G FG VYKG+ HG ++AVK L+ + + FKNEV ++ + +H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
+S + ++ ++ SS+ + + + + I ARG+ YLH I
Sbjct: 88 YSTAP-QLAIVTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLH---AKSI 141
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE---YVTRGH 504
IHRDLK++NI L D KI DFG+A ++ G+ +MAPE
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 505 FSIKSDVFSFGVLVLEIISGQ 525
+S +SDV++FG+++ E+++GQ
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 5e-54
Identities = 69/304 (22%), Positives = 117/304 (38%), Gaps = 44/304 (14%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRNLVRLLG 387
+G+G FG VY GR HG E+A++ + + FK EV+ + +H N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRI 447
+I ++ + D ++ LD +I I +G+ YLH I
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 448 IHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI---VGTFGYMAPE------ 498
+H+DLK+ N+ D + I+DFG+ + + Q+ ++ G ++APE
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 499 ---YVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555
+ FS SDVF+ G + E+ + + +K +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREW----------------PFKTQPAEAIIWQ 254
Query: 556 ID----PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSLPLPSQPAF 611
+ P L + + I L C RPT ++ ML S P
Sbjct: 255 MGTGMKPNLSQIGMGKEIS--DILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGH 312
Query: 612 FMHS 615
F S
Sbjct: 313 FWKS 316
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-52
Identities = 68/298 (22%), Positives = 122/298 (40%), Gaps = 41/298 (13%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNE--VLLVARLQHRNLVRLLG 387
+G+G +G V++G G+ +AVK S + E + E + L+H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 388 ----FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
T+ LI + S+ +D ++ LD + +I+ IA G+ +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 444 RLR-----IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI--VGTFGYMA 496
I HRDLK+ NIL+ + I+D G+A + +Q D VGT YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 497 PE------YVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG 550
PE V + D+++FG+++ E+ +N G + + N+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN----GIVEDYKPPFYDVVPNDP 241
Query: 551 TALNLID--------PTLRNGSSSEIMRCVHIGLL--CVQENVANRPTMASVVVMLNS 598
+ ++ P + N S+ L+ C +N + R T + L
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 5e-52
Identities = 70/296 (23%), Positives = 125/296 (42%), Gaps = 35/296 (11%)
Query: 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNE--VLLVARLQHRNLVRLL 386
++G+G +G V+ G+ G+++AVK E + E + ++H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFI 97
Query: 387 G----FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
+ T+ LI ++ N S+ +D +K LD ++ K+ G+ +LH +
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 443 SRLR-----IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI--VGTFGYM 495
I HRDLK+ NIL+ + I+D G+A F D ++ D VGT YM
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 496 APE------YVTRGHFSIKSDVFSFGVLVL-EIISGQKNN----SFRIGEEAEDLLTYAW 544
PE I +D++SFG L+L E+ + +++ ++
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFG-LILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 545 KNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLL--CVQENVANRPTMASVVVMLNS 598
++ E + + P+ N SS+ L+ C N A+R T V L
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-50
Identities = 68/299 (22%), Positives = 121/299 (40%), Gaps = 41/299 (13%)
Query: 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNE--VLLVARLQHRNLVRLL 386
+G+G FG V++G+ G+E+AVK S + E + E + L+H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFI 102
Query: 387 G----FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
+ T+ L+ ++ + S+ FD + R + E K+ A G+ +LH +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 443 -----SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI--VGTFGYM 495
+ I HRDLK+ NIL+ + I+D G+A + D + VGT YM
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 496 APE------YVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNE 549
APE + ++D+++ G++ EI G + L Y ++
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG----GIHEDYQLPYYDLVPSD 274
Query: 550 GTALNLID--------PTLRNGSSSEIMRCVHIGLL--CVQENVANRPTMASVVVMLNS 598
+ + P + N S V ++ C N A R T + L+
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 8e-44
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRN 381
+ ++G+G FG V+ GRL + +AVK + + +F E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
+VRL+G ++ ++ E V F+ + +L +T +++G A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY----MAP 497
IHRDL A N L+ + KISDFGM+R G + G AP
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA----DGVYAASGGLRQVPVKWTAP 284
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS 523
E + G +S +SDV+SFG+L+ E S
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFS 310
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
+ + ++G G FG V+ G + ++A+K + + E +F E ++ +L H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
+L G E+ L+ EF+ + + ++ +R ET + + G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVT 501
+IHRDL A N L+ + + K+SDFGM R DQ TS F +PE +
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFS 178
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
+S KSDV+SFGVL+ E+ S
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFS 200
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 69/290 (23%), Positives = 129/290 (44%), Gaps = 38/290 (13%)
Query: 330 NKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLV 383
LG+G FG V R + G+++AVK L S + + K E+ ++ L H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 384 RLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
+ G E+ LI EF+P+ S+ +++ + +++ + + K I +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ-----SQGDTSRIVGTFGYMA 496
+ +HRDL A N+L++++ KI DFG+ + E D+ S + + A
Sbjct: 145 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV----FWYA 197
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555
PE + + F I SDV+SFGV + E+++ ++S T+ +N
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR--LVNT 255
Query: 556 ID-----PTLRNGSSS--EIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598
+ P N ++M C + +NR + +++ +
Sbjct: 256 LKEGKRLPCPPNCPDEVYQLM------RKCWEFQPSNRTSFQNLIEGFEA 299
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-42
Identities = 79/361 (21%), Positives = 146/361 (40%), Gaps = 70/361 (19%)
Query: 310 ESLQFDFSTIRDAT----NNFSTDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNS 360
+D T + ++LG+G FG+V R + G +AVK+L +
Sbjct: 5 HHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG 64
Query: 361 VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRV 418
+ +F+ E+ ++ L +V+ G S+ + L+ E++P+ + F+ R
Sbjct: 65 PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRA 122
Query: 419 QLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478
+LD I +G+ YL R +HRDL A NIL++++ KI+DFG+A+L +
Sbjct: 123 RLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179
Query: 479 DQSQGDTSRIVGTFGY------------MAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQ 525
D+ Y APE ++ FS +SDV+SFGV++ E+ +
Sbjct: 180 DKDY-----------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228
Query: 526 KNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRC-------VH-IGLL 577
K+ S + L++ L G + + VH + L
Sbjct: 229 KSCSPSAEFLRMMGCERDVPALSR-----LLE-LLEEG---QRLPAPPACPAEVHELMKL 279
Query: 578 CVQENVANRPTMASVVVMLNSSSLSLPLPSQPAFFMHSTMEQDNLEFTSSDQSKSGSIHF 637
C + +RP+ +++ L+ + + FT+ + K S+ F
Sbjct: 280 CWAPSPQDRPSFSALGPQLDM-------------LWSGSRGCETHAFTAHPEGKHHSLSF 326
Query: 638 T 638
+
Sbjct: 327 S 327
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-42
Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
+ + +LG G FG V G+ ++A+K + + S+ + EF E ++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLV 82
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
+L G ++ +I E++ N + ++ + R + + ++ + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVT 501
+ +HRDL A N L++ + K+SDFG++R D+ TS + F PE +
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLM 194
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
FS KSD+++FGVL+ EI S
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYS 216
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-41
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
+ +LG G FG V G+ ++AVK + + S+ + EF E + +L H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLV 66
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
+ G +E ++ E++ N + ++ L+ ++ + G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVT 501
+ IHRDL A N L+D D+ K+SDFGM R DQ S + F APE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFH 178
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
+S KSDV++FG+L+ E+ S
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFS 200
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-41
Identities = 63/205 (30%), Positives = 106/205 (51%), Gaps = 14/205 (6%)
Query: 329 DNKLGQGGFGAVYKGRLSHGQE---IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVR 384
D +LG G FG+V +G ++ +A+K L + + + + E E ++ +L + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
L+G E +L+ E + KF+ KR ++ +++ ++ G+ YL
Sbjct: 75 LIGVCQAEA-LMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EE 128
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTR 502
+HRDL A N+LL KISDFG+++ D S T+R G + + APE +
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSAGKWPLKWYAPECINF 187
Query: 503 GHFSIKSDVFSFGVLVLEIIS-GQK 526
FS +SDV+S+GV + E +S GQK
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-41
Identities = 74/288 (25%), Positives = 130/288 (45%), Gaps = 34/288 (11%)
Query: 330 NKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
+LG+G FG+V R + G+ +AVK+L ++ + +F+ E+ ++ LQH N+V+
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 385 LLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
G + R LI E++P S+ ++ + ++D + I +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGT- 132
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ-----SQGDTSRIVGTFGYMAP 497
R IHRDL NIL++ + KI DFG+ ++ D+ + S I + AP
Sbjct: 133 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI----FWYAP 186
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557
E +T FS+ SDV+SFGV++ E+ + + + E + + L+
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
Query: 558 PTLR----NGSSSE---IMRCVHIGLLCVQENVANRPTMASVVVMLNS 598
R +G E IM C NV RP+ + + ++
Sbjct: 247 NNGRLPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQ 288
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 329 DNKLGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGE-LEFKNEVLLVARLQHRNLV 383
+ +G G G V GRL +++ A+K L + + +F +E ++ + H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
RL G +++ E++ N S+D F+ Q ++ G+ G+ YL S
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVT 501
L +HRDL A N+L+D++++ K+SDFG++R+ E D + G APE +
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE-DDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 502 RGHFSIKSDVFSFGVLVLEIIS 523
FS SDV+SFGV++ E+++
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 60/208 (28%), Positives = 112/208 (53%), Gaps = 14/208 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGE-LEFKNEVLLVARL 377
+ + +G G FG VYKG L +A+K L + + ++F E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
H N++RL G + ++I E++ N ++DKF+ + K + ++ GIA G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 161
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--M 495
YL + + +HRDL A NIL++++++ K+SDFG++R+ E D + + G
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTTSGGKIPIRWT 217
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIIS 523
APE ++ F+ SDV+SFG+++ E+++
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 69/290 (23%), Positives = 116/290 (40%), Gaps = 40/290 (13%)
Query: 330 NKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLV 383
LG+G FG V G+ +AVK L ++ +K E+ ++ L H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 384 RLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
+ G + L+ E+VP S+ ++ R + I G+ YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG-----YMA 496
IHRDL A N+LLD D + KI DFG+A+ + R V G + A
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYR-VREDGDSPVFWYA 205
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555
PE + F SDV+SFGV + E+++ + S + L
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR--LTEL 263
Query: 556 IDPTLR----NGSSSE---IMRCVHIGLLCVQENVANRPTMASVVVMLNS 598
++ R + +E +M C + + RPT +++ +L +
Sbjct: 264 LERGERLPRPDKCPAEVYHLM------KNCWETEASFRPTFENLIPILKT 307
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-41
Identities = 74/288 (25%), Positives = 130/288 (45%), Gaps = 34/288 (11%)
Query: 330 NKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR 384
+LG+G FG+V R + G+ +AVK+L ++ + +F+ E+ ++ LQH N+V+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 385 LLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
G + R LI E++P S+ ++ + ++D + I +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGT- 163
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ-----SQGDTSRIVGTFGYMAP 497
R IHRDL NIL++ + KI DFG+ ++ D+ + S I + AP
Sbjct: 164 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI----FWYAP 217
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557
E +T FS+ SDV+SFGV++ E+ + + + E + + L+
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277
Query: 558 PTLR----NGSSSE---IMRCVHIGLLCVQENVANRPTMASVVVMLNS 598
R +G E IM C NV RP+ + + ++
Sbjct: 278 NNGRLPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVDQ 319
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 13/210 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQE-----IAVKRLSKNSVQGEL-EFKNEVLLVARL 377
F LG G FG VYKG E +A+K L + + E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
+ ++ RLLG T LI + +P + ++ + + + + IA+G+
Sbjct: 75 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
YL R++HRDL A N+L+ KI+DFG+A+L ++ + +MA
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
E + ++ +SDV+S+GV V E+++ G K
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-41
Identities = 69/196 (35%), Positives = 108/196 (55%), Gaps = 11/196 (5%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
+LG G FG V+ G + ++AVK L + S+ + F E L+ +LQH+ LVRL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVV 77
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
+E +I E++ N S+ F+ ++L + IA G+ ++ IH
Sbjct: 78 TQE-PIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI---EERNYIH 132
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVTRGHFSI 507
RDL+A+NIL+ + KI+DFG+ARL E ++ T+R F APE + G F+I
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 508 KSDVFSFGVLVLEIIS 523
KSDV+SFG+L+ EI++
Sbjct: 190 KSDVWSFGILLTEIVT 205
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-41
Identities = 61/207 (29%), Positives = 107/207 (51%), Gaps = 13/207 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGE-LEFKNEVLLVARLQ 378
N S D +G G FG V GRL + +A+K L + + +F E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
H N++RL G + +++ E++ N S+D F+ Q ++ GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKY 162
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MA 496
L S + +HRDL A NIL++++++ K+SDFG+ R+ E D + + G +
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE-DDPEAAYTTRGGKIPIRWTS 218
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIIS 523
PE + F+ SDV+S+G+++ E++S
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-40
Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 11/203 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
+ + +KLG G +G VY+G + +AVK L +++++ E EF E ++ ++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 71
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
V+LLG E +I EF+ ++ ++ + R ++ + I+ + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYV 500
+ IHRDL A N L+ + + K++DFG++RL D T+ F APE +
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESL 184
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
FSIKSDV++FGVL+ EI +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 71/334 (21%), Positives = 133/334 (39%), Gaps = 56/334 (16%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQE-----IAVKRLSKNSVQGEL-EFKNEVLLVARL 377
F LG G FG VYKG E +A+K L + + E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
+ ++ RLLG T LI + +P + ++ + + + + IA+G+
Sbjct: 75 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
YL R++HRDL A N+L+ KI+DFG+A+L ++ + +MA
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556
E + ++ +SDV+S+GV V E+++ G K + +++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSK----------------PYDGIPASEISSIL 232
Query: 557 DPTLR----NGSSSE---IMRCVHIGLLCVQENVANRPTMASVVVML------------- 596
+ R + + IM + C + +RP +++
Sbjct: 233 EKGERLPQPPICTIDVYMIM------VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 286
Query: 597 -NSSSLSLPLPSQPAFFMHSTMEQDNLEFTSSDQ 629
+ LP P+ F+ E+D + +D+
Sbjct: 287 QGDERMHLPSPTDSNFYRALMDEEDMDDVVDADE 320
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 329 DNKLGQGGFGAVYKGRL-SHGQEI--AVKRLSKNSVQGEL--EFKNEVLLVARLQHRNLV 383
D +LG G FG V KG AVK L + L E E ++ +L + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
R++G E+ +L+ E ++K++ + + + +++ ++ G+ YL
Sbjct: 82 RMIGICEAES-WMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---E 134
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVT 501
+HRDL A N+LL KISDFG+++ D++ ++ G + + APE +
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQTHGKWPVKWYAPECIN 193
Query: 502 RGHFSIKSDVFSFGVLVLEIIS-GQK 526
FS KSDV+SFGVL+ E S GQK
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-40
Identities = 65/196 (33%), Positives = 103/196 (52%), Gaps = 11/196 (5%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
KLG G FG V+ + ++AVK + K F E ++ LQH LV+L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
+E +I EF+ S+ F+ + + IA G+ ++ + IH
Sbjct: 253 TKEP-IYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVTRGHFSI 507
RDL+A+NIL+ A ++ KI+DFG+AR+ E ++ T+R F APE + G F+I
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 508 KSDVFSFGVLVLEIIS 523
KSDV+SFG+L++EI++
Sbjct: 365 KSDVWSFGILLMEIVT 380
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 9e-40
Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 328 TDNKLGQGGFGAVYKGRLSHGQE---IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLV 383
D +LG G FG+V +G ++ +A+K L + + + + E E ++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
RL+G E +L+ E + KF+ KR ++ +++ ++ G+ YL
Sbjct: 400 RLIGVCQAEA-LMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVT 501
+HR+L A N+LL KISDFG+++ D S T+R G + APE +
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY-YTARSAGKWPLKWYAPECIN 512
Query: 502 RGHFSIKSDVFSFGVLVLEIIS-GQK 526
FS +SDV+S+GV + E +S GQK
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 330 NKLGQGGFGAVYKGRLSHGQE------IAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
+LG+G FG V+ + +AVK L + S +F+ E L+ LQH+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKF------------IFDAIKRVQLDWETRYKIIGG 431
R G E L+++E++ + +++F + + L +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
+A G++YL + L +HRDL N L+ ++ KI DFGM+R D D R VG
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYR-VGG 218
Query: 492 FG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+M PE + F+ +SDV+SFGV++ EI +
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-39
Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 11/197 (5%)
Query: 330 NKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF 388
+KLG G +G VY+G + +AVK L +++++ E EF E ++ ++H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 284
Query: 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRII 448
E +I EF+ ++ ++ + R ++ + I+ + YL + I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340
Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVTRGHFS 506
HR+L A N L+ + + K++DFG++RL D T+ F APE + FS
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 507 IKSDVFSFGVLVLEIIS 523
IKSDV++FGVL+ EI +
Sbjct: 398 IKSDVWAFGVLLWEIAT 414
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 330 NKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
+LG+G FG V+ +AVK L ++ +F+ E L+ LQH ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLDWETRYKIIG 430
+ G + ++++E++ + ++KF + +L I
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
IA G++YL + +HRDL N L+ A+++ KI DFGM+R D D R VG
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYR-VG 192
Query: 491 TFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+M PE + F+ +SDV+SFGV++ EI +
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQ 378
+G+G FG V++G + A+K + +F E L + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
H ++V+L+G E +I E + F+ ++ LD + ++ + Y
Sbjct: 75 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 131
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT---FGYM 495
L R +HRD+ A N+L+ ++ K+ DFG++R E + +M
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWM 184
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIIS 523
APE + F+ SDV+ FGV + EI+
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILM 212
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 49/227 (21%), Positives = 89/227 (39%), Gaps = 41/227 (18%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRL--------SHGQEIAVKRLSKNSVQGELEFKNEVLLVA 375
+ + LGQG F ++KG H E+ +K L K F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 376 RLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARG 435
+L H++LV G E +L+ EFV S+D ++ + ++ + ++ +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAA 125
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIP--------KISDFGMARLFEMDQSQGDTSR 487
+ +L +IH ++ A NILL + K+SD G++
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 488 IVGTFGY------MAPE-YVTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
+ PE + ++ +D +SFG + EI S G K
Sbjct: 176 -----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 329 DNKLGQGGFGAVYKGRLSHG----QEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLV 383
+ +G+G FG VY G L AVK L++ + GE+ +F E +++ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 384 RLLGFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
LLG E L++ ++ + + FI + + + +A+G+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLAS- 146
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG------YMA 496
+ +HRDL A N +LD K++DFG+AR D + + G +MA
Sbjct: 147 --KKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIIS 523
E + F+ KSDV+SFGVL+ E+++
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 61/213 (28%), Positives = 90/213 (42%), Gaps = 17/213 (7%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL---EFKNEVLLVAR 376
+ KLG G FG V +G G+ + AVK L + + +F EV +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
L HRNL+RL G ++ E P S+ + + T + +A G+
Sbjct: 78 LDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 134
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY-- 494
YL R IHRDL A N+LL + KI DFG+ R + + +
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY-VMQEHRKVPFAW 190
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQK 526
APE + FS SD + FGV + E+ + GQ+
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 329 DNKLGQGGFGAVYKGRLSHGQE-----IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNL 382
LG G FG V+KG E + +K + S + + +L + L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
VRLLG + L+ +++P S+ + R L + IA+G+ YL
Sbjct: 78 VRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL--- 131
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
++HR+L A N+LL + +++DFG+A L D Q S +MA E +
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 503 GHFSIKSDVFSFGVLVLEIIS-GQK 526
G ++ +SDV+S+GV V E+++ G +
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 13/203 (6%)
Query: 329 DNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLV 383
D +G+G FG VY G + A+K LS+ + ++ F E LL+ L H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 384 RLLGFSFEETERLLI-YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
L+G + ++ + + +FI + + +ARG+ YL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYL--- 140
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF--GYMAPEYV 500
+ + +HRDL A N +LD K++DFG+AR + + A E +
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
F+ KSDV+SFGVL+ E+++
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT 223
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 4e-39
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 330 NKLGQGGFGAVYKGRL------SHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNL 382
+LG+ FG VYKG L Q +A+K L EF++E +L ARLQH N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLDWETRYKII 429
V LLG ++ +I+ + + + +F D + L+ ++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
IA G+ YL S ++H+DL N+L+ + KISD G+ R D ++
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY----AADYYKL- 186
Query: 490 GTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+MAPE + G FSI SD++S+GV++ E+ S
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-39
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRL--SHGQEI--AVKRLSKN-SVQGELEFKNEVLLVARLQ 378
+ + LG+G FG VY+G G++I AVK K+ ++ + +F +E +++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
H ++V+L+G EE +I E P + ++ + L T I + + Y
Sbjct: 72 HPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAY 128
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT---FGYM 495
L + +HRD+ NIL+ + K+ DFG++R E + D + T +M
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE----DYYKASVTRLPIKWM 181
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+PE + F+ SDV+ F V + EI+S
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 8e-39
Identities = 65/308 (21%), Positives = 124/308 (40%), Gaps = 47/308 (15%)
Query: 296 QKQNLRKADEINTVESLQFDFSTIRDATNNFS-TDNKLGQGGFGAVYKGR-LSHGQEIAV 353
Q++ ++ D+I +E+ F D ++G+G F VYKG E+A
Sbjct: 1 QEERNQQQDDIEELETKAVG----MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAW 56
Query: 354 K--RLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGF---SFEETERLLIY-EFVPNSSV 407
+ K + FK E ++ LQH N+VR + + + +++ E + + ++
Sbjct: 57 CELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL 116
Query: 408 DKFIFDAIKRVQ-LDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIP 465
++ KR + + + I +G+ +LH + IIHRDLK NI +
Sbjct: 117 KTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSV 171
Query: 466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
KI D G+A L + ++GT +MAPE + DV++FG+ +LE+ + +
Sbjct: 172 KIGDLGLATL----KRASFAKAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSE 226
Query: 526 KNNSFRIGEEAEDLLTYAWKNWNEGTALNLI-----DPTLRNGSSSEIMRCVHIGLLCVQ 580
Y + + P + + ++ I C++
Sbjct: 227 ----------------YPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK--EIIEGCIR 268
Query: 581 ENVANRPT 588
+N R +
Sbjct: 269 QNKDERYS 276
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-39
Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
+G+G FG V G G ++AVK + ++ F E ++ +L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLV 77
Query: 384 RLLGFSFEETERLLI-YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
+LLG EE L I E++ S+ ++ R L + K + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYV 500
+HRDL A N+L+ D + K+SDFG+ + + +++ G APE +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEAL 186
Query: 501 TRGHFSIKSDVFSFGVLVLEIIS 523
FS KSDV+SFG+L+ EI S
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYS 209
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
+F +G GGFG V+K + G+ +KR+ N+ + + EV +A+L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDK---FI----------FDAIKR---VQLDWETRY 426
V G ++ + +S FI I++ +LD
Sbjct: 67 VHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486
++ I +G+ Y+H ++I+RDLK SNI L KI DFG+ + + G +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK---NDGKRT 179
Query: 487 RIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK 526
R GT YM+PE ++ + + D+++ G+++ E++
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 50/234 (21%), Positives = 100/234 (42%), Gaps = 25/234 (10%)
Query: 308 TVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGEL-- 365
+ + F ++ +S ++G GG V++ Q A+K ++ +
Sbjct: 12 DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD 71
Query: 366 EFKNEVLLVARLQHRNL--VRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDW 422
++NE+ + +LQ + +RL + + + ++ E N ++ ++ K+ +D
Sbjct: 72 SYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECG-NIDLNSWL---KKKKSIDP 126
Query: 423 ETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482
R + + +H+ I+H DLK +N L+ M+ K+ DFG+A + D +
Sbjct: 127 WERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTS 182
Query: 483 GDTSRIVGTFGYMAPE-----------YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
VGT YM PE ++ S KSDV+S G ++ + G+
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 68/213 (31%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 330 NKLGQGGFGAVYKGRL------SHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNL 382
LG G FG VY+G++ ++AVK L + S Q EL+F E L++++ H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFI----FDAIKRVQLDWETRYKIIGGIARGILY 438
VR +G S + R ++ E + + F+ + L + IA G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 439 LHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY- 494
L IHRD+ A N LL + KI DFGMAR D + R G
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYR-KGGCAML 207
Query: 495 ----MAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
M PE G F+ K+D +SFGVL+ EI S
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 31/228 (13%)
Query: 323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN 381
++F LGQG FG V K R + A+K++ + +EV+L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQY 63
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFI----------FDAIKRVQLDWETRY--KII 429
+VR ++ E + FI +D I L+ + ++
Sbjct: 64 VVRYYA-AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE------------ 477
I + Y+H IIHRDLK NI +D KI DFG+A+
Sbjct: 123 RQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 478 MDQSQGDTSRIVGTFGYMAPEYVT-RGHFSIKSDVFSFGVLVLEIISG 524
+ S + + +GT Y+A E + GH++ K D++S G++ E+I
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 66/296 (22%), Positives = 125/296 (42%), Gaps = 18/296 (6%)
Query: 241 LSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQKQNL 300
+SP + S+++G +V I ++ L T ++ + +
Sbjct: 1 MSPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQG 60
Query: 301 RKADEINTVESLQFDFSTIRDATNNFSTDN-----KLGQGGFGAVYKGRLSHG----QEI 351
I+ ++ S+ +G+G FG VY G L
Sbjct: 61 ANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC 120
Query: 352 AVKRLSKNSVQGEL-EFKNEVLLVARLQHRNLVRLLGFSFE-ETERLLIYEFVPNSSVDK 409
AVK L++ + GE+ +F E +++ H N++ LLG E L++ ++ + +
Sbjct: 121 AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 180
Query: 410 FIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD 469
FI + + + +A+G+ +L + + +HRDL A N +LD K++D
Sbjct: 181 FIRN--ETHNPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVAD 235
Query: 470 FGMARLFEMDQSQGDTSRIVGTF--GYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
FG+AR + ++ +MA E + F+ KSDV+SFGVL+ E+++
Sbjct: 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-38
Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 17/197 (8%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
+G+G FG V G G ++AVK + ++ F E ++ +L+H NLV+LLG
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 390 FEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRII 448
EE L ++ E++ S+ ++ R L + K + + YL +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 311
Query: 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVTRGHFS 506
HRDL A N+L+ D + K+SDFG+ + + +++ G APE + FS
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 507 IKSDVFSFGVLVLEIIS 523
KSDV+SFG+L+ EI S
Sbjct: 365 TKSDVWSFGILLWEIYS 381
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-38
Identities = 68/213 (31%), Positives = 97/213 (45%), Gaps = 27/213 (12%)
Query: 330 NKLGQGGFGAVYKGRL------SHGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNL 382
LG G FG VY+G++ ++AVK L + S Q EL+F E L++++ H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFI----FDAIKRVQLDWETRYKIIGGIARGILY 438
VR +G S + R ++ E + + F+ + L + IA G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 439 LHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY- 494
L IHRD+ A N LL + KI DFGMAR D + R G
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYR-KGGCAML 248
Query: 495 ----MAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
M PE G F+ K+D +SFGVL+ EI S
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 330 NKLGQGGFGAVYKGRLSHGQE------IAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNL 382
+LGQG FG VY+G + +A+K +++ + E EF NE ++ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKF-------IFDAIKRVQLDWETRYKIIGGIARG 435
VRLLG + L+I E + + + + + ++ G IA G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY- 494
+ YL+ + +HRDL A N ++ D KI DFGM R D + D R G G
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR-KGGKGLL 202
Query: 495 ----MAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
M+PE + G F+ SDV+SFGV++ EI +
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-38
Identities = 53/209 (25%), Positives = 86/209 (41%), Gaps = 20/209 (9%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKN--SVQGELEFKNEVLLVARL-QHR 380
+F ++LG G +G V+K R G+ AVKR + EV ++ QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 381 NLVRLLGFSFEETERLLIY-EFVPNSSVDKFIFDAIKR--VQLDWETRYKIIGGIARGIL 437
VRL ++EE L + E S + + L + + +
Sbjct: 118 CCVRLEQ-AWEEGGILYLQTELCGPS-----LQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
+LH ++H D+K +NI L K+ DFG+ + G G YMAP
Sbjct: 172 HLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAP 225
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQK 526
E + +G + +DVFS G+ +LE+ +
Sbjct: 226 E-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-38
Identities = 65/196 (33%), Positives = 105/196 (53%), Gaps = 11/196 (5%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
KLGQG FG V+ G + +A+K L ++ E F E ++ +L+H LV+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
EE ++ E++ S+ F+ L + IA G+ Y+ R+ +H
Sbjct: 249 SEEP-IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 303
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVTRGHFSI 507
RDL+A+NIL+ +++ K++DFG+ARL E ++ T+R F APE G F+I
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 508 KSDVFSFGVLVLEIIS 523
KSDV+SFG+L+ E+ +
Sbjct: 361 KSDVWSFGILLTELTT 376
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 55/244 (22%), Positives = 101/244 (41%), Gaps = 22/244 (9%)
Query: 290 RRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHG 348
+ ++ + + E L+ R+ + + ++G+G FG V++ + G
Sbjct: 24 SAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTG 83
Query: 349 QEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY-EFVPNSSV 407
+ AVK++ + E++ A L +V L G + E + I+ E + S+
Sbjct: 84 FQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYG-AVREGPWVNIFMELLEGGSL 137
Query: 408 DKFI--FDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465
+ I + + + G+ YLH RI+H D+KA N+LL +D
Sbjct: 138 GQLIKQMGCLPEDRALYYLGQ-----ALEGLEYLHTR---RILHGDVKADNVLLSSDGSR 189
Query: 466 -KISDFGMARLFEMDQSQGDTSR---IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEI 521
+ DFG A + D I GT +MAPE V K D++S ++L +
Sbjct: 190 AALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM 249
Query: 522 ISGQ 525
++G
Sbjct: 250 LNGC 253
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-37
Identities = 65/196 (33%), Positives = 105/196 (53%), Gaps = 11/196 (5%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
KLGQG FG V+ G + +A+K L ++ E F E ++ +L+H LV+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
EE ++ E++ S+ F+ L + IA G+ Y+ R+ +H
Sbjct: 332 SEEP-IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 386
Query: 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY--MAPEYVTRGHFSI 507
RDL+A+NIL+ +++ K++DFG+ARL E ++ T+R F APE G F+I
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 508 KSDVFSFGVLVLEIIS 523
KSDV+SFG+L+ E+ +
Sbjct: 444 KSDVWSFGILLTELTT 459
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-37
Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 12/208 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE---FKNEVLLVARLQH 379
NF + K+G+G F VY+ L G +A+K++ + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 380 RNLVRLLGFSFEETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWETR-YKIIGGIARGIL 437
N+++ SF E L I E + + I K+ +L E +K + +
Sbjct: 92 PNVIKYYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
++H R++HRD+K +N+ + A + K+ D G+ R F + + +VGT YM+P
Sbjct: 151 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSP 205
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
E + ++ KSD++S G L+ E+ + Q
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
LG+G +G VY GR LS+ IA+K + + + E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 391 EETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
E + I+ E VP S+ + ++ + +T I G+ YLH++ +I+H
Sbjct: 90 EN-GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 450 RDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV---TRGHF 505
RD+K N+L++ + KISDFG ++ +T GT YMAPE + RG+
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGY- 202
Query: 506 SIKSDVFSFGVLVLEIISGQ 525
+D++S G ++E+ +G+
Sbjct: 203 GKAADIWSLGCTIIEMATGK 222
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 49/218 (22%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRN 381
+S ++G GG V++ Q A+K ++ + ++NE+ + +LQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 382 L--VRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
+RL + + + ++ E N ++ ++ K+ +D R + +
Sbjct: 69 DKIIRLYDY-EITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHT 123
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
+H+ I+H DLK +N L+ M+ K+ DFG+A + D + VGT YM PE
Sbjct: 124 IHQ---HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 499 -----------YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
++ S KSDV+S G ++ + G+
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 11/206 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV-QGELEF-KNEVLLVARLQHR 380
+ K+G+G FG + G++ +K ++ + + E E + EV ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 381 NLVRLLGFSFEETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
N+V+ SFEE L I ++ + K I K V + I + ++
Sbjct: 84 NIVQYRE-SFEENGSLYIVMDYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHV 141
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
H+ +I+HRD+K+ NI L D ++ DFG+AR+ +GT Y++PE
Sbjct: 142 HDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEI 196
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
++ KSD+++ G ++ E+ + +
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLK 222
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 27/219 (12%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQE----IAVKRLSKN--SVQGELEFKNEVLLVARL 377
N LG+G FG+V +G L +AVK + + S + EF +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 378 QHRNLVRLLGFSFEE-----TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG-- 430
H N++RLLG E + ++I F+ + ++ + ++
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 431 -GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
IA G+ YL S +HRDL A N +L DM ++DFG+++ GD R
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYR-Q 205
Query: 490 GTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
G ++A E + ++ KSDV++FGV + EI +
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 60/264 (22%), Positives = 107/264 (40%), Gaps = 40/264 (15%)
Query: 325 NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEV-LLVARLQHRNLV 383
+F + LG G G + + +++AVKR+ EV LL +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVI 81
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETR--YKIIGGIARGILYLHE 441
R + + + E + + +++ ++ G+ +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCAATL-----QEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 442 DSRLRIIHRDLKASNILL-----DADMIPKISDFGMARLFEMDQ-SQGDTSRIVGTFGYM 495
L I+HRDLK NIL+ + ISDFG+ + + + S S + GT G++
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 496 APEYVTR---GHFSIKSDVFSFGVLVLEIISG---------QKNNSFRIGEEAEDLLTYA 543
APE ++ + + D+FS G + +IS Q+ + +G + D L +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL-HP 252
Query: 544 WKNWNEGTALNLI------DPTLR 561
K+ + A LI DP R
Sbjct: 253 EKHEDV-IARELIEKMIAMDPQKR 275
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRN 381
+ + + LGQG V++GR G A+K + S ++ E ++ +L H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 382 LVRLLGFSFEETERL--LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
+V+L E T R LI EF P S+ + + L ++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 440 HEDSRLRIIHRDLKASNILL----DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
E I+HR++K NI+ D + K++DFG AR E D Q + + GT Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTEEYL 182
Query: 496 APEYVTRG--------HFSIKSDVFSFGVLVLEIISGQ 525
P+ R + D++S GV +G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 65/213 (30%), Positives = 115/213 (53%), Gaps = 13/213 (6%)
Query: 317 STIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQG---ELEFKNEVL 372
+ I + +F N LG+G F VY+ + G E+A+K + K ++ +NEV
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 373 LVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG 431
+ +L+H +++ L + FE++ + L+ E N +++++ + +K + E R+ +
Sbjct: 64 IHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-ENEARH-FMHQ 120
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
I G+LYLH I+HRDL SN+LL +M KI+DFG+A +M + T + GT
Sbjct: 121 IITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGT 175
Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
Y++PE TR ++SDV+S G + ++ G
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 41/227 (18%)
Query: 330 NKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARLQHRNL 382
+G+G FG V++ R +AVK L + + +F+ E L+A + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKF---------------------IFDAIKRVQLD 421
V+LLG L++E++ +++F + L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
+ I +A G+ YL S + +HRDL N L+ +M+ KI+DFG++R +
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NIY 225
Query: 482 QGDTSRIVGTFGY-----MAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
D + M PE + ++ +SDV+++GV++ EI S
Sbjct: 226 SADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 62/312 (19%), Positives = 118/312 (37%), Gaps = 50/312 (16%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRN 381
+F LG+GGFG V++ + A+KR+ + + E EV +A+L+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 382 LVRLLGFSFEE----------TERLLIY---EFVPNSSVDKFIFDAIKRVQLDWETRYKI 428
+VR ++ E + ++ +Y + ++ ++ + + I
Sbjct: 65 IVRYFN-AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT--- 485
IA + +LH ++HRDLK SNI D + K+ DFG+ + D+ +
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 486 -------SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAED 538
+ VGT YM+PE + +S K D+FS G+++ E++ F +
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-----PF----STQM 231
Query: 539 LLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598
+ P L V + + RP ++ + +
Sbjct: 232 ERVRTLTDVRNLKF-----PPLFTQKYPCEYVMVQ---DMLSPSPMERPEAINI---IEN 280
Query: 599 SSL-SLPLPSQP 609
+ L P +
Sbjct: 281 AVFEDLDFPGKT 292
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 28/220 (12%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHG----QEIAVKRLSKN--SVQGELEFKNEVLLVARL 377
F+ LG+G FG+V + +L ++AVK L + + EF E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 378 QHRNLVRLLGFSFEETER------LLIYEFVPNSSVDKFIFD---AIKRVQLDWETRYKI 428
H ++ +L+G S + ++I F+ + + F+ L +T +
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
+ IA G+ YL S IHRDL A N +L DM ++DFG++R GD R
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYR- 194
Query: 489 VGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
G ++A E + +++ SDV++FGV + EI++
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-36
Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 36/228 (15%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRL--------SHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
+ + LG+G FG V +AVK L ++ + +L + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 375 ARL-QHRNLVRLLGFSFEETERLLIYEFVPN-------------SSVDKFIFDAIKRVQL 420
+ +H+N++ LLG ++ +I E+ + + + Q+
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
++ +ARG+ YL + + IHRDL A N+L+ + + KI+DFG+AR D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 207
Query: 481 SQGDTSRIVGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+ D + T G +MAPE + ++ +SDV+SFGVL+ EI +
Sbjct: 208 NNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-36
Identities = 50/249 (20%), Positives = 102/249 (40%), Gaps = 23/249 (9%)
Query: 292 RKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEI 351
+ ++Q + + ++ I +S ++G GG V++ Q
Sbjct: 24 KFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIY 83
Query: 352 AVKRLSKNSVQGEL--EFKNEVLLVARLQHRNL--VRLLGFSFEETERLLIYEFVPNSSV 407
A+K ++ + ++NE+ + +LQ + +RL + + ++ E N +
Sbjct: 84 AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDL 142
Query: 408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467
+ ++ K+ +D R + + +H+ I+H DLK +N L+ M+ K+
Sbjct: 143 NSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDGML-KL 195
Query: 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPE-----------YVTRGHFSIKSDVFSFGV 516
DFG+A + D + VG YM PE ++ S KSDV+S G
Sbjct: 196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 255
Query: 517 LVLEIISGQ 525
++ + G+
Sbjct: 256 ILYYMTYGK 264
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-36
Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRL--SHGQEI--AVKRLSKNSVQGEL-EFKNEVLLVARLQ 378
+G+G FG V++G + A+K + +F E L + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
H ++V+L+G E +I E + F+ ++ LD + ++ + Y
Sbjct: 450 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAY 506
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG----- 493
L R +HRD+ A N+L+ ++ K+ DFG++R E D++ + G
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME------DSTYYKASKGKLPIK 557
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+MAPE + F+ SDV+ FGV + EI+
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 5e-36
Identities = 62/233 (26%), Positives = 103/233 (44%), Gaps = 41/233 (17%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHG------QEIAVKRLSKNSVQGEL-EFKNEVLLVAR 376
N LG+G FG V K H +AVK L +N+ EL + +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPN---------------------SSVDKFIFDAI 415
+ H ++++L G ++ LLI E+ S + D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 416 KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475
L I++G+ YL + ++++HRDL A NIL+ KISDFG++R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR- 198
Query: 476 FEMDQSQGDTSRIVGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
D + D+ + G +MA E + ++ +SDV+SFGVL+ EI++
Sbjct: 199 ---DVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 34/218 (15%)
Query: 329 DNKLGQGGFGAVYKGRLSHGQE---IAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRNLV 383
+ +G+G FG V K R+ A+KR+ + + + + +F E+ ++ +L H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKF-------------IFDAIKRVQLDWETRYKIIG 430
LLG L E+ P+ ++ F L +
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG 490
+ARG+ YL S+ + IHRDL A NIL+ + + KI+DFG++R +
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYV-KK 198
Query: 491 TFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
T G +MA E + ++ SDV+S+GVL+ EI+S
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 37/236 (15%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQG---ELEFKNEVLLVARLQHRNLVRLLG 387
LG+GGF ++ + A K + K+ + + E+ + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQ--LDWETRYKIIGGIARGILYLHEDSR 444
F FE+ + + ++ E S+ + KR + + E RY + I G YLH R
Sbjct: 109 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQ-IVLGCQYLH---R 159
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
R+IHRDLK N+ L+ D+ KI DFG+A E D + + GT Y+APE +++
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 217
Query: 505 FSIKSDVFSFGVLVLEIISGQ---------------KNNSFR----IGEEAEDLLT 541
S + DV+S G ++ ++ G+ K N + I A L+
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 273
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 36/228 (15%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRL--------SHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
+ + LG+G FG V +AVK L ++ + +L + +E+ ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 375 ARL-QHRNLVRLLGFSFEETERLLIYEFVPN-------------SSVDKFIFDAIKRVQL 420
+ +H+N++ LLG ++ +I E+ + + + Q+
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
++ +ARG+ YL + + IHRDL A N+L+ + + KI+DFG+AR D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 253
Query: 481 SQGDTSRIVGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+ D + T G +MAPE + ++ +SDV+SFGVL+ EI +
Sbjct: 254 NNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRN 381
+ + + LGQG V++GR G A+K + S ++ E ++ +L H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 382 LVRLLGFSFEETERL--LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
+V+L E T R LI EF P S+ + + L ++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 440 HEDSRLRIIHRDLKASNILL----DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
E I+HR++K NI+ D + K++DFG AR E D Q + + GT Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTEEYL 182
Query: 496 APEYVTRG--------HFSIKSDVFSFGVLVLEIISGQ 525
P+ R + D++S GV +G
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 65/253 (25%), Positives = 111/253 (43%), Gaps = 39/253 (15%)
Query: 317 STIRDATN--NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQG---ELEFKNE 370
+ D + + LG+GGF ++ + A K + K+ + + E
Sbjct: 6 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 371 VLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQ--LDWETRYK 427
+ + L H+++V GF FE+ + + ++ E S+ + KR + + E RY
Sbjct: 66 ISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYY 120
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR 487
+ I G YLH R R+IHRDLK N+ L+ D+ KI DFG+A E D +
Sbjct: 121 LRQ-IVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-- 174
Query: 488 IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ---------------KNNSFR- 531
+ GT Y+APE +++ S + DV+S G ++ ++ G+ K N +
Sbjct: 175 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI 234
Query: 532 ---IGEEAEDLLT 541
I A L+
Sbjct: 235 PKHINPVAASLIQ 247
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 62/228 (27%), Positives = 92/228 (40%), Gaps = 36/228 (15%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQE------IAVKRLSKNSVQGEL-EFKNEVLLVAR 376
N S LG G FG V + + +AVK L ++ E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 377 L-QHRNLVRLLGFSFEETERLLIYEFVPN---------------SSVDKFIFDAIKRVQL 420
L H N+V LLG L+I E+ S + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
D E +A+G+ +L + IHRDL A NILL I KI DFG+AR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR----DI 195
Query: 481 SQGDTSRIVGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
V +MAPE + ++ +SDV+S+G+ + E+ S
Sbjct: 196 KNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 10/210 (4%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV-QGELEF-KNEVLLVARLQHR 380
++ +G G +G K R S G+ + K L S+ + E + +EV L+ L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 381 NLVRLLG-FSFEETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWETR-YKIIGGIARGIL 437
N+VR L I E+ + I K Q E +++ + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 438 YLHE--DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
H D ++HRDLK +N+ LD K+ DFG+AR+ D S T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
+PE + R ++ KSD++S G L+ E+ +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 65/276 (23%), Positives = 111/276 (40%), Gaps = 50/276 (18%)
Query: 290 RRRKKKQKQNLRKADEINTVESLQFDFSTIRDAT---------NNFSTDNKLGQGGFGAV 340
+ +K+ + ++ + ++ ++ + R+ N LG G FG V
Sbjct: 2 KYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKV 61
Query: 341 YKGRLSHGQE------IAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRNLVRLLGFSFEE 392
+ +AVK L + + E +E+ ++ +L H N+V LLG
Sbjct: 62 MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121
Query: 393 TERLLIYEFVPN--------SSVDKFIFDAIKRVQLDWETRYKIIGG------------I 432
LI+E+ S +KF D I+ + + +
Sbjct: 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF 492
A+G+ +L +HRDL A N+L+ + KI DFG+AR D V
Sbjct: 182 AKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR----DIMSDSNYV-VRGN 233
Query: 493 G-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+MAPE + G ++IKSDV+S+G+L+ EI S
Sbjct: 234 ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 35/227 (15%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNSVQGEL-EFKNEVLLVAR 376
+ LG+G FG V + + +AVK L + + E +E+ ++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 377 L-QHRNLVRLLGFSFEETE-RLLIYEFVPN-------------SSVDKFIFDAIKRVQLD 421
+ H N+V LLG + ++I EF K + + + L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
E +A+G+ +L + + IHRDL A NILL + KI DFG+AR D
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIY 199
Query: 482 QGDTSRIVGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+ +MAPE + ++I+SDV+SFGVL+ EI S
Sbjct: 200 KDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-35
Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 36/223 (16%)
Query: 329 DNKLGQGGFGAVYKGRL--------SHGQEIAVKRLSKNSVQGEL-EFKNEVLLVARL-Q 378
LG+G FG V + ++AVK L ++ + +L + +E+ ++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 379 HRNLVRLLGFSFEETERLLIYEFV-------------PNSSVDKFIFDAIKRVQLDWETR 425
H+N++ LLG ++ +I E+ P + QL +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485
+ARG+ YL + + IHRDL A N+L+ D + KI+DFG+AR D D
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDY 246
Query: 486 SRIVGTFG-----YMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+ T G +MAPE + ++ +SDV+SFGVL+ EI +
Sbjct: 247 YK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 9e-35
Identities = 63/269 (23%), Positives = 105/269 (39%), Gaps = 44/269 (16%)
Query: 288 FLRRRKKKQKQNLRKADEINTVESLQFDFSTI---------RDATNNFSTDNKLGQGGFG 338
+ ++K K + + + D + + R+ N LG G FG
Sbjct: 4 YKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRN---NLQFGKTLGAGAFG 60
Query: 339 AVYKGRLSHGQE------IAVKRLSKNSVQGEL-EFKNEVLLVARL-QHRNLVRLLGFSF 390
V + + +AVK L + E +E+ +++ L QH N+V LLG
Sbjct: 61 KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120
Query: 391 EETERLLIYEFVPN-----------SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
L+I E+ ++ AI +A+G+ +L
Sbjct: 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL 180
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG-----Y 494
+ IHRD+ A N+LL + KI DFG+AR D V +
Sbjct: 181 ---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYI-VKGNARLPVKW 232
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
MAPE + ++++SDV+S+G+L+ EI S
Sbjct: 233 MAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 68/306 (22%), Positives = 123/306 (40%), Gaps = 44/306 (14%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
++ KLG+GGF V L G A+KR+ + Q E + E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 384 RLLGFSFEETER----LLIYEFVPNSSVDKFIFDAIKRVQ-----LDWETRYKIIGGIAR 434
RL+ + E L+ F ++ ++ I+R++ L + ++ GI R
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTL----WNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF--------EMDQSQGDTS 486
G+ +H HRDLK +NILL + P + D G + Q +
Sbjct: 146 GLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 487 RIVGTFGYMAPEYV-TRGHFSI--KSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYA 543
+ T Y APE + H I ++DV+S G ++ ++ G+ + + + D + A
Sbjct: 203 Q-RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE--GPYDMVFQKGDSVALA 259
Query: 544 WKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSL 603
+N L P + S + + ++ + RP + ++ L +L
Sbjct: 260 VQN-------QLSIPQ--SPRHSSALWQLLNSMM--TVDPHQRPHIPLLLSQL--EALQP 306
Query: 604 PLPSQP 609
P P Q
Sbjct: 307 PAPGQH 312
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 38/230 (16%)
Query: 323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKR--LSKNSVQGELEFKNEVLLVARL-Q 378
T F K+G G FG+V+K G A+KR E EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 379 HRNLVRLLGFSFEETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWETR-YKIIGGIARGI 436
H ++VR ++ E + +LI E+ S+ I + + + E ++ + RG+
Sbjct: 70 HSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIP-------------------KISDFGMARLFE 477
Y+H ++H D+K SNI + IP KI D G
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFS--IKSDVFSFGVLVLEIISGQ 525
Q + G ++A E V + +++ K+D+F+ + V+ +
Sbjct: 186 SPQVE------EGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQG---ELEFKNEVLLVARLQH 379
+F LG+G FG VY R +A+K L K ++ E + + EV + + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQL--DWETRYKIIGGIARGI 436
N++RL G+ F + R+ LI E+ P +V + ++++ + T I +A +
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTA-TYITELANAL 122
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
Y H R+IHRD+K N+LL + KI+DFG + S+ + GT Y+
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTD--LCGTLDYLP 175
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
PE + K D++S GVL E + G
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVG 203
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 64/217 (29%), Positives = 114/217 (52%), Gaps = 20/217 (9%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLL 373
++ D ++ K+GQG G VY ++ GQE+A+++++ + NE+L+
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 374 VARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI 432
+ ++ N+V L S+ + L ++ E++ S+ D + +D E I +
Sbjct: 71 MRENKNPNIVNYLD-SYLVGDELWVVMEYLAGGSLT----DVVTETCMD-E---GQIAAV 121
Query: 433 ARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI 488
R L +LH + ++IHRD+K+ NILL D K++DFG +QS+ T +
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--M 176
Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
VGT +MAPE VTR + K D++S G++ +E+I G+
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 63/237 (26%), Positives = 115/237 (48%), Gaps = 14/237 (5%)
Query: 291 RRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQ 349
+ Q+ E +L+ D + K+G+G G V R G+
Sbjct: 14 GTENLYFQSGVVTHE-QFKAALR-MVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGR 71
Query: 350 EIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVD 408
++AVK + Q NEV+++ QH N+V + S+ E L ++ EF+ ++
Sbjct: 72 QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK-SYLVGEELWVLMEFLQGGALT 130
Query: 409 KFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS 468
D + +V+L+ E + + + + YLH +IHRD+K+ +ILL D K+S
Sbjct: 131 ----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLS 183
Query: 469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
DFG D + + +VGT +MAPE ++R ++ + D++S G++V+E++ G+
Sbjct: 184 DFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 6e-33
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 21/214 (9%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNL 382
+ +LG GGFG V + G+++A+K+ + E + E+ ++ +L H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 383 VRLLGFSFEETER--------LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
V + + LL E+ + K++ L ++ I+
Sbjct: 75 VSA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
+ YLHE RIIHRDLK NI+L +I KI D G A+ + VGT
Sbjct: 133 ALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEF--VGT 186
Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
Y+APE + + +++ D +SFG L E I+G
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 57/239 (23%), Positives = 110/239 (46%), Gaps = 19/239 (7%)
Query: 293 KKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEI 351
KK ++ L + L ++F ++LG G G V+K G +
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61
Query: 352 AVKRLSKNSVQGELEF-KNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF 410
A K + E+ ++ +V G + + E + E + S+D+
Sbjct: 62 ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 121
Query: 411 IFDAIKRVQLDWETRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPK 466
+ K+ E +I+G ++ ++ YL E +I+HRD+K SNIL+++ K
Sbjct: 122 L----KKAGRIPE---QILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIK 172
Query: 467 ISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
+ DFG++ ++ S ++ VGT YM+PE + H+S++SD++S G+ ++E+ G+
Sbjct: 173 LCDFGVSG--QLIDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 25/218 (11%)
Query: 311 SLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FK 368
S + + + F KLG G FG V+ S G E +K ++K+ Q +E +
Sbjct: 9 SGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE 68
Query: 369 NEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY- 426
E+ ++ L H N++++ FE+ + ++ E + + I Q +
Sbjct: 69 AEIEVLKSLDHPNIIKIFEV-FEDYHNMYIVMETCEGGE----LLERIVSAQARGK-ALS 122
Query: 427 -----KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEM 478
+++ + + Y H ++H+DLK NIL KI DFG+A LF+
Sbjct: 123 EGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179
Query: 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGV 516
D+ + GT YMAPE V + + K D++S GV
Sbjct: 180 DEHSTN---AAGTALYMAPE-VFKRDVTFKCDIWSAGV 213
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-32
Identities = 67/290 (23%), Positives = 109/290 (37%), Gaps = 61/290 (21%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEV-LLVARLQ 378
+ N ++ LG G G V G+ +AVKR+ + E+ LL
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDD 67
Query: 379 HRNLVRLLGFSFEETERL--LIYEFVPNSSVDKFIFDAIKRVQLDWETRY--------KI 428
H N++R + E T+R + E + + D ++ + E +
Sbjct: 68 HPNVIRY--YCSETTDRFLYIALELCNLN-----LQDLVESKNVSDENLKLQKEYNPISL 120
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILLD-------------ADMIPKISDFGMARL 475
+ IA G+ +LH L+IIHRDLK NIL+ ++ ISDFG+ +
Sbjct: 121 LRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 476 FEMDQS--QGDTSRIVGTFGYMAPE-------YVTRGHFSIKSDVFSFGVLVLEIISG-- 524
+ QS + + + GT G+ APE T+ + D+FS G + I+S
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 525 -----QKNNSFRIGEEAEDLLTYAWKNWNE--GTALNLI------DPTLR 561
+ + I L + A +LI DP R
Sbjct: 238 HPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR 287
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-32
Identities = 69/227 (30%), Positives = 109/227 (48%), Gaps = 30/227 (13%)
Query: 311 SLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE--LEF 367
S + + ++ LG+G FG V K + QE AVK ++K S + +
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68
Query: 368 KNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY 426
EV L+ +L H N+++L E++ ++ E +FD I + R+
Sbjct: 69 LREVELLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGE----LFDEIIK-----RKRF 118
Query: 427 ------KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFE 477
+II + GI Y+H+ I+HRDLK NILL + D KI DFG++ F+
Sbjct: 119 SEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
+ D +GT Y+APE V RG + K DV+S GV++ ++SG
Sbjct: 176 QNTKMKD---RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 75/296 (25%), Positives = 130/296 (43%), Gaps = 52/296 (17%)
Query: 308 TVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE 366
L + D F+ K+G+G FG V+KG + +A+K + + E+E
Sbjct: 6 VQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE 65
Query: 367 -FKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWET 424
+ E+ ++++ + + G S+ + +L +I E++ S D ++ LD E
Sbjct: 66 DIQQEITVLSQCDSPYVTKYYG-SYLKDTKLWIIMEYLGGGSAL----DLLEPGPLD-E- 118
Query: 425 RYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
I I R IL YLH + + IHRD+KA+N+LL K++DFG+A Q
Sbjct: 119 --TQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ----KNNSFRIGEEA 536
+ +T VGT +MAPE + + + K+D++S G+ +E+ G+ + + +
Sbjct: 174 IKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK----- 226
Query: 537 EDLLTYAWKNWNEGTALNLID----PTLRNGSSSEIMRCVHIGLLCVQENVANRPT 588
L LI PTL S + V C+ + + RPT
Sbjct: 227 ---------------VLFLIPKNNPPTLEGNYSKPLKEFVE---ACLNKEPSFRPT 264
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-31
Identities = 67/248 (27%), Positives = 105/248 (42%), Gaps = 30/248 (12%)
Query: 290 RRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHG 348
+ F S + + KLG G +G V R
Sbjct: 3 HHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTH 62
Query: 349 QEIAVKRLSKNSVQGE--LEFKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNS 405
E A+K + K SV + EV ++ L H N+++L F FE+ L+ E
Sbjct: 63 VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF-FEDKRNYYLVMECYKGG 121
Query: 406 SVDKFIFDAIKRVQLDWETRY------KIIGGIARGILYLHEDSRLRIIHRDLKASNILL 459
+FD I ++ II + G+ YLH+ I+HRDLK N+LL
Sbjct: 122 E----LFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLL 169
Query: 460 ---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGV 516
+ D + KI DFG++ +FE + + +GT Y+APE V R + K DV+S GV
Sbjct: 170 ESKEKDALIKIVDFGLSAVFENQKKMKE---RLGTAYYIAPE-VLRKKYDEKCDVWSIGV 225
Query: 517 LVLEIISG 524
++ +++G
Sbjct: 226 ILFILLAG 233
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 28/207 (13%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH 379
+ F LG G F V+ + G+ A+K + K+ + +NE+ ++ +++H
Sbjct: 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------KIIGGI 432
N+V L +E T L+ + V + FD I Y +I +
Sbjct: 66 ENIVTLEDI-YESTTHYYLVMQLVSGGEL----FDRILE-----RGVYTEKDASLVIQQV 115
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIV 489
+ YLHE I+HRDLK N+L + + I+DFG++++ + G S
Sbjct: 116 LSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTAC 168
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGV 516
GT GY+APE + + +S D +S GV
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGV 195
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 311 SLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE--F 367
S + + ++ LG+G FG V K + QE AVK ++K S + +
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68
Query: 368 KNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY 426
EV L+ +L H N+++L E++ ++ E +FD I + R+
Sbjct: 69 LREVELLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGE----LFDEIIK-----RKRF 118
Query: 427 ------KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFE 477
+II + GI Y+H+ I+HRDLK NILL + D KI DFG++ F+
Sbjct: 119 SEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGV 516
+ D +GT Y+APE V RG + K DV+S GV
Sbjct: 176 QNTKMKD---RIGTAYYIAPE-VLRGTYDEKCDVWSAGV 210
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 24/218 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRN 381
+++ +G G V +++A+KR++ Q ++ E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 382 LVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYK-----IIGGIARG 435
+V SF + L L+ + + SV D IK + E + I I R
Sbjct: 75 IVSYYT-SFVVKDELWLVMKLLSGGSV----LDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 436 IL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM-ARLFEMDQSQGDTSR--I 488
+L YLH++ IHRD+KA NILL D +I+DFG+ A L + R
Sbjct: 130 VLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 489 VGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQ 525
VGT +MAPE + + + K+D++SFG+ +E+ +G
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-31
Identities = 71/231 (30%), Positives = 109/231 (47%), Gaps = 31/231 (13%)
Query: 308 TVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE 366
F + ++ + LG+G FG V + GQE AVK +SK V+ + +
Sbjct: 10 HATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD 69
Query: 367 ---FKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDW 422
EV L+ +L H N+++L F FE+ L+ E +FD I
Sbjct: 70 KESLLREVQLLKQLDHPNIMKLYEF-FEDKGYFYLVGEVYTGGE----LFDEIIS----- 119
Query: 423 ETRY------KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMA 473
R+ +II + GI Y+H+ +I+HRDLK N+LL D +I DFG++
Sbjct: 120 RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176
Query: 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
FE + D +GT Y+APE V G + K DV+S GV++ ++SG
Sbjct: 177 THFEASKKMKD---KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-31
Identities = 39/204 (19%), Positives = 81/204 (39%), Gaps = 26/204 (12%)
Query: 331 KLGQGGFGAVYKG---RLSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLL 386
+ GG G +Y ++ G+ + +K L + E +A + H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVN-GRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 387 --GFSFEETERLLIY---EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
+ + Y E+V S+ K +L + I + YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPALSYLH- 199
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
+ +++ DLK NI+L + + K+ D G ++ + GT G+ APE +
Sbjct: 200 --SIGLVYNDLKPENIMLTEEQL-KLIDLGAVS--RINS----FGYLYGTPGFQAPE-IV 249
Query: 502 RGHFSIKSDVFSFGVLVLEIISGQ 525
R ++ +D+++ G + +
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDL 273
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-31
Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 317 STIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVA 375
ST D ++ +N +G+G +G V A K++ K V+ FK E+ ++
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61
Query: 376 RLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------KI 428
L H N++RL FE+ + L+ E +F+ + + + +I
Sbjct: 62 SLDHPNIIRLYET-FEDNTDIYLVMELCTGGE----LFERVVH-----KRVFRESDAARI 111
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDT 485
+ + + Y H+ L + HRDLK N L D K+ DFG+A F+ +
Sbjct: 112 MKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT- 167
Query: 486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGV 516
VGT Y++P+ V G + + D +S GV
Sbjct: 168 --KVGTPYYVSPQ-VLEGLYGPECDEWSAGV 195
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 30/224 (13%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNS-------VQGELEFKN 369
++ ++ +LG+G +G V K R GQ +AVKR+ + +L+
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI-- 58
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
+ + V G F E + + E + ++S+DKF I + Q E I+
Sbjct: 59 ---SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPE---DIL 111
Query: 430 GGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485
G IA I+ +LH S+L +IHRD+K SN+L++A K+ DFG++ +
Sbjct: 112 GKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKD 167
Query: 486 SRIVGTFGYMAPE----YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
G YMAPE + + +S+KSD++S G+ ++E+ +
Sbjct: 168 I-DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 26/245 (10%), Positives = 52/245 (21%), Gaps = 45/245 (18%)
Query: 317 STIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE---FKNEVL 372
S + L G V+ R + ++ A+K + + E
Sbjct: 55 SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATF 114
Query: 373 LVARLQHRNLVRLLGF--------------------------SFEETERLLIYEFVP--- 403
ARL + + LL+
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDL 174
Query: 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM 463
F + R + + + R L ++H N+ + D
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDG 231
Query: 464 IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH---FSIKSDVFSFGVLVLE 520
+ D G AP F+ + + G+ +
Sbjct: 232 RLMLGDVSALW------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285
Query: 521 IISGQ 525
+
Sbjct: 286 VWCLF 290
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 331 KLGQGGFGAVYKG---RLSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQHRNLVR 384
KLG GG VY L ++A+K + + E F+ EV ++L H+N+V
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSR 444
++ E+ L+ E++ ++ ++I L +T I GI + H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---D 129
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
+RI+HRD+K NIL+D++ KI DFG+A+ + S T+ ++GT Y +PE
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 505 FSIKSDVFSFGVLVLEIISGQ 525
+D++S G+++ E++ G+
Sbjct: 189 TDECTDIYSIGIVLYEMLVGE 209
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV-QGELE--FKNEVLLVARLQH 379
++F LG+G FG VY R +A+K L K+ + + +E + E+ + + L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQL--DWETRYKIIGGIARGI 436
N++R+ + F + +R+ L+ EF P ++ +++ + + + +A +
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGE----LYKELQKHGRFDEQRSA-TFMEELADAL 127
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
Y H ++IHRD+K N+L+ KI+DFG + + T GT Y+
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTM--CGTLDYLP 180
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISG 524
PE + K D++ GVL E + G
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVG 208
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 54/217 (24%), Positives = 89/217 (41%), Gaps = 23/217 (10%)
Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGF 388
L +GGF VY+ + + G+E A+KRL N + EV + +L H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 389 SFEETER-------LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
+ E L+ + + +F+ R L +T KI R + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRI----------VGT 491
+ IIHRDLK N+LL K+ DFG A +++ T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 492 FGYMAPEYV-TRGHFSI--KSDVFSFGVLVLEIISGQ 525
Y PE + +F I K D+++ G ++ + Q
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-30
Identities = 55/243 (22%), Positives = 97/243 (39%), Gaps = 31/243 (12%)
Query: 290 RRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFS----TDNKLGQGGFGAVYKGR- 344
+ R K + D+ ++ + + +LG G FG V++
Sbjct: 13 KVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVE 72
Query: 345 LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVP 403
+ G+ K ++ + KNE+ ++ +L H L+ L FE+ + LI EF+
Sbjct: 73 KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-FEDKYEMVLILEFL- 130
Query: 404 NSSVDKFIFDAIKRVQLDWETRY------KIIGGIARGILYLHEDSRLRIIHRDLKASNI 457
S + +FD I + + + G+ ++HE I+H D+K NI
Sbjct: 131 -SGGE--LFDRI----AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENI 180
Query: 458 LL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSF 514
+ A + KI DFG+A D+ T + APE V R +D+++
Sbjct: 181 MCETKKASSV-KIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAI 236
Query: 515 GVL 517
GVL
Sbjct: 237 GVL 239
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 49/227 (21%), Positives = 93/227 (40%), Gaps = 35/227 (15%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEF--------------- 367
N++ L QG F + + A+K+ K+ ++ + +F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 368 --KNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFI-----FDAIKRVQ 419
KNE+ ++ +++ + G + + +IYE++ N S+ KF D
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 420 LDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479
+ + II + Y+H + I HRD+K SNIL+D + K+SDFG +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV-- 203
Query: 480 QSQGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISG 524
GT+ +M PE+ + + K D++S G+ + +
Sbjct: 204 --DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-30
Identities = 63/260 (24%), Positives = 106/260 (40%), Gaps = 41/260 (15%)
Query: 289 LRRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSH 347
+ + + + ++ KLG G +G V + +
Sbjct: 1 MHHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNG 60
Query: 348 GQEIAVKRLSKNSVQG-------------ELEFKNEVLLVARLQHRNLVRLLGFSFEETE 394
E A+K + K+ E NE+ L+ L H N+++L FE+ +
Sbjct: 61 HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-FEDKK 119
Query: 395 RL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------KIIGGIARGILYLHEDSRLRI 447
L+ EF +F+ I ++ I+ I GI YLH+ I
Sbjct: 120 YFYLVTEFYEGGE----LFEQIIN-----RHKFDECDAANIMKQILSGICYLHK---HNI 167
Query: 448 IHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH 504
+HRD+K NILL ++ + KI DFG++ F D D +GT Y+APE V +
Sbjct: 168 VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD---RLGTAYYIAPE-VLKKK 223
Query: 505 FSIKSDVFSFGVLVLEIISG 524
++ K DV+S GV++ ++ G
Sbjct: 224 YNEKCDVWSCGVIMYILLCG 243
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 8e-30
Identities = 64/241 (26%), Positives = 117/241 (48%), Gaps = 30/241 (12%)
Query: 291 RRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQ 349
+ + ++ L+K DE + + F KLG+G +G+VYK GQ
Sbjct: 6 QLRNPPRRQLKKLDEDSLTK----------QPEEVFDVLEKLGEGSYGSVYKAIHKETGQ 55
Query: 350 EIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD 408
+A+K++ V+ +L+ E+ ++ + ++V+ G F+ T+ ++ E+ SV
Sbjct: 56 IVAIKQVP---VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS 112
Query: 409 KFIFDAIKRVQLDWETRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMI 464
I K + D I I + L YLH R IHRD+KA NILL+ +
Sbjct: 113 DIIRLRNKTLTEDE------IATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGH 163
Query: 465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISG 524
K++DFG+A ++ +T ++GT +MAPE + ++ +D++S G+ +E+ G
Sbjct: 164 AKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
Query: 525 Q 525
+
Sbjct: 222 K 222
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 35/235 (14%), Positives = 75/235 (31%), Gaps = 36/235 (15%)
Query: 317 STIRDATNNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNSVQGELEFKNE 370
+ + + + LG+G F VY+ Q+ +K + EF
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIG 114
Query: 371 VLLVARLQ---HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ------LD 421
L+ RL+ ++ + +L+ E + + +AI + +
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT----LLNAINLYKNTPEKVMP 170
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP-----------KISDF 470
+ I +H+ IIH D+K N +L + + D
Sbjct: 171 QGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL 227
Query: 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
G + ++ + T G+ E ++ ++ + D F V ++ G
Sbjct: 228 GQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 65/247 (26%), Positives = 113/247 (45%), Gaps = 42/247 (17%)
Query: 299 NLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH---GQEIAVKR 355
++ + ++ +DF+ + ++G+G +G+V K H GQ +AVKR
Sbjct: 2 SIESSGKLKISPEQHWDFTA-----EDLKDLGEIGRGAYGSVNKMV--HKPSGQIMAVKR 54
Query: 356 LSKNS-------VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD 408
+ + +L+ +V+ G F E + + E + ++S D
Sbjct: 55 IRSTVDEKEQKQLLMDLDVVMRSS-----DCPYIVQFYGALFREGDCWICMELM-STSFD 108
Query: 409 KFIFDAIKRVQLDWETRY--KIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDAD 462
KF K V + +I+G I + +L E+ L+IIHRD+K SNILLD
Sbjct: 109 KFY----KYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRS 162
Query: 463 MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE----YVTRGHFSIKSDVFSFGVLV 518
K+ DFG++ ++ S T R G YMAPE +R + ++SDV+S G+ +
Sbjct: 163 GNIKLCDFGISG--QLVDSIAKT-RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITL 219
Query: 519 LEIISGQ 525
E+ +G+
Sbjct: 220 YELATGR 226
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 61/237 (25%), Positives = 109/237 (45%), Gaps = 28/237 (11%)
Query: 299 NLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLS 357
++RK+ E V D + +LG G FG VYK + G A K +
Sbjct: 1 SMRKSREYEHVRRDL-------DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE 53
Query: 358 KNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKR 417
S + ++ E+ ++A H +V+LLG + + + ++ EF P +VD + + +
Sbjct: 54 TKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG 113
Query: 418 VQLDWETRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473
+ I + R +L +LH RIIHRDLKA N+L+ + +++DFG++
Sbjct: 114 LTEPQ------IQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS 164
Query: 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS-----IKSDVFSFGVLVLEIISGQ 525
+ D+ +GT +MAPE V K+D++S G+ ++E+ +
Sbjct: 165 AKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
S LG G FG V+K + G ++A K + ++ + E KNE+ ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------KIIGGIARGI 436
+L FE + L+ E+V +FD I +D + I GI
Sbjct: 150 QLYDA-FESKNDIVLVMEYVDGGE----LFDRI----IDESYNLTELDTILFMKQICEGI 200
Query: 437 LYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
++H+ + I+H DLK NIL DA I KI DFG+AR ++ + GT
Sbjct: 201 RHMHQ---MYILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKV---NFGTPE 253
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVL 517
++APE V S +D++S GV+
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVI 277
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 34/231 (14%)
Query: 312 LQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNS-------VQG 363
L + N+ ++G G G V+K R G IAVK++ ++ +
Sbjct: 13 LTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILM 72
Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423
+L+ ++ +V+ G T+ + E + + +K + E
Sbjct: 73 DLDV-----VLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIP---E 123
Query: 424 TRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479
+I+G + I+ YL E +IHRD+K SNILLD K+ DFG++ +
Sbjct: 124 ---RILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISG--RLV 176
Query: 480 QSQGDTSRIVGTFGYMAPE-----YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
+ G YMAPE T+ + I++DV+S G+ ++E+ +GQ
Sbjct: 177 DDKAKDR-SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 50/209 (23%), Positives = 84/209 (40%), Gaps = 28/209 (13%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ 378
++ + LG+G FG V++ S + K + K E+ ++ +
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIAR 59
Query: 379 HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------KIIGG 431
HRN++ L SFE E L +I+EF+ S +D IF+ I +
Sbjct: 60 HRNILHLHE-SFESMEELVMIFEFI--SGLD--IFERI----NTSAFELNEREIVSYVHQ 110
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRI 488
+ + +LH I H D++ NI+ + I KI +FG AR + + +
Sbjct: 111 VCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTI-KIIEFGQARQLKPGDNFRL---L 163
Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
Y APE S +D++S G L
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTL 192
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 48/202 (23%), Positives = 84/202 (41%), Gaps = 17/202 (8%)
Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE--LE-FKNEVLLVARLQHRNLVRLL 386
+G+GG G VY+ + +A+K +S+ + E RLQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI- 99
Query: 387 GFSFEETERLLIY---EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
F E + L Y + + + ++ L I+ I + H
Sbjct: 100 -HDFGEIDGQL-YVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA- 153
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
HRD+K NIL+ AD + DFG+A D+ VGT YMAPE +
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSES 210
Query: 504 HFSIKSDVFSFGVLVLEIISGQ 525
H + ++D+++ ++ E ++G
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-28
Identities = 56/288 (19%), Positives = 108/288 (37%), Gaps = 41/288 (14%)
Query: 238 PSPLSPPSTTTDTTIAKDKGGNSISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQK 297
P + P + +G + G +V R +
Sbjct: 93 PCEPTAPVLIPGDERKRRRGYDVDEQGKIV----------------------RGKGTVSS 130
Query: 298 QNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRL 356
+I Q +++ +LG G FG V++ + G A K +
Sbjct: 131 NYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV 190
Query: 357 SKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAI 415
+ + E+ ++ L+H LV L FE+ + +IYEF+ S + +F+ +
Sbjct: 191 MTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-FEDDNEMVMIYEFM--SGGE--LFEKV 245
Query: 416 --KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDF 470
+ ++ + + + + +G+ ++HE +H DLK NI+ ++ + K+ DF
Sbjct: 246 ADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNEL-KLIDF 301
Query: 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLV 518
G+ + QS GT + APE +D++S GVL
Sbjct: 302 GLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 21/219 (9%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFK---NE 370
+ D FS ++G G FGAVY R + + + +A+K++S + Q +++ E
Sbjct: 45 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 104
Query: 371 VLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
V + +L+H N ++ G E L+ E+ S+ D + + K+ + E +
Sbjct: 105 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTH 161
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM-ARLFEMDQSQGDTSRIV 489
G +G+ YLH +IHRD+KA NILL + K+ DFG + + + ++ V
Sbjct: 162 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANS--FV 211
Query: 490 GTFGYMAPEYV---TRGHFSIKSDVFSFGVLVLEIISGQ 525
GT +MAPE + G + K DV+S G+ +E+ +
Sbjct: 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 36/217 (16%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL------EFKNEVL 372
+ + + +LG G F V K R S G E A K + K + E + EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 373 LVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY----- 426
++ ++ H N++ L +E + LI E V +FD + + +
Sbjct: 68 ILRQVLHHNVITLHDV-YENRTDVVLILELVSGGE----LFDFLAQ-----KESLSEEEA 117
Query: 427 -KIIGGIARGILYLHEDSRLRIIHRDLKASNILL-----DADMIPKISDFGMARLFEMDQ 480
I I G+ YLH +I H DLK NI+L I K+ DFG+A E
Sbjct: 118 TSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHI-KLIDFGLAHEIEDGV 173
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
+ I GT ++APE V +++D++S GV+
Sbjct: 174 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 331 KLGQGGFGAVYKG---RLSHGQEIAVKRLSKNSVQGELE----FKNEVLLVARLQHRNLV 383
LG GG V+ R +++AVK L + + + F+ E A L H +V
Sbjct: 19 ILGFGGMSEVHLARDLRD--HRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 384 RLLGFSFEETERLLIY----EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
+ ET + E+V ++ + + + ++I + + +
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFS 132
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR-LFEMDQSQGDTSRIVGTFGYMAPE 498
H + IIHRD+K +NI++ A K+ DFG+AR + + S T+ ++GT Y++PE
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
+SDV+S G ++ E+++G+
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQ----GELEFKNEVLLVARLQHRNLVRLL 386
LG+G +G V + AVK L K ++ GE K E+ L+ RL+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 387 GFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLD-WETRYK---IIGGIARGILYLH 440
+ E ++ ++ E+ + + D++ + + +I G+ YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG--DTSRIVGTFGYMAPE 498
I+H+D+K N+LL KIS G+A + TS+ G+ + PE
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPAFQPPE 181
Query: 499 YV--TRGHFSIKSDVFSFGVLVLEIISG 524
K D++S GV + I +G
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 37/219 (16%)
Query: 317 STIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL------EFKN 369
S + D ++ +LG G F V K R G+E A K + K + E +
Sbjct: 1 SMVED---HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIER 57
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY-- 426
EV ++ ++H N++ L FE + LI E V +FD + +
Sbjct: 58 EVNILREIRHPNIITLHDI-FENKTDVVLILELVSGGE----LFDFLAE-----KESLTE 107
Query: 427 ----KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEM 478
+ + I G+ YLH RI H DLK NI+L +P K+ DFG+A E
Sbjct: 108 DEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164
Query: 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
+ I GT ++APE V +++D++S GV+
Sbjct: 165 GNEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 56/252 (22%), Positives = 101/252 (40%), Gaps = 38/252 (15%)
Query: 294 KKQKQNLRKADEINTVESLQFDFSTIRDATNN-----------FSTDNKLGQGGFGAVYK 342
K +++ L EI S F ++ + LG G G V
Sbjct: 94 KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL 153
Query: 343 GR-LSHGQEIAVKRLSKNSVQG--------ELEFKNEVLLVARLQHRNLVRLLGFSFEET 393
+++A++ +SK L + E+ ++ +L H ++++ F F+
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAE 212
Query: 394 ERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDL 452
+ ++ E + +FD + +L T + + YLHE IIHRDL
Sbjct: 213 DYYIVLELMEGGE----LFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDL 265
Query: 453 KASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE---YVTRGHFS 506
K N+LL + D + KI+DFG +++ + GT Y+APE V ++
Sbjct: 266 KPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYN 322
Query: 507 IKSDVFSFGVLV 518
D +S GV++
Sbjct: 323 RAVDCWSLGVIL 334
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV--QGELEF-KNEVLLVARLQHRNLVRLLG 387
LG+G F V R A+K L K + + ++ + E +++RL H V+L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 96
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRL 445
F+F++ E+L + N + I+++ ET + I + YLH
Sbjct: 97 FTFQDDEKLYFGLSYAKNGE----LLKYIRKIGSFDETCTRFYTAEIVSALEYLHG---K 149
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
IIHRDLK NILL+ DM +I+DFG A++ + Q + VGT Y++PE +T
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 209
Query: 506 SIKSDVFSFGVLVLEIISGQ 525
SD+++ G ++ ++++G
Sbjct: 210 CKSSDLWALGCIIYQLVAGL 229
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 33/238 (13%), Positives = 64/238 (26%), Gaps = 54/238 (22%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSK----------------------------NSVQ 362
LGQ A + G+ V +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 363 GELEFKNEVLLVARLQHRNLVRLLGF--SFEETERLLIYEFVPNSSVDKF--IFDAI-KR 417
L F LV Q + ++R+ R +Y + ++ +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 418 VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477
L R ++ + R + LH ++H L+ +I+LD ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256
Query: 478 MDQSQGDTSRIVGTFGYMAPEYV-----------TRGHFSIKSDVFSFGVLVLEIISG 524
G + G+ PE R + D ++ G+++ I
Sbjct: 257 -----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 29/217 (13%)
Query: 313 QFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE--FKN 369
+F + ++N+ +LG+G F V + + G E A K ++ + +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY-- 426
E + +LQH N+VRL +E L+++ V +F+ I + Y
Sbjct: 78 EARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGE----LFEDIVARE-----FYSE 127
Query: 427 ----KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMD 479
I I I Y H I+HR+LK N+LL K++DFG+A
Sbjct: 128 ADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGV 516
++ GT GY++PE + + +S D+++ GV
Sbjct: 185 EA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 49/250 (19%), Positives = 101/250 (40%), Gaps = 39/250 (15%)
Query: 290 RRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHG 348
+ + K + E D++ ++ + + +G+G V + + G
Sbjct: 60 KLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG 119
Query: 349 QEIAVKRLSKNSVQG--------ELEFKNEVLLVARL-QHRNLVRLLGFSFEETERL-LI 398
E AVK + + + + E ++ ++ H +++ L+ +E + + L+
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS-YESSSFMFLV 178
Query: 399 YEFVPNSSVDKFIFDAIKRVQLDWETRY------KIIGGIARGILYLHEDSRLRIIHRDL 452
++ + +FD + I+ + + +LH I+HRDL
Sbjct: 179 FDLMRKGE----LFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDL 226
Query: 453 KASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE------YVTRGHFS 506
K NILLD +M ++SDFG + E + + + GT GY+APE T +
Sbjct: 227 KPENILLDDNMQIRLSDFGFSCHLEPGEKLRE---LCGTPGYLAPEILKCSMDETHPGYG 283
Query: 507 IKSDVFSFGV 516
+ D+++ GV
Sbjct: 284 KEVDLWACGV 293
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 59/239 (24%), Positives = 100/239 (41%), Gaps = 29/239 (12%)
Query: 289 LRRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSH 347
L + + V D S ++ F +++LG+G VY+ +
Sbjct: 18 LYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGT 77
Query: 348 GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSS 406
+ A+K L K + + + E+ ++ RL H N+++L FE + L+ E V
Sbjct: 78 QKPYALKVLKKTVDKKIV--RTEIGVLLRLSHPNIIKLKEI-FETPTEISLVLELVTGGE 134
Query: 407 VDKFIFDAIKRVQLDWETRY------KIIGGIARGILYLHEDSRLRIIHRDLKASNILL- 459
+ FD I + Y + I + YLHE I+HRDLK N+L
Sbjct: 135 L----FDRIVE-----KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYA 182
Query: 460 --DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGV 516
D KI+DFG++++ E + GT GY APE + + + D++S G+
Sbjct: 183 TPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 36/216 (16%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL------EFKNEVLL 373
+ + +LG G F V K R S G E A K + K + E + EV +
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 374 VARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------ 426
+ ++ H N++ L +E + LI E V +FD + + +
Sbjct: 69 LRQVLHPNIITLHDV-YENRTDVVLILELVSGGE----LFDFLAQ-----KESLSEEEAT 118
Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILL-----DADMIPKISDFGMARLFEMDQS 481
I I G+ YLH +I H DLK NI+L I K+ DFG+A E
Sbjct: 119 SFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHI-KLIDFGLAHEIEDGVE 174
Query: 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
+ I GT ++APE V +++D++S GV+
Sbjct: 175 FKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE--LEFKNEVLLVARLQH 379
++N+ +LG+G F V + + G E A K ++ + + + E + +LQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGIL 437
N+VRL +E L+++ V +F+ I R I I I
Sbjct: 65 PNIVRLHDS-IQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIA 119
Query: 438 YLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
Y H I+HR+LK N+LL K++DFG+A ++ GT GY
Sbjct: 120 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGY 173
Query: 495 MAPEYVTRGHFSIKSDVFSFGV 516
++PE + + +S D+++ GV
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGV 195
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 34/215 (15%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL------EFKNEVLL 373
+ + + T +LG G F V K R S G + A K + K + + + EV +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 374 VARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------ 426
+ +QH N++ L +E + LI E V +FD + +
Sbjct: 68 LKEIQHPNVITLHEV-YENKTDVILILELVAGGE----LFDFLAE-----KESLTEEEAT 117
Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DADMIPKISDFGMARLFEMDQSQ 482
+ + I G+ YLH L+I H DLK NI+L KI DFG+A +
Sbjct: 118 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
+ I GT ++APE V +++D++S GV+
Sbjct: 175 KN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-27
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLV 374
T T + +LG+G F V + + GQE A ++ + + + E +
Sbjct: 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARIC 64
Query: 375 ARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------K 427
L+H N+VRL E LI++ V +F+ I Y
Sbjct: 65 RLLKHPNIVRLHDS-ISEEGHHYLIFDLVTGGE----LFEDIVA-----REYYSEADASH 114
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGD 484
I I +L+ H+ + ++HR+LK N+LL K++DFG+A E +Q
Sbjct: 115 CIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171
Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGV 516
GT GY++PE + + + D+++ GV
Sbjct: 172 G--FAGTPGYLSPEVLRKDPYGKPVDLWACGV 201
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 67/230 (29%), Positives = 104/230 (45%), Gaps = 30/230 (13%)
Query: 314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVL 372
D S +RD F +G G +G VYKGR + GQ A+K + E E K E+
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEIN 72
Query: 373 LVARL-QHRNLVRLLG------FSFEETERLLIYEFVPNSSV-DKFIFDAIKRVQLDWET 424
++ + HRN+ G + + L+ EF SV D + K L E
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLK-E- 128
Query: 425 RYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
+ I I R IL +LH+ ++IHRD+K N+LL + K+ DFG++ +
Sbjct: 129 --EWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFS-----IKSDVFSFGVLVLEIISGQ 525
+ +T +GT +MAPE + KSD++S G+ +E+ G
Sbjct: 184 GRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 56/208 (26%), Positives = 85/208 (40%), Gaps = 35/208 (16%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFS 389
LG+G V L QE AVK + K EV ++ + Q HRN++ L+ F
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF- 79
Query: 390 FEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------KIIGGIARGILYLHED 442
FEE +R L++E + S I I + + + ++ +A + +LH
Sbjct: 80 FEEEDRFYLVFEKMRGGS----ILSHIHKRR-----HFNELEASVVVQDVASALDFLHN- 129
Query: 443 SRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSR-----IVGTFGY 494
I HRDLK NIL + KI DF + +++ S G+ Y
Sbjct: 130 --KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 495 MAPEYVTRGHFSIKS-----DVFSFGVL 517
MAPE V D++S GV+
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 46/230 (20%), Positives = 86/230 (37%), Gaps = 30/230 (13%)
Query: 315 DFSTIRDATNNFSTDNKLGQG--GFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL--EFKN 369
S+ + +G+G V R G+ + V+R++ + E+ +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDW--ETRY 426
E+ + H N+V +F L ++ F+ S D I +D E
Sbjct: 76 ELHVSKLFNHPNIVPYRA-TFIADNELWVVTSFMAYGSA----KDLICTHFMDGMNEL-- 128
Query: 427 KIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482
I I +G+L Y+H +HR +KAS+IL+ D +S +
Sbjct: 129 -AIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184
Query: 483 GDT-----SRIVGTFGYMAPEYVTRGH--FSIKSDVFSFGVLVLEIISGQ 525
V +++PE + + + KSD++S G+ E+ +G
Sbjct: 185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 32/238 (13%), Positives = 66/238 (27%), Gaps = 53/238 (22%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQ--------- 378
LGQ A + G+ V + K EVL + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 379 ----------------HRNLVRLLGF--SFEETERLLIYEFVPNSSVD--KFIFDAIK-R 417
+ ++R+ R +Y + ++ + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 418 VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477
L R ++ + R + LH ++H L+ +I+LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 259
Query: 478 MDQSQGDTSRIVGTFGYMAPEYVT----------RGHFSIKSDVFSFGVLVLEIISGQ 525
G ++ G+ PE + D ++ G+ + I
Sbjct: 260 ---RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 50/208 (24%), Positives = 82/208 (39%), Gaps = 27/208 (12%)
Query: 326 FSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL-----EFKNEVLLVARLQH 379
+ +G+G F V + GQ+ AVK + + K E + L+H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------KIIGGI 432
++V LL + L +++EF+ + + I + + D Y + I
Sbjct: 86 PHIVELLET-YSSDGMLYMVFEFMDGAD----LCFEIVK-RADAGFVYSEAVASHYMRQI 139
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIV 489
+ Y H+ IIHRD+K +LL + K+ FG+A V
Sbjct: 140 LEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RV 194
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
GT +MAPE V R + DV+ GV+
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 27/210 (12%)
Query: 323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE--------FKNEVLL 373
+ + LG G G V +++A+K +SK + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGI 432
+ +L H ++++ F F+ + ++ E + +FD + +L T +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGE----LFDKVVGNKRLKEATCKLYFYQM 123
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIV 489
+ YLHE IIHRDLK N+LL + D + KI+DFG +++ +
Sbjct: 124 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 177
Query: 490 GTFGYMAPE---YVTRGHFSIKSDVFSFGV 516
GT Y+APE V ++ D +S GV
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV---QGELEFKNE--VL-LVAR 376
N+FS +G+GGFG VY R + ++ A+K L K + QGE NE +L LV+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 377 LQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIAR 434
+V + ++F ++L I + + + + + + E + I
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGD----LHYHLSQHGVFSEADMRFYAAEIIL 303
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
G+ ++H +++RDLK +NILLD +ISD G+A F + VGT GY
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGY 356
Query: 495 MAPEYVTRGHFSIKS-DVFSFGVLVLEIISGQ 525
MAPE + +G S D FS G ++ +++ G
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 50/232 (21%), Positives = 95/232 (40%), Gaps = 37/232 (15%)
Query: 300 LRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSK 358
++ + V+ L + D + +G G + + + E AVK + K
Sbjct: 1 MQTVGVHSIVQQLHRNSIQFTD---GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK 57
Query: 359 NSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIK 416
+ E+ ++ R QH N++ L +++ + + ++ E + + D I
Sbjct: 58 SKRDP----TEEIEILLRYGQHPNIITLKDV-YDDGKYVYVVTELMKGGE----LLDKIL 108
Query: 417 RVQLDWETRY------KIIGGIARGILYLHEDSRLRIIHRDLKASNILL-----DADMIP 465
R + + ++ I + + YLH ++HRDLK SNIL + + I
Sbjct: 109 RQK-----FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESI- 159
Query: 466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
+I DFG A+ + T T ++APE + R + D++S GVL
Sbjct: 160 RICDFGFAKQLRAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVL 209
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 30/213 (14%)
Query: 323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQG---------ELEFKNEVL 372
N+ LG+G V + +E AVK + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 373 LVARL-QHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKII 429
++ ++ H N+++L +E L+++ + +FD + ++V L + KI+
Sbjct: 76 ILRKVSGHPNIIQLKDT-YETNTFFFLVFDLMKKGE----LFDYLTEKVTLSEKETRKIM 130
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
+ I LH+ L I+HRDLK NILLD DM K++DFG + + + + +
Sbjct: 131 RALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VC 184
Query: 490 GTFGYMAPE------YVTRGHFSIKSDVFSFGV 516
GT Y+APE + + D++S GV
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 54/269 (20%), Positives = 96/269 (35%), Gaps = 62/269 (23%)
Query: 310 ESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVK-----RLSKNSVQG 363
E+L F ++ + + +GQG +G V A+K ++ + + +
Sbjct: 12 ENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD 71
Query: 364 ELEFKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDW 422
K EV L+ +L H N+ RL +E+ + + L+ E + D + D
Sbjct: 72 VERIKTEVRLMKKLHHPNIARLYEV-YEDEQYICLVMELCHGGH----LLDKLNVFIDDS 126
Query: 423 ETRY-----------------------------------------KIIGGIARGILYLHE 441
+ I+ I + YLH
Sbjct: 127 TGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186
Query: 442 DSRLRIIHRDLKASNILL--DADMIPKISDFGMARLFEMDQSQGDT--SRIVGTFGYMAP 497
I HRD+K N L + K+ DFG+++ F + + GT ++AP
Sbjct: 187 ---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243
Query: 498 EYVTRGHFSI--KSDVFSFGVLVLEIISG 524
E + + S K D +S GVL+ ++ G
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMG 272
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 19/193 (9%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLGFS 389
LG+G +G V + +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAI-KRVQLD-WETRYK---IIGGIARGILYLHEDSR 444
E + L E+ +FD I + + + + ++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-RG 503
+ I HRD+K N+LLD KISDFG+A +F + + +++ GT Y+APE + R
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 504 HFSIKSDVFSFGV 516
+ DV+S G+
Sbjct: 184 FHAEPVDVWSCGI 196
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-25
Identities = 58/221 (26%), Positives = 105/221 (47%), Gaps = 22/221 (9%)
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKN-EVLL 373
D T ++ +G G FG V++ +L E+A+K+ V + FKN E+ +
Sbjct: 31 DGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKK-----VLQDKRFKNRELQI 85
Query: 374 VARLQHRNLVRLLGFSFEETERL------LIYEFVPNSSVDKFIFDAIKRVQLDWETRYK 427
+ ++H N+V L F + ++ L+ E+VP +V + K Q K
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIK 144
Query: 428 IIG-GIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDT 485
+ + R + Y+H + I HRD+K N+LLD + K+ DFG A++ + +
Sbjct: 145 LYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NV 199
Query: 486 SRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQ 525
S I + Y APE + +++ D++S G ++ E++ GQ
Sbjct: 200 SYIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 35/146 (23%), Positives = 61/146 (41%), Gaps = 14/146 (9%)
Query: 388 FSFEETERLLI-YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
L I + ++ ++ + I IA + +LH
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KG 184
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS----------RIVGTFGYMA 496
++HRDLK SNI D + K+ DFG+ + D+ + VGT YM+
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEII 522
PE + ++S K D+FS G+++ E++
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELL 270
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 28/204 (13%)
Query: 328 TDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHR-NLV 383
T +LG+G F V + S GQE A K L K + E +E+ ++ + ++
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------KIIGGIARGI 436
L +E T + LI E+ IF + ++I I G+
Sbjct: 93 NLHEV-YENTSEIILILEYAAGGE----IFS---LCLPELAEMVSENDVIRLIKQILEGV 144
Query: 437 LYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
YLH+ I+H DLK NILL KI DFGM+R + I+GT
Sbjct: 145 YYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPE 198
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVL 517
Y+APE + + +D+++ G++
Sbjct: 199 YLAPEILNYDPITTATDMWNIGII 222
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 52/213 (24%), Positives = 88/213 (41%), Gaps = 30/213 (14%)
Query: 317 STIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVA 375
S + D LG+G F K Q AVK +SK + E+ +
Sbjct: 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA---NTQKEITALK 60
Query: 376 RLQ-HRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRY------K 427
+ H N+V+L F + L+ E + +F+ IK+ + +
Sbjct: 61 LCEGHPNIVKLHEV-FHDQLHTFLVMELLNGGE----LFERIKKKK-----HFSETEASY 110
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGD 484
I+ + + ++H+ + ++HRDLK N+L + ++ KI DFG ARL D
Sbjct: 111 IMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167
Query: 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
T T Y APE + + + D++S GV+
Sbjct: 168 T--PCFTLHYAAPELLNQNGYDESCDLWSLGVI 198
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 59/237 (24%), Positives = 103/237 (43%), Gaps = 39/237 (16%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN------EV----LLVARLQHR 380
LG+GGFG V+ G L+ ++A+K + +N V G + EV + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLD-WETRYKIIGGIARGILY 438
++RLL + + +L+ E P + D +FD I ++ L +R G + I +
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSR-CFFGQVVAAIQH 154
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIP-KISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
H ++HRD+K NIL+D K+ DFG L + GT Y P
Sbjct: 155 CH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL--LHDEPYTDF--DGTRVYSPP 207
Query: 498 EYVTRGHFS-IKSDVFSFGVL--VL-----------EIISGQKNNSFRIGEEAEDLL 540
E+++R + + + V+S G+L + EI+ + + + + L+
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCALI 264
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 19/193 (9%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRNLVRLLGFS 389
LG+G +G V + +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAI-KRVQLD-WETRYK---IIGGIARGILYLHEDSR 444
E + L E+ +FD I + + + + ++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGE----LFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH---G 123
Query: 445 LRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-RG 503
+ I HRD+K N+LLD KISDFG+A +F + + +++ GT Y+APE + R
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 504 HFSIKSDVFSFGV 516
+ DV+S G+
Sbjct: 184 FHAEPVDVWSCGI 196
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 37/235 (15%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN------EVLLVARLQHR--NL 382
LG GGFG+VY G +S +A+K + K+ + E N EV+L+ ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLD-WETRYKIIGGIARGILYLH 440
+RLL + +LI E P D +FD I +R L R + + + H
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELAR-SFFWQVLEAVRHCH 166
Query: 441 EDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
++HRD+K NIL+D + K+ DFG L + + GT Y PE+
Sbjct: 167 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL--LKDTVYTDF--DGTRVYSPPEW 219
Query: 500 VTRGHFS-IKSDVFSFGVL--VL-----------EIISGQKNNSFRIGEEAEDLL 540
+ + + V+S G+L + EII GQ R+ E + L+
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 274
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-25
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 31/208 (14%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLG 387
LG+GGFG V ++ ++ A K+L K + +GE NE ++ ++ R +V L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 250
Query: 388 FSFEETERL-LIYEFVPN-------SSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILY 438
+++E + L L+ + + + F E R I G+
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---------EARAVFYAAEICCGLED 301
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMAP 497
LH RI++RDLK NILLD +ISD G+A + +G T + VGT GYMAP
Sbjct: 302 LHR---ERIVYRDLKPENILLDDHGHIRISDLGLAV--HV--PEGQTIKGRVGTVGYMAP 354
Query: 498 EYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
E V ++ D ++ G L+ E+I+GQ
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 58/241 (24%), Positives = 103/241 (42%), Gaps = 33/241 (13%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN--------EVLLVA 375
+ST + LG G FG V+ +E+ VK + K V + ++ E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 376 RLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIAR 434
R++H N++++L + L+ E S +D +F I + +LD I +
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKH-GSGLD--LFAFIDRHPRLDEPLASYIFRQLVS 141
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
+ YL IIHRD+K NI++ D K+ DFG A E + T GT Y
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTF--CGTIEY 195
Query: 495 MAPEYVT-RGHFSIKSDVFSFGVL--VL-----------EIISGQKNNSFRIGEEAEDLL 540
APE + + + +++S GV L E + + + + +E L+
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLV 255
Query: 541 T 541
+
Sbjct: 256 S 256
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-25
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLG 387
LG+GGFG V+ ++ ++ A K+L+K + +G E ++A++ R +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 388 FSFEETERL-LIYEFVPNSSVDKF--IFDAIKRVQLDWETRYKI-IGGIARGILYLHEDS 443
++FE L L+ + D I++ + E R I G+ +LH+
Sbjct: 252 YAFETKTDLCLVMTIMNGG--DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-- 307
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
II+RDLK N+LLD D +ISD G+A + Q++ T GT G+MAPE +
Sbjct: 308 -RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGE 364
Query: 504 HFSIKSDVFSFGVLVLEIISGQ 525
+ D F+ GV + E+I+ +
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 50/229 (21%), Positives = 86/229 (37%), Gaps = 41/229 (17%)
Query: 310 ESLQFDFSTIRDATNNFS-----TDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQG 363
L+ F + + LG G G V + GQ+ A+K L +
Sbjct: 10 SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--- 66
Query: 364 ELEFKNEVLLVARLQ-HRNLVRLLGFSFEETER-----LLIYEFVPNSSVDKFIFDAIKR 417
+ + EV + ++V +L +E L+I E + +F I+
Sbjct: 67 --KARQEVDHHWQASGGPHIVCILDV-YENMHHGKRCLLIIMECMEGGE----LFSRIQE 119
Query: 418 VQLDWETRY------KIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKIS 468
+ + +I+ I I +LH I HRD+K N+L + D + K++
Sbjct: 120 RG---DQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLT 173
Query: 469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVL 517
DFG A+ Q T Y+APE + + D++S GV+
Sbjct: 174 DFGFAKETT----QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 56/225 (24%), Positives = 90/225 (40%), Gaps = 57/225 (25%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV-------------------QGELEFKNEV 371
+G+G +G V + A+K LSK + G ++ + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 372 LLVAR-------LQHRNLVRLLGFSFE------ETERLLIYEFVPNSSVDKFIFDAIKRV 418
V + L H N+V+L E E +++E V V +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK 132
Query: 419 QLDWET--RY--KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474
L + Y +I GI YLH +IIHRD+K SN+L+ D KI+DFG++
Sbjct: 133 PLSEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI---KSDVFSFGV 516
F+ + + VGT +MAPE ++ DV++ GV
Sbjct: 186 EFKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 67/199 (33%), Positives = 97/199 (48%), Gaps = 31/199 (15%)
Query: 332 LGQGGFGAVYKGRLSH---GQEIAVKRLSKNSVQGELEFK--NEVLLVARLQHRNLVRLL 386
+G+G F V R H G+E+A+K + K + K EV ++ L H N+V+L
Sbjct: 23 IGKGNFAKVKLAR--HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL- 79
Query: 387 GFSFE--ETERL--LIYEFVPNSSVDKFIFDAI---KRVQLDWETRYKIIGGIARGILYL 439
FE ETE+ LI E+ +FD + R++ E R I + Y
Sbjct: 80 ---FEVIETEKTLYLIMEYASGGE----VFDYLVAHGRMKEK-EAR-SKFRQIVSAVQYC 130
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
H + RI+HRDLKA N+LLDADM KI+DFG + F + + D G Y APE
Sbjct: 131 H---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAF--CGAPPYAAPEL 184
Query: 500 VT-RGHFSIKSDVFSFGVL 517
+ + + DV+S GV+
Sbjct: 185 FQGKKYDGPEVDVWSLGVI 203
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-24
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 25/221 (11%)
Query: 317 STIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN-EVLLV 374
R +++ +G G FG VY+ +L G+ +A+K+ V + FKN E+ ++
Sbjct: 47 GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFKNRELQIM 101
Query: 375 ARLQHRNLVRLLGFSFEETERL------LIYEFVPNSSVDKFIFDAIKRVQL--DWETRY 426
+L H N+VRL F + E+ L+ ++VP +V + + Q +
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKL 160
Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQSQGDT 485
+ + R + Y+H I HRD+K N+LLD D + K+ DFG A+ +
Sbjct: 161 -YMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--V 214
Query: 486 SRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
S I + Y APE + ++ DV+S G ++ E++ GQ
Sbjct: 215 SYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 53/244 (21%), Positives = 93/244 (38%), Gaps = 37/244 (15%)
Query: 290 RRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHG 348
+ ++ + + LQ + I D + T LG G G V +
Sbjct: 30 HPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID--DYKVTSQVLGLGINGKVLQIFNKRTQ 87
Query: 349 QEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETER-----LLIYEFV 402
++ A+K L + + EV L R ++VR++ +E L++ E +
Sbjct: 88 EKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDV-YENLYAGRKCLLIVMECL 141
Query: 403 PNSSVDKFIFDAIKRVQLDWETRY------KIIGGIARGILYLHEDSRLRIIHRDLKASN 456
+F I+ + + +I+ I I YLH + I HRD+K N
Sbjct: 142 DGGE----LFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPEN 191
Query: 457 ILL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFS 513
+L + I K++DFG A+ S T Y+APE + + D++S
Sbjct: 192 LLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPEVLGPEKYDKSCDMWS 248
Query: 514 FGVL 517
GV+
Sbjct: 249 LGVI 252
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 54/226 (23%), Positives = 99/226 (43%), Gaps = 27/226 (11%)
Query: 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN----E 370
R + F + GQG FG V G+ G +A+K+ V + F+N
Sbjct: 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK-----VIQDPRFRNRELQI 69
Query: 371 VLLVARLQHRNLVRLLGF-------SFEETERLLIYEFVPNSSVDKFIFDAIKRVQL--D 421
+ +A L H N+V+L + + ++ E+VP ++ + + +R
Sbjct: 70 MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPP 128
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPKISDFGMARLFEMDQ 480
+ + + R I LH S + + HRD+K N+L++ AD K+ DFG A+ +
Sbjct: 129 ILIKV-FLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE 186
Query: 481 SQGDTSRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
+ I + Y APE + H++ D++S G + E++ G+
Sbjct: 187 PN--VAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 9e-23
Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 26/186 (13%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---------EVLL 373
NF K+G+G +G VYK R G+ +A+K++ L+ + E+ L
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-------LDTETEGVPSTAIREISL 55
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD-KFIFDAIKRVQLDWETRYKIIGGI 432
+ L H N+V+LL E + L++EF+ D K DA + + +
Sbjct: 56 LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ---DLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTF 492
+G+ + H R++HRDLK N+L++ + K++DFG+AR F + T +V T
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TL 167
Query: 493 GYMAPE 498
Y APE
Sbjct: 168 WYRAPE 173
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 34/196 (17%)
Query: 319 IRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN-------- 369
++ + + LG+G F VYK R + Q +A+K++ E K+
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALR 61
Query: 370 EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD--KFIFDAIKRVQLDWETRYK 427
E+ L+ L H N++ LL ++ L+++F+ D I D + L
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET---DLEVIIKD--NSLVLTPSHIKA 116
Query: 428 IIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD--- 484
+ +G+ YLH+ I+HRDLK +N+LLD + + K++DFG+A+ F G
Sbjct: 117 YMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF------GSPNR 167
Query: 485 --TSRIVGTFGYMAPE 498
T ++V T Y APE
Sbjct: 168 AYTHQVV-TRWYRAPE 182
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 34/201 (16%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQHRNLVRLLG 387
LG G FG V G G ++AVK L++ ++ + K E+ + +H ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 388 FSFE--ETER--LLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYK---IIGGIARGIL 437
++ T ++ E+V +FD I RV+ E R I+ +
Sbjct: 77 --YQVISTPTDFFMVMEYVSGGE----LFDYICKHGRVEEM-EARRLFQQILSAVD---- 125
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
Y H R ++HRDLK N+LLDA M KI+DFG++ + D TS G+ Y AP
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTS--CGSPNYAAP 179
Query: 498 EYVT-RGHFSIKSDVFSFGVL 517
E ++ R + + D++S GV+
Sbjct: 180 EVISGRLYAGPEVDIWSCGVI 200
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 46/212 (21%)
Query: 313 QFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKN- 369
+ + + + K+GQG FG V+K R GQ++A+K++ ++ E E F
Sbjct: 7 SVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPIT 62
Query: 370 ---EVLLVARLQHRNLVRLLGFSFEETERL--------LIYEFVP-------NSSVDKFI 411
E+ ++ L+H N+V L+ + L+++F ++ + KF
Sbjct: 63 ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFT 122
Query: 412 FDAIKRV--QLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD 469
IKRV L G+ Y+H + +I+HRD+KA+N+L+ D + K++D
Sbjct: 123 LSEIKRVMQML------------LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 167
Query: 470 FGMARLFEMDQSQGD---TSRIVGTFGYMAPE 498
FG+AR F + ++ T+R+V T Y PE
Sbjct: 168 FGLARAFSLAKNSQPNRYTNRVV-TLWYRPPE 198
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 34/199 (17%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
+G G FG R + +AVK + + + E + E++ L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQREIINHRSLRHPNIVRF----K 82
Query: 391 E--ETER--LLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYK---IIGGIARGILYLH 440
E T +I E+ +++ I R D E R+ ++ G++ Y H
Sbjct: 83 EVILTPTHLAIIMEYASGGE----LYERICNAGRFSED-EARFFFQQLLSGVS----YCH 133
Query: 441 EDSRLRIIHRDLKASNILLDADMIP--KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
++I HRDLK N LLD P KI DFG ++ + SQ ++ VGT Y+APE
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST--VGTPAYIAPE 187
Query: 499 YVT-RGHFSIKSDVFSFGV 516
+ + + +DV+S GV
Sbjct: 188 VLLRQEYDGKIADVWSCGV 206
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 52/184 (28%), Positives = 91/184 (49%), Gaps = 24/184 (13%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKN---------EVLLV 374
+ K+G+G +G VYK + S G+ +A+KR+ L+ ++ E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR-------LDAEDEGIPSTAIREISLL 73
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
L H N+V L+ E L++EF+ + K + + + L + + R
Sbjct: 74 KELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDE--NKTGLQDSQIKIYLYQLLR 130
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
G+ + H+ RI+HRDLK N+L+++D K++DFG+AR F + T +V T Y
Sbjct: 131 GVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV-TLWY 185
Query: 495 MAPE 498
AP+
Sbjct: 186 RAPD 189
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 58/192 (30%), Positives = 91/192 (47%), Gaps = 24/192 (12%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLS-KNSVQGELEFKN----EVLLVA 375
AT+ + ++G G +G VYK R G +A+K + N G EV L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 376 RLQ---HRNLVRLL----GFSFEETERL-LIYEFVPNSSVD-KFIFDAIKRVQLDWETRY 426
RL+ H N+VRL+ + ++ L++E V D + D L ET
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPGLPAETIK 123
Query: 427 KIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486
++ RG+ +LH + I+HRDLK NIL+ + K++DFG+AR++ + T
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TP 178
Query: 487 RIVGTFGYMAPE 498
+V T Y APE
Sbjct: 179 VVV-TLWYRAPE 189
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 8e-22
Identities = 50/184 (27%), Positives = 90/184 (48%), Gaps = 24/184 (13%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKN---------EVLLV 374
+ K+G+G +G VYK + ++G+ A+K++ LE ++ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR-------LEKEDEGIPSTTIREISIL 54
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
L+H N+V+L + +L++E + + K + L+ T + +
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDV--CEGGLESVTAKSFLLQLLN 111
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
GI Y H+ R++HRDLK N+L++ + KI+DFG+AR F + T IV T Y
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIV-TLWY 166
Query: 495 MAPE 498
AP+
Sbjct: 167 RAPD 170
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 29/192 (15%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN--------EV 371
+++ F KLG G + VYKG + G +A+K + L+ + E+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-------LDSEEGTPSTAIREI 54
Query: 372 LLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD-KFIFDAIKRVQLDWETRYKIIG 430
L+ L+H N+VRL E + L++EF+ N D K D+ ++
Sbjct: 55 SLMKELKHENIVRLYDVIHTENKLTLVFEFMDN---DLKKYMDSRTVGNTPRGLELNLVK 111
Query: 431 GIA----RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS 486
+G+ + HE+ +I+HRDLK N+L++ K+ DFG+AR F +S
Sbjct: 112 YFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSS 167
Query: 487 RIVGTFGYMAPE 498
+V T Y AP+
Sbjct: 168 EVV-TLWYRAPD 178
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 45/184 (24%), Positives = 85/184 (46%), Gaps = 24/184 (13%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN--------EVLLV 374
+ +KLG+G + VYKG+ +A+K + LE + EV L+
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-------LEHEEGAPCTAIREVSLL 54
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
L+H N+V L E L++E++ + + +++ D ++ + + R
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDD--CGNIINMHNVKLFLFQLLR 111
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
G+ Y H +++HRDLK N+L++ K++DFG+AR ++ + +V T Y
Sbjct: 112 GLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV-TLWY 166
Query: 495 MAPE 498
P+
Sbjct: 167 RPPD 170
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 3e-21
Identities = 53/186 (28%), Positives = 86/186 (46%), Gaps = 26/186 (13%)
Query: 331 KLGQGGFGAVYKGRLSH---GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLG 387
K+G+G +G VYK + ++ A+K++ + + E+ L+ L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 85
Query: 388 FSFEETERL--LIYEFVPNSSVD--KFI------FDAIKRVQLDWETRYKIIGGIARGIL 437
+R L++++ + D I K VQL ++ I GI
Sbjct: 86 VFLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLF-EMDQSQGDTSRIVGTF 492
YLH + ++HRDLK +NIL+ + KI+D G ARLF + D +V TF
Sbjct: 143 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199
Query: 493 GYMAPE 498
Y APE
Sbjct: 200 WYRAPE 205
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 63/272 (23%), Positives = 114/272 (41%), Gaps = 56/272 (20%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV--QGELEF-KNEVLLVARLQHRNLVRLLG 387
+G+G FG V + + +++ A+K ++K + E+ E+ ++ L+H LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLHEDSRL 445
+SF++ E + ++ + + + +++ E K+ I + + YL
Sbjct: 82 YSFQDEEDMFMVVDLLLGGD----LRYHLQQNVHFKEETVKLFICELVMALDYLQN---Q 134
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR--- 502
RIIHRD+K NILLD I+DF +A + + + + GT YMAPE +
Sbjct: 135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKG 191
Query: 503 -GH-FSIKSDVFSFGVLVLEIISGQ-------KNNSFRI---------------GEEAED 538
G+ F++ D +S GV E++ G+ +S I +E
Sbjct: 192 AGYSFAV--DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVS 249
Query: 539 LLTYAWKNWNEGTALNLIDPTLRNGSSSEIMR 570
LL L +P R S++
Sbjct: 250 LL----------KKLLEPNPDQRFSQLSDVQN 271
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 4e-21
Identities = 44/185 (23%), Positives = 87/185 (47%), Gaps = 25/185 (13%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---------EVLL 373
+ K+G+G +G V+K + + +A+KR+ L+ + E+ L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-------LDDDDEGVPSSALREICL 54
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
+ L+H+N+VRL + + L++EF + K+ LD E + +
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDS--CNGDLDPEIVKSFLFQLL 111
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
+G+ + H ++HRDLK N+L++ + K+++FG+AR F + ++ +V T
Sbjct: 112 KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV-TLW 166
Query: 494 YMAPE 498
Y P+
Sbjct: 167 YRPPD 171
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 28/214 (13%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN----EVLLVARLQ 378
+ +G+G +G V K R G+ +A+K+ S + K E+ L+ +L+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDK-MVKKIAMREIKLLKQLR 82
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
H NLV LL ++ L++EFV + ++ + LD++ K + I GI +
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGF 139
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
H IIHRD+K NIL+ + K+ DFG AR + + T Y APE
Sbjct: 140 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVA-TRWYRAPE 194
Query: 499 -------YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
Y ++ DV++ G LV E+ G+
Sbjct: 195 LLVGDVKYGK----AV--DVWAIGCLVTEMFMGE 222
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 39/203 (19%)
Query: 332 LGQGGFGAVYKGRLSH---GQEIAVKRLSKNSV-QGELEFK--NEVLLVARLQHRNLVRL 385
LG+G FG V H Q++A+K +S+ + + ++ + E+ + L+H ++++L
Sbjct: 17 LGEGSFGKVKLAT--HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 386 LGFSFE--ETER--LLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYK---IIGGIARG 435
++ T +++ E+ +FD I KR+ D E R II I
Sbjct: 75 ----YDVITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTED-EGRRFFQQIICAIE-- 122
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
Y H R +I+HRDLK N+LLD ++ KI+DFG++ + D + TS G+ Y
Sbjct: 123 --YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTS--CGSPNYA 174
Query: 496 APEYVT-RGHFSIKSDVFSFGVL 517
APE + + + + DV+S G++
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIV 197
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 7e-21
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 30/215 (13%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---EVLLVARLQH 379
+ K+G+G +G V+K R GQ +A+K+ S + K E+ ++ +L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
NLV LL + L++E+ + +V + + + I + + +
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFC 118
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD--TSRIVGTFGYMAP 497
H + IHRD+K NIL+ + K+ DFG ARL D + T Y +P
Sbjct: 119 H---KHNCIHRDVKPENILITKHSVIKLCDFGFARLL---TGPSDYYDDEVA-TRWYRSP 171
Query: 498 E-------YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
E Y + DV++ G + E++SG
Sbjct: 172 ELLVGDTQYGP----PV--DVWAIGCVFAELLSGV 200
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-20
Identities = 63/273 (23%), Positives = 120/273 (43%), Gaps = 38/273 (13%)
Query: 270 VVSTSTFIIALVALIT-CVF--LRRRKKKQKQNLRKADEINTVESLQF---DFSTIRDAT 323
V++ + L AL+ F LR+ K R D IN + L+ D+ ++
Sbjct: 19 EVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVK--- 75
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV--QGELE-FKNEVLLVARLQH 379
+G+G FG V R +++ A+K LSK + + + F E ++A
Sbjct: 76 -------VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGIL 437
+V+L ++F++ L ++ E++P + + + + E + + +
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGD----LVNLMSNYDVP-EKWARFYTAEVVLALD 182
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSR-IVGTFGYMA 496
+H + IHRD+K N+LLD K++DFG +M++ VGT Y++
Sbjct: 183 AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM--KMNKEGMVRCDTAVGTPDYIS 237
Query: 497 PEYVTR----GHFSIKSDVFSFGVLVLEIISGQ 525
PE + G++ + D +S GV + E++ G
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 52/264 (19%), Positives = 110/264 (41%), Gaps = 31/264 (11%)
Query: 279 ALVALITCVFLRRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFG 338
L+ ++ C++ ++ + + + +R +F +G+G FG
Sbjct: 29 TLLDILICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFG 88
Query: 339 AVYKGRLSHGQEI-AVKRLSKNSV--QGELE-FKNEVLLVARLQHRNLVRLLGFSFEETE 394
V +L + ++ A+K L+K + + E F+ E ++ + + L ++F++
Sbjct: 89 EVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDN 147
Query: 395 RL-LIYEFVPN----SSVDKF--IFDAIKRVQLDWETRYKI-IGGIARGILYLHEDSRLR 446
L L+ ++ + + KF E + + + I +H+ L
Sbjct: 148 NLYLVMDYYVGGDLLTLLSKFEDRLP---------EEMARFYLAEMVIAIDSVHQ---LH 195
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
+HRD+K NIL+D + +++DFG M+ +S VGT Y++PE +
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKL-MEDGTVQSSVAVGTPDYISPEILQAMEGG 254
Query: 507 IKS-----DVFSFGVLVLEIISGQ 525
D +S GV + E++ G+
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGE 278
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 1e-20
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 38/203 (18%)
Query: 332 LGQGGFGAVYKGRLSH---GQEIAVKRLSKNSVQGELEF---KNEVLLVARLQHRNLVRL 385
LG G FG V G+ H G ++AVK L++ ++ + E+ + +H ++++L
Sbjct: 24 LGVGTFGKVKVGK--HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 386 LGFSFE--ETER--LLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYK---IIGGIARG 435
++ T ++ E+V +FD I R+ E+R I+ G+
Sbjct: 82 ----YQVISTPSDIFMVMEYVSGGE----LFDYICKNGRLDEK-ESRRLFQQILSGVD-- 130
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
Y H R ++HRDLK N+LLDA M KI+DFG++ + D TS G+ Y
Sbjct: 131 --YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTS--CGSPNYA 182
Query: 496 APEYVT-RGHFSIKSDVFSFGVL 517
APE ++ R + + D++S GV+
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVI 205
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 36/195 (18%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR--LSHGQEIAVKRLSKNSVQGELEFKN---------EVL 372
+ ++G+G +G V+K R + G+ +A+KR+ ++ EV
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-------VQTGEEGMPLSTIREVA 63
Query: 373 LVARLQ---HRNLVRLL----GFSFEETERL-LIYEFVPNSSVD-KFIFDAIKRVQLDWE 423
++ L+ H N+VRL + +L L++E V D D + + E
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ---DLTTYLDKVPEPGVPTE 120
Query: 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483
T ++ + RG+ +LH R++HRDLK NIL+ + K++DFG+AR++ +
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL- 176
Query: 484 DTSRIVGTFGYMAPE 498
TS +V T Y APE
Sbjct: 177 -TSVVV-TLWYRAPE 189
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 56/241 (23%), Positives = 105/241 (43%), Gaps = 19/241 (7%)
Query: 297 KQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKR 355
Q+ AD + E + +R ++F +G+G F V ++ ++ A+K
Sbjct: 34 AQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKI 93
Query: 356 LSKNSV--QGELE-FKNEVLLVARLQHRNLVRLLGFSFEETERL-LIYEFVPNSSVDKFI 411
++K + +GE+ F+ E ++ R + +L F+F++ L L+ E+ + +
Sbjct: 94 MNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL 152
Query: 412 FDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471
+R+ + Y + I I +H L +HRD+K NILLD +++DFG
Sbjct: 153 SKFGERIPAEMARFY--LAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFG 207
Query: 472 MARLFEMDQSQGDTSRIVGTFGYMAPE-------YVTRGHFSIKSDVFSFGVLVLEIISG 524
D + + VGT Y++PE G + + D ++ GV E+ G
Sbjct: 208 SCLKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
Query: 525 Q 525
Q
Sbjct: 267 Q 267
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 6e-20
Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEF---KNEVLLVARLQHRNLVRLLG 387
LG+G FG V + A+K L K + + E E ++ +H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLHEDSRL 445
+SF+ +RL + E+ +F + R ++ E R + G I + YLH S
Sbjct: 215 YSFQTHDRLCFVMEYANGGE----LFFHLSRERVFSEDRARFYGAEIVSALDYLH--SEK 268
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
+++RDLK N++LD D KI+DFG+ + + GT Y+APE + +
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGAT-MKTFCGTPEYLAPEVLEDNDY 326
Query: 506 SIKSDVFSFGVLVLEIISGQ 525
D + GV++ E++ G+
Sbjct: 327 GRAVDWWGLGVVMYEMMCGR 346
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-20
Identities = 55/191 (28%), Positives = 79/191 (41%), Gaps = 33/191 (17%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN---------EVLL 373
+ + KLG+G +G VYK + +A+KR+ LE + EV L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR-------LEHEEEGVPGTAIREVSL 86
Query: 374 VARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVD-KFIFDAIKRVQLDWETRYKIIGGI 432
+ LQHRN++ L LI+E+ N D K D K + + +
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAEN---DLKKYMD--KNPDVSMRVIKSFLYQL 141
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDADMIP-----KISDFGMARLFEMDQSQGDTSR 487
G+ + H R +HRDLK N+LL KI DFG+AR F + T
Sbjct: 142 INGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQFTHE 197
Query: 488 IVGTFGYMAPE 498
I+ T Y PE
Sbjct: 198 II-TLWYRPPE 207
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 22/204 (10%)
Query: 332 LGQGGFGAVY---KGRLSHGQEI-AVKRLSKNSVQ--GELEFKNE--VLLVARLQHRNLV 383
LGQG FG V+ K S +++ A+K L K +++ + K E +L+ H +V
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN--HPFIV 89
Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLHE 441
+L ++F+ +L LI +F+ +F + + + E K + +A + +LH
Sbjct: 90 KLH-YAFQTEGKLYLILDFLRGGD----LFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
L II+RDLK NILLD + K++DFG+++ +D + GT YMAPE V
Sbjct: 145 ---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKK-AYSFCGTVEYMAPEVVN 199
Query: 502 RGHFSIKSDVFSFGVLVLEIISGQ 525
R + +D +SFGVL+ E+++G
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV--QGELE-FKNEVLLVARLQH 379
+ F LG G FG V + A+K L K V ++E NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 380 RNLVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGIL 437
LV+L FSF++ L ++ E+V +F ++R+ E + I
Sbjct: 101 PFLVKLE-FSFKDNSNLYMVMEYVAGGE----MFSHLRRIGRFSEPHARFYAAQIVLTFE 155
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP 497
YLH L +I+RDLK N+L+D +++DFG A+ + +G T + GT +AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAP 207
Query: 498 EYVT-RGHFSIKS-DVFSFGVLVLEIISGQ 525
E + +G+ K+ D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGY--NKAVDWWALGVLIYEMAAGY 235
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 69/270 (25%), Positives = 111/270 (41%), Gaps = 56/270 (20%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKNEV--------LLVARLQHRNL 382
LG+G FG V+ + A+K L K+ V ++V +L +H L
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM----DDDVECTMVEKRVLSLAWEHPFL 80
Query: 383 VRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLH 440
+ +F+ E L + E++ + I+ +R I G+ +LH
Sbjct: 81 THMF-CTFQTKENLFFVMEYLNGGD----LMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD-TSRIVGTFGYMAPEY 499
I++RDLK NILLD D KI+DFGM + + T+ GT Y+APE
Sbjct: 136 S---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE---NMLGDAKTNTFCGTPDYIAPEI 189
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ-------KNNSFR------------IGEEAEDLL 540
+ ++ D +SFGVL+ E++ GQ + F + +EA+DLL
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 249
Query: 541 TYAWKNWNEGTALNLIDPTLRNGSSSEIMR 570
L + +P R G +I +
Sbjct: 250 ----------VKLFVREPEKRLGVRGDIRQ 269
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKNEV--------LLVARLQHRNL 382
+G+G FG V R + AVK L K ++ K E +L+ ++H L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK----KKEEKHIMSERNVLLKNVKHPFL 101
Query: 383 VRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLH 440
V L FSF+ ++L + +++ +F ++R + E R + IA + YLH
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGE----LFYHLQRERCFLEPRARFYAAEIASALGYLH 156
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
L I++RDLK NILLD+ ++DFG+ + ++ + TS GT Y+APE +
Sbjct: 157 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNST-TSTFCGTPEYLAPEVL 211
Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
+ + D + G ++ E++ G
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 5e-19
Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 23/202 (11%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSV--QGELE-FKNEVLLVARLQHRNLVRLLG 387
LG G FG V+ R H A+K L K V ++E +E L+++ + H ++R+
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW- 72
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLHEDSRL 445
+F++ +++ +I +++ +F +++ Q K + + YLH
Sbjct: 73 GTFQDAQQIFMIMDYIEGGE----LFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS---K 125
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GH 504
II+RDLK NILLD + KI+DFG A+ T + GT Y+APE V+ +
Sbjct: 126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPEVVSTKPY 180
Query: 505 FSIKS-DVFSFGVLVLEIISGQ 525
KS D +SFG+L+ E+++G
Sbjct: 181 --NKSIDWWSFGILIYEMLAGY 200
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 51/200 (25%), Positives = 89/200 (44%), Gaps = 16/200 (8%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEF---KNEVLLVARLQHRNLVRLLG 387
LG+G FG V R A+K L K + + E E ++ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 388 FSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLHEDSRL 445
++F+ +RL + E+ +F + R ++ E R + I + YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGE----LFFHLSRERVFTEERARFYGAEIVSALEYLHS---R 124
Query: 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF 505
+++RD+K N++LD D KI+DFG+ + + GT Y+APE + +
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGAT-MKTFCGTPEYLAPEVLEDNDY 182
Query: 506 SIKSDVFSFGVLVLEIISGQ 525
D + GV++ E++ G+
Sbjct: 183 GRAVDWWGLGVVMYEMMCGR 202
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 7e-19
Identities = 49/245 (20%), Positives = 94/245 (38%), Gaps = 53/245 (21%)
Query: 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN-EVLLVARLQHR 380
+ +S LG G FG V + G+ A+K+ V + +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK-----VLQDPRYKNRELDIMKVLDHV 60
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDW------------------ 422
N+++L+ + + + P+ +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 423 -ETRYKIIGG-------------------IARGILYLHEDSRLRIIHRDLKASNILLDA- 461
+T +K++ + R + ++H L I HRD+K N+L+++
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177
Query: 462 DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLE 520
D K+ DFG A+ + + I F Y APE + ++ D++S G + E
Sbjct: 178 DNTLKLCDFGSAKKLIPSEP--SVAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 521 IISGQ 525
+I G+
Sbjct: 235 LILGK 239
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 89.3 bits (221), Expect = 1e-18
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKNEV--------LLVARLQHRNL 382
LG+G FG V E+ AVK L K+ V ++V +L + L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ----DDDVECTMVEKRVLALPGKPPFL 404
Query: 383 VRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLH 440
+L F+ +RL + E+V + I++V E IA G+ +L
Sbjct: 405 TQLH-SCFQTMDRLYFVMEYVNGGD----LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD-TSRIVGTFGYMAPEY 499
II+RDLK N++LD++ KI+DFGM + + G T GT Y+APE
Sbjct: 460 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE---NIWDGVTTKTFCGTPDYIAPEI 513
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
+ + D ++FGVL+ E+++GQ
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKNEV--------LLVARLQHRNL 382
LG+G FG V E+ AVK L K+ V ++V +L + L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ----DDDVECTMVEKRVLALPGKPPFL 83
Query: 383 VRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLH 440
+L F+ +RL + E+V + I++V E IA G+ +L
Sbjct: 84 TQLH-SCFQTMDRLYFVMEYVNGGD----LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
II+RDLK N++LD++ KI+DFGM + + T GT Y+APE +
Sbjct: 139 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVT-TKTFCGTPDYIAPEII 193
Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
+ D ++FGVL+ E+++GQ
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKNEV--------LLVARLQHRNL 382
LG+G FG V R+ ++ AVK L K+ + ++V +L H L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ----DDDVECTMTEKRILSLARNHPFL 86
Query: 383 VRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG-IARGILYLH 440
+L F+ +RL + EFV + I++ + E R + I +++LH
Sbjct: 87 TQLF-CCFQTPDRLFFVMEFVNGGD----LMFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
+ II+RDLK N+LLD + K++DFGM + + T+ GT Y+APE +
Sbjct: 142 D---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDYIAPEIL 196
Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
+ D ++ GVL+ E++ G
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
+A+G+ +L + + IHRDL A NILL + KI DFG+AR D
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+MAPE + ++I+SDV+SFGVL+ EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKNEV--------LLVARLQHRNL 382
+G+G + V RL I A+K + K V ++ + H L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND----DEDIDWVQTEKHVFEQASNHPFL 72
Query: 383 VRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLH 440
V L F+ RL + E+V + ++R + E + I+ + YLH
Sbjct: 73 VGLH-SCFQTESRLFFVIEYVNGGD----LMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
E II+RDLK N+LLD++ K++D+GM + TS GT Y+APE +
Sbjct: 128 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEIL 182
Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
+ D ++ GVL+ E+++G+
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 332 LGQGGFGAVY---KGRLSHGQEI-AVKRLSKNSV---QGELEF-KNEVLLVARLQHRNLV 383
LG+GG+G V+ K ++ +I A+K L K + + K E ++ ++H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLHE 441
L+ ++F+ +L LI E++ +F ++R + E + I+ + +LH+
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGE----LFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
II+RDLK NI+L+ K++DFG+ + + T GT YMAPE +
Sbjct: 140 ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTV-THTFCGTIEYMAPEILM 194
Query: 502 RGHFSIKSDVFSFGVLVLEIISGQ 525
R + D +S G L+ ++++G
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGA 218
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 53/205 (25%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 332 LGQGGFGAVYKGRLSHGQEI-AVKRLSKNSVQGELEFKNEV--------LLVARLQHRNL 382
+G+G + V RL I A++ + K V ++ + H L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND----DEDIDWVQTEKHVFEQASNHPFL 115
Query: 383 VRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYLH 440
V L F+ RL + E+V + ++R + E + I+ + YLH
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGD----LMFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
E II+RDLK N+LLD++ K++D+GM + TS GT Y+APE +
Sbjct: 171 E---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEIL 225
Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
+ D ++ GVL+ E+++G+
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 62/210 (29%), Positives = 107/210 (50%), Gaps = 28/210 (13%)
Query: 332 LGQGGFGAVY---KGRLSHGQEI-AVKRLSKNSVQGELEF----KNE--VLLVARLQHRN 381
LG G +G V+ K ++ A+K L K ++ + + + E VL R Q
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPF 120
Query: 382 LVRLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKI-IGGIARGILYL 439
LV L ++F+ +L LI +++ +F + + + E +I +G I + +L
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGE----LFTHLSQRERFTEHEVQIYVGEIVLALEHL 175
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
H+ L II+RD+K NILLD++ ++DFG+++ F D+++ GT YMAP+
Sbjct: 176 HK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDI 231
Query: 500 VT---RGHFSIKS-DVFSFGVLVLEIISGQ 525
V GH K+ D +S GVL+ E+++G
Sbjct: 232 VRGGDSGH--DKAVDWWSLGVLMYELLTGA 259
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 60/247 (24%), Positives = 104/247 (42%), Gaps = 51/247 (20%)
Query: 301 RKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKN 359
++ + +VE F + +G G G V + + +A+K+LS+
Sbjct: 6 KRDNNFYSVEIGDSTF----TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR- 60
Query: 360 SVQGELEFKN---------EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF 410
F+N E++L+ + H+N++ LL F P S+++F
Sbjct: 61 ------PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSLEEF 102
Query: 411 -----IFD-------AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 458
+ + + +++LD E ++ + GI +LH IIHRDLK SNI+
Sbjct: 103 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 159
Query: 459 LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLV 518
+ +D KI DFG+AR V T Y APE + + D++S G ++
Sbjct: 160 VKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVILGMGYKENVDIWSVGCIM 216
Query: 519 LEIISGQ 525
E+I G
Sbjct: 217 GEMIKGG 223
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 21/199 (10%), Positives = 55/199 (27%), Gaps = 41/199 (20%)
Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL---EFKNEVLLVARLQHRNLVRLL 386
G ++ + +++A+ + V + E + L ++R+ + R+L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 387 GFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLR 446
L++ E++ S+ + + + +A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 447 IIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS 506
+ S + + D G L M +
Sbjct: 150 VALSIDHPSRVRVSID--------GDVVL--------------AYPATMPDA-------N 180
Query: 507 IKSDVFSFGVLVLEIISGQ 525
+ D+ G + ++ +
Sbjct: 181 PQDDIRGIGASLYALLVNR 199
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 53/228 (23%), Positives = 94/228 (41%), Gaps = 28/228 (12%)
Query: 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELE--FKN---- 369
+ + + ++ + G +GAV G S G +A+KR+ G +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 370 -----EVLLVARLQHRNLVRLLG-FSFEETERL----LIYEFVPNSSVDKFIFDAIKRVQ 419
E+ L+ H N++ L F E + L+ E + + + + I +R+
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVI--HDQRIV 130
Query: 420 L-DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478
+ +Y + I G+ LHE ++HRDL NILL + I DF +AR
Sbjct: 131 ISPQHIQY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTA 186
Query: 479 DQSQGDTSRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
D ++ V Y APE V F+ D++S G ++ E+ + +
Sbjct: 187 DANKTHY---VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 8e-17
Identities = 54/225 (24%), Positives = 97/225 (43%), Gaps = 47/225 (20%)
Query: 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN---------EVL 372
+ +G G G V + + +A+K+LS+ F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------PFQNQTHAKRAYRELV 113
Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-----IFD-------AIKRVQL 420
L+ + H+N++ LL F P ++++F + + + +++L
Sbjct: 114 LMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 161
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
D E ++ + GI +LH IIHRDLK SNI++ +D KI DFG+AR
Sbjct: 162 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
V T Y APE + + D++S G ++ E++ +
Sbjct: 219 MMTPY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 55/233 (23%), Positives = 105/233 (45%), Gaps = 50/233 (21%)
Query: 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN----- 369
T + + + +G G +G+V G+++A+K+LS+ F++
Sbjct: 16 NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-------PFQSEIFAK 68
Query: 370 ----EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-----IFD------- 413
E+LL+ +QH N++ LL F P SS+ F +
Sbjct: 69 RAYRELLLLKHMQHENVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQ 116
Query: 414 AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473
I ++ E ++ + +G+ Y+H ++HRDLK N+ ++ D KI DFG+A
Sbjct: 117 KIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173
Query: 474 RLFEMDQSQGDTSRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
R + + + V T Y APE + + H++ D++S G ++ E+++G+
Sbjct: 174 RHADAEMTG-----YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 53/229 (23%), Positives = 100/229 (43%), Gaps = 51/229 (22%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN---------E 370
+ + +G G +GAV G ++A+K+L + F++ E
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-------PFQSELFAKRAYRE 74
Query: 371 VLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-----IFD--------AIKR 417
+ L+ ++H N++ LL F P+ ++D F + +K
Sbjct: 75 LRLLKHMRHENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKH 122
Query: 418 VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477
+L + ++ + +G+ Y+H IIHRDLK N+ ++ D KI DFG+AR +
Sbjct: 123 EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD 179
Query: 478 MDQSQGDTSRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
+ + V T Y APE + ++ D++S G ++ E+I+G+
Sbjct: 180 SEMTG-----YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 46/243 (18%), Positives = 96/243 (39%), Gaps = 48/243 (19%)
Query: 290 RRRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHG 348
+++ +Q++ + ++ D+ + + + +G G +G V +
Sbjct: 23 SQQEGQQRKQHHSSKPTASMPRPHSDW----QIPDRYEIRHLIGTGSYGHVCEAYDKLEK 78
Query: 349 QEIAVKRLSKNSVQGELEFKN---------EVLLVARLQHRNLVRLL----GFSFEETER 395
+ +A+K++ + F++ E+ ++ RL H ++V++L E+ +
Sbjct: 79 RVVAIKKILR-------VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131
Query: 396 L-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKA 454
L ++ E S K V L ++ + G+ Y+H S I+HRDLK
Sbjct: 132 LYVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVH--SA-GILHRDLKP 184
Query: 455 SNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP--------------EYV 500
+N L++ D K+ DFG+AR + ++ I M +V
Sbjct: 185 ANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHV 244
Query: 501 -TR 502
TR
Sbjct: 245 VTR 247
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 45/226 (19%), Positives = 98/226 (43%), Gaps = 36/226 (15%)
Query: 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN---------EVL 372
+ + LG GG G V+ + + +A+K++ + E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDK-FIFD--------AIKRVQLDWE 423
++ RL H N+V++ +L + + +++ L E
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 424 -TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEMDQS 481
R + + RG+ Y+H + ++HRDLK +N+ ++ D++ KI DFG+AR+ + S
Sbjct: 121 HARL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 482 QGDT-SRIVGTFGYMAPE-YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
S + T Y +P ++ +++ D+++ G + E+++G+
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 49/236 (20%), Positives = 102/236 (43%), Gaps = 51/236 (21%)
Query: 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN----- 369
+ D ++ + +G+G +G V + +A+K++S F++
Sbjct: 19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQ 70
Query: 370 ----EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-----IFD------- 413
E+ ++ R +H N++ + + + ++++ + D
Sbjct: 71 RTLREIKILLRFRHENIIGIN-------------DIIRAPTIEQMKDVYIVQDLMETDLY 117
Query: 414 AIKRVQL--DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471
+ + Q + Y + I RG+ Y+H + ++HRDLK SN+LL+ KI DFG
Sbjct: 118 KLLKTQHLSNDHICY-FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 173
Query: 472 MARLFEMDQSQGDT-SRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
+AR+ + D + V T Y APE + ++ D++S G ++ E++S +
Sbjct: 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 45/203 (22%), Positives = 75/203 (36%), Gaps = 56/203 (27%)
Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGF 388
LG G G V + ++ A+K L + + EV L R Q ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDV 79
Query: 389 SFEETER-----LLIYEFVPNSSVDKFIFDAIKRVQLDWETRY------KIIGGIARGIL 437
+E L++ E + +F I+ + + +I+ I I
Sbjct: 80 -YENLYAGRKCLLIVMECLDGGE----LFSRIQDRG---DQAFTEREASEIMKSIGEAIQ 131
Query: 438 YLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494
YLH + I HRD+K N+L + I K++DFG
Sbjct: 132 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG----------------------- 165
Query: 495 MAPEYVTRGHFSIKSDVFSFGVL 517
A E T + D++S GV+
Sbjct: 166 FAKE-TTGEKYDKSCDMWSLGVI 187
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 46/222 (20%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 309 VESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEF 367
ES ++ +++ KLG+G + V++ +++ +++ VK L + +
Sbjct: 25 YESHVVEW----GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKI 77
Query: 368 KNEVLLVARLQ-HRNLVRLLGFSFEETER--LLIYEFVPNSSVDKFIFDAIKRVQLDWET 424
K E+ ++ L+ N++ L + R L++E V N+ + + D++
Sbjct: 78 KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-QTLT----DYDI 132
Query: 425 RYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPKISDFGMARLFEMDQSQG 483
R+ + I + + Y H S I+HRD+K N+++D ++ D+G+A + Q
Sbjct: 133 RF-YMYEILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 187
Query: 484 DTSRIVGTFGYMAPE-YVTRGHFSIKSDVFSFGVLVLEIISG 524
R V + + PE V + D++S G ++ +I
Sbjct: 188 -NVR-VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR 227
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 51/227 (22%)
Query: 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN---------EVL 372
+ + +G G +G+V + G +AVK+LS+ F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80
Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-----IFD--------AIKRVQ 419
L+ ++H N++ LL F P S+++F + +K +
Sbjct: 81 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 420 LDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479
L + +I I RG+ Y+H IIHRDLK SN+ ++ D KI DFG+AR +
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 480 QSQGDTSRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ 525
+ V T Y APE + H++ D++S G ++ E+++G+
Sbjct: 186 MTG-----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 55/244 (22%), Positives = 97/244 (39%), Gaps = 64/244 (26%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN------- 369
+ + +++F + LG+G +G V G+ +A+K++ F
Sbjct: 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRT 56
Query: 370 --EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-----IFD--------A 414
E+ ++ +H N++ + S + F I +
Sbjct: 57 LREIKILKHFKHENIITIF-------------NIQRPDSFENFNEVYIIQELMQTDLHRV 103
Query: 415 IKRVQL-DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473
I L D +Y I R + LH + +IHRDLK SN+L++++ K+ DFG+A
Sbjct: 104 ISTQMLSDDHIQY-FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA 159
Query: 474 RLFEMDQSQGDTSRIVGTFGYMAPEYV-TR-----------GHFSIKSDVFSFGVLVLEI 521
R+ D+S D S G M E+V TR +S DV+S G ++ E+
Sbjct: 160 RII--DESAADNSEPTGQQSGM-VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
Query: 522 ISGQ 525
+
Sbjct: 217 FLRR 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 45/258 (17%), Positives = 97/258 (37%), Gaps = 76/258 (29%)
Query: 324 NNFSTDNK------LGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN------- 369
N + +G+G +G VY + + +A+K++++ F++
Sbjct: 20 KNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRI 72
Query: 370 --EVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKF-----IFD--------A 414
E+ ++ RL+ ++RL + + + KF + +
Sbjct: 73 LREITILNRLKSDYIIRLY-------------DLIIPDDLLKFDELYIVLEIADSDLKKL 119
Query: 415 IKRVQL--DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472
K + + I+ + G ++HE IIHRDLK +N LL+ D K+ DFG+
Sbjct: 120 FKTPIFLTEEHIKT-ILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGL 175
Query: 473 ARLFEMDQSQGDTSRIVGTFGYMAP---------EYV-TR-----------GHFSIKSDV 511
AR ++ + + +V TR +++ D+
Sbjct: 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDI 235
Query: 512 FSFGVLVLEIISGQKNNS 529
+S G + E+++ +++
Sbjct: 236 WSTGCIFAELLNMLQSHI 253
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 45/228 (19%), Positives = 88/228 (38%), Gaps = 54/228 (23%)
Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV---QGELEFK-------NEVLLVARLQH 379
KLG G F V+ + + + +A+K + + V E E K + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 380 RNLVRLLG-FSFEETER--------LL---IYEFVPNSSVDKFIFDAIKRVQLDWETRYK 427
++++LL F+ + +L + + +K+
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ---------- 135
Query: 428 IIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIP------KISDFGMARLFE 477
I++ +L Y+H R IIH D+K N+L++ P KI+D G A ++
Sbjct: 136 ----ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
+ +R Y +PE + + +D++S L+ E+I+G
Sbjct: 190 EHYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 57/240 (23%), Positives = 102/240 (42%), Gaps = 70/240 (29%)
Query: 330 NKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKN---------EVLLVARLQ- 378
KLG+G +G V+K G+ +AVK++ F+N E++++ L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-------AFQNSTDAQRTFREIMILTELSG 67
Query: 379 HRNLVRLLGF----SFEETERLLIYEFVPNSSVDKFIFD-------AIKRVQL--DWETR 425
H N+V LL + + +Y +FD A+ R + +
Sbjct: 68 HENIVNLLNVLRADNDRD-----VY----------LVFDYMETDLHAVIRANILEPVHKQ 112
Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485
Y ++ + + I YLH S ++HRD+K SNILL+A+ K++DFG++R F + +
Sbjct: 113 Y-VVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168
Query: 486 SRIVGTFGYMAP--------EYV-TR-----------GHFSIKSDVFSFGVLVLEIISGQ 525
+ +YV TR ++ D++S G ++ EI+ G+
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.7 bits (159), Expect = 1e-11
Identities = 37/260 (14%), Positives = 73/260 (28%), Gaps = 67/260 (25%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRL---SKNSVQGE-----LEFKNEVLL 373
T K+G+G FG V++ H +A+K + + V G E E+++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 374 ---------VARLQHRNLVRLLGF------------------------------SFEETE 394
+ + L F++ +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKA 454
++ EF + ++ T I+ + + LR HRDL
Sbjct: 137 LFIVLEFEFGGI----DLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190
Query: 455 SNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAP--EYVTRGHFSIKSDVF 512
N+LL + K+ + + + G +Y VF
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSST-----------IPSCGLQVSIIDYTLSRLERDGIVVF 239
Query: 513 SFGVLVLEIISGQKNNSFRI 532
+ ++ +G + F I
Sbjct: 240 CDVSMDEDLFTGDGDYQFDI 259
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 52/217 (23%), Positives = 85/217 (39%), Gaps = 42/217 (19%)
Query: 330 NKLGQGGFGAVYKGR-LSHGQEIAVKRLSKN----SVQGELEFKNEVLLVARLQHR---- 380
+ +G+G FG V K + +A+K + KN Q + EV L+ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIK-IIKNKKAFLNQA----QIEVRLLELMNKHDTEM 114
Query: 381 --NLVRLLG-FSFEE-----TERLLI--YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
+V L F F E L Y+ + N++ + + K
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTR----------KFAQ 164
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILLDADMIP--KISDFGMARLFEMDQSQGDTSRI 488
+ +L+L L IIH DLK NILL KI DFG + Q I
Sbjct: 165 QMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYI 219
Query: 489 VGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
F Y +PE + + + D++S G +++E+ +G+
Sbjct: 220 QSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 36/211 (17%)
Query: 332 LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR------NLVR 384
+G+G FG V K Q +A+K + +N + + E+ ++ L+ + N++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 385 LLG-FSFEE-----TERLLI--YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
+L F+F E L + YE + + F ++ K I + +
Sbjct: 164 MLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVR----------KFAHSILQCL 213
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIP--KISDFGMARLFEMDQSQGDTSRIVGTFGY 494
LH + RIIH DLK NILL K+ DFG + + Q + I F Y
Sbjct: 214 DALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRF-Y 265
Query: 495 MAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
APE + + + D++S G ++ E+++G
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 46/265 (17%), Positives = 89/265 (33%), Gaps = 88/265 (33%)
Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH-------RNL 382
KLG G F V+ + + +A+K + E +E+ L+ +++ R +
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102
Query: 383 VRLLGFSFE-------------ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
V L F+ E + +++ S+ +K+ II
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK----------II 152
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDAD--------------------------- 462
+ +G+ YLH ++ RIIH D+K NILL +
Sbjct: 153 QQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 463 ----------------------MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
+ KI+D G A ++ + T Y + E +
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSLEVL 265
Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
++ +D++S + E+ +G
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGD 290
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 35/229 (15%), Positives = 83/229 (36%), Gaps = 34/229 (14%)
Query: 295 KQKQNLRKADEINTVESLQFDFSTIRDAT-NNFSTDNKLGQGGFGAVYKGR--------- 344
+NL ++E+L + + D + + + + G +Y+
Sbjct: 13 LGTENLYFQSMTTSLEALPTG-TVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDS 71
Query: 345 LSHGQEIAVKRLSKNS-VQGELEF------KNEVLLVARLQHRNLV---RLLGFSFEETE 394
Q+ ++K +K+ + E F +V +L L+ +GF + +
Sbjct: 72 GPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDK 131
Query: 395 -RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLK 453
R L+ + S D + L + ++ + + +LHE+ +H ++
Sbjct: 132 YRFLVLPSLGRSLQS--ALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVT 186
Query: 454 ASNILLDADMIPKI--SDFGMARLF-----EMDQSQGDTSRIVGTFGYM 495
A NI +D + ++ + +G A + + +G S G ++
Sbjct: 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 37/158 (23%), Positives = 66/158 (41%), Gaps = 13/158 (8%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH-RN 381
N + K+G G FG +Y G ++ G+E+A+K + +L E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVG 66
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
+ + E +++ E + S D F F + +T + + I Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 442 DSRLRIIHRDLKASNILLDADMIPK---ISDFGMARLF 476
+ IHRD+K N L+ I DFG+A+ +
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 43/183 (23%), Positives = 77/183 (42%), Gaps = 20/183 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
N F K+G G FG +Y G + +E+A+K + + +L + E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTG 64
Query: 383 V-RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
+ + F E +L+ + + S D +F+ R +L +T + + + ++H
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLLGPSLED--LFNFCSR-KLSLKTVLMLADQMINRVEFVHS 121
Query: 442 DSRLRIIHRDLKASNILLDADMIPK---ISDFGMARLFEMDQSQG------DTSRIVGTF 492
S +HRD+K N L+ I DFG+A+ + D S + + GT
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY-RDTSTHQHIPYRENKNLTGTA 177
Query: 493 GYM 495
Y
Sbjct: 178 RYA 180
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 36/184 (19%), Positives = 74/184 (40%), Gaps = 20/184 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
++ ++G+G FG +++G L + Q++A+K + S +L + + +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL-LAGCTGI 68
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
+ F E +L+ + + S D + D R + +T + + +HE
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLGPSLED--LLDLCGR-KFSVKTVAMAAKQMLARVQSIHEK 125
Query: 443 SRLRIIHRDLKASNILLDADMIPK-----ISDFGMARLFEMDQSQG------DTSRIVGT 491
S +++RD+K N L+ + DFGM + + D + + GT
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY-RDPVTKQHIPYREKKNLSGT 181
Query: 492 FGYM 495
YM
Sbjct: 182 ARYM 185
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 34/159 (21%), Positives = 61/159 (38%), Gaps = 13/159 (8%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
NF K+G G FG + G+ L + +A+K S +L + +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGI 67
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
++ F ++ E + S D +FD R +T I + + Y+H
Sbjct: 68 PQVYYFGPCGKYNAMVLELLGPSLED--LFDLCDR-TFSLKTVLMIAIQLISRMEYVHSK 124
Query: 443 SRLRIIHRDLKASNILLDADMIPK-----ISDFGMARLF 476
+ +I+RD+K N L+ I DF +A+ +
Sbjct: 125 N---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 2e-06
Identities = 71/543 (13%), Positives = 135/543 (24%), Gaps = 187/543 (34%)
Query: 161 LKFATDEANLTSSETIYALMQ-------C--TPD-----ISQSDCEFCLRQSMADVQS-- 204
+ F T E + + C D +S+ + + + A +
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLR 66
Query: 205 -----CCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLSPPSTTTDTTIAKDKGGN 259
++ + Y + P T +D+ N
Sbjct: 67 LFWTLLSKQEEMVQKF-----VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYN 121
Query: 260 SISSGTVVIIVVSTSTFIIALVALITCVFLRRRKKKQK-----QNLRKADEINTVESLQF 314
+ + R + K LR A + ++
Sbjct: 122 D--------------------NQVFAKYNVSRLQPYLKLRQALLELRPAKNV-LID---- 156
Query: 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFK------ 368
G G G K + A+ VQ +++FK
Sbjct: 157 ------------------GVLGSG---KTWV------ALDVCLSYKVQCKMDFKIFWLNL 189
Query: 369 ----NEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWET 424
+ ++ LQ L+ + ++ T R + I ++R+
Sbjct: 190 KNCNSPETVLEMLQ--KLLYQIDPNW--TSRSDHSSNIKLRIHS--IQAELRRLLKSK-- 241
Query: 425 RYKIIGGIARGILYLHED--------------SRLRIIHRDLKASNILLDADMIPKISDF 470
Y+ +L L ++ + R + ++ L A IS
Sbjct: 242 PYE------NCLLVL--LNVQNAKAWNAFNLSCKILLTTRFKQVTDF-LSAATTTHISLD 292
Query: 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF 530
+ D+ + + + P V + L I
Sbjct: 293 HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN-----------PRRLSI--------- 332
Query: 531 RIGEEAEDLLTYAWKNW---NEGTALNLIDPTLRNGSSSEIMRC----------VHI--G 575
I E D L W NW N +I+ +L +E + HI
Sbjct: 333 -IAESIRDGLA-TWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTI 390
Query: 576 LLCV--QENVANRPTMASVVVMLNSSSLSLPLPSQPAFFMHSTMEQDNLEFTSSDQSKSG 633
LL + + + + + VV L+ SL +E+ E T
Sbjct: 391 LLSLIWFDVIKSDVMV--VVNKLHKYSL---------------VEKQPKESTI------- 426
Query: 634 SIH 636
SI
Sbjct: 427 SIP 429
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 8e-04
Identities = 73/561 (13%), Positives = 142/561 (25%), Gaps = 213/561 (37%)
Query: 82 VLDMMKNCPNQKEAISWEGMDF----PCVVRYSSRSFFGKLELKPTEIAHNVNNITSSLT 137
V DM K+ +S E +D V + F L K E+ V +
Sbjct: 38 VQDMPKS------ILSKEEIDHIIMSKDAVS-GTLRLFWTLLSKQEEM---VQKFVEEVL 87
Query: 138 QFDRIWRSLMDRVLAKASLGTS--KLKFATDEANLTSSETIYALMQCTPDISQSDCEFCL 195
+ + + LM + S + L + ++A +S+ L
Sbjct: 88 RINYKF--LMSP-IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYN----VSRLQPYLKL 140
Query: 196 RQSMADVQS----CCYGKKGSYIMGPSCIFRWEMYPFYGATADSLSPSPLSPPSTTTDTT 251
RQ++ +++ G GS G + + D +
Sbjct: 141 RQALLELRPAKNVLIDGVLGS---GKTWV-----------ALDVCLSYKV---------Q 177
Query: 252 IAKDKG------GNSISSGTVVIIVVSTSTFIIALVALITCVF---------LRRRKKKQ 296
D N S TV+ ++ L+ I + ++ R
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEMLQK-------LLYQIDPNWTSRSDHSSNIKLRIHSI 230
Query: 297 KQNLRKA-------------DEINTVESLQ-FDFS-----TIRDATNNFSTDNKLGQGGF 337
+ LR+ + ++ F+ S T R TD
Sbjct: 231 QAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQV---TD-------- 279
Query: 338 GAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV-RLLGFSFEETERL 396
L A H +L + + +E + L
Sbjct: 280 ---------------------------------FLSAATTTHISLDHHSMTLTPDEVKSL 306
Query: 397 LIYEFVPNSSVDKF-------------IFDAIKRVQLD-WETRYKIIGGIARGILYLHED 442
L+ +++ + I R L W+ +K +++ D
Sbjct: 307 LL-KYL-DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWD-NWK----------HVNCD 353
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
II L L+ ++F+ + F P
Sbjct: 354 KLTTIIESSLNV----LEPA--------EYRKMFDR----------LSVF----PPSA-- 385
Query: 503 GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTY------AWKNWNEGTALNLI 556
I + +L +I I + ++ K E T +++
Sbjct: 386 ---HIPTI-------LLSLIWFDV-----IKSDVMVVVNKLHKYSLVEKQPKEST-ISIP 429
Query: 557 DPTLRNGSSSEIMRCVHIGLL 577
L E +H ++
Sbjct: 430 SIYLELKVKLENEYALHRSIV 450
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 33/179 (18%), Positives = 63/179 (35%), Gaps = 35/179 (19%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR------LSHGQEIAVKRLSKNSVQGELEFK-----NEVL 372
+ +GQGGFG +Y + VK ++ E K +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 373 LVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGG- 431
+ + ++ LG + + + + F + R D + Y+
Sbjct: 95 QIQKWIRTRKLKYLGVPK------YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR 148
Query: 432 --------IARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKI--SDFGMARLF 476
++ IL Y+HE +H D+KASN+LL+ ++ D+G+A +
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 54/237 (22%), Positives = 87/237 (36%), Gaps = 68/237 (28%)
Query: 331 KLGQGGFGAVYKG--RLSHGQEIAVKRLSKN----SVQGELEFKNEVLLVARLQHR---- 380
LG+G FG V + + G+ +AVK + KN E + VL L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV-KNVDRYCEAARSEIQ--VL--EHLNTTDPNS 75
Query: 381 --NLVRLLG-FSFEE-----TERLLI--YEFVPNSSVDKFIFDAIKRV--QLDWETRYKI 428
V++L F E L + Y+F+ + F D I+++ Q+
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQI-------- 127
Query: 429 IGGIARGILYLHEDSRLRIIHRDLKASNILL-DADMIP------------------KISD 469
+ + +LH ++ H DLK NIL +D K+ D
Sbjct: 128 ----CKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQ 525
FG A + ++ + Y APE V +S DV+S G +++E G
Sbjct: 181 FGSA----TYDDEHHSTLVSTRH-YRAPE-VILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 45/238 (18%), Positives = 82/238 (34%), Gaps = 70/238 (29%)
Query: 331 KLGQGGFGAVYKG--RLSHGQEIAVKRLSKN----SVQGELEFKNEVLLVARLQHR---- 380
LG+G FG V + ++A+K + +N LE VL +++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII-RNVGKYREAARLEIN--VL--KKIKEKDKEN 80
Query: 381 --NLVRLLG-FSFEE-----TERLLI--YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIG 430
V + F+F E L +EF+ ++ + ++
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRH------------- 127
Query: 431 GIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIP-------------------KI 467
+A + +LHE ++ H DLK NIL ++
Sbjct: 128 -MAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
+DFG A + T+ + Y PE + ++ DV+S G ++ E G
Sbjct: 184 ADFGSA----TFDHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 49/235 (20%), Positives = 96/235 (40%), Gaps = 60/235 (25%)
Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKN----SVQGELEFKNEVLLVARLQHR----- 380
K+G G FG V + + + + AVK + +N + ++E +L ++Q+
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRSAKIEAD--IL--KKIQNDDINNN 96
Query: 381 NLVRLLG-FSFEE-----TERLLI--YEFVPNSSVDKFIFDAIKRV--QLDWETRYKIIG 430
N+V+ G F + + E L YE + ++ + F + IK ++
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEI---------- 146
Query: 431 GIARGILYLHEDSRLRIIHRDLKASNILL--DADMIPKISDFGMARLFEMDQSQGDTSRI 488
+ + YL + + + H DLK NILL I+ + ++ + ++ I
Sbjct: 147 --LKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 489 -VGTFG-----------------YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
+ FG Y APE + + + SD++SFG ++ E+ +G
Sbjct: 202 KLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 31/180 (17%), Positives = 66/180 (36%), Gaps = 40/180 (22%)
Query: 324 NNFSTDNKLGQGGFGAVYKG-RLSHGQEIAVKRLS-KNSVQGELEFKNEVLLVARLQHRN 381
N + K+G GGFG +Y + ++ A + + G L +E+ R+ ++
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF--SELKFYQRVAKKD 94
Query: 382 LV---------------RLLGFSFEETE----RLLIYEFVPNSSVDKFIFDAIKRVQLDW 422
+ G E + R ++ E + I +
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQK--ISGQNGTFKK-- 150
Query: 423 ETRYKIIGGIARGIL----YLHEDSRLRIIHRDLKASNILLDADMIPKI--SDFGMARLF 476
+ + +L Y+HE+ +H D+KA+N+LL ++ +D+G++ +
Sbjct: 151 ----STVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 35/200 (17%), Positives = 72/200 (36%), Gaps = 29/200 (14%)
Query: 291 RRKKKQKQNLRKADEINTVESLQFDFSTIRDATNNFSTD-------NKLGQGGFGAVYKG 343
+ + + + F ++ + + +G+G AV+
Sbjct: 52 KYLSDLRVVQNRQKDYEGST-FTFIGLSLY-SLHRLVRSGKVDAIGKLMGEGKESAVFNC 109
Query: 344 RLSHGQEIAVK--RLSKNS--------VQGELEFKNEVLLVARLQHRNLVRLLGFSFEET 393
E VK ++ S G+L F + AR + R L +L G + +
Sbjct: 110 YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK- 168
Query: 394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLK 453
+Y + N+ + + I DA + ++ E +++ I + + I+H DL
Sbjct: 169 ----VYAWEGNAVLMELI-DAKELYRVRVENPDEVLDMILEEVAKFYHR---GIVHGDLS 220
Query: 454 ASNILLDADMIPKISDFGMA 473
N+L+ + I I DF +
Sbjct: 221 QYNVLVSEEGI-WIIDFPQS 239
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 650 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.92 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.92 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.88 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.96 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.51 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.4 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.34 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.18 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.13 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.99 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.91 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.82 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.7 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.53 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.18 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.15 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.1 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.99 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.97 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.6 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.43 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.34 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.33 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.75 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.06 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.41 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 91.49 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 90.96 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.12 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 87.47 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 87.42 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.17 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.1 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=446.15 Aligned_cols=258 Identities=24% Similarity=0.399 Sum_probs=211.4
Q ss_pred cCCCcCCcccccCceeEEEeecc------CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46778899999999999999864 367899999988776777789999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhh----------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEE
Q 006317 398 IYEFVPNSSVDKFIFDAI----------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 467 (650)
|||||++|+|.++|+... ....++|.++++++.||++||+|||+++ |+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997531 2356999999999999999999999987 999999999999999999999
Q ss_pred eeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHh
Q 006317 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKN 546 (650)
Q Consensus 468 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 546 (650)
+|||+++...............||+.|||||++.++.++.++|||||||++|||+| |+.||.... ..++.......
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~i~~~ 246 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNEVIECITQG 246 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHHHHHT
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHcC
Confidence 99999987654433333445679999999999999999999999999999999999 899986322 22233222221
Q ss_pred ccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 547 WNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 547 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
.. +..+...++ ++.+|+.+||+.||++||||+||++.|+..
T Consensus 247 ----~~-----~~~p~~~~~---~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 247 ----RV-----LQRPRTCPQ---EVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp ----CC-----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CC-----CCCCccchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 111222333 355677899999999999999999999763
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-54 Score=440.14 Aligned_cols=263 Identities=25% Similarity=0.445 Sum_probs=200.8
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
+++.+.++||+|+||+||+|++++ .||||+++... ......|.+|+.+|++++|||||+++|++.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 567788999999999999999753 59999987543 3345679999999999999999999998865 568999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
|++|+|.++|+. ....++|.+++.|+.||++||+|||+++ ||||||||+||||++++++||+|||+|+.......
T Consensus 113 ~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 999999999974 3457999999999999999999999987 99999999999999999999999999987654433
Q ss_pred CCccceeecCccccChhcccc---CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 482 QGDTSRIVGTFGYMAPEYVTR---GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
........||+.|||||++.+ +.|+.++|||||||+||||+||+.||...... ..+............. +
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~~~p~~-----~ 260 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGYASPDL-----S 260 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTCCCCCS-----T
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCCc-----c
Confidence 344556789999999999964 46899999999999999999999998632211 1111111111111110 1
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCCCCC
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSLP 604 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~~~~ 604 (650)
.+....++ .+.+|+.+||+.||++||||.||++.|+....++|
T Consensus 261 ~~~~~~~~---~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 261 KLYKNCPK---AMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp TSCTTSCH---HHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred cccccchH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 11122333 45567789999999999999999999876443343
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-54 Score=443.20 Aligned_cols=256 Identities=27% Similarity=0.424 Sum_probs=208.8
Q ss_pred CCCcCCcccccCceeEEEeecc------CCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
.+++.++||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4556789999999999999863 46789999997653 3345679999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhh-------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC
Q 006317 398 IYEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI 464 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~ 464 (650)
|||||++|+|.++|.... ....++|.++++|+.|||+||+|||+++ ||||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 999999999999997431 1346999999999999999999999987 999999999999999999
Q ss_pred eEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHH
Q 006317 465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYA 543 (650)
Q Consensus 465 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~ 543 (650)
+||+|||+++...............||+.|||||++.++.++.++|||||||+||||+| |+.||.... ..++....
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~---~~~~~~~i 260 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVVEMI 260 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC---HHHHHHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC---HHHHHHHH
Confidence 99999999987655444444555689999999999999999999999999999999999 888886322 22333322
Q ss_pred HHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 544 WKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 544 ~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.. +... ......+. .+.+|+.+||+.||++||||.||++.|+.
T Consensus 261 ~~----~~~~-----~~p~~~~~---~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 261 RN----RQVL-----PCPDDCPA---WVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HT----TCCC-----CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred Hc----CCCC-----CCcccchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 21 1111 11222333 35567789999999999999999999986
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-54 Score=446.07 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=203.9
Q ss_pred cCCCcCCcccccCceeEEEeecc------CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
++|...++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45677789999999999999864 367899999988776777789999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhh------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCe
Q 006317 398 IYEFVPNSSVDKFIFDAI------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 465 (650)
|||||++|+|.++|+... ....++|.++++|+.||++||+|||+.+ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999997532 2346999999999999999999999987 9999999999999999999
Q ss_pred EEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHH
Q 006317 466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAW 544 (650)
Q Consensus 466 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~ 544 (650)
||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||.... ..+++....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~i~ 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS---NTEAIDCIT 274 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC---HHHHHHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC---HHHHHHHHH
Confidence 9999999987654444444455689999999999999999999999999999999999 899986322 222222222
Q ss_pred HhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 545 KNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 545 ~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
.. . .+......+++ +.+|+.+||+.||++||||.||+++|+..
T Consensus 275 ~g----~-----~~~~p~~~~~~---~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 275 QG----R-----ELERPRACPPE---VYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp HT----C-----CCCCCTTCCHH---HHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred cC----C-----CCCCcccccHH---HHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 21 1 11112223333 45677799999999999999999999764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=432.28 Aligned_cols=269 Identities=27% Similarity=0.361 Sum_probs=213.7
Q ss_pred ccChhhHHhhccCCCcCCcccccCceeEEEeeccC------CcceeEeeccccCch-hHHHHHHHHHHHhhCCC-Cceee
Q 006317 313 QFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQH-RNLVR 384 (650)
Q Consensus 313 ~~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H-~niv~ 384 (650)
.++.+..+...++|++.++||+|+||+||+|++.. ++.||||++...... ....|.+|+.+|.+++| ||||+
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 34444555566789999999999999999998542 357999999765443 34579999999999965 89999
Q ss_pred ecceeecC-CeeEEEEecCCCCChhHHHHhhhc-------------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEec
Q 006317 385 LLGFSFEE-TERLLIYEFVPNSSVDKFIFDAIK-------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHR 450 (650)
Q Consensus 385 l~g~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHr 450 (650)
++|+|.+. +..+||||||++|+|.++|+.... +..++|.+++.++.|||+||+|||+++ ||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHR 209 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 209 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecC
Confidence 99999764 568999999999999999976322 345899999999999999999999987 9999
Q ss_pred CCCCCceEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCC
Q 006317 451 DLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNS 529 (650)
Q Consensus 451 Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~ 529 (650)
||||+||||++++.+||+|||+|+....+..........||+.|||||++.++.++.++|||||||+||||+| |+.||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999997655444444556789999999999999999999999999999999998 899986
Q ss_pred CCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 530 FRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 530 ~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
..... ..+...... +.. +......++ ++.+++.+||+.||++|||+.||++.|+.
T Consensus 290 ~~~~~--~~~~~~i~~----g~~-----~~~p~~~~~---~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 290 GVKID--EEFCRRLKE----GTR-----MRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp TCCCS--HHHHHHHHH----TCC-----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHH--HHHHHHHHc----CCC-----CCCCccCCH---HHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 32211 112221111 111 112222333 45567779999999999999999998864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-51 Score=423.48 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=205.4
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
+.|+..++||+|+||+||+|+.. +|+.||||++..........+.+|+.+|++++|||||++++++.+++..+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56888999999999999999865 58999999997665555567899999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 224 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 224 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence 99999998853 46999999999999999999999998 9999999999999999999999999998765332
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||... ...+.+....... .+.+..
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~---------~~~~~~ 292 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDNL---------PPRLKN 292 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSS---------CCCCSC
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCC---------CCCCCc
Confidence 2344578999999999999999999999999999999999999998632 2222222222111 111111
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
...-..++.+++.+||+.||++|||+.|+++
T Consensus 293 -~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 293 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111134456777999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=429.02 Aligned_cols=250 Identities=21% Similarity=0.329 Sum_probs=199.4
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
++|++.++||+|+||+||+++. .+|+.||||++.+.. ......+.+|+.+|++++|||||++++++.+++..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5799999999999999999985 458999999997653 2334578999999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
||++|+|.++|... +...+++.+++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999742 3456899999999999999999999988 9999999999999999999999999998654221
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
......+||+.|||||++.+..|+.++|||||||++|||+||+.||... ...+++...... .. +.+
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~----~~-----~~~ 245 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG---SMKNLVLKIISG----SF-----PPV 245 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHT----CC-----CCC
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcC----CC-----CCC
Confidence 1234467999999999999999999999999999999999999999632 222222222111 10 112
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
....+.+ +.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~s~~---~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 SLHYSYD---LRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccCCHH---HHHHHHHHccCChhHCcCHHHHhc
Confidence 2223333 456777999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=419.23 Aligned_cols=265 Identities=23% Similarity=0.318 Sum_probs=199.3
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCC----eeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET----ERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv~ 399 (650)
++|.+.++||+|+||+||+|++ +|+.||||+++..... ...++.|+..+.+++|||||+++|++.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4567789999999999999998 6899999999754322 223445666777899999999999998654 579999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED-----SRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
|||++|+|.++|+. ..++|..+++++.|+++||+|||++ ..++|+||||||+||||++++++||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999963 4699999999999999999999986 23469999999999999999999999999998
Q ss_pred ccccCCCC--CccceeecCccccChhccccC------CCCccccccchhHHHHHHHhCCCCCCCCCCccc--------ch
Q 006317 475 LFEMDQSQ--GDTSRIVGTFGYMAPEYVTRG------HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEA--------ED 538 (650)
Q Consensus 475 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~--------~~ 538 (650)
........ ......+||+.|||||++.+. .++.++|||||||+||||+||+.|+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76543321 223346899999999999764 467899999999999999999877643221110 00
Q ss_pred hHHHHHHhccCCCcccccCccCCCC--ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 539 LLTYAWKNWNEGTALNLIDPTLRNG--SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 539 l~~~~~~~~~~~~~~~~id~~l~~~--~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.......... .+.++|.++.. ..+....+.+|+.+||+.||++||||.||+++|+.
T Consensus 237 ~~~~~~~~~~----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 237 SVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CHHHHHHHHT----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHHHHHh----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 0111111111 11223333322 23445567789999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=419.66 Aligned_cols=252 Identities=22% Similarity=0.268 Sum_probs=201.5
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
.+.|...++||+|+||.||+|+.. +|+.||||+++..... .+|+.++++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456788899999999999999864 5899999999765332 4699999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC-CeEEeeeecccccccCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEMDQ 480 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~~~~ 480 (650)
|++|+|.++|.. .+.+++.++..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+++.+..+.
T Consensus 132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999973 467999999999999999999999987 99999999999999998 69999999999765432
Q ss_pred CCC---ccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 481 SQG---DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 481 ~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
... .....+||+.|||||++.+..++.++|||||||++|||+||+.||....... +...... ......
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~~---~~~~~~--- 276 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCLKIAS---EPPPIR--- 276 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHHHHHH---SCCGGG---
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHHc---CCCCch---
Confidence 211 2334679999999999999999999999999999999999999996433222 2221111 111111
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.+....+.+ +.+++.+||+.||++|||+.||++.|..
T Consensus 277 -~~~~~~s~~---~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 277 -EIPPSCAPL---TAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp -GSCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -hcCccCCHH---HHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 112223333 4466779999999999999999987753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=414.90 Aligned_cols=248 Identities=24% Similarity=0.320 Sum_probs=207.4
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|++.++||+|+||+||+++. .+|+.||||++.+.. ......+.+|+++|++++|||||++++++.+++..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4689999999999999999985 458999999997643 223457899999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.++|. +.+.+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.+...
T Consensus 112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999997 3467999999999999999999999998 999999999999999999999999999987655
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
.........+||+.|||||++.+..++.++||||+||++|||+||+.||... ....+....... +..
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~----------~~~ 252 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEGLIFAKIIKL----------EYD 252 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHT----------CCC
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcC----------CCC
Confidence 4444556679999999999999999999999999999999999999999632 222222222211 111
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVV 593 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl 593 (650)
+.....++ +.+++.+||+.||++|||++|++
T Consensus 253 ~p~~~s~~---~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 FPEKFFPK---ARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCTTCCHH---HHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCcccCHH---HHHHHHHHccCCHhHCcChHHHc
Confidence 22223333 45677799999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=409.62 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=194.5
Q ss_pred CcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeec----CCeeEEEE
Q 006317 327 STDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFE----ETERLLIY 399 (650)
Q Consensus 327 ~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~ 399 (650)
+..++||+|+||+||+|+.. ++..||||++.... ......|.+|+.+|++++|||||++++++.+ +...+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999864 58899999996543 2344569999999999999999999999865 34579999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC-CCCeEEeeeeccccccc
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEM 478 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~~~ 478 (650)
|||++|+|.++|.. ...+++..+..++.||+.||+|||+++ ++|+||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999973 467999999999999999999999875 45999999999999984 79999999999985432
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
......+||+.|||||++.+ .++.++|||||||++|||+||+.||.... ....+.. ....+... +
T Consensus 185 ----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~--~~~~~~~----~i~~~~~~----~ 249 (290)
T 3fpq_A 185 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYR----RVTSGVKP----A 249 (290)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHH----HHTTTCCC----G
T ss_pred ----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC--cHHHHHH----HHHcCCCC----C
Confidence 23445789999999998865 69999999999999999999999985321 1111211 11111111 1
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.+.....+ ++.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~---~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 SFDKVAIP---EVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGCCCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCccCCH---HHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112223 3556777999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=424.44 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=206.6
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
.+.|+..++||+|+||.||+|+.. +|+.||||++..........+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 467999999999999999999864 5899999999876655566789999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
|++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+++.+....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 999999998853 46999999999999999999999998 9999999999999999999999999998765332
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||... ...+.+....... .+.+.
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~---------~~~~~ 368 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDNL---------PPRLK 368 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSC---------CCCCS
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCC---------CCCCc
Confidence 2344578999999999999999999999999999999999999998632 2222222222111 11111
Q ss_pred --CCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 562 --NGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 562 --~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
..... .+.+++.+||+.||++|||+.|+++
T Consensus 369 ~~~~~s~---~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 NLHKVSP---SLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CTTSSCH---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCH---HHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11233 3456777999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=397.39 Aligned_cols=245 Identities=22% Similarity=0.351 Sum_probs=188.7
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|++.+.||+|+||+||+++.. +|+.||||++.+... .....+.+|+.++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999864 589999999976532 23456899999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+ +|+|.+++. ++..+++.++..++.||+.||+|||+++ |+||||||+||||++++++||+|||+++.....
T Consensus 93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 679999886 4567999999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCccceeecCccccChhccccCCC-CccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
......+||+.|||||++.+..+ +.++||||+||++|||+||+.||... ....+....... . .
T Consensus 166 ---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~~~~~~i~~~----~------~ 229 (275)
T 3hyh_A 166 ---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIPVLFKNISNG----V------Y 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHT----C------C
T ss_pred ---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcC----C------C
Confidence 22345689999999999998876 58999999999999999999998632 222222222111 0 1
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.+....+++ +.+++.+||+.||++|||+.|+++
T Consensus 230 ~~p~~~s~~---~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 TLPKFLSPG---AAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCCTTSCHH---HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHH---HHHHHHHHccCChhHCcCHHHHHc
Confidence 112222333 456777999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=404.50 Aligned_cols=247 Identities=27% Similarity=0.327 Sum_probs=194.5
Q ss_pred cCCCcCCcccccCceeEEEeecc----CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS----HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
++|++.+.||+|+||+||+++.. .++.||||++++... .....+.+|+.+|++++|||||++++++.+++..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999752 367899999976532 233468889999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
|||||++|+|.++|.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999973 467999999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
... ......+||+.|||||++.+..++.++|||||||++|||+||+.||... ...++....... .
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~----------~ 242 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK---DRKETMTMILKA----------K 242 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHC----------C
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc---CHHHHHHHHHcC----------C
Confidence 322 2234568999999999999999999999999999999999999999632 222222222211 0
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCC-----HHHHHH
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPT-----MASVVV 594 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~evl~ 594 (650)
..+....+.+ +.+++.+||+.||++||| ++|+++
T Consensus 243 ~~~p~~~s~~---~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 LGMPQFLSPE---AQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCCCTTSCHH---HHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCCCcCCHH---HHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1112222333 456777999999999998 466663
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=402.82 Aligned_cols=251 Identities=22% Similarity=0.347 Sum_probs=187.2
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeecCC--------
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEET-------- 393 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-------- 393 (650)
++|++.+.||+|+||+||+|+.. +|+.||||+++..... ....+.+|+.+|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888999999999999999864 5899999999765433 3457899999999999999999999987544
Q ss_pred ----eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEee
Q 006317 394 ----ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD 469 (650)
Q Consensus 394 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 469 (650)
..++|||||++|+|.+++.........++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999975433345677889999999999999999997 99999999999999999999999
Q ss_pred eecccccccCCCCC----------ccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchh
Q 006317 470 FGMARLFEMDQSQG----------DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDL 539 (650)
Q Consensus 470 FGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l 539 (650)
||+++.+....... .....+||+.|||||++.+..++.++|||||||++|||++ ||... .+.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHH
Confidence 99998765432211 2234579999999999999999999999999999999996 55311 111
Q ss_pred HHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 540 LTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 540 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
...... ..... .+.........+..++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~-~~~~~--------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRTLTD-VRNLK--------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHH-HHTTC--------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHH-HhcCC--------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111 11110 00011122234456888999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=386.96 Aligned_cols=283 Identities=34% Similarity=0.617 Sum_probs=240.9
Q ss_pred ccChhhHHhhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecC
Q 006317 313 QFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE 392 (650)
Q Consensus 313 ~~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 392 (650)
.+++.++...+++|+..+.||+|+||.||+|++.+++.||||++..........+.+|+.++++++||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 44556667788999999999999999999999888999999999877666667899999999999999999999999999
Q ss_pred CeeEEEEecCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeee
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 471 (650)
+..++||||+++|+|.+++.... ....++|..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999986432 1235999999999999999999999987 9999999999999999999999999
Q ss_pred cccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCC
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGT 551 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 551 (650)
+++...............||+.|+|||++.+..++.++||||||+++|||++|+.|+......+......+.......+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 99865433333334456789999999999999999999999999999999999999976665555566666555555566
Q ss_pred cccccCccCCCC-ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 552 ALNLIDPTLRNG-SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 552 ~~~~id~~l~~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
....+++.+... .......+.+++.+||+.||++|||+.||++.|+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 666777766554 45666778899999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=380.60 Aligned_cols=290 Identities=40% Similarity=0.700 Sum_probs=241.5
Q ss_pred ccccChhhHHhhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeeccee
Q 006317 311 SLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFS 389 (650)
Q Consensus 311 ~~~~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~ 389 (650)
...+++.++....++|...+.||+|+||.||+++..+|+.||||++...... ....+.+|+.++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 3467889999999999999999999999999999888999999999765332 233689999999999999999999999
Q ss_pred ecCCeeEEEEecCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEe
Q 006317 390 FEETERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS 468 (650)
Q Consensus 390 ~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 468 (650)
...+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+...++|+||||||+|||+++++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997532 23459999999999999999999999833349999999999999999999999
Q ss_pred eeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCC--CcccchhHHHHHHh
Q 006317 469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRI--GEEAEDLLTYAWKN 546 (650)
Q Consensus 469 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~--~~~~~~l~~~~~~~ 546 (650)
|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... .........+....
T Consensus 177 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999987643322 22334569999999999999999999999999999999999999986321 22333455566566
Q ss_pred ccCCCcccccCccCCCC-ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCC
Q 006317 547 WNEGTALNLIDPTLRNG-SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSL 601 (650)
Q Consensus 547 ~~~~~~~~~id~~l~~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~ 601 (650)
.........++..+... .......+.+++.+||+.||++|||+.||+++|+....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 66666666777666555 56667888899999999999999999999999987544
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=390.37 Aligned_cols=263 Identities=20% Similarity=0.277 Sum_probs=199.6
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeec------CC
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFE------ET 393 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~ 393 (650)
.++|++.++||+|+||+||+|+.. +|+.||||++++... .....+.+|+.+|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999864 689999999976432 334568899999999999999999998753 36
Q ss_pred eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecc
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 473 (650)
..+||||||+ |+|.+++. +...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 7899999996 67988886 4567999999999999999999999998 999999999999999999999999999
Q ss_pred cccccCC--CCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC
Q 006317 474 RLFEMDQ--SQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG 550 (650)
Q Consensus 474 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 550 (650)
+.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||.... ..+.+..........
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~---~~~~l~~I~~~~g~p 282 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN---YVHQLQLIMMVLGTP 282 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS---HHHHHHHHHHHHCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC---HHHHHHHHHHhcCCC
Confidence 8764322 12234457899999999998875 56999999999999999999999986432 222222222211111
Q ss_pred Ccc-----------cccC--ccCCCCChHH-----HHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 551 TAL-----------NLID--PTLRNGSSSE-----IMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 551 ~~~-----------~~id--~~l~~~~~~~-----~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
... ..+. +......... ..++.+++.+||+.||++|||+.|+++-
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 0000 0000001111 1345678889999999999999998753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=380.20 Aligned_cols=202 Identities=22% Similarity=0.340 Sum_probs=171.7
Q ss_pred hHHhhccCCCcCCcccccCceeEEEeecc----CCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceeecC
Q 006317 318 TIRDATNNFSTDNKLGQGGFGAVYKGRLS----HGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEE 392 (650)
Q Consensus 318 ~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 392 (650)
.+....+.|++.++||+|+||+||+|+.+ .++.||||++.... ....+.+|+++|+.+ +|||||++++++.+.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 34455688999999999999999999743 46789999987653 234678999999998 699999999999999
Q ss_pred CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC-CCeEEeeee
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFG 471 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFG 471 (650)
+..+|||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+||||+.+ +.+||+|||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 99999999999999999873 4899999999999999999999998 9999999999999877 799999999
Q ss_pred cccccccCCC--------------------------CCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhC
Q 006317 472 MARLFEMDQS--------------------------QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISG 524 (650)
Q Consensus 472 la~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG 524 (650)
+|+....... .......+||+.|||||++.+. .++.++||||+||++|||+||
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 9986543211 0112345799999999999875 589999999999999999999
Q ss_pred CCCCCC
Q 006317 525 QKNNSF 530 (650)
Q Consensus 525 ~~p~~~ 530 (650)
+.||..
T Consensus 244 ~~Pf~~ 249 (361)
T 4f9c_A 244 RYPFYK 249 (361)
T ss_dssp CSSSSC
T ss_pred CCCCCC
Confidence 999853
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=399.10 Aligned_cols=252 Identities=21% Similarity=0.298 Sum_probs=206.8
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
++|++.+.||+|+||.||+++.+ +|+.||||++..........+.+|+.+|++++|||||++++++.+....+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57999999999999999999864 58999999998776666677899999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC--CCeEEeeeecccccccCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD--MIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~--~~~kl~DFGla~~~~~~~ 480 (650)
++|+|.++|.. +...+++.++..++.||+.||+|||+++ |+||||||+||||+.+ +.+||+|||+++.+...
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 99999998864 3457999999999999999999999998 9999999999999865 89999999999876532
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+.+....... .. +.+..
T Consensus 311 --~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~---~~~~~~~i~~~~--~~----~~~~~ 379 (573)
T 3uto_A 311 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNVKSCD--WN----MDDSA 379 (573)
T ss_dssp --SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHTTC--CC----CCSGG
T ss_pred --CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHhCC--CC----CCccc
Confidence 23445689999999999999999999999999999999999999986322 222222221110 00 01111
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.....+ .+.+++.+||+.||++|||+.|+++-
T Consensus 380 ~~~~s~---~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 380 FSGISE---DGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GTTSCH---HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccCCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223 34567779999999999999999863
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=395.01 Aligned_cols=248 Identities=25% Similarity=0.317 Sum_probs=198.1
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHH---HHHHHHhhCCCCceeeecceeecCCeeE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFK---NEVLLVARLQHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~---~E~~~l~~l~H~niv~l~g~~~~~~~~~ 396 (650)
++|++.++||+|+||+||+++.. +|+.||||++.+... .....+. .++.+++.++|||||++++++.+.+..+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57999999999999999999865 589999999975422 1222233 3466777889999999999999999999
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
|||||++||+|.++|.. .+.+++..+..++.||+.||+|||+++ ||||||||+||||+.+|++||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999973 467999999999999999999999988 999999999999999999999999999876
Q ss_pred ccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 477 EMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 477 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
... .....+||+.|||||++.. ..|+.++|||||||+||||++|+.||......+...+.......
T Consensus 343 ~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--------- 409 (689)
T 3v5w_A 343 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--------- 409 (689)
T ss_dssp SSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC---------
T ss_pred CCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC---------
Confidence 432 2344689999999999975 57999999999999999999999999643333222222222111
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCC-----HHHHHH
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPT-----MASVVV 594 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~evl~ 594 (650)
...+......+ +.+|+.+||+.||++|++ +.||++
T Consensus 410 -~~~~p~~~S~~---a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 -AVELPDSFSPE---LRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -CCCCCTTSCHH---HHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -CCCCCccCCHH---HHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11122223333 456777999999999998 678763
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=361.67 Aligned_cols=282 Identities=38% Similarity=0.571 Sum_probs=230.5
Q ss_pred ccccChhhHHhhccCCCcC------CcccccCceeEEEeeccCCcceeEeeccccC----chhHHHHHHHHHHHhhCCCC
Q 006317 311 SLQFDFSTIRDATNNFSTD------NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS----VQGELEFKNEVLLVARLQHR 380 (650)
Q Consensus 311 ~~~~~~~~~~~~~~~f~~~------~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~ 380 (650)
...|.+.++..++++|... ++||+|+||.||+|+. +++.||||++.... ......+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3568889999999999887 8999999999999987 68899999986532 23345789999999999999
Q ss_pred ceeeecceeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC
Q 006317 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 460 (650)
Q Consensus 381 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~ 460 (650)
||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 999999999999999999999999999999976555667999999999999999999999987 99999999999999
Q ss_pred CCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhH
Q 006317 461 ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL 540 (650)
Q Consensus 461 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~ 540 (650)
+++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.|+......... .
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~ 244 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL--L 244 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT--T
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH--H
Confidence 999999999999986654333223344578999999998764 5889999999999999999999998754332211 1
Q ss_pred HHHHHhc-cCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 541 TYAWKNW-NEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 541 ~~~~~~~-~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
.+..... ........+++.+..........+.+++..||+.||++|||+.+|++.|+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111111 1223334555555555666667788899999999999999999999999753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=363.75 Aligned_cols=266 Identities=26% Similarity=0.395 Sum_probs=203.2
Q ss_pred hHHhhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCee
Q 006317 318 TIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETER 395 (650)
Q Consensus 318 ~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 395 (650)
.+....++|++.++||+|+||.||+++. +|+.||||++..... .....+.+|+.++++++||||+++++++.+.+..
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3334457899999999999999999987 688999999976543 3345789999999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++||||+++|+|.+++........+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999999975433345999999999999999999999874 3499999999999999999999999999975
Q ss_pred cccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........... .
T Consensus 189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~~~~~---~---- 256 (309)
T 3p86_A 189 KASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAVGFKC---K---- 256 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHHHSC---C----
T ss_pred ccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcC---C----
Confidence 43221 223346799999999999999999999999999999999999999863321 11111111110 0
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCC
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSL 601 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~ 601 (650)
...+....+. .+.+++.+||+.||++|||+.+|++.|+....
T Consensus 257 -~~~~~~~~~~---~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 257 -RLEIPRNLNP---QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp -CCCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred -CCCCCccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0111122233 35567779999999999999999999987543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=367.98 Aligned_cols=266 Identities=26% Similarity=0.375 Sum_probs=206.1
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCC----eeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET----ERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv 398 (650)
.++|+..++||+|+||.||+|+.. ++.||||++..... ....+.+|+.++.+++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468899999999999999999874 78999999976432 3335667999999999999999999998754 36999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhc-------CCCcEEecCCCCCceEeCCCCCeEEeeee
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED-------SRLRIIHRDLKASNILLDADMIPKISDFG 471 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------~~~~iiHrDlk~~NILl~~~~~~kl~DFG 471 (650)
|||+++|+|.+++.. ..+++..++.++.||+.||+|||+. ...+|+||||||+||||+.++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999999963 4599999999999999999999987 01139999999999999999999999999
Q ss_pred cccccccCCCCCccceeecCccccChhccccC-----CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHH----
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-----HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTY---- 542 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~---- 542 (650)
+++.+.............||+.|+|||++.+. .++.++||||||+++|||+||+.||..............
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 99877654444344456799999999999863 456789999999999999999999875433222111111
Q ss_pred -----HHHhccCCCcccccCccCCCC--ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 543 -----AWKNWNEGTALNLIDPTLRNG--SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 543 -----~~~~~~~~~~~~~id~~l~~~--~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
....... ....+.+... .......+.+++.+||+.||++|||+.||++.|+.
T Consensus 257 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 257 PSLEDMQEVVVH----KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp CCHHHHHHHHTT----SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Cchhhhhhhhhc----ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 0000000 1111111111 22344567789999999999999999999999874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=357.70 Aligned_cols=259 Identities=25% Similarity=0.430 Sum_probs=208.6
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
.++|...++||+|+||.||+++.. +++.||+|++..........+.+|+.++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 357888999999999999999864 5889999998776666777899999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999975 3567999999999999999999999987 99999999999999999999999999987643322
Q ss_pred CC------------ccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccC
Q 006317 482 QG------------DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNE 549 (650)
Q Consensus 482 ~~------------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 549 (650)
.. ......||+.|+|||++.+..++.++||||||+++|||++|..|+.............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-------- 235 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-------- 235 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC--------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh--------
Confidence 11 1114579999999999999999999999999999999999998876432221110000
Q ss_pred CCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 550 GTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 550 ~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
.....+.......+. .+.+++.+||+.||++|||+.+|++.|+..
T Consensus 236 --~~~~~~~~~~~~~~~---~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 236 --VRGFLDRYCPPNCPP---SFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp --HHHHHHHTCCTTCCT---THHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --hhccccccCCCCCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000011111112222 345677799999999999999999999764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=366.66 Aligned_cols=258 Identities=24% Similarity=0.367 Sum_probs=207.8
Q ss_pred ccCCCcCCcccccCceeEEEeecc--------CCcceeEeeccccCc-hhHHHHHHHHHHHhhC-CCCceeeecceeecC
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS--------HGQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFSFEE 392 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 392 (650)
.++|.+.+.||+|+||.||+++.. ++..||||+++.... .....+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467889999999999999999752 345799999976533 3445789999999999 899999999999999
Q ss_pred CeeEEEEecCCCCChhHHHHhhh-------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 459 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl 459 (650)
+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999997532 1245899999999999999999999987 9999999999999
Q ss_pred CCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccch
Q 006317 460 DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAED 538 (650)
Q Consensus 460 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~ 538 (650)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.... ..+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~---~~~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VEE 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---GGG
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC---HHH
Confidence 9999999999999986654433333444567889999999999999999999999999999999 888886432 222
Q ss_pred hHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 539 LLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 539 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+......... +........ .+.+++.+||+.||++||++.||++.|+.
T Consensus 314 ~~~~~~~~~~---------~~~~~~~~~---~l~~li~~~l~~dP~~Rpt~~ell~~L~~ 361 (370)
T 2psq_A 314 LFKLLKEGHR---------MDKPANCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361 (370)
T ss_dssp HHHHHHTTCC---------CCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhcCCC---------CCCCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 2222211110 111112233 45567779999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=352.47 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=205.4
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
..++|+..++||+|+||.||+++. .+++.||||++..........+.+|+.++++++||||+++++++..++..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 456899999999999999999985 4688999999977665666678999999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++|+|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999863 36999999999999999999999987 9999999999999999999999999998665332
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ............. .. ..
T Consensus 171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~----~~---~~ 238 (297)
T 3fxz_A 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTP----EL---QN 238 (297)
T ss_dssp --CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCSC----CC---SC
T ss_pred --cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCC----CC---CC
Confidence 223446799999999999999999999999999999999999999863221 1111111111000 00 00
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
....+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~---~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 239 PEKLS---AIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GGGSC---HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccC---HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 01112 335567779999999999999999753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=374.09 Aligned_cols=265 Identities=18% Similarity=0.224 Sum_probs=207.1
Q ss_pred cChhhHHhhccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCch---hHHHHHHHHHHHhhCCCCceeeeccee
Q 006317 314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFS 389 (650)
Q Consensus 314 ~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~ 389 (650)
+.+.+++...++|+..++||+|+||+||+++..+ ++.||||++.+.... ....+.+|..++..++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 4556677778999999999999999999999764 788999999754221 122388999999999999999999999
Q ss_pred ecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEee
Q 006317 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD 469 (650)
Q Consensus 390 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 469 (650)
.+.+..+|||||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999999974 2467999999999999999999999987 99999999999999999999999
Q ss_pred eecccccccCCCCCccceeecCccccChhccc-----cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHH
Q 006317 470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAW 544 (650)
Q Consensus 470 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~ 544 (650)
||+++....... ......+||+.|+|||++. .+.++.++|||||||++|||++|+.||..... .+......
T Consensus 219 FGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~---~~~~~~i~ 294 (437)
T 4aw2_A 219 FGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIM 294 (437)
T ss_dssp CTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHH
T ss_pred hhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---hHHHHhhh
Confidence 999976543222 1223467999999999987 56789999999999999999999999864322 12221111
Q ss_pred HhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCC--CCCHHHHHHH
Q 006317 545 KNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVAN--RPTMASVVVM 595 (650)
Q Consensus 545 ~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~--RPt~~evl~~ 595 (650)
.... ...-|.......++ +.+++.+||+.+|++ ||+++|+++-
T Consensus 295 ~~~~-----~~~~p~~~~~~s~~---~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 295 NHKE-----RFQFPTQVTDVSEN---AKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp THHH-----HCCCCSSCCCSCHH---HHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hccc-----cccCCcccccCCHH---HHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1000 00001111122334 345666788777877 9999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=352.63 Aligned_cols=261 Identities=24% Similarity=0.357 Sum_probs=209.7
Q ss_pred ccChhhHHhhccC----------CCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCc
Q 006317 313 QFDFSTIRDATNN----------FSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN 381 (650)
Q Consensus 313 ~~~~~~~~~~~~~----------f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n 381 (650)
.+++++++.+++. |+..++||+|+||.||+|+.. +|+.||||++..........+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4566666666543 666789999999999999875 68999999998766666677899999999999999
Q ss_pred eeeecceeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC
Q 006317 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 461 (650)
Q Consensus 382 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~ 461 (650)
|+++++++...+..++||||+++++|.+++. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 9999999999999999999999999999875 346999999999999999999999987 999999999999999
Q ss_pred CCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHH
Q 006317 462 DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLT 541 (650)
Q Consensus 462 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~ 541 (650)
++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+..... .....
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~~~ 251 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMK 251 (321)
T ss_dssp TCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHH
T ss_pred CCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH
Confidence 9999999999998665332 123346799999999999999999999999999999999999999863321 11111
Q ss_pred HHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 542 YAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 542 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..... ..+.+.. .......+.+++.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~---------~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 252 RLRDS---------PPPKLKN-SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHS---------SCCCCTT-GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhcC---------CCCCcCc-cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 0111110 00111235567779999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=360.13 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=197.1
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcc----eeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQE----IAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~----vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 396 (650)
.++|+..++||+|+||.||+|++. +++. ||+|.+.... ......+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 357889999999999999999854 4544 5888875432 344567999999999999999999999998764 78
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
+|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999975 3467999999999999999999999987 999999999999999999999999999877
Q ss_pred ccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
.............||..|+|||++.+..++.++||||||+++|||+| |+.||....... +.........
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~~~~~~------- 237 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILEKGER------- 237 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHTTCC-------
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHHHHcCCC-------
Confidence 65444334444567889999999999999999999999999999999 999986433222 2221111100
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
... .......+.+++.+||+.||++||++.||++.|+.
T Consensus 238 --~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 275 (327)
T 3poz_A 238 --LPQ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp --CCC---CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred --CCC---CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 001 11122346678889999999999999999998854
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=367.73 Aligned_cols=256 Identities=27% Similarity=0.476 Sum_probs=194.6
Q ss_pred ccCCCcCCcccccCceeEEEeecc----CCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS----HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
.++|++.+.||+|+||.||+|+.. ++..||||+++... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999865 47789999997653 3345579999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999974 3457999999999999999999999987 9999999999999999999999999998765
Q ss_pred cCCCCC-ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 478 MDQSQG-DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 478 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
...... ......+|..|+|||++.+..++.++||||||+++|||++ |+.|+.... ..+..........
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~---~~~~~~~i~~~~~------- 268 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS---NQDVIKAVDEGYR------- 268 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC---HHHHHHHHHTTEE-------
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCC-------
Confidence 432211 1222345778999999999999999999999999999998 999885322 1222222111110
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.......+ ..+.+++.+||+.||++||++.+|+++|+.
T Consensus 269 --~~~~~~~~---~~l~~li~~cl~~dp~~RPs~~~i~~~L~~ 306 (373)
T 2qol_A 269 --LPPPMDCP---AALYQLMLDCWQKDRNNRPKFEQIVSILDK 306 (373)
T ss_dssp --CCCCTTCB---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCcccc---HHHHHHHHHHhCcChhhCcCHHHHHHHHHH
Confidence 00111122 345677889999999999999999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=371.21 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=205.3
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
..++|...+.||+|+||.||+|++. +++.||||+++.... .....+.+|+.++++++||||+++++++..++..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467888999999999999999976 688999999876532 23346889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999975 3456999999999999999999999987 999999999999999999999999999864322
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
..........++..|+|||.+.++.++.++||||||+++|||+| |+.|+..... ......... +.. .
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~~~~~~----~~~-----~ 334 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTREFVEK----GGR-----L 334 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHHHHHHT----TCC-----C
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc----CCC-----C
Confidence 21111222345778999999999999999999999999999999 8888763321 111211111 110 1
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
......++ .+.+++.+||+.||++|||+.+|++.|+.
T Consensus 335 ~~~~~~~~---~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 371 (377)
T 3cbl_A 335 PCPELCPD---AVFRLMEQCWAYEPGQRPSFSTIYQELQS 371 (377)
T ss_dssp CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 11122333 34567779999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=360.25 Aligned_cols=257 Identities=26% Similarity=0.460 Sum_probs=203.9
Q ss_pred ccCCCcCCcccccCceeEEEeecc----CCcceeEeecccc-CchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS----HGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
.++|.+.++||+|+||.||+|++. .+..||||+++.. .......+.+|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 357888999999999999999874 3445999999765 33345579999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999964 3457999999999999999999999987 9999999999999999999999999998765
Q ss_pred cCCCCC-ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 478 MDQSQG-DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 478 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
...... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||..... .+.........
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~~~~-------- 271 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISSVEEGY-------- 271 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTC--------
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCC--------
Confidence 432211 2223456778999999999999999999999999999999 9998853221 12222211110
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
........+. .+.+++..||+.||++|||+.+|+++|+..
T Consensus 272 -~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 272 -RLPAPMGCPH---ALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp -CCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCcCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0111112233 455677899999999999999999999753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=361.84 Aligned_cols=270 Identities=27% Similarity=0.373 Sum_probs=212.5
Q ss_pred cccChhhHHhhccCCCcCCcccccCceeEEEeec------cCCcceeEeeccccCc-hhHHHHHHHHHHHhhC-CCCcee
Q 006317 312 LQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLV 383 (650)
Q Consensus 312 ~~~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv 383 (650)
..++........++|++.++||+|+||.||++++ .+++.||||+++.... .....+.+|+.++.++ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 3455666667788999999999999999999973 3467899999976533 3345789999999999 799999
Q ss_pred eecceeecCC-eeEEEEecCCCCChhHHHHhhhc----------------------------------------------
Q 006317 384 RLLGFSFEET-ERLLIYEFVPNSSVDKFIFDAIK---------------------------------------------- 416 (650)
Q Consensus 384 ~l~g~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------- 416 (650)
++++++.+.+ ..++||||+++|+|.+++.....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 9999988755 48999999999999999975322
Q ss_pred -----------------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 417 -----------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 417 -----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 122899999999999999999999987 999999999999999999999999999866544
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
..........||+.|+|||++.+..++.++||||||+++|||+| |+.|+....... ........ .. ..
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~----~~-----~~ 315 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKE----GT-----RM 315 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHHH----TC-----CC
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHHHHc----CC-----CC
Confidence 33334445678999999999999999999999999999999999 999986432211 11111111 10 01
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
........ .+.+++..||+.||++|||+.||++.|+.
T Consensus 316 ~~~~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 316 RAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCH---HHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 11112233 35567779999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=357.41 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=203.5
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
.++|+..+.||+|+||.||+++. .+|+.||||++.... ......+.+|+.++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46799999999999999999986 568999999997653 234456889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999974 456999999999999999999999987 999999999999999999999999999866432
Q ss_pred CCCCccceeecCccccChhccccCCCC-ccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFS-IKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
.......||+.|+|||++.+..++ .++|||||||++|||++|+.||.... ...+....... . .
T Consensus 168 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~----~------~ 231 (328)
T 3fe3_A 168 ---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---LKELRERVLRG----K------Y 231 (328)
T ss_dssp ---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHC----C------C
T ss_pred ---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhC----C------C
Confidence 223446799999999999988775 89999999999999999999986332 12222221111 0 1
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+...... .+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~p~~~s~---~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 RIPFYMST---DCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CCCTTSCH---HHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCH---HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11111223 34567779999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=359.21 Aligned_cols=264 Identities=25% Similarity=0.425 Sum_probs=201.8
Q ss_pred ccCCCcCCcccccCceeEEEeec-----cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeec--CCee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE--ETER 395 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 395 (650)
.++|++.++||+|+||.||++++ .+++.||||++..........+.+|+.++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46788999999999999999984 3578999999987766666789999999999999999999999865 3568
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHH--CGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHh--cccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 999999999999999975 2345999999999999999999999987 99999999999999999999999999987
Q ss_pred cccCCCC-CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCc---------ccchhHHHHHH
Q 006317 476 FEMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGE---------EAEDLLTYAWK 545 (650)
Q Consensus 476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~---------~~~~l~~~~~~ 545 (650)
....... .......++..|+|||.+.+..++.++||||||+++|||+||..|+.....+ ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6533221 1222345677899999999999999999999999999999999887532110 00000001111
Q ss_pred hccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 546 NWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 546 ~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
...... ........++ .+.+++..||+.||++|||+.||++.|+..
T Consensus 244 ~~~~~~-----~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 244 LLKNNG-----RLPRPDGCPD---EIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHTTC-----CCCCCTTCCH---HHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccC-----cCCCCcCcCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111110 0111112333 455677799999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=344.90 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=207.8
Q ss_pred hccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
..++|+..+.||+|+||.||+++..++..||||++..... ...++.+|+.++.+++||||+++++++.++...++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 3467889999999999999999988888999999976543 345789999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999999975 3446999999999999999999999987 99999999999999999999999999986543321
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
.......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+...... ......... . . ...
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~~----~--~---~~~ 226 (268)
T 3sxs_A 160 -VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS---EVVLKVSQG----H--R---LYR 226 (268)
T ss_dssp -EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHHTT----C--C---CCC
T ss_pred -hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH---HHHHHHHcC----C--C---CCC
Confidence 11223346778999999999899999999999999999999 99888633221 111111110 0 0 001
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCC
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSS 600 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~ 600 (650)
....++ .+.+++..||+.||++|||+.|+++.|+...
T Consensus 227 ~~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 227 PHLASD---TIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CTTSCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCcChH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111223 3556777999999999999999999998743
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=347.36 Aligned_cols=271 Identities=21% Similarity=0.297 Sum_probs=210.6
Q ss_pred ccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCC--eeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEET--ERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv 398 (650)
.++|.+.++||+|+||.||+|+... ++.||||++..... .....+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4678999999999999999998654 88999999976432 33456889999999999999999999988755 77999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe----CCCCCeEEeeeeccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DADMIPKISDFGMAR 474 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGla~ 474 (650)
|||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999986545555999999999999999999999987 9999999999999 888889999999998
Q ss_pred ccccCCCCCccceeecCccccChhccc--------cCCCCccccccchhHHHHHHHhCCCCCCCCCCcc-cchhHHHHHH
Q 006317 475 LFEMDQSQGDTSRIVGTFGYMAPEYVT--------RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE-AEDLLTYAWK 545 (650)
Q Consensus 475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~-~~~l~~~~~~ 545 (650)
...... ......||..|+|||++. +..++.++||||||+++|||++|+.||....... ..........
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 765332 223457999999999986 5788999999999999999999999986433222 2222222222
Q ss_pred hccCCCccccc---------CccCC--CC-ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 546 NWNEGTALNLI---------DPTLR--NG-SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 546 ~~~~~~~~~~i---------d~~l~--~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
........... ...+. .. .......+..++.+||+.||++|||+.|+++.....
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 21111111000 00111 11 233344566788999999999999999999887654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=359.83 Aligned_cols=264 Identities=25% Similarity=0.416 Sum_probs=210.3
Q ss_pred HhhccCCCcCCcccccCceeEEEeecc------CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecC
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEE 392 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 392 (650)
....++|+..+.||+|+||.||+++.. +++.||||+++.... .....+.+|+.++++++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 345678999999999999999999874 347899999976533 3345789999999999999999999999999
Q ss_pred CeeEEEEecCCCCChhHHHHhhhc---------------------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecC
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAIK---------------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRD 451 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrD 451 (650)
+..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+++ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 999999999999999999975321 257999999999999999999999987 99999
Q ss_pred CCCCceEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCC
Q 006317 452 LKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSF 530 (650)
Q Consensus 452 lk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~ 530 (650)
|||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||+| |+.|+..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999987654333233344568899999999999999999999999999999999 9888853
Q ss_pred CCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCC
Q 006317 531 RIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSL 601 (650)
Q Consensus 531 ~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~ 601 (650)
.. ..+...... .+.. +......+. .+.+++.+||+.||++||++.+|++.|+....
T Consensus 280 ~~---~~~~~~~~~----~~~~-----~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 280 MA---HEEVIYYVR----DGNI-----LACPENCPL---ELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp SC---HHHHHHHHH----TTCC-----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CC---hHHHHHHHh----CCCc-----CCCCCCCCH---HHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 22 112221111 1111 111122233 45567779999999999999999999987543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.24 Aligned_cols=263 Identities=23% Similarity=0.387 Sum_probs=192.5
Q ss_pred hHHhhccCCCcCCcccccCceeEEEeeccCCc----ceeEeecccc--CchhHHHHHHHHHHHhhCCCCceeeecceeec
Q 006317 318 TIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQ----EIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFE 391 (650)
Q Consensus 318 ~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~----~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 391 (650)
++....++|+..+.||+|+||.||+++..... .||||++... .......+.+|+.++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 34445678999999999999999999875432 7999999765 33445679999999999999999999999987
Q ss_pred CCee------EEEEecCCCCChhHHHHhhhc---cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC
Q 006317 392 ETER------LLIYEFVPNSSVDKFIFDAIK---RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD 462 (650)
Q Consensus 392 ~~~~------~lv~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~ 462 (650)
.... ++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+++
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence 7655 999999999999999975432 225999999999999999999999987 9999999999999999
Q ss_pred CCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHH
Q 006317 463 MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLT 541 (650)
Q Consensus 463 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~ 541 (650)
+.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... +...
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~ 250 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYN 250 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHH
Confidence 9999999999987654433333334567889999999999999999999999999999999 88888643221 2222
Q ss_pred HHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 542 YAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 542 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
..... .. .......+ ..+.+++.+||+.||++|||+.++++.|+.
T Consensus 251 ~~~~~----~~-----~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 295 (323)
T 3qup_A 251 YLIGG----NR-----LKQPPECM---EEVYDLMYQCWSADPKQRPSFTCLRMELEN 295 (323)
T ss_dssp HHHTT----CC-----CCCCTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhcC----CC-----CCCCCccC---HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11111 00 11111222 345577789999999999999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=347.86 Aligned_cols=254 Identities=27% Similarity=0.438 Sum_probs=206.1
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
.++|+..+.||+|+||.||+++..+++.||+|++..... ...++.+|+.++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 357888999999999999999988888999999976543 3457899999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 161 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 161 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence 99999999964 3456999999999999999999999987 99999999999999999999999999986543211
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
.......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .+......... .+...
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~~~~~~~~~---------~~~~~ 229 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGF---------RLYKP 229 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTC---------CCCCC
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhcCc---------cCCCC
Confidence 11223456778999999999999999999999999999999 8888863221 12221111110 11111
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
...+. .+.+++..||+.||++|||+.|+++.|+.
T Consensus 230 ~~~~~---~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 230 RLAST---HVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CcCCH---HHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 11223 35567779999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=351.82 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=201.7
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
.++|++.++||+|+||.||+++.. +++.||||++..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367999999999999999999865 688999999865433 233468899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++|+|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999886 3456999999999999999999999987 9999999999999999999999999998765443
Q ss_pred CCCccceeecCccccChhccccCCC-CccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
.........||+.|+|||++.+..+ +.++||||||+++|||++|+.||....... ..... +... ... ..+
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~--~~~~--~~~---~~~- 230 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSD--WKEK--KTY---LNP- 230 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHH--HHTT--CTT---STT-
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHH--Hhcc--ccc---CCc-
Confidence 3333445689999999999988775 789999999999999999999986433221 11111 1110 000 000
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 231 ----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 ----WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01112344567789999999999999999865
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=361.89 Aligned_cols=258 Identities=29% Similarity=0.466 Sum_probs=206.6
Q ss_pred ccCCCcCCcccccCceeEEEeecc------CCcceeEeecccc-CchhHHHHHHHHHHHhhCCCCceeeecceeecCCee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETER 395 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 395 (650)
.++|...++||+|+||.||+|++. +++.||||++... .......+.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467889999999999999999853 3568999999754 334455788999999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHHhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC---CeEEe
Q 006317 396 LLIYEFVPNSSVDKFIFDAIK----RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM---IPKIS 468 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~ 468 (650)
++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999976421 245999999999999999999999997 99999999999999555 59999
Q ss_pred eeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhc
Q 006317 469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNW 547 (650)
Q Consensus 469 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 547 (650)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.|+.... ..++.......
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~---~~~~~~~i~~~- 302 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEFVTSG- 302 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHHTT-
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcC-
Confidence 9999986544333333444568999999999999999999999999999999998 888886332 22222222111
Q ss_pred cCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 548 NEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 548 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.. .......+. .+.+++.+||+.||++|||+.+|++.|+.
T Consensus 303 ---~~-----~~~~~~~~~---~l~~li~~~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 303 ---GR-----MDPPKNCPG---PVYRIMTQCWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp ---CC-----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CC-----CCCCccCCH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 10 111112233 35567789999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=371.53 Aligned_cols=264 Identities=25% Similarity=0.407 Sum_probs=205.7
Q ss_pred hhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
...++|...++||+|+||.||+|++.++..||||+++.... ...+|.+|+.+|++++||||+++++++.+ +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 34567888999999999999999998888899999976543 34579999999999999999999999876 67899999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++......
T Consensus 259 ~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999999643 2356999999999999999999999987 9999999999999999999999999998664322
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
. .......++..|+|||.+.++.++.++||||||+++|||++ |+.|+.... ..+.......... ..
T Consensus 335 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~---~~~~~~~i~~~~~---------~~ 401 (452)
T 1fmk_A 335 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQVERGYR---------MP 401 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHTTCC---------CC
T ss_pred e-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCC---------CC
Confidence 1 12223456889999999999999999999999999999999 888875322 1122222211110 11
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCCCCCCC
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSLPLP 606 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~~~~~p 606 (650)
.....++ .+.+++.+||+.||++|||+.+|+++|+.......+.
T Consensus 402 ~~~~~~~---~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 402 CPPECPE---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp CCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred CCCCCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 1112233 4556778999999999999999999998865544433
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=358.03 Aligned_cols=263 Identities=25% Similarity=0.347 Sum_probs=207.3
Q ss_pred hhccCCCcCCcccccCceeEEEeec------cCCcceeEeeccccC-chhHHHHHHHHHHHhhC-CCCceeeecceeecC
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEE 392 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 392 (650)
...++|...+.||+|+||.||+++. .++..||||++.... ......+.+|+.++.++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3457899999999999999999985 235679999997543 23345789999999999 899999999999999
Q ss_pred CeeEEEEecCCCCChhHHHHhhhcc--------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCC
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAIKR--------------------VQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDL 452 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl 452 (650)
+..++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+.+ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 9999999999999999999753221 34899999999999999999999987 999999
Q ss_pred CCCceEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCC
Q 006317 453 KASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFR 531 (650)
Q Consensus 453 k~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~ 531 (650)
||+||||+.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|||+| |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987654433333445667889999999999999999999999999999998 99888643
Q ss_pred CCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCC
Q 006317 532 IGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSS 600 (650)
Q Consensus 532 ~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~ 600 (650)
.... ......... ..+......++ .+.+++.+||+.||.+|||+.||++.|+...
T Consensus 279 ~~~~--~~~~~~~~~---------~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 279 PVDA--NFYKLIQNG---------FKMDQPFYATE---EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp CCSH--HHHHHHHTT---------CCCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CcHH--HHHHHHhcC---------CCCCCCCCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 2211 111111111 01111112233 4556777999999999999999999997643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=372.11 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=209.5
Q ss_pred HHhhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 319 IRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 319 ~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
.+...++|...++||+|+||.||+|+++++..||||+++... .....|.+|+.+|++++||||+++++++. .+..++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 344567889999999999999999999888899999998654 34568999999999999999999999986 5678999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 261 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999999999753 2346899999999999999999999987 99999999999999999999999999986542
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
... .......+|..|+|||++..+.++.++||||||+++|||+| |+.|+.... ..+..........
T Consensus 337 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~---~~~~~~~i~~~~~--------- 403 (454)
T 1qcf_A 337 NEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIRALERGYR--------- 403 (454)
T ss_dssp HHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHHHTCC---------
T ss_pred Cce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCC---------
Confidence 211 11122346788999999999999999999999999999999 999886322 1222222211111
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCC
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSL 601 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~ 601 (650)
.......++ .+.+++.+||+.||++|||+.+|+++|+....
T Consensus 404 ~~~~~~~~~---~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 MPRPENCPE---ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCCCH---HHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 011112233 45567789999999999999999999987543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=344.69 Aligned_cols=263 Identities=22% Similarity=0.327 Sum_probs=200.8
Q ss_pred hhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
...++|+..++||+|+||.||+++..+|+.||||++...... ....+.+|+.++++++||||+++++++.++...++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 345789999999999999999999888999999999754322 235688999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++ +|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 98 FEFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EcCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 999985 78887764 3456999999999999999999999987 99999999999999999999999999986543
Q ss_pred CCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCC---ccc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGT---ALN 554 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~ 554 (650)
.. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+. +........... ...
T Consensus 172 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 172 PV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp CC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGG
T ss_pred Cc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhh
Confidence 22 22334578999999999876 5689999999999999999999999875433322 111111111100 000
Q ss_pred c---------cCccCCCCCh-----HHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 555 L---------IDPTLRNGSS-----SEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 555 ~---------id~~l~~~~~-----~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
. .......... ....++.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 0000000011 11134567888999999999999999985
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=342.24 Aligned_cols=259 Identities=24% Similarity=0.392 Sum_probs=202.2
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
.++|++.+.||+|+||.||+++.. +++.||+|++..... .....+.+|+.++.+++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999854 588999999855432 3345688999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999974 457999999999999999999999987 99999999999999999999999999986543
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
.. ........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ............ .. ...
T Consensus 164 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~-~~-~~~ 234 (294)
T 4eqm_A 164 TS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDSV-PN-VTT 234 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSCC-CC-HHH
T ss_pred cc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhccC-CC-cch
Confidence 22 1223346799999999999999999999999999999999999999863221 111111111110 00 001
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCC-CHHHHHHHhcCC
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRP-TMASVVVMLNSS 599 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RP-t~~evl~~L~~~ 599 (650)
......++ .+.+++.+||+.||++|| ++.++.+.|...
T Consensus 235 ~~~~~~~~---~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 235 DVRKDIPQ---SLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HSCTTSCH---HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred hcccCCCH---HHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 11122223 355677799999999998 999999999764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=350.87 Aligned_cols=259 Identities=27% Similarity=0.361 Sum_probs=208.0
Q ss_pred hccCCCcCCcccccCceeEEEeec------cCCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE 394 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 394 (650)
..++|...+.||+|+||.||+++. .+++.||||++.... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 457889999999999999999975 235789999997653 3344578999999999999999999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhc---------------------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCC
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIK---------------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLK 453 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 453 (650)
.++||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999976322 234899999999999999999999987 9999999
Q ss_pred CCceEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCC
Q 006317 454 ASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRI 532 (650)
Q Consensus 454 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~ 532 (650)
|+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987654333323334567889999999999999999999999999999999 998886433
Q ss_pred CcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 533 GEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 533 ~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.. .+....... . .+......++ .+.+++.+||+.||++||++.||++.|+.
T Consensus 258 ~~---~~~~~~~~~----~-----~~~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 258 PE---RLFNLLKTG----H-----RMERPDNCSE---EMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp GG---GHHHHHHTT----C-----CCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HH---HHHHHhhcC----C-----cCCCCccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 22 222211111 0 0111122233 45567779999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=359.77 Aligned_cols=260 Identities=25% Similarity=0.357 Sum_probs=209.2
Q ss_pred hccCCCcCCcccccCceeEEEeecc--------CCcceeEeeccccCc-hhHHHHHHHHHHHhhC-CCCceeeecceeec
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS--------HGQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFSFE 391 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 391 (650)
..++|.+.++||+|+||.||+++.. .+..||||++..... .....+.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3468889999999999999999852 235799999976533 3345789999999999 99999999999999
Q ss_pred CCeeEEEEecCCCCChhHHHHhhhc-------------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceE
Q 006317 392 ETERLLIYEFVPNSSVDKFIFDAIK-------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 458 (650)
Q Consensus 392 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 458 (650)
++..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999975321 245999999999999999999999987 999999999999
Q ss_pred eCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccc
Q 006317 459 LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAE 537 (650)
Q Consensus 459 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~ 537 (650)
|++++.+||+|||+++...............+|..|+|||++.+..++.++||||||+++|||++ |+.|+.... ..
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~---~~ 300 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---VE 300 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---HH
Confidence 99999999999999987654433334444567889999999999999999999999999999999 988886322 12
Q ss_pred hhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 538 DLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 538 ~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
++....... .. ......... .+.+++.+||+.||++|||+.||++.|+..
T Consensus 301 ~~~~~~~~~----~~-----~~~~~~~~~---~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 301 ELFKLLKEG----HR-----MDKPSNCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp HHHHHHHTT----CC-----CCCCSSCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHcC----CC-----CCCCccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 222222111 10 111112233 455677799999999999999999999764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=346.12 Aligned_cols=256 Identities=24% Similarity=0.379 Sum_probs=204.4
Q ss_pred hhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
...++|+..+.||+|+||.||++...++..||||++..... ...++.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 34568899999999999999999998888999999976543 34578999999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 100 YMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CCTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred ccCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 9999999999975 2456999999999999999999999987 9999999999999999999999999998654321
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
. .......+|..|+|||.+.+..++.++||||||+++|||+| |+.||...... ......... ....
T Consensus 175 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~---------~~~~ 241 (283)
T 3gen_A 175 Y-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHIAQG---------LRLY 241 (283)
T ss_dssp H-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHHTT---------CCCC
T ss_pred c-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHHHHHhcc---------cCCC
Confidence 1 11222346788999999999999999999999999999999 99888633211 111111111 0111
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.....++ .+.+++.+||+.||++|||+.++++.|..
T Consensus 242 ~~~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 242 RPHLASE---KVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp CCTTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcCCH---HHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 1111223 45567789999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=375.17 Aligned_cols=257 Identities=27% Similarity=0.430 Sum_probs=208.4
Q ss_pred hccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
...+|...++||+|+||.||+|++.. +..||||+++.... ...+|.+|+.+|++++||||+++++++......++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34678888999999999999999765 78999999976543 35679999999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 99999999999753 3456999999999999999999999987 9999999999999999999999999998764322
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
. .......++..|+|||++.+..++.++||||||+++|||+| |+.|+..... ............ ..
T Consensus 373 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~---------~~ 439 (495)
T 1opk_A 373 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKDYR---------ME 439 (495)
T ss_dssp E-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHHHTTCC---------CC
T ss_pred e-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC---------CC
Confidence 1 12223456788999999999999999999999999999999 8888764322 222222211110 11
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
.....+. .+.+|+.+||+.||++|||+.+|+++|+..
T Consensus 440 ~~~~~~~---~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 440 RPEGCPE---KVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp CCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCH---HHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1112233 445677799999999999999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=347.47 Aligned_cols=248 Identities=22% Similarity=0.246 Sum_probs=202.6
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|+..+.||+|+||.||+++.. +|+.||||++++.. ......+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57889999999999999999865 58899999997642 233456889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|..++.. ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999873 457999999999999999999999987 999999999999999999999999999753322
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
........||+.|+|||++.+..++.++||||||+++|||++|+.||.... ...+...... . ...
T Consensus 159 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~---~-------~~~ 223 (337)
T 1o6l_A 159 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILM---E-------EIR 223 (337)
T ss_dssp --TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH---C-------CCC
T ss_pred --CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HHHHHHHHHc---C-------CCC
Confidence 223445689999999999999999999999999999999999999986322 1122221111 0 011
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCC-----CHHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRP-----TMASVVVM 595 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~~ 595 (650)
+...... .+.+++.+||+.||++|| ++.||++.
T Consensus 224 ~p~~~s~---~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 FPRTLSP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCTTSCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCCH---HHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1122233 345667799999999999 89999854
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=352.91 Aligned_cols=253 Identities=21% Similarity=0.351 Sum_probs=198.1
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCC-------
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEET------- 393 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------- 393 (650)
.++|+..+.||+|+||.||+++.. +|+.||||++..... .....+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357889999999999999999975 689999999975433 34567899999999999999999999886543
Q ss_pred --------------------------------------------------eeEEEEecCCCCChhHHHHhhhccCCCCHH
Q 006317 394 --------------------------------------------------ERLLIYEFVPNSSVDKFIFDAIKRVQLDWE 423 (650)
Q Consensus 394 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~ 423 (650)
..++||||+++++|.+++..........+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 278999999999999999865455567888
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC----------CccceeecCcc
Q 006317 424 TRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ----------GDTSRIVGTFG 493 (650)
Q Consensus 424 ~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~ 493 (650)
.++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999987 999999999999999999999999999876543211 12234579999
Q ss_pred ccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHH
Q 006317 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVH 573 (650)
Q Consensus 494 y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~ 573 (650)
|+|||++.+..++.++||||||+++|||++|..|+. +..... ...... ............+.+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~~~-~~~~~~--------~~~~~~~~~~~~~~~ 304 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVRII-TDVRNL--------KFPLLFTQKYPQEHM 304 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHHHH-HHHHTT--------CCCHHHHHHCHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHHHH-HHhhcc--------CCCcccccCChhHHH
Confidence 999999999999999999999999999999876532 111111 000000 011011222345567
Q ss_pred HHhcccccCCCCCCCHHHHHHH
Q 006317 574 IGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 574 l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
++.+||+.||++|||+.|+++.
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCCCCcCCCHHHHhhc
Confidence 8889999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=353.20 Aligned_cols=252 Identities=25% Similarity=0.327 Sum_probs=203.2
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch------hHHHHHHHHHHHhhCCCCceeeecceeecCCe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ------GELEFKNEVLLVARLQHRNLVRLLGFSFEETE 394 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 394 (650)
..+.|++.+.||+|+||.||+++.. +|+.||||++.+.... ....+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4567999999999999999999865 5889999999765332 24578999999999999999999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC----CeEEeee
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM----IPKISDF 470 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DF 470 (650)
.++||||+++|+|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999986 3567999999999999999999999987 99999999999998887 7999999
Q ss_pred ecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC
Q 006317 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG 550 (650)
Q Consensus 471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 550 (650)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...........
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~---- 233 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANITAV---- 233 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHTT----
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhc----
Confidence 9998765322 2334679999999999999999999999999999999999999986322 11222111110
Q ss_pred CcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 551 TALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 551 ~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.. .+++....... ..+.+++..||+.||++|||+.|+++
T Consensus 234 ~~--~~~~~~~~~~s---~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SY--DFDEEFFSQTS---ELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC--CCCHHHHTTSC---HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC--CCCchhccCCC---HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00000001122 23456777999999999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=352.89 Aligned_cols=267 Identities=25% Similarity=0.409 Sum_probs=212.7
Q ss_pred ChhhHHhhccCCCcCCcccccCceeEEEeecc------CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecc
Q 006317 315 DFSTIRDATNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLG 387 (650)
Q Consensus 315 ~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g 387 (650)
..++.+...++|...+.||+|+||.||+|+.. .++.||||++..... .....+.+|+.++++++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 34455566788999999999999999999764 367899999976533 34456899999999999999999999
Q ss_pred eeecCCeeEEEEecCCCCChhHHHHhhhc-------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC
Q 006317 388 FSFEETERLLIYEFVPNSSVDKFIFDAIK-------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 460 (650)
Q Consensus 388 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~ 460 (650)
++.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+||||+
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~ 172 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA 172 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEc
Confidence 99999999999999999999999975322 146799999999999999999999987 99999999999999
Q ss_pred CCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchh
Q 006317 461 ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDL 539 (650)
Q Consensus 461 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l 539 (650)
.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.|+.... ....
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~ 249 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQV 249 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HHHH
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC---HHHH
Confidence 999999999999986654333223334567889999999999999999999999999999999 788775322 1122
Q ss_pred HHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 540 LTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 540 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
...... ... +......+. .+.+++.+||+.||++|||+.|+++.|+..
T Consensus 250 ~~~~~~----~~~-----~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 250 LRFVME----GGL-----LDKPDNCPD---MLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HHHHHT----TCC-----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHc----CCc-----CCCCCCCCH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 221111 111 011112233 345677799999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=350.63 Aligned_cols=253 Identities=19% Similarity=0.262 Sum_probs=204.1
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
..++|.+.+.||+|+||.||+++.. +++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 3578999999999999999999865 47889999987543 344568899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC--CCCeEEeeeeccccccc
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--DMIPKISDFGMARLFEM 478 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~--~~~~kl~DFGla~~~~~ 478 (650)
|+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.+..
T Consensus 82 ~~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 82 FISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred eCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 9999999999863 3346999999999999999999999987 999999999999997 78999999999987643
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ............. .+.
T Consensus 157 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~------~~~ 224 (321)
T 1tki_A 157 G---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIMNAEYT------FDE 224 (321)
T ss_dssp T---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTCCC------CCH
T ss_pred C---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHcCCCC------CCh
Confidence 2 233456799999999999988899999999999999999999999863321 2222221111000 000
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
......+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 225 ~~~~~~s---~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 225 EAFKEIS---IEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhccCC---HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0001112 345577889999999999999999974
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=354.87 Aligned_cols=264 Identities=25% Similarity=0.354 Sum_probs=209.1
Q ss_pred hHHhhccCCCcCCcccccCceeEEEeeccC-C-----cceeEeeccccCc-hhHHHHHHHHHHHhhC-CCCceeeeccee
Q 006317 318 TIRDATNNFSTDNKLGQGGFGAVYKGRLSH-G-----QEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFS 389 (650)
Q Consensus 318 ~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-g-----~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 389 (650)
..+...++|...+.||+|+||.||++.... + ..||+|++..... .....+.+|+.++.++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344456789999999999999999998543 2 3699999976533 3445689999999999 899999999999
Q ss_pred ecCCeeEEEEecCCCCChhHHHHhhhc-----------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceE
Q 006317 390 FEETERLLIYEFVPNSSVDKFIFDAIK-----------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 458 (650)
Q Consensus 390 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 458 (650)
...+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 999999999999999999999975321 346899999999999999999999987 999999999999
Q ss_pred eCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccc
Q 006317 459 LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAE 537 (650)
Q Consensus 459 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~ 537 (650)
|+.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+| |..|+.......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-- 274 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-- 274 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--
Confidence 99999999999999986654433333344567889999999999999999999999999999999 888876332211
Q ss_pred hhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 538 DLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 538 ~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.......... ........+. .+.+++..||+.||.+|||+.||++.|+.
T Consensus 275 ~~~~~~~~~~---------~~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 275 KFYKLVKDGY---------QMAQPAFAPK---NIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp HHHHHHHHTC---------CCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHhcCC---------CCCCCCCCCH---HHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 1111111111 0111111223 45567779999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=349.39 Aligned_cols=258 Identities=16% Similarity=0.190 Sum_probs=206.6
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEEEe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 400 (650)
.++|+..+.||+|+||.||+|+. .+++.||||++...... ..+.+|+.+++++ +||||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46789999999999999999985 56889999998754322 3578999999999 99999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC-----eEEeeeecccc
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI-----PKISDFGMARL 475 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~-----~kl~DFGla~~ 475 (650)
|+ +++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998752 467999999999999999999999987 999999999999999887 99999999987
Q ss_pred cccCCCCC-----ccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC
Q 006317 476 FEMDQSQG-----DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG 550 (650)
Q Consensus 476 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 550 (650)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 65433211 1345689999999999999999999999999999999999999997544333322222211110000
Q ss_pred CcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 551 TALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 551 ~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
.. ..+....+ ++.+++..||+.||.+||++.+|++.|+
T Consensus 240 -~~----~~~~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~ 277 (330)
T 2izr_A 240 -PI----EVLCENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFT 277 (330)
T ss_dssp -CH----HHHTTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred -CH----HHHhccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence 00 00111122 5667788999999999999999999885
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=357.07 Aligned_cols=265 Identities=25% Similarity=0.388 Sum_probs=206.6
Q ss_pred cCCCcCCcccccCceeEEEeec-----cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceee--cCCeeE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF--EETERL 396 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~ 396 (650)
++|+..+.||+|+||.||++++ .+++.||||++..........+.+|+.++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6788999999999999999983 357889999998776666677999999999999999999999886 456688
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
+||||+++++|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 999999999999999752 346999999999999999999999987 999999999999999999999999999876
Q ss_pred ccCCCC-CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCccc--------chhHHHHHHhc
Q 006317 477 EMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEA--------EDLLTYAWKNW 547 (650)
Q Consensus 477 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~--------~~l~~~~~~~~ 547 (650)
...... .......||..|+|||++.+..++.++||||||+++|||++|+.|+.....+.. ...........
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 533221 122334678889999999999999999999999999999999998753211100 00000000100
Q ss_pred cCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCC
Q 006317 548 NEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSL 601 (650)
Q Consensus 548 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~ 601 (650)
..+. ........+ ..+.+++.+||+.||++|||+.||++.|+....
T Consensus 258 ~~~~-----~~~~~~~~~---~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 258 EEGQ-----RLPAPPACP---AEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HTTC-----CCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred hccc-----CCCCCCccc---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0000 011111223 345567779999999999999999999986544
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=351.68 Aligned_cols=244 Identities=20% Similarity=0.341 Sum_probs=199.4
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
-++|.+.+.||+|+||.||+++. .+++.||||++..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36789999999999999999986 5688999999865422 2234688999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+ +|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 7889888864 457999999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCccceeecCccccChhccccCCC-CccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
.. ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ .+.+.
T Consensus 161 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~ 221 (336)
T 3h4j_B 161 GN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVN 221 (336)
T ss_dssp SB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCC
T ss_pred Cc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHH
Confidence 22 2334579999999999988776 7899999999999999999999863321111 11111
Q ss_pred ---ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 558 ---PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 558 ---~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..+....+. .+.+++.+||+.||.+|||+.|+++.
T Consensus 222 ~~~~~~p~~~s~---~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 222 SCVYVMPDFLSP---GAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp SSCCCCCTTSCH---HHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred cCCCCCcccCCH---HHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 111122233 34567779999999999999999854
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=344.60 Aligned_cols=260 Identities=24% Similarity=0.350 Sum_probs=197.9
Q ss_pred hccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhh--CCCCceeeecceeec----CCee
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR--LQHRNLVRLLGFSFE----ETER 395 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~----~~~~ 395 (650)
..++|+..++||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++.. ....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 457899999999999999999988 6899999998654 23345566666665 799999999998654 3457
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCcEEecCCCCCceEeCCCCCeEE
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH--------EDSRLRIIHRDLKASNILLDADMIPKI 467 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiHrDlk~~NILl~~~~~~kl 467 (650)
++||||+++|+|.+++. ...+++..++.++.||+.||+||| +.+ |+||||||+||||+.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 89999999999999984 357999999999999999999999 555 999999999999999999999
Q ss_pred eeeecccccccCCCCC--ccceeecCccccChhccccC------CCCccccccchhHHHHHHHhC----------CCCCC
Q 006317 468 SDFGMARLFEMDQSQG--DTSRIVGTFGYMAPEYVTRG------HFSIKSDVFSFGVLVLEIISG----------QKNNS 529 (650)
Q Consensus 468 ~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~S~Gvll~elltG----------~~p~~ 529 (650)
+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||+|| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999998665332211 12334799999999999876 455799999999999999999 66664
Q ss_pred CCCCcccchhHHHHHHhccCCCcccccCccCCCC--ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 530 FRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNG--SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 530 ~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~--~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
........ ............ ..+.+... .......+.+++.+||+.||++|||+.||+++|+.
T Consensus 235 ~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 235 DVVPNDPS--FEDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TTSCSSCC--HHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCCCcc--hhhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 32221111 111111111110 11111111 12344667788999999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=364.47 Aligned_cols=250 Identities=27% Similarity=0.422 Sum_probs=201.8
Q ss_pred hccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCC-eeEEEEe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET-ERLLIYE 400 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e 400 (650)
..++|+..++||+|+||.||+|.+. |+.||||+++... ....|.+|+.+|++++||||+++++++.+.. ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3467888999999999999999884 7899999997654 4457899999999999999999999987765 7899999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 99999999999753 2334799999999999999999999987 999999999999999999999999999854321
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
.....++..|+|||++.+..++.++||||||+++|||+| |+.|+......+ ......... ...
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~~~---------~~~ 406 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKGY---------KMD 406 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHHHHTTC---------CCC
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC---------CCC
Confidence 122357889999999999999999999999999999999 999886433222 222211111 011
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.....+. .+.+++..||+.||++|||+.+|++.|+.
T Consensus 407 ~p~~~~~---~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 407 APDGCPP---AVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp CCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1122333 34567779999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=349.44 Aligned_cols=260 Identities=26% Similarity=0.373 Sum_probs=208.4
Q ss_pred hccCCCcCCcccccCceeEEEeec------cCCcceeEeeccccCc-hhHHHHHHHHHHHhhC-CCCceeeecceeecCC
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFSFEET 393 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 393 (650)
..++|...+.||+|+||.||+++. .+++.||||++..... .....+.+|+.++.++ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 456889999999999999999974 3467899999976543 3445789999999999 9999999999999999
Q ss_pred eeEEEEecCCCCChhHHHHhhhc---------------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceE
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIK---------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 458 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 458 (650)
..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999975321 125899999999999999999999987 999999999999
Q ss_pred eCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccc
Q 006317 459 LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAE 537 (650)
Q Consensus 459 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~ 537 (650)
++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+| |+.|+.......
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 255 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-- 255 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--
Confidence 99999999999999987654433333344567889999999999999999999999999999999 888876432211
Q ss_pred hhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 538 DLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 538 ~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.......... ........+. .+.+++.+||+.||.+|||+.||+++|+.
T Consensus 256 ~~~~~~~~~~---------~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 256 KFYKMIKEGF---------RMLSPEHAPA---EMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp HHHHHHHHTC---------CCCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhccCC---------CCCCcccCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 1111111111 1111112233 45567779999999999999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=344.26 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=202.9
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch------hHHHHHHHHHHHhhCCCCceeeecceeecCCee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ------GELEFKNEVLLVARLQHRNLVRLLGFSFEETER 395 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 395 (650)
.+.|...+.||+|+||.||+++.. +|+.||||++...... ....+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 457889999999999999999865 5889999998765322 356789999999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC----CeEEeeee
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM----IPKISDFG 471 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFG 471 (650)
++||||+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999986 3467999999999999999999999987 99999999999999888 89999999
Q ss_pred cccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCC
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGT 551 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 551 (650)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........... ..
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~--~~ 235 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANVSAVN--YE 235 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHTC--CC
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HHHHHHHHhcC--CC
Confidence 998764322 23345799999999999999999999999999999999999999863221 11221111110 00
Q ss_pred cccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 552 ALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 552 ~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+........+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 236 ----~~~~~~~~~~---~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 ----FEDEYFSNTS---ALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ----CCHHHHTTSC---HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----cCccccccCC---HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000001112 234567779999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=351.80 Aligned_cols=255 Identities=26% Similarity=0.358 Sum_probs=198.9
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcc----eeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQE----IAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~----vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
++|+..++||+|+||.||+|+.. +++. ||+|.+.... ......+.+|+.++.+++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57888999999999999999854 4554 6777765432 222345778999999999999999999886 566899
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||+++|+|.+++.. .+..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 9999999999999874 2457999999999999999999999987 9999999999999999999999999999876
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
............||..|+|||++.+..++.++||||||+++|||+| |+.||....... ........ ...
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~----~~~--- 236 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDLLEKG----ERL--- 236 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHHHHTT----CBC---
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHHHHcC----CCC---
Confidence 5544444455678889999999999999999999999999999999 999986433222 22111111 000
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
........ .+.+++.+||+.||++||++.||++.|+..
T Consensus 237 --~~~~~~~~---~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 237 --AQPQICTI---DVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp --CCCTTBCT---TTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred --CCCCcCcH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00011111 244677799999999999999999998753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=341.52 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=202.0
Q ss_pred ccCCCcCCcccccCceeEEEeeccC-C-------cceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH-G-------QEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE 394 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~-g-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 394 (650)
.++|...+.||+|+||.||+|+... + ..||+|++..........+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3578889999999999999998653 3 4699999987666667789999999999999999999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC--------eE
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI--------PK 466 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~--------~k 466 (650)
.++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999975 3345999999999999999999999987 999999999999999887 99
Q ss_pred EeeeecccccccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHH
Q 006317 467 ISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWK 545 (650)
Q Consensus 467 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~ 545 (650)
|+|||++.... ......||..|+|||++.+ ..++.++||||||+++|||++|..|+...... ....... .
T Consensus 162 l~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~~~~~-~ 232 (289)
T 4fvq_A 162 LSDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRKLQFY-E 232 (289)
T ss_dssp ECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHH-H
T ss_pred eccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--HHHHHHh-h
Confidence 99999986442 1233568999999999987 77999999999999999999976554322111 1111111 1
Q ss_pred hccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCC
Q 006317 546 NWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSL 601 (650)
Q Consensus 546 ~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~ 601 (650)
. . ..+...... .+.+++.+||+.||++|||+.|+++.|+....
T Consensus 233 ~--~--------~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 D--R--------HQLPAPKAA---ELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp T--T--------CCCCCCSSC---TTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred c--c--------CCCCCCCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0 0 011111122 24567779999999999999999999987543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.30 Aligned_cols=265 Identities=17% Similarity=0.215 Sum_probs=202.7
Q ss_pred hccCCCcCCcccccCceeEEEeeccC------CcceeEeeccccCchhH-----------HHHHHHHHHHhhCCCCceee
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNSVQGE-----------LEFKNEVLLVARLQHRNLVR 384 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~ 384 (650)
..++|.+.++||+|+||.||+|.+.. ++.||||++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998754 47899999876542211 12345666778889999999
Q ss_pred ecceeecC----CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC
Q 006317 385 LLGFSFEE----TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD 460 (650)
Q Consensus 385 l~g~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~ 460 (650)
+++++... ...+|||||+ +++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998764 4579999999 9999999875 3467999999999999999999999987 99999999999999
Q ss_pred --CCCCeEEeeeecccccccCCCCC-----ccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCC
Q 006317 461 --ADMIPKISDFGMARLFEMDQSQG-----DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIG 533 (650)
Q Consensus 461 --~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~ 533 (650)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998765432211 12335699999999999999999999999999999999999999874222
Q ss_pred cccchhHHHHHHhccCCCcccccCccCC-CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 534 EEAEDLLTYAWKNWNEGTALNLIDPTLR-NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 534 ~~~~~l~~~~~~~~~~~~~~~~id~~l~-~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.. .........+ .....+++++.+. ...+.+ +.+++..||+.+|++||++.+|+++|+.
T Consensus 267 ~~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~---~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 267 DP--KYVRDSKIRY-RENIASLMDKCFPAANAPGE---IAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp CH--HHHHHHHHHH-HHCHHHHHHHHSCTTCCCHH---HHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred CH--HHHHHHHHHh-hhhHHHHHHHhcccccCHHH---HHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 21 1111111111 1122333444332 223444 4456668999999999999999999865
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=356.03 Aligned_cols=265 Identities=20% Similarity=0.226 Sum_probs=206.1
Q ss_pred ccChhhHHhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch---hHHHHHHHHHHHhhCCCCceeeecce
Q 006317 313 QFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGF 388 (650)
Q Consensus 313 ~~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~ 388 (650)
.+.+++++...++|+..++||+|+||.||+++.+ +|+.||||++.+.... ....+.+|..++.+++||||++++++
T Consensus 50 ~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 50 VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 3455666677889999999999999999999875 5899999999754221 22347889999999999999999999
Q ss_pred eecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEe
Q 006317 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS 468 (650)
Q Consensus 389 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 468 (650)
+.+.+..+|||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHH--HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEe
Confidence 9999999999999999999999974 2347999999999999999999999987 9999999999999999999999
Q ss_pred eeecccccccCCCCCccceeecCccccChhccc-------cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHH
Q 006317 469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-------RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLT 541 (650)
Q Consensus 469 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~ 541 (650)
|||+++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...... +...
T Consensus 205 DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~ 280 (412)
T 2vd5_A 205 DFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---ETYG 280 (412)
T ss_dssp CCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH
T ss_pred echhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---HHHH
Confidence 9999986643221 1223457999999999987 356899999999999999999999998643221 1111
Q ss_pred HHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCC---CCHHHHHHH
Q 006317 542 YAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANR---PTMASVVVM 595 (650)
Q Consensus 542 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~R---Pt~~evl~~ 595 (650)
....... ...-+.+....+.+ +.+++.+||+ +|++| |+++||++.
T Consensus 281 ~i~~~~~-----~~~~p~~~~~~s~~---~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 281 KIVHYKE-----HLSLPLVDEGVPEE---ARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHTHHH-----HCCCC----CCCHH---HHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHhccc-----CcCCCccccCCCHH---HHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1111000 00011111223333 4456678998 99998 699999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=344.34 Aligned_cols=246 Identities=23% Similarity=0.298 Sum_probs=191.5
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 398 (650)
.++|+..++||+|+||+||+|+.. +|+.||||++..... .....+..|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999875 689999999865432 2333455666665555 999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+ +++|.+++.. ....++|..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 6799988875 3456999999999999999999999987 99999999999999999999999999876543
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|..++... ..+..+..+.. .+
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~----~~ 271 (311)
T 3p1a_A 210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYL----PP 271 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCC----CH
T ss_pred CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCC----Cc
Confidence 22 2334569999999998875 7899999999999999999997665321 01111111111 11
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+..... ..+.+++.+||+.||++|||+.|+++.
T Consensus 272 ~~~~~~~---~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 272 EFTAGLS---SELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHTTSC---HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccCCC---HHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1111122 345567779999999999999999853
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=339.67 Aligned_cols=261 Identities=15% Similarity=0.210 Sum_probs=207.7
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEEEe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 400 (650)
.++|+..+.||+|+||.||+++. .+++.||||++..... ...+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999985 5689999999865432 23578899999999 79999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC-----eEEeeeecccc
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI-----PKISDFGMARL 475 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~-----~kl~DFGla~~ 475 (650)
|+ +++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 9999999975 2446999999999999999999999987 999999999999988776 99999999987
Q ss_pred cccCCCC-----CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC
Q 006317 476 FEMDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG 550 (650)
Q Consensus 476 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 550 (650)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6543321 12345679999999999999999999999999999999999999997544333333222221111000
Q ss_pred CcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 551 TALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 551 ~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
...+ +....++ .+.+++..||+.||++||++.+|++.|+..
T Consensus 241 ~~~~-----~~~~~~~---~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 241 PLRE-----LCAGFPE---EFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp CHHH-----HTTTSCH---HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cHHH-----HHhhCcH---HHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 0000 1111223 455677799999999999999999998753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=339.49 Aligned_cols=260 Identities=27% Similarity=0.476 Sum_probs=192.4
Q ss_pred hccCCCcCCcccccCceeEEEeeccCCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
..++|+..++||+|+||.||+|+... .||||+++... ......+.+|+.++++++||||++++++. .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 45689999999999999999998743 59999987553 23445789999999999999999999965 556689999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence 99999999999864 3456999999999999999999999987 999999999999999999999999999865533
Q ss_pred CCCCccceeecCccccChhccc---cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
..........||..|+|||.+. +..++.++||||||+++|||++|+.||..... ...+............ +
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~----~ 247 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLSPD----L 247 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHHHHHHTSCCCC----T
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHHHhcccccCcc----h
Confidence 3333344567999999999986 56788999999999999999999999864322 1122222221111110 0
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
..+....+ ..+.+++..||+.||++|||+.+|+++|+..
T Consensus 248 -~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 248 -SKVRSNCP---KRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp -TSSCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -hhccccCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 01111222 3455677799999999999999999999764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=337.07 Aligned_cols=253 Identities=28% Similarity=0.450 Sum_probs=193.9
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCch----hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ----GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
.++|+..++||+|+||.||+++.. ++.||||++...... ....+.+|+.++++++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 367888999999999999999974 889999998764322 235688999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC--------CCCeEEeee
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--------DMIPKISDF 470 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~--------~~~~kl~DF 470 (650)
|||+++++|.+++. ...+++..++.++.||+.||+|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999884 457999999999999999999999987556999999999999986 778999999
Q ss_pred ecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC
Q 006317 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG 550 (650)
Q Consensus 471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 550 (650)
|+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... . ..+......
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~---~~~~~~~~~ 230 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL---A---VAYGVAMNK 230 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH---H---HHHHHHTSC
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---H---HHHhhhcCC
Confidence 9998654322 22357899999999999999999999999999999999999998632211 1 111111111
Q ss_pred CcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 551 TALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 551 ~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
. ........++ .+.+++.+||+.||++|||+.|+++.|+.
T Consensus 231 ~-----~~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 231 L-----ALPIPSTCPE---PFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp C-----CCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred C-----CCCCCcccCH---HHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0 1111122233 35567779999999999999999999974
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=347.13 Aligned_cols=275 Identities=24% Similarity=0.362 Sum_probs=200.2
Q ss_pred ccccccccChhhHHhhccCCCcCCcccccCceeEEEeeccC----CcceeEeeccccC--chhHHHHHHHHHHHhhCCCC
Q 006317 307 NTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHR 380 (650)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~ 380 (650)
...+.++..+.++....++|...+.||+|+||.||+|+... +..||||++.... ......+.+|+.++++++||
T Consensus 17 ~~~eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 96 (313)
T 3brb_A 17 RGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96 (313)
T ss_dssp -------CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCT
T ss_pred CchHhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCC
Confidence 34445555666666677899999999999999999997542 4579999997543 33345689999999999999
Q ss_pred ceeeecceeecCCe-----eEEEEecCCCCChhHHHHhhh---ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCC
Q 006317 381 NLVRLLGFSFEETE-----RLLIYEFVPNSSVDKFIFDAI---KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDL 452 (650)
Q Consensus 381 niv~l~g~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl 452 (650)
||+++++++.+... .++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||
T Consensus 97 ~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~di 173 (313)
T 3brb_A 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDL 173 (313)
T ss_dssp TBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCC
T ss_pred CeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 99999999987553 499999999999999986432 3456999999999999999999999987 999999
Q ss_pred CCCceEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCC
Q 006317 453 KASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFR 531 (650)
Q Consensus 453 k~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~ 531 (650)
||+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...
T Consensus 174 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 253 (313)
T 3brb_A 174 AARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253 (313)
T ss_dssp SGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 99999999999999999999987654333233344567889999999999999999999999999999999 77787533
Q ss_pred CCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 532 IGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 532 ~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
.. ........... .+......+. .+.+++.+||+.||++|||+.+|++.|+..
T Consensus 254 ~~---~~~~~~~~~~~---------~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 254 QN---HEMYDYLLHGH---------RLKQPEDCLD---ELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp CG---GGHHHHHHTTC---------CCCCBTTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CH---HHHHHHHHcCC---------CCCCCccccH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22 22222221111 0111112223 455677799999999999999999999754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=339.35 Aligned_cols=262 Identities=22% Similarity=0.305 Sum_probs=199.4
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
++|+..++||+|+||+||+++.. +++.||||++..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999865 588999999975432 234568899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++ +|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9986 55555543 3467999999999999999999999997 9999999999999999999999999998664322
Q ss_pred CCCccceeecCccccChhccccCC-CCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCC---cc---
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGT---AL--- 553 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~--- 553 (650)
.......||+.|+|||++.+.. ++.++||||||+++|||++|+.|+.... ...+.+........... ..
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhhhhhc
Confidence 2233457899999999998765 7999999999999999999998864222 22222222222111110 00
Q ss_pred ccc----------CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 554 NLI----------DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 554 ~~i----------d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+.. ...+..........+.+++.+||+.||++|||++|+++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 000000111122345577889999999999999999853
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=352.61 Aligned_cols=255 Identities=22% Similarity=0.290 Sum_probs=199.5
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch---hHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 397 (650)
.++|+..++||+|+||.||+++.. +++.||||++++.... ....+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357899999999999999999865 4788999999765322 223578899999887 89999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999873 457999999999999999999999987 9999999999999999999999999997532
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCccc--chhHHHHHHhccCCCcccc
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEA--EDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~ 555 (650)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ..............
T Consensus 205 ~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----- 277 (396)
T 4dc2_A 205 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----- 277 (396)
T ss_dssp CT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-----
T ss_pred cC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-----
Confidence 21 2234457899999999999999999999999999999999999999964322111 11111111111111
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCH------HHHHH
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTM------ASVVV 594 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~------~evl~ 594 (650)
...+...... .+.+++..||+.||++||++ .||++
T Consensus 278 -~~~~p~~~s~---~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 278 -QIRIPRSLSV---KAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp -CCCCCTTSCH---HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred -ccCCCCcCCH---HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 0111122233 34567779999999999995 56654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=340.96 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=197.5
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
++|+..+.||+|+||.||+++..+|+.||||++...... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 468889999999999999999877999999998654322 235688999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++ +|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 986 89888864 3457999999999999999999999987 9999999999999999999999999998654321
Q ss_pred CCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCC--------c
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGT--------A 552 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--------~ 552 (650)
.......||+.|+|||++.+. .++.++||||||+++|||++|+.||..... .+.+........... .
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHHCCCChhhchhhhc
Confidence 122345789999999998764 589999999999999999999999864321 122222221111100 0
Q ss_pred ccccCccCCC--------CChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 553 LNLIDPTLRN--------GSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 553 ~~~id~~l~~--------~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
....++.... ........+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0011111100 00011234557788999999999999999985
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=350.55 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=202.9
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|++.+.||+|+||.||+++.. +++.||+|++.+.. ......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67899999999999999999865 47889999986542 223456889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|..++. ....+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999987 3557999999999999999999999987 999999999999999999999999999866432
Q ss_pred CCCCccceeecCccccChhcccc---CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTR---GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+........
T Consensus 169 ---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------- 236 (384)
T 4fr4_A 169 ---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--------- 236 (384)
T ss_dssp ---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC---------
T ss_pred ---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc---------
Confidence 23345679999999999874 458999999999999999999999997544443333332221110
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCC-HHHHHH
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPT-MASVVV 594 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-~~evl~ 594 (650)
......... .+.+++..||+.||++||+ +.+|++
T Consensus 237 -~~~p~~~s~---~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 -VTYPSAWSQ---EMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -CCCCTTSCH---HHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -cCCCCcCCH---HHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111112223 4556777999999999998 777774
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=353.27 Aligned_cols=246 Identities=25% Similarity=0.330 Sum_probs=195.3
Q ss_pred cCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCCCC
Q 006317 328 TDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSS 406 (650)
Q Consensus 328 ~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 406 (650)
..+.||+|+||.||+++. .+|+.||+|+++.........+.+|+.++++++||||+++++++.+.+..+|||||+++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 357899999999999986 4588999999988766667789999999999999999999999999999999999999999
Q ss_pred hhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe--CCCCCeEEeeeecccccccCCCCCc
Q 006317 407 VDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL--DADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 407 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl--~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++...... .
T Consensus 173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~ 244 (373)
T 2x4f_A 173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K 244 (373)
T ss_dssp EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence 9998874 3456999999999999999999999987 9999999999999 677899999999998765332 2
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHh-ccCCCcccccCccCCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKN-WNEGTALNLIDPTLRNG 563 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~-~~~~~~~~~id~~l~~~ 563 (650)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+.+...... +. +.+.....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~~~i~~~~~~-------~~~~~~~~ 314 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---AETLNNILACRWD-------LEDEEFQD 314 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHTCCC-------SCSGGGTT
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCC-------CChhhhcc
Confidence 2335699999999999999999999999999999999999999863321 1222211111 10 00000011
Q ss_pred ChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 564 SSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 564 ~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.. ..+.+++.+||+.||++|||+.|+++
T Consensus 315 ~~---~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 IS---EEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SC---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC---HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 22 34556778999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=341.32 Aligned_cols=261 Identities=26% Similarity=0.408 Sum_probs=198.6
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
++|+..+.||+|+||.||+++.. ++.||||++... .....+.+|+.++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 56888899999999999999874 788999998654 334578999999999999999999998874 4799999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC-eEEeeeecccccccCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI-PKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~-~kl~DFGla~~~~~~~~~ 482 (650)
+|+|.+++........+++..++.++.||++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999975433345899999999999999999999943234999999999999998886 799999999754321
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
.....||..|+|||++.+..++.++||||||+++|||++|+.|+....... ....+..... . .+.+..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~-~-----~~~~~~ 227 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVHNG-T-----RPPLIK 227 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHHTT-C-----CCCCBT
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHhcC-C-----CCCccc
Confidence 223468999999999999999999999999999999999999986322211 1111111111 1 111112
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCCCCCCCC
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSLPLPS 607 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~~~~~p~ 607 (650)
..+. .+.+++.+||+.||++|||+.||+++|+.....++.+.
T Consensus 228 ~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 228 NLPK---PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred ccCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 2233 34567779999999999999999999986544444333
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=343.57 Aligned_cols=271 Identities=27% Similarity=0.363 Sum_probs=212.9
Q ss_pred ccccChhhHHhhccCCCcCCcccccCceeEEEeec------cCCcceeEeeccccCc-hhHHHHHHHHHHHhhC-CCCce
Q 006317 311 SLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNL 382 (650)
Q Consensus 311 ~~~~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~ni 382 (650)
.+.++........++|...+.||+|+||.||+++. .+++.||||++..... .....+.+|+.++.++ +||||
T Consensus 14 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i 93 (316)
T 2xir_A 14 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93 (316)
T ss_dssp GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred hccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCe
Confidence 34455666666778999999999999999999973 3467899999976543 3345789999999999 79999
Q ss_pred eeecceeecCC-eeEEEEecCCCCChhHHHHhhhc-------------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEE
Q 006317 383 VRLLGFSFEET-ERLLIYEFVPNSSVDKFIFDAIK-------------RVQLDWETRYKIIGGIARGILYLHEDSRLRII 448 (650)
Q Consensus 383 v~l~g~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii 448 (650)
+++++++...+ ..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+
T Consensus 94 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~ 170 (316)
T 2xir_A 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CI 170 (316)
T ss_dssp CCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred eeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 99999987654 58999999999999999975321 122899999999999999999999987 99
Q ss_pred ecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCC
Q 006317 449 HRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKN 527 (650)
Q Consensus 449 HrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p 527 (650)
||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||+| |+.|
T Consensus 171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p 250 (316)
T 2xir_A 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250 (316)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999986654433333445678899999999999999999999999999999999 9888
Q ss_pred CCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 528 NSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 528 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+....... ......... .. .......+. .+.+++.+||+.||++|||+.||++.|+.
T Consensus 251 ~~~~~~~~--~~~~~~~~~----~~-----~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~ 307 (316)
T 2xir_A 251 YPGVKIDE--EFCRRLKEG----TR-----MRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGN 307 (316)
T ss_dssp STTCCCSH--HHHHHHHHT----CC-----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CcccchhH--HHHHHhccC----cc-----CCCCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 86332211 111111111 10 111111223 45567779999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=348.33 Aligned_cols=253 Identities=21% Similarity=0.323 Sum_probs=194.8
Q ss_pred hccCCCcCCcccccCceeEEEeeccCCcceeEeeccccC--chhHHHHHHHHHHHhhCCC--CceeeecceeecCCeeEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQH--RNLVRLLGFSFEETERLL 397 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~l 397 (650)
..++|++.+.||+|+||.||++...+++.||||++.... ......+.+|+.++.+++| |||+++++++..+...++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 456799999999999999999998889999999987543 2334578999999999986 999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||| +.+++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+ ++.+||+|||+++.+.
T Consensus 87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 568899999973 567999999999999999999999987 99999999999997 6789999999998765
Q ss_pred cCCCCCccceeecCccccChhcccc-----------CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHh
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTR-----------GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKN 546 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~ 546 (650)
............||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ........
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~ 233 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAI 233 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHH
Confidence 4433333445679999999999865 6789999999999999999999999853211 11111111
Q ss_pred ccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 547 WNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 547 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
...... ......... .+.+++..||+.||++|||+.|+++.
T Consensus 234 ~~~~~~-----~~~~~~~~~---~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 234 IDPNHE-----IEFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HCTTSC-----CCCCCCSCH---HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcCCcc-----cCCcccCCH---HHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111100 011111222 45567779999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=341.99 Aligned_cols=260 Identities=25% Similarity=0.361 Sum_probs=188.1
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
.++|+..++||+|+||.||+|+.. +|+.||||++...... ....+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467899999999999999999865 5889999999765332 33568899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhc---cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 401 FVPNSSVDKFIFDAIK---RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
|++ |+|.+++..... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 599999875321 245899999999999999999999987 9999999999999999999999999998664
Q ss_pred cCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccC--CCc--
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNE--GTA-- 552 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~-- 552 (650)
... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... +.+......... ...
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCTTTCG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhHhh
Confidence 322 22334578999999999976 46899999999999999999999998643322 222221111100 000
Q ss_pred --------------------ccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 553 --------------------LNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 553 --------------------~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.+.+.+....... ..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLD---GNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCC---HHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCC---HHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0001111111122 24567788999999999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=351.55 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=202.3
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
..++|+..+.||+|+||.||+++.. +|+.||||++..... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4568999999999999999999864 588999999976532 3345688999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC---CeEEeeeecccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM---IPKISDFGMARL 475 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~DFGla~~ 475 (650)
|||+++|+|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999886 3467999999999999999999999987 99999999999998654 599999999986
Q ss_pred cccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+......... ..
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~~~i~~~~~-----~~ 249 (362)
T 2bdw_A 181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAY-----DY 249 (362)
T ss_dssp CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCC-----CC
T ss_pred ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCC-----CC
Confidence 54322 2334679999999999999999999999999999999999999986322 1222222111100 00
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..+.. ...+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~-~~~~---~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PSPEW-DTVT---PEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CTTGG-GGSC---HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Ccccc-cCCC---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0112 345567779999999999999999854
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=350.09 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=188.1
Q ss_pred hhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
...++|+..+.||+|+||.||+++.. +++.||||++.... ....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 34578999999999999999999975 47789999997643 3346788999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC---CCCeEEeeeeccccc
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMARLF 476 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGla~~~ 476 (650)
||+++|+|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+. ++.+||+|||+++..
T Consensus 128 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 128 ELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EeCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999986 3456999999999999999999999987 999999999999975 889999999999865
Q ss_pred ccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+...... ..+...... .. ....
T Consensus 202 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~i~~----~~-~~~~ 271 (349)
T 2w4o_A 202 EHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMFRRILN----CE-YYFI 271 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHHHHHHT----TC-CCCC
T ss_pred Ccc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHHHHHHh----CC-CccC
Confidence 432 1233467899999999999999999999999999999999999998633221 111111111 10 0011
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+ .....+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 272 ~~-~~~~~~---~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 272 SP-WWDEVS---LNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TT-TTTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred Cc-hhhhCC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 111122 345567789999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=339.61 Aligned_cols=249 Identities=24% Similarity=0.312 Sum_probs=192.8
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch--------------------------hHHHHHHHHHHHh
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--------------------------GELEFKNEVLLVA 375 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--------------------------~~~~~~~E~~~l~ 375 (650)
.++|+..+.||+|+||.||+++.. +++.||||++...... ....+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367899999999999999999854 5889999998754321 1235889999999
Q ss_pred hCCCCceeeecceeec--CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCC
Q 006317 376 RLQHRNLVRLLGFSFE--ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLK 453 (650)
Q Consensus 376 ~l~H~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 453 (650)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++..++.++.||+.||+|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999986 56789999999999998865 3457999999999999999999999987 9999999
Q ss_pred CCceEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCC---CCccccccchhHHHHHHHhCCCCCCC
Q 006317 454 ASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH---FSIKSDVFSFGVLVLEIISGQKNNSF 530 (650)
Q Consensus 454 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDV~S~Gvll~elltG~~p~~~ 530 (650)
|+|||++.++.+||+|||+++...... .......||+.|+|||.+.+.. .+.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 999999999999999999998664322 1233457999999999998765 37889999999999999999999863
Q ss_pred CCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 531 RIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 531 ~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.. ...+....... . .........++ .+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~---~~~~~~~~~~~----~----~~~~~~~~~~~---~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ER---IMCLHSKIKSQ----A----LEFPDQPDIAE---DLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SS---HHHHHHHHHHC----C----CCCCSSSCCCH---HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cc---HHHHHHHHhcc----c----CCCCCccccCH---HHHHHHHHHhhcChhhCCCHHHHhc
Confidence 21 11111111110 0 00000112233 3556777999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=351.10 Aligned_cols=253 Identities=22% Similarity=0.262 Sum_probs=204.9
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
.++|++.+.||+|+||.||+++.. +|+.||+|++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999865 5889999999876655566789999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC--CCCeEEeeeecccccccC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--DMIPKISDFGMARLFEMD 479 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~--~~~~kl~DFGla~~~~~~ 479 (650)
+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999998863 3346999999999999999999999987 999999999999974 478999999999876432
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ....+........ .+++.
T Consensus 205 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~i~~~~~------~~~~~ 272 (387)
T 1kob_A 205 ---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDW------EFDED 272 (387)
T ss_dssp ---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCC------CCCSS
T ss_pred ---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCC------CCCcc
Confidence 22334579999999999999999999999999999999999999986322 1122221111100 01111
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.....+. .+.+++.+||+.||++|||+.|+++.
T Consensus 273 ~~~~~s~---~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 AFSSVSP---EAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTTTSCH---HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccCCH---HHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1112223 45567779999999999999999865
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=359.02 Aligned_cols=254 Identities=23% Similarity=0.297 Sum_probs=202.1
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
..++|+..++||+|+||.||++.. .+|+.+|+|++..... .....+.+|+.++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 457899999999999999999975 4688999999976543 2345688999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC---CCCCeEEeeeecccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---ADMIPKISDFGMARL 475 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGla~~ 475 (650)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999998873 467999999999999999999999997 99999999999998 467899999999986
Q ss_pred cccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+......... ..
T Consensus 163 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~-----~~ 232 (444)
T 3soa_A 163 VEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED---QHRLYQQIKAGAY-----DF 232 (444)
T ss_dssp CCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTCC-----CC
T ss_pred ecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHhCCC-----CC
Confidence 54322 22334679999999999999999999999999999999999999985322 2222222211100 00
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..+.. ...++ .+.+++..||+.||++|||+.|+++.
T Consensus 233 ~~~~~-~~~s~---~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 PSPEW-DTVTP---EAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CTTTT-TTSCH---HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred Ccccc-ccCCH---HHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 01111 11223 34567779999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=340.12 Aligned_cols=258 Identities=27% Similarity=0.426 Sum_probs=209.2
Q ss_pred HhhccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
+...++|+..+.||+|+||.||++.... +..||+|++.... .....+.+|+.++++++||||+++++++.++...++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 3456789999999999999999998764 7889999997644 3445789999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 88 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 9999999999999753 3456999999999999999999999998 99999999999999999999999999986653
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
.. ........+|..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .......... .
T Consensus 164 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~~~~~---------~ 230 (288)
T 3kfa_A 164 DT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLEKDY---------R 230 (288)
T ss_dssp SS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHHTTC---------C
T ss_pred Cc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhccC---------C
Confidence 32 222334567889999999999999999999999999999999 88887643222 2222111111 1
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.......++ .+.+++..||+.||++|||+.+|+++|+.
T Consensus 231 ~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 231 MERPEGCPE---KVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCCH---HHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 111112233 45567779999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=350.61 Aligned_cols=248 Identities=24% Similarity=0.296 Sum_probs=197.0
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 397 (650)
.++|+..++||+|+||.||+++.. +|+.||||++++.. ......+.+|..++..+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 367999999999999999999865 58899999997642 22344678899999988 79999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999874 467999999999999999999999987 9999999999999999999999999997533
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..++....... .
T Consensus 176 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i~~~----~------ 240 (353)
T 3txo_A 176 CN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILND----E------ 240 (353)
T ss_dssp C-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHC----C------
T ss_pred cC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC---HHHHHHHHHcC----C------
Confidence 22 223445689999999999999899999999999999999999999986432 22222222111 0
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCH------HHHHH
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTM------ASVVV 594 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~------~evl~ 594 (650)
..+...... .+.+++..||+.||++||++ .|+++
T Consensus 241 ~~~p~~~~~---~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 VVYPTWLHE---DATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCCCTTSCH---HHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCCCCH---HHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111112233 34567779999999999998 77774
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=346.23 Aligned_cols=254 Identities=22% Similarity=0.267 Sum_probs=201.3
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-----hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-----QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 396 (650)
.+.|++.+.||+|+||.||+++.. +|+.||||++..... .....+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 357889999999999999999864 588999999864321 23567899999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC---eEEeeeec
Q 006317 397 LIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI---PKISDFGM 472 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFGl 472 (650)
+||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998886543 2345899999999999999999999987 999999999999987654 99999999
Q ss_pred ccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCc
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA 552 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 552 (650)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+....... ..
T Consensus 180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i~~~----~~ 249 (351)
T 3c0i_A 180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGIIKG----KY 249 (351)
T ss_dssp CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHHHHT----CC
T ss_pred eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHHHcC----CC
Confidence 98765322 22334579999999999999999999999999999999999999986321 1121111111 00
Q ss_pred ccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 553 LNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 553 ~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
...+......+ ..+.+++.+||+.||++|||+.|+++
T Consensus 250 --~~~~~~~~~~s---~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 --KMNPRQWSHIS---ESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCCHHHHTTSC---HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCCccccccCC---HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000001112 34556778999999999999999985
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=334.99 Aligned_cols=254 Identities=28% Similarity=0.536 Sum_probs=199.9
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhH-------HHHHHHHHHHhhCCCCceeeecceeecCCe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGE-------LEFKNEVLLVARLQHRNLVRLLGFSFEETE 394 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~-------~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 394 (650)
.++|+..+.||+|+||.||+++.. +++.||||++........ ..+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467899999999999999999864 688999999865432211 56889999999999999999999986655
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC-----eEEee
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI-----PKISD 469 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~-----~kl~D 469 (650)
++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999998875 3457999999999999999999999875 34999999999999988876 99999
Q ss_pred eecccccccCCCCCccceeecCccccChhccc--cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhc
Q 006317 470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT--RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNW 547 (650)
Q Consensus 470 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 547 (650)
||+++.... ......||+.|+|||++. ...++.++||||||+++|||++|+.||........ .........
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~- 245 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINMIREE- 245 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHHHHHHHS-
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHHHHHhcc-
Confidence 999974322 233467899999999984 45678999999999999999999999864332221 111111111
Q ss_pred cCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 548 NEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 548 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
...+.+....+. .+.+++..||+.||++|||+.||++.|+.
T Consensus 246 -------~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 246 -------GLRPTIPEDCPP---RLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -------CCCCCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -------CCCCCCCcccCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 011122222333 45567779999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=340.16 Aligned_cols=255 Identities=22% Similarity=0.341 Sum_probs=192.5
Q ss_pred hccCCCcCCcccccCceeEEEeeccC----CcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 396 (650)
..++|+..+.||+|+||.||+|+... +..||+|++.... ......+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34688899999999999999998643 4469999987643 334457899999999999999999999974 56789
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
+||||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 99999999999999974 3456999999999999999999999987 999999999999999999999999999876
Q ss_pred ccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .+........ ..
T Consensus 167 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~---~~~~~~i~~~----~~--- 235 (281)
T 1mp8_A 167 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENG----ER--- 235 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHTT----CC---
T ss_pred Ccccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH---HHHHHHHHcC----CC---
Confidence 43221 12233456789999999999999999999999999999997 8888864322 2222221111 00
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
..+....+. .+.+++..||+.||++|||+.||++.|+.
T Consensus 236 --~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 236 --LPMPPNCPP---TLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp --CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCCCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111122333 34567779999999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=347.75 Aligned_cols=266 Identities=16% Similarity=0.203 Sum_probs=198.2
Q ss_pred ccCCCcCCcccccCceeEEEeecc----CCcceeEeeccccCch-----------hHHHHHHHHHHHhhCCCCceeeecc
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS----HGQEIAVKRLSKNSVQ-----------GELEFKNEVLLVARLQHRNLVRLLG 387 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g 387 (650)
.++|.+.+.||+|+||.||+++.. .+..+|||++...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999875 5778999998765322 1123667888999999999999999
Q ss_pred eeec----CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC
Q 006317 388 FSFE----ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM 463 (650)
Q Consensus 388 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~ 463 (650)
++.. ....++||||+ +++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9987 67889999999 9999999864 337999999999999999999999987 99999999999999887
Q ss_pred --CeEEeeeecccccccCCCC-----CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCccc
Q 006317 464 --IPKISDFGMARLFEMDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEA 536 (650)
Q Consensus 464 --~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~ 536 (650)
.+||+|||+++.+...... .......||..|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP- 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence 9999999999876433211 11244579999999999999999999999999999999999999985322111
Q ss_pred chhHHHHHHhccCCCcccccCccCC-CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCC
Q 006317 537 EDLLTYAWKNWNEGTALNLIDPTLR-NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSL 601 (650)
Q Consensus 537 ~~l~~~~~~~~~~~~~~~~id~~l~-~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~ 601 (650)
... ........... ...+..... ...+. .+.+++..||+.||++||++.+|++.|+....
T Consensus 268 ~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 VAV-QTAKTNLLDEL-PQSVLKWAPSGSSCC---EIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHH-HHHHHHHHHTT-THHHHHHSCTTSCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHH-HHHHHhhcccc-cHHHHhhccccccHH---HHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111 11111111100 000101111 12233 45567779999999999999999999987654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=346.91 Aligned_cols=259 Identities=24% Similarity=0.369 Sum_probs=206.0
Q ss_pred hccCCCcCCcccccCceeEEEeecc--------CCcceeEeeccccCc-hhHHHHHHHHHHHhhC-CCCceeeecceeec
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS--------HGQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFSFE 391 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 391 (650)
..++|...+.||+|+||.||+++.. ++..||||++..... .....+.+|+.+++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3478899999999999999999853 466899999976533 3445788999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCChhHHHHhhhc-------------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceE
Q 006317 392 ETERLLIYEFVPNSSVDKFIFDAIK-------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 458 (650)
Q Consensus 392 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 458 (650)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999975321 234899999999999999999999987 999999999999
Q ss_pred eCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccc
Q 006317 459 LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAE 537 (650)
Q Consensus 459 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~ 537 (650)
|+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.... ..
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~ 266 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VE 266 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---HH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC---HH
Confidence 99999999999999987654332223334567889999999999899999999999999999999 988886322 12
Q ss_pred hhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 538 DLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 538 ~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
++......... .......+. .+.+++.+||+.||++|||+.||++.|+.
T Consensus 267 ~~~~~~~~~~~---------~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~ 315 (334)
T 2pvf_A 267 ELFKLLKEGHR---------MDKPANCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315 (334)
T ss_dssp HHHHHHHHTCC---------CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHhcCCC---------CCCCccCCH---HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 22222211110 111112233 35567779999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=352.36 Aligned_cols=210 Identities=26% Similarity=0.304 Sum_probs=181.7
Q ss_pred ccccChhhHHhhccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCC-----CCceee
Q 006317 311 SLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-----HRNLVR 384 (650)
Q Consensus 311 ~~~~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~niv~ 384 (650)
...+.+.......++|.+.++||+|+||.||+++. .+++.||||++... ......+..|+.++.+++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 44566666667789999999999999999999986 45889999999753 233446788999999986 999999
Q ss_pred ecceeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC---
Q 006317 385 LLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--- 461 (650)
Q Consensus 385 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~--- 461 (650)
+++++...+..++||||+ +++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccc
Confidence 999999999999999999 99999998753 2345999999999999999999999987 999999999999986
Q ss_pred ----------------------CCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHH
Q 006317 462 ----------------------DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVL 519 (650)
Q Consensus 462 ----------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ 519 (650)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||||+++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 78999999999986432 123457899999999999999999999999999999
Q ss_pred HHHhCCCCCCCC
Q 006317 520 EIISGQKNNSFR 531 (650)
Q Consensus 520 elltG~~p~~~~ 531 (650)
||++|+.||...
T Consensus 251 ell~g~~pf~~~ 262 (360)
T 3llt_A 251 ELYTGSLLFRTH 262 (360)
T ss_dssp HHHHSSCSCCCS
T ss_pred HHHHCCCCCCCC
Confidence 999999998643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=348.10 Aligned_cols=262 Identities=25% Similarity=0.402 Sum_probs=201.0
Q ss_pred cCCCcCCcccccCceeEEEeec-----cCCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecC--Cee
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TER 395 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 395 (650)
+.|+..++||+|+||.||++++ .+++.||||++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5688899999999999999983 358899999997543 23446789999999999999999999999876 668
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 999999999999999964 3456999999999999999999999987 99999999999999999999999999987
Q ss_pred cccCCCC-CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCC--------cccchhHHHHHHh
Q 006317 476 FEMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIG--------EEAEDLLTYAWKN 546 (650)
Q Consensus 476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~--------~~~~~l~~~~~~~ 546 (650)
....... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+..... .............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 6543221 122334678889999999999999999999999999999999987542110 0000000001111
Q ss_pred ccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 547 WNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 547 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
..... ........+ ..+.+++.+||+.||++|||+.+++++|+.
T Consensus 256 ~~~~~-----~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 256 LKEGK-----RLPCPPNCP---DEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHTTC-----CCCCCTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HhccC-----CCCCCCCCC---HHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 11110 011111222 345567779999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=345.30 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=195.9
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcce----eEeecccc-CchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEI----AVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~v----avK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 396 (650)
.++|+..++||+|+||.||+|+.. +++.+ ++|.+... .......+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367899999999999999999854 45554 66666543 3345567899999999999999999999998765 78
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
+|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999975 3456999999999999999999999987 999999999999999999999999999876
Q ss_pred ccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
.............+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+........
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~~~~-------- 236 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEKGE-------- 236 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHTTC--------
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCC--------
Confidence 54433333444567889999999999999999999999999999999 99998643322 2222211110
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
........+. .+.+++.+||+.||++||++.|+++.|+..
T Consensus 237 -~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 237 -RLPQPPICTI---DVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp -CCCCCTTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0011111222 455677899999999999999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.81 Aligned_cols=258 Identities=24% Similarity=0.358 Sum_probs=193.0
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCch---hHHHHHHHHHHHhhCCCCceeeecceeecCCe---
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFSFEETE--- 394 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--- 394 (650)
..++|++.++||+|+||.||+++. .+++.||||++...... ....+.+|+.++.+++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 357899999999999999999985 56889999999765332 23468899999999999999999999876543
Q ss_pred -eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecc
Q 006317 395 -RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473 (650)
Q Consensus 395 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 473 (650)
.++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 3999999999999999974 457999999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCC-CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCc
Q 006317 474 RLFEMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA 552 (650)
Q Consensus 474 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 552 (650)
+........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .. ..+........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~---~~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VS---VAYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HH---HHHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HH---HHHHHhcCCCC
Confidence 866533221 223345789999999999999999999999999999999999999863221 11 11111111110
Q ss_pred ccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH-Hhc
Q 006317 553 LNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV-MLN 597 (650)
Q Consensus 553 ~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~-~L~ 597 (650)
.. .......+ ..+.+++.+||+.||++||+..+++. .|.
T Consensus 238 ~~---~~~~~~~~---~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 238 PP---SARHEGLS---ADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp CH---HHHSTTCC---HHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred Cc---ccccCCCC---HHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 00 00011122 23556777999999999997666654 343
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=338.49 Aligned_cols=254 Identities=27% Similarity=0.429 Sum_probs=205.5
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
.++|+..+.||+|+||.||+++..+++.||+|++..... ....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 357888999999999999999988888999999976543 3457899999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++++|.+++.. ....+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 86 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 99999999975 3456899999999999999999999987 99999999999999999999999999986532211
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ........... .....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~i~~~~---------~~~~~ 227 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGF---------RLYKP 227 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTC---------CCCCC
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---HHHHHHHhcCC---------cCCCC
Confidence 11223456788999999999999999999999999999999 8888763221 11111111110 01111
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
...+. .+.+++.+||+.||++||++.++++.|+.
T Consensus 228 ~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 261 (267)
T 3t9t_A 228 RLAST---HVYQIMNHCWRERPEDRPAFSRLLRQLAE 261 (267)
T ss_dssp TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCcH---HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 11223 45567789999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=343.55 Aligned_cols=264 Identities=22% Similarity=0.280 Sum_probs=203.7
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeec----CCeeE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE----ETERL 396 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 396 (650)
..++|+..+.||+|+||.||+++. .+++.||||++..........+.+|+.++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 456899999999999999999986 5689999999977666666789999999999999999999999873 44788
Q ss_pred EEEecCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 397 LIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
+||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999997532 2466999999999999999999999987 99999999999999999999999999875
Q ss_pred cccCCCCC-------ccceeecCccccChhccccCC---CCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHH
Q 006317 476 FEMDQSQG-------DTSRIVGTFGYMAPEYVTRGH---FSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWK 545 (650)
Q Consensus 476 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~ 545 (650)
........ ......||+.|+|||++.... ++.++||||||+++|||++|+.||........ .. .....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~-~~~~~ 261 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SV-ALAVQ 261 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CH-HHHHH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hh-hHHhh
Confidence 43211110 112345799999999987554 68999999999999999999999853111100 01 11111
Q ss_pred hccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCC
Q 006317 546 NWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSL 601 (650)
Q Consensus 546 ~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~ 601 (650)
. . .........+ ..+.+++.+||+.||.+|||+.+|++.|+....
T Consensus 262 ~---~-----~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 262 N---Q-----LSIPQSPRHS---SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp C---C-------CCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred c---c-----CCCCccccCC---HHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0 0 0000011122 345577789999999999999999999987543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=373.02 Aligned_cols=262 Identities=26% Similarity=0.414 Sum_probs=208.8
Q ss_pred HhhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
+...++|++.++||+|+||.||+|++.++..||||+++.... ...+|.+|+.+|++++||||+++++++.+ +..+|||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 344567888999999999999999998888899999976543 34579999999999999999999999876 6789999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.++|... ....+++..++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.....
T Consensus 341 e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred ehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999999999643 2356999999999999999999999987 999999999999999999999999999865422
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
.. .......++..|+|||++..+.++.++||||||++||||++ |+.|+.... ..+.+........ .
T Consensus 417 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~---~~~~~~~i~~~~~---------~ 483 (535)
T 2h8h_A 417 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQVERGYR---------M 483 (535)
T ss_dssp HH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC---HHHHHHHHHTTCC---------C
T ss_pred ce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCC---------C
Confidence 11 11122346788999999999999999999999999999999 888875322 1222222211110 0
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCCCC
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSL 603 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~~~ 603 (650)
......++ .+.+|+.+||+.||++|||+.+|+++|+......
T Consensus 484 ~~~~~~~~---~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 484 PCPPECPE---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp CCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CCCCCCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 11112333 3456777999999999999999999998764433
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.95 Aligned_cols=252 Identities=23% Similarity=0.313 Sum_probs=192.3
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
..++|+..++||+|+||.||+++.. +++.||||++..... ....+.+|+.++++++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3468999999999999999999865 688999999976433 23468899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC--eEEeeeeccccccc
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI--PKISDFGMARLFEM 478 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~--~kl~DFGla~~~~~ 478 (650)
|+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 9999999999863 456999999999999999999999987 999999999999988775 99999999974332
Q ss_pred CCCCCccceeecCccccChhccccCCCCcc-ccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIK-SDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
. .......||+.|+|||++.+..++.+ +||||||+++|||++|+.||....... .............
T Consensus 171 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~------- 238 (361)
T 3uc3_A 171 H---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSVK------- 238 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTTC-------
T ss_pred c---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcCC-------
Confidence 1 22334579999999999988887765 899999999999999999986433221 1111111111100
Q ss_pred ccCCC--CChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 558 PTLRN--GSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 558 ~~l~~--~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..+.. ... ..+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~s---~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 239 YSIPDDIRIS---PECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCCTTSCCC---HHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCcCCCC---HHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00110 122 345567789999999999999999854
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.21 Aligned_cols=245 Identities=23% Similarity=0.309 Sum_probs=201.0
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|+..+.||+|+||.||+++.. +|+.||+|++++... .....+.+|..+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57889999999999999999865 588999999976422 23456788999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 99999999999973 457999999999999999999999987 99999999999999999999999999986532
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......... .. ..
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~---~~-------~~ 221 (318)
T 1fot_A 159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKTYEKILN---AE-------LR 221 (318)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHH---CC-------CC
T ss_pred ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHh---CC-------CC
Confidence 2334679999999999999999999999999999999999999986322 1111111111 10 11
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCC-----CHHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRP-----TMASVVVM 595 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~~ 595 (650)
+...... .+.+++.+||+.||++|| +++||++.
T Consensus 222 ~p~~~~~---~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 222 FPPFFNE---DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CCTTSCH---HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCH---HHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1122233 345667799999999999 89999843
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=350.54 Aligned_cols=252 Identities=20% Similarity=0.324 Sum_probs=195.1
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccC--chhHHHHHHHHHHHhhCC--CCceeeecceeecCCeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQ--HRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv 398 (650)
..+|++.+.||+|+||.||++...+++.||||++.... ......+.+|+.++.+++ ||||+++++++..++..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 35699999999999999999998889999999986543 334457899999999996 59999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|| +.+++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+ ++.+||+|||+++.+..
T Consensus 135 ~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 678899999974 457899999999999999999999987 99999999999995 58999999999987654
Q ss_pred CCCCCccceeecCccccChhcccc-----------CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTR-----------GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNW 547 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 547 (650)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .........
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~ 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHh
Confidence 433333345679999999999865 4689999999999999999999999863211 111111111
Q ss_pred cCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 548 NEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 548 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.... .......... .+.+++.+||+.||++|||+.||++.
T Consensus 282 ~~~~-----~~~~~~~~~~---~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 DPNH-----EIEFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CTTS-----CCCCCCCSCH---HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred Cccc-----cCCCCccchH---HHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1110 0011111223 45567779999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=355.49 Aligned_cols=260 Identities=20% Similarity=0.242 Sum_probs=204.4
Q ss_pred hhhHHhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeec
Q 006317 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFE 391 (650)
Q Consensus 316 ~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 391 (650)
...++...++|+..++||+|+||.||+++.. +++.||+|++.+... .....+.+|+.++..++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455667789999999999999999999875 478899999865321 122347899999999999999999999999
Q ss_pred CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeee
Q 006317 392 ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471 (650)
Q Consensus 392 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 471 (650)
+...++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999998853 46899999999999999999999987 9999999999999999999999999
Q ss_pred cccccccCCCCCccceeecCccccChhccccCC----CCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhc
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH----FSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNW 547 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 547 (650)
+++....... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ...........
T Consensus 214 ~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~ 289 (410)
T 3v8s_A 214 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMNHK 289 (410)
T ss_dssp TCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTHH
T ss_pred eeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh---hhHHHHHHhcc
Confidence 9986543221 1233467999999999998765 78999999999999999999999863321 12221111100
Q ss_pred cCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCC--CCCHHHHHHH
Q 006317 548 NEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVAN--RPTMASVVVM 595 (650)
Q Consensus 548 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~--RPt~~evl~~ 595 (650)
.... -+ .......+ +.+++.+||+.+|.+ ||++.||++.
T Consensus 290 ---~~~~--~p-~~~~~s~~---~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 290 ---NSLT--FP-DDNDISKE---AKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---HHCC--CC-TTCCCCHH---HHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---cccc--CC-CcccccHH---HHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0000 00 01122333 445666899999998 9999999965
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=335.65 Aligned_cols=251 Identities=21% Similarity=0.275 Sum_probs=202.1
Q ss_pred hccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
..++|+..++||+|+||.||+++... +..||+|++..........+.+|+.++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 45679999999999999999998654 67899999987666666789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe---CCCCCeEEeeeecccccc
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFE 477 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~~~~ 477 (650)
|+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999998874 456999999999999999999999987 9999999999999 888999999999998665
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.|+..... ............ ....
T Consensus 161 ~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~--~~~~--- 228 (277)
T 3f3z_A 161 PGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD---SEVMLKIREGTF--TFPE--- 228 (277)
T ss_dssp TTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCC--CCCH---
T ss_pred Ccc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhCCC--CCCc---
Confidence 322 2334578999999998865 489999999999999999999999864321 111111111100 0000
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
. .....+ ..+.+++.+||+.||++|||+.++++
T Consensus 229 ~-~~~~~~---~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 K-DWLNVS---PQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp H-HHTTSC---HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred h-hhhcCC---HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000112 34557778999999999999999974
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=331.69 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=200.1
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecC--CeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~ 399 (650)
++|...+.||+|+||.||+|+.. ++.||||++.... ......+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 57888999999999999999984 8899999997653 33445789999999999999999999999877 7889999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++... ....+++..++.++.||+.||+|||+.+ .+++||||||+|||++.++.++|.|||++....
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-- 164 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence 999999999999742 2335999999999999999999999864 359999999999999999999999999875422
Q ss_pred CCCCccceeecCccccChhccccCCCCc---cccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSI---KSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
.....||+.|+|||.+.+..++. ++||||||+++|||++|+.|+..... ......... .. .
T Consensus 165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~---~~-----~ 228 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---MEIGMKVAL---EG-----L 228 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---HHHHHHHHH---SC-----C
T ss_pred -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---HHHHHHHHh---cC-----C
Confidence 12346899999999998765444 89999999999999999999863221 111111111 11 1
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
.+.+....+.+ +.+++..||+.||++|||+.|+++.|+..
T Consensus 229 ~~~~~~~~~~~---~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 229 RPTIPPGISPH---VSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp CCCCCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 11222223333 45677789999999999999999998753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=332.00 Aligned_cols=253 Identities=25% Similarity=0.398 Sum_probs=202.2
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
.++|+..+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357889999999999999999865 58899999986543 2344578999999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++++|.+++. ....+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999885 3456999999999999999999999987 9999999999999999999999999998665433
Q ss_pred CCCccceeecCccccChhccccCCC-CccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
.........||..|+|||.+.+..+ +.++||||||+++|||++|+.||....... ..... +. ..... ..+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~--~~---~~~~~--~~~- 230 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSD--WK---EKKTY--LNP- 230 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHH--HH---TTCTT--STT-
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHH--hh---hcccc--cCc-
Confidence 2233345678999999999987765 789999999999999999999986433221 11111 11 11000 000
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
....+ ..+.+++..||+.||++|||+.|+++
T Consensus 231 -~~~~~---~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 -WKKID---SAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -GGGSC---HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -hhhcC---HHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00112 24456778999999999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=345.27 Aligned_cols=248 Identities=24% Similarity=0.320 Sum_probs=200.9
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 396 (650)
..++|...+.||+|+||.||+++.+ +|+.||||++++.. ......+..|..++..+ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4578999999999999999999975 58899999997642 22344677899998876 9999999999999999999
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 95 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999874 457999999999999999999999987 999999999999999999999999999754
Q ss_pred ccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.......
T Consensus 169 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~---------- 233 (345)
T 1xjd_A 169 MLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRMD---------- 233 (345)
T ss_dssp CCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHC----------
T ss_pred ccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHhC----------
Confidence 322 123445689999999999999999999999999999999999999986332 12222211111
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHH-HHH
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMA-SVV 593 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~-evl 593 (650)
.+.+...... .+.+++.+||+.||++||++. +|+
T Consensus 234 ~~~~p~~~s~---~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 234 NPFYPRWLEK---EAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCCCCTTSCH---HHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCCcccCH---HHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1111222233 345677799999999999998 665
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=341.39 Aligned_cols=254 Identities=23% Similarity=0.294 Sum_probs=199.5
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 398 (650)
++|+..+.||+|+||.||+++.. +++.||||++.+... .....+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57888999999999999999865 488999999976532 2344578899999988 899999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999999873 457999999999999999999999987 99999999999999999999999999975332
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCccc--chhHHHHHHhccCCCccccc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEA--EDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~i 556 (650)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...............
T Consensus 163 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 235 (345)
T 3a8x_A 163 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 235 (345)
T ss_dssp T--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-----
T ss_pred C--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-----
Confidence 1 1234456899999999999999999999999999999999999999864221110 011111111111110
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCH------HHHHH
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTM------ASVVV 594 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~------~evl~ 594 (650)
..+...... .+.+++.+||+.||++||++ .|+++
T Consensus 236 -~~~p~~~s~---~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 236 -IRIPRSLSV---KAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp -CCCCTTSCH---HHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred -CCCCCCCCH---HHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 111122233 34567779999999999995 56663
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.72 Aligned_cols=256 Identities=29% Similarity=0.464 Sum_probs=204.6
Q ss_pred hccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
..++|+..+.||+|+||.||+|+..++..||||++..... ....+.+|+.++++++||||+++++++. .+..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 4567889999999999999999988888999999976543 3457899999999999999999999886 4568999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9999999998642 2236999999999999999999999987 99999999999999999999999999987653221
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ..+......... ....
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~~~~~~---------~~~~ 231 (279)
T 1qpc_A 165 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---NPEVIQNLERGY---------RMVR 231 (279)
T ss_dssp -ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHTTC---------CCCC
T ss_pred -ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC---HHHHHHHHhccc---------CCCC
Confidence 11223456788999999998899999999999999999999 888875322 112222111110 1111
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
....+. .+.+++..||+.||++|||+.+|+++|+..
T Consensus 232 ~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 232 PDNCPE---ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccH---HHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 122233 455677799999999999999999998753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=336.61 Aligned_cols=264 Identities=21% Similarity=0.294 Sum_probs=196.9
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
++|+..++||+|+||.||+++.. +|+.||||++...... ....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57889999999999999999875 4889999998665332 24568899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999998876 3466999999999999999999999987 9999999999999999999999999998654322
Q ss_pred CCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHH--------HHhccCCC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYA--------WKNWNEGT 551 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~ 551 (650)
.......||..|+|||++.+ ..++.++||||||+++|||++|+.||......+........ +..+....
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 --DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred --cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 22234578999999999976 67899999999999999999999998643322211111110 00000000
Q ss_pred cc---cccCccCCCC----ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 552 AL---NLIDPTLRNG----SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 552 ~~---~~id~~l~~~----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.. ...++..... .+.....+.+++..||+.||++|||++|+++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0001100000 01112345678889999999999999999854
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=340.00 Aligned_cols=249 Identities=24% Similarity=0.290 Sum_probs=192.9
Q ss_pred ccCCCcCCcccccCceeEEEeec----cCCcceeEeeccccCc----hhHHHHHHHHHHHhhCCCCceeeecceeecCCe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLLGFSFEETE 394 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 394 (650)
.++|+..+.||+|+||.||+++. .+++.||||++++... .....+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46789999999999999999986 4688999999976532 233457889999999999999999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.++||||+++++|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999873 456899999999999999999999987 9999999999999999999999999997
Q ss_pred ccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ...........
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~-------- 236 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN---RKKTIDKILKC-------- 236 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHT--------
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhC--------
Confidence 543221 12234579999999999999999999999999999999999999986322 11222211111
Q ss_pred ccCccCCCCChHHHHHHHHHHhcccccCCCCCC-----CHHHHHHH
Q 006317 555 LIDPTLRNGSSSEIMRCVHIGLLCVQENVANRP-----TMASVVVM 595 (650)
Q Consensus 555 ~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~~ 595 (650)
...+...... .+.+++.+||+.||++|| ++.|+++.
T Consensus 237 --~~~~p~~~~~---~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 237 --KLNLPPYLTQ---EARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp --CCCCCTTSCH---HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred --CCCCCCCCCH---HHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0111122233 345677799999999999 78888754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=335.04 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=196.8
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
..++|...++||+|+||.||+++.. ++..+|+|++.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 3467899999999999999999864 58899999987653 234567899999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe---CCCCCeEEeeeecccc
Q 006317 400 EFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARL 475 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~~ 475 (650)
||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 9999999999987532 3467999999999999999999999987 9999999999999 5568899999999986
Q ss_pred cccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
+.... ......||..|+|||++. +.++.++||||||+++|||++|+.||..... .+....... ..... ..
T Consensus 177 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~~~~~~~~~--~~~~~-~~ 246 (285)
T 3is5_A 177 FKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---EEVQQKATY--KEPNY-AV 246 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH--CCCCC-CC
T ss_pred cCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---HHHHhhhcc--CCccc-cc
Confidence 54322 233457899999999875 5789999999999999999999999863321 111111111 01000 00
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
...... ..+.+++.+||+.||++|||+.||++
T Consensus 247 ----~~~~~~---~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 ----ECRPLT---PQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ------CCCC---HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----ccCcCC---HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001122 34456777999999999999999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=344.90 Aligned_cols=255 Identities=28% Similarity=0.482 Sum_probs=197.0
Q ss_pred cCCCcCCcccccCceeEEEeeccC-----CcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-----GQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
++|...+.||+|+||.||+|+... +..||||++..... .....+.+|+.++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 567778999999999999998643 23599999976533 344578999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999974 3457999999999999999999999987 9999999999999999999999999998765
Q ss_pred cCCCCC-ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 478 MDQSQG-DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 478 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
...... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+..... .++........
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~~~~-------- 267 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAINDGF-------- 267 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTC--------
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHCCC--------
Confidence 332211 2223456788999999999999999999999999999999 9998853221 12222111110
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
........+. .+.+++.+||+.||++||++.+|++.|+.
T Consensus 268 -~~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 306 (333)
T 1mqb_A 268 -RLPTPMDCPS---AIYQLMMQCWQQERARRPKFADIVSILDK 306 (333)
T ss_dssp -CCCCCTTCBH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -cCCCcccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 0111112233 35567789999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=344.90 Aligned_cols=250 Identities=22% Similarity=0.281 Sum_probs=177.2
Q ss_pred CCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCC-CCceeeecceeecCCeeEEEEecCCCCC
Q 006317 329 DNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEFVPNSS 406 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gs 406 (650)
.++||+|+||.||+++.. +++.||||++... ....+.+|+.++.+++ ||||+++++++.++...++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999865 5889999999653 3446788999999997 9999999999999999999999999999
Q ss_pred hhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC---CeEEeeeecccccccCCCCC
Q 006317 407 VDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM---IPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 407 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~DFGla~~~~~~~~~~ 483 (650)
|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...... .
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~ 164 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--Q 164 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--C
Confidence 9999973 467999999999999999999999987 99999999999998766 89999999998654322 2
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNG 563 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 563 (650)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.....................+.. .....
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~ 238 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGE 238 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCSH
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCcc
Confidence 233457899999999999999999999999999999999999998743322111111111111111110 00000
Q ss_pred C-hHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 564 S-SSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 564 ~-~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
. ......+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 0 0112345677889999999999999998744
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=334.64 Aligned_cols=249 Identities=23% Similarity=0.400 Sum_probs=201.9
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeec---------
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE--------- 391 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------- 391 (650)
..++|+..+.||+|+||.||+++.. +++.||||++.... ..+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467889999999999999999875 68999999997653 246789999999999999999998754
Q ss_pred -------CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC
Q 006317 392 -------ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI 464 (650)
Q Consensus 392 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~ 464 (650)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 34578999999999999999753 3467999999999999999999999987 999999999999999999
Q ss_pred eEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHH
Q 006317 465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAW 544 (650)
Q Consensus 465 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~ 544 (650)
+||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|..|+... .. .+
T Consensus 161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~----~~ 228 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SK----FF 228 (284)
T ss_dssp EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HH----HH
T ss_pred EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HH----HH
Confidence 9999999998665332 223356899999999999999999999999999999999998875310 01 11
Q ss_pred HhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCC
Q 006317 545 KNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSL 601 (650)
Q Consensus 545 ~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~ 601 (650)
...... .+....+.+ +.+++.+||+.||++|||+.|+++.|.....
T Consensus 229 ~~~~~~--------~~~~~~~~~---~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 229 TDLRDG--------IISDIFDKK---EKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHHTT--------CCCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred HHhhcc--------cccccCCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 111111 111222333 4567779999999999999999999976543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=347.76 Aligned_cols=265 Identities=25% Similarity=0.368 Sum_probs=200.7
Q ss_pred cCC-CcCCcccccCceeEEEeecc-----CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecC--Ce
Q 006317 324 NNF-STDNKLGQGGFGAVYKGRLS-----HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEE--TE 394 (650)
Q Consensus 324 ~~f-~~~~~LG~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~ 394 (650)
++| +..++||+|+||.||++.+. +++.||||++..... .....+.+|+.++++++||||+++++++.+. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 444 88999999999999887542 578899999986543 3455689999999999999999999999874 57
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.++||||+++|+|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 8999999999999999853 45999999999999999999999987 9999999999999999999999999998
Q ss_pred ccccCCCC-CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcc
Q 006317 475 LFEMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553 (650)
Q Consensus 475 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 553 (650)
........ .......||..|+|||++.+..++.++||||||+++|||++|+.|+....... .....+...........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLT 261 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHH
Confidence 76543221 12233457888999999999999999999999999999999999875321100 00000000000000000
Q ss_pred cccCc----cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 554 NLIDP----TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 554 ~~id~----~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
+.++. ......+ ..+.+++.+||+.||++|||+.|+++.|+..
T Consensus 262 ~~~~~~~~~~~~~~~~---~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 262 ELLERGERLPRPDKCP---AEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHHTTCCCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcccCCCCCcccc---HHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11111 1111222 3455677799999999999999999999753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.04 Aligned_cols=245 Identities=22% Similarity=0.244 Sum_probs=201.8
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|+..+.||+|+||.||+++.. +|+.||||++.+... .....+.+|+.++++++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57889999999999999999865 588999999965422 23456889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC-
Confidence 99999999999974 356999999999999999999999987 99999999999999999999999999986542
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ...+...... +. ..
T Consensus 194 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~----~~------~~ 256 (350)
T 1rdq_E 194 ----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYEKIVS----GK------VR 256 (350)
T ss_dssp ----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH----CC------CC
T ss_pred ----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC---HHHHHHHHHc----CC------CC
Confidence 2234679999999999999999999999999999999999999986322 1122211111 10 11
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCC-----HHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPT-----MASVVVM 595 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~evl~~ 595 (650)
+...... .+.+++.+||+.||++||+ +.||++.
T Consensus 257 ~p~~~~~---~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 257 FPSHFSS---DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCTTCCH---HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCH---HHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1122233 3456777999999999998 8888753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=350.73 Aligned_cols=205 Identities=19% Similarity=0.267 Sum_probs=177.1
Q ss_pred hccCCCcCCccccc--CceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeE
Q 006317 322 ATNNFSTDNKLGQG--GFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 322 ~~~~f~~~~~LG~G--~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 396 (650)
..++|++.++||+| +||.||+++.. +|+.||||++.... ......+.+|+.++++++||||+++++++.+++..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45789999999999 99999999975 58999999997653 233456888999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
+||||+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999998753 2356999999999999999999999987 999999999999999999999999998654
Q ss_pred ccCCC-----CCccceeecCccccChhcccc--CCCCccccccchhHHHHHHHhCCCCCCC
Q 006317 477 EMDQS-----QGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQKNNSF 530 (650)
Q Consensus 477 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvll~elltG~~p~~~ 530 (650)
..... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 32211 112233478999999999987 5789999999999999999999999864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=347.44 Aligned_cols=255 Identities=15% Similarity=0.148 Sum_probs=204.1
Q ss_pred hhHHhhccCCCcCCcccccCceeEEEee------ccCCcceeEeeccccCchhHHHHHHHHHHHhhCC---CCceeeecc
Q 006317 317 STIRDATNNFSTDNKLGQGGFGAVYKGR------LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ---HRNLVRLLG 387 (650)
Q Consensus 317 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g 387 (650)
.++....++|.+.++||+|+||.||+|. ...++.||||++.... ..++..|+.++.+++ |+||+++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3344556789999999999999999994 4458899999997653 346778888888886 999999999
Q ss_pred eeecCCeeEEEEecCCCCChhHHHHhhh--ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC----
Q 006317 388 FSFEETERLLIYEFVPNSSVDKFIFDAI--KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---- 461 (650)
Q Consensus 388 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~---- 461 (650)
++...+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence 9999999999999999999999997532 2456999999999999999999999987 999999999999998
Q ss_pred -------CCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCc
Q 006317 462 -------DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGE 534 (650)
Q Consensus 462 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~ 534 (650)
++.+||+|||+++.+.............||..|+|||++.+..++.++|||||||++|||+||+.|+......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 8999999999997655333333445567999999999999999999999999999999999999987532211
Q ss_pred ccchhHHHHHHhccCCCcccccCccCCCC-ChHHHHHHHHHHhcccccCCCCC-CCHHHHHHHhcC
Q 006317 535 EAEDLLTYAWKNWNEGTALNLIDPTLRNG-SSSEIMRCVHIGLLCVQENVANR-PTMASVVVMLNS 598 (650)
Q Consensus 535 ~~~~l~~~~~~~~~~~~~~~~id~~l~~~-~~~~~~~~~~l~~~Cl~~~p~~R-Pt~~evl~~L~~ 598 (650)
. ..+...+... ..+.+ .+++..|++.+|.+| |++.++.+.|+.
T Consensus 292 ~------------------~~~~~~~~~~~~~~~~---~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 292 E------------------CKPEGLFRRLPHLDMW---NEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp E------------------EEECSCCTTCSSHHHH---HHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred c------------------eeechhccccCcHHHH---HHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 0 0011112111 23333 356668999999999 678888877764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=351.24 Aligned_cols=270 Identities=21% Similarity=0.304 Sum_probs=208.4
Q ss_pred ccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCC--eeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEET--ERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv 398 (650)
.++|.+.++||+|+||.||+|+... |+.||||++..... .....+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4678999999999999999998754 88999999976433 33456789999999999999999999988755 67999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe----CCCCCeEEeeeeccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DADMIPKISDFGMAR 474 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl~DFGla~ 474 (650)
|||+++|+|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976544455999999999999999999999987 9999999999999 788889999999998
Q ss_pred ccccCCCCCccceeecCccccChhcccc--------CCCCccccccchhHHHHHHHhCCCCCCCCCCc-ccchhHHHHHH
Q 006317 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTR--------GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGE-EAEDLLTYAWK 545 (650)
Q Consensus 475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~-~~~~l~~~~~~ 545 (650)
...... ......||..|+|||++.+ ..++.++||||||+++|||++|+.||...... ...+.......
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 764322 2234569999999999875 56788999999999999999999998643322 22222222222
Q ss_pred hccCCCccccc---------CccCC--CC-ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 546 NWNEGTALNLI---------DPTLR--NG-SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 546 ~~~~~~~~~~i---------d~~l~--~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
..........- ...+. .. .......+.+++..||+.||++||++.|+++.+..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 11111110000 00111 11 23344556688899999999999999999988754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=332.05 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=202.0
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
..++|+..+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999864 58899999986543 23345688999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC---eEEeeeecccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI---PKISDFGMARL 475 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFGla~~ 475 (650)
|||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999988864 457999999999999999999999987 999999999999987665 99999999976
Q ss_pred cccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+..... ............ ..
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~-----~~ 226 (284)
T 3kk8_A 158 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYAQIKAGAY-----DY 226 (284)
T ss_dssp CCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCC-----CC
T ss_pred cccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch---hHHHHHHHhccc-----cC
Confidence 54322 22345789999999999999999999999999999999999999853221 122211111100 00
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..+. ....++ .+.+++.+||+.||++|||+.|+++.
T Consensus 227 ~~~~-~~~~~~---~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 227 PSPE-WDTVTP---EAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CTTT-TTTSCH---HHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred Cchh-hcccCH---HHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0010 011223 35567779999999999999999853
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=333.81 Aligned_cols=249 Identities=27% Similarity=0.444 Sum_probs=181.0
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
.++|...+.||+|+||.||+++. .+|+.||||++..... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46788999999999999999986 4688999999965422 2235688999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999874 3457999999999999999999999987 99999999999999999999999999986543
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+........ . .... ..+.
T Consensus 165 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~~~~-------~~~~ 229 (278)
T 3cok_A 165 PHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---L---NKVV-------LADY 229 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC-------SSCC
T ss_pred CCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---H---HHHh-------hccc
Confidence 221 22335789999999999998999999999999999999999999864322111 0 0000 0011
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.+....+. .+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 EMPSFLSI---EAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCTTSCH---HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCccccCH---HHHHHHHHHcccCHhhCCCHHHHhc
Confidence 11122233 4456777999999999999999974
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.17 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=200.3
Q ss_pred hccCCCcCCcccccCceeEEEeeccC----CcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 396 (650)
..++|...+.||+|+||.||+|+..+ +..||||++.... ......+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45678999999999999999998543 3359999997653 3345678999999999999999999999765 4568
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
+||||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999975 3456999999999999999999999987 999999999999999999999999999865
Q ss_pred ccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
..... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+...... +..........
T Consensus 164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~~~~~~------- 232 (281)
T 3cc6_A 164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVLEKGDR------- 232 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHHHHTCC-------
T ss_pred ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHHhcCCC-------
Confidence 43221 12233457889999999999999999999999999999999 99998643322 22222111110
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.......++ .+.+++.+||+.||++||++.|+++.|+.
T Consensus 233 --~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 233 --LPKPDLCPP---VLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp --CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCCCCH---HHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 011111223 35567779999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=350.34 Aligned_cols=256 Identities=24% Similarity=0.382 Sum_probs=190.4
Q ss_pred cCCCcCCcccccCceeEEEeeccC----CcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeec-CCeeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFE-ETERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~l 397 (650)
..|...++||+|+||.||+|++.+ +..||||.++... ......+.+|+.++++++||||+++++++.. ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 346677899999999999998643 2358999987543 3445679999999999999999999998754 567899
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||+++|+|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+||||++++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999974 3456899999999999999999999987 9999999999999999999999999998654
Q ss_pred cCCCC--CccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 478 MDQSQ--GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 478 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
..... .......+|..|+|||.+.+..++.++||||||+++|||+| |..|+...... +........ ..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~~~~~~----~~-- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLLQG----RR-- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHHHHHTT----CC--
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHHHHHcC----CC--
Confidence 32211 12233457889999999999999999999999999999999 55555432222 222221111 00
Q ss_pred ccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 555 LIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 555 ~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
.......+. .+.+++.+||+.||++|||+.||++.|+..
T Consensus 315 ---~~~p~~~~~---~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 315 ---LLQPEYCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp ---CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011112233 355677799999999999999999999763
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=338.24 Aligned_cols=253 Identities=25% Similarity=0.329 Sum_probs=203.5
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch------hHHHHHHHHHHHhhCCCCceeeecceeecCCe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ------GELEFKNEVLLVARLQHRNLVRLLGFSFEETE 394 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 394 (650)
..++|++.+.||+|+||.||+++.. +|+.||||++...... ....+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467899999999999999999865 5889999998765322 35678999999999999999999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC----CeEEeee
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM----IPKISDF 470 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DF 470 (650)
.++||||+++++|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHH---TCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999996 3457899999999999999999999987 99999999999999988 7999999
Q ss_pred ecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC
Q 006317 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG 550 (650)
Q Consensus 471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 550 (650)
|+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..+........
T Consensus 164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~---- 233 (321)
T 2a2a_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANITSV---- 233 (321)
T ss_dssp TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHTT----
T ss_pred ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhc----
Confidence 9998665322 2234568999999999999999999999999999999999999986322 11121111110
Q ss_pred CcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 551 TALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 551 ~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
. ...++......+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 234 ~--~~~~~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 234 S--YDFDEEFFSHTS---ELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp C--CCCCHHHHTTCC---HHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred c--cccChhhhcccC---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 000111111122 235577889999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=341.61 Aligned_cols=268 Identities=24% Similarity=0.340 Sum_probs=198.5
Q ss_pred hHHhhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhh--CCCCceeeecceeecC---
Q 006317 318 TIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR--LQHRNLVRLLGFSFEE--- 392 (650)
Q Consensus 318 ~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~--- 392 (650)
......++|++.++||+|+||.||+|+.. ++.||||++.... ...+..|.+++.. ++||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 33445678999999999999999999875 8999999986432 2344555555555 4999999999999877
Q ss_pred -CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCcEEecCCCCCceEeCCCCCeE
Q 006317 393 -TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS-----RLRIIHRDLKASNILLDADMIPK 466 (650)
Q Consensus 393 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiHrDlk~~NILl~~~~~~k 466 (650)
...++||||+++|+|.+++.. ..+++..++.++.||+.||+|||+.. .++|+||||||+||||+.++.+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 688999999999999999953 46999999999999999999999871 12399999999999999999999
Q ss_pred EeeeecccccccCCCCC--ccceeecCccccChhccccCCCCcc------ccccchhHHHHHHHhC----------CCCC
Q 006317 467 ISDFGMARLFEMDQSQG--DTSRIVGTFGYMAPEYVTRGHFSIK------SDVFSFGVLVLEIISG----------QKNN 528 (650)
Q Consensus 467 l~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~------sDV~S~Gvll~elltG----------~~p~ 528 (650)
|+|||+++.+....... ......||+.|+|||++.+...+.+ +||||||+++|||+|| +.|+
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999997654332221 1224579999999999988766655 9999999999999999 4554
Q ss_pred CCCCCcccchhHHHHHHhccCCCcccccCccCCCC--ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 529 SFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNG--SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 529 ~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~--~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
......... .......... ....+.+... ......++.+++.+||+.||++|||+.||++.|+..
T Consensus 263 ~~~~~~~~~--~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 263 HDLVPSDPS--YEDMREIVCI----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TTTSCSSCC--HHHHHHHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhcCCCCc--hhhhHHHHhh----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 322211110 1111111111 1111211111 123445677889999999999999999999999753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=347.36 Aligned_cols=263 Identities=23% Similarity=0.264 Sum_probs=191.1
Q ss_pred HHhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCC-CCceeeecceee------
Q 006317 319 IRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSF------ 390 (650)
Q Consensus 319 ~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~------ 390 (650)
+.....+|+..++||+|+||.||+++.. +++.||||++..........+.+|+.++.++. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 3344568999999999999999999864 68899999997766666677899999999996 999999999984
Q ss_pred --cCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEe
Q 006317 391 --EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS 468 (650)
Q Consensus 391 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 468 (650)
.....++||||+. |+|.+++........+++..++.++.||+.||+|||+.+ ++|+||||||+||||+.++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEe
Confidence 3345789999996 799999876555677999999999999999999999874 349999999999999999999999
Q ss_pred eeecccccccCCCCC----------ccceeecCccccChhcc---ccCCCCccccccchhHHHHHHHhCCCCCCCCCCcc
Q 006317 469 DFGMARLFEMDQSQG----------DTSRIVGTFGYMAPEYV---TRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535 (650)
Q Consensus 469 DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~ 535 (650)
|||+++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.|+.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 999998765322211 11234689999999998 56678999999999999999999999985321110
Q ss_pred cchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCC
Q 006317 536 AEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSL 601 (650)
Q Consensus 536 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~ 601 (650)
.... ............+ +.+++..||+.||++|||+.|+++.|.....
T Consensus 261 ------~~~~---------~~~~~~~~~~~~~---~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 261 ------IVNG---------KYSIPPHDTQYTV---FHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp --------------------CCCCTTCCSSGG---GHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------hhcC---------cccCCcccccchH---HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0000 0000111112222 4467779999999999999999999976433
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=346.68 Aligned_cols=264 Identities=22% Similarity=0.268 Sum_probs=200.6
Q ss_pred hhHHhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC-----chhHHHHHHHHHHHhhCCCCceeeecceee
Q 006317 317 STIRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-----VQGELEFKNEVLLVARLQHRNLVRLLGFSF 390 (650)
Q Consensus 317 ~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 390 (650)
..+....++|+..+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 345567789999999999999999999864 57889999986542 234457899999999999999999999999
Q ss_pred cCCeeEEEEecCCCCChhHHHHhhhc-------------------------------------cCCCCHHHHHHHHHHHH
Q 006317 391 EETERLLIYEFVPNSSVDKFIFDAIK-------------------------------------RVQLDWETRYKIIGGIA 433 (650)
Q Consensus 391 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~ia 433 (650)
+.+..++||||+++|+|.+++..... ...+++..++.++.||+
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 99999999999999999998842100 11246778889999999
Q ss_pred HHHHHhhhcCCCcEEecCCCCCceEeCCCC--CeEEeeeecccccccCCCCC--ccceeecCccccChhcccc--CCCCc
Q 006317 434 RGILYLHEDSRLRIIHRDLKASNILLDADM--IPKISDFGMARLFEMDQSQG--DTSRIVGTFGYMAPEYVTR--GHFSI 507 (650)
Q Consensus 434 ~~L~yLH~~~~~~iiHrDlk~~NILl~~~~--~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~s~ 507 (650)
.||+|||+.+ |+||||||+||||+.++ .+||+|||+++.+....... ......||+.|+|||++.+ ..++.
T Consensus 179 ~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 179 SALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 9999999987 99999999999998777 89999999998664322211 2345679999999999875 67899
Q ss_pred cccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCC
Q 006317 508 KSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRP 587 (650)
Q Consensus 508 ~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RP 587 (650)
++||||||+++|||++|+.||..... .+....... ..... ..+.. .... ..+.+++.+||+.||++||
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~---~~~~~--~~~~~-~~~~---~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVND---ADTISQVLN---KKLCF--ENPNY-NVLS---PLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHH---CCCCT--TSGGG-GGSC---HHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCh---HHHHHHHHh---ccccc--CCccc-ccCC---HHHHHHHHHHcCCChhHCC
Confidence 99999999999999999999863321 111111111 11000 00000 0112 3455677899999999999
Q ss_pred CHHHHHHH
Q 006317 588 TMASVVVM 595 (650)
Q Consensus 588 t~~evl~~ 595 (650)
++.|+++-
T Consensus 324 s~~~~l~h 331 (345)
T 3hko_A 324 DAMRALQH 331 (345)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=336.59 Aligned_cols=256 Identities=26% Similarity=0.353 Sum_probs=200.5
Q ss_pred CCCcCCcccccCceeEEEeeccC----CcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCee-EEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETER-LLI 398 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lv 398 (650)
.|...++||+|+||.||+|+..+ +..||+|++..... .....+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999998533 23699999876433 3445789999999999999999999999876655 999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+.+|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999974 3467899999999999999999999987 99999999999999999999999999986543
Q ss_pred CC--CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 479 DQ--SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 479 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
.. .........+|..|+|||.+.+..++.++||||||+++|||++|+.|+.... ...+..........
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~--~~~~~~~~~~~~~~-------- 246 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI--DPFDLTHFLAQGRR-------- 246 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--CGGGHHHHHHTTCC--------
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC--CHHHHHHHhhcCCC--------
Confidence 22 1122334567889999999999999999999999999999999776653221 12222222211110
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
.......++ .+.+++.+||+.||++|||+.+++++|+..
T Consensus 247 -~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 247 -LPQPEYCPD---SLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp -CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCccchH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111223 455677799999999999999999998763
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=358.25 Aligned_cols=249 Identities=20% Similarity=0.225 Sum_probs=193.3
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
.++|+..++||+|+||.||+++.. +|+.||||++.... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467899999999999999999854 58899999997542 22334578899999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999863 4579999999999999999999998 66 9999999999999999999999999997543
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..+....... .
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~i~~~---~------- 365 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILME---E------- 365 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHC---C-------
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHHHHhC---C-------
Confidence 221 223446799999999999999999999999999999999999999863321 2222221111 0
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCC-----CHHHHHHH
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRP-----TMASVVVM 595 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~~ 595 (650)
..+...... .+.+++..||+.||++|| ++.|+++.
T Consensus 366 ~~~p~~~~~---~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 366 IRFPRTLGP---EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CCCCTTSCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCccCCH---HHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 111112223 345677799999999999 99999854
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=345.15 Aligned_cols=267 Identities=24% Similarity=0.330 Sum_probs=192.7
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHH--HHhhCCCCceeeecceeec-----CCee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVL--LVARLQHRNLVRLLGFSFE-----ETER 395 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~--~l~~l~H~niv~l~g~~~~-----~~~~ 395 (650)
-++|+..++||+|+||.||+|+. +++.||||++..... ..+..|.+ .+..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 36788999999999999999987 689999999965432 23344444 4556899999999985532 2356
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcC------CCcEEecCCCCCceEeCCCCCeEEee
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS------RLRIIHRDLKASNILLDADMIPKISD 469 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~iiHrDlk~~NILl~~~~~~kl~D 469 (650)
++||||+++|+|.+++.. ..+++..++.++.||+.||+|||+.. .++|+||||||+||||+.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 899999999999999853 34589999999999999999999881 11399999999999999999999999
Q ss_pred eecccccccCCC------CCccceeecCccccChhcccc-------CCCCccccccchhHHHHHHHhCCCCCCCCCCccc
Q 006317 470 FGMARLFEMDQS------QGDTSRIVGTFGYMAPEYVTR-------GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEA 536 (650)
Q Consensus 470 FGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~ 536 (650)
||+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.|+........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999987653221 112223469999999999976 3566789999999999999999877643222111
Q ss_pred -chhHHH----------HHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 537 -EDLLTY----------AWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 537 -~~l~~~----------~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
...... .............+.... .........+.+++.+||+.||++|||+.||++.|+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW-KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC-CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCccc-ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 111100 000000011011111111 1122344567788999999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.16 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=196.7
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
+.|...+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999985 5688999999975432 23346889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+. |+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 206 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC-
Confidence 9997 688887754 3467999999999999999999999987 99999999999999999999999999976542
Q ss_pred CCCCccceeecCccccChhccc---cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
.....||+.|+|||++. .+.++.++||||||+++|||++|+.|+..... ...+..... ..
T Consensus 207 -----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---~~~~~~~~~---~~------ 269 (348)
T 1u5q_A 207 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQ---NE------ 269 (348)
T ss_dssp -----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHH---SC------
T ss_pred -----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHh---cC------
Confidence 22357899999999985 56789999999999999999999999853221 111111111 11
Q ss_pred CccCC-CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 557 DPTLR-NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 557 d~~l~-~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+.+. ...+++ +.+++.+||+.||++|||+.++++.
T Consensus 270 ~~~~~~~~~~~~---l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 270 SPALQSGHWSEY---FRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCCCCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCCCCCCHH---HHHHHHHHcccChhhCcCHHHHhhC
Confidence 11111 122333 4467779999999999999999854
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=355.12 Aligned_cols=246 Identities=23% Similarity=0.383 Sum_probs=201.6
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57889999999999999999865 689999999975432 23456889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999986 4567999999999999999999999987 999999999999999999999999999876432
Q ss_pred CCCCccceeecCccccChhccccCCC-CccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ...+...... +. .
T Consensus 170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~----~~------~ 233 (476)
T 2y94_A 170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH---VPTLFKKICD----GI------F 233 (476)
T ss_dssp C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS---SHHHHHHHHT----TC------C
T ss_pred c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC---HHHHHHHHhc----CC------c
Confidence 2 2334579999999999988765 689999999999999999999986322 1222221111 10 0
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
........ .+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~p~~~s~---~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 YTPQYLNP---SVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CCCTTCCH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCccCCH---HHHHHHHHHcCCCchhCcCHHHHHh
Confidence 01111223 3556777999999999999999996
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.87 Aligned_cols=262 Identities=25% Similarity=0.341 Sum_probs=195.7
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCc-----hhHHHHHHHHHHHhhC---CCCceeeecceeecC
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV-----QGELEFKNEVLLVARL---QHRNLVRLLGFSFEE 392 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~ 392 (650)
.+++|+..++||+|+||.||+++. .+++.||||++..... .....+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999985 4688999999864321 1123566777777766 499999999999875
Q ss_pred C-----eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEE
Q 006317 393 T-----ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467 (650)
Q Consensus 393 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl 467 (650)
. ..++||||+. ++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999997 5999998743 2334999999999999999999999998 999999999999999999999
Q ss_pred eeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhc
Q 006317 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNW 547 (650)
Q Consensus 468 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 547 (650)
+|||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+.........
T Consensus 162 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~ 235 (308)
T 3g33_A 162 ADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGKIFDLI 235 (308)
T ss_dssp CSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH---HHHHHHHHHHH
T ss_pred eeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHh
Confidence 999999865422 223446789999999999999999999999999999999999999864322 22222221111
Q ss_pred c---CCCccc-------ccCccCCCC----ChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 548 N---EGTALN-------LIDPTLRNG----SSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 548 ~---~~~~~~-------~id~~l~~~----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
. ...+.. .+.+..... .+.....+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1 000000 000000000 0011234567888999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=330.65 Aligned_cols=248 Identities=26% Similarity=0.393 Sum_probs=198.6
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
+.++|++.+.||+|+||.||+++.. +++.||||++..... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467899999999999999999865 467899999865422 234568899999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999999874 356999999999999999999999987 9999999999999999999999999986443
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
.. ......||..|+|||.+.+..++.++||||||+++|||++|+.|+..... .......... .
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~----------~ 223 (279)
T 3fdn_A 161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QETYKRISRV----------E 223 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHT----------C
T ss_pred cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH---HHHHHHHHhC----------C
Confidence 22 22345789999999999999999999999999999999999999863221 1111111110 1
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..+....++ .+.+++..||+.||++|||+.|+++.
T Consensus 224 ~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 FTFPDFVTE---GARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCCTTSCH---HHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCCcCCH---HHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111122233 34567779999999999999999964
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=340.87 Aligned_cols=262 Identities=24% Similarity=0.301 Sum_probs=196.1
Q ss_pred ccCCCcC-CcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEEE
Q 006317 323 TNNFSTD-NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 323 ~~~f~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 399 (650)
.+.|.+. ++||+|+||.||+++.. +++.||||++..........+.+|+.++.++ +||||+++++++.+++..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 78999999999999854 6889999999876655566889999999985 7999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC---eEEeeeeccccc
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI---PKISDFGMARLF 476 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFGla~~~ 476 (650)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999974 457999999999999999999999987 999999999999998876 999999999765
Q ss_pred ccCCC-----CCccceeecCccccChhcccc-----CCCCccccccchhHHHHHHHhCCCCCCCCCCcccch--------
Q 006317 477 EMDQS-----QGDTSRIVGTFGYMAPEYVTR-----GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAED-------- 538 (650)
Q Consensus 477 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~-------- 538 (650)
..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 112223569999999999875 567899999999999999999999987543221000
Q ss_pred hHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 539 LLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 539 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.............. ..... .....+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~i~~~~~-~~~~~-~~~~~~---~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKY-EFPDK-DWAHIS---CAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCC-CCCHH-HHTTSC---HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCc-ccCch-hcccCC---HHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000111100000 00000 000111 345678889999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=342.81 Aligned_cols=249 Identities=24% Similarity=0.260 Sum_probs=200.9
Q ss_pred ccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccC---chhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNS---VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 397 (650)
.++|+..+.||+|+||.||+++... ++.||||++++.. ......+.+|..++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4679999999999999999998754 7889999997642 22345678899999888 89999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999874 356999999999999999999999987 9999999999999999999999999997533
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+....... .
T Consensus 173 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i~~~----~------ 237 (353)
T 2i0e_A 173 WD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIMEH----N------ 237 (353)
T ss_dssp CT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHC----C------
T ss_pred cC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC---HHHHHHHHHhC----C------
Confidence 21 223445689999999999999999999999999999999999999986322 22222222111 0
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCC-----HHHHHHH
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPT-----MASVVVM 595 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~evl~~ 595 (650)
..+...... .+.+++.+||+.||++||+ +.+|++.
T Consensus 238 ~~~p~~~s~---~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 238 VAYPKSMSK---EAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CCCCTTSCH---HHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCCCCCCCH---HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111122233 3456777999999999995 5777643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.44 Aligned_cols=243 Identities=24% Similarity=0.305 Sum_probs=199.3
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCch--------hHHHHHHHHHHHhhCCCCceeeecceeecC
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ--------GELEFKNEVLLVARLQHRNLVRLLGFSFEE 392 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 392 (650)
..++|+..+.||+|+||.||+++. .+++.||||++...... ....+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999985 46889999999765321 222467899999999999999999999999
Q ss_pred CeeEEEEecCCCC-ChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeee
Q 006317 393 TERLLIYEFVPNS-SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471 (650)
Q Consensus 393 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 471 (650)
+..++||||+.+| +|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999877 9999886 4457999999999999999999999987 9999999999999999999999999
Q ss_pred cccccccCCCCCccceeecCccccChhccccCCC-CccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG 550 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 550 (650)
+++..... .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... .
T Consensus 176 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~---- 236 (335)
T 3dls_A 176 SAAYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------T---- 236 (335)
T ss_dssp TCEECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------G----
T ss_pred cceECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------H----
Confidence 99876432 22344679999999999988876 8899999999999999999999852110 0
Q ss_pred CcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 551 TALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 551 ~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
....+.+ ....+. .+.+++..||+.||++|||+.|+++.
T Consensus 237 -~~~~~~~--~~~~~~---~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -VEAAIHP--PYLVSK---ELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -TTTCCCC--SSCCCH---HHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -HhhccCC--CcccCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 111233 35567779999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.24 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=198.9
Q ss_pred hccCCCcCCcccccCceeEEEeeccC----CcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceee-cCCee
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSF-EETER 395 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~ 395 (650)
...+|+..++||+|+||.||+|+..+ ...+|+|.+..... .....+.+|+.++++++||||+++++++. .++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 34568888999999999999998643 22589999876433 34457899999999999999999999865 45678
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 103 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999999974 3456899999999999999999999987 99999999999999999999999999986
Q ss_pred cccCCC--CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcc
Q 006317 476 FEMDQS--QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553 (650)
Q Consensus 476 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 553 (650)
...... ........||+.|+|||.+.+..++.++||||||+++|||++|..|+.... ...+.........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~~~~~~------ 249 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQGR------ 249 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS--CTTTHHHHHHTTC------
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC--CHHHHHHHHhcCC------
Confidence 543221 122334567889999999999999999999999999999999655433211 1112221111110
Q ss_pred cccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 554 NLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 554 ~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
........+. .+.+++.+||+.||++|||+.|++++|+..
T Consensus 250 ---~~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 250 ---RLLQPEYCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp ---CCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111111233 355677799999999999999999999763
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=331.94 Aligned_cols=261 Identities=17% Similarity=0.258 Sum_probs=200.8
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeeccee-ecCCeeEEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS-FEETERLLIY 399 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv~ 399 (650)
..++|+..+.||+|+||.||+++. .+++.||||++...... ..+.+|+.++..++|++++..++.+ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999985 56889999987554322 2478899999999998888777766 5667789999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe---CCCCCeEEeeeeccccc
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLF 476 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~~~ 476 (650)
||+ +++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||| ++++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999999874 3456999999999999999999999997 9999999999999 78999999999999876
Q ss_pred ccCCCC-----CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCC
Q 006317 477 EMDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGT 551 (650)
Q Consensus 477 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 551 (650)
...... .......||..|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543321 123356799999999999999999999999999999999999999975443333232222111100000
Q ss_pred cccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 552 ALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 552 ~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.. .+....+ ..+.+++..||+.||++|||+.+|++.|+.
T Consensus 239 -~~----~~~~~~~---~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 239 -IE----VLCKGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp -HH----HHTTTSC---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred -hh----hhhccCC---HHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 00 0011122 245567779999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=341.36 Aligned_cols=259 Identities=29% Similarity=0.469 Sum_probs=201.5
Q ss_pred hccCCCcCCcccccCceeEEEeecc------CCcceeEeecccc-CchhHHHHHHHHHHHhhCCCCceeeecceeecCCe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE 394 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 394 (650)
..++|...+.||+|+||.||+|++. +++.||||++... .......+.+|+.++++++||||+++++++.....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 3478999999999999999999842 4678999999754 33445578999999999999999999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC---CCCeEE
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIK----RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPKI 467 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl 467 (650)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999976321 145899999999999999999999987 999999999999994 446999
Q ss_pred eeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHh
Q 006317 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKN 546 (650)
Q Consensus 468 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 546 (650)
+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+| |+.|+.... ...........
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~~~~~~~ 261 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEFVTSG 261 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHHHTT
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC---HHHHHHHHhcC
Confidence 99999986554333333344567899999999999999999999999999999999 888875322 11222221111
Q ss_pred ccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 547 WNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 547 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.. +......+. .+.+++.+||+.||++||++.+|++.|..
T Consensus 262 ----~~-----~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 262 ----GR-----MDPPKNCPG---PVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp ----CC-----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CC-----CCCCCCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 00 111112233 45567779999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=371.08 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=196.9
Q ss_pred CCCcCC-cccccCceeEEEeecc---CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 325 NFSTDN-KLGQGGFGAVYKGRLS---HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 325 ~f~~~~-~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++...+ +||+|+||.||+|.+. ++..||||+++.... ....++.+|+.+|++++|||||++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 333344 7999999999999764 456799999976533 345679999999999999999999999876 5689999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.....
T Consensus 415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999964 3456999999999999999999999987 999999999999999999999999999876433
Q ss_pred CCC-CccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 480 QSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 480 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
... .......+|..|+|||++.+..++.++|||||||++|||+| |+.||...... +....... +...
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i~~----~~~~---- 558 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQ----GKRM---- 558 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHHHT----TCCC----
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHc----CCCC----
Confidence 221 11222345789999999999999999999999999999998 99998643322 22222211 1111
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
......+. .+.+|+..||+.||++||++.+|++.|+.
T Consensus 559 -~~p~~~~~---~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 559 -ECPPECPP---ELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp -CCCTTCCH---HHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCCCcCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11122333 45567779999999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=333.50 Aligned_cols=258 Identities=19% Similarity=0.264 Sum_probs=195.8
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch---hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
-++|+..+.||+|+||.||+++.. +++.||||++...... ....+.+|+.++.+++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 367999999999999999999864 5889999999765332 235688999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999974 357999999999999999999999987 99999999999999999999999999976543
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
... .......||..|+|||.+.+..++.++||||||+++|||++|+.||..... ........ .......
T Consensus 187 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~--~~~~~~~---- 255 (309)
T 2h34_A 187 EKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL----SVMGAHIN--QAIPRPS---- 255 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH----HHHHHHHH--SCCCCGG----
T ss_pred ccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH----HHHHHHhc--cCCCCcc----
Confidence 221 223345789999999999999999999999999999999999999863211 11111111 0000001
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCC-CHHHHHHHhcCCC
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRP-TMASVVVMLNSSS 600 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RP-t~~evl~~L~~~~ 600 (650)
......+. .+.+++.+||+.||++|| +++++++.|+...
T Consensus 256 ~~~~~~~~---~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 256 TVRPGIPV---AFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp GTSTTCCT---HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred ccCCCCCH---HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 11122233 344677799999999999 9999999998643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=331.02 Aligned_cols=262 Identities=18% Similarity=0.258 Sum_probs=204.8
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeeccee-ecCCeeEEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS-FEETERLLIY 399 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv~ 399 (650)
..++|+..+.||+|+||.||+|+. .+++.||||++...... ..+.+|+.++..++|++++..+.++ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999985 56899999998665432 3588999999999998877777665 5567789999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe---CCCCCeEEeeeeccccc
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLF 476 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~~~ 476 (650)
||+ +++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 9999999864 3457999999999999999999999987 9999999999999 48899999999999876
Q ss_pred ccCCCCC-----ccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCC
Q 006317 477 EMDQSQG-----DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGT 551 (650)
Q Consensus 477 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 551 (650)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 5433211 23456799999999999999999999999999999999999999975433332222222211100000
Q ss_pred cccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 552 ALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 552 ~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
. +.+....+. .+.+++.+||+.||++|||+.+|++.|+..
T Consensus 239 -~----~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 239 -I----EVLCKGYPS---EFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp -H----HHHTTTSCH---HHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred -h----HHHHhhCCH---HHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 0 001111223 355677799999999999999999999753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=334.81 Aligned_cols=255 Identities=26% Similarity=0.426 Sum_probs=202.5
Q ss_pred cCCCcCC-cccccCceeEEEeecc---CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 324 NNFSTDN-KLGQGGFGAVYKGRLS---HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 324 ~~f~~~~-~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
++|.+.+ .||+|+||.||+|... ++..||||++..... .....+.+|+.++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555665 9999999999999753 477899999987533 3455789999999999999999999999 55678999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999864 3456999999999999999999999987 99999999999999999999999999987643
Q ss_pred CCCC-CccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 479 DQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 479 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
.... .......||+.|+|||++.+..++.++||||||+++|||++ |+.|+...... +....... ..
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~i~~----~~----- 230 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQ----GK----- 230 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHHT----TC-----
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHhc----CC-----
Confidence 3221 12223456889999999998899999999999999999999 99998643221 22221111 11
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
.+......+. .+.+++..||+.||++||++.+|++.|+..
T Consensus 231 ~~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 231 RMECPPECPP---ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp CCCCCTTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCcCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111122333 455677799999999999999999998754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=332.76 Aligned_cols=259 Identities=22% Similarity=0.365 Sum_probs=195.0
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|++.+.||+|+||.||++.. .+|+.||||++.... ......+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5788999999999999999985 468899999987532 334457889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 400 EFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+||||+.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999999997533 3456999999999999999999999987 99999999999999999999999999986543
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
.. .......|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...+..... .... .+
T Consensus 189 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~----~~~~----~~ 257 (310)
T 2wqm_A 189 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIE----QCDY----PP 257 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHHHHH----TTCS----CC
T ss_pred CC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHHHhh----cccC----CC
Confidence 22 1223456899999999999999999999999999999999999998532211 111111111 1110 01
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
......+. .+.+++.+||+.||++|||+.+|++.|+..
T Consensus 258 ~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 258 LPSDHYSE---ELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp CCTTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccccCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11112233 345677799999999999999999999764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.81 Aligned_cols=263 Identities=25% Similarity=0.425 Sum_probs=203.7
Q ss_pred ccCCCcCCcccccCceeEEEeec-----cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCC--ee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-----SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET--ER 395 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~ 395 (650)
.++|+..++||+|+||.||++++ .+++.||||++..........+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688899999999999999983 358899999998776666678999999999999999999999887654 78
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++||||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 999999999999999975 3356999999999999999999999987 99999999999999999999999999987
Q ss_pred cccCCCCC-ccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCc---------ccchhHHHHHH
Q 006317 476 FEMDQSQG-DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGE---------EAEDLLTYAWK 545 (650)
Q Consensus 476 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~---------~~~~l~~~~~~ 545 (650)
........ ......++..|+|||.+.+..++.++||||||+++|||+||+.|+.....+ ...........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 65432211 122345677899999999988999999999999999999999886522100 00000000001
Q ss_pred hccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 546 NWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 546 ~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
...... ........+. .+.+++.+||+.||++|||+.||++.|+.
T Consensus 275 ~~~~~~-----~~~~~~~~~~---~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 275 LLKNNG-----RLPRPDGCPD---EIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHHTTC-----CCCCCTTCCH---HHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HhhcCC-----CCCCCCcccH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 110000 0111122233 45567779999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=329.15 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=198.7
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch------hHHHHHHHHHHHhhCCCCceeeecceeecCCeeE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ------GELEFKNEVLLVARLQHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 396 (650)
++|+..+.||+|+||.||+++.. +++.||||++...... ....+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888999999999999999875 5889999998764322 3567899999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC----CeEEeeeec
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM----IPKISDFGM 472 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFGl 472 (650)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999963 457999999999999999999999987 99999999999999887 899999999
Q ss_pred ccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCc
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA 552 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 552 (650)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+..... .+........ .. .
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~-~~-~- 229 (283)
T 3bhy_A 159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---QETLTNISAV-NY-D- 229 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTT-CC-C-
T ss_pred ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---HHHHHHhHhc-cc-C-
Confidence 98654322 22345689999999999999999999999999999999999999863221 1111111100 00 0
Q ss_pred ccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 553 LNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 553 ~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
..+......+ ..+.+++.+||+.||++|||+.|+++
T Consensus 230 ---~~~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 230 ---FDEEYFSNTS---ELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp ---CCHHHHTTCC---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CcchhcccCC---HHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0000001112 34557788999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=329.69 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=198.4
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
+.|.....||+|+||.||+|+. .+++.||||++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455567999999999999985 457899999998766555667999999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC-CCCeEEeeeecccccccCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFGla~~~~~~~~ 481 (650)
++++|.+++........+++..++.++.||+.||+|||+.+ ++||||||+|||++. ++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 99999999976444456789999999999999999999987 999999999999987 8999999999998654321
Q ss_pred CCccceeecCccccChhccccCC--CCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGH--FSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
.......||..|+|||++.+.. ++.++||||||+++|||++|+.|+....... ..... .... ...+.
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~--~~~~-------~~~~~ 246 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-AAMFK--VGMF-------KVHPE 246 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-HHHHH--HHHH-------CCCCC
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-HHHHh--hccc-------ccccc
Confidence 1223457899999999997653 8899999999999999999999985322111 01111 0000 01122
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+....+. .+.+++.+||+.||++||++.|+++.
T Consensus 247 ~~~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 247 IPESMSA---EAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCTTSCH---HHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccccCCH---HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2222333 34567779999999999999999853
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=331.88 Aligned_cols=247 Identities=24% Similarity=0.321 Sum_probs=196.8
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 397 (650)
..++|+..+.||+|+||.||+++.. +++.||||++.... .....++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467899999999999999999875 68999999987642 33455788999999999 99999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC--------------
Q 006317 398 IYEFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-------------- 462 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~-------------- 462 (650)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999976432 366999999999999999999999987 9999999999999844
Q ss_pred -----CCeEEeeeecccccccCCCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCccc
Q 006317 463 -----MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEA 536 (650)
Q Consensus 463 -----~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~ 536 (650)
..+||+|||++....... ...||..|+|||.+.+. .++.++||||||+++|||++|..++...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----- 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----- 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----
Confidence 479999999998654322 23589999999999876 5678999999999999999998765311
Q ss_pred chhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 537 EDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 537 ~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+.. .....+.. +.+....+.+ +.+++.+||+.||++|||+.|+++.
T Consensus 235 -~~~----~~~~~~~~-----~~~~~~~~~~---~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 235 -DQW----HEIRQGRL-----PRIPQVLSQE---FTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -HHH----HHHHTTCC-----CCCSSCCCHH---HHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -hHH----HHHHcCCC-----CCCCcccCHH---HHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111 11111111 1222223333 4567779999999999999999753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=339.34 Aligned_cols=265 Identities=23% Similarity=0.293 Sum_probs=196.1
Q ss_pred hhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchh-----HHHHHHHHHHHhhCCCCceeeecceeecCCe
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQG-----ELEFKNEVLLVARLQHRNLVRLLGFSFEETE 394 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-----~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 394 (650)
...++|...+.||+|+||.||+++.. +|+.||||++....... ...+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999875 48899999997543221 2357899999999999999999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.++||||+++ +|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 88888764 3456899999999999999999999988 9999999999999999999999999998
Q ss_pred ccccCCCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC---
Q 006317 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG--- 550 (650)
Q Consensus 475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--- 550 (650)
.+.... .......||+.|+|||++.+. .++.++||||||+++|||++|..|+.... ..+.+..........
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~---~~~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS---DLDQLTRIFETLGTPTEE 235 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCTT
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHHHcCCCChh
Confidence 664322 223345789999999998764 58999999999999999999998875332 222222222211111
Q ss_pred Cccc---ccCc----cCCCCC-----hHHHHHHHHHHhcccccCCCCCCCHHHHHHHh
Q 006317 551 TALN---LIDP----TLRNGS-----SSEIMRCVHIGLLCVQENVANRPTMASVVVML 596 (650)
Q Consensus 551 ~~~~---~id~----~l~~~~-----~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L 596 (650)
.+.+ ..+. ...... ......+.+++.+||+.||++|||+.|+++.-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 0000 0000 000001 11114566788899999999999999999764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=334.57 Aligned_cols=254 Identities=29% Similarity=0.437 Sum_probs=198.6
Q ss_pred ccCCCcCC-cccccCceeEEEeec---cCCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeE
Q 006317 323 TNNFSTDN-KLGQGGFGAVYKGRL---SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 323 ~~~f~~~~-~LG~G~~g~Vy~~~~---~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 396 (650)
.++|.+.+ .||+|+||.||+|.+ ..++.||||++..... .....+.+|+.++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 999999999999954 2367899999976532 2345789999999999999999999998 567789
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
+||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999974 456999999999999999999999987 999999999999999999999999999876
Q ss_pred ccCCCC-CccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 477 EMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 477 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
...... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ......... ...
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~----~~~-- 238 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEK----GER-- 238 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHT----TCC--
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHc----CCC--
Confidence 433221 11222346788999999998889999999999999999999 9998864322 112211111 110
Q ss_pred ccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 555 LIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 555 ~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+......+. .+.+++..||+.||++||++.+|++.|+.
T Consensus 239 ---~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 239 ---MGCPAGCPR---EMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp ---CCCCTTCCH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---CCCCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111122233 35567779999999999999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=345.13 Aligned_cols=251 Identities=21% Similarity=0.244 Sum_probs=187.6
Q ss_pred cCCCcC-CcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHh-hCCCCceeeecceeec----CCeeE
Q 006317 324 NNFSTD-NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVA-RLQHRNLVRLLGFSFE----ETERL 396 (650)
Q Consensus 324 ~~f~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~----~~~~~ 396 (650)
++|... ++||+|+||.||+++.. +++.||||++... ..+.+|+.++. ..+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456555 68999999999999865 5889999998642 35677888874 4589999999998865 56789
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC---CCCeEEeeeecc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMA 473 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGla 473 (650)
|||||+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999999742 2346999999999999999999999987 999999999999998 789999999999
Q ss_pred cccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccc-hhHHHHHHhccCCCc
Q 006317 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAE-DLLTYAWKNWNEGTA 552 (650)
Q Consensus 474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~ 552 (650)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......... ..
T Consensus 212 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~----~~ 284 (400)
T 1nxk_A 212 KETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG----QY 284 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT----CC
T ss_pred cccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC----cc
Confidence 865422 2234567899999999999999999999999999999999999998654332211 111111110 00
Q ss_pred ccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 553 LNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 553 ~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
....+. ..... ..+.+++..||+.||++|||+.||++.
T Consensus 285 -~~~~~~-~~~~s---~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 -EFPNPE-WSEVS---EEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -CCCTTT-TTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -cCCCcc-cccCC---HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000000 01122 345567789999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=340.31 Aligned_cols=263 Identities=22% Similarity=0.318 Sum_probs=191.8
Q ss_pred HhhccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeecCCeeE
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 396 (650)
....++|+..++||+|+||.||+++. .+++.||||++...... ....+.+|+.++++++||||+++++++.+++..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 34557899999999999999999985 46889999999765332 2345779999999999999999999999999999
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe-----CCCCCeEEeeee
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL-----DADMIPKISDFG 471 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl-----~~~~~~kl~DFG 471 (650)
+||||+++ +|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||| ++++.+||+|||
T Consensus 110 lv~e~~~~-~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCSE-EHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCCC-CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99999985 99998863 456999999999999999999999987 9999999999999 455569999999
Q ss_pred cccccccCCCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhcc--
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWN-- 548 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~-- 548 (650)
+++...... .......||..|+|||++.+. .++.++|||||||++|||++|+.||...... +.+........
T Consensus 183 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 183 LARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---DQLFKIFEVLGLP 257 (329)
T ss_dssp HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCC
T ss_pred CccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH---HHHHHHHHHhCCC
Confidence 998764322 223345789999999999874 5899999999999999999999998643221 11111111110
Q ss_pred CCCcc-c--------ccCccCCCCChH------HHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 549 EGTAL-N--------LIDPTLRNGSSS------EIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 549 ~~~~~-~--------~id~~l~~~~~~------~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
..... . ...+........ ....+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 0 000001111111 1134567888999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=338.17 Aligned_cols=261 Identities=22% Similarity=0.342 Sum_probs=193.0
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchh-HHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQG-ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
++|...++||+|+||.||+++.. +++.||||++....... ...+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999865 68899999986543221 11355799999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
++ |+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 97 588888875 3456999999999999999999999987 9999999999999999999999999997554221
Q ss_pred CCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC---CcccccC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG---TALNLID 557 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~id 557 (650)
.......||..|+|||++.+ ..++.++||||||+++|||++|+.||..... .+.+.......... .+.....
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV---EEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChHhchhhhc
Confidence 22334578999999999876 5689999999999999999999999864332 22222222211110 0100000
Q ss_pred ---------ccCCCC-----ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 558 ---------PTLRNG-----SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 558 ---------~~l~~~-----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+..... .......+.+++.+||+.||++|||+.|+++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 00111345678889999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=333.57 Aligned_cols=264 Identities=24% Similarity=0.367 Sum_probs=186.0
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
..++|...+.||+|+||.||+++.. +++.||||++.... .....++.+|+.++.+++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 4578999999999999999999864 58899999987543 233456889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhh-----ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 400 EFVPNSSVDKFIFDAI-----KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 9999999999987522 2345999999999999999999999987 9999999999999999999999999998
Q ss_pred ccccCCC---CCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC
Q 006317 475 LFEMDQS---QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG 550 (650)
Q Consensus 475 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 550 (650)
....... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.|+...... .............
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~ 246 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM---KVLMLTLQNDPPS 246 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHHHHHTSSCCC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh---hHHHHHhccCCCc
Confidence 6543221 112234578999999999876 56899999999999999999999998643221 1111111111111
Q ss_pred CcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 551 TALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 551 ~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
......++.+....+. .+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 247 LETGVQDKEMLKKYGK---SFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTC-----CCCCCCCH---HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cccccccchhhhhhhH---HHHHHHHHHccCChhhCcCHHHHhh
Confidence 1111112222222333 3456777999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=337.06 Aligned_cols=266 Identities=24% Similarity=0.335 Sum_probs=204.2
Q ss_pred hhhHHhhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhh--CCCCceeeecceeecCC
Q 006317 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR--LQHRNLVRLLGFSFEET 393 (650)
Q Consensus 316 ~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~ 393 (650)
...-....++|...+.||+|+||.||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 333445567899999999999999999998 5899999999653 33467788888877 79999999999998876
Q ss_pred ----eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCcEEecCCCCCceEeCC
Q 006317 394 ----ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH--------EDSRLRIIHRDLKASNILLDA 461 (650)
Q Consensus 394 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiHrDlk~~NILl~~ 461 (650)
..++||||+++|+|.+++.. ..+++..++.++.||+.||+||| +.+ |+||||||+||||+.
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK 182 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred CccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence 78999999999999999863 46899999999999999999999 555 999999999999999
Q ss_pred CCCeEEeeeecccccccCCCCC--ccceeecCccccChhccccCC------CCccccccchhHHHHHHHhC---------
Q 006317 462 DMIPKISDFGMARLFEMDQSQG--DTSRIVGTFGYMAPEYVTRGH------FSIKSDVFSFGVLVLEIISG--------- 524 (650)
Q Consensus 462 ~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~s~~sDV~S~Gvll~elltG--------- 524 (650)
++.+||+|||+++......... ......||+.|+|||++.+.. ++.++||||||+++|||+||
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 9999999999998765432211 223457899999999987752 34789999999999999999
Q ss_pred -CCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCC--ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 525 -QKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNG--SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 525 -~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~--~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+.|+........ .. .......... ...+.+... ..+....+.+++.+||+.||++|||+.||++.|+.
T Consensus 263 ~~~p~~~~~~~~~-~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 263 YQLPYYDLVPSDP-SV-EEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCCTTTTTSCSSC-CH-HHHHHHHTTS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccCccccCcCcc-cH-HHHHHHHHHH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 556543221111 11 1111111111 111222111 22445567789999999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=338.95 Aligned_cols=261 Identities=22% Similarity=0.291 Sum_probs=202.1
Q ss_pred hhhHHhhccCCCcC-CcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCC-CCceeeecceee
Q 006317 316 FSTIRDATNNFSTD-NKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQ-HRNLVRLLGFSF 390 (650)
Q Consensus 316 ~~~~~~~~~~f~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~ 390 (650)
+.......+.|... ++||+|+||.||+++.. +++.||||++.... ......+.+|+.++.+++ ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 44455566777777 88999999999999865 58899999987643 233567899999999994 699999999999
Q ss_pred cCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC---CCCeEE
Q 006317 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPKI 467 (650)
Q Consensus 391 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl 467 (650)
+.+..++||||+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+. ++.+||
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999999999988532 2457999999999999999999999987 999999999999998 789999
Q ss_pred eeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhc
Q 006317 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNW 547 (650)
Q Consensus 468 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 547 (650)
+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...........
T Consensus 176 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~ 249 (327)
T 3lm5_A 176 VDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---QETYLNISQVN 249 (327)
T ss_dssp CCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTC
T ss_pred eeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHhcc
Confidence 9999998664322 22345799999999999999999999999999999999999999864321 11111111110
Q ss_pred cCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 548 NEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 548 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.. .......... ..+.+++.+||+.||++|||+.|+++.
T Consensus 250 -~~-----~~~~~~~~~~---~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 250 -VD-----YSEETFSSVS---QLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -CC-----CCTTTTTTSC---HHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -cc-----cCchhhcccC---HHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00 0000111122 335567779999999999999999865
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=352.01 Aligned_cols=259 Identities=23% Similarity=0.264 Sum_probs=193.3
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeecccc--CchhHHHHHHHHHHHhhCCCCceeeecceeecC------
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------ 392 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 392 (650)
..++|+..++||+|+||.||+++.. +++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999854 5889999999764 233445688999999999999999999998654
Q ss_pred CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeec
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 472 (650)
...++||||++++ |.+.+. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 4569999999875 555543 34899999999999999999999997 99999999999999999999999999
Q ss_pred ccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC--
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG-- 550 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-- 550 (650)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+..........
T Consensus 211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~---~~~~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 211 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPCP 284 (464)
T ss_dssp C-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSCCH
T ss_pred eeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCH
Confidence 9865432 223456899999999999999999999999999999999999999864321 11111111110000
Q ss_pred -----------------------CcccccCccCCCC-C---hHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 551 -----------------------TALNLIDPTLRNG-S---SSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 551 -----------------------~~~~~id~~l~~~-~---~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.....+...+... . ......+.+++.+||+.||++|||+.|+++-
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000011111011 0 1113456788899999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=340.13 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=198.8
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 399 (650)
..++|+..+.||+|+||.||+++.. +|+.||||++.+.... ..+|++++.++ +||||+++++++.++...++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999999999999865 5889999999765432 34688888887 7999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC----CCeEEeeeecccc
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD----MIPKISDFGMARL 475 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~----~~~kl~DFGla~~ 475 (650)
||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999986 3457999999999999999999999987 9999999999998543 3599999999986
Q ss_pred cccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+....... .. .
T Consensus 170 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~----~~-~- 241 (342)
T 2qr7_A 170 LRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG----KF-S- 241 (342)
T ss_dssp CBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC----CC-C-
T ss_pred CcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC----Cc-c-
Confidence 54332 2233457899999999998888899999999999999999999998754333333333222211 10 0
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
+.........+ .+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~s~---~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 LSGGYWNSVSD---TAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCSTTTTTSCH---HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCccccccCCH---HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00111111233 3456777999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=341.07 Aligned_cols=255 Identities=24% Similarity=0.330 Sum_probs=201.1
Q ss_pred ccCCCcCCcccccCceeEEEeec----cCCcceeEeeccccCc----hhHHHHHHHHHHHhhC-CCCceeeecceeecCC
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSV----QGELEFKNEVLLVARL-QHRNLVRLLGFSFEET 393 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 393 (650)
.++|+..++||+|+||.||+++. .+++.||||+++.... .....+.+|+.++.++ +||||+++++++..+.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36789999999999999999986 3688999999875421 2334567899999999 6999999999999999
Q ss_pred eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecc
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 473 (650)
..++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999974 457999999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCCccceeecCccccChhccccC--CCCccccccchhHHHHHHHhCCCCCCCCCCcccch-hHHHHHHhccCC
Q 006317 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRG--HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAED-LLTYAWKNWNEG 550 (650)
Q Consensus 474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~ 550 (650)
+.+..... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||.......... +.......
T Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---- 281 (355)
T 1vzo_A 207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---- 281 (355)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC----
T ss_pred eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc----
Confidence 86543222 123345799999999999863 47899999999999999999999987543322211 11111110
Q ss_pred CcccccCccCCCCChHHHHHHHHHHhcccccCCCCCC-----CHHHHHHHhc
Q 006317 551 TALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRP-----TMASVVVMLN 597 (650)
Q Consensus 551 ~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~~L~ 597 (650)
.+.+...... .+.+++.+||+.||++|| ++.|+++..-
T Consensus 282 ------~~~~~~~~~~---~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 282 ------EPPYPQEMSA---LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp ------CCCCCTTSCH---HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred ------CCCCCcccCH---HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 1111222222 345677799999999999 9999987643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=339.57 Aligned_cols=267 Identities=20% Similarity=0.334 Sum_probs=199.5
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeec--------
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFE-------- 391 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------- 391 (650)
.++|+..++||+|+||.||+++. .+|+.||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36799999999999999999986 4688999999865432 234467899999999999999999999876
Q ss_pred CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeee
Q 006317 392 ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFG 471 (650)
Q Consensus 392 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 471 (650)
.+..++||||+++ +|.+.+.. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 4468999999985 77777654 3356999999999999999999999987 9999999999999999999999999
Q ss_pred cccccccCCC--CCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhcc
Q 006317 472 MARLFEMDQS--QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWN 548 (650)
Q Consensus 472 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 548 (650)
+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.|+...........+........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9987653222 222344578999999999876 4589999999999999999999999864332221111111111111
Q ss_pred CCCccc--------ccCccC--CCCChHHH------HHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 549 EGTALN--------LIDPTL--RNGSSSEI------MRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 549 ~~~~~~--------~id~~l--~~~~~~~~------~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
...... .+.... .......+ ..+.+++.+||+.||++|||+.|+++-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 110000 000000 00011111 236678889999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=356.27 Aligned_cols=253 Identities=26% Similarity=0.330 Sum_probs=203.9
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
.++|+..+.||+|+||.||+++.. +|+.||||++.+.. ......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467889999999999999999865 58999999997642 22345688999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++|+|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999998742 2345999999999999999999999987 99999999999999999999999999986643
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccc-hhHHHHHHhccCCCcccccC
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAE-DLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~id 557 (650)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .+...... . .
T Consensus 339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~---------~ 405 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-V---------P 405 (576)
T ss_dssp TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-C---------C
T ss_pred Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-c---------c
Confidence 22 233457999999999999989999999999999999999999998754322211 11111111 0 0
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCC-----CHHHHHHH
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRP-----TMASVVVM 595 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~~ 595 (650)
..+...... .+.+++.+||+.||++|| ++.||++.
T Consensus 406 ~~~p~~~s~---~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 EEYSERFSP---QARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCCCTTSCH---HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ccCCccCCH---HHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 111122233 345677799999999999 78888743
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=343.59 Aligned_cols=270 Identities=21% Similarity=0.245 Sum_probs=198.5
Q ss_pred cChhhHHhhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCch-----------hHHHHHHHHHHHhhCCCCce
Q 006317 314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ-----------GELEFKNEVLLVARLQHRNL 382 (650)
Q Consensus 314 ~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~ni 382 (650)
....++....++|...+.||+|+||.||++...+|+.||||++...... ....+.+|+.++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 3456777888999999999999999999999888999999998654221 12578999999999999999
Q ss_pred eeecceeec-----CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCce
Q 006317 383 VRLLGFSFE-----ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 457 (650)
Q Consensus 383 v~l~g~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NI 457 (650)
+++++++.. ....++||||++ |+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 999999854 336799999998 588888764 3457999999999999999999999987 99999999999
Q ss_pred EeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCccc
Q 006317 458 LLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEA 536 (650)
Q Consensus 458 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~ 536 (650)
||+.++.+||+|||+++..... .......||..|+|||++.+ ..++.++||||||+++|||++|+.||......
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-- 240 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-- 240 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--
T ss_pred EEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH--
Confidence 9999999999999999754322 22334578999999999887 67899999999999999999999998643211
Q ss_pred chhHHHHHHhccCCC-----------cccccCccCCC---C-----ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 537 EDLLTYAWKNWNEGT-----------ALNLIDPTLRN---G-----SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 537 ~~l~~~~~~~~~~~~-----------~~~~id~~l~~---~-----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
+............. ..+.+...+.. . .......+.+++..||+.||++|||+.|+++.
T Consensus 241 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 241 -NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp -HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 11111111111000 00001011100 0 01112345678889999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=331.86 Aligned_cols=249 Identities=27% Similarity=0.423 Sum_probs=194.5
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecC-CeeEEEEec
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-TERLLIYEF 401 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lv~e~ 401 (650)
.++|+..+.||+|+||.||+++. .|+.||||++.... ....+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46788999999999999999987 48899999997643 345789999999999999999999987654 478999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++++|.+++... ....+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 9999999999753 2234899999999999999999999987 999999999999999999999999999754322
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
.....++..|+|||.+.+..++.++||||||+++|||+| |+.|+..... .+....... + ..+..
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~----~-----~~~~~ 235 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEK----G-----YKMDA 235 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHTT----T-----CCCCC
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhc----C-----CCCCC
Confidence 123357889999999999999999999999999999999 9988864322 122211111 1 01111
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
....+. .+.+++..||+.||++||++.|+++.|+.
T Consensus 236 ~~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 236 PDGCPP---AVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cccCCH---HHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 222333 34567779999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=367.72 Aligned_cols=247 Identities=29% Similarity=0.435 Sum_probs=193.9
Q ss_pred CcccccCceeEEEeecc---CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLS---HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
++||+|+||.||+|.+. .++.||||+++.... ....++.+|+.++.+++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999653 367899999976533 335679999999999999999999999864 568899999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC-C
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-G 483 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 483 (650)
|+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999996 3567999999999999999999999987 999999999999999999999999999876543321 2
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
......+|..|+|||++.+..++.++|||||||++|||++ |+.||..... .+....... +.. .....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~----~~~-----~~~p~ 595 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEK----GER-----MGCPA 595 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHT----TCC-----CCCCT
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc----CCC-----CCCCC
Confidence 2233456889999999999999999999999999999999 9999864322 122222111 111 11112
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
..+. .+.+|+..||+.||++||++.+|+++|+.
T Consensus 596 ~~~~---~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 596 GCPR---EMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp TCCH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 2333 45567779999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=342.80 Aligned_cols=261 Identities=16% Similarity=0.210 Sum_probs=201.2
Q ss_pred ccCCCcCCcccccCceeEEEeeccC---------CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceee---------
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH---------GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVR--------- 384 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~--------- 384 (650)
.++|.+.+.||+|+||.||+++... ++.||||++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999998753 789999998754 25788999999999999998
Q ss_pred ------ecceeec-CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCce
Q 006317 385 ------LLGFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNI 457 (650)
Q Consensus 385 ------l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NI 457 (650)
+++++.. +...++||||+ +++|.+++... ....+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 5566655 67889999999 99999999753 2467999999999999999999999987 99999999999
Q ss_pred EeCCCC--CeEEeeeecccccccCCCC-----CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCC
Q 006317 458 LLDADM--IPKISDFGMARLFEMDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSF 530 (650)
Q Consensus 458 Ll~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~ 530 (650)
|++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999876533221 122335799999999999999999999999999999999999999874
Q ss_pred CCCcccchhHHHHHHhccCCCcccccCccCC-CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 531 RIGEEAEDLLTYAWKNWNEGTALNLIDPTLR-NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 531 ~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~-~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
..... ..+...... +. .....+.+.... ...+. .+.+++.+||+.||++||++.+|+++|+..
T Consensus 271 ~~~~~-~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 271 CLPNT-EDIMKQKQK-FV-DKPGPFVGPCGHWIRPSE---TLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GTTCH-HHHHHHHHH-HH-HSCCCEECTTSCEECCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CCcCH-HHHHHHHHh-cc-CChhhhhhhccccCCCcH---HHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 33111 112211111 11 111111111111 01233 455677799999999999999999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=343.88 Aligned_cols=244 Identities=22% Similarity=0.260 Sum_probs=189.8
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch---hHHHHHHHHHH-HhhCCCCceeeecceeecCCeeEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ---GELEFKNEVLL-VARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
++|+..+.||+|+||.||+++.. +++.||||++.+.... ....+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 57888999999999999999875 4788999999765432 23346667666 5678999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999873 457899999999999999999999987 99999999999999999999999999985432
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+....... . .
T Consensus 192 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i~~~---~-------~ 256 (373)
T 2r5t_A 192 H--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNILNK---P-------L 256 (373)
T ss_dssp C--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB---HHHHHHHHHHS---C-------C
T ss_pred C--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhc---c-------c
Confidence 2 223445689999999999999999999999999999999999999986322 12222211111 0 0
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMAS 591 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~e 591 (650)
.+...... .+.+++..||+.||++||++.+
T Consensus 257 ~~~~~~~~---~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 257 QLKPNITN---SARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CCCSSSCH---HHHHHHHHHTCSSGGGSTTTTT
T ss_pred CCCCCCCH---HHHHHHHHHcccCHHhCCCCCC
Confidence 11122233 3456777999999999999853
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=331.07 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=202.4
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
.++|...+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467889999999999999999875 47789999986542 23445688999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999998863 457999999999999999999999987 99999999999999999999999999986543
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
.. .......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... +...... ... .
T Consensus 168 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~----~~~------~ 232 (294)
T 2rku_A 168 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---ETYLRIK----KNE------Y 232 (294)
T ss_dssp TT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHH----TTC------C
T ss_pred Cc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh----hcc------C
Confidence 22 2233457899999999999989999999999999999999999998643211 1111110 110 1
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+...... .+.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 SIPKHINP---VAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCCTTSCH---HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCccccCH---HHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11122223 34567779999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=341.89 Aligned_cols=199 Identities=25% Similarity=0.381 Sum_probs=175.1
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
.++|+..++||+|+||.||+++.. +++.||+|++.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999865 58899999997653 3334578999999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
|+++++|.+++.. ...+++..+..++.||+.||+|||+. + |+||||||+||||+.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999974 45699999999999999999999986 6 999999999999999999999999999765322
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCC
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR 531 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~ 531 (650)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 123357899999999999999999999999999999999999998643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=326.57 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=195.6
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeec----CCeeE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFE----ETERL 396 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 396 (650)
..|...+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45777889999999999999864 57789999987543 3344568999999999999999999998865 35679
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC-CCCCeEEeeeecccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPKISDFGMARL 475 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~~ 475 (650)
+||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ +++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 99999999999999974 467999999999999999999999874 3599999999999998 789999999999975
Q ss_pred cccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
... .......||+.|+|||++. +.++.++||||||+++|||++|+.||..... ...... ....+.....
T Consensus 182 ~~~----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~----~~~~~~~~~~ 250 (290)
T 1t4h_A 182 KRA----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYR----RVTSGVKPAS 250 (290)
T ss_dssp CCT----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHH----HHTTTCCCGG
T ss_pred ccc----cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHHHH----HHhccCCccc
Confidence 432 2233457899999999886 4689999999999999999999999863221 111111 1111111111
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
...... ..+.+++..||+.||++|||+.|+++.
T Consensus 251 ----~~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 251 ----FDKVAI---PEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----GGGCCC---HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----cCCCCC---HHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111122 245677889999999999999999853
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=349.34 Aligned_cols=254 Identities=21% Similarity=0.311 Sum_probs=190.0
Q ss_pred hhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch--------hHHHHHHHHHHHhhCCCCceeeecceeec
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--------GELEFKNEVLLVARLQHRNLVRLLGFSFE 391 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 391 (650)
...++|...++||+|+||.||+|... +++.||||++...... ....+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34678999999999999999999864 5789999998754211 1124789999999999999999999975
Q ss_pred CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC---CeEEe
Q 006317 392 ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM---IPKIS 468 (650)
Q Consensus 392 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~---~~kl~ 468 (650)
.+..++||||+++|+|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++ .+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 456899999999999999886 4567999999999999999999999987 99999999999997544 59999
Q ss_pred eeecccccccCCCCCccceeecCccccChhcccc---CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHH
Q 006317 469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR---GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWK 545 (650)
Q Consensus 469 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~ 545 (650)
|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .+......
T Consensus 285 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i~~ 359 (419)
T 3i6u_A 285 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITS 359 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHHHT
T ss_pred ecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHHhc
Confidence 99999875422 22344679999999999863 678899999999999999999999986432211 11111111
Q ss_pred hccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 546 NWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 546 ~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
. .. .. .+....... ..+.+++.+||+.||++|||+.|+++.
T Consensus 360 ~----~~-~~-~~~~~~~~~---~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 360 G----KY-NF-IPEVWAEVS---EKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp T----CC-CC-CHHHHTTSC---HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred C----CC-CC-CchhhcccC---HHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1 00 00 000001112 345677889999999999999999863
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=330.16 Aligned_cols=259 Identities=24% Similarity=0.322 Sum_probs=201.4
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceee--cCCeeEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSF--EETERLL 397 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~~l 397 (650)
.++|+..+.||+|+||.||+++.. +++.||+|++.... ......+.+|+.++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467889999999999999999865 58899999997643 234456899999999999999999999875 3668899
Q ss_pred EEecCCCCChhHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcC--CCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 398 IYEFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999999999999976432 345999999999999999999999875 2349999999999999999999999999998
Q ss_pred ccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
...... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+..... .++....... ..
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~~~----~~-- 233 (279)
T 2w5a_A 165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIREG----KF-- 233 (279)
T ss_dssp HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHT----CC--
T ss_pred eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHHhhc----cc--
Confidence 654321 112335689999999999999999999999999999999999999864321 1222211111 11
Q ss_pred ccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 555 LIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 555 ~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+.+....+. .+.+++.+||+.||++||++.||++.+..
T Consensus 234 ---~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 ---RRIPYRYSD---ELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ---CCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---ccCCcccCH---HHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 111122233 34567779999999999999999987654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=353.24 Aligned_cols=195 Identities=24% Similarity=0.423 Sum_probs=154.6
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeecccc--CchhHHHHHHHHHHHhhCCCCceeeecceeecC-----Ce
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-----TE 394 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 394 (650)
.++|++.++||+|+||.||+++.. +++.||||++... .......+.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999864 5889999998654 233445788999999999999999999998543 56
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.++||||+ +++|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 468988886 4567999999999999999999999987 9999999999999999999999999998
Q ss_pred ccccCCCC-------------------------CccceeecCccccChhcc-ccCCCCccccccchhHHHHHHHhC
Q 006317 475 LFEMDQSQ-------------------------GDTSRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISG 524 (650)
Q Consensus 475 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDV~S~Gvll~elltG 524 (650)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 76432211 123345789999999976 556799999999999999999995
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=350.99 Aligned_cols=244 Identities=14% Similarity=0.136 Sum_probs=187.7
Q ss_pred hhccCCCcCCcccccCceeEEEeec-cCCcceeEeecccc---CchhHHHHHHHH---HHHhhCCCCceeeec-------
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN---SVQGELEFKNEV---LLVARLQHRNLVRLL------- 386 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~------- 386 (650)
...++|...+.||+|+||.||+|+. .+|+.||||++... .......+.+|+ .++++++|||||+++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 3457889999999999999999996 45899999999743 233456788999 555666899999998
Q ss_pred ceeecCC-----------------eeEEEEecCCCCChhHHHHhhhc----cCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 006317 387 GFSFEET-----------------ERLLIYEFVPNSSVDKFIFDAIK----RVQLDWETRYKIIGGIARGILYLHEDSRL 445 (650)
Q Consensus 387 g~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 445 (650)
+++...+ ..++||||+ +|+|.+++..... ...+++..++.++.||+.||+|||+++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 226 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 226 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 4544432 278999999 6899999975321 122446889999999999999999987
Q ss_pred cEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccC-----------CCCccccccch
Q 006317 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-----------HFSIKSDVFSF 514 (650)
Q Consensus 446 ~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDV~S~ 514 (650)
|+||||||+||||+.++.+||+|||+++... .......| +.|+|||++.+. .++.++|||||
T Consensus 227 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred -eecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 9999999999999999999999999998532 12334567 999999999887 89999999999
Q ss_pred hHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 515 GVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 515 Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
||++|||++|+.||........ .+.+.... ...++ .+.+++.+||+.||++|||+.|+++
T Consensus 300 G~il~elltg~~Pf~~~~~~~~----------------~~~~~~~~-~~~~~---~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAALGG----------------SEWIFRSC-KNIPQ---PVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHHSSCCC------CC----------------SGGGGSSC-CCCCH---HHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHHCCCCCcccccccc----------------hhhhhhhc-cCCCH---HHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999999853221111 01111111 12233 3456777999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=339.42 Aligned_cols=263 Identities=24% Similarity=0.360 Sum_probs=196.4
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
++|+..+.||+|+||.||+++.. +|+.||||++...... ....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57889999999999999999865 4889999998654332 34457899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++++|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 105 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999998765 3456999999999999999999999987 9999999999999999999999999998654322
Q ss_pred CCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHH--------HHHhccCCC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTY--------AWKNWNEGT 551 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~~ 551 (650)
.......||..|+|||++.+. .++.++||||||+++|||++|+.||......+....... .+..+....
T Consensus 179 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 179 --EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred --cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 223345689999999999875 789999999999999999999999864332111110000 000000000
Q ss_pred -cccccCccCCCC-C-----hHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 552 -ALNLIDPTLRNG-S-----SSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 552 -~~~~id~~l~~~-~-----~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
......+.+... . +.....+.+++.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000111111111 1 111244667888999999999999999974
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=331.59 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=200.7
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
..++|...+.||+|+||.||+++.. +|+.||||++..........+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467889999999999999999865 688999999987655455678899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe---CCCCCeEEeeeecccccc
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFE 477 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~~~~ 477 (650)
|+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999999864 457999999999999999999999987 9999999999999 788999999999987543
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.... ...+......... . ..
T Consensus 161 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~-----~-~~ 227 (304)
T 2jam_A 161 N----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET---ESKLFEKIKEGYY-----E-FE 227 (304)
T ss_dssp C----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHCCC-----C-CC
T ss_pred C----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCC-----C-CC
Confidence 2 12334568999999999999999999999999999999999999986322 1222222111110 0 01
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.......+ ..+.+++.+||+.||++|||+.|+++-
T Consensus 228 ~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 228 SPFWDDIS---ESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTTTTTSC---HHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccccCC---HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111222 345567779999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=346.29 Aligned_cols=202 Identities=27% Similarity=0.437 Sum_probs=162.2
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeecccc--CchhHHHHHHHHHHHhhCC-CCceeeecceeecCC--ee
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEET--ER 395 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~ 395 (650)
..++|+..++||+|+||.||+++. .+|+.||||++... .......+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999985 45889999998654 2334456789999999997 999999999997544 68
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999998 588888853 47999999999999999999999987 99999999999999999999999999986
Q ss_pred cccCC-------------------CCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCC
Q 006317 476 FEMDQ-------------------SQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFR 531 (650)
Q Consensus 476 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~ 531 (650)
+.... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 53211 1112334579999999999986 67899999999999999999999998643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=335.64 Aligned_cols=249 Identities=23% Similarity=0.340 Sum_probs=202.6
Q ss_pred ccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
.++|...+.||+|+||.||+++..+ ++.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 3578889999999999999998654 7789999986542 23445688999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999998863 457999999999999999999999987 99999999999999999999999999986643
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
.. .......||..|+|||++.+..++.++||||||+++|||++|+.|+...... +........ ..
T Consensus 194 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~----------~~ 258 (335)
T 2owb_A 194 DG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---ETYLRIKKN----------EY 258 (335)
T ss_dssp TT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHT----------CC
T ss_pred Cc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHhcC----------CC
Confidence 22 2233457899999999999999999999999999999999999998643211 111111110 01
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+...... .+.+++.+||+.||++|||+.|+++.
T Consensus 259 ~~~~~~~~---~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 SIPKHINP---VAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CCCTTSCH---HHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCCccCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11122223 34567779999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=330.97 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=196.2
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
..++|++.+.||+|+||.||+++.. +++.||+|++..........+.+|+.++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4568999999999999999999975 488999999987666666789999999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999999875 3456999999999999999999999987 9999999999999999999999999976432111
Q ss_pred CCCccceeecCccccChhccc-----cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 481 SQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
.......||..|+|||++. ...++.++||||||+++|||++|+.|+..... .......... .. ...
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~---~~-~~~ 242 (302)
T 2j7t_A 172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKS---DP-PTL 242 (302)
T ss_dssp --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHS---CC-CCC
T ss_pred --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHHHhcc---CC-ccc
Confidence 1122356899999999984 56789999999999999999999999863221 1111111111 00 000
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
. .....+ ..+.+++.+||+.||++|||+.++++
T Consensus 243 ~---~~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 243 L---TPSKWS---VEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp S---SGGGSC---HHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred C---CccccC---HHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 001122 34556777999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=326.89 Aligned_cols=245 Identities=23% Similarity=0.339 Sum_probs=200.2
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|+..+.||+|+||.||+++.. +++.||||++..... .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57889999999999999999865 477899999865422 23457889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999874 356999999999999999999999987 999999999999999999999999998754322
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+...... +....... . +..
T Consensus 168 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~----~------~~~ 230 (284)
T 2vgo_A 168 ----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT---ETHRRIVN----V------DLK 230 (284)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHT----T------CCC
T ss_pred ----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh---HHHHHHhc----c------ccC
Confidence 223457899999999999999999999999999999999999998643211 11111110 0 111
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
+....+. .+.+++.+||+.||++||++.++++
T Consensus 231 ~~~~~~~---~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 FPPFLSD---GSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCTTSCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCcCCH---HHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1222233 3456777999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=327.67 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=197.0
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC----chhHHHHHHHHHHHhhCCCCceeeecceee--cCCee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS----VQGELEFKNEVLLVARLQHRNLVRLLGFSF--EETER 395 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~ 395 (650)
.++|.+.+.||+|+||.||++... +++.||||++.... ......+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999864 57899999997643 234457899999999999999999999984 45678
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++||||++++ |.+++... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999887 77766543 3567999999999999999999999987 99999999999999999999999999987
Q ss_pred cccCCCCCccceeecCccccChhccccCCC--CccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcc
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHF--SIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 553 (650)
..............||..|+|||++.+... +.++||||||+++|||++|+.|+.... .......... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~~----~~-- 229 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKLFENIGK----GS-- 229 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHH----CC--
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHHhc----CC--
Confidence 654333333345568999999999876543 789999999999999999999986322 1111111111 10
Q ss_pred cccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 554 NLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 554 ~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..+...... .+.+++.+||+.||++|||+.|+++.
T Consensus 230 ----~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 ----YAIPGDCGP---PLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----CCCCSSSCH---HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----CCCCCccCH---HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111222333 34467779999999999999999965
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=335.15 Aligned_cols=255 Identities=20% Similarity=0.355 Sum_probs=201.9
Q ss_pred HHhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--------hhHHHHHHHHHHHhhC-CCCceeeecce
Q 006317 319 IRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--------QGELEFKNEVLLVARL-QHRNLVRLLGF 388 (650)
Q Consensus 319 ~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~g~ 388 (650)
.....++|...+.||+|+||.||+++.. +|+.||||++..... .....+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445578999999999999999999975 689999999865431 1134578899999999 79999999999
Q ss_pred eecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEe
Q 006317 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS 468 (650)
Q Consensus 389 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 468 (650)
+......++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999874 457999999999999999999999987 9999999999999999999999
Q ss_pred eeecccccccCCCCCccceeecCccccChhcccc------CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHH
Q 006317 469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR------GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTY 542 (650)
Q Consensus 469 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~ 542 (650)
|||++....... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... .......
T Consensus 243 DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~ 316 (365)
T 2y7j_A 243 DFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILMLRM 316 (365)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH
T ss_pred ecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHHHHH
Confidence 999998665322 2334679999999999864 357899999999999999999999985321 1112221
Q ss_pred HHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 543 AWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 543 ~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
....... ...+.. ...+ ..+.+++.+||+.||++|||+.|+++
T Consensus 317 i~~~~~~-----~~~~~~-~~~~---~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 IMEGQYQ-----FSSPEW-DDRS---STVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHTCCC-----CCHHHH-SSSC---HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhCCCC-----CCCccc-ccCC---HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111000 000000 0111 34557788999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=326.29 Aligned_cols=248 Identities=21% Similarity=0.354 Sum_probs=193.6
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
.++|.+.+.||+|+||.||+++.. +|+.||||++..... .....+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367889999999999999999875 689999999865422 2345788999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ ++|+||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999974 356999999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCccceeecCccccChhccccCCC-CccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
.. ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.|+.... ........... .
T Consensus 164 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~----~------ 227 (276)
T 2h6d_A 164 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLFKKIRGG----V------ 227 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHC----C------
T ss_pred Cc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcC----c------
Confidence 22 2234568999999999988765 689999999999999999999986322 11122111111 0
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..+...... .+.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 FYIPEYLNR---SVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCCCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ccCchhcCH---HHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011112223 34567779999999999999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=329.00 Aligned_cols=249 Identities=26% Similarity=0.390 Sum_probs=203.0
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
.+.|+..+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 45688899999999999999985 458899999997653 2345678999999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++++|.+++. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999885 357999999999999999999999987 9999999999999999999999999998664322
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
.......||..|+|||++.+..++.++||||||+++|||++|+.|+..... .......... ..+.+
T Consensus 174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~---------~~~~~ 239 (303)
T 3a7i_A 174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFLIPKN---------NPPTL 239 (303)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHS---------CCCCC
T ss_pred --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHHhhcC---------CCCCC
Confidence 223345789999999999999999999999999999999999999863221 1111111111 01112
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
....+.+ +.+++..||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~---l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNYSKP---LKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSCCHH---HHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccccCHH---HHHHHHHHcCCChhhCcCHHHHhhC
Confidence 2223333 4567779999999999999999854
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=329.01 Aligned_cols=257 Identities=28% Similarity=0.393 Sum_probs=193.6
Q ss_pred ccCCCcCCcccccCceeEEEeecc--CCc--ceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS--HGQ--EIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETER 395 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~--~g~--~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 395 (650)
.++|+..+.||+|+||.||+|++. +++ .||||+++... ......+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467899999999999999999853 233 58999987642 234457899999999999999999999988765 8
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999999753 456999999999999999999999987 99999999999999999999999999987
Q ss_pred cccCCCC-CccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcc
Q 006317 476 FEMDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553 (650)
Q Consensus 476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 553 (650)
....... .......+|..|+|||++.+..++.++||||||+++|||++ |+.||..... ......... ...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~---~~~-- 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDK---EGE-- 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHT---SCC--
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHHHHHHc---cCC--
Confidence 6433221 12233467889999999998889999999999999999999 9998863321 122211111 110
Q ss_pred cccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 554 NLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 554 ~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
........+ ..+.+++.+||+.||++|||+.++++.|+..
T Consensus 243 ---~~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 243 ---RLPRPEDCP---QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp ---CCCCCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCcCcC---HHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 011111223 3455677799999999999999999999764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=337.96 Aligned_cols=254 Identities=28% Similarity=0.436 Sum_probs=198.4
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcc--eeEeeccccC-chhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQE--IAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~--vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 398 (650)
++|+..+.||+|+||.||+++.. ++.. +|||++.... ......+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57889999999999999999865 3554 4999987542 23344688999999999 899999999999999999999
Q ss_pred EecCCCCChhHHHHhhh-------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCe
Q 006317 399 YEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 465 (650)
|||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997531 2347999999999999999999999987 9999999999999999999
Q ss_pred EEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHH
Q 006317 466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAW 544 (650)
Q Consensus 466 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~ 544 (650)
||+|||+++..... .......++..|+|||++.+..++.++||||||+++|||+| |+.||..... .++..
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~--- 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYE--- 252 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH---
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---HHHHH---
Confidence 99999999743221 12223456889999999998889999999999999999998 9998853221 11111
Q ss_pred HhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 545 KNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 545 ~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
....+. ........+ ..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 253 -~~~~~~-----~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 253 -KLPQGY-----RLEKPLNCD---DEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp -HGGGTC-----CCCCCTTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HhhcCC-----CCCCCCCCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 111110 011111222 345567779999999999999999998875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.97 Aligned_cols=260 Identities=18% Similarity=0.258 Sum_probs=202.6
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCC-ceeeecceeecCCeeEEEEe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR-NLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~e 400 (650)
.++|++.++||+|+||.||+|+. .+++.||||++...... .++.+|++++..++|+ ++..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999985 56889999987654332 2478899999999875 55555566677888899999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe---CCCCCeEEeeeecccccc
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFE 477 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~~~~ 477 (650)
|+ +++|.+++.. ....+++..++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999874 2457999999999999999999999987 9999999999999 688999999999998765
Q ss_pred cCCCC-----CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCc
Q 006317 478 MDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA 552 (650)
Q Consensus 478 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 552 (650)
..... .......||..|+|||++.+..++.++||||||++||||++|+.||...........+............
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 43322 1223567999999999999999999999999999999999999999754433332222222111100000
Q ss_pred ccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 553 LNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 553 ~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.. +....+. ++.+++..||+.+|++||++.+|+++|+.
T Consensus 238 ~~-----l~~~~p~---~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 238 EA-----LCRGYPT---EFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp HH-----HHTTSCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred HH-----HhcCCcH---HHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 00 0111223 45567779999999999999999988753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=345.80 Aligned_cols=200 Identities=25% Similarity=0.435 Sum_probs=167.0
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeecccc--CchhHHHHHHHHHHHhhCCCCceeeecceeecC-----C
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE-----T 393 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~ 393 (650)
..++|.+.+.||+|+||.||+++.. +++.||||++... .......+.+|+.++++++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3578999999999999999999864 5788999999754 233445788999999999999999999998766 5
Q ss_pred eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecc
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 473 (650)
..++||||+. ++|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 7899999986 59999886 3466999999999999999999999997 999999999999999999999999999
Q ss_pred cccccCCCC--------------------CccceeecCccccChhcc-ccCCCCccccccchhHHHHHHHhCCCCC
Q 006317 474 RLFEMDQSQ--------------------GDTSRIVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQKNN 528 (650)
Q Consensus 474 ~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDV~S~Gvll~elltG~~p~ 528 (650)
+........ .......||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 876533211 123456899999999986 5567999999999999999999865554
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.85 Aligned_cols=252 Identities=27% Similarity=0.367 Sum_probs=184.8
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCch-h-HHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ-G-ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
..++|+..+.||+|+||.||+++. .+|+.||||++...... . ...+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 457899999999999999999986 46889999999765322 2 22344555668889999999999999999999999
Q ss_pred EecCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 399 YEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
|||++ |+|.+++.... ....+++..++.++.||+.||+|||++ + |+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99997 58888876532 346799999999999999999999997 7 999999999999999999999999999865
Q ss_pred ccCCCCCccceeecCccccChhcc----ccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCc
Q 006317 477 EMDQSQGDTSRIVGTFGYMAPEYV----TRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA 552 (650)
Q Consensus 477 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 552 (650)
.... ......||+.|+|||++ .+..++.++||||||+++|||++|+.|+..... ....+..... ...
T Consensus 161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~---~~~- 231 (290)
T 3fme_A 161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--PFQQLKQVVE---EPS- 231 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--HHHHHHHHHH---SCC-
T ss_pred cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--hHHHHHHHhc---cCC-
Confidence 4322 22334689999999996 556789999999999999999999999863211 1111111111 100
Q ss_pred ccccCccCC-CCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 553 LNLIDPTLR-NGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 553 ~~~id~~l~-~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
+... ...+. .+.+++.+||+.||++|||+.|+++
T Consensus 232 -----~~~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 -----PQLPADKFSA---EFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----CCCCTTTSCH---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCcccccCCH---HHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111 11223 3556777999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=334.93 Aligned_cols=270 Identities=25% Similarity=0.377 Sum_probs=198.6
Q ss_pred hHHhhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCee
Q 006317 318 TIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETER 395 (650)
Q Consensus 318 ~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 395 (650)
+.....++|+..+.||+|+||.||+|+.. ..+|+|++..... .....+.+|+.++++++||||+++++++.+.+..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 33344578999999999999999999874 3699999875432 2233577899999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
++||||+++++|.+++.. ....+++..++.++.||+.||+|||+.+ ++||||||+|||++ ++.+||+|||+++.
T Consensus 105 ~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred EEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 999999999999999864 3446999999999999999999999987 99999999999998 67999999999876
Q ss_pred cccCC---CCCccceeecCccccChhcccc---------CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHH
Q 006317 476 FEMDQ---SQGDTSRIVGTFGYMAPEYVTR---------GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYA 543 (650)
Q Consensus 476 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~ 543 (650)
..... .........||..|+|||++.+ ..++.++||||||+++|||++|+.|+..... .......
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~ 255 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIWQM 255 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHHHHHH
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHh
Confidence 53221 1122334568999999999874 4578999999999999999999999863221 1111111
Q ss_pred HHhccCCCcccccCccCCC-CChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCCCCCCCCCCc
Q 006317 544 WKNWNEGTALNLIDPTLRN-GSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSLPLPSQPA 610 (650)
Q Consensus 544 ~~~~~~~~~~~~id~~l~~-~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~~~~~p~~p~ 610 (650)
.. +. .+.+.. ..+. .+.+++..||+.||++|||+.+|+++|+.........+.|.
T Consensus 256 ~~----~~-----~~~~~~~~~~~---~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~ 311 (319)
T 2y4i_B 256 GT----GM-----KPNLSQIGMGK---EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPG 311 (319)
T ss_dssp HT----TC-----CCCCCCSSCCT---THHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----------
T ss_pred cc----CC-----CCCCCcCCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCc
Confidence 11 11 111111 1222 34567779999999999999999999998655444444443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.06 Aligned_cols=260 Identities=29% Similarity=0.444 Sum_probs=198.3
Q ss_pred ccChhhHHhhccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceee
Q 006317 313 QFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSF 390 (650)
Q Consensus 313 ~~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 390 (650)
.+++..+....++|+..+.||+|+||.||+|+. .+++.||||++..... ....+.+|+.+++++ +||||+++++++.
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 355667777889999999999999999999986 4688999999875432 345788999999999 8999999999997
Q ss_pred c------CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC
Q 006317 391 E------ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI 464 (650)
Q Consensus 391 ~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~ 464 (650)
. ....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCC
Confidence 6 46789999999999999999753 3457999999999999999999999987 999999999999999999
Q ss_pred eEEeeeecccccccCCCCCccceeecCccccChhccc-----cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchh
Q 006317 465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDL 539 (650)
Q Consensus 465 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l 539 (650)
+||+|||++....... .......||..|+|||++. +..++.++||||||+++|||++|+.|+..... ...
T Consensus 168 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~ 242 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRA 242 (326)
T ss_dssp EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHH
T ss_pred EEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHH
Confidence 9999999997654221 1233457899999999987 56789999999999999999999999853221 111
Q ss_pred HHHHHHhccCCCcccccCccC-CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 540 LTYAWKNWNEGTALNLIDPTL-RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 540 ~~~~~~~~~~~~~~~~id~~l-~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
....... . .+.+ ....+. .+.+++.+||+.||++||++.++++
T Consensus 243 ~~~~~~~----~-----~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 243 LFLIPRN----P-----APRLKSKKWSK---KFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHS----C-----CCCCSCSCSCH---HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhhcC----c-----cccCCccccCH---HHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111110 0 0111 111233 3456777999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=349.78 Aligned_cols=254 Identities=25% Similarity=0.331 Sum_probs=203.1
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
.++|...+.||+|+||.||+++.. +|+.||||++.+... .....+.+|+.++++++||||+++++++......++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467888999999999999999875 589999999976432 2345688999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 399 YEFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
|||+++|+|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999875322 446999999999999999999999987 9999999999999999999999999998764
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCccc-chhHHHHHHhccCCCccccc
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEA-EDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~i 556 (650)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+....... .
T Consensus 341 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~----~----- 409 (543)
T 3c4z_A 341 AGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ----A----- 409 (543)
T ss_dssp TTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC----C-----
T ss_pred CCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc----c-----
Confidence 332 223345899999999999999999999999999999999999999874432211 1122111110 0
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCH-----HHHHH
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTM-----ASVVV 594 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~-----~evl~ 594 (650)
..+....+. .+.+++..||+.||++||++ .+|++
T Consensus 410 -~~~p~~~s~---~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 -VTYPDKFSP---ASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp -CCCCTTSCH---HHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred -cCCCcccCH---HHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 111122233 34466779999999999975 56663
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=331.71 Aligned_cols=256 Identities=17% Similarity=0.254 Sum_probs=196.4
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCC-CCceeeecceeec--CCeeEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFE--ETERLLI 398 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lv 398 (650)
.++|+..++||+|+||.||+++. .+++.||||+++... ...+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36789999999999999999985 568899999997543 356889999999997 9999999999987 6678999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC-CeEEeeeecccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFE 477 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~ 477 (650)
|||+++++|.+++. .+++..++.++.||+.||+|||+.+ |+||||||+||||+.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998874 3899999999999999999999987 99999999999999777 89999999998665
Q ss_pred cCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCC-----
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGT----- 551 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----- 551 (650)
... ......||..|+|||++.+ ..++.++||||||+++|||++|+.|+...... .+.+...........
T Consensus 183 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 183 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHH
T ss_pred CCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch--HHHHHHHHHhcCCchhhhHH
Confidence 332 2334578999999999887 67899999999999999999999998532221 111111000000000
Q ss_pred ------------------cccccCccCCCC-ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 552 ------------------ALNLIDPTLRNG-SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 552 ------------------~~~~id~~l~~~-~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
............ .......+.+++.+||+.||++|||++|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000001111 01112455678889999999999999999853
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=336.44 Aligned_cols=257 Identities=23% Similarity=0.290 Sum_probs=191.8
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCC------
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEET------ 393 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 393 (650)
.++|+..+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46789999999999999999986 458999999996542 233456889999999999999999999987653
Q ss_pred eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecc
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 473 (650)
..++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 8899998863 46999999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC--
Q 006317 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG-- 550 (650)
Q Consensus 474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-- 550 (650)
+..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+.+..........
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTGTPPA 247 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCH
Confidence 865422 234578999999999887 6899999999999999999999999864322 11111111110000
Q ss_pred ---------Ccccc-------cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 551 ---------TALNL-------IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 551 ---------~~~~~-------id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..... -...+..........+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00000 0000000011112345677789999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=326.45 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=196.6
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
..++|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.+|+.++.+++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567999999999999999999865 48899999997643 33468899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999999864 3567999999999999999999999987 9999999999999999999999999998654322
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
.......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... ......... . ......
T Consensus 180 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~---~-~~~~~~--- 247 (314)
T 3com_A 180 --AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM---RAIFMIPTN---P-PPTFRK--- 247 (314)
T ss_dssp --SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHS---C-CCCCSS---
T ss_pred --cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHhcC---C-CcccCC---
Confidence 2233457899999999999999999999999999999999999998632211 111111010 0 000000
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
....+ ..+.+++.+||+.||++|||+.++++
T Consensus 248 ~~~~~---~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 PELWS---DNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGGSC---HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccCC---HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00112 34556777999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=352.24 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=196.1
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
..++|+..++||+|+||.||+++.. ++..||||++.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457899999999999999999865 58889999997653 23345789999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC---CCeEEeeeecccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMARL 475 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGla~~ 475 (650)
|||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.+ +.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999998863 467999999999999999999999987 9999999999999764 4599999999987
Q ss_pred cccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
+.... ......||+.|+|||++. +.++.++|||||||++|||++|+.||..... .+++........ ..
T Consensus 189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~-----~~ 256 (494)
T 3lij_A 189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEILRKVEKGKY-----TF 256 (494)
T ss_dssp CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCC-----CC
T ss_pred CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCC-----CC
Confidence 65322 233457999999999886 5689999999999999999999999864322 222222211100 00
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
..+.. ...+. .+.+++.+||+.||++|||+.|+++
T Consensus 257 ~~~~~-~~~s~---~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 DSPEW-KNVSE---GAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CSGGG-TTSCH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cchhc-ccCCH---HHHHHHHHHCCCChhhCccHHHHhc
Confidence 00111 11222 3456777999999999999999984
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=350.26 Aligned_cols=252 Identities=27% Similarity=0.350 Sum_probs=199.6
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
..++|++.++||+|+||.||+++.. +++.||||++.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4567999999999999999999865 68899999986532 23455789999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC---CCCCeEEeeeecccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---ADMIPKISDFGMARL 475 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGla~~ 475 (650)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999998864 457999999999999999999999987 99999999999995 456799999999986
Q ss_pred cccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
+.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.... ..+.+......... ..
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~---~~- 242 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVETGKYA---FD- 242 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCC---SC-
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC---CC-
Confidence 64322 2334579999999999875 59999999999999999999999986322 22222222111000 00
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+.. ...+ ..+.+++..||+.||++|||+.|+++.
T Consensus 243 -~~~~-~~~s---~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 -LPQW-RTIS---DDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -SGGG-GGSC---HHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -Cccc-CCCC---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 0112 345567779999999999999999974
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=347.29 Aligned_cols=252 Identities=27% Similarity=0.360 Sum_probs=198.2
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-------------hhHHHHHHHHHHHhhCCCCceeeecc
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-------------QGELEFKNEVLLVARLQHRNLVRLLG 387 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g 387 (650)
..++|...++||+|+||.||+++.. +++.||||++..... .....+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999865 478899999876432 22456889999999999999999999
Q ss_pred eeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC---C
Q 006317 388 FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM---I 464 (650)
Q Consensus 388 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~---~ 464 (650)
++.+....++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999998864 457999999999999999999999987 99999999999999876 6
Q ss_pred eEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHH
Q 006317 465 PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAW 544 (650)
Q Consensus 465 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~ 544 (650)
+||+|||+++.+.... ......||+.|+|||++. +.++.++|||||||++|||++|+.||..... .+++....
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~ 260 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND---QDIIKKVE 260 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHH
Confidence 9999999998765332 233457999999999987 5689999999999999999999999864322 22222221
Q ss_pred HhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 545 KNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 545 ~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.. ... .+.......+ ..+.+++.+||+.||.+|||+.|+++.
T Consensus 261 ~~----~~~--~~~~~~~~~s---~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 261 KG----KYY--FDFNDWKNIS---DEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HC----CCC--CCHHHHTTSC---HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cC----CCC--CCccccCCCC---HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11 000 0000001112 345567779999999999999999853
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=352.21 Aligned_cols=252 Identities=27% Similarity=0.353 Sum_probs=202.1
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
..++|+..++||+|+||.||+++.. +|+.||||++.... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467899999999999999999865 68899999986543 2345678999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe---CCCCCeEEeeeeccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMAR 474 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl---~~~~~~kl~DFGla~ 474 (650)
||||+.+|+|.+++. ....+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999886 4567999999999999999999999987 9999999999999 567899999999998
Q ss_pred ccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
.+.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.... ..+.+......... ..
T Consensus 178 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~---~~ 247 (484)
T 3nyv_A 178 HFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDILKKVEKGKYT---FE 247 (484)
T ss_dssp HBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC---CC
T ss_pred Eccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCC---CC
Confidence 765322 2334579999999999875 68999999999999999999999986332 22222222111000 00
Q ss_pred ccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 555 LIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 555 ~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.+.. ...+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 248 --~~~~-~~~s---~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 248 --LPQW-KKVS---ESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp --SGGG-GGSC---HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --Cccc-ccCC---HHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0000 0112 345567779999999999999999853
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=329.16 Aligned_cols=261 Identities=20% Similarity=0.322 Sum_probs=196.9
Q ss_pred cChhhHHhhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccC--chhHHHHHHHHHHHhhCC--CCceeeeccee
Q 006317 314 FDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQ--HRNLVRLLGFS 389 (650)
Q Consensus 314 ~~~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~--H~niv~l~g~~ 389 (650)
+.+..+....++|++.+.||+|+||.||+++..+++.||||++.... ......+.+|+.++.+++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 33444455667899999999999999999998889999999996543 334457899999999997 59999999999
Q ss_pred ecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEee
Q 006317 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISD 469 (650)
Q Consensus 390 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~D 469 (650)
...+..++||| +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||+++ +.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 99999999999 678899999873 457999999999999999999999987 999999999999964 8999999
Q ss_pred eecccccccCCCCCccceeecCccccChhcccc-----------CCCCccccccchhHHHHHHHhCCCCCCCCCCcccch
Q 006317 470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-----------GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAED 538 (650)
Q Consensus 470 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~ 538 (650)
||+++...............||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+......
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---- 245 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---- 245 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH----
Confidence 999987654333323344578999999999875 47889999999999999999999998532211
Q ss_pred hHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 539 LLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 539 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
............ ...+....+. .+.+++.+||+.||++||++.|+++.
T Consensus 246 -~~~~~~~~~~~~-----~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 246 -ISKLHAIIDPNH-----EIEFPDIPEK---DLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -HHHHHHHHCTTS-----CCCCCCCSCH---HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHHHhccc-----ccCCcccchH---HHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111111111110 0111112223 45567779999999999999999854
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=338.42 Aligned_cols=261 Identities=22% Similarity=0.254 Sum_probs=199.2
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCC--------CCceeeecceee---
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ--------HRNLVRLLGFSF--- 390 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~--- 390 (650)
.++|.+.++||+|+||.||+++. .+++.||||++.... .....+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47899999999999999999985 458899999997542 33456889999999985 788999999987
Q ss_pred -cCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEecCCCCCceEeCCCC-----
Q 006317 391 -EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDADM----- 463 (650)
Q Consensus 391 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlk~~NILl~~~~----- 463 (650)
.....++||||+ +++|.+++... ....+++..++.++.||+.||+|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 556789999999 55666666532 335699999999999999999999998 6 99999999999999775
Q ss_pred --------------------------------------------CeEEeeeecccccccCCCCCccceeecCccccChhc
Q 006317 464 --------------------------------------------IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499 (650)
Q Consensus 464 --------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~ 499 (650)
.+||+|||+++..... .....||..|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 8999999999865432 233578999999999
Q ss_pred cccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccc---hhHHHHHHhccC------------------CCcccccCc
Q 006317 500 VTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAE---DLLTYAWKNWNE------------------GTALNLIDP 558 (650)
Q Consensus 500 ~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~---~l~~~~~~~~~~------------------~~~~~~id~ 558 (650)
+.+..++.++|||||||++|||++|+.||......... +.+......... ......+..
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999754433221 111111111000 000000000
Q ss_pred cC-----------CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 559 TL-----------RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 559 ~l-----------~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.. ..........+.+++.+||+.||++|||+.|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 0113444567789999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=324.58 Aligned_cols=252 Identities=22% Similarity=0.296 Sum_probs=200.0
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---------hhHHHHHHHHHHHhhCC-CCceeeecceee
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---------QGELEFKNEVLLVARLQ-HRNLVRLLGFSF 390 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~g~~~ 390 (650)
..++|+..+.||+|+||.||+++.. +|+.||||++..... .....+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999865 588999999865431 12345789999999996 999999999999
Q ss_pred cCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeee
Q 006317 391 EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF 470 (650)
Q Consensus 391 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 470 (650)
.....++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999974 457999999999999999999999987 999999999999999999999999
Q ss_pred ecccccccCCCCCccceeecCccccChhccc------cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHH
Q 006317 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVT------RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAW 544 (650)
Q Consensus 471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~ 544 (650)
|++....... ......||..|+|||++. ...++.++||||||+++|||++|+.|+..... ........
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~ 242 (298)
T 1phk_A 169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLRMIM 242 (298)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH
T ss_pred cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---HHHHHHHh
Confidence 9998654322 233457899999999985 45688999999999999999999999853221 11111111
Q ss_pred HhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 545 KNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 545 ~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.. .. ....+ ........+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~----~~-~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 SG----NY-QFGSP----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HT----CC-CCCTT----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cC----Cc-ccCcc----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11 00 00000 00111234567788999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=341.48 Aligned_cols=251 Identities=10% Similarity=0.059 Sum_probs=178.2
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHHHHHHHhhC--CCCceeeec-------ce
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKNEVLLVARL--QHRNLVRLL-------GF 388 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l--~H~niv~l~-------g~ 388 (650)
....|...++||+|+||.||+|+.. +|+.||||++..... .....+.+|+.++..+ +||||++++ ++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 3456889999999999999999864 688999999987543 2334577785544444 699988755 33
Q ss_pred eecC-----------------CeeEEEEecCCCCChhHHHHhhhccCCCCHHHH------HHHHHHHHHHHHHhhhcCCC
Q 006317 389 SFEE-----------------TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETR------YKIIGGIARGILYLHEDSRL 445 (650)
Q Consensus 389 ~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~ 445 (650)
+... ...++||||++ |+|.+++... ...+.+..+ +.++.||+.||+|||+++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 3322 33799999999 8999999863 234566666 788899999999999987
Q ss_pred cEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhcccc--CCCCccccccchhHHHHHHHh
Q 006317 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIIS 523 (650)
Q Consensus 446 ~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvll~ellt 523 (650)
|+||||||+||||+.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 99999999999999999999999999986532 1213457799999999987 679999999999999999999
Q ss_pred CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC--C--CCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 524 GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL--R--NGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 524 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l--~--~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
|+.||......... .+............+ . ...+ ..+.+++.+||+.||++|||+.|+++
T Consensus 289 g~~Pf~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKG--------SWKRPSLRVPGTDSLAFGSCTPLP---DFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTT--------CCCBCCTTSCCCCSCCCTTSSCCC---HHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCccccc--------chhhhhhhhccccccchhhccCCC---HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99998744322110 000000000000011 1 1122 34556777999999999999999973
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.41 Aligned_cols=252 Identities=22% Similarity=0.305 Sum_probs=193.7
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--------hhHHHHHHHHHHHhhCCCCceeeecceeecC
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--------QGELEFKNEVLLVARLQHRNLVRLLGFSFEE 392 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 392 (650)
..++|.+.+.||+|+||.||+++.. +++.||||++..... .....+.+|+.++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999864 578999999875422 1223478999999999999999999998765
Q ss_pred CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC---eEEee
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI---PKISD 469 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~D 469 (650)
. .++||||+++++|.+++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 899999999999999886 3467999999999999999999999987 999999999999987664 99999
Q ss_pred eecccccccCCCCCccceeecCccccChhccc---cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHh
Q 006317 470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKN 546 (650)
Q Consensus 470 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~ 546 (650)
||+++..... .......||+.|+|||++. ...++.++||||||+++|||++|+.||....... .+.......
T Consensus 161 fg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~ 235 (322)
T 2ycf_A 161 FGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITSG 235 (322)
T ss_dssp CTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHHHT
T ss_pred Cccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHHhC
Confidence 9999865421 1223456899999999974 4678999999999999999999999986433221 122111111
Q ss_pred ccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 547 WNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 547 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
. . . ..+......+ ..+.+++.+||+.||++||++.|+++
T Consensus 236 ~----~-~-~~~~~~~~~~---~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 236 K----Y-N-FIPEVWAEVS---EKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp C----C-C-CCHHHHTTSC---HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c----c-c-cCchhhhhcC---HHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0 0 0 0000001112 34557788999999999999999984
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=333.82 Aligned_cols=258 Identities=22% Similarity=0.258 Sum_probs=189.7
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCC------
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEET------ 393 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 393 (650)
.++|+..+.||+|+||.||+++.. +++.||||++.... ......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999854 58899999997542 233456889999999999999999999987654
Q ss_pred eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecc
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 473 (650)
..++||||+++ +|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999975 6777764 35899999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC---
Q 006317 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG--- 550 (650)
Q Consensus 474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--- 550 (650)
+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... +............
T Consensus 175 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 175 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGTPCPE 248 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHC-CCCCCHH
T ss_pred cccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHH
Confidence 865422 1233457899999999999999999999999999999999999998643211 1111111100000
Q ss_pred ----------------------CcccccCccCCCC----ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 551 ----------------------TALNLIDPTLRNG----SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 551 ----------------------~~~~~id~~l~~~----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
...+.+....... .......+.+++.+||+.||++|||+.|+++-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000000000011 01123456788899999999999999999964
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=358.18 Aligned_cols=248 Identities=24% Similarity=0.265 Sum_probs=201.3
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 397 (650)
.++|++.++||+|+||.||+++.. +++.||||++++.. ......+..|..++..+ +||||+++++++.+.+..+|
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 467999999999999999999865 47789999997642 22344678899999887 79999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++...
T Consensus 420 V~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999974 357999999999999999999999987 9999999999999999999999999998543
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..++...... ..
T Consensus 494 ~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~---~~------- 558 (674)
T 3pfq_A 494 WD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSIME---HN------- 558 (674)
T ss_dssp CT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHS---SC-------
T ss_pred cC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC---HHHHHHHHHh---CC-------
Confidence 22 223445789999999999999999999999999999999999999986422 2222222211 10
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCH-----HHHHH
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTM-----ASVVV 594 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~-----~evl~ 594 (650)
..+...... ++.+|+..||+.||++||++ +||++
T Consensus 559 ~~~p~~~s~---~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 VAYPKSMSK---EAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CCCCTTSCH---HHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCCCccCCH---HHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111122233 34567779999999999997 77764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=343.01 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=193.7
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCe------eE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE------RL 396 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~ 396 (650)
..+|...++||+|+||.||+++...+..+|+|++...... ..+|+.+++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 4578899999999999999999877777999988654322 2369999999999999999999865433 78
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC-CCCCeEEeeeecccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPKISDFGMARL 475 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~~ 475 (650)
+||||++++.+............+++..++.++.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999987655544333334567999999999999999999999987 99999999999999 799999999999987
Q ss_pred cccCCCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC----
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG---- 550 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---- 550 (650)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +.+....+.....
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI---DQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHH
Confidence 643322 2335689999999998765 5899999999999999999999998643221 1111111111000
Q ss_pred ------CcccccCccCCCCChH------HHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 551 ------TALNLIDPTLRNGSSS------EIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 551 ------~~~~~id~~l~~~~~~------~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
...+..-+........ ....+.+++.+||+.||++|||+.|+++-
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000111111111 11356678889999999999999999964
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=339.46 Aligned_cols=202 Identities=28% Similarity=0.473 Sum_probs=155.1
Q ss_pred cCCCc-CCcccccCceeEEEeecc---CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeec--CCeeEE
Q 006317 324 NNFST-DNKLGQGGFGAVYKGRLS---HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE--ETERLL 397 (650)
Q Consensus 324 ~~f~~-~~~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 397 (650)
+.|++ .++||+|+||.||+++.. +++.||||++..... ...+.+|+.++++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34555 568999999999999865 478899999976533 2367899999999999999999999954 678899
Q ss_pred EEecCCCCChhHHHHhhh------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe----CCCCCeEE
Q 006317 398 IYEFVPNSSVDKFIFDAI------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL----DADMIPKI 467 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl----~~~~~~kl 467 (650)
||||+.+ +|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 7877775422 1224999999999999999999999987 9999999999999 77889999
Q ss_pred eeeecccccccCCC-CCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCC
Q 006317 468 SDFGMARLFEMDQS-QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFR 531 (650)
Q Consensus 468 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~ 531 (650)
+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99999987653221 1233456799999999999874 5899999999999999999999998643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=340.41 Aligned_cols=258 Identities=23% Similarity=0.328 Sum_probs=191.4
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecC----C--eeE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE----T--ERL 396 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----~--~~~ 396 (650)
.+|+..+.||+|+||.||+|+.. +|+.||||++..... ...+|++++++++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888899999999999999975 589999999865432 234699999999999999999988542 2 357
Q ss_pred EEEecCCCCChhHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC-CCeEEeeeeccc
Q 006317 397 LIYEFVPNSSVDKFIFDA-IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMAR 474 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~-~~~kl~DFGla~ 474 (650)
+||||+++ +|.+++... .....+++..++.++.||++||+|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 566665432 23567999999999999999999999987 9999999999999965 578999999998
Q ss_pred ccccCCCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccC----
Q 006317 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNE---- 549 (650)
Q Consensus 475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---- 549 (650)
.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .+.+....+....
T Consensus 206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~---~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG---VDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSCCHH
T ss_pred hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHH
Confidence 654322 22335789999999998765 789999999999999999999999864322 1111111111100
Q ss_pred ------CCcccccCccCCCCChH------HHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 550 ------GTALNLIDPTLRNGSSS------EIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 550 ------~~~~~~id~~l~~~~~~------~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
....+...+.+...... ....+.+|+.+||+.||++|||+.|+++.
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 01111111111111111 11356678889999999999999999853
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.44 Aligned_cols=267 Identities=21% Similarity=0.281 Sum_probs=187.6
Q ss_pred hHHhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCe--
Q 006317 318 TIRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE-- 394 (650)
Q Consensus 318 ~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-- 394 (650)
......++|++.++||+|+||.||+|+.. +|+.||||++...... ...+.+|+..+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34456688999999999999999999864 5889999998654322 2345678888899999999999999865433
Q ss_pred -----eEEEEecCCCCChhHHHHh-hhccCCCCHHHHHHHHHHHHHHHHHhh--hcCCCcEEecCCCCCceEeCC-CCCe
Q 006317 395 -----RLLIYEFVPNSSVDKFIFD-AIKRVQLDWETRYKIIGGIARGILYLH--EDSRLRIIHRDLKASNILLDA-DMIP 465 (650)
Q Consensus 395 -----~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~iiHrDlk~~NILl~~-~~~~ 465 (650)
.++||||+++ +|...+.. ......+++..++.++.||+.||.||| +.+ |+||||||+||||+. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999987 45544443 234567899999999999999999999 766 999999999999997 8999
Q ss_pred EEeeeecccccccCCCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHH
Q 006317 466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAW 544 (650)
Q Consensus 466 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~ 544 (650)
||+|||+++...... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...... ..+....
T Consensus 172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~~~ 245 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA---GQLHEIV 245 (360)
T ss_dssp EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH
T ss_pred EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH---HHHHHHH
Confidence 999999998665332 22335689999999998765 4899999999999999999999998643322 1111111
Q ss_pred Hh-----------ccCC-CcccccCc-------cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 545 KN-----------WNEG-TALNLIDP-------TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 545 ~~-----------~~~~-~~~~~id~-------~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.. +... ......+. .+..........+.+++.+||+.||++|||+.|+++-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11 1000 00000000 0011111233566788889999999999999999854
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=329.47 Aligned_cols=262 Identities=20% Similarity=0.308 Sum_probs=191.5
Q ss_pred ccCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceee-----------
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF----------- 390 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----------- 390 (650)
.++|...+.||+|+||.||+++... ++.||||++..........+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4678999999999999999998754 8899999998766666678999999999999999999998873
Q ss_pred ---cCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC-CCCCeE
Q 006317 391 ---EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPK 466 (650)
Q Consensus 391 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~-~~~~~k 466 (650)
+....++||||++ |+|.+++. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 69998874 356999999999999999999999987 99999999999997 567999
Q ss_pred EeeeecccccccCCC-CCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHH
Q 006317 467 ISDFGMARLFEMDQS-QGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAW 544 (650)
Q Consensus 467 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~ 544 (650)
|+|||+++....... ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...... +......
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL---EQMQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH
Confidence 999999987643221 122333467899999998876 67899999999999999999999998643221 1111111
Q ss_pred HhccCC---Ccccc-------cCccCC--CCC-----hHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 545 KNWNEG---TALNL-------IDPTLR--NGS-----SSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 545 ~~~~~~---~~~~~-------id~~l~--~~~-----~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
...... ...++ +..... ... ......+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 110000 00000 000000 000 0112345678889999999999999999863
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=333.84 Aligned_cols=263 Identities=19% Similarity=0.265 Sum_probs=199.1
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecC-----Ce
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEE-----TE 394 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 394 (650)
..++|+..++||+|+||.||+++.. +++.||||++..... .....+.+|+.++.+++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3568999999999999999999854 578899999975433 3345788999999999999999999998654 46
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.++||||+. |+|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 899999997 588888753 46999999999999999999999987 9999999999999999999999999998
Q ss_pred ccccCCCCC-ccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCc
Q 006317 475 LFEMDQSQG-DTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA 552 (650)
Q Consensus 475 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 552 (650)
......... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ .+............
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQ 253 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHHCSCCH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHhCCCCH
Confidence 765332221 2344679999999998765 458999999999999999999999986433222 11111111100000
Q ss_pred c-----------cccCccC--CCCC-----hHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 553 L-----------NLIDPTL--RNGS-----SSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 553 ~-----------~~id~~l--~~~~-----~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
. ....... .... ......+.+++.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000000 0000 0112345678889999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=340.68 Aligned_cols=199 Identities=22% Similarity=0.290 Sum_probs=170.9
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhC------CCCceeeecceeecCCe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARL------QHRNLVRLLGFSFEETE 394 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~ 394 (650)
...+|++.++||+|+||.||+++.. +++.||||++.... .....+.+|+.++..+ .|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 3467999999999999999999864 48899999997642 3334677888888776 57799999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC--eEEeeeec
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI--PKISDFGM 472 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~--~kl~DFGl 472 (650)
.++||||+. ++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 6899888753 2345999999999999999999999997 999999999999999987 99999999
Q ss_pred ccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCC
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR 531 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~ 531 (650)
++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 249 a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 249 SCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 975432 223357899999999999999999999999999999999999988643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=335.16 Aligned_cols=261 Identities=21% Similarity=0.275 Sum_probs=193.3
Q ss_pred HhhccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecC------
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------ 392 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 392 (650)
....++|...++||+|+||.||+++. .+|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999985 56899999998654322 24699999999999999999998442
Q ss_pred --------------------------------CeeEEEEecCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHh
Q 006317 393 --------------------------------TERLLIYEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYL 439 (650)
Q Consensus 393 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yL 439 (650)
...++||||++ |+|.+.+.... ....+++..++.++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999998 58888876532 356799999999999999999999
Q ss_pred hhcCCCcEEecCCCCCceEeC-CCCCeEEeeeecccccccCCCCCccceeecCccccChhccccC-CCCccccccchhHH
Q 006317 440 HEDSRLRIIHRDLKASNILLD-ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVL 517 (650)
Q Consensus 440 H~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvl 517 (650)
|+.+ |+||||||+|||++ .++.+||+|||+++...... ......||..|+|||++.+. .++.++||||||++
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9987 99999999999998 68899999999998664332 22345689999999998775 58999999999999
Q ss_pred HHHHHhCCCCCCCCCCcccchhHHHHHHhccCC----------CcccccCccCCCCCh------HHHHHHHHHHhccccc
Q 006317 518 VLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG----------TALNLIDPTLRNGSS------SEIMRCVHIGLLCVQE 581 (650)
Q Consensus 518 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----------~~~~~id~~l~~~~~------~~~~~~~~l~~~Cl~~ 581 (650)
+|||++|+.||..... .+.+.......... ...+..-+.+..... .....+.+++.+||+.
T Consensus 232 l~ell~g~~pf~~~~~---~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETS---IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999999864322 12221111111110 000000011111100 0113356778899999
Q ss_pred CCCCCCCHHHHHH
Q 006317 582 NVANRPTMASVVV 594 (650)
Q Consensus 582 ~p~~RPt~~evl~ 594 (650)
||++|||+.|+++
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999984
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=334.76 Aligned_cols=258 Identities=24% Similarity=0.323 Sum_probs=182.2
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeecccc--CchhHHHHHHHHHHHhhCCCCceeeecceeecC------
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------ 392 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 392 (650)
..++|+..+.||+|+||.||+|+. .+|+.||||++... .......+.+|+.++++++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 357899999999999999999985 46889999999654 223445788999999999999999999998654
Q ss_pred CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeec
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 472 (650)
...++|+|++ +++|.+++.. ..+++..++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999999 6899988753 56999999999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC-
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG- 550 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~- 550 (650)
++.... ......||..|+|||++.+ ..++.++||||||+++|||++|+.||..... .+.+..........
T Consensus 179 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~p~ 250 (367)
T 2fst_X 179 ARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTPG 250 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCC
T ss_pred cccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCC
Confidence 986432 1234578999999999887 6789999999999999999999999864322 12222111111100
Q ss_pred ----------CcccccCc--cCCCCChH-----HHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 551 ----------TALNLIDP--TLRNGSSS-----EIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 551 ----------~~~~~id~--~l~~~~~~-----~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.....+.. ........ ....+.+++.+||+.||++|||+.|+++-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000000 00000111 11345678889999999999999999865
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=330.05 Aligned_cols=262 Identities=21% Similarity=0.276 Sum_probs=200.5
Q ss_pred hccCCCcCCcccccCceeEEEeec--cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCc------eeeecceeecCC
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL--SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN------LVRLLGFSFEET 393 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~ 393 (650)
..++|++.+.||+|+||.||++.. .+++.||||+++... .....+.+|+.++.+++|++ ++++++++...+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 346899999999999999999985 358899999997542 33456888999998887654 999999999999
Q ss_pred eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC------------
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA------------ 461 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~------------ 461 (650)
..++||||+ +++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred cEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 999999999 88999998753 2346899999999999999999999987 999999999999988
Q ss_pred -------CCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCc
Q 006317 462 -------DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGE 534 (650)
Q Consensus 462 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~ 534 (650)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+......
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 67899999999976432 123457899999999999999999999999999999999999998754322
Q ss_pred ccchhHHHHH--------HhccCCCcc------------------cccCcc--CCCCChHHHHHHHHHHhcccccCCCCC
Q 006317 535 EAEDLLTYAW--------KNWNEGTAL------------------NLIDPT--LRNGSSSEIMRCVHIGLLCVQENVANR 586 (650)
Q Consensus 535 ~~~~l~~~~~--------~~~~~~~~~------------------~~id~~--l~~~~~~~~~~~~~l~~~Cl~~~p~~R 586 (650)
+......... ......... ....+. ...........+.+++.+||+.||++|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 2111111110 000000000 000000 001122344567788999999999999
Q ss_pred CCHHHHHH
Q 006317 587 PTMASVVV 594 (650)
Q Consensus 587 Pt~~evl~ 594 (650)
||+.|+++
T Consensus 321 pt~~ell~ 328 (339)
T 1z57_A 321 ITLREALK 328 (339)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999974
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=333.35 Aligned_cols=261 Identities=22% Similarity=0.314 Sum_probs=201.4
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchh-----------------HHHHHHHHHHHhhCCCCceeee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQG-----------------ELEFKNEVLLVARLQHRNLVRL 385 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~l 385 (650)
.++|.+.+.||+|+||.||+++. +++.||||++....... ...+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 89999999987543221 1678999999999999999999
Q ss_pred cceeecCCeeEEEEecCCCCChhHH------HHhhhccCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEecCCCCCceE
Q 006317 386 LGFSFEETERLLIYEFVPNSSVDKF------IFDAIKRVQLDWETRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNIL 458 (650)
Q Consensus 386 ~g~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlk~~NIL 458 (650)
++++.+.+..++||||+++++|.++ +... ....+++..++.++.||+.||.|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 4321 25679999999999999999999998 76 999999999999
Q ss_pred eCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccC-CCCc-cccccchhHHHHHHHhCCCCCCCCCCccc
Q 006317 459 LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSI-KSDVFSFGVLVLEIISGQKNNSFRIGEEA 536 (650)
Q Consensus 459 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~sDV~S~Gvll~elltG~~p~~~~~~~~~ 536 (650)
++.++.+||+|||++...... ......||..|+|||.+.+. .++. ++||||||+++|||++|+.|+......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 999999999999999865432 23345789999999999887 6666 999999999999999999998643321
Q ss_pred chhHHHHHHhcc-CCC-cccccCccCCCC----ChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 537 EDLLTYAWKNWN-EGT-ALNLIDPTLRNG----SSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 537 ~~l~~~~~~~~~-~~~-~~~~id~~l~~~----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.+.......... ... ......+..... .......+.+++.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 122221111100 000 000000000000 0111234567778999999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.57 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=197.2
Q ss_pred hhccCCCcCCcccccCceeEEEeec--cCCcceeEeeccccCch--hHHHHHHHHHHHhhC---CCCceeeecceee---
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRL--SHGQEIAVKRLSKNSVQ--GELEFKNEVLLVARL---QHRNLVRLLGFSF--- 390 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~g~~~--- 390 (650)
.+.++|++.+.||+|+||.||+++. .+|+.||||++...... ....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4567899999999999999999986 45788999998654321 122466777777666 8999999999987
Q ss_pred --cCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEe
Q 006317 391 --EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS 468 (650)
Q Consensus 391 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 468 (650)
.....++||||++ |+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999998 6999998753 2345999999999999999999999987 9999999999999999999999
Q ss_pred eeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhcc
Q 006317 469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWN 548 (650)
Q Consensus 469 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 548 (650)
|||+++...... ......||..|+|||++.+..++.++||||||+++|||++|+.|+..... .+.+........
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~ 236 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIG 236 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHC
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHHcC
Confidence 999998654221 23345789999999999999999999999999999999999999864322 122211111110
Q ss_pred --------CCCcc--cccC----c---cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 549 --------EGTAL--NLID----P---TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 549 --------~~~~~--~~id----~---~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
..... ..+. . .+....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID---ELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC---HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCC---HHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 0000 0 0111122 34456778999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=333.20 Aligned_cols=263 Identities=22% Similarity=0.312 Sum_probs=196.9
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecC-----Ce
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEE-----TE 394 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 394 (650)
..++|...+.||+|+||.||+++.. +|+.||||++..... .....+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999999999999865 588999999975432 3345688999999999999999999987654 67
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.++||||+. ++|.+++.. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 589888753 46999999999999999999999987 9999999999999999999999999998
Q ss_pred ccccCCCCC--------ccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHH
Q 006317 475 LFEMDQSQG--------DTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWK 545 (650)
Q Consensus 475 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~ 545 (650)
......... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||...... +.+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR---HQLLLIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHH
Confidence 765322111 1223578999999998765 67899999999999999999999998643211 11111111
Q ss_pred hccCCC---ccc---------ccC--ccCCCCC-----hHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 546 NWNEGT---ALN---------LID--PTLRNGS-----SSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 546 ~~~~~~---~~~---------~id--~~l~~~~-----~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
...... ... .+. +...... ......+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 111000 000 000 0000000 0112345678889999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=320.43 Aligned_cols=252 Identities=27% Similarity=0.354 Sum_probs=199.4
Q ss_pred hhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
...++|++.++||+|+||.||+++.. +++.||||++.... ......+.+|+.++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999865 68899999986543 2345678999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC---CCeEEeeeeccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD---MIPKISDFGMAR 474 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~---~~~kl~DFGla~ 474 (650)
||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||||+|||++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999998864 357999999999999999999999987 9999999999999764 469999999998
Q ss_pred ccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
...... ......||..|+|||.+.+ .++.++||||||+++|||++|+.|+.... ..+....... +...
T Consensus 173 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~----~~~~- 240 (287)
T 2wei_A 173 CFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVET----GKYA- 240 (287)
T ss_dssp TBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH----CCCC-
T ss_pred eecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHc----CCCC-
Confidence 654322 2223468999999998875 58999999999999999999999986332 1122221111 1100
Q ss_pred ccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 555 LIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 555 ~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.+.......+. .+.+++.+||+.||++|||+.|+++
T Consensus 241 -~~~~~~~~~~~---~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 -FDLPQWRTISD---DAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -CCSGGGTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCchhhhhcCH---HHHHHHHHHcccChhhCcCHHHHhc
Confidence 00000011222 4556777999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=358.35 Aligned_cols=255 Identities=22% Similarity=0.340 Sum_probs=199.2
Q ss_pred hccCCCcCCcccccCceeEEEeeccC----CcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 396 (650)
..++|+..+.||+|+||.||+|++.. +..||||++..... .....+.+|+.++++++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 44678888999999999999998643 45699999876433 33457899999999999999999999985 45689
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
+||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 99999999999999974 3456999999999999999999999987 999999999999999999999999999876
Q ss_pred ccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.... ..+..........
T Consensus 542 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~---~~~~~~~i~~~~~------- 610 (656)
T 2j0j_A 542 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---NNDVIGRIENGER------- 610 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHHTCC-------
T ss_pred CCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHcCCC-------
Confidence 43221 12233457889999999999999999999999999999997 888875322 1222222211110
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
..+....+. .+.+++.+||+.||++|||+.||++.|+.
T Consensus 611 --~~~~~~~~~---~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 611 --LPMPPNCPP---TLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp --CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCccccH---HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111122233 45567779999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.88 Aligned_cols=253 Identities=25% Similarity=0.413 Sum_probs=189.2
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeec----------
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE---------- 391 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------- 391 (650)
.++|+..+.||+|+||.||+++.. +++.||||++... ......+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 467899999999999999999864 6889999999653 2344578899999999999999999998765
Q ss_pred ---CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEe
Q 006317 392 ---ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS 468 (650)
Q Consensus 392 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 468 (650)
....++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 3567899999999999999975 3456889999999999999999999987 9999999999999999999999
Q ss_pred eeecccccccCCC------------CCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcc
Q 006317 469 DFGMARLFEMDQS------------QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535 (650)
Q Consensus 469 DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~ 535 (650)
|||+++....... ........||..|+|||++.+. .++.++||||||+++|||++ |+.. ...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~--~~~ 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST--GME 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS--HHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC--chh
Confidence 9999986542210 1123345689999999999864 78999999999999999998 3321 111
Q ss_pred cchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 536 AEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 536 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
........ .... ..+.+.+..... ..+.+++.+||+.||.+|||+.++++.
T Consensus 234 ~~~~~~~~----~~~~--~~~~~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 RVNILKKL----RSVS--IEFPPDFDDNKM---KVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHH----HSTT--CCCCTTCCTTTS---HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhc----cccc--cccCccccccch---HHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 11111111 1100 011111222222 345567789999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=327.35 Aligned_cols=262 Identities=19% Similarity=0.258 Sum_probs=197.1
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCC-----------CCceeeecceee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-----------HRNLVRLLGFSF 390 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~ 390 (650)
.++|.+.+.||+|+||.||+++. .+++.||||++.... .....+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36799999999999999999985 468899999997543 33456788999998886 899999999987
Q ss_pred cCC----eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEecCCCCCceEeC-----
Q 006317 391 EET----ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLD----- 460 (650)
Q Consensus 391 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlk~~NILl~----- 460 (650)
..+ ..++||||+ +++|.+++... ....+++..++.++.||+.||+|||++ + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 789999999 88999998753 345699999999999999999999997 7 99999999999994
Q ss_pred -CCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCccc---
Q 006317 461 -ADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEA--- 536 (650)
Q Consensus 461 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~--- 536 (650)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4458999999999865432 2234789999999999999999999999999999999999999874432211
Q ss_pred chhHHHHHHhc------------------cCCCcccccCcc-----------CCCCChHHHHHHHHHHhcccccCCCCCC
Q 006317 537 EDLLTYAWKNW------------------NEGTALNLIDPT-----------LRNGSSSEIMRCVHIGLLCVQENVANRP 587 (650)
Q Consensus 537 ~~l~~~~~~~~------------------~~~~~~~~id~~-----------l~~~~~~~~~~~~~l~~~Cl~~~p~~RP 587 (650)
.+.+....... ........+... ...........+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 11111111100 000000000000 0011234456677899999999999999
Q ss_pred CHHHHHHH
Q 006317 588 TMASVVVM 595 (650)
Q Consensus 588 t~~evl~~ 595 (650)
|+.|+++.
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=329.98 Aligned_cols=207 Identities=22% Similarity=0.295 Sum_probs=172.6
Q ss_pred hhhHHhhccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCC-CC-----ceeeecce
Q 006317 316 FSTIRDATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HR-----NLVRLLGF 388 (650)
Q Consensus 316 ~~~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~ 388 (650)
........++|++.++||+|+||.||+|+.. +++.||||+++... ....++..|+.++..++ |+ +|++++++
T Consensus 46 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 46 VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred eecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 3444456789999999999999999999864 57889999997542 33446778888888875 55 49999999
Q ss_pred eecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC--CCCCeE
Q 006317 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--ADMIPK 466 (650)
Q Consensus 389 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~--~~~~~k 466 (650)
+...+..++||||++ ++|.+++... ....+++..+..++.||+.||.|||++ ..+|+||||||+||||+ .++.+|
T Consensus 125 ~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEETTEEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEE
T ss_pred eccCCceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEE
Confidence 999999999999996 5999998753 234699999999999999999999963 12499999999999995 478899
Q ss_pred EeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCC
Q 006317 467 ISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR 531 (650)
Q Consensus 467 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~ 531 (650)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 202 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 202 IVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp ECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999865422 23457899999999999999999999999999999999999998743
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.39 Aligned_cols=255 Identities=24% Similarity=0.345 Sum_probs=176.4
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHH-HHhhCCCCceeeecceeecCCeeEEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVL-LVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
.++|+..+.||+|+||.||+++.. +|+.||||++..... ....++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467889999999999999999874 688999999976533 23345556665 777889999999999999999999999
Q ss_pred ecCCCCChhHHHHhhh--ccCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 400 EFVPNSSVDKFIFDAI--KRVQLDWETRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
||+++ +|.+++.... ....+++..++.++.|++.||.|||+. + |+||||||+||||+.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 8888775421 256799999999999999999999998 7 999999999999999999999999999865
Q ss_pred ccCCCCCccceeecCccccChhcc----ccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCc
Q 006317 477 EMDQSQGDTSRIVGTFGYMAPEYV----TRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA 552 (650)
Q Consensus 477 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 552 (650)
.... ......||..|+|||++ .+..++.++||||||+++|||++|+.|+...... ...... ...+..
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~-~~~~~~ 247 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-----FDQLTQ-VVKGDP 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-CCCSCC
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-----HHHHHH-HhcCCC
Confidence 4322 22234689999999998 4567899999999999999999999998632110 000000 000000
Q ss_pred ccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 553 LNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 553 ~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.. +......... ..+.+++.+||+.||++|||+.||++
T Consensus 248 ~~-~~~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQ-LSNSEEREFS---PSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CC-CCCCSSCCCC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC-CCCcccccCC---HHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00 0111111122 34556777999999999999999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=329.57 Aligned_cols=257 Identities=24% Similarity=0.339 Sum_probs=193.1
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCee---
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETER--- 395 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~--- 395 (650)
..++|...+.||+|+||.||+++.. +|+.||||++..... .....+.+|+.++++++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 3578999999999999999999854 588999999976432 2345788999999999999999999999877654
Q ss_pred ---EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeec
Q 006317 396 ---LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472 (650)
Q Consensus 396 ---~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 472 (650)
++||||+. ++|.+++. ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 57877653 35999999999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC-
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG- 550 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~- 550 (650)
++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .+.+..........
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~ 262 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPG 262 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCC
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCc
Confidence 9855422 233568999999999887 6889999999999999999999999864321 11111111110000
Q ss_pred ----------Ccccc---cCccCCCC----ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 551 ----------TALNL---IDPTLRNG----SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 551 ----------~~~~~---id~~l~~~----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..... +....... .......+.+++.+||+.||++|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000 00000000 00112355678889999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.06 Aligned_cols=242 Identities=24% Similarity=0.454 Sum_probs=189.1
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCch------hHHHHHHHHHHHhhC----CCCceeeecceee
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ------GELEFKNEVLLVARL----QHRNLVRLLGFSF 390 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l----~H~niv~l~g~~~ 390 (650)
..++|+..+.||+|+||.||+++. .+++.||||++...... ....+.+|+.++.++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 457899999999999999999986 45889999999765332 122356789999888 8999999999999
Q ss_pred cCCeeEEEEec-CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC-CCCCeEEe
Q 006317 391 EETERLLIYEF-VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPKIS 468 (650)
Q Consensus 391 ~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~ 468 (650)
..+..++|||+ +.+++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++ +++.+||+
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEE
Confidence 99999999999 789999999974 456999999999999999999999997 99999999999999 88999999
Q ss_pred eeecccccccCCCCCccceeecCccccChhccccCCCC-ccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhc
Q 006317 469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFS-IKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNW 547 (650)
Q Consensus 469 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 547 (650)
|||+++..... ......||..|+|||++.+..+. .++||||||+++|||++|+.|+... .... ..
T Consensus 183 dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~----~~- 248 (312)
T 2iwi_A 183 DFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----QEIL----EA- 248 (312)
T ss_dssp CCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHHH----HT-
T ss_pred EcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-----HHHh----hh-
Confidence 99999876532 22345689999999999877664 5899999999999999999998521 0100 00
Q ss_pred cCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 548 NEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 548 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
...+...... .+.+++.+||+.||++|||+.|+++.
T Consensus 249 ---------~~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 249 ---------ELHFPAHVSP---DCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---------CCCCCTTSCH---HHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------ccCCcccCCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011112223 34567779999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=325.03 Aligned_cols=261 Identities=18% Similarity=0.249 Sum_probs=196.8
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CC-cceeEeeccccCchhHHHHHHHHHHHhhCCCCc------eeeecceeecCCe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HG-QEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN------LVRLLGFSFEETE 394 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 394 (650)
.++|++.+.||+|+||.||+++.. ++ +.||||+++... .....+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 478999999999999999999864 34 689999997542 34456888999999987766 8999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe---------------
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL--------------- 459 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl--------------- 459 (650)
.++||||+ +++|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 56777766542 2346999999999999999999999987 9999999999999
Q ss_pred ----CCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcc
Q 006317 460 ----DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535 (650)
Q Consensus 460 ----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~ 535 (650)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 56789999999999764321 233578999999999999999999999999999999999999986433221
Q ss_pred cchhHHHHH--------HhccCCCccc------------------ccCc--cCCCCChHHHHHHHHHHhcccccCCCCCC
Q 006317 536 AEDLLTYAW--------KNWNEGTALN------------------LIDP--TLRNGSSSEIMRCVHIGLLCVQENVANRP 587 (650)
Q Consensus 536 ~~~l~~~~~--------~~~~~~~~~~------------------~id~--~l~~~~~~~~~~~~~l~~~Cl~~~p~~RP 587 (650)
......... .......... ...+ ........+...+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 111111100 0000000000 0000 00011223345677889999999999999
Q ss_pred CHHHHHH
Q 006317 588 TMASVVV 594 (650)
Q Consensus 588 t~~evl~ 594 (650)
|+.|+++
T Consensus 327 t~~e~l~ 333 (355)
T 2eu9_A 327 TLAEALL 333 (355)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999973
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=327.22 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=192.7
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeecCCe-----
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE----- 394 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 394 (650)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467889999999999999999864 58899999997643 2234568899999999999999999999987654
Q ss_pred -eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecc
Q 006317 395 -RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473 (650)
Q Consensus 395 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 473 (650)
.++||||+. ++|.+++. ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 58887763 35999999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccC---
Q 006317 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNE--- 549 (650)
Q Consensus 474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--- 549 (650)
+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .+.+.........
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGT 245 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH---HHHHHHHHHHHCBCCH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCH
Confidence 764321 234578999999999887 6789999999999999999999999864321 1111111111000
Q ss_pred --------CCc-------ccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 550 --------GTA-------LNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 550 --------~~~-------~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
... .....+.+..........+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 0000011111111122345677789999999999999999854
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.19 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=176.9
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch-hH-HHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ-GE-LEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
-++|+..+.||+|+||.||+++.. +|+.||||++...... .. ..+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999875 6889999999765432 22 23445556788889999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
||+ ++.+..+... ....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4455554432 346799999999999999999999985 6 99999999999999999999999999976543
Q ss_pred CCCCCccceeecCccccChhccc-----cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 553 (650)
.. ......||+.|+|||++. ...++.++||||||+++|||++|+.||..... ..+.........
T Consensus 178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~------ 246 (318)
T 2dyl_A 178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQEE------ 246 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHHSC------
T ss_pred Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHHHhccC------
Confidence 22 223456899999999984 55788999999999999999999999863211 111221111110
Q ss_pred cccCccCC--CCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 554 NLIDPTLR--NGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 554 ~~id~~l~--~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.+.+. ...+. .+.+++.+||+.||.+||++.|+++
T Consensus 247 ---~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 ---PPLLPGHMGFSG---DFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ---CCCCCSSSCCCH---HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CCCCCccCCCCH---HHHHHHHHHccCChhHCcCHHHHhh
Confidence 01111 11223 3456777999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.31 Aligned_cols=243 Identities=25% Similarity=0.398 Sum_probs=196.9
Q ss_pred hhccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCch------hHHHHHHHHHHHhhCC--CCceeeecceeec
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ------GELEFKNEVLLVARLQ--HRNLVRLLGFSFE 391 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~g~~~~ 391 (650)
...++|+..+.||+|+||.||+|+. .+++.||||++...... ....+.+|+.++++++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 4457899999999999999999985 46889999999765322 1234678999999996 5999999999999
Q ss_pred CCeeEEEEecCCC-CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC-CCCCeEEee
Q 006317 392 ETERLLIYEFVPN-SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPKISD 469 (650)
Q Consensus 392 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~D 469 (650)
.+..++|||++.+ ++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+||||+ +++.+||+|
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred CCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999986 899999874 467999999999999999999999987 99999999999999 789999999
Q ss_pred eecccccccCCCCCccceeecCccccChhccccCCC-CccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhcc
Q 006317 470 FGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWN 548 (650)
Q Consensus 470 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 548 (650)
||+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.|+.... . . ..
T Consensus 194 fg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~---~-~~--- 257 (320)
T 3a99_A 194 FGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E---I-IR--- 257 (320)
T ss_dssp CTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H---H-HH---
T ss_pred Cccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----h---h-hc---
Confidence 9999866432 2234568999999999987766 688999999999999999999985211 0 0 00
Q ss_pred CCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 549 EGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 549 ~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
.. ..+....+. .+.+++.+||+.||++|||+.||++.
T Consensus 258 ~~-------~~~~~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 258 GQ-------VFFRQRVSS---ECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CC-------CCCSSCCCH---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cc-------ccccccCCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 011122233 34567779999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=323.17 Aligned_cols=254 Identities=20% Similarity=0.238 Sum_probs=170.3
Q ss_pred hccCCCcCC-cccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeec----CCee
Q 006317 322 ATNNFSTDN-KLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE----ETER 395 (650)
Q Consensus 322 ~~~~f~~~~-~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 395 (650)
..++|.+.+ +||+|+||.||+++.. +|+.||||++..... ...+....+..++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 346788854 6999999999999875 589999999865321 12223344667799999999999876 4457
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC---CCCeEEeeeec
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGM 472 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGl 472 (650)
++||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999999753 2346999999999999999999999987 999999999999986 45599999999
Q ss_pred ccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCc
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA 552 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 552 (650)
++..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||............ ....... .
T Consensus 178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~-~ 249 (336)
T 3fhr_A 178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLG-Q 249 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhcc-c
Confidence 9865422 223457899999999998888999999999999999999999998643322110000 0000000 0
Q ss_pred ccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 553 LNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 553 ~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
... ........+ ..+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~-~~~~~~~~~---~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 250 YGF-PNPEWSEVS---EDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -CC-CTTTSTTCC---HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccc-CchhhccCC---HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 000001122 345567779999999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=335.21 Aligned_cols=253 Identities=21% Similarity=0.320 Sum_probs=186.8
Q ss_pred HhhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEE
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 398 (650)
.....+|...++||+|+||+||.....+++.||||++...... .+.+|+.+++++ +|||||++++++.+....++|
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 3445678999999999999966554557899999999765433 346799999999 799999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC-----CCCeEEeeeecc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-----DMIPKISDFGMA 473 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~-----~~~~kl~DFGla 473 (650)
|||+. |+|.+++.. ....+.+..++.++.||+.||+|||+.+ |+||||||+||||+. ...+||+|||++
T Consensus 97 ~E~~~-g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 97 IELCA-ATLQEYVEQ--KDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EECCS-EEHHHHHHS--SSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EECCC-CCHHHHHHh--cCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 99996 599999874 2334556667899999999999999987 999999999999953 336889999999
Q ss_pred cccccCCC-CCccceeecCccccChhccc---cCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhcc
Q 006317 474 RLFEMDQS-QGDTSRIVGTFGYMAPEYVT---RGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWN 548 (650)
Q Consensus 474 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 548 (650)
+....... ........||+.|+|||++. ...++.++|||||||++|||++ |+.|+...... .... ..
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----~~~~---~~- 242 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----QANI---LL- 242 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----HHHH---HT-
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----HHHH---Hh-
Confidence 87653321 12334467999999999997 4567889999999999999999 88887422111 1111 10
Q ss_pred CCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 549 EGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 549 ~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
....... + .........+.+++.+||+.||++|||+.||++
T Consensus 243 ~~~~~~~----~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 243 GACSLDC----L-HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TCCCCTT----S-CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCccc----c-CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1000111 1 111223344567888999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=333.84 Aligned_cols=253 Identities=23% Similarity=0.265 Sum_probs=183.6
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEEEecC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
+.|...++||+|+||+||.+...+|+.||||++.... ...+.+|+.++.++ +||||+++++++.+++..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 3455568899999999987666679999999986532 33578899999876 8999999999999999999999999
Q ss_pred CCCChhHHHHhhhccC----CCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC-------------CCe
Q 006317 403 PNSSVDKFIFDAIKRV----QLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-------------MIP 465 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~-------------~~~ 465 (650)
. |+|.+++....... ..++..++.++.||+.||+|||+.+ |+||||||+||||+.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 69999997532111 1133456789999999999999987 9999999999999754 489
Q ss_pred EEeeeecccccccCCCCC--ccceeecCccccChhcccc-------CCCCccccccchhHHHHHHHh-CCCCCCCCCCcc
Q 006317 466 KISDFGMARLFEMDQSQG--DTSRIVGTFGYMAPEYVTR-------GHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEE 535 (650)
Q Consensus 466 kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~ 535 (650)
||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.|+.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999998765432211 2234579999999999975 678999999999999999999 888885322111
Q ss_pred cchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 536 AEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 536 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
........... ............++.+++.+||+.||++|||+.||++
T Consensus 248 ----~~i~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 ----SNIIRGIFSLD-------EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----HHHHHTCCCCC-------CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHHhcCCCCcc-------cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11111110000 0000112233456778888999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=343.97 Aligned_cols=259 Identities=24% Similarity=0.321 Sum_probs=194.9
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeecccc-CchhHHHHHHHHHHHhhCCCCceeeecceeec------CCe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFE------ETE 394 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 394 (650)
.++|++.++||+|+||.||++... +|+.||||++... .......+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999864 5889999998765 33345578999999999999999999998765 667
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCC---eEEeeee
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMI---PKISDFG 471 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~---~kl~DFG 471 (650)
.++||||+++|+|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999986444456999999999999999999999987 999999999999997765 9999999
Q ss_pred cccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHh-----
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKN----- 546 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~----- 546 (650)
++....... ......||..|+|||++.+..++.++||||||+++|||++|+.||..... ...|....
T Consensus 170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC----
T ss_pred ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccc
Confidence 998664322 23346789999999999999999999999999999999999999863210 00000000
Q ss_pred ---ccCCCccc--ccCccC---CCCChHHHHHHHHHHhcccccCCCCCCCHHHH
Q 006317 547 ---WNEGTALN--LIDPTL---RNGSSSEIMRCVHIGLLCVQENVANRPTMASV 592 (650)
Q Consensus 547 ---~~~~~~~~--~id~~l---~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~ev 592 (650)
........ .+...+ ..........+.+++..||+.||++|||+.|+
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 00000000 000111 11122334566788889999999999999763
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=342.17 Aligned_cols=236 Identities=18% Similarity=0.285 Sum_probs=188.3
Q ss_pred ccCCCcCCcccccCceeEEEeecc--CCcceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCe-----
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS--HGQEIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETE----- 394 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 394 (650)
.++|++.++||+|+||.||+++.. +|+.||||++.... ......+.+|+.++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999865 58899999986543 2344568899999999999999999999987655
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.+|||||+++++|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+||||+++ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 699999999999998764 26999999999999999999999987 9999999999999986 99999999998
Q ss_pred ccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
..... ....||+.|+|||++.++. +.++|||||||++|||++|..|+.......
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------- 283 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------- 283 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------------
Confidence 65422 3457999999999987754 899999999999999999987764211000
Q ss_pred ccCccCCCC-ChHHHHHHHHHHhcccccCCCCCCC-HHHHHHHhc
Q 006317 555 LIDPTLRNG-SSSEIMRCVHIGLLCVQENVANRPT-MASVVVMLN 597 (650)
Q Consensus 555 ~id~~l~~~-~~~~~~~~~~l~~~Cl~~~p~~RPt-~~evl~~L~ 597 (650)
+ .... .......+.+++.+||+.||++||+ ++++.+.|.
T Consensus 284 -~---~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 284 -L---PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp -C---CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -c---cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 0000 0111245667888999999999995 555655554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=301.33 Aligned_cols=227 Identities=10% Similarity=0.055 Sum_probs=177.7
Q ss_pred cCCCcCCcccccCceeEEEeeccC-CcceeEeeccccCch---hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|++.+.||+|+||.||+++... ++.||||++...... ....+.+|+..+.+++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 678999999999999999998754 899999999765332 2357899999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++++|.+++.. .....++.+++.||+.||+|||+++ |+||||||+||||++++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~-----~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhc-----CCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999842 2456678999999999999999997 9999999999999999999997443
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc-
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP- 558 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~- 558 (650)
|++| ++.++||||||+++|||+||+.||............ ...... . ...+
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~~~-~---~~~~~ 226 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDTAG-Q---PIEPA 226 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCTTS-C---BCCHH
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHhcc-C---CCChh
Confidence 3433 688999999999999999999998743322110000 000000 0 0000
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.+....+. .+.+++.+||+.||++| |+.|+++.|+.
T Consensus 227 ~~~~~~~~---~l~~li~~~l~~dP~~R-s~~el~~~L~~ 262 (286)
T 3uqc_A 227 DIDRDIPF---QISAVAARSVQGDGGIR-SASTLLNLMQQ 262 (286)
T ss_dssp HHCTTSCH---HHHHHHHHHHCTTSSCC-CHHHHHHHHHH
T ss_pred hcccCCCH---HHHHHHHHHcccCCccC-CHHHHHHHHHH
Confidence 01111222 35567789999999999 99999999976
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=324.65 Aligned_cols=243 Identities=15% Similarity=0.124 Sum_probs=178.1
Q ss_pred hhccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCch---hHHHHHHHHHHHhhCCC-Cceeeecc--------
Q 006317 321 DATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQH-RNLVRLLG-------- 387 (650)
Q Consensus 321 ~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H-~niv~l~g-------- 387 (650)
..+..|...++||+|+||.||+|+. .+|+.||||++...... ....+.+|+.++..++| +|......
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 3445678889999999999999994 56899999998743322 34578999999999987 32211111
Q ss_pred -------------eeec-----CCeeEEEEecCCCCChhHHHHhh----hccCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 006317 388 -------------FSFE-----ETERLLIYEFVPNSSVDKFIFDA----IKRVQLDWETRYKIIGGIARGILYLHEDSRL 445 (650)
Q Consensus 388 -------------~~~~-----~~~~~lv~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 445 (650)
+... ....+++|+++ +++|.+++... .....+++..++.++.||++||+|||+++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 231 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 231 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 1111 12356677765 68999988532 12445888999999999999999999987
Q ss_pred cEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhcc----------ccCCCCccccccchh
Q 006317 446 RIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV----------TRGHFSIKSDVFSFG 515 (650)
Q Consensus 446 ~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~sDV~S~G 515 (650)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++||||||
T Consensus 232 -iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG 304 (413)
T 3dzo_A 232 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG 304 (413)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred -cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence 999999999999999999999999998764422 334567 999999999 555688999999999
Q ss_pred HHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHH
Q 006317 516 VLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVV 593 (650)
Q Consensus 516 vll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl 593 (650)
|++|||++|+.||......... ..++.. . ...++ .+.+++..||+.||++||++.+++
T Consensus 305 vil~elltg~~Pf~~~~~~~~~---------------~~~~~~-~-~~~~~---~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 305 LAIYWIWCADLPNTDDAALGGS---------------EWIFRS-C-KNIPQ---PVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHHHSSCCCCTTGGGSCS---------------GGGGSS-C-CCCCH---HHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHHHCCCCCCCcchhhhH---------------HHHHhh-c-ccCCH---HHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999999998643221110 011110 0 11223 455677799999999999977765
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=298.70 Aligned_cols=227 Identities=20% Similarity=0.220 Sum_probs=174.1
Q ss_pred cCCCcC-CcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHH-hhCCCCceeeecceeec----CCeeE
Q 006317 324 NNFSTD-NKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLV-ARLQHRNLVRLLGFSFE----ETERL 396 (650)
Q Consensus 324 ~~f~~~-~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~ 396 (650)
++|... +.||+|+||.||++.. .+++.||||++... ..+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456666 7899999999999986 45889999998642 3567788887 66699999999999876 66789
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC---CCCeEEeeeecc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMA 473 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGla 473 (650)
+||||+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999999753 2346999999999999999999999987 999999999999998 789999999998
Q ss_pred cccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcc
Q 006317 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553 (650)
Q Consensus 474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 553 (650)
.... +..++.++||||||+++|||++|+.||........ . ....
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-------~-----~~~~ 211 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------S-----PGMK 211 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCSC
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-------h-----HHHH
Confidence 6432 23457899999999999999999999863221110 0 0000
Q ss_pred cccCccCCCCCh----HHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 554 NLIDPTLRNGSS----SEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 554 ~~id~~l~~~~~----~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..+......... .....+.+++.+||+.||++|||+.|+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000000010 112345677789999999999999999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-35 Score=306.26 Aligned_cols=191 Identities=17% Similarity=0.175 Sum_probs=158.5
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCc--------hhHHHHHHHHHHHhhCC---------CCceeee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV--------QGELEFKNEVLLVARLQ---------HRNLVRL 385 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~---------H~niv~l 385 (650)
.++|+..++||+|+||.||+++. +|+.||||++..... .....+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 36788899999999999999998 689999999976532 22357889999998886 5555554
Q ss_pred -----------------cceeec-------------CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHH
Q 006317 386 -----------------LGFSFE-------------ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARG 435 (650)
Q Consensus 386 -----------------~g~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 435 (650)
++++.+ ....++||||+++|++.+.+. +..+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 444443 678999999999997666553 2568999999999999999
Q ss_pred HHHhh-hcCCCcEEecCCCCCceEeCCCC--------------------CeEEeeeecccccccCCCCCccceeecCccc
Q 006317 436 ILYLH-EDSRLRIIHRDLKASNILLDADM--------------------IPKISDFGMARLFEMDQSQGDTSRIVGTFGY 494 (650)
Q Consensus 436 L~yLH-~~~~~~iiHrDlk~~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 494 (650)
|+||| +.+ |+||||||+||||+.++ .+||+|||+++.... ....||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecc
Confidence 99999 887 99999999999999887 899999999987642 235899999
Q ss_pred cChhccccCCCCccccccchhHH-HHHHHhCCCCCC
Q 006317 495 MAPEYVTRGHFSIKSDVFSFGVL-VLEIISGQKNNS 529 (650)
Q Consensus 495 ~aPE~~~~~~~s~~sDV~S~Gvl-l~elltG~~p~~ 529 (650)
+|||++.+.. +.++||||++++ .+++++|..|+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 9999998766 899999998766 788899988863
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-29 Score=279.22 Aligned_cols=184 Identities=18% Similarity=0.212 Sum_probs=130.3
Q ss_pred cccccCceeEEEee-ccCCcceeEeeccccCc----------hhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEE
Q 006317 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV----------QGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 331 ~LG~G~~g~Vy~~~-~~~g~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 398 (650)
..+.|++|.+..++ .--|+.++||.+.+... ...++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45667777666654 33488999999975421 1234699999999999 799999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||++|++|.++|.. .+.++.. +|+.||+.||+|||+++ ||||||||+||||++++++||+|||+++....
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999973 4567654 58899999999999998 99999999999999999999999999987653
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCC
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK 526 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~ 526 (650)
.. ......+||+.|||||++.+ .+..++|+||+|+++++|.++..
T Consensus 392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 32 23445689999999999875 46778999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7e-27 Score=259.67 Aligned_cols=185 Identities=16% Similarity=0.235 Sum_probs=145.9
Q ss_pred CcCCcccccCceeEEEeeccCCcceeEeeccccCch--------hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 327 STDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ--------GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 327 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
...++||+|+||.||++.. .++.+++|+....... ..+.+.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4567999999999999955 5788899886443211 123478999999999999999877777788888999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++++|.+++.. +..++.||++||+|||+++ |+||||||+|||+++ ++||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999863 5689999999999999987 999999999999999 999999999987653
Q ss_pred CCCCC-----ccceeecCccccChhcccc--CCCCccccccchhHHHHHHHhCCCCC
Q 006317 479 DQSQG-----DTSRIVGTFGYMAPEYVTR--GHFSIKSDVFSFGVLVLEIISGQKNN 528 (650)
Q Consensus 479 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~S~Gvll~elltG~~p~ 528 (650)
..... ......||+.|||||++.. ..|+...|+|+..+-.++.+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 22111 1235689999999999987 56788899999999999988887654
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=191.34 Aligned_cols=99 Identities=25% Similarity=0.459 Sum_probs=90.3
Q ss_pred CCCCCCCccCCCChHHHHHHHHHHHhHhhhcC-CCCceeeecCC-CCCceEEEEeccCCCChhhhHHHHHHHHHHHHhcC
Q 006317 12 QTCYDTGNFTTNSTYGKNRDLFLSSLASTVTA-NKGFYTATIGQ-IPDEVYGLALCRGDSSPESCASCLNFTVLDMMKNC 89 (650)
Q Consensus 12 ~~C~~~~~~~~~s~y~~nl~~ll~~l~~~~~~-~~~f~~~~~g~-~~~~vyg~~~C~~D~~~~~C~~Cl~~a~~~~~~~C 89 (650)
+.|+ +++|+++++|++||+.||+.|+++++. +.+|+++..|. ++++|||++|||||+++++|..||+.|+.++.+.|
T Consensus 8 ~~Cn-~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~~C 86 (108)
T 3a2e_A 8 SACN-TQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFSIC 86 (108)
T ss_dssp EEEC-SSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHHHT
T ss_pred eecC-CCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHHHC
Confidence 5797 589999999999999999999998854 45677776664 56999999999999999999999999999999999
Q ss_pred CCcccceEecCCCcceEEEecCccc
Q 006317 90 PNQKEAISWEGMDFPCVVRYSSRSF 114 (650)
Q Consensus 90 ~~~~~a~~~~~~~~~C~~ry~~~~f 114 (650)
+++++|+||++ .|+||||+++|
T Consensus 87 ~~~~g~~i~~~---~C~lRY~~~~F 108 (108)
T 3a2e_A 87 NNAIGARVQLV---DCFIQYEQRSF 108 (108)
T ss_dssp TSBSSEEEEET---TEEEEEESSCC
T ss_pred CCCceEEEECC---CEEEEEeCCcC
Confidence 99999999999 99999999998
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.1e-23 Score=176.84 Aligned_cols=103 Identities=25% Similarity=0.453 Sum_probs=92.4
Q ss_pred eeEEeeccccCCChHHHHHHHHHHHHHHHHHhccCCCccceeeeeeccCCCcceeEEeecccCCCccchhhHHHHhHhhh
Q 006317 123 TEIAHNVNNITSSLTQFDRIWRSLMDRVLAKASLGTSKLKFATDEANLTSSETIYALMQCTPDISQSDCEFCLRQSMADV 202 (650)
Q Consensus 123 ~~~~~~~~~~~~~~~~f~~~~~~l~~~l~~~a~~~~~~~~fa~~~~~~~~~~~vy~laQC~~Dl~~~~C~~CL~~~~~~~ 202 (650)
....|+..+++ +++.|+.+++.||..|...|+.+ ..+|+++..+..+.++||||+||+|||++++|+.||+.|+.++
T Consensus 6 v~~~Cn~~~~t-~~s~f~~nl~~ll~~L~~~a~~s--~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~ 82 (108)
T 3a2e_A 6 VSSACNTQKIP-SGSPFNRNLRAMLADLRQNTAFS--GYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRI 82 (108)
T ss_dssp EEEEECSSBCC-TTCTHHHHHHHHHHHHHHHGGGT--TSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTH
T ss_pred eeeecCCCccC-CCChHHHHHHHHHHHHHhhCccc--cCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHH
Confidence 45678888887 67899999999999999988765 3578887776666789999999999999999999999999999
Q ss_pred hhccCCCcceEEeCcccccccccCcc
Q 006317 203 QSCCYGKKGSYIMGPSCIFRWEMYPF 228 (650)
Q Consensus 203 ~~~c~~~~g~~~~~~~C~lry~~~~f 228 (650)
+++|++++||+||+++|+||||.++|
T Consensus 83 ~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 83 FSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHCCCCceEEEECCCEEEEEeCCcC
Confidence 99999999999999999999999987
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.1e-23 Score=211.38 Aligned_cols=150 Identities=17% Similarity=0.107 Sum_probs=120.7
Q ss_pred HhhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCc------------------hhHHHHHHHHHHHhhCCCCc
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV------------------QGELEFKNEVLLVARLQHRN 381 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~n 381 (650)
......|...+.||+|+||.||+|+..+|+.||||+++.... .....+.+|+.++++++ |
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 334455667799999999999999997799999999964321 12446889999999999 5
Q ss_pred eeeecceeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC
Q 006317 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA 461 (650)
Q Consensus 382 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~ 461 (650)
+++.+++.. +..++||||+++++|.+ +. ......++.||+.||.|||+.+ |+||||||+||||+
T Consensus 164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~- 227 (282)
T 1zar_A 164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS- 227 (282)
T ss_dssp -SSSCCEEEE-ETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-
T ss_pred -CCcCeEEec-cceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-
Confidence 777775543 56699999999999987 42 1234579999999999999987 99999999999999
Q ss_pred CCCeEEeeeecccccccCCCCCccceeecCccccChhcccc
Q 006317 462 DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502 (650)
Q Consensus 462 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 502 (650)
++.+||+|||+++. +..++|||++..
T Consensus 228 ~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 228 EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99999999999863 335789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=4.6e-19 Score=178.19 Aligned_cols=136 Identities=17% Similarity=0.190 Sum_probs=105.5
Q ss_pred CCcCCcccccCceeEEEeec-cCCcc--eeEeeccccCch------------------------hHHHHHHHHHHHhhCC
Q 006317 326 FSTDNKLGQGGFGAVYKGRL-SHGQE--IAVKRLSKNSVQ------------------------GELEFKNEVLLVARLQ 378 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 378 (650)
|.+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+..+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999997 67888 999987543111 1135788999999998
Q ss_pred CCce--eeecceeecCCeeEEEEecCCC-C----ChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhh-hcCCCcEEec
Q 006317 379 HRNL--VRLLGFSFEETERLLIYEFVPN-S----SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH-EDSRLRIIHR 450 (650)
Q Consensus 379 H~ni--v~l~g~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiHr 450 (650)
|+++ ..++.+ ...+|||||+.+ | +|.+++.. .++..+..++.||+.+|.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8864 333322 356899999942 4 66655431 234567889999999999999 877 9999
Q ss_pred CCCCCceEeCCCCCeEEeeeeccccc
Q 006317 451 DLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 451 Dlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
||||.|||+++ .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-16 Score=167.52 Aligned_cols=138 Identities=16% Similarity=0.189 Sum_probs=96.9
Q ss_pred CCCcCCcccccCceeEEEeeccCCcceeEeeccccCc--------------hhHHHHHHHHHHHhhCCCCceeeecceee
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV--------------QGELEFKNEVLLVARLQHRNLVRLLGFSF 390 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 390 (650)
-|.+.+.||+|+||.||+|...+|+.||||+++.... ........++++.....|+|+++++....
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4888999999999999999998999999998753210 01112222333333334444444432211
Q ss_pred ------cCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC-
Q 006317 391 ------EETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM- 463 (650)
Q Consensus 391 ------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~- 463 (650)
.....+|||||+++++|.++.. ......++.||+.+|.|||+.+ ||||||||.||||++++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred CCCeeeeccCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence 1123479999999988765431 1234567899999999999987 99999999999998877
Q ss_pred ---------CeEEeeeeccc
Q 006317 464 ---------IPKISDFGMAR 474 (650)
Q Consensus 464 ---------~~kl~DFGla~ 474 (650)
.+.|+||+-+.
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCE
T ss_pred cccccccccceEEEEeCCcc
Confidence 38899998664
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=1.4e-11 Score=123.58 Aligned_cols=143 Identities=17% Similarity=0.133 Sum_probs=111.6
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCC-CCceeeecceeecCCeeEEEEec
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
-.+|.....++.|+.+.||+.... ++.+++|+...........+.+|+.+++.+. |.++.+++++....+..++||||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 356777788888999999999764 6889999986532222335888999999884 67788999999888899999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhc---------------------------------------
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED--------------------------------------- 442 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------------------------------------- 442 (650)
++|.+|.+.+. +......++.+++++|..||+.
T Consensus 92 i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 92 ADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred cCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999876531 1122347788999999999981
Q ss_pred -----------------CCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 443 -----------------SRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 443 -----------------~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
....++|+|+++.|||++++..+.|.||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11459999999999999876667799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=5e-11 Score=118.98 Aligned_cols=137 Identities=17% Similarity=0.129 Sum_probs=100.0
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCc--eeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~ 401 (650)
.++....+.+.|..+.||+....+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 3444433334566699999987778889999976542 235678999998886544 45688888877788999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcC--------------------------------------
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS-------------------------------------- 443 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------------- 443 (650)
+++.+|. .. ..+ ...++.++++.|..||+..
T Consensus 97 i~G~~l~--~~------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SS------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TS------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cC------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998874 21 011 2256677777788887642
Q ss_pred -----------------CCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 444 -----------------RLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 444 -----------------~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
...++|+|++|.|||+++++.+.|.||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887667899999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.96 E-value=1.6e-09 Score=113.71 Aligned_cols=141 Identities=16% Similarity=0.223 Sum_probs=106.5
Q ss_pred CCcccccCceeEEEeeccCCcceeEeecc--ccC-chhHHHHHHHHHHHhhCC--CCceeeecceeecC---CeeEEEEe
Q 006317 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLS--KNS-VQGELEFKNEVLLVARLQ--HRNLVRLLGFSFEE---TERLLIYE 400 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lv~e 400 (650)
.+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 467899999999998875 4678888876 332 123346788999999987 45578888888766 45899999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcC-------------------------------------
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS------------------------------------- 443 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------- 443 (650)
|+++..+.+.. ...++..++..++.++++.|..||+..
T Consensus 122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99998875421 234778888999999999999999731
Q ss_pred ------------------CCcEEecCCCCCceEeCCCCC--eEEeeeecccc
Q 006317 444 ------------------RLRIIHRDLKASNILLDADMI--PKISDFGMARL 475 (650)
Q Consensus 444 ------------------~~~iiHrDlk~~NILl~~~~~--~kl~DFGla~~ 475 (650)
...++|+|+++.|||++.++. +.|.||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999998753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=1.4e-09 Score=111.51 Aligned_cols=187 Identities=18% Similarity=0.253 Sum_probs=120.9
Q ss_pred CCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCC-CCc--eeeecceeecCC---eeEEEEecC
Q 006317 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRN--LVRLLGFSFEET---ERLLIYEFV 402 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lv~e~~ 402 (650)
.+.++.|....||+.. ..+++|+.... .....+.+|..+++.+. +.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999864 56889986432 33456889999998874 333 334444333332 347899999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhc----------------------------------------
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED---------------------------------------- 442 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------------------- 442 (650)
+|.+|.+... ..++..++..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998875432 2467777888888888888888861
Q ss_pred ---------------CCCcEEecCCCCCceEeCC--CCCeEEeeeecccccccCCCCCcc------------ceeecCcc
Q 006317 443 ---------------SRLRIIHRDLKASNILLDA--DMIPKISDFGMARLFEMDQSQGDT------------SRIVGTFG 493 (650)
Q Consensus 443 ---------------~~~~iiHrDlk~~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~------------~~~~gt~~ 493 (650)
..+.++|+|+++.||++++ ...+.|.||+.+..-.....-... .......+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1245899999999999998 456789999988643211000000 00000001
Q ss_pred ccC-hhccccCCCCccccccchhHHHHHHHhCCCCC
Q 006317 494 YMA-PEYVTRGHFSIKSDVFSFGVLVLEIISGQKNN 528 (650)
Q Consensus 494 y~a-PE~~~~~~~s~~sDV~S~Gvll~elltG~~p~ 528 (650)
... |+.... .....+.|+++.++|++.+|..++
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 222111 112368999999999999998653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=2e-06 Score=87.96 Aligned_cols=136 Identities=19% Similarity=0.163 Sum_probs=92.2
Q ss_pred CCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCC---ceeeecceee-cCCeeEEEEecCCC
Q 006317 329 DNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR---NLVRLLGFSF-EETERLLIYEFVPN 404 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lv~e~~~~ 404 (650)
.+.++.|....||+. |..++||+-.. ......+.+|..+|..+.+. .+.+.+.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356788888899987 67889998532 23345688999999998753 3455666653 34567899999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhc------------------------------------------
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED------------------------------------------ 442 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------ 442 (650)
.+|..... ..++..+...++.++++.|..||+.
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88876321 1233444444444444444444432
Q ss_pred ---------------CCCcEEecCCCCCceEeCC---CCC-eEEeeeecccc
Q 006317 443 ---------------SRLRIIHRDLKASNILLDA---DMI-PKISDFGMARL 475 (650)
Q Consensus 443 ---------------~~~~iiHrDlk~~NILl~~---~~~-~kl~DFGla~~ 475 (650)
..+.++|+|+++.|||++. ++. +.|.||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2345799999999999998 455 48999998753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=2e-06 Score=86.03 Aligned_cols=134 Identities=16% Similarity=0.186 Sum_probs=95.4
Q ss_pred cccccCce-eEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCC-CCceeeecceeecCCeeEEEEecCCCCCh
Q 006317 331 KLGQGGFG-AVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLIYEFVPNSSV 407 (650)
Q Consensus 331 ~LG~G~~g-~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gsL 407 (650)
.+..|..| .||+.... ++..++||+-... ...++.+|...|+.+. +-.+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 44455555 68987654 4567899986433 3446788999988874 33467788888888999999999999888
Q ss_pred hHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhc---------------------------------------------
Q 006317 408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED--------------------------------------------- 442 (650)
Q Consensus 408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------------------------------------------- 442 (650)
.+.... .......+..+++..|.-||+.
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 765432 1122334556666666666642
Q ss_pred ----------CCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 443 ----------SRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 443 ----------~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
..+.++|+|+.+.|||+++++.+-|.||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 12238999999999999988777899998874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=1.8e-06 Score=90.18 Aligned_cols=80 Identities=6% Similarity=0.052 Sum_probs=55.3
Q ss_pred CCcc-cccCceeEEEeecc-------CCcceeEeeccccC---chhHHHHHHHHHHHhhCCC---CceeeecceeecC--
Q 006317 329 DNKL-GQGGFGAVYKGRLS-------HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQH---RNLVRLLGFSFEE-- 392 (650)
Q Consensus 329 ~~~L-G~G~~g~Vy~~~~~-------~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~-- 392 (650)
.+.| +.|....+|+.... ++..+++|+..... ......+.+|+.+++.+.. -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998764 26788999865432 1112356788888887742 3466777776654
Q ss_pred -CeeEEEEecCCCCChh
Q 006317 393 -TERLLIYEFVPNSSVD 408 (650)
Q Consensus 393 -~~~~lv~e~~~~gsL~ 408 (650)
+..++||||+++..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.99 E-value=3.4e-05 Score=79.63 Aligned_cols=140 Identities=16% Similarity=0.211 Sum_probs=80.1
Q ss_pred CcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCC-----CCceeeec-c--eeecCCeeEEEEec
Q 006317 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-----HRNLVRLL-G--FSFEETERLLIYEF 401 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~-g--~~~~~~~~~lv~e~ 401 (650)
+.|+.|..+.||+....+| .+++|+.... ...+..|..++..|. .|.++... | +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999887555 4899998652 123344555555442 24443321 1 12345678999999
Q ss_pred CCCCChh-----H---------HHHhhhccC-----------CCCHHHHH------------------------------
Q 006317 402 VPNSSVD-----K---------FIFDAIKRV-----------QLDWETRY------------------------------ 426 (650)
Q Consensus 402 ~~~gsL~-----~---------~l~~~~~~~-----------~l~~~~~~------------------------------ 426 (650)
+++..+. . -++...... ...|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9987543 1 112111100 11332211
Q ss_pred -HHHHHHHHHHHHhhh----------cCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 427 -KIIGGIARGILYLHE----------DSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 427 -~i~~~ia~~L~yLH~----------~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.+...+..++.+|++ .....++|+|+++.|||++.++.+.|.||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445667763 124569999999999999888899999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.91 E-value=6.1e-05 Score=75.96 Aligned_cols=78 Identities=21% Similarity=0.287 Sum_probs=56.5
Q ss_pred CCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCC---ceeeecceeecCCeeEEEEecC
Q 006317 326 FSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR---NLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 326 f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~~~~lv~e~~ 402 (650)
....+.+|.|..+.||+.++.+|+.|+||+-..........|..|...|+.|.-. .+.+++++ +..++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEee
Confidence 4445788999999999999999999999987654433344578899988887422 23444443 2347899999
Q ss_pred CCCCh
Q 006317 403 PNSSV 407 (650)
Q Consensus 403 ~~gsL 407 (650)
+.+..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=5.2e-05 Score=80.32 Aligned_cols=75 Identities=12% Similarity=0.113 Sum_probs=48.5
Q ss_pred CCcccccCceeEEEeecc-CCcceeEeeccccCc-------hhHHHHHHHHHHHhhCCC--Cc-eeeecceeecCCeeEE
Q 006317 329 DNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-------QGELEFKNEVLLVARLQH--RN-LVRLLGFSFEETERLL 397 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H--~n-iv~l~g~~~~~~~~~l 397 (650)
.+.||.|..+.||++... +++.++||....... .....+..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467899999999999764 467899998643211 112345678888887732 33 3345433 4455689
Q ss_pred EEecCCCC
Q 006317 398 IYEFVPNS 405 (650)
Q Consensus 398 v~e~~~~g 405 (650)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00018 Score=73.28 Aligned_cols=139 Identities=18% Similarity=0.160 Sum_probs=92.2
Q ss_pred cCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCC---CCceeeecceeecCCeeEEEEecCCC
Q 006317 328 TDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ---HRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 328 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
..+.|+.|....+|+... ++..++||+.... ....+..|...|+.|. ...+.+++.+....+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346789999999999886 4678889987543 2446788988888873 35678888888878889999999998
Q ss_pred CChhH--------H---HHhhhccC-------------------CCCHHHHH---HHH----------------HHHHHH
Q 006317 405 SSVDK--------F---IFDAIKRV-------------------QLDWETRY---KII----------------GGIARG 435 (650)
Q Consensus 405 gsL~~--------~---l~~~~~~~-------------------~l~~~~~~---~i~----------------~~ia~~ 435 (650)
..+.. . |+...... .-+|.... ++. ..+..-
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 86521 1 22111100 12454322 111 111111
Q ss_pred -HHHhhh-cCCCcEEecCCCCCceEeCCCCCeEEeeee
Q 006317 436 -ILYLHE-DSRLRIIHRDLKASNILLDADMIPKISDFG 471 (650)
Q Consensus 436 -L~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFG 471 (650)
...|.. ...+.++|+|+.+.||+++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223432 2356799999999999999887 8888873
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00035 Score=74.55 Aligned_cols=78 Identities=14% Similarity=0.186 Sum_probs=47.7
Q ss_pred CCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCccceeec--CccccChhccccC---CCCccccccchhHHH
Q 006317 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVG--TFGYMAPEYVTRG---HFSIKSDVFSFGVLV 518 (650)
Q Consensus 444 ~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~s~~sDV~S~Gvll 518 (650)
...++|+|+++.|||++.++ ++|.||+.+..-.... ....... ...|.+|+..... .-....++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~---Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF---DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH---HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH---HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45699999999999999876 9999998876422100 0000000 1235566544311 112235566888888
Q ss_pred HHHHhCC
Q 006317 519 LEIISGQ 525 (650)
Q Consensus 519 ~elltG~ 525 (650)
|+.++++
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8888764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0011 Score=67.62 Aligned_cols=142 Identities=15% Similarity=0.137 Sum_probs=79.0
Q ss_pred CcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCc--eeeecce------eecCCeeEEEEec
Q 006317 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN--LVRLLGF------SFEETERLLIYEF 401 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lv~e~ 401 (650)
+.|+.|....+|+....+| .+++|+..... ....+..|+.++..+...+ +.+++.. ....+..+++|+|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4567788889999887555 68899886531 1224556777776664222 2333321 1224567899999
Q ss_pred CCCCChhH----H----------HHhhhcc---C---C---CCHHHHHHH------------HHHHHHHHHHhhhc----
Q 006317 402 VPNSSVDK----F----------IFDAIKR---V---Q---LDWETRYKI------------IGGIARGILYLHED---- 442 (650)
Q Consensus 402 ~~~gsL~~----~----------l~~~~~~---~---~---l~~~~~~~i------------~~~ia~~L~yLH~~---- 442 (650)
+++..+.. . ++..... . . ..|...+.- ...+.+.++++++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99865421 1 1111000 0 0 113221110 01134445555532
Q ss_pred CCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 443 SRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 443 ~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
....++|+|+++.|||++++..+.|.||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23469999999999999987666899998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.001 Score=67.34 Aligned_cols=73 Identities=8% Similarity=0.171 Sum_probs=45.2
Q ss_pred cCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCce-eeecceeecCCeeEEEEecC-CCC
Q 006317 328 TDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL-VRLLGFSFEETERLLIYEFV-PNS 405 (650)
Q Consensus 328 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~-~~g 405 (650)
..+.|+.|....+|+. ..+++|+....... .....+|+.+++.+...++ .+++++ +.+.-++++||+ ++.
T Consensus 22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp SCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred ceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 3678999999999998 67888887643211 1123567777776643233 344443 344457899999 655
Q ss_pred Chh
Q 006317 406 SVD 408 (650)
Q Consensus 406 sL~ 408 (650)
+|.
T Consensus 94 ~l~ 96 (301)
T 3dxq_A 94 TMS 96 (301)
T ss_dssp ECC
T ss_pred cCC
Confidence 543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0044 Score=63.28 Aligned_cols=141 Identities=16% Similarity=0.159 Sum_probs=81.3
Q ss_pred CcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCC--ceeeecce-----eecCCeeEEEEecC
Q 006317 330 NKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHR--NLVRLLGF-----SFEETERLLIYEFV 402 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~-----~~~~~~~~lv~e~~ 402 (650)
..|+ |....||+....+|+.+++|+...... ....+..|..++..+... .+.+++.. ...++..+++|||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 778899998877788899999864321 234566788887777422 23444443 12245567899999
Q ss_pred CCCChh-----HH---------HHhhhc------cCCCCHHHH----------------------HHHHHHHHHHHHHhh
Q 006317 403 PNSSVD-----KF---------IFDAIK------RVQLDWETR----------------------YKIIGGIARGILYLH 440 (650)
Q Consensus 403 ~~gsL~-----~~---------l~~~~~------~~~l~~~~~----------------------~~i~~~ia~~L~yLH 440 (650)
++..+. .+ ++.... ...+++... ...+..++..++-+-
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875432 11 111111 112232211 011111222222111
Q ss_pred h-cCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 441 E-DSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 441 ~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
. .....++|+|+++.|||++ + .+.|.||+.+.
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 1 1234689999999999999 4 89999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0041 Score=63.76 Aligned_cols=141 Identities=18% Similarity=0.140 Sum_probs=71.7
Q ss_pred CcccccCcee-EEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCC--CceeeecceeecCCeeEEEEecCCCCC
Q 006317 330 NKLGQGGFGA-VYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH--RNLVRLLGFSFEETERLLIYEFVPNSS 406 (650)
Q Consensus 330 ~~LG~G~~g~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~gs 406 (650)
+.|+.|.... +|+....+|..+++|....... ..+..|+.++..+.. -.+.+++.+..+.+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4555554443 6676654466777776543221 123456666666532 23455665533333 78999998777
Q ss_pred hhHHHHhhh--------------------c---cCCCCHHHHH-------H-------------HHHHHHHHHHHhh---
Q 006317 407 VDKFIFDAI--------------------K---RVQLDWETRY-------K-------------IIGGIARGILYLH--- 440 (650)
Q Consensus 407 L~~~l~~~~--------------------~---~~~l~~~~~~-------~-------------i~~~ia~~L~yLH--- 440 (650)
+.+++.... . ...++..... . ....+...++.|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 655443110 0 0111111100 0 0001112222221
Q ss_pred hcCCCcEEecCCCCCceEeCCC----CCeEEeeeecccc
Q 006317 441 EDSRLRIIHRDLKASNILLDAD----MIPKISDFGMARL 475 (650)
Q Consensus 441 ~~~~~~iiHrDlk~~NILl~~~----~~~kl~DFGla~~ 475 (650)
......++|+|+.+.|||++.+ +.+.|.||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123569999999999999875 6789999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0011 Score=70.66 Aligned_cols=72 Identities=18% Similarity=0.295 Sum_probs=48.0
Q ss_pred CcccccCceeEEEeeccC--------CcceeEeeccccCchhHHHHHHHHHHHhhCCCCce-eeecceeecCCeeEEEEe
Q 006317 330 NKLGQGGFGAVYKGRLSH--------GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL-VRLLGFSFEETERLLIYE 400 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e 400 (650)
+.|+.|....||+....+ +..+++|+..... ....+.+|..++..+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 567888889999988653 4678899874321 11355678888888753344 456655432 38999
Q ss_pred cCCCCCh
Q 006317 401 FVPNSSV 407 (650)
Q Consensus 401 ~~~~gsL 407 (650)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0041 Score=64.99 Aligned_cols=140 Identities=18% Similarity=0.224 Sum_probs=81.3
Q ss_pred CcccccCceeEEEeeccC--------CcceeEeeccccCchhHHHHHHHHHHHhhCCCCc-eeeecceeecCCeeEEEEe
Q 006317 330 NKLGQGGFGAVYKGRLSH--------GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRN-LVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lv~e 400 (650)
+.|..|-...+|+....+ ++.+++|+.... ......+.+|..+++.+.-.+ ..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 567778888899987642 467888886332 223446678999888774322 3456655543 29999
Q ss_pred cCCCCChhHH--------------H---Hhh-h-ccCCCC--HHHHHHHHHHHHH-------------------HHHHhh
Q 006317 401 FVPNSSVDKF--------------I---FDA-I-KRVQLD--WETRYKIIGGIAR-------------------GILYLH 440 (650)
Q Consensus 401 ~~~~gsL~~~--------------l---~~~-~-~~~~l~--~~~~~~i~~~ia~-------------------~L~yLH 440 (650)
|+++.+|..- | +.. . -..... |.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665311 0 110 0 011122 4455555544321 233332
Q ss_pred ----hc-CCCcEEecCCCCCceEeCCC----CCeEEeeeeccc
Q 006317 441 ----ED-SRLRIIHRDLKASNILLDAD----MIPKISDFGMAR 474 (650)
Q Consensus 441 ----~~-~~~~iiHrDlk~~NILl~~~----~~~kl~DFGla~ 474 (650)
.. ....++|+|+.+.|||++++ +.+.|.||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 21 23469999999999999876 789999998775
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0068 Score=65.08 Aligned_cols=74 Identities=12% Similarity=0.093 Sum_probs=47.3
Q ss_pred CCcccccCceeEEEeeccC-CcceeEeeccccCchhHHHHHHHHHHHhhCCCCce-eeecceeecCCeeEEEEecCCCCC
Q 006317 329 DNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL-VRLLGFSFEETERLLIYEFVPNSS 406 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~~~gs 406 (650)
.+.|+.|-...+|+....+ +..+++|+..... ....+..+|..++..|...++ .++++.+. + .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3578888889999998754 4778888874432 111123578888888865555 45666552 2 35999998755
Q ss_pred h
Q 006317 407 V 407 (650)
Q Consensus 407 L 407 (650)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.34 E-value=0.033 Score=57.16 Aligned_cols=31 Identities=23% Similarity=0.356 Sum_probs=27.4
Q ss_pred CCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 444 RLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 444 ~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
...++|+|+.+.||++++++.+.|.||+.+.
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 3569999999999999988889999998765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0036 Score=65.27 Aligned_cols=73 Identities=11% Similarity=0.089 Sum_probs=42.5
Q ss_pred CcccccCceeEEEeeccC---------CcceeEeeccccCchhHHHHHHHHHHHhhCCCCce-eeecceeecCCeeEEEE
Q 006317 330 NKLGQGGFGAVYKGRLSH---------GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL-VRLLGFSFEETERLLIY 399 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~ 399 (650)
+.|+.|....+|+....+ +..+++|+...... ...+...|..++..+...++ .++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 567778888999987654 25788888654321 11124567777777743333 3555433 2 37899
Q ss_pred ecCCCCCh
Q 006317 400 EFVPNSSV 407 (650)
Q Consensus 400 e~~~~gsL 407 (650)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987544
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.75 E-value=0.079 Score=50.09 Aligned_cols=103 Identities=11% Similarity=0.043 Sum_probs=66.8
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCCc
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD 484 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 484 (650)
-||.++|.. .+.+++++++|.++.|.++.|.-+-.... + ..+=+-|..|+|..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 388998875 56789999999999999999877621110 1 1222346899999999987753 1110
Q ss_pred cceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCC
Q 006317 485 TSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKN 527 (650)
Q Consensus 485 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p 527 (650)
.....+.+||... ...+.+.=|||+|++||.-+-=..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122466888653 3456888999999999988874443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.41 E-value=0.096 Score=55.40 Aligned_cols=140 Identities=14% Similarity=0.132 Sum_probs=82.1
Q ss_pred CCcccccCceeEEEeeccC--------CcceeEeeccccCchhHHHHHHHHHHHhhCCCCce-eeecceeecCCeeEEEE
Q 006317 329 DNKLGQGGFGAVYKGRLSH--------GQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL-VRLLGFSFEETERLLIY 399 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~ 399 (650)
.+.|..|-...+|+....+ +..+++|+..... ....+..+|..+++.+...++ .++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3567778888899987653 5778888864432 111234578888877743233 4445432 2 37899
Q ss_pred ecCCCCChhH-------H----------HHhh-h---------ccCCCCHHHHHHHHHHH-------------------H
Q 006317 400 EFVPNSSVDK-------F----------IFDA-I---------KRVQLDWETRYKIIGGI-------------------A 433 (650)
Q Consensus 400 e~~~~gsL~~-------~----------l~~~-~---------~~~~l~~~~~~~i~~~i-------------------a 433 (650)
||+++.+|.. . |+.. . .+.+.-|.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999876421 1 1110 1 01111244444443322 2
Q ss_pred HHHHHhh---------------------hcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 434 RGILYLH---------------------EDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 434 ~~L~yLH---------------------~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
..+.+|. ......++|+|+.+.||+ ++++.+.|.||..+.
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 2233332 112346899999999999 888899999998875
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.49 E-value=0.053 Score=36.89 Aligned_cols=20 Identities=35% Similarity=0.549 Sum_probs=9.5
Q ss_pred HHHHHHHHHHhhhhhhcchh
Q 006317 277 IIALVALITCVFLRRRKKKQ 296 (650)
Q Consensus 277 ~i~l~~~~~~~~~rrr~~~~ 296 (650)
+++++++.+++++|||++++
T Consensus 23 ~~~ii~~~~~~~~RRr~~~~ 42 (44)
T 2ks1_B 23 LLLVVALGIGLFMRRRHIVR 42 (44)
T ss_dssp HHHHHHHHHHHHHHTTTCCS
T ss_pred HHHHHHHHHHHHhhhhHhhc
Confidence 33344444455555555443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.96 E-value=0.052 Score=36.83 Aligned_cols=21 Identities=38% Similarity=0.752 Sum_probs=10.4
Q ss_pred HHHHHHHHHHHhhhhhhcchh
Q 006317 276 FIIALVALITCVFLRRRKKKQ 296 (650)
Q Consensus 276 ~~i~l~~~~~~~~~rrr~~~~ 296 (650)
++++++++.+++++|||++++
T Consensus 21 ~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 21 FILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHTTCSSC
T ss_pred HHHHHHHHHHHHHhhhhhhhh
Confidence 333344455455556555544
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.12 E-value=0.77 Score=48.04 Aligned_cols=29 Identities=28% Similarity=0.368 Sum_probs=24.6
Q ss_pred cEEecCCCCCceEe------CCCCCeEEeeeeccc
Q 006317 446 RIIHRDLKASNILL------DADMIPKISDFGMAR 474 (650)
Q Consensus 446 ~iiHrDlk~~NILl------~~~~~~kl~DFGla~ 474 (650)
.++|+|+.+.|||+ +++..+.+.||..+.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 46799999999999 456779999998875
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=87.47 E-value=0.12 Score=34.93 Aligned_cols=19 Identities=16% Similarity=0.649 Sum_probs=9.4
Q ss_pred HHHHHHHHHHhhhhhhcch
Q 006317 277 IIALVALITCVFLRRRKKK 295 (650)
Q Consensus 277 ~i~l~~~~~~~~~rrr~~~ 295 (650)
+++++++++++|+|||+.+
T Consensus 23 l~vi~~l~~~~~~RRR~~~ 41 (44)
T 2jwa_A 23 LVVVLGVVFGILIKRRQQK 41 (44)
T ss_dssp HHHHHHHHHHHHHHHHCSC
T ss_pred HHHHHHHHHHhheehhhhh
Confidence 3344444445555555544
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=87.42 E-value=0.13 Score=55.04 Aligned_cols=61 Identities=8% Similarity=0.114 Sum_probs=18.6
Q ss_pred CcCCcccccCceeEEEeeccC-CcceeE------eeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceee
Q 006317 327 STDNKLGQGGFGAVYKGRLSH-GQEIAV------KRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSF 390 (650)
Q Consensus 327 ~~~~~LG~G~~g~Vy~~~~~~-g~~vav------K~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 390 (650)
...++|| ||.||+|.+.. ..+||| |..+.... +....+.+|..++.+++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456777 99999999864 468999 76654322 22346788999999999999999988754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.17 E-value=4.1 Score=38.39 Aligned_cols=116 Identities=9% Similarity=0.038 Sum_probs=75.4
Q ss_pred CCCCceeeecceeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHH-HhhhcCCCcEEecCCCCC
Q 006317 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL-YLHEDSRLRIIHRDLKAS 455 (650)
Q Consensus 377 l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~-yLH~~~~~~iiHrDlk~~ 455 (650)
..||++ -..+-.+++...+.++--+++.=..-+ ..++...+++++..|+.... +++. -+|--|.|+
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 367877 333445666666666655333211122 35788999999999988766 5554 478889999
Q ss_pred ceEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCC
Q 006317 456 NILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529 (650)
Q Consensus 456 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~ 529 (650)
|++++.++.++|.-.|+-.. ++|.-+ +...=+-.+=+++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~-------------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKES-------------------LPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTT-------------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCccc-------------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999988876532 233211 111112256678888888887653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.10 E-value=3.1 Score=39.06 Aligned_cols=117 Identities=10% Similarity=0.076 Sum_probs=78.4
Q ss_pred CCCCceeeecceeecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCc
Q 006317 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASN 456 (650)
Q Consensus 377 l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~N 456 (650)
..||+++.. .+..+++...+.++.-++ ...|- .-..++...+++++..|+....+++. =+|--|.|.|
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDN--HTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTT--SEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcc--cCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 468888876 455666666666655432 22221 22457889999999999988766654 3788899999
Q ss_pred eEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCC
Q 006317 457 ILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNS 529 (650)
Q Consensus 457 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~ 529 (650)
++++.++.++|.-.|+-..+ +|. ..+...=.-.+=+++..+++++..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999887765322 222 11111222356678888999987764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 650 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-72 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-67 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-63 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-56 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-26 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 1e-72
Identities = 69/284 (24%), Positives = 130/284 (45%), Gaps = 19/284 (6%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
+ ++G G FG VYKG+ + + ++ + Q FKNEV ++ + +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
+G+S + ++ ++ SS+ + + + I A+G+ YLH S
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT-- 501
IIHRDLK++NI L D+ KI DFG+A + ++ G+ +MAPE +
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 502 -RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560
+ +S +SDV++FG+++ E+++GQ S D + + + P L
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGR-------GYLSPDL 231
Query: 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSLP 604
S+ + C+++ RP ++ + + SLP
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 4e-67
Identities = 74/274 (27%), Positives = 124/274 (45%), Gaps = 23/274 (8%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
+LG G FG V+ G + ++AVK L + S+ + F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLV 71
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
RL + +I E++ N S+ F+ ++L + IA G+ ++ E +
Sbjct: 72 RLYAV-VTQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
IHRDL+A+NIL+ + KI+DFG+ARL E ++ + APE + G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYG 185
Query: 504 HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNG 563
F+IKSDV+SFG+L+ EI++ + + + ++ R
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMV 230
Query: 564 SSSEIM-RCVHIGLLCVQENVANRPTMASVVVML 596
+ LC +E +RPT + +L
Sbjct: 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 4e-66
Identities = 71/288 (24%), Positives = 123/288 (42%), Gaps = 23/288 (7%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
+ + KLGQG FG V+ G + +A+K L ++ E F E ++ +L+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLV 75
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
+L E ++ E++ S+ F+ + + IA G+ Y+
Sbjct: 76 QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE--- 130
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
R+ +HRDL+A+NIL+ +++ K++DFG+ARL E ++ + APE G
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189
Query: 504 HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNG 563
F+IKSDV+SFG+L+ E+ + + + L+ ++ R
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMP 234
Query: 564 SSSEIM-RCVHIGLLCVQENVANRPTMASVVVMLNSSSLSLPLPSQPA 610
E + C ++ RPT + L S QP
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 2e-65
Identities = 66/273 (24%), Positives = 119/273 (43%), Gaps = 21/273 (7%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
+ + ++G G FG V+ G + ++A+K + + ++ E +F E ++ +L H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLV 63
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
+L G E+ L++EF+ + + ++ +R ET + + G +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEG---MAYLE 118
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
+IHRDL A N L+ + + K+SDFGM R DQ ++ + +PE +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 504 HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNG 563
+S KSDV+SFGVL+ E+ S K +++ + L P L
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK--IPYENRSNSEVVEDISTGF------RLYKPRL--- 226
Query: 564 SSSEIMRCVHIGLLCVQENVANRPTMASVVVML 596
I C +E +RP + ++ L
Sbjct: 227 ---ASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (547), Expect = 3e-65
Identities = 66/291 (22%), Positives = 123/291 (42%), Gaps = 29/291 (9%)
Query: 331 KLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSF 390
+G+G FG V++G+ G+E+AVK S + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 391 EE----TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED---- 442
++ T+ L+ ++ + S +FD + R + E K+ A G+ +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGS----LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 443 -SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD--TSRIVGTFGYMAPEY 499
+ I HRDLK+ NIL+ + I+D G+A + D + VGT YMAPE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 500 ------VTRGHFSIKSDVFSFGVLVLEIISGQK----NNSFRIGEEAEDLLTYAWKNWNE 549
+ ++D+++ G++ EI + +++ + + +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 550 GTALNLIDPTLRNG-SSSEIMRCVH-IGLLCVQENVANRPTMASVVVMLNS 598
+ P + N S E +R + I C N A R T + L+
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 4e-64
Identities = 64/274 (23%), Positives = 114/274 (41%), Gaps = 23/274 (8%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
+ + +LG G FG V G+ ++A+K + + S E EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
+L G ++ +I E++ N + ++ + R + + ++ + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG 503
+ +HRDL A N L++ + K+SDFG++R D+ + + PE +
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYS 176
Query: 504 HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNG 563
FS KSD+++FGVL+ EI S K ++ + I LR
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLY 221
Query: 564 SSSEIM-RCVHIGLLCVQENVANRPTMASVVVML 596
+ I C E RPT ++ +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (539), Expect = 5e-64
Identities = 73/302 (24%), Positives = 133/302 (44%), Gaps = 38/302 (12%)
Query: 314 FDFSTIRDATNNFST---------DNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNS 360
F F +A F+ + +G G FG V G L +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 361 VQGEL-EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ 419
+ + +F +E ++ + H N++ L G + T ++I EF+ N S+D F+ +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 420 LDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479
++ GIA G+ YL + +HRDL A NIL++++++ K+SDFG++R E D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 480 QSQGDTSRIVG---TFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEA 536
S + +G + APE + F+ SDV+S+G+++ E++S +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231
Query: 537 EDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIM-RCVHIGLLCVQENVANRPTMASVVVM 595
+ + +N I+ R + + L C Q++ +RP +V
Sbjct: 232 -----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 596 LN 597
L+
Sbjct: 287 LD 288
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 7e-64
Identities = 69/300 (23%), Positives = 121/300 (40%), Gaps = 28/300 (9%)
Query: 322 ATNNFS-TDNKLGQGGFGAVYKGRL---SHGQEIAVKRLSKNSVQGELE-FKNEVLLVAR 376
+N D +LG G FG+V +G ++A+K L + + + + E E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
L + +VRL+G + +L+ E + KF+ KR ++ +++ ++ G+
Sbjct: 66 LDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD-TSRIVGTFGYM 495
YL +HRDL A N+LL KISDFG+++ D S S +
Sbjct: 123 KYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555
APE + FS +SDV+S+GV + E +S + +K +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ---------------KPYKKMKGPEVMAF 224
Query: 556 IDPTLRNGSSSEI-MRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSLPLPSQPAFFMH 614
I+ R E + C +RP +V + + SL + H
Sbjct: 225 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHHH 284
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (534), Expect = 1e-63
Identities = 70/277 (25%), Positives = 125/277 (45%), Gaps = 23/277 (8%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
+ + +KLG G +G VY+G + +AVK L +++++ E EF E ++ ++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 75
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
V+LLG E +I EF+ ++ ++ + R ++ + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE-- 132
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
+ IHRDL A N L+ + + K++DFG++RL D + APE +
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190
Query: 503 GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562
FSIKSDV++FGVL+ EI + + + + L++ R
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLEKDYRM 235
Query: 563 GSSSEIM-RCVHIGLLCVQENVANRPTMASVVVMLNS 598
+ + C Q N ++RP+ A + +
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (528), Expect = 1e-62
Identities = 65/313 (20%), Positives = 123/313 (39%), Gaps = 45/313 (14%)
Query: 312 LQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNSVQGEL 365
L ++ NN +G+G FG V++ R +AVK L + +
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 366 -EFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFD----------- 413
+F+ E L+A + N+V+LLG L++E++ +++F+
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 414 ----------AIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM 463
+ L + I +A G+ YL E + +HRDL N L+ +M
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENM 177
Query: 464 IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS 523
+ KI+DFG++R +M PE + ++ +SDV+++GV++ EI S
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 524 GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENV 583
+ +E + D + + + ++ LC +
Sbjct: 238 YGL--------------QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLP 283
Query: 584 ANRPTMASVVVML 596
A+RP+ S+ +L
Sbjct: 284 ADRPSFCSIHRIL 296
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 7e-62
Identities = 50/206 (24%), Positives = 98/206 (47%), Gaps = 11/206 (5%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQH 379
++F ++LG G G V+K G +A K + E+ ++
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
+V G + + E + E + S+D+ + K ++ + K+ + +G+ YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
+ +I+HRD+K SNIL+++ K+ DFG++ + VGT YM+PE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
+ H+S++SD++S G+ ++E+ G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-61
Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 29/277 (10%)
Query: 329 DNKLGQGGFGAVYKGRLSH---GQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRNLV 383
D +LG G FG V KG + +AVK L + L E E ++ +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
R++G E +L+ E ++K++ + + + +++ ++ G+ YL
Sbjct: 72 RMIGI-CEAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE--- 124
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTS-RIVGTFGYMAPEYVTR 502
+HRDL A N+LL KISDFG+++ D++ + APE +
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 503 GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562
FS KSDV+SFGVL+ E S + ++ +++ R
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAMLEKGERM 229
Query: 563 GSSSEI-MRCVHIGLLCVQENVANRPTMASVVVMLNS 598
G + + LC +V NRP A+V + L +
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 1e-61
Identities = 69/274 (25%), Positives = 113/274 (41%), Gaps = 27/274 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLV 383
+G+G FG V G G ++AVK + ++ F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLV 63
Query: 384 RLLGFSFEETERL-LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
+LLG EE L ++ E++ S+ ++ R L + K + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 443 SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTR 502
+HRDL A N+L+ D + K+SDFG+ + Q G + APE +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALRE 174
Query: 503 GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562
FS KSDV+SFG+L+ EI S + +D++ K + +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGR--VPYPRIPLKDVVPRVEKGY---------KMDAPD 223
Query: 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVML 596
G + C + A RP+ + L
Sbjct: 224 GCPPA---VYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 2e-61
Identities = 71/283 (25%), Positives = 133/283 (46%), Gaps = 28/283 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQE-----IAVKRLSKNSVQGEL-EFKNEVLLVARL 377
+ + +G G FG VYKG L +A+K L + + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 378 QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGIL 437
H N++RL G + ++I E++ N ++DKF+ + K + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 438 YLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT-SRIVGTFGYMA 496
YL + +HRDL A NIL++++++ K+SDFG++R+ E D T S + A
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556
PE ++ F+ SDV+SFG+++ E+++ + + + + I
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP---------------YWELSNHEVMKAI 226
Query: 557 DPTLRNGSSSEIM-RCVHIGLLCVQENVANRPTMASVVVMLNS 598
+ R + + + + C Q+ A RP A +V +L+
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 3e-59
Identities = 68/325 (20%), Positives = 132/325 (40%), Gaps = 42/325 (12%)
Query: 326 FSTDNKLGQGGFGAVYKGR-LSHGQE----IAVKRLSK-NSVQGELEFKNEVLLVARLQH 379
F LG G FG VYKG + G++ +A+K L + S + E +E ++A + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
++ RLLG + LI + +P + ++ + + + + IA+G+ YL
Sbjct: 71 PHVCRLLGI-CLTSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
R++HRDL A N+L+ KI+DFG+A+L ++ + +MA E
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559
+ ++ +SDV+S+GV V E+++ + ++++
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEISSILEKG 229
Query: 560 LRNGSSSEIM-RCVHIGLLCVQENVANRPTMASVVVML--------------NSSSLSLP 604
R I + C + +RP +++ + LP
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 289
Query: 605 LPSQPAFFMHSTMEQDNLEFTSSDQ 629
P+ F+ E+D + +D+
Sbjct: 290 SPTDSNFYRALMDEEDMDDVVDADE 314
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 3e-59
Identities = 71/297 (23%), Positives = 110/297 (37%), Gaps = 41/297 (13%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKNSVQGELE-FKNEVLLVAR 376
N S LG G FG V + +AVK L ++ E E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 377 L-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFD---------------AIKRVQL 420
L H N+V LLG L+I E+ + F+ + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
D E +A+G+ +L IHRDL A NILL I KI DFG+AR + D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL 540
+ +MAPE + ++ +SDV+S+G+ + E+ S +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY----------- 248
Query: 541 TYAWKNWNEGTALNLIDPTLRNGSSSEI-MRCVHIGLLCVQENVANRPTMASVVVML 596
+ +I R S I C + RPT +V ++
Sbjct: 249 ---PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (506), Expect = 3e-59
Identities = 77/284 (27%), Positives = 124/284 (43%), Gaps = 41/284 (14%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVAR 376
D FS ++G G FGAVY R + + + +A+K++S + Q + EV + +
Sbjct: 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
L+H N ++ G E L+ E+ S+ D + + L + G +G+
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGL 128
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
YLH +IHRD+KA NILL + K+ DFG A + + VGT +MA
Sbjct: 129 AYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMA 179
Query: 497 PEYV---TRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553
PE + G + K DV+S G+ +E+ + N N +AL
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERK----------------PPLFNMNAMSAL 223
Query: 554 NLI----DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVV 593
I P L++G SE R + C+Q+ +RPT ++
Sbjct: 224 YHIAQNESPALQSGHWSEYFR--NFVDSCLQKIPQDRPTSEVLL 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-58
Identities = 63/272 (23%), Positives = 113/272 (41%), Gaps = 22/272 (8%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQHRN 381
++ LG+G +G V + +AVK + E K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
+V+ G E + L E+ + I + + + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVT 501
+ I HRD+K N+LLD KISDFG+A +F + + +++ GT Y+APE +
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 502 RGHF-SIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560
R F + DV+S G+++ +++G+ E + +W E +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTYLNPWKKI 232
Query: 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASV 592
S + +H + EN + R T+ +
Sbjct: 233 ----DSAPLALLH---KILVENPSARITIPDI 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-58
Identities = 65/298 (21%), Positives = 120/298 (40%), Gaps = 29/298 (9%)
Query: 309 VESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSVQGE 364
V+++Q +F + +G+G FG VY G L AVK L++ + GE
Sbjct: 14 VQAVQHVVIGPSSLIVHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 71
Query: 365 LE-FKNEVLLVARLQHRNLVRLLGFSFE-ETERLLIYEFVPNSSVDKFIFDAIKRVQLDW 422
+ F E +++ H N++ LLG E L++ ++ + + FI + +
Sbjct: 72 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD 131
Query: 423 ETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482
+ + + + + +HRDL A N +LD K++DFG+AR +
Sbjct: 132 LIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186
Query: 483 GDTSR--IVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL 540
++ +MA E + F+ KSDV+SFGVL+ E+++ D+
Sbjct: 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDIT 244
Query: 541 TYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598
Y + L+ P + L C RP+ + +V +++
Sbjct: 245 VYLLQGR------RLLQP---EYCPDP---LYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-57
Identities = 71/303 (23%), Positives = 115/303 (37%), Gaps = 44/303 (14%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSVQGELE-FKNEVLLVAR 376
N LG G FG V ++AVK L + + E E +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 377 L-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ---------------- 419
L H N+V LLG LI+E+ + ++ ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 420 ----LDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475
L +E +A+G+ +L +HRDL A N+L+ + KI DFG+AR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEE 535
D + +MAPE + G ++IKSDV+S+G+L+ EI S N I +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 536 AEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595
A +K G ++ E I C + RP+ ++
Sbjct: 274 AN-----FYKLIQNG-----FKMDQPFYATEE---IYIIMQSCWAFDSRKRPSFPNLTSF 320
Query: 596 LNS 598
L
Sbjct: 321 LGC 323
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 6e-57
Identities = 65/281 (23%), Positives = 114/281 (40%), Gaps = 33/281 (11%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHRN 381
++ +G G +G K R S G+ + K L S+ +EV L+ L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 382 LVRLLGFSFEETERLL--IYEFVPNSSVDKFIFDAIK-RVQLDWETRYKIIGGIARGILY 438
+VR + T L + E+ + I K R LD E +++ + +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 439 LHE--DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
H D ++HRDLK +N+ LD K+ DFG+AR+ D S VGT YM+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMS 182
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556
PE + R ++ KSD++S G L+ E+ + + +++ I
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM----------------PPFTAFSQKELAGKI 226
Query: 557 ----DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVV 593
+ S E+ + + +RP++ ++
Sbjct: 227 REGKFRRIPYRYSDELNEII---TRMLNLKDYHRPSVEEIL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-56
Identities = 70/292 (23%), Positives = 121/292 (41%), Gaps = 38/292 (13%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHG---QEIAVKRLSKN-SVQGELEFKNEVLLVARL-Q 378
N+ + +G+G FG V K R+ + A+KR+ + S +F E+ ++ +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFI-------------FDAIKRVQLDWETR 425
H N++ LLG L E+ P+ ++ F+ L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 426 YKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT 485
+ARG+ YL + + IHRDL A NIL+ + + KI+DFG++R E+
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---K 183
Query: 486 SRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWK 545
+ +MA E + ++ SDV+S+GVL+ EI+S + G +L +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG--TPYCGMTCAELYEKLPQ 241
Query: 546 NWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597
+ E + C +E RP+ A ++V LN
Sbjct: 242 GY---------RLEKPLNCDDE---VYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-56
Identities = 59/273 (21%), Positives = 114/273 (41%), Gaps = 30/273 (10%)
Query: 329 DNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRL 385
D ++G+G F VYKG + E+A L + FK E ++ LQH N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 386 LGFSFEETER----LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
+ +L+ E + + ++ ++ + + + I +G+ +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 442 DSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
+ IIHRDLK NI + KI D G+A L ++GT +MAPE
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMY 185
Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560
+ DV++FG+ +LE+ + + + + A + ++ G + +
Sbjct: 186 -EEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQI----YRRVTSG----VKPASF 234
Query: 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVV 593
+ E+ + C+++N R ++ ++
Sbjct: 235 DKVAIPEVKEII---EGCIRQNKDERYSIKDLL 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-56
Identities = 65/278 (23%), Positives = 119/278 (42%), Gaps = 26/278 (9%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH 379
+ + + +LG G FG VYK + A K + S + ++ E+ ++A H
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
N+V+LL + E ++ EF +VD + + L + + YL
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYL 126
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
H+ +IIHRDLKA NIL D K++DFG++ + D+ +GT +MAPE
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEV 181
Query: 500 V-----TRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554
V + K+DV+S G+ ++E+ + + +L +
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH---ELNPMRVL----LKIAKSEPPT 234
Query: 555 LIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASV 592
L P+ + + + ++ C+++NV R T + +
Sbjct: 235 LAQPSRWSSNFKDFLKK------CLEKNVDARWTTSQL 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 8e-56
Identities = 68/286 (23%), Positives = 104/286 (36%), Gaps = 37/286 (12%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSV---QGELEFKNEVLLVAR 376
+ KLG G FG V +G +AVK L + + + +F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
L HRNL+RL G ++ E P S+ + + T + +A G+
Sbjct: 68 LDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD-TSRIVGTFGYM 495
YL R IHRDL A N+LL + KI DFG+ R + F +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555
APE + FS SD + FGV + E + TY + W +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWE------------------MFTYGQEPWIGLNGSQI 223
Query: 556 IDPTLRNGSSSEI-----MRCVHIGLLCVQENVANRPTMASVVVML 596
+ + G ++ + C +RPT ++ L
Sbjct: 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-55
Identities = 67/305 (21%), Positives = 125/305 (40%), Gaps = 35/305 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH------GQEIAVKRLSKN-SVQGELEFKNEVLLVAR 376
+ +LGQG FG VY+G +A+K +++ S++ +EF NE ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIF-------DAIKRVQLDWETRYKII 429
++VRLLG + L+I E + + ++ + ++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIV 489
G IA G+ YL+ + + +HRDL A N ++ D KI DFGM R + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 490 GTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNE 549
+M+PE + G F+ SDV+SFGV++ EI + + ++ +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---------------QPYQGLSN 241
Query: 550 GTALNLI-DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSLPLPSQ 608
L + + L + + + +C Q N RP+ ++ + P +
Sbjct: 242 EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK--EEMEPGFRE 299
Query: 609 PAFFM 613
+F+
Sbjct: 300 VSFYY 304
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 6e-55
Identities = 66/276 (23%), Positives = 123/276 (44%), Gaps = 23/276 (8%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVAR 376
++ D ++ K+GQG G VY ++ GQE+A+++++ + NE+L++
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
++ N+V L E ++ E++ S + D + +D + + +
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECLQAL 129
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
+LH ++IHRD+K+ NILL D K++DFG +QS+ S +VGT +MA
Sbjct: 130 EFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMA 184
Query: 497 PEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556
PE VTR + K D++S G++ +E+I G+ + L A E +
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--YLNENPLRALYLIATNGTPELQNPEKL 242
Query: 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASV 592
R+ + C+ +V R + +
Sbjct: 243 SAIFRD-----FLNR------CLDMDVEKRGSAKEL 267
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-54
Identities = 72/297 (24%), Positives = 115/297 (38%), Gaps = 38/297 (12%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR------LSHGQEIAVKRLSKNSVQGELE--FKNEVLLVA 375
+ LG+G FG V + + + +AVK L + + E +L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 376 RLQHRNLVRLLGFSFEETERLLI-YEFVPNSSVDKFIF-------------DAIKRVQLD 421
H N+V LLG + L++ EF ++ ++ + + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 422 WETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481
E +A+G+ +L + IHRDL A NILL + KI DFG+AR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLT 541
+MAPE + ++I+SDV+SFGVL+ EI S + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-----YPGVKIDE 244
Query: 542 YAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598
+ EGT + D T L C + RPT + +V L +
Sbjct: 245 EFCRRLKEGTRMRAPDYTTP--------EMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-54
Identities = 67/277 (24%), Positives = 115/277 (41%), Gaps = 36/277 (12%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQH 379
+F LG+G FG VY R +A+K L K + E + + EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
N++RL G+ + T LI E+ P +V + + K + D + I +A + Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 122
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
H R+IHRD+K N+LL + KI+DFG + + + + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI--- 556
+ K D++S GVL E + G+ ++ I
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK----------------PPFEANTYQETYKRISRV 219
Query: 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVV 593
+ T + + + ++ N + RP + V+
Sbjct: 220 EFTFPDFVTEGARDLI---SRLLKHNPSQRPMLREVL 253
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 4e-53
Identities = 57/280 (20%), Positives = 104/280 (37%), Gaps = 26/280 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNSVQGELE-FKNEVLLVARLQ 378
+G+G FG V++G +A+K + E F E L + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
H ++V+L+G E +I E + F+ LD + ++ + Y
Sbjct: 67 HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
L R +HRD+ A N+L+ ++ K+ DFG++R E S+ +MAPE
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPE 179
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558
+ F+ SDV+ FGV + EI+ G + D++
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV--KPFQGVKNNDVIGRIENGE---------RL 228
Query: 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598
+ + + C + + RP + L++
Sbjct: 229 PMPPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLST 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 1e-51
Identities = 71/297 (23%), Positives = 127/297 (42%), Gaps = 40/297 (13%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRL--------SHGQEIAVKRLSKNSVQGEL-EFKNEVLLV 374
+ LG+G FG V + ++AVK L ++ + +L + +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 375 ARL-QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIF-------------DAIKRVQL 420
+ +H+N++ LLG ++ +I E+ ++ +++ QL
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
+ +ARG+ YL + IHRDL A N+L+ D + KI+DFG+AR
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL 540
T+ +MAPE + ++ +SDV+SFGVL+ EI + S G E+L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG--SPYPGVPVEEL- 246
Query: 541 TYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597
+K EG ++ ++E + C + RPT +V L+
Sbjct: 247 ---FKLLKEGHRMDKPS-----NCTNE---LYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (443), Expect = 8e-50
Identities = 58/272 (21%), Positives = 112/272 (41%), Gaps = 23/272 (8%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
+++ +LG G FG V++ + G A K + + + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
V L ++ E ++IYEF+ + + + D + ++ + + + + +G+ ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 443 SRLRIIHRDLKASNILLDADM--IPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
+H DLK NI+ K+ DFG+ + QS GT + APE
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVA 197
Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560
+D++S GVL ++SG + F + E L +WN +D +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL--SPFGGENDDETLRNVKSCDWN-------MDDSA 248
Query: 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASV 592
+G S + + + R T+
Sbjct: 249 FSGISED---GKDFIRKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 1e-49
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 10/205 (4%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQHR 380
+F LG+G F V R L+ +E A+K L K + E E +++RL H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
V+L ++ + + N + K+I K D I + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV 500
IIHRDLK NILL+ DM +I+DFG A++ + Q + VGT Y++PE +
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ 525
T SD+++ G ++ ++++G
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (436), Expect = 1e-48
Identities = 64/315 (20%), Positives = 125/315 (39%), Gaps = 27/315 (8%)
Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
+LG G FG V++ + G+ K ++ + KNE+ ++ +L H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
++ E +LI EF+ + I + ++ + G+ ++HE I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVH 150
Query: 450 RDLKASNILLDADMIP--KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
D+K NI+ + KI DFG+A D+ T + APE V R
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGF 207
Query: 508 KSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSE 567
+D+++ GVL ++SG F ++ E L +W D + S E
Sbjct: 208 YTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDWE-------FDEDAFSSVSPE 258
Query: 568 IMRCVHIGLLCVQENVANRPTMASVV----VMLNSSSLSLPLPSQPAFFMHSTMEQDNLE 623
+Q+ R T+ + + + S+L+ +PS + +++ +
Sbjct: 259 ---AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 315
Query: 624 FTSSDQSKSGSIHFT 638
+ + + +F+
Sbjct: 316 WPAPQPAIGRIANFS 330
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-48
Identities = 58/294 (19%), Positives = 121/294 (41%), Gaps = 22/294 (7%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVA 375
+ D ++ + +G+G +G V + +A+K++S Q + E+ ++
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 376 RLQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARG 435
R +H N++ + T + ++ + ++ +K L + + I RG
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 436 ILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT-SRIVGTFGY 494
+ Y+H ++HRDLK SN+LL+ KI DFG+AR+ + D + V T Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 495 MAPEYVTRGHFSIKS-DVFSFGVLVLEIISGQ-----KNNSFRIGEEAEDLLTYAWKNWN 548
APE + KS D++S G ++ E++S + K+ ++ L + + ++ N
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 549 EGTALNLIDPTLRNGSSSEIM----------RCVHIGLLCVQENVANRPTMASV 592
L + L +++ + + + + N R +
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 7e-46
Identities = 50/285 (17%), Positives = 99/285 (34%), Gaps = 26/285 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
N + K+G G FG +Y G ++ G+E+A+K + + E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVG 64
Query: 383 VRLLGFSFEETERLLIY-EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
+ + + E + ++ E + S D F F + +T + + I Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 442 DSRLRIIHRDLKASNIL---LDADMIPKISDFGMARLFEMDQSQGD-----TSRIVGTFG 493
IHRD+K N L + I DFG+A+ + ++ + GT
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553
Y + S + D+ S G +++ G + +
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----M 233
Query: 554 NLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598
+ L G SE ++ C ++P + + + +
Sbjct: 234 STPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 159 bits (403), Expect = 5e-45
Identities = 62/280 (22%), Positives = 120/280 (42%), Gaps = 27/280 (9%)
Query: 323 TNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGE---LEFKNEVLLVARLQ 378
++ + LG GG V+ R L +++AVK L + + L F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 379 HRNLVRLLGFSFEETERL----LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
H +V + ET ++ E+V ++ + + + ++I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGD-TSRIVGTFG 493
+ + H+ IIHRD+K +NI++ A K+ DFG+AR + T+ ++GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553
Y++PE +SDV+S G ++ E+++G+ + G+ + +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT---GDSPVSVAYQHVRE------- 229
Query: 554 NLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVV 593
+ I P+ R+ S + L + +N NR A+ +
Sbjct: 230 DPIPPSARHEGLSA--DLDAVVLKALAKNPENRYQTAAEM 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 161 bits (408), Expect = 1e-44
Identities = 63/276 (22%), Positives = 108/276 (39%), Gaps = 31/276 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSV---QGELEFKNEVLLVARLQ- 378
N+FS +G+GGFG VY R + G+ A+K L K + QGE NE ++++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 379 --HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
+V + + I + + + + + I G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMA 496
++H +++RDLK +NILLD +ISD G+A F + VGT GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 497 PEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555
PE + +G + +D FS G ++ +++ G + +D
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR---QHKTKDKHEIDRMTLTM------ 224
Query: 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMAS 591
L + S E + +Q +V R
Sbjct: 225 -AVELPDSFSPE---LRSLLEGLLQRDVNRRLGCLG 256
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (396), Expect = 1e-43
Identities = 62/277 (22%), Positives = 113/277 (40%), Gaps = 26/277 (9%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE-FKNEVLLVARLQ 378
D + + + LG G F V + +A+K ++K +++G+ +NE+ ++ +++
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
H N+V L LI + V + I +++ ++I + + Y
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKY 122
Query: 439 LHEDSRLRIIHRDLKASNILL---DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
LH+ I+HRDLK N+L D D ISDFG++++ + S GT GY+
Sbjct: 123 LHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYV 176
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555
APE + + +S D +S GV+ ++ G F E L K E
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYP--PFY-DENDAKLFEQILKAEYE------ 227
Query: 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASV 592
D + S + ++++ R T
Sbjct: 228 FDSPYWDDISDSAKDFI---RHLMEKDPEKRFTCEQA 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 5e-43
Identities = 68/264 (25%), Positives = 114/264 (43%), Gaps = 28/264 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKN----EVLLVARLQ 378
+F LG+G FG V+ Q A+K L K+ V + + + + +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 379 HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILY 438
H L + + + E++ + I + D I G+ +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 439 LHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
LH I++RDLK NILLD D KI+DFGM + + ++ +T GT Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL------TYAWKNWNEGTA 552
+ ++ D +SFGVL+ E++ GQ + F G++ E+L + W E A
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFH-GQDEEELFHSIRMDNPFYPRWLEKEA 230
Query: 553 LNLI------DPTLRNGSSSEIMR 570
+L+ +P R G +I +
Sbjct: 231 KDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 155 bits (392), Expect = 6e-43
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 15/207 (7%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV---QGELEFKNEVLLVARLQH 379
+F LG G FG V+ R +G+ A+K L K V + +E L+++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
++R+ G + + +I +++ + + + + + + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
II+RDLK NILLD + KI+DFG A+ + GT Y+APE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEV 172
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQK 526
V+ ++ D +SFG+L+ E+++G
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 154 bits (389), Expect = 6e-43
Identities = 60/285 (21%), Positives = 114/285 (40%), Gaps = 24/285 (8%)
Query: 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVK--RLSKNSVQGELEFKNEVLLVARLQHRN 381
+ K+G+G +G VYK + ++G+ A+K RL K E+ ++ L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
+V+L + +L++E + L+ T + + GI Y H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE-YV 500
R++HRDLK N+L++ + KI+DFG+AR F + + + T Y AP+ +
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173
Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ--------KNNSFRIGEEAEDLLTYAWKNWNEGTA 552
+S D++S G + E+++G + RI + W N E
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 553 LNLIDPTLRNGSSSEIMRCVHIGLL-----CVQENVANRPTMASV 592
+ ++ + + ++ + R T
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 7e-43
Identities = 65/292 (22%), Positives = 128/292 (43%), Gaps = 27/292 (9%)
Query: 322 ATNNFSTDNKLGQGGFGAVYKGR--LSHGQEIAVKRLSKNSVQG--ELEFKNEVLLVARL 377
A + ++G+G +G V+K R + G+ +A+KR+ + + L EV ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 378 ---QHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQ---LDWETRYKIIGG 431
+H N+VRL + VD+ + + +V + ET ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 432 IARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGT 491
+ RG+ +LH R++HRDLK NIL+ + K++DFG+AR++ + + +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178
Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ-----KNNSFRIGEEAEDLLTYAWKN 546
Y APE + + ++ D++S G + E+ + ++ ++G+ + + ++
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 547 WNEGTALNLIDPTLRNGSSSEIMR------CVHIGLLCVQENVANRPTMASV 592
W AL ++ E + L C+ N A R + S
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-42
Identities = 66/303 (21%), Positives = 122/303 (40%), Gaps = 30/303 (9%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRN 381
NF K+G+G +G VYK R G+ +A+K++ ++ E+ L+ L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 382 LVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
+V+LL E + L++EF+ K DA + + + +G+ + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDL--KKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 442 DSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE-YV 500
R++HRDLK N+L++ + K++DFG+AR F + V T Y APE +
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILL 175
Query: 501 TRGHFSIKSDVFSFGVLVLEIISGQ--------KNNSFRIGEEAEDLLTYAWKNWNEGTA 552
++S D++S G + E+++ + + FRI W
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 553 LNLIDPTLRNGSSSEIMRCVHIGLL-----CVQENVANRPTMASVVVMLNS---SSLSLP 604
P S+++ + + + R + + L ++ P
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA---LAHPFFQDVTKP 292
Query: 605 LPS 607
+P
Sbjct: 293 VPH 295
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-42
Identities = 62/316 (19%), Positives = 118/316 (37%), Gaps = 31/316 (9%)
Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
LG+G FG V++ S + K + ++ K E+ ++ +HRN++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 390 FEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449
E ++I+EF+ + + I +L+ + + + +LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 450 RDLKASNILLDAD--MIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSI 507
D++ NI+ KI +FG AR + + + Y APE S
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVST 182
Query: 508 KSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSE 567
+D++S G LV ++SG N F E + ++ N A D S E
Sbjct: 183 ATDMWSLGTLVYVLLSGI--NPFL-AETNQQII------ENIMNAEYTFDEEAFKEISIE 233
Query: 568 IMRCVHIGLLCVQENVANRPTMASVV-------VMLNSSSLSLPLPSQPAFFMHSTMEQD 620
M V + + +R T + + + S+ + ++ +
Sbjct: 234 AMDFVD---RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDL 290
Query: 621 NLEFTSSDQSKSGSIH 636
N+ +++ S G+I
Sbjct: 291 NMVVSAARISCGGAIR 306
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (387), Expect = 1e-42
Identities = 41/286 (14%), Positives = 102/286 (35%), Gaps = 26/286 (9%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL 382
++ ++G+G FG +++G L + Q++A+K + S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTG 62
Query: 383 VRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED 442
+ + + +E ++ + S++ + + +T + + +HE
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 443 SRLRIIHRDLKASNILLDADMIP-----KISDFGMARLFEMDQSQG-----DTSRIVGTF 492
+++RD+K N L+ + DFGM + + ++ + + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 493 GYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA 552
YM+ S + D+ + G + + + G ++ + A + Y +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP--WQGLKAATNKQKYERIGEKK--- 232
Query: 553 LNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598
+ L G E + +H P + + +
Sbjct: 233 QSTPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSK 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (384), Expect = 3e-42
Identities = 58/285 (20%), Positives = 107/285 (37%), Gaps = 38/285 (13%)
Query: 325 NFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE---------FKNEVLLV 374
N+ LG+G V + +E AVK + EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 375 ARLQ-HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
++ H N+++L T L+++ + + ++ ++V L + KI+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
I LH+ L I+HRDLK NILLD DM K++DFG + + + + GT
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPS 174
Query: 494 YMAPEYVT------RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNW 547
Y+APE + + + D++S GV++ +++G F + +L
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS--PPFW-HRKQMLMLRMIMSGN 231
Query: 548 NEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASV 592
P + S + + + R T
Sbjct: 232 -----YQFGSPEWDDYSDT----VKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-41
Identities = 66/301 (21%), Positives = 120/301 (39%), Gaps = 31/301 (10%)
Query: 330 NKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELE-----FKNEVLLVARLQHRNLV 383
+ LG+G F VYK R + Q +A+K++ + E+ L+ L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 384 RLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDS 443
LL ++ L+++F+ D + + L + +G+ YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMET---DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 444 RLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYV-TR 502
I+HRDLK +N+LLD + + K++DFG+A+ F + V T Y APE +
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGA 175
Query: 503 GHFSIKSDVFSFGVLVLEIISGQ-----KNNSFRIGEEAEDLLTYAWKNWNEGTALN--L 555
+ + D+++ G ++ E++ ++ ++ E L T + W + +L +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 556 IDPTLRNGSSSEIMRCVHIGLL-----CVQENVANRPTMASVVVMLNSSSLS-LPLPSQP 609
+ I LL N R T L S P P+
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA---LKMKYFSNRPGPTPG 292
Query: 610 A 610
Sbjct: 293 C 293
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 4e-40
Identities = 60/280 (21%), Positives = 106/280 (37%), Gaps = 42/280 (15%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE------FKNEVLLVAR 376
+ + LG GGFG+VY G +S +A+K + K+ + E EV+L+ +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 377 LQ--HRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIAR 434
+ ++RLL + +LI E +R L E +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLE 121
Query: 435 GILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
+ + H ++HRD+K NIL+D + K+ DFG L + + GT
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRV 174
Query: 494 YMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA 552
Y PE++ + + V+S G+L+ +++ G +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------IPFEHDEE 215
Query: 553 LNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASV 592
+ R SSE C H+ C+ ++RPT +
Sbjct: 216 IIRGQVFFRQRVSSE---CQHLIRWCLALRPSDRPTFEEI 252
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 6e-40
Identities = 59/294 (20%), Positives = 120/294 (40%), Gaps = 30/294 (10%)
Query: 320 RDATNNFSTDNKLGQGGFGAVYKGRLSH-GQEIAVKRLSKNSVQGELEFKNEVLLVARLQ 378
R +++ +G G FG VY+ +L G+ +A+K++ ++ + E+ ++ +L
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLD 71
Query: 379 HRNLVRLLGFSFEETER------LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGI 432
H N+VRL F + E+ L+ ++VP + + + L + +
Sbjct: 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 433 ARGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMARLFEMDQSQGDTSRIVGT 491
R + Y+H I HRD+K N+LLD D + K+ DFG A+ + + + S I
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSR 186
Query: 492 FGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ-----KNNSFRIGEEAEDLLTYAWKN 546
+ ++ DV+S G ++ E++ GQ + ++ E + L T +
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 547 WNEGTA--LNLIDPTLRNGSSSEIMR------CVHIGLLCVQENVANRPTMASV 592
E P ++ +++ R + + ++ R T
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-39
Identities = 64/280 (22%), Positives = 116/280 (41%), Gaps = 32/280 (11%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL------EFKNEVLLVAR 376
+ + T +LG G F V K R S G + A K + K + + + EV ++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 377 LQHRNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
+QH N++ L +T+ +LI E V + F+ ++ L E + + I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNG- 125
Query: 437 LYLHEDSRLRIIHRDLKASNILLDADMIP----KISDFGMARLFEMDQSQGDTSRIVGTF 492
++ L+I H DLK NI+L +P KI DFG+A + I GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 493 GYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA 552
++APE V +++D++S GV+ ++SG +G+ ++ L E
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---PFLGDTKQETLANVSAVNYE--- 234
Query: 553 LNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASV 592
+ + +S+ + + ++ R T+
Sbjct: 235 ---FEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDS 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 5e-38
Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 12/206 (5%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELE---FKNEVLLVARLQH 379
N+F LG+G FG V R + G+ A+K L K + + E E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
L L + E+ +F + R ++ E R + A + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANG----GELFFHLSRERVFTEERARFY--GAEIVSAL 118
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
+++RD+K N++LD D KI+DFG+ + D + GT Y+APE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEV 176
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQ 525
+ + D + GV++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 55/274 (20%), Positives = 96/274 (35%), Gaps = 29/274 (10%)
Query: 328 TDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARL-QHRNLVRL 385
T LG G G V + ++ A+K L + + EV L R Q ++VR+
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRI 70
Query: 386 LG----FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE 441
+ L++ E + + I D + +I+ I I YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLHS 129
Query: 442 DSRLRIIHRDLKASNILLDA---DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE 498
+ I HRD+K N+L + + I K++DFG A+ S T Y+APE
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPE 183
Query: 499 YVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558
+ + D++S GV++ ++ G ++ K +P
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGY----PPFYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASV 592
S + ++ R T+
Sbjct: 240 EWSEVSEE----VKMLIRNLLKTEPTQRMTITEF 269
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-37
Identities = 62/320 (19%), Positives = 129/320 (40%), Gaps = 40/320 (12%)
Query: 321 DATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARL 377
D + + K+GQG FG V+K R GQ++A+K++ + + E+ ++ L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 378 QHRNLVRLLGFSFEETER--------LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKII 429
+H N+V L+ + L+++F + V+ +++
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVM 123
Query: 430 GGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDT--SR 487
+ G L+ R +I+HRD+KA+N+L+ D + K++DFG+AR F + ++ +
Sbjct: 124 QMLLNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 488 IVGTFGYMAPEYV-TRGHFSIKSDVFSFGVLVLEIISGQ--------KNNSFRIGEEAED 538
V T Y PE + + D++ G ++ E+ + ++ I +
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240
Query: 539 LLTYAWKNWNEGTALNLID------PTLRNGSSSEIMRCVHIGLL--CVQENVANRPTMA 590
+ W N + ++ +++ + + + L+ + + A R
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300
Query: 591 SVVVMLNSSSL-SLPLPSQP 609
LN S P+PS
Sbjct: 301 DA---LNHDFFWSDPMPSDL 317
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 7e-37
Identities = 62/289 (21%), Positives = 119/289 (41%), Gaps = 30/289 (10%)
Query: 324 NNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL--EFKNEVLLVARLQHR 380
+ K+G+G +G V+K + + +A+KR+ + + E+ L+ L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 381 NLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLH 440
N+VRL + + L++EF D + LD E + + +G+ + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ---DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 441 EDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPE-Y 499
++HRDLK N+L++ + K+++FG+AR F + S V T Y P+
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVL 173
Query: 500 VTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL--------TYAWKNWNEGT 551
+S D++S G + E+ + + G + +D L T + W T
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGR--PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231
Query: 552 ALNLIDPTLRNGSSSEIMRCVH------IGLL--CVQENVANRPTMASV 592
L P +++ ++ V LL ++ N R +
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (339), Expect = 2e-35
Identities = 57/240 (23%), Positives = 96/240 (40%), Gaps = 18/240 (7%)
Query: 293 KKKQKQNLRKADEINTVESLQFDFSTIRDAT---NNFSTDNKLGQGGFGAVYKGR-LSHG 348
KK +Q K E + T T + F LG G FG V + G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 349 QEIAVKRLSKNSVQGELE---FKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPNS 405
A+K L K V + NE ++ + LV+L + + ++ E+V
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 406 SVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465
+ + + + I YLH L +I+RDLK N+L+D
Sbjct: 127 EMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYI 180
Query: 466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
+++DFG A+ + +G T + GT +APE + ++ D ++ GVL+ E+ +G
Sbjct: 181 QVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 8e-35
Identities = 61/295 (20%), Positives = 116/295 (39%), Gaps = 28/295 (9%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGEL--EFKNEVLLV 374
T + + +G G +GAV G ++A+K+L + E+ L+
Sbjct: 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71
Query: 375 ARLQHRNLVRLLGFSFEETERLLIYEF-VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
++H N++ LL + +F + + + +K +L + ++ +
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 131
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
+G+ Y+H IIHRDLK N+ ++ D KI DFG+AR Q+ + + V T
Sbjct: 132 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRW 183
Query: 494 YMAPE-YVTRGHFSIKSDVFSFGVLVLEIISGQ--------KNNSFRIGEEAEDLLTYAW 544
Y APE + ++ D++S G ++ E+I+G+ + I +
Sbjct: 184 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243
Query: 545 KNWNEGTALNLID--PTLRNGSSSEIMRCVH---IGLL--CVQENVANRPTMASV 592
+ A N + P L + I+ + LL + + R T
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 127 bits (319), Expect = 6e-33
Identities = 45/233 (19%), Positives = 99/233 (42%), Gaps = 25/233 (10%)
Query: 299 NLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLS 357
N + E ES ++ +++ KLG+G + V++ +++ +++ VK L
Sbjct: 14 NTHRPREYWDYESHVVEWGNQ----DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK 69
Query: 358 KNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERL--LIYEFVPNSSVDKFIFDA 414
+ + K E+ ++ L+ N++ L + R L++E V N+ +
Sbjct: 70 PVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-- 124
Query: 415 IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD-MIPKISDFGMA 473
L + I + + Y H + I+HRD+K N+++D + ++ D+G+A
Sbjct: 125 ----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177
Query: 474 RLFEMDQSQGDTSRIVGTFGYMAPE-YVTRGHFSIKSDVFSFGVLVLEIISGQ 525
+ Q + V + + PE V + D++S G ++ +I +
Sbjct: 178 EFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-31
Identities = 63/305 (20%), Positives = 123/305 (40%), Gaps = 39/305 (12%)
Query: 297 KQNLRKADEINTVESLQFDFSTIRDATNNFSTDNKLGQGGFGAVYKGRLSH----GQEIA 352
K LR A+ E + + NF LG G +G V+ R G+ A
Sbjct: 6 KHELRTANLTGHAEKVGIE---------NFELLKVLGTGAYGKVFLVRKISGHDTGKLYA 56
Query: 353 VKRLSKNSV----QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI-YEFVPNSSV 407
+K L K ++ + + E ++ ++ + L ++F+ +L + +++ +
Sbjct: 57 MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL 116
Query: 408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKI 467
+ +R + +G I + +LH+ L II+RD+K NILLD++ +
Sbjct: 117 FTHLS---QRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVL 170
Query: 468 SDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGH--FSIKSDVFSFGVLVLEIISGQ 525
+DFG+++ F D+++ GT YMAP+ V G D +S GVL+ E+++G
Sbjct: 171 TDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
Query: 526 KNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVAN 585
+ F + E + + +P S+ + + ++
Sbjct: 230 --SPFTVDGEKNSQAEISRRILKS-------EPPYPQEMSALAKDLI---QRLLMKDPKK 277
Query: 586 RPTMA 590
R
Sbjct: 278 RLGCG 282
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-30
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 11/212 (5%)
Query: 318 TIRDATNNFSTDNKLGQGGFGAVYKGR-LSHGQEIAVKRLSKN--SVQGELEFKNEVLLV 374
TI + + + +G G +G+V G +AVK+LS+ S+ E+ L+
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 375 ARLQHRNLVRLLG-FSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIA 433
++H N++ LL F+ + ++ + + + +K +L + +I I
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 434 RGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFG 493
RG+ Y+H IIHRDLK SN+ ++ D KI DFG+AR + + T + +
Sbjct: 132 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWY 184
Query: 494 YMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
+ H++ D++S G ++ E+++G+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-30
Identities = 54/225 (24%), Positives = 103/225 (45%), Gaps = 25/225 (11%)
Query: 315 DFSTIRDATNNFSTDNK------LGQGGFGAVYKGR-LSHGQEIAVKRLSKNSV--QGEL 365
F ++ + F+ + +G G G V + +A+K+LS+
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 366 EFKNEVLLVARLQHRNLVRLLGF-----SFEETERLLIYEFVPNSSVDKFIFDAIKRVQL 420
E++L+ + H+N++ LL + EE + + + + ++++ + I +++L
Sbjct: 62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-----QMEL 116
Query: 421 DWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480
D E ++ + GI +LH IIHRDLK SNI++ +D KI DFG+AR
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173
Query: 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
+ V T Y APE + + D++S G ++ E++ +
Sbjct: 174 M---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (302), Expect = 2e-30
Identities = 41/210 (19%), Positives = 82/210 (39%), Gaps = 18/210 (8%)
Query: 331 KLGQGGFGAVYKGR-LSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFS 389
KLG G F V+ + + + +A+K + + V E ++E+ L+ R+ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSMG 78
Query: 390 FEETERLLIY-------------EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGI 436
+LL + F + + + +I + G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 437 LYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYM 495
Y+H R IIH D+K N+L++ D + +A L + + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 496 APEYVTRGHFSIKSDVFSFGVLVLEIISGQ 525
+PE + + +D++S L+ E+I+G
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 104 bits (261), Expect = 2e-26
Identities = 37/201 (18%), Positives = 71/201 (35%), Gaps = 25/201 (12%)
Query: 330 NKLGQGGFGAVYKGRLSHGQEIAVK--RLSKNS--------VQGELEFKNEVLLVARLQH 379
+G+G AV+ E VK ++ S G+L F + AR +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 380 RNLVRLLGFSFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYL 439
R L +L G + + +Y + N+ + + I +++ I +
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 440 HEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEY 499
+ I+H DL N+L+ + I DF + + + R V Y
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNI----ITY 171
Query: 500 VTRGHFSIKSDVFSFGVLVLE 520
+R + + D+ S +L+
Sbjct: 172 FSR-TYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 650 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.44 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.04 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.38 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.79 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.18 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.99 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-51 Score=413.53 Aligned_cols=263 Identities=26% Similarity=0.462 Sum_probs=201.6
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeecccc--CchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKN--SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
.++|++.++||+|+||+||+|+++ ..||||+++.. .......|.+|+.++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467899999999999999999874 35999999754 33445679999999999999999999998754 56899999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++|+|.++|.. .+..+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999974 3456999999999999999999999987 9999999999999999999999999998765444
Q ss_pred CCCccceeecCccccChhcccc---CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTR---GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
.........||+.|||||++.+ +.++.++|||||||++|||+||+.||...... ..+.............
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~--~~~~~~~~~~~~~p~~----- 231 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIFMVGRGYLSPDL----- 231 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHHTSCCCCG-----
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCcc-----
Confidence 4444556789999999999864 35899999999999999999999998632211 1122222222111111
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCCCC
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSL 603 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~~~ 603 (650)
+.+....++ .+.+++.+||+.||++|||+.||++.|+.....+
T Consensus 232 ~~~~~~~~~---~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 232 SKVRSNCPK---AMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp GGSCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred hhccccchH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 011122333 4456777999999999999999999997644333
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=413.81 Aligned_cols=254 Identities=26% Similarity=0.420 Sum_probs=198.2
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
++|+..++||+|+||+||+|++.+++.||||+++... ....+|.+|+.++++++|||||+++|++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5688889999999999999999888899999997654 345679999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
+|+|.+++.. ....++|..++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++....... .
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 157 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence 9999999874 3456899999999999999999999987 99999999999999999999999999987653322 2
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNG 563 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 563 (650)
......||+.|+|||++.+..++.++|||||||++|||+|++.|+... .....+......... +.....
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~--~~~~~~~~~i~~~~~---------~~~p~~ 226 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--RSNSEVVEDISTGFR---------LYKPRL 226 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS--CCHHHHHHHHHHTCC---------CCCCTT
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC--CCHHHHHHHHHhcCC---------CCCccc
Confidence 233457899999999999999999999999999999999965554321 122223322222111 111112
Q ss_pred ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 564 SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 564 ~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.++ ++.+++.+||+.||++||||+||++.|+.
T Consensus 227 ~~~---~l~~li~~cl~~~p~~Rps~~~il~~L~~ 258 (263)
T d1sm2a_ 227 AST---HVYQIMNHCWKERPEDRPAFSRLLRQLAE 258 (263)
T ss_dssp SCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCH---HHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 223 45577889999999999999999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-51 Score=411.76 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=205.3
Q ss_pred ccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
.++|++.++||+|+||.||+|++++++.||||+++.... ..++|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 357888899999999999999998888999999976543 44579999999999999999999998755 5679999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++|+|.+++... ....++|..+++++.||++||+|||+++ |+||||||+||||++++.+||+|||+++.......
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~- 164 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-
Confidence 999999987643 3346999999999999999999999987 99999999999999999999999999987654322
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
.......||+.|||||++.++.++.++|||||||++|||+||+.|+.... ...++....... ..+....
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~--~~~~~~~~i~~~---------~~~~~p~ 233 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEVIQNLERG---------YRMVRPD 233 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTT---------CCCCCCT
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC--CHHHHHHHHHhc---------CCCCCcc
Confidence 22334578999999999999999999999999999999999776654221 122222222111 1111222
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
..+++ +.+++.+||+.||++||||+||+++|+.
T Consensus 234 ~~~~~---l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 234 NCPEE---LYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp TCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cChHH---HHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 23333 4567779999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-50 Score=413.04 Aligned_cols=258 Identities=27% Similarity=0.433 Sum_probs=209.7
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
..++|+..++||+|+||+||+|++. +++.||||+++.... ..++|.+|+.+|++++|||||++++++.+++..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3467888999999999999999875 488999999976543 45579999999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+++......
T Consensus 94 ~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999998753 3467999999999999999999999987 9999999999999999999999999998765332
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
. .......||+.|+|||++.++.++.++|||||||++|||++|+.|+.... ....+........ .+..
T Consensus 170 ~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--~~~~~~~~i~~~~---------~~~~ 237 (287)
T d1opja_ 170 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDY---------RMER 237 (287)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHTTC---------CCCC
T ss_pred c-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--hHHHHHHHHhcCC---------CCCC
Confidence 2 22334568999999999999999999999999999999999877764221 2222222221111 1112
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
....++ ++.+|+..||+.||++||||.||++.|+..
T Consensus 238 ~~~~~~---~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 238 PEGCPE---KVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CccchH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 222333 455677899999999999999999988753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=403.29 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=201.0
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
++|++.++||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+.++++++|||||++++++.+++..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57899999999999999999864 589999999976533 2344689999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++|+|.++|. +...+++.++..++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999986 4567999999999999999999999987 99999999999999999999999999997765444
Q ss_pred CCccceeecCccccChhccccCCC-CccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
.......+||+.|||||++.+..+ +.++|||||||++|||+||+.||....... ..... ... ...... +
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~~-~~~--~~~~~~---~-- 228 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSD-WKE--KKTYLN---P-- 228 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHHH-HHT--TCTTST---T--
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHHHH-Hhc--CCCCCC---c--
Confidence 344456789999999999988876 578999999999999999999986433221 11111 110 000000 0
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVV 593 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl 593 (650)
....+ .++.+++.+||+.||++|||++|++
T Consensus 229 ~~~~s---~~~~~li~~~L~~dP~~R~t~~eil 258 (271)
T d1nvra_ 229 WKKID---SAPLALLHKILVENPSARITIPDIK 258 (271)
T ss_dssp GGGSC---HHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred cccCC---HHHHHHHHHHcCCChhHCcCHHHHh
Confidence 00112 3445677799999999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-50 Score=413.51 Aligned_cols=255 Identities=27% Similarity=0.460 Sum_probs=193.7
Q ss_pred cCCCcCCcccccCceeEEEeeccC-Cc---ceeEeeccccC-chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQ---EIAVKRLSKNS-VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~---~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
++|++.++||+|+||+||+|+++. ++ .||||++.... ....+.|.+|+.+|++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456677899999999999998753 32 48899887653 33455799999999999999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++|+|.+++.. ....++|.+++.++.||++||+|||+++ |+||||||+||||+.++++||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998874 3457999999999999999999999987 99999999999999999999999999987654
Q ss_pred CCCCC---ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 479 DQSQG---DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 479 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
..... ......||+.|||||.+.++.++.++|||||||++|||+| |+.|+.... ..++.........
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~---~~~~~~~i~~~~~------ 251 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT---NQDVINAIEQDYR------ 251 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTCC------
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC---HHHHHHHHHcCCC------
Confidence 33222 1223457999999999999999999999999999999998 888875322 2223222221111
Q ss_pred ccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 555 LIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 555 ~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+......++ .+.+|+.+||+.||++||||.||++.|+.
T Consensus 252 ---~~~~~~~~~---~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 252 ---LPPPMDCPS---ALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp ---CCCCTTCCH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---CCCCccchH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111122333 35567789999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=396.59 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=209.1
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
++|+..++||+|+||+||+|++++++.||||++++... ...+|.+|+.++++++||||++++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 67899999999999999999998888999999987544 34589999999999999999999999999999999999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
+|+|.+++.. ....+++..+++++.||++||+|||+.+ |+||||||+||||++++.+||+|||+++....... .
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 156 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T 156 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-C
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-e
Confidence 9999999765 4567999999999999999999999987 99999999999999999999999999987654332 2
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
......||+.|+|||.+.+..++.++||||||+++|||+| |+.||..... .++...... +. . +....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~~~~i~~----~~--~---~~~p~ 224 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQ----GL--R---LYRPH 224 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHT----TC--C---CCCCT
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HHHHHHHHh----CC--C---CCCcc
Confidence 3334578999999999999999999999999999999998 7888763322 222222211 11 1 11112
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
..++ .+.+++.+||+.||++|||++||++.|.
T Consensus 225 ~~~~---~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 225 LASE---KVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp TCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred cccH---HHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 2233 4556777999999999999999999884
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=400.88 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=205.0
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
.++|+..++||+|+||+||+|+. .+|+.||||++........+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 35799999999999999999985 46899999999876655667799999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++.+....
T Consensus 99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 999999988753 46999999999999999999999987 9999999999999999999999999998765332
Q ss_pred CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+.+...... ... .....
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~~~~~---~~~----~~~~~ 239 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN---PLRALYLIATN---GTP----ELQNP 239 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHH---CSC----CCSSG
T ss_pred -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC---HHHHHHHHHhC---CCC----CCCCc
Confidence 23345679999999999999999999999999999999999999985322 11222111111 100 00011
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
...+ ..+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~s---~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 240 EKLS---AIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGSC---HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122 33456777999999999999999863
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-50 Score=405.34 Aligned_cols=265 Identities=26% Similarity=0.405 Sum_probs=206.2
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVP 403 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 403 (650)
++|++.+.||+|+||+||+|++++++.||||+++... .....|.+|+.++++++|||||+++|++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 5788899999999999999999888899999997654 345679999999999999999999999854 56899999999
Q ss_pred CCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCCC
Q 006317 404 NSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQG 483 (650)
Q Consensus 404 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 483 (650)
+|+|..++... ....++|.+++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++....... .
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~ 169 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 169 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence 99999988753 3456999999999999999999999987 99999999999999999999999999987653322 2
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNG 563 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~ 563 (650)
......||+.|+|||++..+.++.++||||||+++|||+||+.|+.... ...+++....... .+.....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~--~~~~~~~~i~~~~---------~~~~~~~ 238 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQVERGY---------RMPCPPE 238 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHHHHTTC---------CCCCCTT
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC--CHHHHHHHHHhcC---------CCCCCcc
Confidence 2334578999999999999999999999999999999999877764322 2222333222111 1112222
Q ss_pred ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCCCCCCCCCCCC
Q 006317 564 SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSSSLSLPLPSQP 609 (650)
Q Consensus 564 ~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~~~~~~~p~~p 609 (650)
.++ ++.+++.+||+.||++||+|++|+++|+......+++.+|
T Consensus 239 ~~~---~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 239 CPE---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp SCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred cCH---HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 333 3556778999999999999999999998755444433333
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=405.55 Aligned_cols=256 Identities=27% Similarity=0.481 Sum_probs=198.2
Q ss_pred cCCCcCCcccccCceeEEEeeccCC-----cceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHG-----QEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g-----~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
+.|+..++||+|+||+||+|+++.. ..||||++..... ....+|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577889999999999999987542 3699999976533 334578999999999999999999999999999999
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||+.+++|.+++.. ....++|.++++++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999998764 4467999999999999999999999987 9999999999999999999999999998765
Q ss_pred cCCCC-CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 478 MDQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 478 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
..... .......||+.|||||++.++.++.++|||||||++|||++|+.|+.... ...++........
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~~--------- 230 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAINDGF--------- 230 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTC---------
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC--CHHHHHHHHhccC---------
Confidence 43322 22334568999999999999999999999999999999999777654322 1122222221111
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.+......+. ++.+|+.+||+.||++||||.||+++|+.
T Consensus 231 ~~~~~~~~~~---~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 231 RLPTPMDCPS---AIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp CCCCCTTCBH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCchhhHH---HHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 1111222333 45577889999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=395.12 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=202.8
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|++.+.||+|+||+||+++.+ +++.||||++.+.. ......+.+|+.++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999875 58899999986542 223457889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++. +...+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 158 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC-
Confidence 9999999999997 3457999999999999999999999987 99999999999999999999999999976542
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
.......||+.|||||++.+..++.++|||||||++|||++|+.||.... ..++...... . ++.
T Consensus 159 ---~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~----~------~~~ 222 (263)
T d2j4za1 159 ---SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRISR----V------EFT 222 (263)
T ss_dssp ---CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHT----T------CCC
T ss_pred ---CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC---HHHHHHHHHc----C------CCC
Confidence 22345679999999999999999999999999999999999999986322 2222222111 1 111
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
+....+++ +.+++.+||+.||++|||+.|+++
T Consensus 223 ~p~~~s~~---~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 FPDFVTEG---ARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccCCHH---HHHHHHHHccCCHhHCcCHHHHHc
Confidence 22223333 446777999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=399.27 Aligned_cols=254 Identities=25% Similarity=0.358 Sum_probs=192.6
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeec--CCeeEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFE--ETERLLI 398 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv 398 (650)
++|++.+.||+|+||+||+++.. +|+.||||++..... .....+.+|+.++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57899999999999999999864 588999999976533 234568899999999999999999999865 4567999
Q ss_pred EecCCCCChhHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHhhhcC--CCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 399 YEFVPNSSVDKFIFDAI-KRVQLDWETRYKIIGGIARGILYLHEDS--RLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
|||+++|+|.+++.... .+..+++..++.++.||+.||+|||+++ ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999987543 3567999999999999999999999865 23599999999999999999999999999987
Q ss_pred cccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 476 FEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 476 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
+.... .......||+.|||||++.+..++.++|||||||++|||+||+.||.... ..++...... +..
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~~i~~----~~~--- 231 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIRE----GKF--- 231 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHH----TCC---
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHHHHHHc----CCC---
Confidence 65332 22345689999999999999999999999999999999999999986322 2222222211 111
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
+.+....+++ +.+++.+||+.||++|||+.|+++
T Consensus 232 --~~~~~~~s~~---l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 --RRIPYRYSDE---LNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --CCCCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCcccCHH---HHHHHHHHcCCChhHCcCHHHHHh
Confidence 1112223333 456777999999999999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=410.93 Aligned_cols=258 Identities=25% Similarity=0.357 Sum_probs=204.2
Q ss_pred ccCCCcCCcccccCceeEEEeeccC-C-----cceeEeeccccC-chhHHHHHHHHHHHhhC-CCCceeeecceeecCCe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH-G-----QEIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETE 394 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~-g-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 394 (650)
.++|++.++||+|+||+||+|++.. + ..||||++.... ......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4678899999999999999998643 2 258999986543 33445789999999998 89999999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhc--------------------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCC
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIK--------------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKA 454 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~ 454 (650)
.++||||+++|+|.++|..... ...+++..++.++.||++||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999975321 235899999999999999999999987 99999999
Q ss_pred CceEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCC
Q 006317 455 SNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIG 533 (650)
Q Consensus 455 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~ 533 (650)
+|||++.++.+||+|||+++...............||+.|||||++.++.++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987665444334445678999999999999999999999999999999998 8888753222
Q ss_pred cccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhc
Q 006317 534 EEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLN 597 (650)
Q Consensus 534 ~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~ 597 (650)
. ..+........ .+......++ ++.+|+.+||+.||++|||++||+++|.
T Consensus 273 ~--~~~~~~~~~~~---------~~~~p~~~~~---~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 D--ANFYKLIQNGF---------KMDQPFYATE---EIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp S--HHHHHHHHTTC---------CCCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H--HHHHHHHhcCC---------CCCCCCcCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 11221111111 1111222333 4556777999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=399.96 Aligned_cols=251 Identities=26% Similarity=0.335 Sum_probs=202.5
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
+.|++.+.||+|+||+||+|+.. +|+.||||+++.........+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46888999999999999999864 58899999998766666667899999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++|+|.+++.+ ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 99999998864 3456999999999999999999999987 9999999999999999999999999997543211
Q ss_pred CccceeecCccccChhccc-----cCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccC
Q 006317 483 GDTSRIVGTFGYMAPEYVT-----RGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLID 557 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id 557 (650)
.......||+.|+|||++. ...++.++|||||||++|||+||+.||..... .+.+....... .....
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~---~~~~~~i~~~~----~~~~~- 236 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP---MRVLLKIAKSE----PPTLA- 236 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG---GGHHHHHHHSC----CCCCS-
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH---HHHHHHHHcCC----CCCCC-
Confidence 1233467999999999984 45689999999999999999999999863322 22222221110 00000
Q ss_pred ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 558 PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 558 ~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 237 --~~~~~s---~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 --QPSRWS---SNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --SGGGSC---HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --ccccCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001122 34556777999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=400.55 Aligned_cols=247 Identities=29% Similarity=0.432 Sum_probs=195.1
Q ss_pred CcccccCceeEEEeeccC---CcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecCCC
Q 006317 330 NKLGQGGFGAVYKGRLSH---GQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFVPN 404 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~---g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 404 (650)
++||+|+||+||+|.+++ ++.||||+++.... ....+|.+|+.+|++++|||||+++|++.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 46799999975432 234579999999999999999999999865 467899999999
Q ss_pred CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC-C
Q 006317 405 SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ-G 483 (650)
Q Consensus 405 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 483 (650)
|+|.+++. ....+++..+++++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999987 4567999999999999999999999987 999999999999999999999999999876543322 2
Q ss_pred ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCCC
Q 006317 484 DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRN 562 (650)
Q Consensus 484 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~ 562 (650)
......||+.|||||.+.+..++.++|||||||++|||+| |+.||.... ..++...... +.. +....
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~---~~~~~~~i~~----~~~-----~~~p~ 233 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAMLEK----GER-----MGCPA 233 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHHT----TCC-----CCCCT
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC---HHHHHHHHHc----CCC-----CCCCc
Confidence 2334578999999999999999999999999999999998 899886322 2222222221 111 11122
Q ss_pred CChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 563 GSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 563 ~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
..+++ +.+|+.+||+.||++|||+++|+++|+.
T Consensus 234 ~~~~~---~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 234 GCPRE---MYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp TCCHH---HHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ccCHH---HHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 23343 4567779999999999999999998864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=397.18 Aligned_cols=254 Identities=26% Similarity=0.421 Sum_probs=202.8
Q ss_pred cCCCcCC-cccccCceeEEEeecc---CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEE
Q 006317 324 NNFSTDN-KLGQGGFGAVYKGRLS---HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 324 ~~f~~~~-~LG~G~~g~Vy~~~~~---~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 398 (650)
++|...+ +||+|+||+||+|.++ ++..||||+++.... ....+|.+|+++|++++|||||+++|++.. +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4555666 4999999999999764 345799999976543 345679999999999999999999999865 468999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++|+|.+++.. .+..+++..+++++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998864 3467999999999999999999999987 99999999999999999999999999987654
Q ss_pred CCCC-CccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 479 DQSQ-GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 479 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
.... .......||+.|+|||++..+.++.++|||||||++|||+| |+.||..... .++...... +..
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~i~~----~~~---- 230 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQ----GKR---- 230 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHT----TCC----
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHHHHHHc----CCC----
Confidence 3321 22334568999999999999999999999999999999998 8999864322 222222211 111
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+......++ ++.+|+.+||+.||++||||.+|++.|+.
T Consensus 231 -~~~p~~~~~---~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 231 -MECPPECPP---ELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp -CCCCTTCCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCCcCCH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 112222333 34567779999999999999999998864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=408.01 Aligned_cols=200 Identities=25% Similarity=0.382 Sum_probs=177.5
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
..++|+..++||+|+||+||+|+. .+|+.||+|+++.... .....+.+|+.+|++++|||||++++++.+++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357899999999999999999986 4688999999976533 33457899999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhc-CCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED-SRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++ + |+||||||+||||++++++||+|||+|+.+..
T Consensus 84 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 99999999999973 45799999999999999999999975 5 99999999999999999999999999987643
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCC
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFR 531 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~ 531 (650)
.. ....+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 158 ~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 158 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp HT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred Cc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 22 23468999999999999999999999999999999999999999654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=389.43 Aligned_cols=246 Identities=24% Similarity=0.365 Sum_probs=193.9
Q ss_pred CcCCcccccCceeEEEeecc-CCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeec----CCeeEEEE
Q 006317 327 STDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFE----ETERLLIY 399 (650)
Q Consensus 327 ~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~ 399 (650)
+..++||+|+||+||+|+.. +++.||+|++.... ......+.+|+++|++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55678999999999999864 58899999987543 2334568999999999999999999999865 34578999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC-CCCCeEEeeeeccccccc
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD-ADMIPKISDFGMARLFEM 478 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~-~~~~~kl~DFGla~~~~~ 478 (650)
||+++|+|.+++.. ...+++..++.++.||++||+|||+++ ++|+||||||+||||+ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999973 467999999999999999999999874 4599999999999996 578999999999986432
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
.......||+.|||||++.+ .++.++|||||||++|||++|+.||.... ....+.. ....+... +
T Consensus 168 ----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~--~~~~~~~----~i~~~~~~----~ 232 (270)
T d1t4ha_ 168 ----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYR----RVTSGVKP----A 232 (270)
T ss_dssp ----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHH----HHTTTCCC----G
T ss_pred ----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc--cHHHHHH----HHHcCCCC----c
Confidence 23345689999999998865 69999999999999999999999985221 1111211 11111111 1
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.+.....+ ++.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~---~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 SFDKVAIP---EVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGCCCH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCccCCH---HHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11112223 3556778999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=396.07 Aligned_cols=248 Identities=24% Similarity=0.303 Sum_probs=200.7
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|++.+.||+|+||+||+|+.. +|+.||||++.+.. ......+.+|+.++++++|||||++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56899999999999999999864 68899999997542 223456899999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++. ..+.+++..++.++.||+.||+|||+.+ |+||||||+||||++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999887 4567999999999999999999999987 999999999999999999999999999977644
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+...... .. ..
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~----~~------~~ 228 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EYLIFQKIIK----LE------YD 228 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHT----TC------CC
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC---HHHHHHHHHc----CC------CC
Confidence 44444455689999999999999999999999999999999999999986322 2222221111 11 11
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCCHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPTMASVV 593 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl 593 (650)
+.....+ ++.+++.+||+.||++|||++|++
T Consensus 229 ~p~~~s~---~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 229 FPEKFFP---KARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp CCTTCCH---HHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CCccCCH---HHHHHHHHHccCCHhHCcCHHHHc
Confidence 2222333 345677799999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.3e-49 Score=402.31 Aligned_cols=264 Identities=25% Similarity=0.404 Sum_probs=210.5
Q ss_pred hHHhhccCCCcCCcccccCceeEEEeecc------CCcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceee
Q 006317 318 TIRDATNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSF 390 (650)
Q Consensus 318 ~~~~~~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~ 390 (650)
+++...++|++.+.||+|+||+||+|+++ +++.||||+++..... ...+|.+|+.++++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445678999999999999999999853 3568999999765433 3457999999999999999999999999
Q ss_pred cCCeeEEEEecCCCCChhHHHHhhh---------------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEe
Q 006317 391 EETERLLIYEFVPNSSVDKFIFDAI---------------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIH 449 (650)
Q Consensus 391 ~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 449 (650)
..+..++||||+++|+|.++|.... ....+++..++.++.||+.||+|||+++ |+|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 9999999999999999999996421 1235899999999999999999999987 999
Q ss_pred cCCCCCceEeCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCC-CC
Q 006317 450 RDLKASNILLDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK-NN 528 (650)
Q Consensus 450 rDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~-p~ 528 (650)
|||||+||||+.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|.. |+
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 99999999999999999999999987655444444455678999999999999999999999999999999999975 44
Q ss_pred CCCCCcccchhHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 529 SFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 529 ~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
... ...++...... +.. +......+. ++.+|+.+||+.||++||||.||+++|+..
T Consensus 244 ~~~---~~~e~~~~v~~----~~~-----~~~p~~~~~---~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 244 YGM---AHEEVIYYVRD----GNI-----LACPENCPL---ELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTS---CHHHHHHHHHT----TCC-----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCC---CHHHHHHHHHc----CCC-----CCCCccchH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 322 22222222211 111 111222233 456788899999999999999999999753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-48 Score=395.85 Aligned_cols=253 Identities=23% Similarity=0.306 Sum_probs=189.0
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
..+.|++.+.||+|+||+||+++.. +|+.||||++.+.... ....+.+|+.+|++++|||||++++++.+++..+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4467999999999999999999864 5889999999765433 3346889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC---CCCCeEEeeeeccccc
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD---ADMIPKISDFGMARLF 476 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~---~~~~~kl~DFGla~~~ 476 (650)
||+++|+|.++|. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999997 4567999999999999999999999987 99999999999994 5789999999999865
Q ss_pred ccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 477 EMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 477 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
.... ......||+.|||||++.+..++.++|||||||++|||++|+.||.... ..++....... .. . +
T Consensus 161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~~---~~--~-~ 228 (307)
T d1a06a_ 161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN---DAKLFEQILKA---EY--E-F 228 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHTT---CC--C-C
T ss_pred cCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHhcc---CC--C-C
Confidence 4322 2334679999999999999999999999999999999999999986322 12222221111 00 0 1
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
........++ .+.+++.+||+.||++|||+.|+++-
T Consensus 229 ~~~~~~~~s~---~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 DSPYWDDISD---SAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CTTTTTTSCH---HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCccccCCCH---HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1111112223 35567779999999999999999873
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-47 Score=393.97 Aligned_cols=244 Identities=29% Similarity=0.417 Sum_probs=198.0
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCch---hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
+.|+..++||+|+||+||+|+. .+|+.||||++...... ....+.+|+.+|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4588899999999999999985 46889999999765432 3346889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
|||++|+|..++. .+..+++..++.++.||+.||.|||+++ |+||||||+||||++++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999987665 3567999999999999999999999987 99999999999999999999999999986432
Q ss_pred CCCCccceeecCccccChhcccc---CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTR---GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
.....||+.|||||++.+ +.++.++|||||||++|||++|+.||.... ..+.+...... .
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~---~~~~~~~i~~~---~------ 230 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQN---E------ 230 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHS---C------
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhC---C------
Confidence 234579999999999864 468999999999999999999999985321 11111111111 0
Q ss_pred CccCC-CCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 557 DPTLR-NGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 557 d~~l~-~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.+.+. ...++ .+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~s~---~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 231 SPALQSGHWSE---YFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCCCSCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCCH---HHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11111 12233 3456777999999999999999975
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.6e-47 Score=398.36 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=206.5
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
++|++.+.||+|+||.||+++. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999986 468999999998776666678999999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC--CCCeEEeeeecccccccCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA--DMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~--~~~~kl~DFGla~~~~~~~ 480 (650)
++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+||||+. ++.+||+|||+++.+...
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 99999999864 3456999999999999999999999988 999999999999964 678999999999876532
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
.......||+.|||||++.+..++.++|||||||++|||++|+.||.... ..+.+........ . ++...
T Consensus 180 --~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~--~----~~~~~ 248 (350)
T d1koaa2 180 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNVKSCDW--N----MDDSA 248 (350)
T ss_dssp --SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCC--C----SCCGG
T ss_pred --cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCC--C----CCccc
Confidence 23445789999999999999999999999999999999999999986322 2222222211100 0 00111
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
....++ .+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~s~---~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 FSGISE---DGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGCCH---HHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccCCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111222 45567779999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=396.48 Aligned_cols=254 Identities=24% Similarity=0.403 Sum_probs=198.0
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCc----ceeEeecccc-CchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQ----EIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
.+|+..++||+|+||+||+|++. +|+ .||+|+++.. ..+..++|.+|+.++++++|||||+++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 45889999999999999999864 344 5888888654 334566899999999999999999999999865 5678
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
++||+.+|+|.+++.. ....+++..+++++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999998875 4567999999999999999999999987 9999999999999999999999999999876
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
............||+.|+|||++.++.++.++|||||||++|||+| |+.|+..... ..+.........
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~---~~~~~~i~~~~~-------- 231 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILEKGER-------- 231 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG---GGHHHHHHHTCC--------
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHcCCC--------
Confidence 5444444455678999999999999999999999999999999999 6777753322 222222222110
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+......+ ..+.+|+.+||+.||++|||+.||++.|..
T Consensus 232 -~~~p~~~~---~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 232 -LPQPPICT---IDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp -CCCCTTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCcccC---HHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 11111222 345567889999999999999999988753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=383.84 Aligned_cols=251 Identities=25% Similarity=0.338 Sum_probs=202.7
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCc------hhHHHHHHHHHHHhhCCCCceeeecceeecCCee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV------QGELEFKNEVLLVARLQHRNLVRLLGFSFEETER 395 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 395 (650)
.++|++.+.||+|+||+||+|+. .+|+.||||++++... .....+.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999986 4689999999865432 2346799999999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC----CeEEeeee
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM----IPKISDFG 471 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~----~~kl~DFG 471 (650)
+|||||+++|+|.++|.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999974 457999999999999999999999987 99999999999998877 49999999
Q ss_pred cccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCC
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGT 551 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 551 (650)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........ ...
T Consensus 163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~~--~~~ 234 (293)
T d1jksa_ 163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSAV--NYE 234 (293)
T ss_dssp TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHTT--CCC
T ss_pred hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC---HHHHHHHHHhc--CCC
Confidence 998764332 2334578999999999999999999999999999999999999986322 22222111110 000
Q ss_pred cccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 552 ALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 552 ~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.. +......+ ..+.+++.+||+.||++|||++|+++
T Consensus 235 ~~----~~~~~~~s---~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 FE----DEYFSNTS---ALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CC----HHHHTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC----chhcCCCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00001112 24556778999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=381.90 Aligned_cols=248 Identities=27% Similarity=0.430 Sum_probs=194.2
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeec-CCeeEEEEecC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFE-ETERLLIYEFV 402 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~ 402 (650)
++|++.++||+|+||.||+|++ .|+.||||+++... ..++|.+|++++++++||||++++|++.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4677889999999999999998 57899999997643 34578999999999999999999999865 45689999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++|+|.++|... ....++|..+++++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 999999999753 2345899999999999999999999987 999999999999999999999999999864422
Q ss_pred CccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCcccccCccCC
Q 006317 483 GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTLR 561 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~ 561 (650)
.....+|..|+|||++.++.++.++||||||+++|||+| |+.|+... ...++...... + ..+.+.
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~---~~~~~~~~i~~----~-----~~~~~~ 222 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEK----G-----YKMDAP 222 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS---CGGGHHHHHTT----T-----CCCCCC
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC---CHHHHHHHHHc----C-----CCCCCC
Confidence 223467899999999999999999999999999999999 56665432 22233332211 1 112222
Q ss_pred CCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 562 NGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 562 ~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
...+. ++.+++.+||+.||++||||.||+++|+.
T Consensus 223 ~~~~~---~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 223 DGCPP---AVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCH---HHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 22333 44567779999999999999999999864
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-47 Score=387.24 Aligned_cols=260 Identities=26% Similarity=0.344 Sum_probs=195.9
Q ss_pred hccCCCcCCcccccCceeEEEeecc------CCcceeEeeccccCc-hhHHHHHHHHHHHhhC-CCCceeeecceeecC-
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFSFEE- 392 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~- 392 (650)
..++|++.++||+|+||.||+|++. +++.||||+++.... .....+.+|...+.++ +|+||+++++++.+.
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 3467899999999999999999853 246799999976533 3445678888888777 689999999988664
Q ss_pred CeeEEEEecCCCCChhHHHHhhhc-------------cCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAIK-------------RVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 459 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl 459 (650)
...++||||+++|+|.++|..... ...+++.+++.++.||++||+|||+++ |+||||||+||||
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence 568999999999999999975322 245899999999999999999999987 9999999999999
Q ss_pred CCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCC-CCCCCCCcccch
Q 006317 460 DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQK-NNSFRIGEEAED 538 (650)
Q Consensus 460 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~-p~~~~~~~~~~~ 538 (650)
++++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+||.. |+..... ...
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~--~~~ 245 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DEE 245 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC--SHH
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH--HHH
Confidence 9999999999999987665544445556789999999999999999999999999999999999865 5542211 111
Q ss_pred hHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 539 LLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 539 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+....... .. +......++ ++.+++.+||+.||++|||+.||++.|+.
T Consensus 246 ~~~~~~~~----~~-----~~~~~~~~~---~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 246 FCRRLKEG----TR-----MRAPDYTTP---EMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp HHHHHHHT----CC-----CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhcC----CC-----CCCCccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11111111 11 112222333 35567789999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-46 Score=392.38 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=206.4
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
++|++.++||+|+||.||+|+. .+|+.||||+++.........+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999986 468999999998776666667899999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeC--CCCCeEEeeeecccccccCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLD--ADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~--~~~~~kl~DFGla~~~~~~~ 480 (650)
++|+|.+++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||+++.+...
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 99999887753 3456999999999999999999999987 99999999999998 6789999999999876532
Q ss_pred CCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+++........ . +....
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~--~----~~~~~ 251 (352)
T d1koba_ 183 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDW--E----FDEDA 251 (352)
T ss_dssp --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCC--C----CCSST
T ss_pred --CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCC--C----CCccc
Confidence 23445679999999999999999999999999999999999999986322 2222222221100 0 01111
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
....+. ++.+++.+||+.||.+|||+.|+++.
T Consensus 252 ~~~~s~---~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 252 FSSVSP---EAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTTSCH---HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccCCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112223 34567789999999999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=382.40 Aligned_cols=255 Identities=27% Similarity=0.386 Sum_probs=193.4
Q ss_pred cCCCcCCcccccCceeEEEeeccC--C--cceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH--G--QEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~--g--~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 396 (650)
++|++.+.||+|+||.||+|++.. + ..||||++++.. .+..++|.+|+.+|++++|||||+++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568889999999999999998532 2 368999987642 2334579999999999999999999999976 4678
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
+||||+++|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999998875 3456999999999999999999999987 999999999999999999999999999976
Q ss_pred ccCCCCC-ccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCccc
Q 006317 477 EMDQSQG-DTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALN 554 (650)
Q Consensus 477 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 554 (650)
....... ......||..|+|||++.+..++.++|||||||++|||+| |+.||... ...+...... ..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~---~~~~~~~~i~---~~~~~-- 233 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKID---KEGER-- 233 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHH---TSCCC--
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc---CHHHHHHHHH---hCCCC--
Confidence 5443322 2334567889999999999999999999999999999998 89887522 2222222221 11111
Q ss_pred ccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 555 LIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 555 ~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+......+. .+.+|+.+||+.||++||||.||+++|+.
T Consensus 234 ---~~~~~~~~~---~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 234 ---LPRPEDCPQ---DIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ---CCCCTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCcccccH---HHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111122233 35567779999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=379.52 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=193.1
Q ss_pred ccCCCcCCcccccCceeEEEeeccC----CcceeEeeccccCch-hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEE
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH----GQEIAVKRLSKNSVQ-GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLL 397 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 397 (650)
.++|++.+.||+|+||.||+|++.. +..||||+++..... ....|.+|+.++++++|||||+++|++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578889999999999999998643 345889998654333 3456999999999999999999999986 467899
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFE 477 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~ 477 (650)
||||+++|+|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999998764 4567999999999999999999999987 9999999999999999999999999998765
Q ss_pred cCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccchhHHHHHHhccCCCccccc
Q 006317 478 MDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLI 556 (650)
Q Consensus 478 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i 556 (650)
.... .......||+.|+|||++.++.++.++|||||||++|||+| |..|+..... .++....... ..
T Consensus 160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~~~i~~~----~~---- 227 (273)
T d1mp8a_ 160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENG----ER---- 227 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHTT----CC----
T ss_pred CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH---HHHHHHHHcC----CC----
Confidence 3322 23344678999999999999999999999999999999998 7888764322 2233222221 11
Q ss_pred CccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 557 DPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 557 d~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+.+....+++ +.+|+..||+.||++|||+.||++.|+.
T Consensus 228 -~~~~~~~~~~---~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 228 -LPMPPNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp -CCCCTTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCCCCCHH---HHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1122223333 4567779999999999999999998864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=389.69 Aligned_cols=265 Identities=23% Similarity=0.319 Sum_probs=197.8
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCC----eeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEET----ERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv~ 399 (650)
..|...++||+|+||.||+|++ +|+.||||+++..... ....+.|+..+.+++|||||++++++.+++ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4566778999999999999997 6899999999654322 222344556667889999999999998654 578999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED-----SRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
||+++|+|.++|+. ..++|..+++++.|++.||+|||+. ..++|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999963 4699999999999999999999974 13469999999999999999999999999998
Q ss_pred ccccCCCC--CccceeecCccccChhccccCC------CCccccccchhHHHHHHHhCCCCCCCCCCcccc--------h
Q 006317 475 LFEMDQSQ--GDTSRIVGTFGYMAPEYVTRGH------FSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAE--------D 538 (650)
Q Consensus 475 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~--------~ 538 (650)
........ .......||+.|+|||++.+.. ++.++|||||||+||||+||..|+......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 76543321 2334568999999999987643 577999999999999999998776532211110 0
Q ss_pred hHHHHHHhccCCCcccccCccCCCC--ChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 539 LLTYAWKNWNEGTALNLIDPTLRNG--SSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 539 l~~~~~~~~~~~~~~~~id~~l~~~--~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
........... +.++|.+... ..+....+.+|+.+||+.||++|||+.||+++|+.
T Consensus 237 ~~~~~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 237 SVEEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CHHHHHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 01111111111 1122222221 22344567789999999999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=390.22 Aligned_cols=261 Identities=25% Similarity=0.361 Sum_probs=208.0
Q ss_pred hccCCCcCCcccccCceeEEEeec------cCCcceeEeeccccCch-hHHHHHHHHHHHhhC-CCCceeeecceeecCC
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL------SHGQEIAVKRLSKNSVQ-GELEFKNEVLLVARL-QHRNLVRLLGFSFEET 393 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 393 (650)
..++|++.++||+|+||.||+|++ .+++.||||+++..... ...+|.+|+.+++++ +|||||++++++.+..
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 346788899999999999999975 23568999999765433 445789999999999 6999999999999999
Q ss_pred eeEEEEecCCCCChhHHHHhhh---------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceE
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAI---------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNIL 458 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIL 458 (650)
..++||||+++|+|.++|+... ....+++..++.++.||++||+|||+++ ++||||||+|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 9999999999999999997532 2235899999999999999999999998 999999999999
Q ss_pred eCCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccch
Q 006317 459 LDADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAED 538 (650)
Q Consensus 459 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~ 538 (650)
++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+|++.|+....... ..
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-~~ 256 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SK 256 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HH
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-HH
Confidence 99999999999999997665444444455789999999999999999999999999999999999655543222111 11
Q ss_pred hHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 539 LLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 539 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+........ .+......+ .++.+|+.+||+.||++||||.||+++|++
T Consensus 257 ~~~~i~~~~---------~~~~~~~~~---~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 257 FYKMIKEGF---------RMLSPEHAP---AEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHHHHHHTC---------CCCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhcCC---------CCCCccccc---HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111111 111111222 345677889999999999999999999974
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=389.17 Aligned_cols=259 Identities=25% Similarity=0.430 Sum_probs=209.3
Q ss_pred ccCCCcCCcccccCceeEEEeecc------CCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCCee
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS------HGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEETER 395 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 395 (650)
.++|...++||+|+||+||+|.+. +++.||||+++.... .....|.+|+.++++++|||||+++|++..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 467888899999999999999863 357899999976533 3445689999999999999999999999999999
Q ss_pred EEEEecCCCCChhHHHHhhh-------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEe
Q 006317 396 LLIYEFVPNSSVDKFIFDAI-------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS 468 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 468 (650)
++||||+++|+|.+++.... ....+++..+.+++.||++||.|||+++ |+||||||+||||++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999987532 1235799999999999999999999987 9999999999999999999999
Q ss_pred eeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCC-CCCCCCCCcccchhHHHHHHhc
Q 006317 469 DFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQ-KNNSFRIGEEAEDLLTYAWKNW 547 (650)
Q Consensus 469 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~-~p~~~~~~~~~~~l~~~~~~~~ 547 (650)
|||+++...............||+.|+|||.+.++.++.++||||||+++|||+||+ .|+.. ......+....+
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~---~~~~~~~~~i~~-- 250 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQVLRFVME-- 250 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT---SCHHHHHHHHHT--
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC---CCHHHHHHHHHh--
Confidence 999998776554444455567899999999999999999999999999999999996 44432 122222222221
Q ss_pred cCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 548 NEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 548 ~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
+.... .....+ ..+.+++.+||+.||++||||.+|+++|+..
T Consensus 251 --~~~~~-----~p~~~~---~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 251 --GGLLD-----KPDNCP---DMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp --TCCCC-----CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred --CCCCC-----Ccccch---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11111 111222 3456778899999999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=384.04 Aligned_cols=252 Identities=24% Similarity=0.400 Sum_probs=199.8
Q ss_pred CCcccccCceeEEEeeccCC----cceeEeecccc-CchhHHHHHHHHHHHhhCCCCceeeecceeec-CCeeEEEEecC
Q 006317 329 DNKLGQGGFGAVYKGRLSHG----QEIAVKRLSKN-SVQGELEFKNEVLLVARLQHRNLVRLLGFSFE-ETERLLIYEFV 402 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~~g----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~ 402 (650)
.++||+|+||+||+|++.++ ..||||+++.. ......+|.+|+++|++++|||||+++|++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999987542 25899999754 33445679999999999999999999999875 56889999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
++|+|.+++.. ....+++..+++++.||++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999874 4556889999999999999999999987 999999999999999999999999999876543322
Q ss_pred --CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCccC
Q 006317 483 --GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPTL 560 (650)
Q Consensus 483 --~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l 560 (650)
.......||..|+|||.+..+.++.++||||||+++|||+||+.|+.... ...++......... +..
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~--~~~~~~~~i~~g~~---------~~~ 255 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQGRR---------LLQ 255 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCC---------CCC
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCC---------CCC
Confidence 22334578999999999999999999999999999999999888875322 12222222222111 111
Q ss_pred CCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 561 RNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 561 ~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
....++ ++.+++.+||+.||++||+|.||++.|++.
T Consensus 256 p~~~~~---~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 256 PEYCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp CTTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCcH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 122333 455677899999999999999999999764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=384.00 Aligned_cols=258 Identities=26% Similarity=0.376 Sum_probs=203.8
Q ss_pred ccCCCcCCcccccCceeEEEeeccC--------CcceeEeeccccCc-hhHHHHHHHHHHHhhC-CCCceeeecceeecC
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLSH--------GQEIAVKRLSKNSV-QGELEFKNEVLLVARL-QHRNLVRLLGFSFEE 392 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 392 (650)
.++|++.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4578888999999999999997532 34799999977644 3446788899999888 899999999999999
Q ss_pred CeeEEEEecCCCCChhHHHHhhh-------------ccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEe
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAI-------------KRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILL 459 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl 459 (650)
+..++||||+++|+|.++|.... ....+++.+++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999997532 1245899999999999999999999997 9999999999999
Q ss_pred CCCCCeEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHh-CCCCCCCCCCcccch
Q 006317 460 DADMIPKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIIS-GQKNNSFRIGEEAED 538 (650)
Q Consensus 460 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~ellt-G~~p~~~~~~~~~~~ 538 (650)
+.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++ |+.|+.... ...
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~---~~~ 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---VEE 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC---HHH
Confidence 9999999999999998766555555566789999999999999999999999999999999998 566664221 122
Q ss_pred hHHHHHHhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 539 LLTYAWKNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 539 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
+... +..+.. +......++ ++.+++.+||+.||++|||+.||+++|+.
T Consensus 246 ~~~~----i~~~~~-----~~~p~~~~~---~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 246 LFKL----LKEGHR-----MDKPSNCTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp HHHH----HHTTCC-----CCCCSSCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHH----HHcCCC-----CCCCccchH---HHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 2221 111111 111122233 45578889999999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=388.38 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=199.8
Q ss_pred cCCCcCCcccccCceeEEEeeccC-Cc--ceeEeeccccC-chhHHHHHHHHHHHhhC-CCCceeeecceeecCCeeEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSH-GQ--EIAVKRLSKNS-VQGELEFKNEVLLVARL-QHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 398 (650)
++|++.++||+|+||+||+|++++ |. .||||+++... .....+|.+|+++|.++ +|||||+++|++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 577888999999999999998754 33 47888876543 33445799999999998 799999999999999999999
Q ss_pred EecCCCCChhHHHHhh-------------hccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCe
Q 006317 399 YEFVPNSSVDKFIFDA-------------IKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIP 465 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~ 465 (650)
|||+++|+|.++|+.. .....++|..+++++.||++||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999743 13467999999999999999999999987 9999999999999999999
Q ss_pred EEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCC-CCCCCCcccchhHHHHH
Q 006317 466 KISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKN-NSFRIGEEAEDLLTYAW 544 (650)
Q Consensus 466 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p-~~~~~~~~~~~l~~~~~ 544 (650)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|..| +.. ....++.....
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~---~~~~~~~~~i~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG---MTCAELYEKLP 240 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT---CCHHHHHHHGG
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC---CCHHHHHHHHH
Confidence 999999998654322 22345689999999999999999999999999999999998754 432 12222222221
Q ss_pred HhccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcCC
Q 006317 545 KNWNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNSS 599 (650)
Q Consensus 545 ~~~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~~ 599 (650)
. +. .+......++ ++.+++.+||+.||++||||+||++.|+..
T Consensus 241 ~----~~-----~~~~~~~~~~---~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 241 Q----GY-----RLEKPLNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp G----TC-----CCCCCTTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred h----cC-----CCCCCccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 11 1112222233 455677799999999999999999988753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=383.08 Aligned_cols=247 Identities=22% Similarity=0.253 Sum_probs=203.8
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|++.+.||+|+||.||+++. .+|+.||||++++.. ......+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5789999999999999999986 468999999997653 223456889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|.+++. +...+++..++.++.||+.||+|||+++ |+||||||+||||+++|.+||+|||+++.....
T Consensus 85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999987 4567999999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...+....... ...
T Consensus 159 --~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~~~i~~~----------~~~ 223 (337)
T d1o6la_ 159 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILME----------EIR 223 (337)
T ss_dssp --TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHC----------CCC
T ss_pred --CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC---HHHHHHHHhcC----------CCC
Confidence 223445789999999999999999999999999999999999999986432 22222222111 011
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCCC-----HHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRPT-----MASVVV 594 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~evl~ 594 (650)
+......+ +.+++..||+.||++||+ +.|+++
T Consensus 224 ~p~~~s~~---~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 FPRTLSPE---AKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCTTSCHH---HHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCccCCHH---HHHHHHhhccCCchhhcccccccHHHHHc
Confidence 12223333 456777999999999995 788875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-45 Score=374.17 Aligned_cols=257 Identities=24% Similarity=0.361 Sum_probs=196.7
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCch---hHHHHHHHHHHHhhCCCCceeeecceeecCC----e
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---GELEFKNEVLLVARLQHRNLVRLLGFSFEET----E 394 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~ 394 (650)
.++|++.+.||+|+||+||+++. .+|+.||||+++..... ....+.+|+.++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999985 46899999999765332 3346899999999999999999999987654 3
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.+|||||+++++|.+++. ....+++.+++.++.||+.||+|||+.+ |+||||||+||||+.++..+|+|||++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 789999999999999886 3467999999999999999999999987 9999999999999999999999999987
Q ss_pred ccccCCC-CCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcc
Q 006317 475 LFEMDQS-QGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553 (650)
Q Consensus 475 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 553 (650)
....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..+.. +.........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~---~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS---PVSVA---YQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHH---HHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC---HHHHH---HHHHhcCCCC
Confidence 6543222 223445689999999999999999999999999999999999999986322 11111 1111111110
Q ss_pred cccCccCCCCChHHHHHHHHHHhcccccCCCCCC-CHHHHHHHhc
Q 006317 554 NLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRP-TMASVVVMLN 597 (650)
Q Consensus 554 ~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RP-t~~evl~~L~ 597 (650)
........++ .+.+++.+||+.||++|| |++++++.|.
T Consensus 234 ---~~~~~~~~s~---~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 234 ---PSARHEGLSA---DLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp ---GGGTSSSCCH---HHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ---CchhccCCCH---HHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 0011112233 345677799999999999 8999988775
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-45 Score=379.55 Aligned_cols=244 Identities=23% Similarity=0.322 Sum_probs=201.1
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|++.+.||+|+||+||+++. .+|+.||||++++.. ......+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688999999999999999986 458999999997542 233457889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~- 156 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 156 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc-
Confidence 9999999999886 4567899999999999999999999987 99999999999999999999999999987542
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
......||+.|||||++.+..++.++|||||||++|||+||+.||.... ...+....... ...
T Consensus 157 ----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~i~~~----------~~~ 219 (316)
T d1fota_ 157 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKTYEKILNA----------ELR 219 (316)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHC----------CCC
T ss_pred ----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC---HHHHHHHHHcC----------CCC
Confidence 2234689999999999999999999999999999999999999986322 12222211111 011
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCCC-----CHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANRP-----TMASVVV 594 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~ 594 (650)
+....+++ +.+++.+||+.||++|| |++|+++
T Consensus 220 ~p~~~s~~---~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 FPPFFNED---VKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCTTSCHH---HHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCHH---HHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11222333 44667799999999996 8999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-45 Score=372.58 Aligned_cols=250 Identities=23% Similarity=0.306 Sum_probs=200.0
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCch---------hHHHHHHHHHHHhhCC-CCceeeecceeecC
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ---------GELEFKNEVLLVARLQ-HRNLVRLLGFSFEE 392 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 392 (650)
++|++.+.||+|+||+||+++. .+|+.||||++++.... ....+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6789999999999999999986 46899999998764321 1235889999999997 99999999999999
Q ss_pred CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeec
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 472 (650)
+..+|||||+++|+|.++|.. ...+++.+++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999974 457999999999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCCCCccceeecCccccChhcccc------CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHh
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTR------GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKN 546 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~ 546 (650)
++.+.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ..+........
T Consensus 157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~~~~~i~~~ 230 (277)
T d1phka_ 157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLRMIMSG 230 (277)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHT
T ss_pred eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHHHHHHHHhC
Confidence 98765332 2334679999999999863 356889999999999999999999986332 12222111111
Q ss_pred ccCCCcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 547 WNEGTALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 547 ~~~~~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.. ....+ .....+ .++.+++.+||+.||++|||+.||++
T Consensus 231 ----~~-~~~~~-~~~~~s---~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 231 ----NY-QFGSP-EWDDYS---DTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ----CC-CCCTT-TGGGSC---HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ----CC-CCCCc-ccccCC---HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 10 00000 001122 34556778999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-44 Score=378.69 Aligned_cols=244 Identities=21% Similarity=0.244 Sum_probs=201.9
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 399 (650)
++|++.++||+|+||.||+++.+ +|+.||||++.+.. ......+.+|+.+|++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999864 68999999986542 223456889999999999999999999999999999999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccC
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMD 479 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~ 479 (650)
||+.+|+|..++.. ...+++..++.++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+++....
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc-
Confidence 99999999999873 457999999999999999999999987 99999999999999999999999999987642
Q ss_pred CCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCcc
Q 006317 480 QSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDPT 559 (650)
Q Consensus 480 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~ 559 (650)
......||+.|||||++.+..++.++|||||||++|||+||+.||... ....+........ +.
T Consensus 194 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~----------~~ 256 (350)
T d1rdqe_ 194 ----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGK----------VR 256 (350)
T ss_dssp ----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCC----------CC
T ss_pred ----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---CHHHHHHHHhcCC----------CC
Confidence 223468999999999999999999999999999999999999998632 2222222221110 11
Q ss_pred CCCCChHHHHHHHHHHhcccccCCCCC-----CCHHHHHH
Q 006317 560 LRNGSSSEIMRCVHIGLLCVQENVANR-----PTMASVVV 594 (650)
Q Consensus 560 l~~~~~~~~~~~~~l~~~Cl~~~p~~R-----Pt~~evl~ 594 (650)
.....+++ +.+++.+||+.||++| ||++|+++
T Consensus 257 ~p~~~s~~---~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 FPSHFSSD---LKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCTTCCHH---HHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCccCCHH---HHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11223333 4466779999999999 48999985
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=376.44 Aligned_cols=256 Identities=23% Similarity=0.259 Sum_probs=193.3
Q ss_pred CCcccccCceeEEEeecc-CCcceeEeeccccCchh-----HHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEecC
Q 006317 329 DNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQG-----ELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEFV 402 (650)
Q Consensus 329 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-----~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 402 (650)
+++||+|+||+||+|+.. +|+.||||+++...... ...+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999964 58899999997543221 235889999999999999999999999999999999999
Q ss_pred CCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCCC
Q 006317 403 PNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQSQ 482 (650)
Q Consensus 403 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 482 (650)
.++++..++. .+..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-- 154 (299)
T d1ua2a_ 83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-- 154 (299)
T ss_dssp SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--
T ss_pred cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc--
Confidence 9887766543 4567999999999999999999999987 9999999999999999999999999998654332
Q ss_pred CccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcc------cc
Q 006317 483 GDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL------NL 555 (650)
Q Consensus 483 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~------~~ 555 (650)
.......||+.|+|||++... .++.++|||||||++|||+||+.||.... ..+.+....+........ ..
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~---~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS---DLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC---HHHHHHHHHHhcCCCChhhccchhcc
Confidence 223345799999999998754 67999999999999999999998886432 222222222211110000 00
Q ss_pred ----cCccCCCCChH-----HHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 556 ----IDPTLRNGSSS-----EIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 556 ----id~~l~~~~~~-----~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
........... ....+.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00000011111 12356678889999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=378.07 Aligned_cols=252 Identities=19% Similarity=0.256 Sum_probs=203.0
Q ss_pred hccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
..++|++.+.||+|+||+||+|+.. +|+.||||+++.... ....+.+|+.+|++++|||||++++++.+++..+||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3467999999999999999999864 588999999977543 34468899999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCC--CCeEEeeeeccccccc
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDAD--MIPKISDFGMARLFEM 478 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~--~~~kl~DFGla~~~~~ 478 (650)
|+++|+|.+++.. ....+++.+++.++.||+.||+|||+++ |+||||||+|||++.+ ..+||+|||+++....
T Consensus 82 ~~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 9999999999864 3346999999999999999999999987 9999999999999854 4899999999986543
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
. .......||+.|+|||.+.+..++.++||||+||++|||++|+.||..... .+........ .......
T Consensus 157 ~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~~~~~~i~~~--~~~~~~~--- 225 (321)
T d1tkia_ 157 G---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIMNA--EYTFDEE--- 225 (321)
T ss_dssp T---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHT--CCCCCHH---
T ss_pred C---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhC--CCCCChh---
Confidence 2 234456789999999999999999999999999999999999999864321 2222221111 0000000
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
.....+ .++.+++..||+.||++|||+.|+++
T Consensus 226 -~~~~~s---~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 -AFKEIS---IEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -HHTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hccCCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001112 23556778999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4e-45 Score=383.99 Aligned_cols=248 Identities=25% Similarity=0.328 Sum_probs=196.9
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc---hhHHHHHH---HHHHHhhCCCCceeeecceeecCCeeE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV---QGELEFKN---EVLLVARLQHRNLVRLLGFSFEETERL 396 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~---E~~~l~~l~H~niv~l~g~~~~~~~~~ 396 (650)
++|++.++||+|+||.||+|+.. +|+.||||++.+... .....+.+ |+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57899999999999999999864 589999999865422 12223334 467778889999999999999999999
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLF 476 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~ 476 (650)
+||||+++|+|.++|.. ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999974 467899999999999999999999988 999999999999999999999999999866
Q ss_pred ccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccc
Q 006317 477 EMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNL 555 (650)
Q Consensus 477 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 555 (650)
... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||......+...+ .......
T Consensus 158 ~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~---~~~~~~~------ 224 (364)
T d1omwa3 158 SKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTM------ 224 (364)
T ss_dssp SSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH---HHHSSSC------
T ss_pred CCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcccC------
Confidence 532 2334579999999999975 5689999999999999999999999875433222111 1111110
Q ss_pred cCccCCCCChHHHHHHHHHHhcccccCCCCCCC-----HHHHHH
Q 006317 556 IDPTLRNGSSSEIMRCVHIGLLCVQENVANRPT-----MASVVV 594 (650)
Q Consensus 556 id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt-----~~evl~ 594 (650)
...+....+++ +.+++.+||+.||++||| ++|+++
T Consensus 225 -~~~~~~~~s~~---~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 -AVELPDSFSPE---LRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -CCCCCSSSCHH---HHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -CCCCCCCCCHH---HHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11111222333 456777999999999999 688874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-45 Score=375.35 Aligned_cols=247 Identities=24% Similarity=0.325 Sum_probs=199.4
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccC---chhHHHHHHHHHHHh-hCCCCceeeecceeecCCeeEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNS---VQGELEFKNEVLLVA-RLQHRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lv 398 (650)
++|++.+.||+|+||+||+|+.. +|+.||||++++.. ......+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46889999999999999999864 58899999997542 223345666776665 68999999999999999999999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccccccc
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEM 478 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~ 478 (650)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999973 457899999999999999999999997 99999999999999999999999999986543
Q ss_pred CCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcccccCc
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTALNLIDP 558 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~ 558 (650)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ...+...... + .+
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~----~------~~ 220 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRM----D------NP 220 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH----C------CC
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHc----C------CC
Confidence 22 23344679999999999999999999999999999999999999986322 2222222111 1 12
Q ss_pred cCCCCChHHHHHHHHHHhcccccCCCCCCCHH-HHHH
Q 006317 559 TLRNGSSSEIMRCVHIGLLCVQENVANRPTMA-SVVV 594 (650)
Q Consensus 559 ~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~-evl~ 594 (650)
.+....+.+ +.+++.+||+.||++||++. ||++
T Consensus 221 ~~p~~~s~~---~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 FYPRWLEKE---AKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCTTSCHH---HHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCccCCHH---HHHHHHHhcccCCCCCcCHHHHHHh
Confidence 222223333 45677799999999999995 7753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=370.25 Aligned_cols=262 Identities=22% Similarity=0.327 Sum_probs=197.3
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
++|+..++||+|+||+||+|+. .+|+.||||+++.... .....+.+|+.++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999986 5689999999965432 234578999999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
|+.++.+. ++.. .....+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~-~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKK-FMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHH-HHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhh-hhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99765444 4432 24566999999999999999999999988 9999999999999999999999999998764322
Q ss_pred CCCccceeecCccccChhccccCC-CCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccC--CCcccc--
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNE--GTALNL-- 555 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~~~-- 555 (650)
.......||+.|+|||.+.... ++.++|||||||++|||++|+.||..... .+.+......... +.....
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE---IDQLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGG
T ss_pred --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH---HHHHHHHHHhcCCCchhhccccc
Confidence 2334457999999999887765 57899999999999999999999864321 1221111111100 000000
Q ss_pred ----cCccC---CCCCh-----HHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 556 ----IDPTL---RNGSS-----SEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 556 ----id~~l---~~~~~-----~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..... ..... ....++.+++.+||+.||++|||+.|+++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 00011 111355678889999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-45 Score=376.88 Aligned_cols=250 Identities=21% Similarity=0.218 Sum_probs=193.4
Q ss_pred cCCCcCC-cccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhh-CCCCceeeecceeec----CCeeE
Q 006317 324 NNFSTDN-KLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVAR-LQHRNLVRLLGFSFE----ETERL 396 (650)
Q Consensus 324 ~~f~~~~-~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~----~~~~~ 396 (650)
++|.+.+ .||+|+||+||+|+. .+++.||||+++.. ..+.+|+.++.+ .+|||||++++++.+ +...+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5787765 599999999999985 56899999998643 356789988765 489999999999865 45689
Q ss_pred EEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC---CCCeEEeeeecc
Q 006317 397 LIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMA 473 (650)
Q Consensus 397 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGla 473 (650)
+|||||++|+|.++|... ....+++.++..++.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||++
T Consensus 86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 999999999999999742 2346999999999999999999999987 999999999999986 567999999999
Q ss_pred cccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcc
Q 006317 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553 (650)
Q Consensus 474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 553 (650)
+...... ......||+.|||||++.+..++.++|||||||++|||+||+.||.......... ........
T Consensus 162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~---- 231 (335)
T d2ozaa1 162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRM---- 231 (335)
T ss_dssp EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCS----
T ss_pred eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhc----
Confidence 8765332 2344679999999999999999999999999999999999999986432221110 00000000
Q ss_pred cccCccCCCCCh-HHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 554 NLIDPTLRNGSS-SEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 554 ~~id~~l~~~~~-~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
-...+..... .-..++.+++.+||+.||++|||+.|+++
T Consensus 232 --~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 232 --GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --CSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0001111111 11235667888999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.9e-44 Score=363.40 Aligned_cols=260 Identities=22% Similarity=0.322 Sum_probs=197.7
Q ss_pred cCCCcCCcccccCceeEEEeeccCCcceeEeeccccCch--hHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQ--GELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 401 (650)
++|+..++||+|+||+||+|+.++|+.||||+++..... ....+.+|+.+|++++|||||++++++..++..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 578899999999999999999988999999999765332 345789999999999999999999999999999999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCCC
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQS 481 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 481 (650)
+.++.+..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence 98877766654 4567999999999999999999999987 9999999999999999999999999998764322
Q ss_pred CCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCC---c---cc
Q 006317 482 QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGT---A---LN 554 (650)
Q Consensus 482 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~---~~ 554 (650)
.......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.... ..+.+........... . ..
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS---EADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC---HHHHHHHHHHhhCCCChhhccchhh
Confidence 223345689999999998764 56899999999999999999999986322 1222222111111100 0 00
Q ss_pred c--cCccCC---CC-----ChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 555 L--IDPTLR---NG-----SSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 555 ~--id~~l~---~~-----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
. .+.... .. ...-...+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000000 00 0011134567788999999999999999973
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=365.97 Aligned_cols=240 Identities=25% Similarity=0.413 Sum_probs=193.3
Q ss_pred ccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCch------hHHHHHHHHHHHhhCC--CCceeeecceeecCC
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQ------GELEFKNEVLLVARLQ--HRNLVRLLGFSFEET 393 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~ 393 (650)
.++|++.++||+|+||+||+|+. .+|+.||||++.+.... ....+.+|+.++++++ |||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 36799999999999999999985 46899999998754221 1223678999999986 899999999999999
Q ss_pred eeEEEEecCCC-CChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC-CCCeEEeeee
Q 006317 394 ERLLIYEFVPN-SSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-DMIPKISDFG 471 (650)
Q Consensus 394 ~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~-~~~~kl~DFG 471 (650)
..++||||+.+ +++.+++. .+..+++.+++.++.||+.||+|||+.+ |+||||||+||||+. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 57777776 3467999999999999999999999987 999999999999985 4799999999
Q ss_pred cccccccCCCCCccceeecCccccChhccccCCC-CccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC
Q 006317 472 MARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHF-SIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG 550 (650)
Q Consensus 472 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 550 (650)
+++..... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||.... . ....
T Consensus 157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~----i~~~---- 219 (273)
T d1xwsa_ 157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E----IIRG---- 219 (273)
T ss_dssp TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H----HHHC----
T ss_pred cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H----Hhhc----
Confidence 99865422 2334679999999999988765 577899999999999999999986311 1 1110
Q ss_pred CcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 551 TALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 551 ~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
...+....+++ +.+++.+||+.||++|||++|+++
T Consensus 220 ------~~~~~~~~s~~---~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 ------QVFFRQRVSSE---CQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ------CCCCSSCCCHH---HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------ccCCCCCCCHH---HHHHHHHHccCCHhHCcCHHHHhc
Confidence 01112223344 456777999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-44 Score=367.48 Aligned_cols=258 Identities=25% Similarity=0.361 Sum_probs=193.3
Q ss_pred ccCCCcCCcccccCceeEEEeec-cC-CcceeEeeccccCch--hHHHHHHHHHHHhhC---CCCceeeecceeec----
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRL-SH-GQEIAVKRLSKNSVQ--GELEFKNEVLLVARL---QHRNLVRLLGFSFE---- 391 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~-~~-g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~g~~~~---- 391 (650)
.++|++.++||+|+||+||+++. .+ ++.||||+++..... ....+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999986 34 567999998654322 222456777776665 89999999998853
Q ss_pred -CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeee
Q 006317 392 -ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDF 470 (650)
Q Consensus 392 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DF 470 (650)
....+++|||+.++++...... ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 3467899999998877654432 4567999999999999999999999987 999999999999999999999999
Q ss_pred ecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHh----
Q 006317 471 GMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKN---- 546 (650)
Q Consensus 471 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~---- 546 (650)
|+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+.+......
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLP 234 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCC
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCC
Confidence 999765422 233456799999999999999999999999999999999999999864322 1222111111
Q ss_pred ----ccCCCc-c-ccc----Cc---cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 547 ----WNEGTA-L-NLI----DP---TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 547 ----~~~~~~-~-~~i----d~---~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
+..... . ... .. .+..... ..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s---~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDID---ELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC---HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhcccccccchhhhhccccccchhhccccCC---HHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 0 000 00 0011112 23456778999999999999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=359.48 Aligned_cols=266 Identities=20% Similarity=0.309 Sum_probs=194.9
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccC--chhHHHHHHHHHHHhhCCCCceeeecceeec--------C
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNS--VQGELEFKNEVLLVARLQHRNLVRLLGFSFE--------E 392 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--------~ 392 (650)
++|++.++||+|+||+||+|+. .+|+.||||++.... ......+.+|+.+|++++||||+++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6899999999999999999986 468999999986542 2334568899999999999999999998755 3
Q ss_pred CeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeec
Q 006317 393 TERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472 (650)
Q Consensus 393 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 472 (650)
...++||||+.++++..+.. ....++...+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 46789999999887765443 4567899999999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCC--CCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccC
Q 006317 473 ARLFEMDQS--QGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNE 549 (650)
Q Consensus 473 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 549 (650)
++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.....................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 986653322 1223335799999999998765 6899999999999999999999998633222211111111111111
Q ss_pred CCccc--------ccCccCCC-CCh-HH------HHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 550 GTALN--------LIDPTLRN-GSS-SE------IMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 550 ~~~~~--------~id~~l~~-~~~-~~------~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
..... .+...... ... +. ...+++++.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 11000 00000000 011 11 1244578889999999999999999865
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=363.58 Aligned_cols=259 Identities=22% Similarity=0.314 Sum_probs=190.7
Q ss_pred CCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeecceeecC------CeeEE
Q 006317 325 NFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLLGFSFEE------TERLL 397 (650)
Q Consensus 325 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 397 (650)
+|+..++||+|+||+||+|+.. +|+.||||++...... +.+|+.+|++++||||+++++++... ...+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5778899999999999999965 5899999999765322 34799999999999999999998543 34689
Q ss_pred EEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC-CeEEeeeeccccc
Q 006317 398 IYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLF 476 (650)
Q Consensus 398 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~ 476 (650)
||||++++.+..+.........+++.++..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987655554433335667999999999999999999999987 99999999999999875 8999999999876
Q ss_pred ccCCCCCccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHH--------HHHHhc
Q 006317 477 EMDQSQGDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLT--------YAWKNW 547 (650)
Q Consensus 477 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~--------~~~~~~ 547 (650)
.... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+. ..+...
T Consensus 174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 5332 2234579999999998875 578999999999999999999999986433211111000 011111
Q ss_pred cCCCcccccCccCC------CCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 548 NEGTALNLIDPTLR------NGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 548 ~~~~~~~~id~~l~------~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
..... +..-+.+. .........+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 251 NPNYT-EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CC----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchh-hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11000 00000000 001111234556777999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=356.83 Aligned_cols=255 Identities=23% Similarity=0.302 Sum_probs=189.3
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCC-----
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEET----- 393 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 393 (650)
..++|+..++||+|+||+||+|+. .+|+.||||+++.... .....+.+|+.+|++++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 357899999999999999999985 4589999999976432 23456889999999999999999999987654
Q ss_pred -eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeec
Q 006317 394 -ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGM 472 (650)
Q Consensus 394 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGl 472 (650)
..++||||+ +.+|..++. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 569999999 557776653 457999999999999999999999988 99999999999999999999999999
Q ss_pred ccccccCCCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC-
Q 006317 473 ARLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG- 550 (650)
Q Consensus 473 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~- 550 (650)
++..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.|+...... +.+..........
T Consensus 168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTGTPP 239 (346)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCC
T ss_pred eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH---HHHHHHHhccCCCc
Confidence 9865422 2345799999999998764 5789999999999999999999998643211 1111110000000
Q ss_pred ----------C-------cccccCc---cCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 551 ----------T-------ALNLIDP---TLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 551 ----------~-------~~~~id~---~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
. ..+.-.. .+..... ..+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s---~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNAS---PLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCC---HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhcchhhhhhhccCCcccccchHHhccCCC---HHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0000000 0011112 234567779999999999999999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8e-42 Score=350.32 Aligned_cols=259 Identities=18% Similarity=0.247 Sum_probs=194.2
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCceeeec-ceeecCCeeEEEEec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNLVRLL-GFSFEETERLLIYEF 401 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~-g~~~~~~~~~lv~e~ 401 (650)
++|++.+.||+|+||.||+|+. .+|+.||||++...... .++..|++++++++|+|++..+ .+..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5699999999999999999986 45889999998765332 3578899999999887766555 455677888999999
Q ss_pred CCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC---CCCeEEeeeeccccccc
Q 006317 402 VPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA---DMIPKISDFGMARLFEM 478 (650)
Q Consensus 402 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~---~~~~kl~DFGla~~~~~ 478 (650)
+. ++|.+.+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++. +..+||+|||+++.+..
T Consensus 85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 95 566665543 4567999999999999999999999988 999999999999864 55799999999997754
Q ss_pred CCCC-----CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcc
Q 006317 479 DQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553 (650)
Q Consensus 479 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 553 (650)
.... .......||+.|||||.+.+..++.++|||||||++|||+||+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-- 236 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-- 236 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC--
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC--
Confidence 3322 223456899999999999999999999999999999999999999975433332222211111000000
Q ss_pred cccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 554 NLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 554 ~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
.+.+....+++ +.+++..||+.+|++||+++++.+.|+.
T Consensus 237 ---~~~~~~~~p~~---~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 237 ---IEVLCKGYPSE---FATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp ---HHHHTTTSCHH---HHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred ---hhHhccCCCHH---HHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 01111223333 4456668999999999999999888764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=360.97 Aligned_cols=264 Identities=21% Similarity=0.273 Sum_probs=195.4
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCc-hhHHHHHHHHHHHhhCCCCceeeecceeecCC----ee
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV-QGELEFKNEVLLVARLQHRNLVRLLGFSFEET----ER 395 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~ 395 (650)
.+.+|+..++||+|+||+||+|+. .+|+.||||++.+... .....+.+|+.+|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 346799999999999999999985 5689999999976543 33456889999999999999999999987643 34
Q ss_pred EEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccc
Q 006317 396 LLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARL 475 (650)
Q Consensus 396 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~ 475 (650)
+++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.
T Consensus 86 ~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 556667789999999853 46999999999999999999999987 99999999999999999999999999986
Q ss_pred cccCCCC-CccceeecCccccChhcccc-CCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCcc
Q 006317 476 FEMDQSQ-GDTSRIVGTFGYMAPEYVTR-GHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTAL 553 (650)
Q Consensus 476 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 553 (650)
....... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||...... +...............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~---~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL---DQLNHILGILGSPSQE 235 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH---HHHHHHhhhccCCChh
Confidence 6443222 23445679999999999854 56789999999999999999999998643221 1111111111000000
Q ss_pred -----------c--ccCccCCCCChHH-----HHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 554 -----------N--LIDPTLRNGSSSE-----IMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 554 -----------~--~id~~l~~~~~~~-----~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
. ...+......... ..++.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000000001110 1346678889999999999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.2e-41 Score=345.65 Aligned_cols=260 Identities=15% Similarity=0.223 Sum_probs=202.5
Q ss_pred ccCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCchhHHHHHHHHHHHhhCCC-CceeeecceeecCCeeEEEEe
Q 006317 323 TNNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH-RNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 323 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e 400 (650)
.++|++.++||+|+||+||+|+.. +|+.||||++..... ...+.+|++.+..++| +|++.+++++..+...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 367999999999999999999854 588999999865432 2246789999999975 899999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCC-----CCCeEEeeeecccc
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDA-----DMIPKISDFGMARL 475 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~-----~~~~kl~DFGla~~ 475 (650)
|+ +++|.+++.. ....+++.++..++.|++.||+|||+.+ |+||||||+||||+. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 6899988864 3457999999999999999999999988 999999999999974 57899999999997
Q ss_pred cccCCCC-----CccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC
Q 006317 476 FEMDQSQ-----GDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG 550 (650)
Q Consensus 476 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 550 (650)
+...... .......||+.|||||++.+..++.++|||||||++|||+||+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 6543221 22345679999999999999999999999999999999999999997544333322222111110000
Q ss_pred CcccccCccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHHHhcC
Q 006317 551 TALNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVVMLNS 598 (650)
Q Consensus 551 ~~~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~L~~ 598 (650)
...+ +....+++ +.+++..|++.+|++||+++.+.+.|+.
T Consensus 236 ~~~~-----l~~~~p~~---l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 236 PLRE-----LCAGFPEE---FYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp CHHH-----HTTTSCHH---HHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ChHH-----hcCCCCHH---HHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 0001 11222334 4456668999999999999988877653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=347.06 Aligned_cols=261 Identities=22% Similarity=0.301 Sum_probs=200.9
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeecCCeeEEEEe
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFEETERLLIYE 400 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 400 (650)
++|+..++||+|+||+||+|+. .+++.||||+++.... .....+.+|+.++++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4789999999999999999996 4688899999865432 334578999999999999999999999999999999999
Q ss_pred cCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecccccccCC
Q 006317 401 FVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMARLFEMDQ 480 (650)
Q Consensus 401 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~~~~~~~ 480 (650)
++.+++|..++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999888775 4567899999999999999999999987 9999999999999999999999999998765332
Q ss_pred CCCccceeecCccccChhccccCC-CCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCC---c---c
Q 006317 481 SQGDTSRIVGTFGYMAPEYVTRGH-FSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGT---A---L 553 (650)
Q Consensus 481 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~---~ 553 (650)
. ......++..|+|||.+.... ++.++|||||||++|||++|+.|+.... ...+............. . .
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC--CHHHHHHHHHhhcCCCChhhhhhhh
Confidence 2 223345788999999987665 6899999999999999999999975322 22222222211111100 0 0
Q ss_pred cccC----------ccCCCCChHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 554 NLID----------PTLRNGSSSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 554 ~~id----------~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
+..+ .............+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0000011111234567778999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=351.92 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=197.9
Q ss_pred cCCCcCCcccccCceeEEEeec----cCCcceeEeeccccCc----hhHHHHHHHHHHHhhCCC-CceeeecceeecCCe
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL----SHGQEIAVKRLSKNSV----QGELEFKNEVLLVARLQH-RNLVRLLGFSFEETE 394 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~ 394 (650)
++|++.++||+|+||+||+|+. .+|+.||||++++... .....+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999974 2478899999875422 233467899999999976 899999999999999
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.+++|||+.+|+|.+++.. ...++......++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999874 456788999999999999999999987 9999999999999999999999999998
Q ss_pred ccccCCCCCccceeecCccccChhccccC--CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCCCc
Q 006317 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRG--HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEGTA 552 (650)
Q Consensus 475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 552 (650)
.+..... .......|++.|++||.+.+. .++.++|||||||+||||++|+.||......+....+...... .
T Consensus 178 ~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~--~--- 251 (322)
T d1vzoa_ 178 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--S--- 251 (322)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--C---
T ss_pred hhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc--C---
Confidence 7653322 223345799999999998764 4688999999999999999999998754433322222111111 0
Q ss_pred ccccCccCCCCChHHHHHHHHHHhcccccCCCCCC-----CHHHHHH
Q 006317 553 LNLIDPTLRNGSSSEIMRCVHIGLLCVQENVANRP-----TMASVVV 594 (650)
Q Consensus 553 ~~~id~~l~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----t~~evl~ 594 (650)
.+.+....++ ++.+++.+||+.||++|| |++|+++
T Consensus 252 ----~~~~~~~~s~---~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 ----EPPYPQEMSA---LAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----CCCCCTTSCH---HHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----CCCCcccCCH---HHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1112222333 445566799999999999 4788875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.9e-41 Score=346.74 Aligned_cols=255 Identities=17% Similarity=0.275 Sum_probs=192.9
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCC-CCceeeecceeec--CCeeEEEE
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFE--ETERLLIY 399 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lv~ 399 (650)
++|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+|+.+|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999986 468999999997543 346889999999995 9999999999874 45689999
Q ss_pred ecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCC-CeEEeeeeccccccc
Q 006317 400 EFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADM-IPKISDFGMARLFEM 478 (650)
Q Consensus 400 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~-~~kl~DFGla~~~~~ 478 (650)
||+.+++|..+. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987653 35999999999999999999999998 99999999999998765 699999999987653
Q ss_pred CCCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhH-----------HHHHHh
Q 006317 479 DQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLL-----------TYAWKN 546 (650)
Q Consensus 479 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~-----------~~~~~~ 546 (650)
.. ......||+.|+|||.+.+. .++.++||||+|++++||++|+.|+............ .+. ..
T Consensus 183 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~-~~ 258 (328)
T d3bqca1 183 GQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI-DK 258 (328)
T ss_dssp TC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH-HH
T ss_pred CC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh-hh
Confidence 32 23445789999999998765 4799999999999999999999998643322111000 000 00
Q ss_pred ccCCCccc---cc--------CccCCCCC-hHHHHHHHHHHhcccccCCCCCCCHHHHHH
Q 006317 547 WNEGTALN---LI--------DPTLRNGS-SSEIMRCVHIGLLCVQENVANRPTMASVVV 594 (650)
Q Consensus 547 ~~~~~~~~---~i--------d~~l~~~~-~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~ 594 (650)
........ .. ........ .....++.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000 00 00000000 111134567788999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-40 Score=349.81 Aligned_cols=260 Identities=23% Similarity=0.244 Sum_probs=187.3
Q ss_pred cCCCcCCcccccCceeEEEeecc-CCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeec------CCe
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRLS-HGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFE------ETE 394 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~ 394 (650)
++|++.++||+|+||+||+|+.. +|+.||||++..... .....+.+|+.++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999864 589999999976532 333468899999999999999999999864 367
Q ss_pred eEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 395 RLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 395 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.++||||+.++.+.. + ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~-~-----~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-I-----QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHH-H-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHh-h-----hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 899999997765543 3 245899999999999999999999998 9999999999999999999999999988
Q ss_pred ccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHH--------HHHh
Q 006317 475 LFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTY--------AWKN 546 (650)
Q Consensus 475 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~--------~~~~ 546 (650)
..... .......||+.|+|||++.+..++.++||||+||+++||++|+.||.............. .|..
T Consensus 168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 65432 233455789999999999999999999999999999999999999863321111000000 0000
Q ss_pred c--------c------CCCcccccCccCCCC----ChHHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 547 W--------N------EGTALNLIDPTLRNG----SSSEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 547 ~--------~------~~~~~~~id~~l~~~----~~~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
. . .......+....... .......+.+++.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0 000011111111111 11223456788999999999999999999844
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-41 Score=350.21 Aligned_cols=259 Identities=24% Similarity=0.303 Sum_probs=192.4
Q ss_pred hccCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCc--hhHHHHHHHHHHHhhCCCCceeeecceeec-----CC
Q 006317 322 ATNNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSV--QGELEFKNEVLLVARLQHRNLVRLLGFSFE-----ET 393 (650)
Q Consensus 322 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~ 393 (650)
.+++|+..++||+|+||+||+|+. .+|+.||||++++... .....+.+|+.+|++++|||||++++++.. ..
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 357899999999999999999985 5699999999976532 334568899999999999999999999863 33
Q ss_pred eeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEeeeecc
Q 006317 394 ERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKISDFGMA 473 (650)
Q Consensus 394 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla 473 (650)
..+++++|+.+|+|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 4567788889999999884 346999999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCCccceeecCccccChhccccC-CCCccccccchhHHHHHHHhCCCCCCCCCCcccchhHHHHHHhccCC--
Q 006317 474 RLFEMDQSQGDTSRIVGTFGYMAPEYVTRG-HFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDLLTYAWKNWNEG-- 550 (650)
Q Consensus 474 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-- 550 (650)
..... ......||..|+|||.+.+. .++.++|||||||++|||++|+.||....... ............
T Consensus 169 ~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~---~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 169 RHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGA 240 (348)
T ss_dssp -CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCH
T ss_pred cccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCh
Confidence 75432 23345789999999987765 46899999999999999999999986432211 111111110000
Q ss_pred ---------CcccccCc--cCCCCCh-----HHHHHHHHHHhcccccCCCCCCCHHHHHHH
Q 006317 551 ---------TALNLIDP--TLRNGSS-----SEIMRCVHIGLLCVQENVANRPTMASVVVM 595 (650)
Q Consensus 551 ---------~~~~~id~--~l~~~~~-----~~~~~~~~l~~~Cl~~~p~~RPt~~evl~~ 595 (650)
........ ....... .....+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000000 0000000 011345677889999999999999999863
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-36 Score=317.40 Aligned_cols=263 Identities=19% Similarity=0.213 Sum_probs=190.5
Q ss_pred cCCCcCCcccccCceeEEEeec-cCCcceeEeeccccCchhHHHHHHHHHHHhhCC-----------CCceeeecceeec
Q 006317 324 NNFSTDNKLGQGGFGAVYKGRL-SHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-----------HRNLVRLLGFSFE 391 (650)
Q Consensus 324 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~ 391 (650)
++|++.++||+|+||+||+|+. .+|+.||||++++.... ...+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~-~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH-HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc-hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999986 46999999999765432 346788998888775 5789999988764
Q ss_pred --CCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhh-cCCCcEEecCCCCCceEeCCCCC----
Q 006317 392 --ETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDADMI---- 464 (650)
Q Consensus 392 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlk~~NILl~~~~~---- 464 (650)
....+++|+++..+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 34566777777666544444444456779999999999999999999998 55 999999999999987653
Q ss_pred --eEEeeeecccccccCCCCCccceeecCccccChhccccCCCCccccccchhHHHHHHHhCCCCCCCCCCcccchh---
Q 006317 465 --PKISDFGMARLFEMDQSQGDTSRIVGTFGYMAPEYVTRGHFSIKSDVFSFGVLVLEIISGQKNNSFRIGEEAEDL--- 539 (650)
Q Consensus 465 --~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~S~Gvll~elltG~~p~~~~~~~~~~~l--- 539 (650)
+|++|||.+..... ......||+.|+|||++....++.++||||+||+++||++|+.||...........
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 89999999975432 22345799999999999999999999999999999999999999864432211111
Q ss_pred HHHHHHhc------------------cCCCcccccCcc-----------CCCCChHHHHHHHHHHhcccccCCCCCCCHH
Q 006317 540 LTYAWKNW------------------NEGTALNLIDPT-----------LRNGSSSEIMRCVHIGLLCVQENVANRPTMA 590 (650)
Q Consensus 540 ~~~~~~~~------------------~~~~~~~~id~~-----------l~~~~~~~~~~~~~l~~~Cl~~~p~~RPt~~ 590 (650)
+....... ........+... ..........++.+++.+||+.||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 11000000 000000000000 0111334556788899999999999999999
Q ss_pred HHHHH
Q 006317 591 SVVVM 595 (650)
Q Consensus 591 evl~~ 595 (650)
|+++-
T Consensus 324 e~L~H 328 (362)
T d1q8ya_ 324 GLVNH 328 (362)
T ss_dssp HHHTC
T ss_pred HHhcC
Confidence 99864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=3.7e-23 Score=196.04 Aligned_cols=164 Identities=16% Similarity=0.181 Sum_probs=119.9
Q ss_pred CcCCcccccCceeEEEeeccCCcceeEeeccccCc------------------hhHHHHHHHHHHHhhCCCCceeeecce
Q 006317 327 STDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSV------------------QGELEFKNEVLLVARLQHRNLVRLLGF 388 (650)
Q Consensus 327 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g~ 388 (650)
.+.++||+|+||+||+|+..+|+.||||+++.... .......+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35689999999999999988899999998753210 011235578889999999999887755
Q ss_pred eecCCeeEEEEecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhcCCCcEEecCCCCCceEeCCCCCeEEe
Q 006317 389 SFEETERLLIYEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHEDSRLRIIHRDLKASNILLDADMIPKIS 468 (650)
Q Consensus 389 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NILl~~~~~~kl~ 468 (650)
. ..+++|||+++..+.+ +++.....++.|++++|+|||+.+ |+||||||+|||+++++ ++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence 3 2379999998865432 444556789999999999999987 99999999999999654 8999
Q ss_pred eeecccccccCCCCCccceeecCccccCh------hccccCCCCccccccchhHHHH
Q 006317 469 DFGMARLFEMDQSQGDTSRIVGTFGYMAP------EYVTRGHFSIKSDVFSFGVLVL 519 (650)
Q Consensus 469 DFGla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~s~~sDV~S~Gvll~ 519 (650)
|||++........ . .|... |. ..+.|+.++|+||..--++
T Consensus 145 DFG~a~~~~~~~~----~------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGW----R------EILERDVRNIITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTH----H------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCc----H------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence 9999975432111 0 11111 11 1356788999999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.44 E-value=2.4e-07 Score=89.88 Aligned_cols=146 Identities=17% Similarity=0.136 Sum_probs=97.9
Q ss_pred HhhccCCCcCCcccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCC-CCceeeecceeecCCeeEEE
Q 006317 320 RDATNNFSTDNKLGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQ-HRNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 320 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv 398 (650)
+..-..|+..+..+.+....||+... +++.++||+...........+.+|...+..+. +--+.+++.+...++..++|
T Consensus 10 ~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 33334555555544455578998865 56678889886654444445778888887764 43456777788888889999
Q ss_pred EecCCCCChhHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhhhc------------------------------------
Q 006317 399 YEFVPNSSVDKFIFDAIKRVQLDWETRYKIIGGIARGILYLHED------------------------------------ 442 (650)
Q Consensus 399 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------ 442 (650)
|+++++.++.+.... ......++.++++.|..||+.
T Consensus 89 ~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 89 MSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 999999887554321 111223445555555556542
Q ss_pred --------------------CCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 443 --------------------SRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 443 --------------------~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
....++|+|+.|.|||+++++..-|.||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 12238999999999999987777799998774
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.04 E-value=6.9e-06 Score=78.76 Aligned_cols=130 Identities=18% Similarity=0.170 Sum_probs=83.9
Q ss_pred cccccCc-eeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCC--CceeeecceeecCCeeEEEEecCCCCCh
Q 006317 331 KLGQGGF-GAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQH--RNLVRLLGFSFEETERLLIYEFVPNSSV 407 (650)
Q Consensus 331 ~LG~G~~-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~gsL 407 (650)
.+..|.. ..||+....++..+++|........ .+..|...++.+.. -.+.+++.+..+.+..++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4444543 6789998877888899986554322 35677777776643 3356678787888888999999988665
Q ss_pred hHHHHhhhccCCCCHHHHHHHHHHHHHHHHHhh-----------------------------------------------
Q 006317 408 DKFIFDAIKRVQLDWETRYKIIGGIARGILYLH----------------------------------------------- 440 (650)
Q Consensus 408 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH----------------------------------------------- 440 (650)
.+.. +.. ..++.++++.|.-||
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3210 000 011122222222222
Q ss_pred ----hc----CCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 441 ----ED----SRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 441 ----~~----~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.. ..+.++|+|+.|.|||++++..+-|.||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11 22348999999999999988777899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.38 E-value=0.00033 Score=71.45 Aligned_cols=75 Identities=13% Similarity=0.123 Sum_probs=45.9
Q ss_pred CcccccCceeEEEeeccC-CcceeEeecccc------Cch-hHHHHHHHHHHHhhCC-C--CceeeecceeecCCeeEEE
Q 006317 330 NKLGQGGFGAVYKGRLSH-GQEIAVKRLSKN------SVQ-GELEFKNEVLLVARLQ-H--RNLVRLLGFSFEETERLLI 398 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~-g~~vavK~l~~~------~~~-~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~lv 398 (650)
+.||.|....||+....+ ++.++||.-... ... .......|.+.+..+. + ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998755 668899864321 111 1123445777776552 2 334555543 45567899
Q ss_pred EecCCCCC
Q 006317 399 YEFVPNSS 406 (650)
Q Consensus 399 ~e~~~~gs 406 (650)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.79 E-value=0.0027 Score=62.57 Aligned_cols=134 Identities=16% Similarity=0.170 Sum_probs=76.9
Q ss_pred eeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCce--eeecc-----eeecCCeeEEEEecCCCCChh--
Q 006317 338 GAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL--VRLLG-----FSFEETERLLIYEFVPNSSVD-- 408 (650)
Q Consensus 338 g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g-----~~~~~~~~~lv~e~~~~gsL~-- 408 (650)
-.||+...++|+.+++|+..... ....++..|+..+..|...++ +..+. ....++..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 47999999999999999986543 244567788888877743222 11111 233456678899998764321
Q ss_pred ---HH---------HHhhh------ccCCCCHH----------------------HHHHHHHHHHHHHHHh-hhcCCCcE
Q 006317 409 ---KF---------IFDAI------KRVQLDWE----------------------TRYKIIGGIARGILYL-HEDSRLRI 447 (650)
Q Consensus 409 ---~~---------l~~~~------~~~~l~~~----------------------~~~~i~~~ia~~L~yL-H~~~~~~i 447 (650)
.+ ++... .+..+++. ....++..+...+.-+ .+.....+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 11 01100 01112221 1112222222222221 22234568
Q ss_pred EecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 448 IHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 448 iHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
||+|+.+.|||++++ ..+.||+-+.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ecCCCCcccEEEeCC--ceEEechhcc
Confidence 999999999999754 4578998775
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.18 E-value=0.0053 Score=62.13 Aligned_cols=72 Identities=18% Similarity=0.289 Sum_probs=47.1
Q ss_pred CcccccCceeEEEeeccCC--------cceeEeeccccCchhHHHHHHHHHHHhhCCCCce-eeecceeecCCeeEEEEe
Q 006317 330 NKLGQGGFGAVYKGRLSHG--------QEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL-VRLLGFSFEETERLLIYE 400 (650)
Q Consensus 330 ~~LG~G~~g~Vy~~~~~~g--------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e 400 (650)
+.|+.|-.=.+|+....++ +.|.+++... ........+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5678788889999876543 3456665542 2233456788888888753344 466666543 68999
Q ss_pred cCCCCCh
Q 006317 401 FVPNSSV 407 (650)
Q Consensus 401 ~~~~gsL 407 (650)
|+++.+|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.99 E-value=0.028 Score=54.46 Aligned_cols=157 Identities=14% Similarity=0.095 Sum_probs=79.5
Q ss_pred ChhhHHhhccCCCcCCc-----ccccCceeEEEeeccCCcceeEeeccccCchhHHHHHHHHHHHhhCCCCce-----ee
Q 006317 315 DFSTIRDATNNFSTDNK-----LGQGGFGAVYKGRLSHGQEIAVKRLSKNSVQGELEFKNEVLLVARLQHRNL-----VR 384 (650)
Q Consensus 315 ~~~~~~~~~~~f~~~~~-----LG~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-----v~ 384 (650)
+.++++..-.+|..++. |..|---+.|+.+..+| .+++|+....... .++..|+.++..|...++ +.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~--~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK--NDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C--CHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCH--HHHHHHHHHHHhhhhccccccccce
Confidence 34556666666766544 34565677899887655 5899998653222 234456666666643222 11
Q ss_pred ec-c--eeecCCeeEEEEecCCCCChhHH--------------HHhhhcc------CCC------------------CHH
Q 006317 385 LL-G--FSFEETERLLIYEFVPNSSVDKF--------------IFDAIKR------VQL------------------DWE 423 (650)
Q Consensus 385 l~-g--~~~~~~~~~lv~e~~~~gsL~~~--------------l~~~~~~------~~l------------------~~~ 423 (650)
.. | +.........++.+..+...... ++..... ... ...
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11 1 11223455666766655432110 0000000 000 001
Q ss_pred HHHHHHHHHHHHHHHhhh-cCCCcEEecCCCCCceEeCCCCCeEEeeeeccc
Q 006317 424 TRYKIIGGIARGILYLHE-DSRLRIIHRDLKASNILLDADMIPKISDFGMAR 474 (650)
Q Consensus 424 ~~~~i~~~ia~~L~yLH~-~~~~~iiHrDlk~~NILl~~~~~~kl~DFGla~ 474 (650)
.....+..+...+.-.+. .-+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111222222222333222 123469999999999999998877899999874
|